An estimate of the bulk viscosity of the hadronic medium

NASA Astrophysics Data System (ADS)

Sarwar, Golam; Chatterjee, Sandeep; Alam, Jane

2017-05-01

The bulk viscosity (ζ) of the hadronic medium has been estimated within the ambit of the Hadron Resonance Gas (HRG) model including the Hagedorn density of states. The HRG thermodynamics within a grand canonical ensemble provides the mean hadron number as well as its fluctuation. The fluctuation in the chemical composition of the hadronic medium in the grand canonical ensemble can result in non-zero divergence of the hadronic fluid flow velocity, allowing us to estimate the ζ of the hadronic matter up to a relaxation time. We study the influence of the hadronic spectrum on ζ and find its correlation with the conformal symmetry breaking measure, ε -3P. We estimate ζ along the contours with constant, S/{N}B (total entropy/net baryon number) in the T-μ plane (temperature-baryonic chemical potential) for S/{N}B=30,45 and 300. We also assess the value of ζ on the chemical freeze-out curve for various centers of mass energy (\\sqrt{{s}{NN}}) and find that the bulk viscosity to entropy density ratio, \\zeta /s is larger in the energy range of the beam energy scan program of RHIC, low energy SPS run, AGS, NICA and FAIR, than LHC energies.

Confinement and hadron-hadron interactions by general relativistic methods

NASA Astrophysics Data System (ADS)

Recami, Erasmo

By postulating covariance of physical laws under global dilations, one can describe gravitational and strong interactions in a unified way. Namely, in terms of the new discrete dilational degree of freedom, our cosmos and hadrons can be regarded as finite, similar systems. And a discrete hierarchy of finite ``universes'' may be defined, which are governed by fields with strengths inversally proportional to their radii; in each universe an Equivalence Principle holds, so that the relevant field can be there geometrized. Scaled-down Einstein equations -with cosmological term- are assumed to hold inside hadrons (= strong micro-cosmoses); and they yield in a natural way classical confinement, as well as ``asymptotic freedom'', of the hadron constituents. In other words, the association of strong micro-universes of Friedmann type with hadrons (i.e., applying the methods of General Relativity to subnuclear particle physics) allows avoiding recourse to phenomenological models such as the Bag Model. Inside hadrons we have to deal with a tensorial field (= strong gravity), and hadron constituents are supposed to exchange spin-2 ``gluons''. Our approach allows us also to write down a tensorial, bi-scale field theory of hadron-hadron interactions, based on modified Einstein-type equations here proposed for strong interactions in our space. We obtain in particular: (i) the correct Yukawa behaviour of the strong scalar potential at the static limit and for r>~l fm; (ii) the value of hadron radii. As a byproduct, we derive a whole ``numerology'', connecting our gravitational cosmos with the strong micro-cosmoses (hadrons), such that it does imply no variation of G with the epoch. Finally, since a structute of the ``micro-universe'' type seems to be characteristic even of leptons, a hope for the future is including also weak interactions in our classical unification of the fundamental forces.

Hadronic molecules

NASA Astrophysics Data System (ADS)

Guo, Feng-Kun; Hanhart, Christoph; Meißner, Ulf-G.; Wang, Qian; Zhao, Qiang; Zou, Bing-Song

2018-01-01

A large number of experimental discoveries especially in the heavy quarkonium sector that did not meet the expectations of the until then very successful quark model led to a renaissance of hadron spectroscopy. Among various explanations of the internal structure of these excitations, hadronic molecules, being analogs of light nuclei, play a unique role since for those predictions can be made with controlled uncertainty. Experimental evidence of various candidates of hadronic molecules and methods of identifying such structures are reviewed. Nonrelativistic effective field theories are the suitable framework for studying hadronic molecules and are discussed in both the continuum and finite volumes. Also pertinent lattice QCD results are presented. Further, the production mechanisms and decays of hadronic molecules are discussed and comments are given on the reliability of certain assertions often made in the literature.

Measurement of the hadronic final state in deep inelastic scattering at HERA

NASA Astrophysics Data System (ADS)

Ahmed, T.; Andreev, V.; Andrieu, B.; Arpagaus, M.; Babaev, A.; Bärwolff, H.; Bán, J.; Baranov, P.; Barrelet, E.; Bartel, W.; Bassler, U.; Beck, G. A.; Beck, H. P.; Behrend, H.-J.; Belousov, A.; Berger, Ch.; Bergstein, H.; Bernardi, G.; Bernet, R.; Berthon, U.; Bertrand-Coremans, G.; Besançon, M.; Biddulph, P.; Binder, E.; Bizot, J. C.; Blobel, V.; Borras, K.; Bosetti, P. C.; Boudry, V.; Bourdarios, C.; Brasse, F.; Braun, U.; Braunschweig, W.; Brisson, V.; Bruncko, D.; Bürger, J.; Büsser, F. W.; Buniatian, A.; Burke, S.; Buschhorn, G.; Campbell, A. J.; Carli, T.; Charles, F.; Clarke, D.; Clegg, A. B.; Colombo, M.; Coughlan, J. A.; Courau, A.; Coutures, Ch.; Cozzika, G.; Criegee, L.; Cvach, J.; Dainton, J. B.; Danilov, M.; Dann, A. W. E.; Dau, W. D.; David, M.; Deffur, E.; Delcourt, B.; Del Buono, L.; Devel, M.; De Roeck, A.; Dingus, P.; Dollfus, C.; Dowell, J. D.; Dreis, H. B.; Drescher, A.; Duboc, J.; Düllmann, D.; Dünger, O.; Duhm, H.; Eberle, M.; Ebert, J.; Ebert, T. R.; Eckerlin, G.; Efremenko, V.; Egli, S.; Eichenberger, S.; Eichler, R.; Eisele, F.; Eisenhandler, E.; Ellis, N. N.; Ellison, R. J.; Elsen, E.; Erdmann, M.; Evrard, E.; Favart, L.; Fedotov, A.; Feeken, D.; Felst, R.; Feltesse, J.; Feng, Y.; Fensome, I. F.; Ferencei, J.; Ferrarotto, F.; Flauger, W.; Fleischer, M.; Flower, P. S.; Flügge, G.; Fomenko, A.; Fominykh, B.; Forbush, M.; Formánek, J.; Foster, J. M.; Franke, G.; Fretwurst, E.; Fuhrmann, P.; Gabathuler, E.; Gamerdinger, K.; Garvey, J.; Gayler, J.; Gellrich, A.; Gennis, M.; Gensch, U.; Genzel, H.; Gerhards, R.; Gillespie, D.; Godfrey, L.; Goerlach, U.; Goerlich, L.; Goldberg, M.; Goodall, A. M.; Gorelov, I.; Goritchev, P.; Grab, C.; Grässler, H.; Grässler, R.; Greenshaw, T.; Greif, H.; Grindhammer, G.; Gruber, C.; Haack, J.; Haidt, D.; Hajduk, L.; Hamon, O.; Handschuh, D.; Hanlon, E. M.; Hapke, M.; Haries, J.; Hartz, P.; Haydar, R.; Haynes, W. J.; Heatherington, J.; Hedberg, V.; Hedgecock, R.; Heinzelmann, G.; Henderson, R. C. W.; Henschel, H.; Herma, R.; Herynek, I.; Hildesheim, W.; Hill, P.; Hilton, C. D.; Hladký, J.; Hoeger, K. C.; Huet, Ph.; Hufnagel, H.; Huot, N.; Ibbotson, M.; Jabiol, M. A.; Jacholkowska, A.; Jacobsson, C.; Jaffre, M.; Jöhnsson, L.; Johannsen, K.; Johnson, D. P.; Johnson, L.; Jung, H.; Kalmus, P. I. P.; Kasarian, S.; Kaschowitz, R.; Kasselmann, P.; Kathage, U.; Kaufmann, H. H.; Kenyon, I. R.; Kermiche, S.; Kiesling, C.; Klein, M.; Kleinwort, C.; Knies, G.; Köhler, T.; Kolanoski, H.; Kole, F.; Kolya, S. D.; Korbel, V.; Korn, M.; Kostka, P.; Kotelnikov, S. K.; Krasny, M. W.; Krehbiel, H.; Krücker, D.; Krüger, U.; Kubenka, J. P.; Küster, H.; Kuhlen, M.; Kurça, T.; Kurzhöfer, J.; Kuznik, B.; Lander, R.; London, M. P. J.; Langkau, R.; Lanius, P.; Laporte, J. F.; Lebedev, A.; Lebedev, A.; Leuschner, A.; Leverenz, C.; Levin, D.; Levonian, S.; Ley, Ch.; Lindner, A.; Lindström, G.; Loch, P.; Lohmander, H.; Lopez, G. C.; Lüers, D.; Magnussen, N.; Malinovski, E.; Mani, S.; Marage, P.; Marks, J.; Marshall, R.; Martens, J.; Martin, R.; Martyn, H.-U.; Martyniak, J.; Masson, S.; Mavroidis, A.; Maxfield, S. J.; McMahon, S. J.; Mehta, A.; Meier, K.; Merz, T.; Meyer, C. A.; Meyer, H.; Meyer, J.; Mikocki, S.; Milone, V.; Monnier, E.; Moreau, F.; Moreels, J.; Morris, J. V.; Morton, J. M.; Müller, K.; Murín, P.; Murray, S. A.; Nagovizin, V.; Naroska, B.; Naumann, Th.; Newton, D.; Nguyen, H. K.; Niebergall, F.; Nisius, R.; Nowak, G.; Noyes, G. W.; Nyberg, M.; Oberlack, H.; Obrock, U.; Olsson, J. E.; Orenstein, S.; Ould-Saada, F.; Pascaud, C.; Patel, G. D.; Peppel, E.; Peters, S.; Phillips, H. T.; Phillips, J. P.; Pichler, Ch.; Pilgram, W.; Pitzl, D.; Prosi, R.; Raupach, F.; Rauschnabel, K.; Reimer, P.; Ribarics, P.; Riech, V.; Riedlberger, J.; Rietz, M.; Robertson, S. M.; Robmann, P.; Roosen, R.; Rostovtsev, A.; Royon, C.; Rudowicz, M.; Ruffer, M.; Rusakov, S.; Rybicki, K.; Ryseck, E.; Sacton, J.; Sahlmann, N.; Sanchez, E.; Sankey, D. P. C.; Savitsky, M.; Schacht, P.; Schleper, P.; von Schlippe, W.; Schmidt, C.; Schmidt, D.; Schmitz, W.; Schröder, V.; Schulz, M.; Schwind, A.; Scobel, W.; Seehausen, U.; Sell, R.; Seman, M.; Semenov, A.; Shekelyan, V.; Sheviakov, I.; Shooshtari, H.; Siegmon, G.; Siewert, U.; Sirois, Y.; Skillicorn, I. O.; Smirnov, P.; Smith, J. R.; Smolik, L.; Soloviev, Y.; Spitzer, H.; Staroba, P.; Steenbock, M.; Steffen, P.; Steinberg, R.; Steiner, H.; Stella, B.; Stephens, K.; Stier, J.; Strachota, J.; Straumann, U.; Struczinski, W.; Sutton, J. P.; Taylor, R. E.; Thompson, G.; Thompson, R. J.; Tichomirov, I.; Trenkel, C.; Truöl, P.; Tchernyshov, V.; Turnau, J.; Tutas, J.; Urban, L.; Usik, A.; Valkar, S.; Valkarova, A.; Vallee, C.; Van Esch, P.; Vartapetian, A.; Vazdik, Y.; Vecko, M.; Verrecchia, P.; Vick, R.; Villet, G.; Vogel, E.; Wacker, K.; Walker, I. W.; Walther, A.; Weber, G.; Wegener, D.; Wegner, A.; Wellisch, H. P.; Willard, S.; Winde, M.; Winter, G.-G.; Wolff, Th.; Womersley, L. A.; Wright, A. E.; Wulff, N.; Yiou, T. P.; Ząçek, J.; Závada, P.; Zeitnitz, C.; Ziaeepour, H.; Zimmer, M.; Zimmermann, W.; Zomer, F.; H1 Collaboration

1993-01-01

We report on the first experimental study of the hadronic final state in deep inelastic electron-proton scattering with the H1 detector at HERA. Energy flow and transverse momentum characteristics are measured and presented both in the laboratory and in the hadronic center of mass frames. Comparison is made with QCD models distinguished by their different treatment of parton emission.

Role of particle radiotherapy in the management of head and neck cancer.

PubMed

Laramore, George E

2009-05-01

Modern imaging techniques and powerful computers allow a radiation oncologist to design treatments delivering higher doses of radiation than previously possible. Dose distributions imposed by the physics of 'standard' photon and electron beams limit further dose escalation. Hadron radiotherapy offers advantages in either dose distribution and/or improved radiobiology that may significantly improve the treatment of certain head and neck malignancies. Clinical studies support the effectiveness of fast-neutron radiotherapy in the treatment of major and minor salivary gland tumors. Data show highly favorable outcomes with proton radiotherapy for skull-base malignancies and tumors near highly critical normal tissues compared with that expected with standard radiotherapy. Heavy-ion radiotherapy clinical studies are mainly being conducted with fully stripped carbon ions, and limited data seem to indicate a possible improvement over proton radiotherapy for the same subset of radioresistant tumors where neutrons show a benefit over photons. Fast-neutron radiotherapy has different radiobiological properties compared with standard radiotherapy but similar depth dose distributions. Its role in the treatment of head and neck cancer is currently limited to salivary gland malignancies and certain radioresistant tumors such as sarcomas. Protons have the same radiobiological properties as standard radiotherapy beams but more optimal depth dose distributions, making it particularly advantageous when treating tumors adjacent to highly critical structures. Heavy ions combine the radiobiological properties of fast neutrons with the physical dose distributions of protons, and preliminary data indicate their utility for radioresistant tumors adjacent to highly critical structures.

Two-photon production of leptons at hadron colliders in semielastic and elastic cases

DOE Office of Scientific and Technical Information (OSTI.GOV)

Manko, A. Yu., E-mail: andrej.j.manko@gmail.com; Shulyakovsky, R. G., E-mail: shul@ifanbel.bas-net.by, E-mail: shulyakovsky@iaph.bas-net.by

The mechanism of two-photon dilepton production is studied in the equivalent-photon (Weizsäcker–Williams) approximation. This approximation is shown to describe well experimental data from hadron accelerators. The respective total and differential cross sections were obtained for the LHC and for the Tevatron collider at various energies of colliding hadrons. The differential cross sections were studied versus the dilepton invariant mass, transverse momentum, and emission angle in the reference frame comoving with the center of mass of colliding hadrons. The cases of semielastic and inelastic collisions were examined.

Black Holes and the Large Hadron Collider

ERIC Educational Resources Information Center

Roy, Arunava

2011-01-01

The European Center for Nuclear Research or CERN's Large Hadron Collider (LHC) has caught our attention partly due to the film "Angels and Demons." In the movie, an antimatter bomb attack on the Vatican is foiled by the protagonist. Perhaps just as controversial is the formation of mini black holes (BHs). Recently, the American Physical Society…

A beam monitor based on MPGD detectors for hadron therapy

NASA Astrophysics Data System (ADS)

Altieri, P. R.; Di Benedetto, D.; Galetta, G.; Intonti, R. A.; Mercadante, A.; Nuzzo, S.; Verwilligen, P.

2018-02-01

Remarkable scientific and technological progress during the last years has led to the construction of accelerator based facilities dedicated to hadron therapy. This kind of technology requires precise and continuous control of position, intensity and shape of the ions or protons used to irradiate cancers. Patient safety, accelerator operation and dose delivery should be optimized by a real time monitoring of beam intensity and profile during the treatment, by using non-destructive, high spatial resolution detectors. In the framework of AMIDERHA (AMIDERHA - Enhanced Radiotherapy with HAdron) project funded by the Ministero dell'Istruzione, dell'Università e della Ricerca (Italian Ministry of Education and Research) the authors are studying and developing an innovative beam monitor based on Micro Pattern Gaseous Detectors (MPDGs) characterized by a high spatial resolution and rate capability. The Monte Carlo simulation of the beam monitor prototype was carried out to optimize the geometrical set up and to predict the behavior of the detector. A first prototype has been constructed and successfully tested using 55Fe, 90Sr and also an X-ray tube. Preliminary results on both simulations and tests will be presented.

Test of Hadronic Interaction Models with the KASCADE Hadron Calorimeter

NASA Astrophysics Data System (ADS)

Milke, J.; KASCADE Collaboration

The interpretation of extensive air shower (EAS) measurements often requires the comparison with EAS simulations based on high-energy hadronic interaction models. These interaction models have to extrapolate into kinematical regions and energy ranges beyond the limit of present accelerators. Therefore, it is necessary to test whether these models are able to describe the EAS development in a consistent way. By measuring simultaneously the hadronic, electromagnetic, and muonic part of an EAS the experiment KASCADE offers best facilities for checking the models. For the EAS simulations the program CORSIKA with several hadronic event generators implemented is used. Different hadronic observables, e.g. hadron number, energy spectrum, lateral distribution, are investigated, as well as their correlations with the electromagnetic and muonic shower size. By comparing measurements and simulations the consistency of the description of the EAS development is checked. First results with the new interaction model NEXUS and the version II.5 of the model DPMJET, recently included in CORSIKA, are presented and compared with QGSJET simulations.

Hadron therapy: history, status, prospects

NASA Astrophysics Data System (ADS)

Klenov, G. I.; Khoroshkov, V. S.

2016-08-01

A brief historical review is given of external radiation therapy (RT), one of the main cancer treatment methods along with surgery and chemotherapy. Cellular mechanisms of radiation damage are described. Special attention is paid to hadron (proton and ion) therapy, its history, results, problems, challenges, current trends, and prospects. Undeniably great contributions to proton therapy have been made by Russian researchers, notably at the experimental centers that have operated since the mid-20th century at the Joint Institute for Nuclear Research, the A I Alikhanov Institute for Theoretical and Experimental Physics (ITEP), and the B P Konstantinov Petersburg Institute of Nuclear Physics. A quarter of the global clinical experience was accumulated by 1990 at the world's largest ITEP-hosted multicabin proton therapy center.

Measurement of the total hadronic cross section in e+e- annihilation below 10.56GeV

NASA Astrophysics Data System (ADS)

Besson, D.; Pedlar, T. K.; Cronin-Hennessy, D.; Gao, K. Y.; Hietala, J.; Klein, T.; Kubota, Y.; Lang, B. W.; Poling, R.; Scott, A. W.; Smith, A.; Zweber, P.; Dobbs, S.; Metreveli, Z.; Seth, K. K.; Tomaradze, A.; Ernst, J.; Ecklund, K. M.; Severini, H.; Dytman, S. A.; Love, W.; Savinov, V.; Aquines, O.; Lopez, A.; Mehrabyan, S.; Mendez, H.; Ramirez, J.; Huang, G. S.; Miller, D. H.; Pavlunin, V.; Sanghi, B.; Shipsey, I. P. J.; Xin, B.; Adams, G. S.; Anderson, M.; Cummings, J. P.; Danko, I.; Hu, D.; Moziak, B.; Napolitano, J.; He, Q.; Insler, J.; Muramatsu, H.; Park, C. S.; Thorndike, E. H.; Yang, F.; Artuso, M.; Blusk, S.; Butt, J.; Li, J.; Menaa, N.; Mountain, R.; Nisar, S.; Randrianarivony, K.; Sia, R.; Skwarnicki, T.; Stone, S.; Wang, J. C.; Zhang, K.; Bonvicini, G.; Cinabro, D.; Dubrovin, M.; Lincoln, A.; Asner, D. M.; Edwards, K. W.; Naik, P.; Briere, R. A.; Ferguson, T.; Tatishvili, G.; Vogel, H.; Watkins, M. E.; Rosner, J. L.; Adam, N. E.; Alexander, J. P.; Berkelman, K.; Cassel, D. G.; Duboscq, J. E.; Ehrlich, R.; Fields, L.; Galik, R. S.; Gibbons, L.; Gray, R.; Gray, S. W.; Hartill, D. L.; Heltsley, B. K.; Hertz, D.; Jones, C. D.; Kandaswamy, J.; Kreinick, D. L.; Kuznetsov, V. E.; Mahlke-Krüger, H.; Mohapatra, D.; Onyisi, P. U. E.; Patterson, J. R.; Peterson, D.; Pivarski, J.; Riley, D.; Ryd, A.; Sadoff, A. J.; Schwarthoff, H.; Shi, X.; Stroiney, S.; Sun, W. M.; Wilksen, T.; Athar, S. B.; Patel, R.; Potlia, V.; Yelton, J.; Rubin, P.; Cawlfield, C.; Eisenstein, B. I.; Karliner, I.; Kim, D.; Lowrey, N.; Selen, M.; White, E. J.; Wiss, J.; Mitchell, R. E.; Shepherd, M. R.

2007-10-01

Using the CLEO III detector, we measure absolute cross sections for e+e-→hadrons at seven center-of-mass energies between 6.964 and 10.538 GeV. The values of R, the ratio of hadronic and muon pair production cross sections, are determined within 2% total root-mean-square uncertainty.

Barriers to radiotherapy access at the University College Hospital in Ibadan, Nigeria.

PubMed

Anakwenze, Chidinma P; Ntekim, Atara; Trock, Bruce; Uwadiae, Iyobosa B; Page, Brandi R

2017-08-01

Nigeria has the biggest gap between radiotherapy availability and need, with one machine per 19.4 million people, compared to one machine per 250,000 people in high-income countries. This study aims to identify its patient-level barriers to radiotherapy access. This was a cross sectional study consisting of patient questionnaires ( n  = 50) conducted in January 2016 to assess patient demographics, types of cancers seen, barriers to receiving radiotherapy, health beliefs and practices, and factors leading to treatment delay. Eighty percent of patients could not afford radiotherapy without financial assistance and only 6% of the patients had federal insurance, which did not cover radiotherapy services. Of the patients who had completed radiotherapy treatment, 91.3% had experienced treatment delay or often cancellation due to healthcare worker strike, power failure, machine breakdown, or prolonged wait time. The timeliness of a patient's radiotherapy care correlated with their employment status and distance from radiotherapy center ( p  < 0.05). Barriers to care at a radiotherapy center in a low- and middle-income country (LMIC) have previously not been well characterized. These findings can be used to inform efforts to expand the availability of radiotherapy and improve current treatment capacity in Nigeria and in other LMICs.

Stereotactic body radiotherapy for lung cancer: how much does it really cost?

PubMed

Lievens, Yolande; Obyn, Caroline; Mertens, Anne-Sophie; Van Halewyck, Dries; Hulstaert, Frank

2015-03-01

Despite the lack of randomized evidence, stereotactic body radiotherapy (SBRT) is being accepted as superior to conventional radiotherapy for patients with T1-2N0 non-small-cell lung cancer in the periphery of the lung and unfit or unwilling to undergo surgery. To introduce SBRT in a system of coverage with evidence development, a correct financing had to be determined. A time-driven activity-based costing model for radiotherapy was developed. Resource cost calculation of all radiotherapy treatments, standard and innovative, was conducted in 10 Belgian radiotherapy centers in the second half of 2012. The average cost of lung SBRT across the 10 centers (6221&OV0556;) is in the range of the average costs of standard fractionated 3D-conformal radiotherapy (5919&OV0556;) and intensity-modulated radiotherapy (7379&OV0556;) for lung cancer. Hypofractionated 3D-conformal radiotherapy and intensity-modulated radiotherapy schemes are less costly (3993&OV0556; respectively 4730&OV0556;). The SBRT cost increases with the number of fractions and is highly dependent of personnel and equipment use. SBRT cost varies more by centre than conventional radiotherapy cost, reflecting different technologies, stages in the learning curve and a lack of clear guidance in this field. Time-driven activity-based costing of radiotherapy is feasible in a multicentre setup, resulting in real-life resource costs that can form the basis for correct reimbursement schemes, supporting an early yet controlled introduction of innovative radiotherapy techniques in clinical practice.

30 Years of radiotherapy service in Southern Thailand: workload vs resources.

PubMed

Phungrassami, Temsak; Funsian, Amporn; Sriplung, Hutcha

2013-01-01

To study the pattern of patient load, personnel and equipment resources from 30-years experience in Southern Thailand. This retrospective study collected secondary data from the Division of Therapeutic Radiology and Oncology and the Songklanagarind Hospital Tumor Registry database, Faculty of Medicine, Prince of Songkla University, during the period of 1982-2012. The number of new patients who had radiation treatment gradually increased from 121 in 1982 to 2,178 in 2011. Shortages of all kinds of personnel were demonstrated as compared to the recommendations, especially in radiotherapy technicians. In 2011, Southern Thailand, with two radiotherapy centers, had 0.44 megavoltage radiotherapy machines (cobalt or linear accelerator) per million of population. This number is suboptimal, but could be managed cost-effectively by prolonging machine operating times during personnel shortages. This study identified a discrepancy between workload and resources in one medical school radiotherapy center in.

Rope Hadronization and Strange Particle Production

NASA Astrophysics Data System (ADS)

Bierlich, Christian

2018-02-01

Rope Hadronization is a model extending the Lund string hadronization model to describe environments with many overlapping strings, such as high multiplicity pp collisions or AA collisions. Including effects of Rope Hadronization drastically improves description of strange/non-strange hadron ratios as function of event multiplicity in all systems from e+e- to AA. Implementation of Rope Hadronization in the MC event generators Dipsy and PYTHIA8 is discussed, as well as future prospects for jet studies and studies of small systems.

Di-hadron production at Jefferson Lab

DOE Office of Scientific and Technical Information (OSTI.GOV)

Anefalos Pereira, Sergio; et. al.,

Semi-inclusive deep inelastic scattering (SIDIS) has been used extensively in recent years as an important testing ground for QCD. Studies so far have concentrated on better determination of parton distribution functions, distinguishing between the quark and antiquark contributions, and understanding the fragmentation of quarks into hadrons. Hadron pair (di-hadron) SIDIS provides information on the nucleon structure and hadronization dynamics that complement single hadron SIDIS. Di-hadrons allow the study of low- and high-twist distribution functions and Dihadron Fragmentation Functions (DiFF). Together with the twist-2 PDFs ( f1, g1, h1), the Higher Twist (HT) e and hL functions are very interesting becausemore » they offer insights into the physics of the largely unexplored quark-gluon correlations, which provide access into the dynamics inside hadrons. The CLAS spectrometer, installed in Hall-B at Jefferson Lab, has collected data using the CEBAF 6 GeV longitudinally polarized electron beam on longitudinally polarized solid NH3 targets. Preliminary results on di-hadron beam-, target- and double-spin asymmetries will be presented.« less

Incidence of second cancers after radiotherapy and systemic chemotherapy in heritable retinoblastoma survivors: A report from the German reference center.

PubMed

Temming, Petra; Arendt, Marina; Viehmann, Anja; Eisele, Lewin; Le Guin, Claudia H D; Schündeln, Michael M; Biewald, Eva; Astrahantseff, Kathy; Wieland, Regina; Bornfeld, Norbert; Sauerwein, Wolfgang; Eggert, Angelika; Jöckel, Karl-Heinz; Lohmann, Dietmar R

2017-01-01

Survivors of heritable retinoblastoma carry a high risk to develop second cancers. Eye-preserving radiotherapy raises this risk, while the impact of chemotherapy remains less defined. This population-based study characterizes the impact of all treatment modalities on second cancers incidence and type after retinoblastoma treatment in Germany. Data on second cancer incidence in 648 patients with heritable retinoblastoma treated between 1940 and 2008 at the German national reference center for retinoblastoma were analyzed to identify associations with treatment. The cumulative incidence ratio (per 1,000 person years) of second cancers was 8.6 (95% confidence interval 7.0-10.4). Second cancer incidence was influenced by type of retinoblastoma treatment but not by the year of diagnosis or by sex. Radiotherapy and systemic chemotherapy increased the incidence of second cancers (by 3.0- and 1.8-fold, respectively). While radiotherapy was specifically associated with second cancers arising within the periorbital region in the previously irradiated field, chemotherapy was the strongest risk factor for second cancers in other localizations. Soft tissue sarcomas and osteosarcomas were the most prevalent second cancers (standardized incidence ratio 179.35 compared to the German population). Second cancers remain a major concern in heritable retinoblastoma survivors. Consistent with previous reports, radiotherapy increased second cancer incidence and influenced type and localization. However, chemotherapy was the strongest risk factor for second malignancies outside the periorbital region. Our results provide screening priorities during life-long oncological follow-up based on the curative therapy the patient has received and emphasize the need for less-detrimental therapies for children with heritable retinoblastoma. © 2016 Wiley Periodicals, Inc.

Radiotherapy of Painful Vertebral Hemangiomas: The Single Center Retrospective Analysis of 137 Cases

DOE Office of Scientific and Technical Information (OSTI.GOV)

Miszczyk, Leszek, E-mail: leszek@io.gliwice.pl; Tukiendorf, Andrzej

2012-02-01

Purpose: An evaluation of dose-response relationship and an attempt to define predictive factors. Methods and Materials: A total of 137 cases of painful vertebral hemangioma irradiations (101 patients). Fraction dose (fd) varied from 2 to 15 Gy (123 fractionated and 14 radiosurgical treatments), and total dose (TD) from 8 to 30 Gy (111 cases irradiated with fd of 2 GY to TD of 24 Gy). We evaluated pain relief, changes in analgesic requirements, and reossification. Results: Means of pain relief 1, 6, 12, and 18 months after radiotherapy (defined as a decrease of primary pain level expressed in percent) weremore » 60.5%, 65.4%, 68.3%, and 78.4%, respectively. Proportion of patients with no need for analgesics and patients using tramadol were 39%, 40%, 44%, 57%, and 20%, 17%, 22%, and 11% in these times. The proportion of patients experiencing complete/partial pain relief changed from 36/48% 1 month, to 64/22% 1.5 years after radiotherapy. No impact of radiotherapy on reossification was found. The positive impact of fd and TD increase for analgesics uptake reduction and pain relief was found. An increase of the fd by 1 Gy results in 27% chance of analgesics uptake reduction and 3.8% reduction of pain, whereas 14% analgesics uptake reduction and 2.2% of pain reduction in case of the TD. The predictive factors improving results were found: female gender, older age, better performance states (the chance of the lower analgesic treatment decreases over 2.5 times in comparison to the higher Zubrod degree), bigger Hb concentration, shorter symptoms duration and lower analgesics uptake before radiotherapy. Conclusions: The obtained data support the efficacy of radiotherapy in improving pain secondary to vertebral hemangioma, with the degree of pain amelioration being related to increasing fd and TD. The positive predictive factors were defined: female gender, older age, better performance status, increased Hb concentration, shorter symptoms duration, and lower analgesics

Multiplicity moments at low and high energy in hadron--hadron scattering

DOE Office of Scientific and Technical Information (OSTI.GOV)

Antich, P.; Calligarich, E.; Cecchet, G.

1974-01-19

A phenomenological investigation is made of the relation obtained by Weingarten for the multiplicity moments in hadron -hadron interactions. The predictions are compared with moments computed from the experimental data, over a wide energy range, of the reactions pp, pp, pi /sup approximately /p, and K/sup approximately /p. (LBS)

Digital Hadron Calorimetry

NASA Astrophysics Data System (ADS)

Bilki, Burak

2018-03-01

The Particle Flow Algorithms attempt to measure each particle in a hadronic jet individually, using the detector providing the best energy/momentum resolution. Therefore, the spatial segmentation of the calorimeter plays a crucial role. In this context, the CALICE Collaboration developed the Digital Hadron Calorimeter. The Digital Hadron Calorimeter uses Resistive Plate Chambers as active media and has a 1-bit resolution (digital) readout of 1 × 1 cm2 pads. The calorimeter was tested with steel and tungsten absorber structures, as well as with no absorber structure, at the Fermilab and CERN test beam facilities over several years. In addition to conventional calorimetric measurements, the Digital Hadron Calorimeter offers detailed measurements of event shapes, rigorous tests of simulation models and various tools for improved performance due to its very high spatial granularity. Here we report on the results from the analysis of pion and positron events. Results of comparisons with the Monte Carlo simulations are also discussed. The analysis demonstrates the unique utilization of detailed event topologies.

Hadronic Resonance production in ALICE

NASA Astrophysics Data System (ADS)

Markert, Christina; ALICE Collaboration

2017-07-01

In heavy ion collisions a fireball of hot and dense matter is created. Short lived hadronic resonances are sensitive to the medium properties, in particular to the temperature, density and system size. Resonance yields and momentum distributions are used to gain insight into the hadronic phase, its expansion velocity and time duration. The multiplicity dependent hadronic resonance production in p-p, p-Pb and Pb-Pb collisions will be discussed within the context of the possible extended hadronic and partonic phase. The experimental results will be compared to EPOS+UrQMD model calculations to discuss the system size dependent interactions of the hadronic medium on various resonances. Small systems such as p-p and p-Pb collisions will be discussed with respect to resonance and strange particle measurements.

Gamma-hadron families and scaling violation

NASA Technical Reports Server (NTRS)

Gaisser, T. K.; Stanev, T.; Wrotniak, J. A.

1985-01-01

For three different interaction models we have simulated gamma-hadron families, including the detector (Pamir emulsion chamber) response. Rates of gamma families, hadrons, and hadron-gamma ratios were compared with experiments.

[Urethral stricture rate after prostate cancer radiotherapy : Five-year data of a certified prostate cancer center].

PubMed

Kranz, J; Maurer, G; Maurer, U; Deserno, O; Schulte, S; Steffens, J

2017-03-01

A urethral stricture is a scar of the urethral epithelium which can cause obstructive voiding dysfunction with consequential damage of the upper urinary tract. Almost 45% of all strictures are iatrogenic; they develop in 2-9% of patients after radical prostatectomy, but can also occur after prostate cancer radiotherapy. This study provides 5‑year data of a certified prostate cancer center (PKZ) in terms of urethral strictures. Between 01/2008 and 12/2012 a total of 519 men were irradiated for prostate cancer (LDR and HDR brachytherapy as well as external beam radiation). The entire cohort was followed-up prospectively according to a standardized protocol (by type of irradiation). Short segment urethral strictures were treated by urethrotomy, recurrent and long segment stenosis with buccal mucosa urethroplasty. A total of 18 of 519 (3.4%) patients developed a urethral stricture post-therapeutically, which recurred in 66% of cases after the first operative treatment. The largest risk for developing a urethral stricture is attributed to the HDR brachytherapy (8.9%). Urethral strictures after prostate cancer radiotherapy should be diagnosed and treated in time for long-term preservation of renal function. The rate of radiogenic urethral strictures (3.4%) is equivalent to those after radical prostatectomy. Due to a high rate of recurrences, urethrotomy has a limited importance after irradiation.

Theoretical study of EAS hadronic structure

NASA Technical Reports Server (NTRS)

Popova, L.

1985-01-01

The structure of extensive air showers (EAS) is determined mainly by the energetic hadrons. They are strongly collimated in the core of the shower and essential difficulties are encountered for resolution of individual hadrons. The properties for resolution are different from the variety of hadron detectors used in EAS experiments. This is the main difficulty in obtaining a general agreement between actually registered data with different detectors. The most plausible source for disagreement is the uncertainty in determination of the energy of individual hadrons. This research demonstrates that a better agreement can be obtained with the average tendency of hadronic measurements if one assumes a larger coefficient of inelasticity and stronger energy increase of the total inelastic cross section in high energy pion interactions. EAS data above 10 to the 5th power GeV are revealing a faster development of hadronic cascades in the air then can be expected by extrapolating the parameters of hadron interactions obtained in accelerator measurements.

Black Holes and the Large Hadron Collider

NASA Astrophysics Data System (ADS)

Roy, Arunava

2011-12-01

The European Center for Nuclear Research or CERN's Large Hadron Collider (LHC) has caught our attention partly due to the film ``Angels and Demons.'' In the movie, an antimatter bomb attack on the Vatican is foiled by the protagonist. Perhaps just as controversial is the formation of mini black holes (BHs). Recently, the American Physical Society1 website featured an article on BH formation at the LHC.2 This article examines some aspects of mini BHs and explores the possibility of their detection at the LHC.

Pseudorapidity distributions of charged hadrons in proton-lead collisions at √{s_{NN}}=5.02 and 8.16 TeV

NASA Astrophysics Data System (ADS)

Sirunyan, A. M.; Tumasyan, A.; Adam, W.; Ambrogi, F.; Asilar, E.; Bergauer, T.; Brandstetter, J.; Brondolin, E.; Drag-icevic, M.; Erö, J.; Flechl, M.; Friedl, M.; Frühwirth, R.; Ghete, V. M.; Grossmann, J.; Hrubec, J.; Jeitler, M.; König, A.; Krammer, N.; Krätschmer, I.; Liko, D.; Madlener, T.; Mikulec, I.; Pree, E.; Rad, N.; Rohringer, H.; Schieck, J.; Schöfbeck, R.; Spanring, M.; Spitzbart, D.; Waltenberger, W.; Wittmann, J.; Wulz, C.-E.; Zarucki, M.; Chekhovsky, V.; Mossolov, V.; Suarez Gonzalez, J.; De Wolf, E. A.; Di Croce, D.; Janssen, X.; Lauwers, J.; Van De Klundert, M.; Van Haevermaet, H.; Van Mechelen, P.; Van Remortel, N.; Abu Zeid, S.; Blekman, F.; D'Hondt, J.; De Bruyn, I.; De Clercq, J.; Deroover, K.; Flouris, G.; Lontkovskyi, D.; Lowette, S.; Moortgat, S.; Moreels, L.; Python, Q.; Skovpen, K.; Tavernier, S.; Van Doninck, W.; Van Mulders, P.; Van Parijs, I.; Beghin, D.; Brun, H.; Clerbaux, B.; De Lentdecker, G.; Delannoy, H.; Dorney, B.; Fasanella, G.; Favart, L.; Goldouzian, R.; Grebenyuk, A.; Karapostoli, G.; Lenzi, T.; Luetic, J.; Maerschalk, T.; Marinov, A.; Seva, T.; Starling, E.; Vander Velde, C.; Vanlaer, P.; Vannerom, D.; Yonamine, R.; Zenoni, F.; Zhang, F.; Cimmino, A.; Cornelis, T.; Dobur, D.; Fagot, A.; Gul, M.; Khvastunov, I.; Poyraz, D.; Roskas, C.; Salva, S.; Tytgat, M.; Verbeke, W.; Zaganidis, N.; Bakhshiansohi, H.; Bondu, O.; Brochet, S.; Bruno, G.; Caputo, C.; Caudron, A.; David, P.; De Visscher, S.; Delaere, C.; Delcourt, M.; Francois, B.; Giammanco, A.; Komm, M.; Krintiras, G.; Lemaitre, V.; Magitteri, A.; Mertens, A.; Musich, M.; Piotrzkowski, K.; Quertenmont, L.; Saggio, A.; Vidal Marono, M.; Wertz, S.; Zobec, J.; Beliy, N.; Aldá Júnior, W. L.; Alves, F. L.; Alves, G. A.; Brito, L.; Correa Martins Junior, M.; Hensel, C.; Moraes, A.; Pol, M. E.; Rebello Teles, P.; Belchior Batista Das Chagas, E.; Carvalho, W.; Chinellato, J.; Coelho, E.; Da Costa, E. M.; Da Silveira, G. G.; De Jesus Damiao, D.; Fonseca De Souza, S.; Huertas Guativa, L. M.; Malbouisson, H.; Melo De Almeida, M.; Mora Herrera, C.; Mundim, L.; Nogima, H.; Sanchez Rosas, L. J.; Santoro, A.; Sznajder, A.; Thiel, M.; Tonelli Manganote, E. J.; Torres Da Silva De Araujo, F.; Vilela Pereira, A.; Ahuja, S.; Bernardes, C. A.; Fernandez Perez Tomei, T. R.; Gregores, E. M.; Mercadante, P. G.; Novaes, S. F.; Padula, Sandra S.; Romero Abad, D.; Ruiz Vargas, J. C.; Aleksandrov, A.; Hadjiiska, R.; Iaydjiev, P.; Misheva, M.; Rodozov, M.; Shopova, M.; Sultanov, G.; Dimitrov, A.; Glushkov, I.; Litov, L.; Pavlov, B.; Petkov, P.; Fang, W.; Gao, X.; Yuan, L.; Ahmad, M.; Bian, J. G.; Chen, G. M.; Chen, H. S.; Chen, M.; Chen, Y.; Jiang, C. H.; Leggat, D.; Liao, H.; Liu, Z.; Romeo, F.; Shaheen, S. M.; Spiezia, A.; Tao, J.; Wang, C.; Wang, Z.; Yazgan, E.; Zhang, H.; Zhang, S.; Zhao, J.; Ban, Y.; Chen, G.; Li, Q.; Liu, S.; Mao, Y.; Qian, S. J.; Wang, D.; Xu, Z.; Avila, C.; Cabrera, A.; Chaparro Sierra, L. F.; Florez, C.; González Hernández, C. F.; Ruiz Alvarez, J. D.; Segura Delgado, M. A.; Courbon, B.; Godinovic, N.; Lelas, D.; Puljak, I.; Ribeiro Cipriano, P. M.; Sculac, T.; Antunovic, Z.; Kovac, M.; Brigljevic, V.; Ferencek, D.; Kadija, K.; Mesic, B.; Starodumov, A.; Susa, T.; Ather, M. W.; Attikis, A.; Mavromanolakis, G.; Mousa, J.; Nicolaou, C.; Ptochos, F.; Razis, P. A.; Rykaczewski, H.; Finger, M.; Finger, M.; Carrera Jarrin, E.; Abdelalim, A. A.; Mohammed, Y.; Salama, E.; Dewanjee, R. K.; Kadastik, M.; Perrini, L.; Raidal, M.; Tiko, A.; Veelken, C.; Eerola, P.; Kirschenmann, H.; Pekkanen, J.; Voutilainen, M.; Havukainen, J.; Heikkilä, J. K.; Järvinen, T.; Karimäki, V.; Kinnunen, R.; Lampén, T.; Lassila-Perini, K.; Laurila, S.; Lehti, S.; Lindén, T.; Luukka, P.; Siikonen, H.; Tuominen, E.; Tuominiemi, J.; Talvitie, J.; Tuuva, T.; Besancon, M.; Couderc, F.; Dejardin, M.; Denegri, D.; Faure, J. L.; Ferri, F.; Ganjour, S.; Ghosh, S.; Givernaud, A.; Gras, P.; Hamel de Monchenault, G.; Jarry, P.; Kucher, I.; Leloup, C.; Locci, E.; Machet, M.; Malcles, J.; Negro, G.; Rander, J.; Rosowsky, A.; Sahin, M. Ö.; Titov, M.; Abdulsalam, A.; Amendola, C.; Antropov, I.; Baffioni, S.; Beaudette, F.; Busson, P.; Cadamuro, L.; Charlot, C.; Granier de Cassagnac, R.; Jo, M.; Lisniak, S.; Lobanov, A.; Martin Blanco, J.; Nguyen, M.; Ochando, C.; Ortona, G.; Paganini, P.; Pigard, P.; Salerno, R.; Sauvan, J. B.; Sirois, Y.; Stahl Leiton, A. G.; Strebler, T.; Yilmaz, Y.; Zabi, A.; Zghiche, A.; Agram, J.-L.; Andrea, J.; Bloch, D.; Brom, J.-M.; Buttignol, M.; Chabert, E. C.; Chanon, N.; Collard, C.; Conte, E.; Coubez, X.; Fontaine, J.-C.; Gelé, D.; Goerlach, U.; Jansová, M.; Le Bihan, A.-C.; Tonon, N.; Van Hove, P.; Gadrat, S.; Beauceron, S.; Bernet, C.; Boudoul, G.; Chierici, R.; Contardo, D.; Depasse, P.; El Mamouni, H.; Fay, J.; Finco, L.; Gascon, S.; Gouzevitch, M.; Grenier, G.; Ille, B.; Lagarde, F.; Laktineh, I. B.; Lethuillier, M.; Mirabito, L.; Pequegnot, A. L.; Perries, S.; Popov, A.; Sordini, V.; Vander Donckt, M.; Viret, S.; Toriashvili, T.; Tsamalaidze, Z.; Autermann, C.; Feld, L.; Kiesel, M. K.; Klein, K.; Lipinski, M.; Preuten, M.; Schomakers, C.; Schulz, J.; Zhukov, V.; Albert, A.; Dietz-Laursonn, E.; Duchardt, D.; Endres, M.; Erdmann, M.; Erdweg, S.; Esch, T.; Fischer, R.; Güth, A.; Hamer, M.; Hebbeker, T.; Heidemann, C.; Hoepfner, K.; Knutzen, S.; Merschmeyer, M.; Meyer, A.; Millet, P.; Mukherjee, S.; Pook, T.; Radziej, M.; Reithler, H.; Rieger, M.; Scheuch, F.; Teyssier, D.; Thüer, S.; Flügge, G.; Kargoll, B.; Kress, T.; Künsken, A.; Müller, T.; Nehrkorn, A.; Nowack, A.; Pistone, C.; Pooth, O.; Stahl, A.; Aldaya Martin, M.; Arndt, T.; Asawatangtrakuldee, C.; Beernaert, K.; Behnke, O.; Behrens, U.; Bermúdez Martínez, A.; Bin Anuar, A. A.; Borras, K.; Botta, V.; Campbell, A.; Connor, P.; Contreras-Campana, C.; Costanza, F.; Diez Pardos, C.; Eckerlin, G.; Eckstein, D.; Eichhorn, T.; Eren, E.; Gallo, E.; Garay Garcia, J.; Geiser, A.; Gizhko, A.; Grados Luyando, J. M.; Grohsjean, A.; Gunnellini, P.; Guthoff, M.; Harb, A.; Hauk, J.; Hempel, M.; Jung, H.; Kalogeropoulos, A.; Kasemann, M.; Keaveney, J.; Kleinwort, C.; Korol, I.; Krücker, D.; Lange, W.; Lelek, A.; Lenz, T.; Leonard, J.; Lipka, K.; Lohmann, W.; Mankel, R.; Melzer-Pellmann, I.-A.; Meyer, A. B.; Mittag, G.; Mnich, J.; Mussgiller, A.; Ntomari, E.; Pitzl, D.; Raspereza, A.; Savitskyi, M.; Saxena, P.; Shevchenko, R.; Spannagel, S.; Stefaniuk, N.; Van Onsem, G. P.; Walsh, R.; Wen, Y.; Wichmann, K.; Wissing, C.; Zenaiev, O.; Aggleton, R.; Bein, S.; Blobel, V.; Centis Vignali, M.; Dreyer, T.; Garutti, E.; Gonzalez, D.; Haller, J.; Hinzmann, A.; Hoffmann, M.; Karavdina, A.; Klanner, R.; Kogler, R.; Kovalchuk, N.; Kurz, S.; Lapsien, T.; Marchesini, I.; Marconi, D.; Meyer, M.; Niedziela, M.; Nowatschin, D.; Pantaleo, F.; Peiffer, T.; Perieanu, A.; Scharf, C.; Schleper, P.; Schmidt, A.; Schumann, S.; Schwandt, J.; Sonneveld, J.; Stadie, H.; Steinbrück, G.; Stober, F. M.; Stöver, M.; Tholen, H.; Troendle, D.; Usai, E.; Vanhoefer, A.; Vormwald, B.; Akbiyik, M.; Barth, C.; Baselga, M.; Baur, S.; Butz, E.; Caspart, R.; Chwalek, T.; Colombo, F.; De Boer, W.; Dierlamm, A.; Faltermann, N.; Freund, B.; Friese, R.; Giffels, M.; Harrendorf, M. A.; Hartmann, F.; Heindl, S. M.; Husemann, U.; Kassel, F.; Kudella, S.; Mildner, H.; Mozer, M. U.; Müller, Th.; Plagge, M.; Quast, G.; Rabbertz, K.; Schröder, M.; Shvetsov, I.; Sieber, G.; Simonis, H. J.; Ulrich, R.; Wayand, S.; Weber, M.; Weiler, T.; Williamson, S.; Wöhrmann, C.; Wolf, R.; Anagnostou, G.; Daskalakis, G.; Geralis, T.; Kyriakis, A.; Loukas, D.; Topsis-Giotis, I.; Karathanasis, G.; Kesisoglou, S.; Panagiotou, A.; Saoulidou, N.; Kousouris, K.; Evangelou, I.; Foudas, C.; Kokkas, P.; Mallios, S.; Manthos, N.; Papadopoulos, I.; Paradas, E.; Strologas, J.; Triantis, F. A.; Csanad, M.; Filipovic, N.; Pasztor, G.; Surányi, O.; Veres, G. I.; Bencze, G.; Hajdu, C.; Horvath, D.; Hunyadi, Á.; Sikler, F.; Veszpremi, V.; Beni, N.; Czellar, S.; Karancsi, J.; Makovec, A.; Molnar, J.; Szillasi, Z.; Bartók, M.; Raics, P.; Trocsanyi, Z. L.; Ujvari, B.; Choudhury, S.; Komaragiri, J. R.; Bahinipati, S.; Bhowmik, S.; Mal, P.; Mandal, K.; Nayak, A.; Sahoo, D. K.; Sahoo, N.; Swain, S. K.; Bansal, S.; Beri, S. B.; Bhatnagar, V.; Chawla, R.; Dhingra, N.; Kalsi, A. K.; Kaur, A.; Kaur, M.; Kaur, S.; Kumar, R.; Kumari, P.; Mehta, A.; Singh, J. B.; Walia, G.; Kumar, Ashok; Shah, Aashaq; Bhardwaj, A.; Chauhan, S.; Choudhary, B. C.; Garg, R. B.; Keshri, S.; Kumar, A.; Malhotra, S.; Naimuddin, M.; Ranjan, K.; Sharma, R.; Bhardwaj, R.; Bhattacharya, R.; Bhattacharya, S.; Bhawandeep, U.; Dey, S.; Dutt, S.; Dutta, S.; Ghosh, S.; Majumdar, N.; Modak, A.; Mondal, K.; Mukhopadhyay, S.; Nandan, S.; Purohit, A.; Roy, A.; Roy Chowdhury, S.; Sarkar, S.; Sharan, M.; Thakur, S.; Behera, P. K.; Chudasama, R.; Dutta, D.; Jha, V.; Kumar, V.; Mohanty, A. K.; Netrakanti, P. K.; Pant, L. M.; Shukla, P.; Topkar, A.; Aziz, T.; Dugad, S.; Mahakud, B.; Mitra, S.; Mohanty, G. B.; Sur, N.; Sutar, B.; Banerjee, S.; Bhattacharya, S.; Chatterjee, S.; Das, P.; Guchait, M.; Jain, Sa.; Kumar, S.; Maity, M.; Majumder, G.; Mazumdar, K.; Sarkar, T.; Wickramage, N.; Chauhan, S.; Dube, S.; Hegde, V.; Kapoor, A.; Kothekar, K.; Pandey, S.; Rane, A.; Sharma, S.; Chenarani, S.; Eskandari Tadavani, E.; Etesami, S. M.; Khakzad, M.; Mohammadi Najafabadi, M.; Naseri, M.; Paktinat Mehdiabadi, S.; Rezaei Hosseinabadi, F.; Safarzadeh, B.; Zeinali, M.; Felcini, M.; Grunewald, M.; Abbrescia, M.; Calabria, C.; Colaleo, A.; Creanza, D.; Cristella, L.; De Filippis, N.; De Palma, M.; Errico, F.; Fiore, L.; Iaselli, G.; Lezki, S.; Maggi, G.; Maggi, M.; Miniello, G.; My, S.; Nuzzo, S.; Pompili, A.; Pugliese, G.; Radogna, R.; Ranieri, A.; Selvaggi, G.; Sharma, A.; Silvestris, L.; Venditti, R.; Verwilligen, P.; Abbiendi, G.; Battilana, C.; Bonacorsi, D.; Borgonovi, L.; Braibant-Giacomelli, S.; Campanini, R.; Capiluppi, P.; Castro, A.; Cavallo, F. R.; Chhibra, S. S.; Codispoti, G.; Cuffiani, M.; Dallavalle, G. M.; Fabbri, F.; Fanfani, A.; Fasanella, D.; Giacomelli, P.; Grandi, C.; Guiducci, L.; Marcellini, S.; Masetti, G.; Montanari, A.; Navarria, F. L.; Perrotta, A.; Rossi, A. M.; Rovelli, T.; Siroli, G. P.; Tosi, N.; Albergo, S.; Costa, S.; Di Mattia, A.; Giordano, F.; Potenza, R.; Tricomi, A.; Tuve, C.; Barbagli, G.; Chatterjee, K.; Ciulli, V.; Civinini, C.; D'Alessandro, R.; Focardi, E.; Lenzi, P.; Meschini, M.; Paoletti, S.; Russo, L.; Sguazzoni, G.; Strom, D.; Viliani, L.; Benussi, L.; Bianco, S.; Fabbri, F.; Piccolo, D.; Primavera, F.; Calvelli, V.; Ferro, F.; Robutti, E.; Tosi, S.; Benaglia, A.; Beschi, A.; Brianza, L.; Brivio, F.; Ciriolo, V.; Dinardo, M. E.; Fiorendi, S.; Gennai, S.; Ghezzi, A.; Govoni, P.; Malberti, M.; Malvezzi, S.; Manzoni, R. A.; Menasce, D.; Moroni, L.; Paganoni, M.; Pauwels, K.; Pedrini, D.; Pigazzini, S.; Ragazzi, S.; Redaelli, N.; Tabarelli de Fatis, T.; Buontempo, S.; Cavallo, N.; Di Guida, S.; Fabozzi, F.; Fienga, F.; Iorio, A. O. M.; Khan, W. A.; Lista, L.; Meola, S.; Paolucci, P.; Sciacca, C.; Thyssen, F.; Azzi, P.; Bacchetta, N.; Benato, L.; Bisello, D.; Boletti, A.; Carlin, R.; Carvalho Antunes De Oliveira, A.; Checchia, P.; De Castro Manzano, P.; Dorigo, T.; Dosselli, U.; Gasparini, F.; Gasparini, U.; Gozzelino, A.; Lacaprara, S.; Margoni, M.; Meneguzzo, A. T.; Pozzobon, N.; Ronchese, P.; Rossin, R.; Simonetto, F.; Torassa, E.; Zanetti, M.; Zotto, P.; Zumerle, G.; Braghieri, A.; Magnani, A.; Montagna, P.; Ratti, S. P.; Re, V.; Ressegotti, M.; Riccardi, C.; Salvini, P.; Vai, I.; Vitulo, P.; Alunni Solestizi, L.; Biasini, M.; Bilei, G. M.; Cecchi, C.; Ciangottini, D.; Fanò, L.; Lariccia, P.; Leonardi, R.; Manoni, E.; Mantovani, G.; Mariani, V.; Menichelli, M.; Rossi, A.; Santocchia, A.; Spiga, D.; Androsov, K.; Azzurri, P.; Bagliesi, G.; Boccali, T.; Borrello, L.; Castaldi, R.; Ciocci, M. A.; Dell'Orso, R.; Fedi, G.; Giannini, L.; Giassi, A.; Grippo, M. T.; Ligabue, F.; Lomtadze, T.; Manca, E.; Mandorli, G.; Messineo, A.; Palla, F.; Rizzi, A.; Savoy-Navarro, A.; Spagnolo, P.; Tenchini, R.; Tonelli, G.; Venturi, A.; Verdini, P. G.; Barone, L.; Cavallari, F.; Cipriani, M.; Daci, N.; Del Re, D.; Di Marco, E.; Diemoz, M.; Gelli, S.; Longo, E.; Margaroli, F.; Marzocchi, B.; Meridiani, P.; Organtini, G.; Paramatti, R.; Preiato, F.; Rahatlou, S.; Rovelli, C.; Santanastasio, F.; Amapane, N.; Arcidiacono, R.; Argiro, S.; Arneodo, M.; Bartosik, N.; Bellan, R.; Biino, C.; Cartiglia, N.; Cenna, F.; Costa, M.; Covarelli, R.; Degano, A.; Demaria, N.; Kiani, B.; Mariotti, C.; Maselli, S.; Migliore, E.; Monaco, V.; Monteil, E.; Monteno, M.; Obertino, M. M.; Pacher, L.; Pastrone, N.; Pelliccioni, M.; Pinna Angioni, G. L.; Ravera, F.; Romero, A.; Ruspa, M.; Sacchi, R.; Shchelina, K.; Sola, V.; Solano, A.; Staiano, A.; Traczyk, P.; Belforte, S.; Casarsa, M.; Cossutti, F.; Della Ricca, G.; Zanetti, A.; Kim, D. H.; Kim, G. N.; Kim, M. S.; Lee, J.; Lee, S.; Lee, S. W.; Moon, C. S.; Oh, Y. D.; Sekmen, S.; Son, D. C.; Yang, Y. C.; Lee, A.; Kim, H.; Moon, D. H.; Oh, G.; Brochero Cifuentes, J. A.; Goh, J.; Kim, T. J.; Cho, S.; Choi, S.; Go, Y.; Gyun, D.; Ha, S.; Hong, B.; Jo, Y.; Kim, Y.; Lee, K.; Lee, K. S.; Lee, S.; Lim, J.; Park, S. K.; Roh, Y.; Almond, J.; Kim, J.; Kim, J. S.; Lee, H.; Lee, K.; Nam, K.; Oh, S. B.; Radburn-Smith, B. C.; Seo, S. h.; Yang, U. K.; Yoo, H. D.; Yu, G. B.; Choi, M.; Kim, H.; Kim, J. H.; Lee, J. S. H.; Park, I. C.; Choi, Y.; Hwang, C.; Lee, J.; Yu, I.; Dudenas, V.; Juodagalvis, A.; Vaitkus, J.; Ahmed, I.; Ibrahim, Z. A.; Ali, M. A. B. Md; Mohamad Idris, F.; Wan Abdullah, W. A. T.; Yusli, M. N.; Zolkapli, Z.; Reyes-Almanza, R.; Ramirez-Sanchez, G.; Duran-Osuna, M. C.; Castilla-Valdez, H.; De La Cruz-Burelo, E.; Heredia-De La Cruz, I.; Rabadan-Trejo, R. I.; Lopez-Fernandez, R.; Mejia Guisao, J.; Sanchez-Hernandez, A.; Carrillo Moreno, S.; Oropeza Barrera, C.; Vazquez Valencia, F.; Pedraza, I.; Salazar Ibarguen, H. A.; Uribe Estrada, C.; Morelos Pineda, A.; Krofcheck, D.; Butler, P. H.; Ahmad, A.; Ahmad, M.; Hassan, Q.; Hoorani, H. R.; Saddique, A.; Shah, M. A.; Shoaib, M.; Waqas, M.; Bialkowska, H.; Bluj, M.; Boimska, B.; Frueboes, T.; Górski, M.; Kazana, M.; Nawrocki, K.; Szleper, M.; Zalewski, P.; Bunkowski, K.; Byszuk, A.; Doroba, K.; Kalinowski, A.; Konecki, M.; Krolikowski, J.; Misiura, M.; Olszewski, M.; Pyskir, A.; Walczak, M.; Bargassa, P.; Beirão Da Cruz E Silva, C.; Di Francesco, A.; Faccioli, P.; Galinhas, B.; Gallinaro, M.; Hollar, J.; Leonardo, N.; Lloret Iglesias, L.; Nemallapudi, M. V.; Seixas, J.; Strong, G.; Toldaiev, O.; Vadruccio, D.; Varela, J.; Afanasiev, S.; Bunin, P.; Gavrilenko, M.; Golutvin, I.; Gorbunov, I.; Kamenev, A.; Karjavin, V.; Lanev, A.; Malakhov, A.; Matveev, V.; Palichik, V.; Perelygin, V.; Shmatov, S.; Shulha, S.; Skatchkov, N.; Smirnov, V.; Voytishin, N.; Zarubin, A.; Ivanov, Y.; Kim, V.; Kuznetsova, E.; Levchenko, P.; Murzin, V.; Oreshkin, V.; Smirnov, I.; Sulimov, V.; Uvarov, L.; Vavilov, S.; Vorobyev, A.; Andreev, Yu.; Dermenev, A.; Gninenko, S.; Golubev, N.; Karneyeu, A.; Kirsanov, M.; Krasnikov, N.; Pashenkov, A.; Tlisov, D.; Toropin, A.; Epshteyn, V.; Gavrilov, V.; Lychkovskaya, N.; Popov, V.; Pozdnyakov, I.; Safronov, G.; Spiridonov, A.; Stepennov, A.; Toms, M.; Vlasov, E.; Zhokin, A.; Aushev, T.; Bylinkin, A.; Chadeeva, M.; Parygin, P.; Philippov, D.; Polikarpov, S.; Popova, E.; Rusinov, V.; Andreev, V.; Azarkin, M.; Dremin, I.; Kirakosyan, M.; Terkulov, A.; Baskakov, A.; Belyaev, A.; Boos, E.; Demiyanov, A.; Ershov, A.; Gribushin, A.; Kodolova, O.; Korotkikh, V.; Lokhtin, I.; Miagkov, I.; Obraztsov, S.; Petrushanko, S.; Savrin, V.; Snigirev, A.; Vardanyan, I.; Blinov, V.; Skovpen, Y.; Shtol, D.; Azhgirey, I.; Bayshev, I.; Bitioukov, S.; Elumakhov, D.; Kachanov, V.; Kalinin, A.; Konstantinov, D.; Mandrik, P.; Petrov, V.; Ryutin, R.; Sobol, A.; Troshin, S.; Tyurin, N.; Uzunian, A.; Volkov, A.; Adzic, P.; Cirkovic, P.; Devetak, D.; Dordevic, M.; Milosevic, J.; Rekovic, V.; Alcaraz Maestre, J.; Barrio Luna, M.; Cerrada, M.; Colino, N.; De La Cruz, B.; Delgado Peris, A.; Escalante Del Valle, A.; Fernandez Bedoya, C.; Fernández Ramos, J. P.; Flix, J.; Fouz, M. C.; Gonzalez Lopez, O.; Goy Lopez, S.; Hernandez, J. M.; Josa, M. I.; Moran, D.; Pérez-Calero Yzquierdo, A.; Puerta Pelayo, J.; Quintario Olmeda, A.; Redondo, I.; Romero, L.; Soares, M. S.; Álvarez Fernández, A.; Albajar, C.; de Trocóniz, J. F.; Missiroli, M.; Cuevas, J.; Erice, C.; Fernandez Menendez, J.; Gonzalez Caballero, I.; González Fernández, J. R.; Palencia Cortezon, E.; Sanchez Cruz, S.; Vischia, P.; Vizan Garcia, J. M.; Cabrillo, I. J.; Calderon, A.; Chazin Quero, B.; Curras, E.; Duarte Campderros, J.; Fernandez, M.; Garcia-Ferrero, J.; Gomez, G.; Lopez Virto, A.; Marco, J.; Martinez Rivero, C.; Martinez Ruiz del Arbol, P.; Matorras, F.; Piedra Gomez, J.; Rodrigo, T.; Ruiz-Jimeno, A.; Scodellaro, L.; Trevisani, N.; Vila, I.; Vilar Cortabitarte, R.; Abbaneo, D.; Akgun, B.; Auffray, E.; Baillon, P.; Ball, A. H.; Barney, D.; Bendavid, J.; Bianco, M.; Bloch, P.; Bocci, A.; Botta, C.; Camporesi, T.; Castello, R.; Cepeda, M.; Cerminara, G.; Chapon, E.; Chen, Y.; d'Enterria, D.; Dabrowski, A.; Daponte, V.; David, A.; De Gruttola, M.; De Roeck, A.; Deelen, N.; Dobson, M.; du Pree, T.; Dünser, M.; Dupont, N.; Elliott-Peisert, A.; Everaerts, P.; Fallavollita, F.; Franzoni, G.; Fulcher, J.; Funk, W.; Gigi, D.; Gilbert, A.; Gill, K.; Glege, F.; Gulhan, D.; Harris, P.; Hegeman, J.; Innocente, V.; Jafari, A.; Janot, P.; Karacheban, O.; Kieseler, J.; Knünz, V.; Kornmayer, A.; Kortelainen, M. J.; Krammer, M.; Lange, C.; Lecoq, P.; Lourenço, C.; Lucchini, M. T.; Malgeri, L.; Mannelli, M.; Martelli, A.; Meijers, F.; Merlin, J. A.; Mersi, S.; Meschi, E.; Milenovic, P.; Moortgat, F.; Mulders, M.; Neugebauer, H.; Ngadiuba, J.; Orfanelli, S.; Orsini, L.; Pape, L.; Perez, E.; Peruzzi, M.; Petrilli, A.; Petrucciani, G.; Pfeiffer, A.; Pierini, M.; Rabady, D.; Racz, A.; Reis, T.; Rolandi, G.; Rovere, M.; Sakulin, H.; Schäfer, C.; Schwick, C.; Seidel, M.; Selvaggi, M.; Sharma, A.; Silva, P.; Sphicas, P.; Stakia, A.; Steggemann, J.; Stoye, M.; Tosi, M.; Treille, D.; Triossi, A.; Tsirou, A.; Veckalns, V.; Verweij, M.; Zeuner, W. D.; Bertl, W.; Caminada, L.; Deiters, K.; Erdmann, W.; Horisberger, R.; Ingram, Q.; Kaestli, H. C.; Kotlinski, D.; Langenegger, U.; Rohe, T.; Wiederkehr, S. A.; Backhaus, M.; Bäni, L.; Berger, P.; Bianchini, L.; Casal, B.; Dissertori, G.; Dittmar, M.; Donegà, M.; Dorfer, C.; Grab, C.; Heidegger, C.; Hits, D.; Hoss, J.; Kasieczka, G.; Klijnsma, T.; Lustermann, W.; Mangano, B.; Marionneau, M.; Meinhard, M. T.; Meister, D.; Micheli, F.; Musella, P.; Nessi-Tedaldi, F.; Pandolfi, F.; Pata, J.; Pauss, F.; Perrin, G.; Perrozzi, L.; Quittnat, M.; Reichmann, M.; Sanz Becerra, D. A.; Schönenberger, M.; Shchutska, L.; Tavolaro, V. R.; Theofilatos, K.; Vesterbacka Olsson, M. L.; Wallny, R.; Zhu, D. H.; Aarrestad, T. K.; Amsler, C.; Canelli, M. F.; De Cosa, A.; Del Burgo, R.; Donato, S.; Galloni, C.; Hreus, T.; Kilminster, B.; Pinna, D.; Rauco, G.; Robmann, P.; Salerno, D.; Schweiger, K.; Seitz, C.; Takahashi, Y.; Zucchetta, A.; Candelise, V.; Doan, T. H.; Jain, Sh.; Khurana, R.; Kuo, C. M.; Lin, W.; Pozdnyakov, A.; Yu, S. S.; Kumar, Arun; Chang, P.; Chao, Y.; Chen, K. F.; Chen, P. H.; Fiori, F.; Hou, W.-S.; Hsiung, Y.; Liu, Y. F.; Lu, R.-S.; Paganis, E.; Psallidas, A.; Steen, A.; Tsai, J. f.; Asavapibhop, B.; Kovitanggoon, K.; Singh, G.; Srimanobhas, N.; Bakirci, M. N.; Bat, A.; Boran, F.; Damarseckin, S.; Demiroglu, Z. S.; Dozen, C.; Girgis, S.; Gokbulut, G.; Guler, Y.; Hos, I.; Kangal, E. E.; Kara, O.; Kiminsu, U.; Oglakci, M.; Onengut, G.; Ozdemir, K.; Ozturk, S.; Polatoz, A.; Tali, B.; Tok, U. G.; Topakli, H.; Turkcapar, S.; Zorbakir, I. S.; Zorbilmez, C.; Bilin, B.; Karapinar, G.; Ocalan, K.; Yalvac, M.; Zeyrek, M.; Gülmez, E.; Kaya, M.; Kaya, O.; Tekten, S.; Yetkin, E. A.; Agaras, M. N.; Atay, S.; Cakir, A.; Cankocak, K.; Grynyov, B.; Levchuk, L.; Ball, F.; Beck, L.; Brooke, J. J.; Burns, D.; Clement, E.; Cussans, D.; Davignon, O.; Flacher, H.; Goldstein, J.; Heath, G. P.; Heath, H. F.; Kreczko, L.; Newbold, D. M.; Paramesvaran, S.; Sakuma, T.; Seif El Nasr-storey, S.; Smith, D.; Smith, V. J.; Belyaev, A.; Brew, C.; Brown, R. M.; Calligaris, L.; Cieri, D.; Cockerill, D. J. A.; Coughlan, J. A.; Harder, K.; Harper, S.; Olaiya, E.; Petyt, D.; Shepherd-Themistocleous, C. H.; Thea, A.; Tomalin, I. R.; Williams, T.; Auzinger, G.; Bainbridge, R.; Borg, J.; Breeze, S.; Buchmuller, O.; Bundock, A.; Casasso, S.; Citron, M.; Colling, D.; Corpe, L.; Dauncey, P.; Davies, G.; De Wit, A.; Della Negra, M.; Di Maria, R.; Elwood, A.; Haddad, Y.; Hall, G.; Iles, G.; James, T.; Lane, R.; Laner, C.; Lyons, L.; Magnan, A.-M.; Malik, S.; Mastrolorenzo, L.; Matsushita, T.; Nash, J.; Nikitenko, A.; Palladino, V.; Pesaresi, M.; Raymond, D. M.; Richards, A.; Rose, A.; Scott, E.; Seez, C.; Shtipliyski, A.; Summers, S.; Tapper, A.; Uchida, K.; Vazquez Acosta, M.; Virdee, T.; Wardle, N.; Winterbottom, D.; Wright, J.; Zenz, S. C.; Cole, J. E.; Hobson, P. R.; Khan, A.; Kyberd, P.; Reid, I. D.; Symonds, P.; Teodorescu, L.; Turner, M.; Zahid, S.; Borzou, A.; Call, K.; Dittmann, J.; Hatakeyama, K.; Liu, H.; Pastika, N.; Smith, C.; Bartek, R.; Dominguez, A.; Buccilli, A.; Cooper, S. I.; Henderson, C.; Rumerio, P.; West, C.; Arcaro, D.; Avetisyan, A.; Bose, T.; Gastler, D.; Rankin, D.; Richardson, C.; Rohlf, J.; Sulak, L.; Zou, D.; Benelli, G.; Cutts, D.; Garabedian, A.; Hadley, M.; Hakala, J.; Heintz, U.; Hogan, J. M.; Kwok, K. H. M.; Laird, E.; Landsberg, G.; Lee, J.; Mao, Z.; Narain, M.; Pazzini, J.; Piperov, S.; Sagir, S.; Syarif, R.; Yu, D.; Band, R.; Brainerd, C.; Burns, D.; Calderon De La Barca Sanchez, M.; Chertok, M.; Conway, J.; Conway, R.; Cox, P. T.; Erbacher, R.; Flores, C.; Funk, G.; Gardner, M.; Ko, W.; Lander, R.; Mclean, C.; Mulhearn, M.; Pellett, D.; Pilot, J.; Shalhout, S.; Shi, M.; Smith, J.; Stolp, D.; Tos, K.; Tripathi, M.; Wang, Z.; Bachtis, M.; Bravo, C.; Cousins, R.; Dasgupta, A.; Florent, A.; Hauser, J.; Ignatenko, M.; Mccoll, N.; Regnard, S.; Saltzberg, D.; Schnaible, C.; Valuev, V.; Bouvier, E.; Burt, K.; Clare, R.; Ellison, J.; Gary, J. W.; Ghiasi Shirazi, S. M. A.; Hanson, G.; Heilman, J.; Kennedy, E.; Lacroix, F.; Long, O. R.; Olmedo Negrete, M.; Paneva, M. I.; Si, W.; Wang, L.; Wei, H.; Wimpenny, S.; Yates, B. R.; Branson, J. G.; Cittolin, S.; Derdzinski, M.; Gerosa, R.; Gilbert, D.; Hashemi, B.; Holzner, A.; Klein, D.; Kole, G.; Krutelyov, V.; Letts, J.; Macneill, I.; Masciovecchio, M.; Olivito, D.; Padhi, S.; Pieri, M.; Sani, M.; Sharma, V.; Simon, S.; Tadel, M.; Vartak, A.; Wasserbaech, S.; Wood, J.; Würthwein, F.; Yagil, A.; Zevi Della Porta, G.; Amin, N.; Bhandari, R.; Bradmiller-Feld, J.; Campagnari, C.; Dishaw, A.; Dutta, V.; Franco Sevilla, M.; George, C.; Golf, F.; Gouskos, L.; Gran, J.; Heller, R.; Incandela, J.; Ovcharova, A.; Qu, H.; Richman, J.; Stuart, D.; Suarez, I.; Yoo, J.; Anderson, D.; Bornheim, A.; Lawhorn, J. M.; Newman, H. B.; Nguyen, T.; Pena, C.; Spiropulu, M.; Vlimant, J. R.; Xie, S.; Zhang, Z.; Zhu, R. Y.; Andrews, M. B.; Ferguson, T.; Mudholkar, T.; Paulini, M.; Russ, J.; Sun, M.; Vogel, H.; Vorobiev, I.; Weinberg, M.; Cumalat, J. P.; Ford, W. T.; Jensen, F.; Johnson, A.; Krohn, M.; Leontsinis, S.; Mulholland, T.; Stenson, K.; Wagner, S. R.; Alexander, J.; Chaves, J.; Chu, J.; Dittmer, S.; Mcdermott, K.; Mirman, N.; Patterson, J. R.; Quach, D.; Rinkevicius, A.; Ryd, A.; Skinnari, L.; Soffi, L.; Tan, S. M.; Tao, Z.; Thom, J.; Tucker, J.; Wittich, P.; Zientek, M.; Abdullin, S.; Albrow, M.; Alyari, M.; Apollinari, G.; Apresyan, A.; Apyan, A.; Banerjee, S.; Bauerdick, L. A. T.; Beretvas, A.; Berryhill, J.; Bhat, P. C.; Bolla, G.; Burkett, K.; Butler, J. N.; Canepa, A.; Cerati, G. B.; Cheung, H. W. K.; Chlebana, F.; Cremonesi, M.; Duarte, J.; Elvira, V. D.; Freeman, J.; Gecse, Z.; Gottschalk, E.; Gray, L.; Green, D.; Grünendahl, S.; Gutsche, O.; Harris, R. M.; Hasegawa, S.; Hirschauer, J.; Hu, Z.; Jayatilaka, B.; Jindariani, S.; Johnson, M.; Joshi, U.; Klima, B.; Kreis, B.; Lammel, S.; Lincoln, D.; Lipton, R.; Liu, M.; Liu, T.; Lopes De Sá, R.; Lykken, J.; Maeshima, K.; Magini, N.; Marraffino, J. M.; Mason, D.; McBride, P.; Merkel, P.; Mrenna, S.; Nahn, S.; O'Dell, V.; Pedro, K.; Prokofyev, O.; Rakness, G.; Ristori, L.; Schneider, B.; Sexton-Kennedy, E.; Soha, A.; Spalding, W. J.; Spiegel, L.; Stoynev, S.; Strait, J.; Strobbe, N.; Taylor, L.; Tkaczyk, S.; Tran, N. V.; Uplegger, L.; Vaandering, E. W.; Vernieri, C.; Verzocchi, M.; Vidal, R.; Wang, M.; Weber, H. A.; Whitbeck, A.; Acosta, D.; Avery, P.; Bortignon, P.; Bourilkov, D.; Brinkerhoff, A.; Carnes, A.; Carver, M.; Curry, D.; Field, R. D.; Furic, I. K.; Gleyzer, S. V.; Joshi, B. M.; Konigsberg, J.; Korytov, A.; Kotov, K.; Ma, P.; Matchev, K.; Mei, H.; Mitselmakher, G.; Rank, D.; Shi, K.; Sperka, D.; Terentyev, N.; Thomas, L.; Wang, J.; Wang, S.; Yelton, J.; Joshi, Y. R.; Linn, S.; Markowitz, P.; Rodriguez, J. L.; Ackert, A.; Adams, T.; Askew, A.; Hagopian, S.; Hagopian, V.; Johnson, K. F.; Kolberg, T.; Martinez, G.; Perry, T.; Prosper, H.; Saha, A.; Santra, A.; Sharma, V.; Yohay, R.; Baarmand, M. M.; Bhopatkar, V.; Colafranceschi, S.; Hohlmann, M.; Noonan, D.; Roy, T.; Yumiceva, F.; Adams, M. R.; Apanasevich, L.; Berry, D.; Betts, R. R.; Cavanaugh, R.; Chen, X.; Evdokimov, O.; Gerber, C. E.; Hangal, D. A.; Hofman, D. J.; Jung, K.; Kamin, J.; Sandoval Gonzalez, I. D.; Tonjes, M. B.; Trauger, H.; Varelas, N.; Wang, H.; Wu, Z.; Zhang, J.; Bilki, B.; Clarida, W.; Dilsiz, K.; Durgut, S.; Gandrajula, R. P.; Haytmyradov, M.; Khristenko, V.; Merlo, J.-P.; Mermerkaya, H.; Mestvirishvili, A.; Moeller, A.; Nachtman, J.; Ogul, H.; Onel, Y.; Ozok, F.; Penzo, A.; Snyder, C.; Tiras, E.; Wetzel, J.; Yi, K.; Blumenfeld, B.; Cocoros, A.; Eminizer, N.; Fehling, D.; Feng, L.; Gritsan, A. V.; Maksimovic, P.; Roskes, J.; Sarica, U.; Swartz, M.; Xiao, M.; You, C.; Al-bataineh, A.; Baringer, P.; Bean, A.; Boren, S.; Bowen, J.; Castle, J.; Khalil, S.; Kropivnitskaya, A.; Majumder, D.; Mcbrayer, W.; Murray, M.; Royon, C.; Sanders, S.; Schmitz, E.; Tapia Takaki, J. D.; Wang, Q.; Ivanov, A.; Kaadze, K.; Maravin, Y.; Mohammadi, A.; Saini, L. K.; Skhirtladze, N.; Toda, S.; Rebassoo, F.; Wright, D.; Anelli, C.; Baden, A.; Baron, O.; Belloni, A.; Calvert, B.; Eno, S. C.; Feng, Y.; Ferraioli, C.; Hadley, N. J.; Jabeen, S.; Jeng, G. Y.; Kellogg, R. G.; Kunkle, J.; Mignerey, A. C.; Ricci-Tam, F.; Shin, Y. H.; Skuja, A.; Tonwar, S. C.; Abercrombie, D.; Allen, B.; Azzolini, V.; Barbieri, R.; Baty, A.; Bi, R.; Brandt, S.; Busza, W.; Cali, I. A.; D'Alfonso, M.; Demiragli, Z.; Gomez Ceballos, G.; Goncharov, M.; Hsu, D.; Hu, M.; Iiyama, Y.; Innocenti, G. M.; Klute, M.; Kovalskyi, D.; Lai, Y. S.; Lee, Y.-J.; Levin, A.; Luckey, P. D.; Maier, B.; Marini, A. C.; Mcginn, C.; Mironov, C.; Narayanan, S.; Niu, X.; Paus, C.; Roland, C.; Roland, G.; Salfeld-Nebgen, J.; Stephans, G. S. F.; Tatar, K.; Velicanu, D.; Wang, J.; Wang, T. W.; Wyslouch, B.; Benvenuti, A. C.; Chatterjee, R. M.; Evans, A.; Hansen, P.; Hiltbrand, J.; Kalafut, S.; Kubota, Y.; Lesko, Z.; Mans, J.; Nourbakhsh, S.; Ruckstuhl, N.; Rusack, R.; Turkewitz, J.; Wadud, M. A.; Acosta, J. G.; Oliveros, S.; Avdeeva, E.; Bloom, K.; Claes, D. R.; Fangmeier, C.; Gonzalez Suarez, R.; Kamalieddin, R.; Kravchenko, I.; Monroy, J.; Siado, J. E.; Snow, G. R.; Stieger, B.; Dolen, J.; Godshalk, A.; Harrington, C.; Iashvili, I.; Nguyen, D.; Parker, A.; Rappoccio, S.; Roozbahani, B.; Alverson, G.; Barberis, E.; Hortiangtham, A.; Massironi, A.; Morse, D. M.; Orimoto, T.; Teixeira De Lima, R.; Trocino, D.; Wood, D.; Bhattacharya, S.; Charaf, O.; Hahn, K. A.; Mucia, N.; Odell, N.; Pollack, B.; Schmitt, M. H.; Sung, K.; Trovato, M.; Velasco, M.; Dev, N.; Hildreth, M.; Hurtado Anampa, K.; Jessop, C.; Karmgard, D. J.; Kellams, N.; Lannon, K.; Loukas, N.; Marinelli, N.; Meng, F.; Mueller, C.; Musienko, Y.; Planer, M.; Reinsvold, A.; Ruchti, R.; Smith, G.; Taroni, S.; Wayne, M.; Wolf, M.; Woodard, A.; Alimena, J.; Antonelli, L.; Bylsma, B.; Durkin, L. S.; Flowers, S.; Francis, B.; Hart, A.; Hill, C.; Ji, W.; Liu, B.; Luo, W.; Winer, B. L.; Wulsin, H. W.; Cooperstein, S.; Driga, O.; Elmer, P.; Hardenbrook, J.; Hebda, P.; Higginbotham, S.; Lange, D.; Luo, J.; Marlow, D.; Mei, K.; Ojalvo, I.; Olsen, J.; Palmer, C.; Piroué, P.; Stickland, D.; Tully, C.; Malik, S.; Norberg, S.; Barker, A.; Barnes, V. E.; Das, S.; Folgueras, S.; Gutay, L.; Jha, M. K.; Jones, M.; Jung, A. W.; Khatiwada, A.; Miller, D. H.; Neumeister, N.; Peng, C. C.; Qiu, H.; Schulte, J. F.; Sun, J.; Wang, F.; Xie, W.; Cheng, T.; Parashar, N.; Stupak, J.; Adair, A.; Chen, Z.; Ecklund, K. M.; Freed, S.; Geurts, F. J. M.; Guilbaud, M.; Kilpatrick, M.; Li, W.; Michlin, B.; Northup, M.; Padley, B. P.; Roberts, J.; Rorie, J.; Shi, W.; Tu, Z.; Zabel, J.; Zhang, A.; Bodek, A.; de Barbaro, P.; Demina, R.; Duh, Y. t.; Ferbel, T.; Galanti, M.; Garcia-Bellido, A.; Han, J.; Hindrichs, O.; Khukhunaishvili, A.; Lo, K. H.; Tan, P.; Verzetti, M.; Ciesielski, R.; Goulianos, K.; Mesropian, C.; Agapitos, A.; Chou, J. P.; Gershtein, Y.; Gómez Espinosa, T. A.; Halkiadakis, E.; Heindl, M.; Hughes, E.; Kaplan, S.; Kunnawalkam Elayavalli, R.; Kyriacou, S.; Lath, A.; Montalvo, R.; Nash, K.; Osherson, M.; Saka, H.; Salur, S.; Schnetzer, S.; Sheffield, D.; Somalwar, S.; Stone, R.; Thomas, S.; Thomassen, P.; Walker, M.; Delannoy, A. G.; Foerster, M.; Heideman, J.; Riley, G.; Rose, K.; Spanier, S.; Thapa, K.; Bouhali, O.; Castaneda Hernandez, A.; Celik, A.; Dalchenko, M.; De Mattia, M.; Delgado, A.; Dildick, S.; Eusebi, R.; Gilmore, J.; Huang, T.; Kamon, T.; Mueller, R.; Pakhotin, Y.; Patel, R.; Perloff, A.; Perniè, L.; Rathjens, D.; Safonov, A.; Tatarinov, A.; Ulmer, K. A.; Akchurin, N.; Damgov, J.; De Guio, F.; Dudero, P. R.; Faulkner, J.; Gurpinar, E.; Kunori, S.; Lamichhane, K.; Lee, S. W.; Libeiro, T.; Mengke, T.; Muthumuni, S.; Peltola, T.; Undleeb, S.; Volobouev, I.; Wang, Z.; Greene, S.; Gurrola, A.; Janjam, R.; Johns, W.; Maguire, C.; Melo, A.; Ni, H.; Padeken, K.; Sheldon, P.; Tuo, S.; Velkovska, J.; Xu, Q.; Arenton, M. W.; Barria, P.; Cox, B.; Hirosky, R.; Joyce, M.; Ledovskoy, A.; Li, H.; Neu, C.; Sinthuprasith, T.; Wang, Y.; Wolfe, E.; Xia, F.; Harr, R.; Karchin, P. E.; Poudyal, N.; Sturdy, J.; Thapa, P.; Zaleski, S.; Brodski, M.; Buchanan, J.; Caillol, C.; Dasu, S.; Dodd, L.; Duric, S.; Gomber, B.; Grothe, M.; Herndon, M.; Hervé, A.; Hussain, U.; Klabbers, P.; Lanaro, A.; Levine, A.; Long, K.; Loveless, R.; Polese, G.; Ruggles, T.; Savin, A.; Smith, N.; Smith, W. H.; Taylor, D.; Woods, N.

2018-01-01

The pseudorapidity distributions of charged hadrons in proton-lead collisions at nucleon-nucleon center-of-mass energies √{s_{NN}}=5.02 and 8.16 TeV are presented. The measurements are based on data samples collected by the CMS experiment at the LHC. The number of primary charged hadrons produced in non-single-diffractive proton-lead collisions is determined in the pseudorapidity range | η lab| < 2 .4. The charged-hadron multiplicity distributions are compared to the predictions from theoretical calculations and Monte Carlo event generators. In the center-of-mass pseudorapidity range | η cm| < 0 .5, the average charged-hadron multiplicity densities 〈d N ch/d η cm〉| ηcm| < 0.5 are 17 .31 ± 0 .01 (stat) ± 0 .59 (syst) and 20 .10 ± 0 .01 (stat) ± 0 .85(syst) at √{s_{NN}}=5.02 and 8.16 TeV, respectively. The particle densities per participant nucleon are compared to similar measurements in proton-proton, proton-nucleus, and nucleus-nucleus collisions. [Figure not available: see fulltext.

[Principles of radiotherapy of non-small cell lung cancer].

PubMed

Esik, Olga; Horváth, Akos; Bajcsay, András; Hideghéty, Katalin; Agócs, László; Pikó, Béla; Lengyel, Zsolt; Petrányi, Agota; Pisch, Julianna

2002-01-01

The long-term survival probability for Hungarian lung cancer patients is 10% worse than the best results published in the most highly developed countries (the mean 5-year survival probability in Hungary is 5%, in contrast with the 15% survival probability in the USA). On the basis of the international recommendations and personal experience, an attempt was made to formulate the guidelines for radiotherapy as one of the fundamental non-small cell lung cancer (NSCLC) treatment modalities for national use. An expert panel was set up comprising physicians from 6 radiotherapeutic centers (the National Institute of Oncology / Semmelweis University, Budapest; the Beth Israel Medical Center, New York; the University of Kaposvár; the University of Essen; the University of Debrecen; and the County Hospital of Gyula). Experts in two important medical fields closely related to radiotherapy (surgery and diagnostic imaging) were also engaged in the elaboration of the manuscript. Discussion of the most important principles of the radiotherapy and an overview of the prognostic factors was followed by a critical analysis of the protocols applied in the radiotherapy of Hungarian NSCLC patients during recent decades. The new guidelines suggested for the radiotherapy of NSCLC are presented separately for the postoperative period, marginally resectable tumors, and the aggressive or non-aggressive radiotherapy of inoperable tumors. Detailed accounts are given of the techniques of external irradiation and brachytherapy, and of the acute and late radiation-induced damage of normal tissues. The authors believe that this document may be instrumental in improving the survival index of Hungarian NSCLC patients in the near future.

Hard Diffraction in Hadron--Hadron Collisions

NASA Astrophysics Data System (ADS)

Bialas, A.

2002-11-01

Breakdown of factorization observed recently in the diffractive dijet production in deep inelastic lepton induced and hadron induced processes is explained using the Good-Walker picture of diffraction dissociation. Numerical estimates agree with the recent data.

Energy Weighted Angular Correlations Between Hadrons Produced in Electron-Positron Annihilation.

NASA Astrophysics Data System (ADS)

Strharsky, Roger Joseph

Electron-positron annihilation at large center of mass energy produces many hadronic particles. Experimentalists then measure the energies of these particles in calorimeters. This study investigated correlations between the angular locations of one or two such calorimeters and the angular orientation of the electron beam in the laboratory frame of reference. The calculation of these correlations includes weighting by the fraction of the total center of mass energy which the calorimeter measures. Starting with the assumption that the reaction proceeeds through the intermediate production of a single quark/anti-quark pair, a simple statistical model was developed to provide a phenomenological description of the distribution of final state hadrons. The model distributions were then used to calculate the one- and two-calorimeter correlation functions. Results of these calculations were compared with available data and several predictions were made for those quantities which had not yet been measured. Failure of the model to reproduce all of the data was discussed in terms of quantum chromodynamics, a fundamental theory which includes quark interactions.

PREFACE: Focus section on Hadronic Physics Focus section on Hadronic Physics

NASA Astrophysics Data System (ADS)

Roberts, Craig; Swanson, Eric

2007-07-01

Hadronic physics is the study of strongly interacting matter and its underlying theory, Quantum Chromodynamics (QCD). The field had its beginnings after World War Two, when hadrons were discovered in ever increasing numbers. Today, it encompasses topics like the quark-gluon structure of hadrons at varying scales, the quark-gluon plasma and hadronic matter at extreme temperature and density; it also underpins nuclear physics and has significant impact on particle physics, astrophysics, and cosmology. Among the goals of hadronic physics are to determine the parameters of QCD, understand the origin and characteristics of confinement, understand the dynamics and consequences of dynamical chiral symmetry breaking, explore the role of quarks and gluons in nuclei and in matter under extreme conditions and understand the quark and gluon structure of hadrons. In general, the process is one of discerning the relevant degrees of freedom and relating these to the fundamental fields of QCD. The emphasis is on understanding QCD, rather than testing it. The papers gathered in this special focus section of Journal of Physics G: Nuclear and Particle Physics attempt to cover this broad range of subjects. Alkofer and Greensite examine the issue of quark and gluon confinement with the focus on models of the QCD vacuum, lattice gauge theory investigations, and the relationship to the AdS/CFT correspondence postulate. Arrington et al. review nucleon form factors and their role in determining quark orbital momentum, the strangeness content of the nucleon, meson cloud effects, and the transition from nonperturbative to perturbative QCD dynamics. The physics associated with hadronic matter at high temperature and density and at low Bjorken-x at the Relativistic Heavy Ion Collider (RHIC), the SPS at CERN, and at the future LHC is summarized by d'Enterria. The article of Lee and Smith examines experiment and theory associated with electromagnetic meson production from nucleons and

Di-hadron production at Jefferson Laboratory

NASA Astrophysics Data System (ADS)

Anefalos Pereira, Sergio; CLAS Collaboration

2015-04-01

Semi-inclusive deep inelastic scattering (SIDIS) has been used extensively in recent years as an important testing ground for QCD. Studies so far have concentrated on better determination of parton distribution functions, distinguishing between the quark and antiquark contributions, and understanding the fragmentation of quarks into hadrons. Pair of hadrons (di-hadron) SIDIS provides information on the nucleon structure and hadronization dynamics that complements single-hadron SIDIS. The study of di-hadrons allow us to study higher twist distribution functions and Dihadron Fragmentation Functions (DiFF). Together with the twist-2 PDFs (f 1, g 1, h 1), the Higher Twist (HT) e and hL functions are very interesting because they offer insights into the physics of the largely unexplored quark-gluon correlations which provide direct and unique insights into the dynamics inside hadrons. The CLAS spectrometer, installed in Hall-B at Jefferson Lab, has collected data using the CEBAF 6 GeV longitudinally polarized electron beam on longitudinally polarized solid NH3 targets. Preliminary results on beam-, target- and double-spin asymmetries will be presented.

Hadron-quark crossover and hot neutron stars at birth

NASA Astrophysics Data System (ADS)

Masuda, Kota; Hatsuda, Tetsuo; Takatsuka, Tatsuyuki

2016-02-01

We construct a new isentropic equation of state (EOS) at finite temperature, "CRover," on the basis of the hadron-quark crossover at high density. By using the new EOS, we study the structure of hot neutron stars at birth with typical lepton fraction (Y_l=0.3-0.4) and typical entropy per baryon (hat {S}=1{-}2). Due to the gradual appearance of quark degrees of freedom at high density, the temperature T and the baryon density ρ at the center of hot neutron stars with hadron-quark crossover are found to be smaller than those without the crossover by a factor of two or more. Typical energy release due to the contraction of a hot neutron star to a cold neutron star with mass M=1.4 M_{⊙} is shown to be about 0.04 M_{⊙}, with a spin-up rate of about 14%.

Unstable Hadrons in Hot Hadron Gas in Laboratory and in the Early Universe

NASA Astrophysics Data System (ADS)

Kuznetsova, Inga; Rafelski, Johann

2011-04-01

We study kinetic master equations for reactions involving the formation and the natural decay of unstable particles in a thermal expanding hadronic gas in the laboratory and in the early Universe. We consider here for the first time the role of the decay channel of one (hadron resonance) into two daughter particles, and also by token of detailed balance the inverse process, fusion of two (thermal) particles into one. We obtain the thermal invariant reaction rate using as an input the free space (vacuum) decay time and show the medium quantum effects on π+π<->ρ reaction relaxation time. As another laboratory example we describe the K+K<->φ process in thermal expanding hadronic gas in heavy ions collisions. A particularly interesting application of our formalism is the 0̂<->γ+γ process in the early Universe. We also explore the fate of charged pions and the muon freeze-out in the Universe. Another interesting field of application of our formalism is the study of short lived hadronic resonances, which are in general not able to reach yield equilibrium. We study the evolution of hadron resonances in small drops of QGP and use the insight gained to generalize the dynamics to QED effects as well.

Hadron Collider Detectors

DOE Office of Scientific and Technical Information (OSTI.GOV)

Incandela, J.R.

2000-03-07

Experiments are being prepared at the Fermilab Tevatron and the CERN Large Hadron Collider that promise to deliver extraordinary insights into the nature of spontaneous symmetry breaking, and the role of supersymmetry in the universe. This article reviews the goals, challenges, and designs of these experiments. The first hadron collider, the ISR at CERN, has to overcome two initial obstacles. The first was low luminosity, which steadily improved over time. The second was the broad angular spread of interesting events. In this regard Maurice Jacob noted (1): The answer is ... sophisticated detectors covering at least the whole central regionmore » (45{degree} {le} {theta} {le} 135{degree}) and full azimuth. This statement, while obvious today, reflects the major revelation of the ISR period that hadrons have partonic substructure. The result was an unexpectedly strong hadronic yield at large transverse momentum (p{sub T}). Partly because of this, the ISR missed the discovery of the J/{psi} and later missed the {Upsilon}. The ISR era was therefore somewhat less auspicious than it might have been. It did however make important contributions in areas such as jet production and charm excitation and it paved the way for the SPS collider, also at CERN.« less

The Emergence of Hadrons from QCD Color

NASA Astrophysics Data System (ADS)

Brooks, William; Color Dynamics in Cold Matter (CDCM) Collaboration

2015-10-01

The formation of hadrons from energetic quarks, the dynamical enforcement of QCD confinement, is not well understood at a fundamental level. In Deep Inelastic Scattering, modifications of the distributions of identified hadrons emerging from nuclei of different sizes reveal a rich variety of spatial and temporal characteristics of the hadronization process, including its dependence on spin, flavor, energy, and hadron mass and structure. The EIC will feature a wide range of kinematics, allowing a complete investigation of medium-induced gluon bremsstrahlung by the propagating quarks, leading to partonic energy loss. This fundamental process, which is also at the heart of jet quenching in heavy ion collisions, can be studied for light and heavy quarks at the EIC through observables quantifying hadron ``attenuation'' for a variety of hadron species. Transverse momentum broadening of hadrons, which is sensitive to the nuclear gluonic field, will also be accessible, and can be used to test our understanding from pQCD of how this quantity evolves with pathlength, as well as its connection to partonic energy loss. The evolution of the forming hadrons in the medium will shed new light on the dynamical origins of the forces between hadrons, and thus ultimately on the nuclear force. Supported by the Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) of Chile.

Sexual Quality of Life and Needs for Sexology Care of Cancer Patients Admitted for Radiotherapy: A 3-Month Cross-Sectional Study in a Regional Comprehensive Reference Cancer Center.

PubMed

Almont, Thierry; Delannes, Martine; Ducassou, Anne; Corman, André; Bondil, Pierre; Moyal, Elizabeth; Schover, Leslie; Huyghe, Eric

2017-04-01

Providing early and better care in onco-sexuality and a better understanding of the sexual health care needs of patients before they start treatment is required. To assess sexual quality of life and need for sexology care of patients when they are starting radiotherapy. We performed a cross-sectional study of adult patients with cancer admitted for radiotherapy treatment in a regional comprehensive cancer center. We selected all consecutive adult patients scheduled to start radiotherapy within a 3-month period and excluded patients who could not complete the questionnaires. Patients were asked to complete the Sexual Quality of Life Questionnaire (SQoL) and a needs-assessment questionnaire. Total score on the SQoL and willingness (yes or no) to get help for a sexual problem. The study sample was composed of 77 men and 123 women. The average SQoL scores were 68.4 ± 20.9 and 47.1 ± 13.0 for men and women, respectively (P < .001). Of sexually active patients, 58% had decreased frequency of intercourse or had completely stopped sexual activity after their cancer diagnosis. Half the participants wanted care for their sexual concerns. The proportion desiring specific types of care varied from 28.5% (couple counseling) to 54.5% (sexual physician) with variation by sex or type of cancer. Furthermore, 11.5% of participants declared their willingness to join support groups. Early interventions before radiotherapy could improve sexual quality of life, particularly in women. Strengths are the SQoL validated in men and women, the original window for assessment, and the study location. Limitations are the monocentric design, the potential recall bias for data before cancer diagnosis, and the fact that some patients had treatments before radiotherapy. Our data suggest the need to examine the sexual health trajectory in a prospective fashion from diagnosis to survivorship. Almont T, Delannes M, Ducasson A, et al. Sexual Quality of Life and Needs for Sexology Care of Cancer

Medical Applications at CERN and the ENLIGHT Network

PubMed Central

Dosanjh, Manjit; Cirilli, Manuela; Myers, Steve; Navin, Sparsh

2016-01-01

State-of-the-art techniques derived from particle accelerators, detectors, and physics computing are routinely used in clinical practice and medical research centers: from imaging technologies to dedicated accelerators for cancer therapy and nuclear medicine, simulations, and data analytics. Principles of particle physics themselves are the foundation of a cutting edge radiotherapy technique for cancer treatment: hadron therapy. This article is an overview of the involvement of CERN, the European Organization for Nuclear Research, in medical applications, with specific focus on hadron therapy. It also presents the history, achievements, and future scientific goals of the European Network for Light Ion Hadron Therapy, whose co-ordination office is at CERN. PMID:26835422

Medical Applications at CERN and the ENLIGHT Network.

PubMed

Dosanjh, Manjit; Cirilli, Manuela; Myers, Steve; Navin, Sparsh

2016-01-01

State-of-the-art techniques derived from particle accelerators, detectors, and physics computing are routinely used in clinical practice and medical research centers: from imaging technologies to dedicated accelerators for cancer therapy and nuclear medicine, simulations, and data analytics. Principles of particle physics themselves are the foundation of a cutting edge radiotherapy technique for cancer treatment: hadron therapy. This article is an overview of the involvement of CERN, the European Organization for Nuclear Research, in medical applications, with specific focus on hadron therapy. It also presents the history, achievements, and future scientific goals of the European Network for Light Ion Hadron Therapy, whose co-ordination office is at CERN.

Hadron collider searches for diboson resonances

NASA Astrophysics Data System (ADS)

Dorigo, Tommaso

2018-05-01

This review covers results of searches for new elementary particles that decay into boson pairs (dibosons), performed at the CERN Large Hadron Collider in proton-proton collision data collected by the ATLAS and CMS experiments at 7-, 8-, and 13-TeV center-of-mass energy until the year 2017. The available experimental results of the analysis of final states including most of the possible two-object combinations of W and Z bosons, photons, Higgs bosons, and gluons place stringent constraints on a variety of theoretical ideas that extend the standard model, pushing into the multi-TeV region the scale of allowed new physics phenomena.

Hadron-nucleus interactions at high energies

DOE Office of Scientific and Technical Information (OSTI.GOV)

Chiu, C.B.; He, Z.; Tow, D.M.

1982-06-01

A simple space-time description of high-energy hadron-nucleus interactions is presented. The model is based on the DTU (dual topologial unitarization)-parton-model description of soft multiparticle production in hadron-hadron interactions. The essentially parameter-free model agrees well with the general features of high-energy data for hadron-nucleus interactions; in particular, this DTU-parton model has a natural explanation for an approximate nu-bar universality. The expansion to high-energy nucleus-nucleus interactions is presented. We also compare and contrast this model with several previously proposed models.

Hadron-nucleus interactions at high energies

NASA Astrophysics Data System (ADS)

Chiu, Charles B.; He, Zuoxiu; Tow, Don M.

1982-06-01

A simple space-time description of high-energy hadron-nucleus interactions is presented. The model is based on the DTU (dual topological unitarization) -parton-model description of soft multiparticle production in hadron-hadron interactions. The essentially parameter-free model agrees well with the general features of high-energy data for hadron-nucleus interactions; in particular, this DTU-parton model has a natural explanation for an approximate ν¯ universality. The extension to high-energy nucleus-nucleus interactions is presented. We also compare and contrast this model with several previously proposed models.

Radiotherapy in Italy after conservative treatment of early breast cancer. A survey by the Italian Society of Radiation Oncology (AIRO).

PubMed

Aristei, Cynthia; Amichetti, Maurizio; Ciocca, Mario; Nardone, Luigia; Bertoni, Filippo; Vidali, Cristiana

2008-01-01

The aim of surveys on clinical practice is to stimulate discussion and optimize practice. In this paper the current Italian radiotherapy practice after breast-conserving surgery for early breast cancer is described and adherence to national and international guidelines is assessed. Furthermore, results are compared with an earlier survey in northern Italy and international reports. A multiple-choice questionnaire sent to all 138 Italian radiation oncology centers. 48% of centers responded. Most performed breast-conserving surgery when tumor size was < or =3 cm. All centers routinely performed axillary dissection; 45 carried out sentinel node biopsy followed by axillary dissection when the sentinel node was positive. Most centers re-excised when resection margins were positive. The median interval between surgery and radiotherapy, when chemotherapy was not administered, was 60 days. Adjuvant chemotherapy was preferably administered before radiotherapy. Regional lymph nodes were never irradiated in 10 centers; in all others irradiation depended on the number of positive lymph nodes and/or involvement of axillary fat and/or tumor location in medial quadrants. All centers used standard fractionation; hypofractionated schemes were available in 6. Most centers used 4-6 MV photons. In 59 centers the boost dose of 10 Gy could be increased if margins were not negative. All centers ensured patient setup reproducibility. Treatment planning was computerized in 59 centers. The irradiation dose was prescribed at the ICRU point in 56 centers and portal films were made in 54 centers. Intraoperative radiotherapy was used in 4 centers: for partial breast irradiation in 1 and for boost administration in 3 centers. Although the quality of radiotherapy delivery has improved in Italy in recent years, approaches that do not conform to international standards persist.

Going beyond the second virial coefficient in the hadron resonance gas model

NASA Astrophysics Data System (ADS)

Bugaev, K. A.; Sagun, V. V.; Ivanytskyi, A. I.; Yakimenko, I. P.; Nikonov, E. G.; Taranenko, A. V.; Zinovjev, G. M.

2018-02-01

We develop a novel formulation of the hadron resonance gas model which, besides a hard-core repulsion, explicitly accounts for the surface tension induced by the interaction between the particles. Such an equation of state allows us to go beyond the Van der Waals approximation for any number of different hard-core radii. A comparison with the Carnahan-Starling equation of state shows that the new model is valid for packing fractions 0.2-0.22, while the usual Van der Waals model is inapplicable at packing fractions above 0.1-0.11. Moreover, it is shown that the equation of state with induced surface tension is softer than the one of hard spheres and remains causal at higher particle densities. The great advantage of our model is that there are only two equations to be solved and neither their number nor their form depend on the values of the hard-core radii used for different hadronic resonances. Such an advantage leads to a significant mathematical simplification compared to other versions of truly multi-component hadron resonance gas models. Using this equation of state we obtain a high-quality fit of the ALICE hadron multiplicities measured at the center-of-mass energy 2.76 TeV per nucleon and we find that the dependence of χ2 / ndf on the temperature has a single global minimum in the traditional hadron resonance gas model with the multi-component hard-core repulsion. Also we find two local minima of χ2 / ndf in the model in which the proper volume of each hadron is proportional to its mass. However, it is shown that in the latter model a second local minimum located at higher temperatures always appears far above the limit of its applicability.

Teleradiotherapy Network: Applications and Feasibility for Providing Cost-Effective Comprehensive Radiotherapy Care in Low- and Middle-Income Group Countries for Cancer Patients.

PubMed

Datta, Niloy Ranjan; Heuser, Michael; Samiei, Massoud; Shah, Ragesh; Lutters, Gerd; Bodis, Stephan

2015-07-01

Globally, new cancer cases will rise by 57% within the next two decades, with the majority in the low- and middle-income countries (LMICs). Consequently, a steep increase of about 40% in cancer deaths is expected there, mainly because of lack of treatment facilities, especially radiotherapy. Radiotherapy is required for more than 50% of patients, but the capital cost for equipment often deters establishment of such facilities in LMICs. Presently, of the 139 LMICs, 55 do not even have a radiotherapy facility, whereas the remaining 84 have a deficit of 61.4% of their required radiotherapy units. Networking between centers could enhance the effectiveness and reach of existing radiotherapy in LMICs. A teleradiotherapy network could enable centers to share and optimally utilize their resources, both infrastructure and staffing. This could be in the form of a three-tier radiotherapy service consisting of primary, secondary, and tertiary radiotherapy centers interlinked through a network. The concept has been adopted in some LMICs and could also be used as a "service provider model," thereby reducing the investments to set up such a network. Teleradiotherapy networks could be a part of the multipronged approach to address the enormous gap in radiotherapy services in a cost-effective manner and to support better accessibility to radiotherapy facilities, especially for LMICs.

Pseudorapidity distributions of charged hadrons in proton-lead collisions at $$ \\sqrt{s_{\\mathrm{NN}}}=5.02 $$ and 8.16 TeV

DOE PAGES

Sirunyan, A. M.; Tumasyan, A.; Adam, W.; ...

2018-01-11

The pseudorapidity distributions of charged hadrons in proton-lead collisions at nucleon-nucleon center-of-mass energiesmore » $$\\sqrt{s_{_\\mathrm{NN}}} =$$ 5.02 and 8.16 TeV are presented. The measurements are based on data samples collected by the CMS experiment at the LHC. The number of primary charged hadrons produced in non-single-diffractive proton-lead collisions is determined in the pseudorapidity range $$|\\eta_\\mathrm{lab}| <$$ 2.4. The charged-hadron multiplicity distributions are compared to the predictions from theoretical calculations and Monte Carlo event generators. In the center-of-mass pseudorapidity range $$|\\eta_\\mathrm{cm}| < 0.5$$, the average charged-hadron multiplicity densities $$<\\mathrm{d}N_{\\mathrm{ch}}/\\mathrm{d}\\eta_{\\mathrm{cm}}>$$$\\vert_{|\\eta_{\\mathrm{cm}}| < 0.5}$$ are 17.31$$\\pm $$0.01 (stat) $$\\pm$$ 0.59 (syst) and 20.10$$\\pm$$0.01 (stat)$$\\pm$$0.85 (syst) at $$\\sqrt{s_{_\\mathrm{NN}}} =$$ 5.02 and 8.16 TeV, respectively. As a result, the particle densities per participant nucleon are compared to similar measurements in proton-proton, proton-nucleus, and nucleus-nucleus collisions.« less

A Data Analysis Center for Electromagnetic and Hadronic Interaction. Products of the DAC members

DOE Office of Scientific and Technical Information (OSTI.GOV)

Briscoe, William John; Strakovsky, Igor I.; Workman, Ronald L.

The Data Analysis Center (DAC) of the Center for Nuclear Studies (CNS) at the George Washington University (GW) has made significant progress in its program to enhance and expand the partial-wave (and multipole) analyses of fundamental two- and three-body reactions (such as pion-nucleon, photon-nucleon, and nucleon-nucleon scattering) by maintaining and augmenting the analysis codes and databases associated with these reactions. These efforts provide guidance to experimental groups at the international level, forming an important link between theory and experiment. A renaissance in light hadron spectroscopy is underway as a continuous stream of polarization data issues from existing precision electromagnetic facilitiesmore » and the coming Jefferson Lab 12 GeV Upgrade. Our principal goals have been focused on supporting the national N* resonance physics program. We have also continued to study topics more generally related to the problems associated with partial-wave analysis. On the Experimental side of the CNS DAC. Its primary goal is the enhancement of the body of data necessary for our analyses of fundamental γ - N reactions. We perform experiments that study the dynamics responsible for the internal structure of the nucleon and its excitations. Our principal focus is on the N* programs at JLab and MAMI. At JLab we study spin-polarization observables using polarized photons, protons and neutrons and yielding charged final states. Similarly at MAMI we study neutral meson photoproduction off polarized protons and neutrons. We use the Crystal Ball and TAPS spectrometers (CBT) to detect photons and neutrons to measure the photoproduction of π0, η, 2π0, π0η, and K0 off the neutron. The CBT program complements our program at JLab, which studies reactions resulting in charged final states. We are also involved in a renewed effort to make neutral pion photoproduction measurements close to threshold at Mainz. In addition to the programs underway, we are

Investigation of the leading and subleading high-energy behavior of hadron-hadron total cross sections using a best-fit analysis of hadronic scattering data

NASA Astrophysics Data System (ADS)

Giordano, M.; Meggiolaro, E.; Silva, P. V. R. G.

2017-08-01

In the present investigation we study the leading and subleading high-energy behavior of hadron-hadron total cross sections using a best-fit analysis of hadronic scattering data. The parametrization used for the hadron-hadron total cross sections at high energy is inspired by recent results obtained by Giordano and Meggiolaro [J. High Energy Phys. 03 (2014) 002, 10.1007/JHEP03(2014)002] using a nonperturbative approach in the framework of QCD, and it reads σtot˜B ln2s +C ln s ln ln s . We critically investigate if B and C can be obtained by means of best-fits to data for proton-proton and antiproton-proton scattering, including recent data obtained at the LHC, and also to data for other meson-baryon and baryon-baryon scattering processes. In particular, following the above-mentioned nonperturbative QCD approach, we also consider fits where the parameters B and C are set to B =κ Bth and C =κ Cth, where Bth and Cth are universal quantities related to the QCD stable spectrum, while κ (treated as an extra free parameter) is related to the asymptotic value of the ratio σel/σtot. Different possible scenarios are then considered and compared.

PREFACE: 5th DAE-BRNS Workshop on Hadron Physics (Hadron 2011)

NASA Astrophysics Data System (ADS)

Jyoti Roy, Bidyut; Chatterjee, A.; Kailas, S.

2012-07-01

The 5th DAE-BRNS Workshop on Hadron Physics was held at the Bhabha Atomic Research Centre (BARC), Mumbai from 31 October to 4 November 2011. This workshop series, supported by the Board of Research in Nuclear Sciences, Department of Atomic Energy (BRNS, DAE), Govt. of India, began ten years ago with the first one being held at BARC, Mumbai in October 2002. The second one was held at Puri in 2005, organized jointly by Institute of Physics, Bhubneswar and Saha Institute of Nuclear Physics, Kolkata. The 3rd and 4th ones took place, respectively, at Shantineketan in 2006, organized by Visva Bharati University, and at Aligarh in 2008, organized by Aligarh Muslim University, Aligarh. The aim of the present workshop was to bring together the experts and young researchers in the field of hadron physics (both experiment and theory) and to have in-depth discussions on the current research activities in this field. The format of the workshop was: a series of review lectures by various experts from India and abroad, the presentation of advanced research results by researchers in the field, and a review of major experimental programs being planned and pursued in major laboratories in the field of hadron physics, with the aim of providing a platform for the young participants for interaction with their peers. The upcoming international FAIR facility at GSI is a unique future facility for studies of hadron physics in the charm sector and hyper nuclear physics. The Indian hadron physics community is involved in this mega science project and is working with the PANDA collaboration on the development of detectors, simulation and software tools for the hadron physics programme with antiprotons at FAIR. A one-day discussion session was held at this workshop to discuss India-PANDA activities, the current collaboration status and the work plan. This volume presents the workshop proceedings consisting of lectures and seminars which were delivered during the workshop. We are thankful to

Hadronic production of the doubly heavy baryon {Xi}{sub bc} at the LHC

DOE Office of Scientific and Technical Information (OSTI.GOV)

Zhang Jiawei; Wu Xinggang; Zhong Tao

We investigate the hadronic production of the doubly heavy baryon {Xi}{sub bc} at the Large Hadron Collider (LHC), where contributions from the four (bc)-diquark states (bc){sub 3,6}[{sup 1}S{sub 0}] and (bc){sub 3,6}[{sup 3}S{sub 1}] have been taken into consideration. Numerical results show that under the condition of p{sub T}>4 GeV and |y|<1.5, sizable {Xi}{sub bc} events about 1.7x10{sup 7} and 3.5x10{sup 9} per year can be produced for the center-of-mass energy {radical}(S)=7 TeV and {radical}(S)=14 TeV, respectively. For experimental usage, the total and the interested differential cross sections are estimated under some typical p{sub T} and y cuts for themore » LHC detectors CMS, ATLAS, and LHCb. The main uncertainties are discussed and a comparative study on the hadronic production of {Xi}{sub cc}, {Xi}{sub bc}, and {Xi}{sub bb} at the LHC are also presented.« less

Teleradiotherapy Network: Applications and Feasibility for Providing Cost-Effective Comprehensive Radiotherapy Care in Low- and Middle-Income Group Countries for Cancer Patients

PubMed Central

Heuser, Michael; Samiei, Massoud; Shah, Ragesh; Lutters, Gerd; Bodis, Stephan

2015-01-01

Abstract Globally, new cancer cases will rise by 57% within the next two decades, with the majority in the low- and middle-income countries (LMICs). Consequently, a steep increase of about 40% in cancer deaths is expected there, mainly because of lack of treatment facilities, especially radiotherapy. Radiotherapy is required for more than 50% of patients, but the capital cost for equipment often deters establishment of such facilities in LMICs. Presently, of the 139 LMICs, 55 do not even have a radiotherapy facility, whereas the remaining 84 have a deficit of 61.4% of their required radiotherapy units. Networking between centers could enhance the effectiveness and reach of existing radiotherapy in LMICs. A teleradiotherapy network could enable centers to share and optimally utilize their resources, both infrastructure and staffing. This could be in the form of a three-tier radiotherapy service consisting of primary, secondary, and tertiary radiotherapy centers interlinked through a network. The concept has been adopted in some LMICs and could also be used as a “service provider model,” thereby reducing the investments to set up such a network. Teleradiotherapy networks could be a part of the multipronged approach to address the enormous gap in radiotherapy services in a cost-effective manner and to support better accessibility to radiotherapy facilities, especially for LMICs. PMID:25763906

KMR kt-factorization procedure for the description of the LHCb forward hadron-hadron Z0 production at √{ s} = 13TeV

NASA Astrophysics Data System (ADS)

Modarres, M.; Masouminia, M. R.; Aminzadeh Nik, R.; Hosseinkhani, H.; Olanj, N.

2017-09-01

Quite recently, two sets of new experimental data from the LHCb and the CMS Collaborations have been published, concerning the production of the Z0 vector boson in hadron-hadron collisions with the center-of-mass energy ECM =√{ s} = 13TeV. On the other hand, in our recent work, we have conducted a set of semi-NLO calculations for the production of the electro-weak gauge vector bosons, utilizing the unintegrated parton distribution functions (UPDF) in the frameworks of Kimber-Martin-Ryskin (KMR) or Martin-Ryskin-Watt (MRW) and the kt-factorization formalism, concluding that the results of the KMR scheme are arguably better in describing the existing experimental data, coming from D0, CDF, CMS and ATLAS Collaborations. In the present work, we intend to follow the same semi-NLO formalism and calculate the rate of the production of the Z0 vector boson, utilizing the UPDF of KMR within the dynamics of the recent data. It will be shown that our results are in good agreement with the new measurements of the LHCb and the CMS Collaborations.

Hadronic interactions and EAS muon pseudorapidities investigated with the Muon Tracking Detector in KASCADE-Grande

NASA Astrophysics Data System (ADS)

Zabierowski, J.; Apel, W. D.; Arteaga, J. C.; Badea, F.; Bekk, K.; Bertaina, M.; Blümer, H.; Bozdog, H.; Brancus, I. M.; Brüggemann, M.; Buchholz, P.; Cantoni, E.; Chiavassa, A.; Cossavella, F.; Daumiller, K.; de Souza, V.; di Pierro, F.; Doll, P.; Engel, R.; Engler, J.; Finger, M.; Fuhrmann, D.; Ghia, P. L.; Gils, H. J.; Glasstetter, R.; Grupen, C.; Haungs, A.; Heck, D.; Hörandel, J. R.; Huege, T.; Isar, P. G.; Kampert, K.-H.; Kang, D.; Kickelbick, D.; Klages, H. O.; Kolotaev, Y.; Łuczak, P.; Mathes, H. J.; Mayer, H. J.; Milke, J.; Mitrica, B.; Morello, C.; Navarra, G.; Nehls, S.; Oehlschläger, J.; Ostapchenko, S.; Petcu, M.; Pierog, T.; Rebel, H.; Roth, M.; Schieler, H.; Schröder, F.; Sima, O.; Stümpert, M.; Toma, G.; Trinchero, G. C.; Ulrich, H.; van Buren, J.; Walkowiak, W.; Weindl, A.; Wochele, J.; Wommer, M.; KASCADE-Grande Collaboration

2009-12-01

The Muon Tracking Detector in the KASCADE-Grande EAS experiment allows the precise measurement of shower muon directions up to 700 m distance from the shower center. This directional information is used to study the pseudorapidity of muons in EAS, closely related to the pseudorapidity of their parent mesons. Moreover, the mean value of muon pseudorapidity in a registered shower reflects the longitudinal development of its hadronic component. All of this makes it a good tool for testing hadronic interaction models. The possibilities of such tests given by the KASCADE-Grande experimental setup are discussed and an example of the obtained muon pseudorapidity spectrum is shown.

Hadron masses in a gauge theory

DOE Office of Scientific and Technical Information (OSTI.GOV)

De Rujula, A.; Georgi, H.; Glashow, S.L.

1975-07-01

We explore the implications for hadron spectroscopy of the ''standard'' gauge model of weak, electromagnetic, and strong interactions. The model involves four types of fractionally charged quarks, each in three colors, coupling to massless gauge gluons. The quarks are confined within colorless hadrons by a long-range spin-independent force realizing infrared slavery. We use the asymptotic freedom of the model to argue that for the calculation of hadron masses, the short-range quark-quark interaction may be taken to be Coulomb- like. We rederive many successful quark-model mass relations for the low-lying hadrons. Because a specific interaction and symmetry-breaking mechanism are forced onmore » us by the underlying renormalizable gauge field theory, we also obtain new mass relations. They are well satisfied. We develop a qualitative understanding of many features of the hadron mass spectrum, such as the origin and sign of the $Sigma$-$lambda$ mass splitting. Interpreting the newly discovered narrow boson resonances as states of charmonium, we use the model to predict the masses of charmed mesons and baryons.« less

Hadron Spectra in p+p Collisions at Rhic and Lhc Energies

NASA Astrophysics Data System (ADS)

Khandai, P. K.; Sett, P.; Shukla, P.; Singh, V.

2013-06-01

We present the systematic analysis of transverse momentum (pT) spectra of identified hadrons in p+p collisions at Relativistic Heavy Ion Collider (√ {s} = 62.4 and 200 GeV) and at Large Hadron Collider (LHC) energies (√ {s} = 0.9, 2.76 and 7.0 TeV) using phenomenological fit functions. We review various forms of Hagedorn and Tsallis distributions and show their equivalence. We use Tsallis distribution which successfully describes the spectra in p+p collisions using two parameters, Tsallis temperature T which governs the soft bulk spectra and power n which determines the initial production in partonic collisions. We obtain these parameters for pions, kaons and protons as a function of center-of-mass energy (√ {s}). It is found that the parameter T has a weak but decreasing trend with increasing √ {s}. The parameter n decreases with increasing √ {s} which shows that production of hadrons at higher energies are increasingly dominated by point like qq scatterings. Another important observation is with increasing √ {s}, the separation between the powers for protons and pions narrows down hinting that the baryons and mesons are governed by same production process as one moves to the highest LHC energy.

Scattering and stopping of hadrons in nuclear matter

NASA Technical Reports Server (NTRS)

Strugalski, Z.

1985-01-01

It was observed, in the 180 litre xenon bubble chamber, that when hadrons with kinetic energy higher than the pion production threshold fall on a layer of nuclear matter - on an atomic nucleus in other words - in many cases they can pass through it without causing particles production but they are deflected through some deflection angles; if the energy is lower than a few GeV and the nuclear matter layer is thick enough, the hadrons can be stopped in it. The amount of the deflection at a given incident hadron energy varies with the way the hadron strikes the atomic nucleus; the probability of the occurrence of stopping depends on the incident hadron identity and energy, and on the way the hadron passed through the nucleus, as well.

Hadronic interactions in the MINOS detectors

DOE Office of Scientific and Technical Information (OSTI.GOV)

Kordosky, Michael Alan

2004-08-01

MINOS, the Main Injector Neutrino Oscillation Search, will study neutrino flavor transformations using a Near detector at the Fermi National Accelerator Laboratory and a Far detector located in the Soudan Underground Laboratory in northern Minnesota. The MINOS collaboration also constructed the CalDet (calibration detector), a smaller version of the Near and Far detectors, to determine the topological and signal response to hadrons, electrons and muons. The detector was exposed to test-beams in the CERN Proton Synchrotron East Hall during 2001-2003, where it collected events at momentum settings between 200 MeV/c and 10 GeV/c. In this dissertation we present results ofmore » the CalDet experiment, focusing on the topological and signal response to hadrons. We briefly describe the MINOS experiment and its iron-scintillator tracking-sampling calorimters as a motivation for the CalDet experiment. We discuss the operation of the CalDet in the beamlines as well as the trigger and particle identification systems used to isolate the hadron sample. The method used to calibrate the MINOS detector is described and validated with test-beam data. The test-beams were simulated to model the muon flux, energy loss upstream of the detector and the kaon background. We describe the procedure used to discriminate between pions and muons on the basis of the event topology. The hadron samples were used to benchmark the existing GEANT3 based hadronic shower codes and determine the detector response and resolution for pions and protons. We conclude with comments on the response to single hadrons and to neutrino induced hadronic showers.« less

Radiotherapy Treatment Planning for Testicular Seminoma

DOE Office of Scientific and Technical Information (OSTI.GOV)

Wilder, Richard B., E-mail: richardbwilder@yahoo.com; Buyyounouski, Mark K.; Efstathiou, Jason A.

2012-07-15

Virtually all patients with Stage I testicular seminoma are cured regardless of postorchiectomy management. For patients treated with adjuvant radiotherapy, late toxicity is a major concern. However, toxicity may be limited by radiotherapy techniques that minimize radiation exposure of healthy normal tissues. This article is an evidence-based review that provides radiotherapy treatment planning recommendations for testicular seminoma. The minority of Stage I patients who choose adjuvant treatment over surveillance may be considered for (1) para-aortic irradiation to 20 Gy in 10 fractions, or (2) carboplatin chemotherapy consisting of area under the curve, AUC = 7 Multiplication-Sign 1-2 cycles. Two-dimensional radiotherapymore » based on bony anatomy is a simple and effective treatment for Stage IIA or IIB testicular seminoma. Centers with expertise in vascular and nodal anatomy may consider use of anteroposterior-posteroanterior fields based on three-dimensional conformal radiotherapy instead. For modified dog-leg fields delivering 20 Gy in 10 fractions, clinical studies support placement of the inferior border at the top of the acetabulum. Clinical and nodal mapping studies support placement of the superior border of all radiotherapy fields at the top of the T12 vertebral body. For Stage IIA and IIB patients, an anteroposterior-posteroanterior boost is then delivered to the adenopathy with a 2-cm margin to the block edge. The boost dose consists of 10 Gy in 5 fractions for Stage IIA and 16 Gy in 8 fractions for Stage IIB. Alternatively, bleomycin, etoposide, and cisplatin chemotherapy for 3 cycles or etoposide and cisplatin chemotherapy for 4 cycles may be delivered to Stage IIA or IIB patients (e.g., if they have a horseshoe kidney, inflammatory bowel disease, or a history of radiotherapy).« less

Radiotherapy in the elderly: a multicentric prospective study on 2060 patients referred to 37 Italian radiation therapy centers.

PubMed

Olmi, P; Ausili-Cefaro, G

1997-01-01

60-70% of all cancers will develop in the year 2000 in persons aged 65 and over. Radiation therapy will play a major role in the treatment of cancer, especially in the elderly. The Italian "Geriatric Radiation Oncology Group" (GROG) performed in 1994 a prospective study, in order to assess the characteristics of any old cancer patient referred to radiation oncology centers (age, gender performance status, comorbidity, activities of daily living, family status) and the main features of the tumor in that patient. In about 6 months 2060 patients aged 70 and over entered the study, of whom 1809 were treated with radiotherapy alone, with curative intent in 563 patients, in combination with surgery and/or chemotherapy in 476 and with palliative intent in 769 patients. Most patients had grade 0-1 acute toxicity.

Dose constraints for moderate hypofractionated radiotherapy for prostate cancer: The French genito-urinary group (GETUG) recommendations.

PubMed

Langrand-Escure, J; de Crevoisier, R; Llagostera, C; Créhange, G; Delaroche, G; Lafond, C; Bonin, C; Bideault, F; Sargos, P; Belhomme, S; Pasquier, D; Latorzeff, I; Supiot, S; Hennequin, C

2018-04-01

Considering recent phase III trials results, moderate hypofractionated radiotherapy can be considered as a standard treatment for low and intermediate risk prostate cancer management. This assessment call for a framework allowing homogeneous and reproducible practices in the different centers using this radiotherapy schedule. The French Genito-Urinary Group (GETUG) provides here recommendations for daily practice of moderate hypofractionated radiotherapy for prostate cancer, with indications, dose, fractionation, pre-treatment planning, volume of interest delineation (target volume and organs at risk) and margins, dose constraints and radiotherapy techniques. Copyright © 2018. Published by Elsevier SAS.

Statistical hadronization and microcanonical ensemble

DOE PAGES

Becattini, F.; Ferroni, L.

2004-01-01

We present a Monte Carlo calculation of the microcanonical ensemble of the of the ideal hadron-resonance gas including all known states up to a mass of 1. 8 GeV, taking into account quantum statistics. The computing method is a development of a previous one based on a Metropolis Monte Carlo algorithm, with a the grand-canonical limit of the multi-species multiplicity distribution as proposal matrix. The microcanonical average multiplicities of the various hadron species are found to converge to the canonical ones for moderately low values of the total energy. This algorithm opens the way for event generators based for themore » statistical hadronization model.« less

Carbon Ion Radiotherapy at the Gunma University Heavy Ion Medical Center: New Facility Set-up.

PubMed

Ohno, Tatsuya; Kanai, Tatsuaki; Yamada, Satoru; Yusa, Ken; Tashiro, Mutsumi; Shimada, Hirofumi; Torikai, Kota; Yoshida, Yukari; Kitada, Yoko; Katoh, Hiroyuki; Ishii, Takayoshi; Nakano, Takashi

2011-10-26

Carbon ion radiotherapy (C-ion RT) offers superior dose conformity in the treatment of deep-seated tumors compared with conventional X-ray therapy. In addition, carbon ion beams have a higher relative biological effectiveness compared with protons or X-ray beams. C-ion RT for the first patient at Gunma University Heavy Ion Medical Center (GHMC) was initiated in March of 2010. The major specifications of the facility were determined based on the experience of clinical treatments at the National Institute of Radiological Sciences (NIRS), with the size and cost being reduced to one-third of those at NIRS. The currently indicated sites of cancer treatment at GHMC are lung, prostate, head and neck, liver, rectum, bone and soft tissue. Between March 2010 and July 2011, a total of 177 patients were treated at GHMC although a total of 100 patients was the design specification during the period in considering the optimal machine performance. In the present article, we introduce the facility set-up of GHMC, including the facility design, treatment planning systems, and clinical preparations.

Carbon Ion Radiotherapy at the Gunma University Heavy Ion Medical Center: New Facility Set-up

PubMed Central

Ohno, Tatsuya; Kanai, Tatsuaki; Yamada, Satoru; Yusa, Ken; Tashiro, Mutsumi; Shimada, Hirofumi; Torikai, Kota; Yoshida, Yukari; Kitada, Yoko; Katoh, Hiroyuki; Ishii, Takayoshi; Nakano, Takashi

2011-01-01

Carbon ion radiotherapy (C-ion RT) offers superior dose conformity in the treatment of deep-seated tumors compared with conventional X-ray therapy. In addition, carbon ion beams have a higher relative biological effectiveness compared with protons or X-ray beams. C-ion RT for the first patient at Gunma University Heavy Ion Medical Center (GHMC) was initiated in March of 2010. The major specifications of the facility were determined based on the experience of clinical treatments at the National Institute of Radiological Sciences (NIRS), with the size and cost being reduced to one-third of those at NIRS. The currently indicated sites of cancer treatment at GHMC are lung, prostate, head and neck, liver, rectum, bone and soft tissue. Between March 2010 and July 2011, a total of 177 patients were treated at GHMC although a total of 100 patients was the design specification during the period in considering the optimal machine performance. In the present article, we introduce the facility set-up of GHMC, including the facility design, treatment planning systems, and clinical preparations. PMID:24213124

Mass hierarchy and energy scaling of the Tsallis - Pareto parameters in hadron productions at RHIC and LHC energies

NASA Astrophysics Data System (ADS)

Bíró, Gábor; Barnaföldi, Gergely Gábor; Biró, Tamás Sándor; Shen, Keming

2018-02-01

The latest, high-accuracy identified hadron spectra measurements in highenergy nuclear collisions led us to the investigation of the strongly interacting particles and collective effects in small systems. Since microscopical processes result in a statistical Tsallis - Pareto distribution, the fit parameters q and T are well suited for identifying system size scalings and initial conditions. Moreover, parameter values provide information on the deviation from the extensive, Boltzmann - Gibbs statistics in finite-volumes. We apply here the fit procedure developed in our earlier study for proton-proton collisions [1, 2]. The observed mass and center-of-mass energy trends in the hadron production are compared to RHIC dAu and LHC pPb data in different centrality/multiplicity classes. Here we present new results on mass hierarchy in pp and pA from light to heavy hadrons.

Exclusive processes and the fundamental structure of hadrons

DOE PAGES

Brodsky, Stanley J.

2015-01-20

I review the historical development of QCD predictions for exclusive hadronic processes, beginning with constituent counting rules and the quark interchange mechanism, phenomena which gave early validation for the quark structure of hadrons. The subsequent development of pQCD factorization theorems for hard exclusive amplitudes and the development of evolution equations for the hadron distribution amplitudes provided a rigorous framework for calculating hadronic form factors and hard scattering exclusive scattering processes at high momentum transfer. I also give a brief introduction to the field of "light-front holography" and the insights it brings to quark confinement, the behavior of the QCD couplingmore » in the nonperturbative domain, as well as hadron spectroscopy and the dynamics of exclusive processes.« less

Exclusive processes and the fundamental structure of hadrons

DOE Office of Scientific and Technical Information (OSTI.GOV)

Brodsky, Stanley J.

I review the historical development of QCD predictions for exclusive hadronic processes, beginning with constituent counting rules and the quark interchange mechanism, phenomena which gave early validation for the quark structure of hadrons. The subsequent development of pQCD factorization theorems for hard exclusive amplitudes and the development of evolution equations for the hadron distribution amplitudes provided a rigorous framework for calculating hadronic form factors and hard scattering exclusive scattering processes at high momentum transfer. I also give a brief introduction to the field of "light-front holography" and the insights it brings to quark confinement, the behavior of the QCD couplingmore » in the nonperturbative domain, as well as hadron spectroscopy and the dynamics of exclusive processes.« less

Mean transverse momenta correlations in hadron-hadron collisions in MC toy model with repulsing strings

DOE Office of Scientific and Technical Information (OSTI.GOV)

Altsybeev, Igor

2016-01-22

In the present work, Monte-Carlo toy model with repulsing quark-gluon strings in hadron-hadron collisions is described. String repulsion creates transverse boosts for the string decay products, giving modifications of observables. As an example, long-range correlations between mean transverse momenta of particles in two observation windows are studied in MC toy simulation of the heavy-ion collisions.

Hadron mass spectrum from lattice QCD.

PubMed

Majumder, Abhijit; Müller, Berndt

2010-12-17

Finite temperature lattice simulations of quantum chromodynamics (QCD) are sensitive to the hadronic mass spectrum for temperatures below the "critical" temperature T(c) ≈ 160 MeV. We show that a recent precision determination of the QCD trace anomaly shows evidence for the existence of a large number of hadron states beyond those known from experiment. The lattice results are well represented by an exponentially growing mass spectrum up to a temperature T=155 MeV. Using simple parametrizations of the hadron mass spectrum we show how one may estimate the total spectral weight in these yet undermined states.

Hadron molecules

NASA Astrophysics Data System (ADS)

Thomas, Gutsche; Tanja, Branz; Amand, Faessler; Ian, Woo Lee; Valery, E. Lyubovitskij

2010-09-01

We discuss a possible interpretation of the open charm mesons D*s0(2317), Ds1(2460) and the hidden charm mesons X(3872), Y(3940) and Y(4140) as hadron molecules. Using a phenomenological Lagrangian approach we review the strong and radiative decays of the D*s0(2317) and Ds1(2460) states. The X(3872) is assumed to consist dominantly of molecular hadronic components with an additional small admixture of a charmonium configuration. Determing the radiative (γJ/Ψ and γΨ(2s)) and strong (J/Ψ2π and J/Ψ3π) decay modes we show that the present experimental observation is consistent with the molecular structure assumption of the X(3872). Finally, we give evidence for molecular interpretations of the Y(3940) and Y(4140) related to the observed strong decay modes J/Ψ + ω or J/Ψ + varphi, respectively.

Hadron Physics with Antiprotons

DOE Office of Scientific and Technical Information (OSTI.GOV)

Wiedner, Ulrich

2005-10-26

The new FAIR facility which comes into operation at GSI in the upcoming years has a dedicated program of utilizing antiprotons for hadron physics. In particular, the planned PANDA experiment belongs to the group of core experiments at the new FAIR facility in Darmstadt/Germany. PANDA will be a universal detector to study the strong interaction by utilizing the annihilation process of antiprotons with protons and nuclear matter. The current paper gives an introduction into the hadron physics with antiprotons and part of the planned physics program with PANDA.

Quality of Life Perception, Cognitive Function, and Psychological Status in a Real-world Population of Glioblastoma Patients Treated With Radiotherapy and Temozolomide: A Single-center Prospective Study.

PubMed

Lombardi, Giuseppe; Bergo, Eleonora; Del Bianco, Paola; Bellu, Luisa; Pambuku, Ardi; Caccese, Mario; Trentin, Leonardo; Zagonel, Vittorina

2018-05-10

Health-related quality of life (HRQoL), cognitive function, and psychological status represent an important focus during the treatment of glioblastoma patients. Nevertheless, few randomized, prospective clinical trials have analyzed these factors, and very little is known in the real-clinical world. We evaluated these characteristics in glioblastoma patients treated with standard first-line therapy outside clinical trials. In total, 111 newly, histologically diagnosed glioblastoma patients treated at our oncology center with radiotherapy and temozolomide were prospectively enrolled. No patient was enrolled in an experimental clinical trial. We assessed HRQoL, cognitive function, and psychological status before starting treatment, at the end of radiotherapy, and every 3 months until 9 months after the end of radiotherapy using EORTC QLQ-C30, BN20, MMSE, and HADS questionnaires. Global health status, physical, cognitive, and social functioning remained unchanged throughout the study period. A statistically significant change was found in emotional functioning as well as a clinically meaningful amelioration in role functioning between the baseline assessment and 9 months after radiotherapy. Patients older than 65 years reported greater impairment on the bladder control scale than younger patients. When considering tumor location, global health status, communication deficit, and drowsiness, scores were significantly different between the right and left hemispheres. Female patients had a clinically relevant lower score for physical functioning at baseline and 3 months after radiation therapy. Female patients also had a clinically relevant lower depression score at 9 months after radiation therapy. In routine neurooncology practice, HRQoL, cognitive function, and psychological status did not worsen during first-line treatment in glioblastoma patients receiving standard radiotherapy and temozolomide treatment. However, some patient subgroups, such as elderly and female

Charmed hadron production in pp collision

NASA Astrophysics Data System (ADS)

Goswami, Umananda Dev

2007-10-01

We investigated the production of charmed hadrons ( D+, D-, D0, D, Λc+, Λ¯c-) in pp collisions as a function of √{s}, xF, p⊥2 and p⊥ in the framework of the QGSJET model. The study of charmed hadron production characteristics in pp collision is particularly important for cosmic ray physics in the context of atmospheric prompt lepton fluxes. Here our aim is to check the reliability of the QGSJET model to be used to study the production of charmed hadrons in cosmic ray hadronic interactions with air nuclei. Charmed hadroproduction cross sections or the charmed hadron average multiplicities in pp collisions are relatively very small. The maximum production of all charmed hadrons takes place with low values of xF, p⊥2, and p⊥ within a small range for all values of √{s} under study. Charmed hadroproduction cross sections as a function of xF and p⊥2 are compared with the LEBC-EHS and LEBC-MPS experiment data for D-meson production. The agreement is quite satisfactory for smaller values of p⊥2 (⩽2 (GeV/c) 2). There is an asymmetry in charmed hadroproduction in pp collision. For all xF, asymmetry is prominent in the low value of √{s}. There is a strong preference for producing Λc+ rather than Λ¯c-baryons, while that for producing D¯ rather than D-mesons for this range of √{s}. Asymmetry increases from zero to ±1 around xF = 0.3 for all values of √{s} and for all charmed hardron groups. The patterns of asymmetric production of different charmed hadrons with xF are approximately the same as that with √{s}. We compare our calculation with the data from Fermilab experiment E781 (SELEX) for Λc-baryon production. The agreement is quite good. The asymmetry of charmed hadroproduction with p⊥ does not follow any well defined pattern.

OPENMED: A facility for biomedical experiments based on the CERN Low Energy Ion Ring (LEIR)

NASA Astrophysics Data System (ADS)

Carli, Christian

At present protons and carbon ions are in clinical use for hadron therapy at a growing number of treatment centers all over the world. Nevertheless, only limited direct clinical evidence of their superiority over other forms of radiotherapy is available [1]. Furthermore fundamental studies on biological effects of hadron beams have been carried out at different times (some a long time ago) in different laboratories and under different conditions. Despite an increased availability of ion beams for hadron therapy, beam time for preclinical studies is expected to remain insufficient as the priority for therapy centers is to treat the maximum number of patients. Most of the remaining beam time is expected to be required for setting up and measurements to guarantee appropriate good quality beams for treatments. The proposed facility for biomedical research [2] in support of hadron therapy centers would provide ion beams for interested research groups and allow them to carry out basic studies under well defined conditions. Typical studies would include radiobiological phenomena like relative biological effectiveness with different energies, ion species, and intensities. Furthermore possible studies include the development of advanced dosimetry in heterogeneous materials that resemble the human body, imaging techniques and, at a later stage, when the maximum energy with the LEIR magnets can be reached, fragmentation.

Failure mode and effects analysis based risk profile assessment for stereotactic radiosurgery programs at three cancer centers in Brazil.

PubMed

Teixeira, Flavia C; de Almeida, Carlos E; Saiful Huq, M

2016-01-01

The goal of this study was to evaluate the safety and quality management program for stereotactic radiosurgery (SRS) treatment processes at three radiotherapy centers in Brazil by using three industrial engineering tools (1) process mapping, (2) failure modes and effects analysis (FMEA), and (3) fault tree analysis. The recommendations of Task Group 100 of American Association of Physicists in Medicine were followed to apply the three tools described above to create a process tree for SRS procedure for each radiotherapy center and then FMEA was performed. Failure modes were identified for all process steps and values of risk priority number (RPN) were calculated from O, S, and D (RPN = O × S × D) values assigned by a professional team responsible for patient care. The subprocess treatment planning was presented with the highest number of failure modes for all centers. The total number of failure modes were 135, 104, and 131 for centers I, II, and III, respectively. The highest RPN value for each center is as follows: center I (204), center II (372), and center III (370). Failure modes with RPN ≥ 100: center I (22), center II (115), and center III (110). Failure modes characterized by S ≥ 7, represented 68% of the failure modes for center III, 62% for center II, and 45% for center I. Failure modes with RPNs values ≥100 and S ≥ 7, D ≥ 5, and O ≥ 5 were considered as high priority in this study. The results of the present study show that the safety risk profiles for the same stereotactic radiotherapy process are different at three radiotherapy centers in Brazil. Although this is the same treatment process, this present study showed that the risk priority is different and it will lead to implementation of different safety interventions among the centers. Therefore, the current practice of applying universal device-centric QA is not adequate to address all possible failures in clinical processes at different radiotherapy centers. Integrated approaches to

Ultra-Fast Hadronic Calorimetry

DOE Office of Scientific and Technical Information (OSTI.GOV)

Denisov, Dmitri; Lukić, Strahinja; Mokhov, Nikolai

2017-12-18

Calorimeters for particle physics experiments with integration time of a few ns will substantially improve the capability of the experiment to resolve event pileup and to reject backgrounds. In this paper time development of hadronic showers induced by 30 and 60 GeV positive pions and 120 GeV protons is studied using Monte Carlo simulation and beam tests with a prototype of a sampling steel-scintillator hadronic calorimeter. In the beam tests, scintillator signals induced by hadronic showers in steel are sampled with a period of 0.2 ns and precisely time-aligned in order to study the average signal waveform at various locationsmore » w.r.t. the beam particle impact. Simulations of the same setup are performed using the MARS15 code. Both simulation and test beam results suggest that energy deposition in steel calorimeters develop over a time shorter than 3 ns providing opportunity for ultra-fast calorimetry. Simulation results for an "ideal" calorimeter consisting exclusively of bulk tungsten or copper are presented to establish the lower limit of the signal integration window.« less

Sum rules for quasifree scattering of hadrons

NASA Astrophysics Data System (ADS)

Peterson, R. J.

2018-02-01

The areas d σ /d Ω of fitted quasifree scattering peaks from bound nucleons for continuum hadron-nucleus spectra measuring d2σ /d Ω d ω are converted to sum rules akin to the Coulomb sums familiar from continuum electron scattering spectra from nuclear charge. Hadronic spectra with or without charge exchange of the beam are considered. These sums are compared to the simple expectations of a nonrelativistic Fermi gas, including a Pauli blocking factor. For scattering without charge exchange, the hadronic sums are below this expectation, as also observed with Coulomb sums. For charge exchange spectra, the sums are near or above the simple expectation, with larger uncertainties. The strong role of hadron-nucleon in-medium total cross sections is noted from use of the Glauber model.

On the hadron mass decomposition

NASA Astrophysics Data System (ADS)

Lorcé, Cédric

2018-02-01

We argue that the standard decompositions of the hadron mass overlook pressure effects, and hence should be interpreted with great care. Based on the semiclassical picture, we propose a new decomposition that properly accounts for these pressure effects. Because of Lorentz covariance, we stress that the hadron mass decomposition automatically comes along with a stability constraint, which we discuss for the first time. We show also that if a hadron is seen as made of quarks and gluons, one cannot decompose its mass into more than two contributions without running into trouble with the consistency of the physical interpretation. In particular, the so-called quark mass and trace anomaly contributions appear to be purely conventional. Based on the current phenomenological values, we find that in average quarks exert a repulsive force inside nucleons, balanced exactly by the gluon attractive force.

Averages of $b$-hadron, $c$-hadron, and $$\\tau$$-lepton properties as of summer 2014

DOE Office of Scientific and Technical Information (OSTI.GOV)

Amhis, Y.; et al.

2014-12-23

This article reports world averages of measurements ofmore » $b$-hadron, $c$-hadron, and $$\\tau$$-lepton properties obtained by the Heavy Flavor Averaging Group (HFAG) using results available through summer 2014. For the averaging, common input parameters used in the various analyses are adjusted (rescaled) to common values, and known correlations are taken into account. The averages include branching fractions, lifetimes, neutral meson mixing parameters, $CP$ violation parameters, parameters of semileptonic decays and CKM matrix elements.« less

Quark Hadron Duality - Recent Jefferson Lab Results

DOE Office of Scientific and Technical Information (OSTI.GOV)

Niculescu, Maria Ioana

2016-08-01

The duality between the partonic and hadronic descriptions of electron--nucleon scattering is a remarkable feature of nuclear interactions. When averaged over appropriate energy intervals the cross section at low energy which is dominated by nucleon resonances resembles the smooth behavior expected from perturbative QCD. Recent Jefferson Lab results indicate that quark-hadron duality is present in a variety of observables, not just the proton F2 structure function. An overview of recent results, especially local quark-hadron duality on the neutron, are presented here.

Di-hadron correlations with identified leading hadrons in 200 GeV Au + Au and d + Au collisions at STAR

NASA Astrophysics Data System (ADS)

Adamczyk, L.; Adkins, J. K.; Agakishiev, G.; Aggarwal, M. M.; Ahammed, Z.; Alekseev, I.; Aparin, A.; Arkhipkin, D.; Aschenauer, E. C.; Averichev, G. S.; Bai, X.; Bairathi, V.; Banerjee, A.; Bellwied, R.; Bhasin, A.; Bhati, A. K.; Bhattarai, P.; Bielcik, J.; Bielcikova, J.; Bland, L. C.; Bordyuzhin, I. G.; Bouchet, J.; Brandenburg, D.; Brandin, A. V.; Bunzarov, I.; Butterworth, J.; Caines, H.; Calderón de la Barca Sánchez, M.; Campbell, J. M.; Cebra, D.; Cervantes, M. C.; Chakaberia, I.; Chaloupka, P.; Chang, Z.; Chattopadhyay, S.; Chen, X.; Chen, J. H.; Cheng, J.; Cherney, M.; Christie, W.; Contin, G.; Crawford, H. J.; Das, S.; De Silva, L. C.; Debbe, R. R.; Dedovich, T. G.; Deng, J.; Derevschikov, A. A.; di Ruzza, B.; Didenko, L.; Dilks, C.; Dong, X.; Drachenberg, J. L.; Draper, J. E.; Du, C. M.; Dunkelberger, L. E.; Dunlop, J. C.; Efimov, L. G.; Engelage, J.; Eppley, G.; Esha, R.; Evdokimov, O.; Eyser, O.; Fatemi, R.; Fazio, S.; Federic, P.; Fedorisin, J.; Feng, Z.; Filip, P.; Fisyak, Y.; Flores, C. E.; Fulek, L.; Gagliardi, C. A.; Garand, D.; Geurts, F.; Gibson, A.; Girard, M.; Greiner, L.; Grosnick, D.; Gunarathne, D. S.; Guo, Y.; Gupta, S.; Gupta, A.; Guryn, W.; Hamad, A.; Hamed, A.; Haque, R.; Harris, J. W.; He, L.; Heppelmann, S.; Heppelmann, S.; Hirsch, A.; Hoffmann, G. W.; Hofman, D. J.; Horvat, S.; Huang, T.; Huang, B.; Huang, H. Z.; Huang, X.; Huck, P.; Humanic, T. J.; Igo, G.; Jacobs, W. W.; Jang, H.; Jia, J.; Jiang, K.; Judd, E. G.; Kabana, S.; Kalinkin, D.; Kang, K.; Kauder, K.; Ke, H. W.; Keane, D.; Kechechyan, A.; Khan, Z. H.; Kikoła, D. P.; Kisiel, A.; Kochenda, L.; Koetke, D. D.; Kosarzewski, L. K.; Kraishan, A. F.; Kravtsov, P.; Krueger, K.; Kumar, L.; Lamont, M. A. C.; Landgraf, J. M.; Landry, K. D.; Lauret, J.; Lebedev, A.; Lednicky, R.; Lee, J. H.; Li, X.; Li, W.; Li, Z. M.; Li, Y.; Li, C.; Li, X.; Lisa, M. A.; Liu, F.; Ljubicic, T.; Llope, W. J.; Lomnitz, M.; Longacre, R. S.; Luo, X.; Ma, G. L.; Ma, Y. G.; Ma, R.; Ma, L.; Magdy, N.; Majka, R.; Manion, A.; Margetis, S.; Markert, C.; Masui, H.; Matis, H. S.; McDonald, D.; Meehan, K.; Mei, J. C.; Minaev, N. G.; Mioduszewski, S.; Mishra, D.; Mohanty, B.; Mondal, M. M.; Morozov, D. A.; Mustafa, M. K.; Nandi, B. K.; Nasim, Md.; Nayak, T. K.; Nigmatkulov, G.; Niida, T.; Nogach, L. V.; Noh, S. Y.; Novak, J.; Nurushev, S. B.; Odyniec, G.; Ogawa, A.; Oh, K.; Okorokov, V.; Olvitt, D.; Page, B. S.; Pak, R.; Pan, Y. X.; Pandit, Y.; Panebratsev, Y.; Pawlik, B.; Pei, H.; Perkins, C.; Peterson, A.; Pile, P.; Pluta, J.; Poniatowska, K.; Porter, J.; Posik, M.; Poskanzer, A. M.; Pruthi, N. K.; Putschke, J.; Qiu, H.; Quintero, A.; Ramachandran, S.; Raniwala, R.; Raniwala, S.; Ray, R. L.; Ritter, H. G.; Roberts, J. B.; Rogachevskiy, O. V.; Romero, J. L.; Roy, A.; Ruan, L.; Rusnak, J.; Rusnakova, O.; Sahoo, N. R.; Sahu, P. K.; Sakrejda, I.; Salur, S.; Sandweiss, J.; Sarkar, A.; Schambach, J.; Scharenberg, R. P.; Schmah, A. M.; Schmidke, W. B.; Schmitz, N.; Seger, J.; Seyboth, P.; Shah, N.; Shahaliev, E.; Shanmuganathan, P. V.; Shao, M.; Sharma, B.; Sharma, M. K.; Shen, W. Q.; Shi, S. S.; Shou, Q. Y.; Sichtermann, E. P.; Sikora, R.; Simko, M.; Singha, S.; Skoby, M. J.; Smirnov, N.; Smirnov, D.; Song, L.; Sorensen, P.; Spinka, H. M.; Srivastava, B.; Stanislaus, T. D. S.; Stepanov, M.; Strikhanov, M.; Stringfellow, B.; Sumbera, M.; Summa, B.; Sun, Y.; Sun, Z.; Sun, X. M.; Sun, X.; Surrow, B.; Svirida, D. N.; Szelezniak, M. A.; Tang, A. H.; Tang, Z.; Tarnowsky, T.; Tawfik, A.; Thomas, J. H.; Timmins, A. R.; Tlusty, D.; Todoroki, T.; Tokarev, M.; Trentalange, S.; Tribble, R. E.; Tribedy, P.; Tripathy, S. K.; Tsai, O. D.; Ullrich, T.; Underwood, D. G.; Upsal, I.; Van Buren, G.; van Nieuwenhuizen, G.; Vandenbroucke, M.; Varma, R.; Vasiliev, A. N.; Vertesi, R.; Videbæk, F.; Viyogi, Y. P.; Vokal, S.; Voloshin, S. A.; Vossen, A.; Wang, J. S.; Wang, F.; Wang, H.; Wang, G.; Wang, Y.; Wang, Y.; Webb, G.; Webb, J. C.; Wen, L.; Westfall, G. D.; Wieman, H.; Wissink, S. W.; Witt, R.; Wu, Y. F.; Wu; Xiao, Z. G.; Xie, W.; Xin, K.; Xu, H.; Xu, Z.; Xu, Q. H.; Xu, Y. F.; Xu, N.; Yang, S.; Yang, Y.; Yang, Q.; Yang, Y.; Yang, C.; Yang, Y.; Ye, Z.; Ye, Z.; Yepes, P.; Yi, L.; Yip, K.; Yoo, I.-K.; Yu, N.; Zbroszczyk, H.; Zha, W.; Zhang, Y.; Zhang, Z.; Zhang, J. B.; Zhang, J.; Zhang, X. P.; Zhang, S.; Zhang, J.; Zhao, J.; Zhong, C.; Zhou, L.; Zhu, X.; Zoulkarneeva, Y.

2015-12-01

The STAR Collaboration presents for the first time two-dimensional di-hadron correlations with identified leading hadrons in 200 GeV central Au + Au and minimum-bias d + Au collisions to explore hadronization mechanisms in the quark gluon plasma. The enhancement of the jet-like yield for leading pions in Au + Au data with respect to the d + Au reference and the absence of such an enhancement for leading non-pions (protons and kaons) are discussed within the context of a quark recombination scenario. The correlated yield at large angles, specifically in the ridge region, is found to be significantly higher for leading non-pions than pions. The consistencies of the constituent quark scaling, azimuthal harmonic model and a mini-jet modification model description of the data are tested, providing further constraints on hadronization.

Energy-range relations for hadrons in nuclear matter

NASA Technical Reports Server (NTRS)

Strugalski, Z.

1985-01-01

Range-energy relations for hadrons in nuclear matter exist similarly to the range-energy relations for charged particles in materials. When hadrons of GeV kinetic energies collide with atomic nuclei massive enough, events occur in which incident hadron is stopped completely inside the target nucleus without causing particle production - without pion production in particular. The stoppings are always accompanied by intensive emission of nucleons with kinetic energy from about 20 up to about 400 MeV. It was shown experimentally that the mean number of the emitted nucleons is a measure of the mean path in nuclear matter in nucleons on which the incident hadrons are stopped.

Dosimetry audit simulation of treatment planning system in multicenters radiotherapy

NASA Astrophysics Data System (ADS)

Kasmuri, S.; Pawiro, S. A.

2017-07-01

Treatment Planning System (TPS) is an important modality that determines radiotherapy outcome. TPS requires input data obtained through commissioning and the potentially error occurred. Error in this stage may result in the systematic error. The aim of this study to verify the TPS dosimetry to know deviation range between calculated and measurement dose. This study used CIRS phantom 002LFC representing the human thorax and simulated all external beam radiotherapy stages. The phantom was scanned using CT Scanner and planned 8 test cases that were similar to those in clinical practice situation were made, tested in four radiotherapy centers. Dose measurement using 0.6 cc ionization chamber. The results of this study showed that generally, deviation of all test cases in four centers was within agreement criteria with average deviation about -0.17±1.59 %, -1.64±1.92 %, 0.34±1.34 % and 0.13±1.81 %. The conclusion of this study was all TPS involved in this study showed good performance. The superposition algorithm showed rather poor performance than either analytic anisotropic algorithm (AAA) and convolution algorithm with average deviation about -1.64±1.92 %, -0.17±1.59 % and -0.27±1.51 % respectively.

Universal effective hadron dynamics from superconformal algebra

DOE PAGES

Brodsky, Stanley J.; de Teramond, Guy F.; Dosch, Hans Gunter; ...

2016-05-25

An effective supersymmetric QCD light-front Hamiltonian for hadrons composed of light quarks, which includes a spin–spin interaction between the hadronic constituents, is constructed by embedding superconformal quantum mechanics into AdS space. A specific breaking of conformal symmetry inside the graded algebra determines a unique effective quark-confining potential for light hadrons, as well as remarkable connections between the meson and baryon spectra. The results are consistent with the empirical features of the light-quark hadron spectra, including a universal mass scale for the slopes of the meson and baryon Regge trajectories and a zero-mass pion in the limit of massless quarks. Ourmore » analysis is consistently applied to the excitation spectra of the π , ρ , K , K* and Φ meson families as well as to the N , Δ, Λ, Σ, Σ* , Ξ and Ξ* in the baryon sector. Here, we also predict the existence of tetraquarks which are degenerate in mass with baryons with the same angular momentum. The mass of light hadrons is expressed in a universal and frame-independent decomposition in the semiclassical approximation described here.« less

Averages of b-hadron, c-hadron, and τ-lepton properties as of summer 2016

DOE PAGES

Amhis, Y.; Banerjee, Sw.; Ben-Haim, E.; ...

2017-12-21

Here, this article reports world averages of measurements of b-hadron, c-hadron, and τ-lepton properties obtained by the Heavy Flavor Averaging Group using results available through summer 2016. For the averaging, common input parameters used in the various analyses are adjusted (rescaled) to common values, and known correlations are taken into account. The averages include branching fractions, lifetimes, neutral meson mixing parameters,more » $$C\\!P$$  violation parameters, parameters of semileptonic decays, and Cabbibo–Kobayashi–Maskawa matrix elements.« less

Averages of b-hadron, c-hadron, and τ-lepton properties as of summer 2016

DOE Office of Scientific and Technical Information (OSTI.GOV)

Amhis, Y.; Banerjee, Sw.; Ben-Haim, E.

Here, this article reports world averages of measurements of b-hadron, c-hadron, and τ-lepton properties obtained by the Heavy Flavor Averaging Group using results available through summer 2016. For the averaging, common input parameters used in the various analyses are adjusted (rescaled) to common values, and known correlations are taken into account. The averages include branching fractions, lifetimes, neutral meson mixing parameters,more » $$C\\!P$$  violation parameters, parameters of semileptonic decays, and Cabbibo–Kobayashi–Maskawa matrix elements.« less

Signatures for Black Hole Production from Hadronic Observables at the Large Hadron Collider

NASA Astrophysics Data System (ADS)

Humanic, Thomas J.; Koch, Benjamin; Stöcker, Horst

The concept of Large Extra Dimensions (LED) provides a way of solving the Hierarchy Problem which concerns the weakness of gravity compared with the strong and electro-weak forces. A consequence of LED is that miniature Black Holes (mini-BHs) may be produced at the Large Hadron Collider in p + p collisions. The present work uses the CHARYBDIS mini-BH generator code to simulate the hadronic signal which might be expected in a mid-rapidity particle tracking detector from the decay of these exotic objects if indeed they are produced. An estimate is also given for Pb+Pb collisions.

Peculiarities of biological action of hadrons of space radiation.

PubMed

Akoev, I G; Yurov, S S

1975-01-01

Biological investigations in space enable one to make a significant contribution on high-energy hadrons to biological effects under the influence of factors of space flights. Physical and molecular principles of the action of high-energy hadrons are analysed. Genetic and somatic hadron effects produced by the secondary radiation from 70 GeV protons have been studied experimentally. The high biological effectiveness of hadrons, great variability in biological effects, and specifically of their action, are associated with strong interactions of high-energy hadrons. These are the probability of nuclear interaction with any atom nucleus, generation of a great number of secondary particles (among them, probably, highly effective multicharged and heavy nuclei, antiprotons, pi(-)-mesons), and the spatial distribution of secondary particles as a narrow cone with extremely high density of particles in its first part. The secondary radiation generated by high- and superhigh-energy hadrons upon their interaction with the spaceship is likely to be the greatest hazard of radiation to the crew during space flights.

The GEANT4 toolkit capability in the hadron therapy field: simulation of a transport beam line

NASA Astrophysics Data System (ADS)

Cirrone, G. A. P.; Cuttone, G.; Di Rosa, F.; Raffaele, L.; Russo, G.; Guatelli, S.; Pia, M. G.

2006-01-01

At Laboratori Nazionali del Sud of the Instituto Nazionale di Fisica Nucleare of Catania (Sicily, Italy), the first Italian hadron therapy facility named CATANA (Centro di AdroTerapia ed Applicazioni Nucleari Avanzate) has been realized. Inside CATANA 62 MeV proton beams, accelerated by a superconducting cyclotron, are used for the radiotherapeutic treatments of some types of ocular tumours. Therapy with hadron beams still represents a pioneer technique, and only a few centers worldwide can provide this advanced specialized cancer treatment. On the basis of the experience so far gained, and considering the future hadron-therapy facilities to be developed (Rinecker, Munich Germany, Heidelberg/GSI, Darmstadt, Germany, PSI Villigen, Switzerland, CNAO, Pavia, Italy, Centro di Adroterapia, Catania, Italy) we decided to develop a Monte Carlo application based on the GEANT4 toolkit, for the design, the realization and the optimization of a proton-therapy beam line. Another feature of our project is to provide a general tool able to study the interactions of hadrons with the human tissue and to test the analytical-based treatment planning systems actually used in the routine practice. All the typical elements of a hadron-therapy line, such as diffusers, range shifters, collimators and detectors were modelled. In particular, we simulated the Markus type ionization chamber and a Gaf Chromic film as dosimeters to reconstruct the depth (Bragg peak and Spread Out Bragg Peak) and lateral dose distributions, respectively. We validated our simulated detectors comparing the results with the experimental data available in our facility.

Di-hadron correlations with identified leading hadrons in 200 GeV Au + Au and d + Au collisions at STAR

DOE PAGES

Adamczyk, L.

2015-10-23

The STAR Collaboration presents for the first time two-dimensional di-hadron correlations with identified leading hadrons in 200 GeV central Au + Au and minimum-bias d + Au collisions to explore hadronization mechanisms in the quark gluon plasma. The enhancement of the jet-like yield for leading pions in Au + Au data with respect to the d + Au reference and the absence of such an enhancement for leading non-pions (protons and kaons) are discussed within the context of a quark recombination scenario. The correlated yield at large angles, specifically in the ridge region, is found to be significantly higher formore » leading non-pions than pions. As a result, the consistencies of the constituent quark scaling, azimuthal harmonic model and a mini-jet modification model description of the data are tested, providing further constraints on hadronization.« less

Moving toward uniform and evidence-based practice of radiotherapy for management of cervical cancer in Ontario, Canada.

PubMed

Shahid, Negin; Craig, Timothy; Westerland, Mary; Ashworth, Allison; Ang, Michelle; D'Souza, David; Sankreacha, Raxa; Fyles, Anthony; Milosevic, Michael; Kong, Iwa

2018-04-19

To recognize the practice of radiotherapy for management of cervical cancer in Ontario, Canada, and to use the results of the survey to harmonize and standardize practice across the province. An electronic survey (SurveyMonkey) was sent to all 14 provincial cancer centers by Cancer Care Ontario Gynecology Community of Practice (CoP) in 2013. The survey included 72 questions in four different categories: general/demographic, pretreatment assessment, external beam radiotherapy (EBRT), and brachytherapy (BT). Ten of 14 centers treated cervical cancer patients and had a dedicated BT suite. All 10 centers had a peer review process for quality assurance. EBRT technique was a 4-field box in eight of 10 centers. The dose/fractionation for pelvic EBRT was 45-50 Gy in 1.8-2 Gy/fraction in all but one center. Nine of 10 centers used high-dose-rate BT. Only one center offered interstitial BT. For treatment planning, two centers used CT and MRI, five centers used CT, and three centers used orthogonal x-rays. Groupe Européen de Curiethérapie and the European Society for Radiotherapy & Oncology guidelines were used in four of seven of the centers for target volume delineation and in five of seven centers for organs at risk dose constraints. All but one center prescribed and reported dose to Point A. The survey identified areas where practice varied across the province. Gynecology CoP used this information to identify priorities for practice change and implemented several strategies to harmonize the care of women with cervical cancer. This highlights the value of interdisciplinary, grass-roots initiatives such as CoPs to standardize practice in a practical manner that directly benefits patients. Copyright © 2018 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.

PREFACE: Focus section on Hadronic Physics

NASA Astrophysics Data System (ADS)

Roberts, Craig; Swanson, Eric

2007-07-01

Hadronic physics is the study of strongly interacting matter and its underlying theory, Quantum Chromodynamics (QCD). The field had its beginnings after World War Two, when hadrons were discovered in ever increasing numbers. Today, it encompasses topics like the quark-gluon structure of hadrons at varying scales, the quark-gluon plasma and hadronic matter at extreme temperature and density; it also underpins nuclear physics and has significant impact on particle physics, astrophysics, and cosmology. Among the goals of hadronic physics are to determine the parameters of QCD, understand the origin and characteristics of confinement, understand the dynamics and consequences of dynamical chiral symmetry breaking, explore the role of quarks and gluons in nuclei and in matter under extreme conditions and understand the quark and gluon structure of hadrons. In general, the process is one of discerning the relevant degrees of freedom and relating these to the fundamental fields of QCD. The emphasis is on understanding QCD, rather than testing it. The papers gathered in this special focus section of Journal of Physics G: Nuclear and Particle Physics attempt to cover this broad range of subjects. Alkofer and Greensite examine the issue of quark and gluon confinement with the focus on models of the QCD vacuum, lattice gauge theory investigations, and the relationship to the AdS/CFT correspondence postulate. Arrington et al. review nucleon form factors and their role in determining quark orbital momentum, the strangeness content of the nucleon, meson cloud effects, and the transition from nonperturbative to perturbative QCD dynamics. The physics associated with hadronic matter at high temperature and density and at low Bjorken-x at the Relativistic Heavy Ion Collider (RHIC), the SPS at CERN, and at the future LHC is summarized by d'Enterria. The article of Lee and Smith examines experiment and theory associated with electromagnetic meson production from nucleons and

Hadronic energy resolution of a highly granular scintillator-steel hadron calorimeter using software compensation techniques

NASA Astrophysics Data System (ADS)

Adloff, C.; Blaha, J.; Blaising, J.-J.; Drancourt, C.; Espargilière, A.; Gaglione, R.; Geffroy, N.; Karyotakis, Y.; Prast, J.; Vouters, G.; Francis, K.; Repond, J.; Smith, J.; Xia, L.; Baldolemar, E.; Li, J.; Park, S. T.; Sosebee, M.; White, A. P.; Yu, J.; Buanes, T.; Eigen, G.; Mikami, Y.; Watson, N. K.; Goto, T.; Mavromanolakis, G.; Thomson, M. A.; Ward, D. R.; Yan, W.; Benchekroun, D.; Hoummada, A.; Khoulaki, Y.; Benyamna, M.; Cârloganu, C.; Fehr, F.; Gay, P.; Manen, S.; Royer, L.; Blazey, G. C.; Dyshkant, A.; Lima, J. G. R.; Zutshi, V.; Hostachy, J.-Y.; Morin, L.; Cornett, U.; David, D.; Falley, G.; Gadow, K.; Göttlicher, P.; Günter, C.; Hermberg, B.; Karstensen, S.; Krivan, F.; Lucaci-Timoce, A.-I.; Lu, S.; Lutz, B.; Morozov, S.; Morgunov, V.; Reinecke, M.; Sefkow, F.; Smirnov, P.; Terwort, M.; Vargas-Trevino, A.; Feege, N.; Garutti, E.; Marchesini, I.; Ramilli, M.; Eckert, P.; Harion, T.; Kaplan, A.; Schultz-Coulon, H.-Ch; Shen, W.; Stamen, R.; Tadday, A.; Bilki, B.; Norbeck, E.; Onel, Y.; Wilson, G. W.; Kawagoe, K.; Dauncey, P. D.; Magnan, A.-M.; Wing, M.; Salvatore, F.; Calvo Alamillo, E.; Fouz, M.-C.; Puerta-Pelayo, J.; Balagura, V.; Bobchenko, B.; Chadeeva, M.; Danilov, M.; Epifantsev, A.; Markin, O.; Mizuk, R.; Novikov, E.; Rusinov, V.; Tarkovsky, E.; Kirikova, N.; Kozlov, V.; Smirnov, P.; Soloviev, Y.; Buzhan, P.; Dolgoshein, B.; Ilyin, A.; Kantserov, V.; Kaplin, V.; Karakash, A.; Popova, E.; Smirnov, S.; Kiesling, C.; Pfau, S.; Seidel, K.; Simon, F.; Soldner, C.; Szalay, M.; Tesar, M.; Weuste, L.; Bonis, J.; Bouquet, B.; Callier, S.; Cornebise, P.; Doublet, Ph; Dulucq, F.; Faucci Giannelli, M.; Fleury, J.; Li, H.; Martin-Chassard, G.; Richard, F.; de la Taille, Ch; Pöschl, R.; Raux, L.; Seguin-Moreau, N.; Wicek, F.; Anduze, M.; Boudry, V.; Brient, J.-C.; Jeans, D.; Mora de Freitas, P.; Musat, G.; Reinhard, M.; Ruan, M.; Videau, H.; Bulanek, B.; Zacek, J.; Cvach, J.; Gallus, P.; Havranek, M.; Janata, M.; Kvasnicka, J.; Lednicky, D.; Marcisovsky, M.; Polak, I.; Popule, J.; Tomasek, L.; Tomasek, M.; Ruzicka, P.; Sicho, P.; Smolik, J.; Vrba, V.; Zalesak, J.; Belhorma, B.; Ghazlane, H.; Takeshita, T.; Uozumi, S.; Sauer, J.; Weber, S.; Zeitnitz, C.

2012-09-01

The energy resolution of a highly granular 1 m3 analogue scintillator-steel hadronic calorimeter is studied using charged pions with energies from 10 GeV to 80 GeV at the CERN SPS. The energy resolution for single hadrons is determined to be approximately 58%/√E/GeV. This resolution is improved to approximately 45%/√E/GeV with software compensation techniques. These techniques take advantage of the event-by-event information about the substructure of hadronic showers which is provided by the imaging capabilities of the calorimeter. The energy reconstruction is improved either with corrections based on the local energy density or by applying a single correction factor to the event energy sum derived from a global measure of the shower energy density. The application of the compensation algorithms to geant4 simulations yield resolution improvements comparable to those observed for real data.

Ultra-Fast Hadronic Calorimetry

DOE Office of Scientific and Technical Information (OSTI.GOV)

Denisov, Dmitri; Lukić, Strahinja; Mokhov, Nikolai

2018-08-01

Calorimeters for particle physics experiments with integration time of a few ns will substantially improve the capability of the experiment to resolve event pileup and to reject backgrounds. In this paper the time development of hadronic showers induced by 30 and 60 GeV positive pions and 120 GeV protons is studied using Monte Carlo simulation and beam tests with a prototype of a sampling steel-scintillator hadronic calorimeter. In the beam tests, scintillator signals induced by hadronic showers in steel are sampled with a period of 0.2 ns and precisely time-aligned in order to study the average signal waveform at various locations with respectmore » to the beam particle impact. Simulations of the same setup are performed using the MARS15 code. Both simulation and test beam results suggest that energy deposition in steel calorimeters develop over a time shorter than 2 ns providing opportunity for ultra-fast calorimetry. Simulation results for an “ideal” calorimeter consisting exclusively of bulk tungsten or copper are presented to establish the lower limit of the signal integration window.« less

Ultra-fast hadronic calorimetry

DOE PAGES

Denisov, Dmitri; Lukic, Strahinja; Mokhov, Nikolai; ...

2018-05-08

Calorimeters for particle physics experiments with integration time of a few ns will substantially improve the capability of the experiment to resolve event pileup and to reject backgrounds. In this paper the time development of hadronic showers induced by 30 and 60 GeV positive pions and 120 GeV protons is studied using Monte Carlo simulation and beam tests with a prototype of a sampling steel-scintillator hadronic calorimeter. In the beam tests, scintillator signals induced by hadronic showers in steel are sampled with a period of 0.2 ns and precisely time-aligned in order to study the average signal waveform at various locations with respectmore » to the beam particle impact. Simulations of the same setup are performed using the MARS15 code. Both simulation and test beam results suggest that energy deposition in steel calorimeters develop over a time shorter than 2 ns providing opportunity for ultra-fast calorimetry. As a result, simulation results for an “ideal” calorimeter consisting exclusively of bulk tungsten or copper are presented to establish the lower limit of the signal integration window.« less

Averages of B-Hadron, C-Hadron, and tau-lepton properties as of early 2012

DOE Office of Scientific and Technical Information (OSTI.GOV)

Amhis, Y.; et al.

2012-07-01

This article reports world averages of measurements of b-hadron, c-hadron, and tau-lepton properties obtained by the Heavy Flavor Averaging Group (HFAG) using results available through the end of 2011. In some cases results available in the early part of 2012 are included. For the averaging, common input parameters used in the various analyses are adjusted (rescaled) to common values, and known correlations are taken into account. The averages include branching fractions, lifetimes, neutral meson mixing parameters, CP violation parameters, parameters of semileptonic decays and CKM matrix elements.

[Cost analysis of radiotherapy provided in inpatient setting -  testing potential predictors for a new prospective payment system].

PubMed

Sedo, J; Bláha, M; Pavlík, T; Klika, P; Dušek, L; Büchler, T; Abrahámová, J; Srámek, V; Slampa, P; Komínek, L; Pospíšil, P; Sláma, O; Vyzula, R

2014-01-01

As a part of the development of a new prospective payment model for radiotherapy we analyzed data on costs of care provided by three comprehensive cancer centers in the Czech Republic. Our aim was to find a combination of variables (predictors) which could be used to sort hospitalization cases into groups according to their costs, with each group having the same reimbursement rate. We tested four variables as possible predictors -  number of fractions, stage of disease, radiotherapy technique and diagnostic group. We analyzed 7,440 hospitalization cases treated in three comprehensive cancer centers from 2007 to 2011. We acquired data from the I COP database developed by Institute of Biostatistics and Analyses of Masaryk University in cooperation with oncology centers that contains records from the National Oncological Registry along with data supplied by healthcare providers to insurance companies for the purpose of retrospective reimbursement. When comparing the four variables mentioned above we found that number of fractions and radiotherapy technique were much stronger predictors than the other two variables. Stage of disease did not prove to be a relevant indicator of cost distinction. There were significant differences in costs among diagnostic groups but these were mostly driven by the technique of radiotherapy and the number of fractions. Within the diagnostic groups, the distribution of costs was too heterogeneous for the purpose of the new payment model. The combination of number of fractions and radiotherapy technique appears to be the most appropriate cost predictors to be involved in the prospective payment model proposal. Further analysis is planned to test the predictive value of intention of radiotherapy in order to determine differences in costs between palliative and curative treatment.

Observation of exclusive electron-positron production in hadron-hadron collisions.

PubMed

Abulencia, A; Adelman, J; Affolder, T; Akimoto, T; Albrow, M G; Ambrose, D; Amerio, S; Amidei, D; Anastassov, A; Anikeev, K; Annovi, A; Antos, J; Aoki, M; Apollinari, G; Arguin, J-F; Arisawa, T; Artikov, A; Ashmanskas, W; Attal, A; Azfar, F; Azzi-Bacchetta, P; Azzurri, P; Bacchetta, N; Badgett, W; Barbaro-Galtieri, A; Barnes, V E; Barnett, B A; Baroiant, S; Bartsch, V; Bauer, G; Bedeschi, F; Behari, S; Belforte, S; Bellettini, G; Bellinger, J; Belloni, A; Benjamin, D; Beretvas, A; Beringer, J; Berry, T; Bhatti, A; Binkley, M; Bisello, D; Blair, R E; Blocker, C; Blumenfeld, B; Bocci, A; Bodek, A; Boisvert, V; Bolla, G; Bolshov, A; Bortoletto, D; Boudreau, J; Boveia, A; Brau, B; Brigliadori, L; Bromberg, C; Brubaker, E; Budagov, J; Budd, H S; Budd, S; Budroni, S; Burkett, K; Busetto, G; Bussey, P; Byrum, K L; Cabrera, S; Campanelli, M; Campbell, M; Canelli, F; Canepa, A; Carillo, S; Carlsmith, D; Caron, B; Carosi, R; Casarsa, M; Castro, A; Catastini, P; Cauz, D; Cavalli-Sforza, M; Cerri, A; Cerrito, L; Chang, S H; Chen, Y C; Chertok, M; Chiarelli, G; Chlachidze, G; Chlebana, F; Cho, I; Cho, K; Chokheli, D; Chou, J P; Choudalakis, G; Chuang, S H; Chung, K; Chung, W H; Chung, Y S; Ciljak, M; Ciobanu, C I; Ciocci, M A; Clark, A; Clark, D; Coca, M; Compostella, G; Convery, M E; Conway, J; Cooper, B; Copic, K; Cordelli, M; Cortiana, G; Crescioli, F; Almenar, C Cuenca; Cuevas, J; Culbertson, R; Cully, J C; Cyr, D; Daronco, S; D'Auria, S; Davies, T; D'Onofrio, M; Dagenhart, D; de Barbaro, P; Cecco, S De; Deisher, A; Lentdecker, G De; Dell'orso, M; Paoli, F Delli; Demortier, L; Deng, J; Deninno, M; Pedis, D De; Derwent, P F; Giovanni, G P Di; Dionisi, C; Ruzza, B Di; Dittmann, J R; Dituro, P; Dörr, C; Donati, S; Donega, M; Dong, P; Donini, J; Dorigo, T; Dube, S; Efron, J; Erbacher, R; Errede, D; Errede, S; Eusebi, R; Fang, H C; Farrington, S; Fedorko, I; Fedorko, W T; Feild, R G; Feindt, M; Fernandez, J P; Field, R; Flanagan, G; Foland, A; Forrester, S; Foster, G W; Franklin, M; Freeman, J C; Furic, I; Gallinaro, M; Galyardt, J; Garcia, J E; Garberson, F; Garfinkel, A F; Gay, C; Gerberich, H; Gerdes, D; Giagu, S; Giannetti, P; Gibson, A; Gibson, K; Gimmell, J L; Ginsburg, C; Giokaris, N; Giordani, M; Giromini, P; Giunta, M; Giurgiu, G; Glagolev, V; Glenzinski, D; Gold, M; Goldschmidt, N; Goldstein, J; Gomez, G; Gomez-Ceballos, G; Goncharov, M; González, O; Gorelov, I; Goshaw, A T; Goulianos, K; Gresele, A; Griffiths, M; Grinstein, S; Grosso-Pilcher, C; Grundler, U; da Costa, J Guimaraes; Gunay-Unalan, Z; Haber, C; Hahn, K; Hahn, S R; Halkiadakis, E; Hamilton, A; Han, B-Y; Han, J Y; Handler, R; Happacher, F; Hara, K; Hare, M; Harper, S; Harr, R F; Harris, R M; Hartz, M; Hatakeyama, K; Hauser, J; Heijboer, A; Heinemann, B; Heinrich, J; Henderson, C; Herndon, M; Heuser, J; Hidas, D; Hill, C S; Hirschbuehl, D; Hocker, A; Holloway, A; Hou, S; Houlden, M; Hsu, S-C; Huffman, B T; Hughes, R E; Husemann, U; Huston, J; Incandela, J; Introzzi, G; Iori, M; Ishizawa, Y; Ivanov, A; Iyutin, B; James, E; Jang, D; Jayatilaka, B; Jeans, D; Jensen, H; Jeon, E J; Jindariani, S; Jones, M; Joo, K K; Jun, S Y; Jung, J E; Junk, T R; Kamon, T; Karchin, P E; Kato, Y; Kemp, Y; Kephart, R; Kerzel, U; Khotilovich, V; Kilminster, B; Kim, D H; Kim, H S; Kim, J E; Kim, M J; Kim, S B; Kim, S H; Kim, Y K; Kimura, N; Kirsch, L; Klimenko, S; Klute, M; Knuteson, B; Ko, B R; Kondo, K; Kong, D J; Konigsberg, J; Korytov, A; Kotwal, A V; Kovalev, A; Kraan, A C; Kraus, J; Kravchenko, I; Kreps, M; Kroll, J; Krumnack, N; Kruse, M; Krutelyov, V; Kubo, T; Kuhlmann, S E; Kuhr, T; Kusakabe, Y; Kwang, S; Laasanen, A T; Lai, S; Lami, S; Lammel, S; Lancaster, M; Lander, R L; Lannon, K; Lath, A; Latino, G; Lazzizzera, I; Lecompte, T; Lee, J; Lee, J; Lee, Y J; Lee, S W; Lefèvre, R; Leonardo, N; Leone, S; Levy, S; Lewis, J D; Lin, C; Lin, C S; Lindgren, M; Lipeles, E; Lister, A; Litvintsev, D O; Liu, T; Lockyer, N S; Loginov, A; Loreti, M; Loverre, P; Lu, R-S; Lucchesi, D; Lujan, P; Lukens, P; Lungu, G; Lyons, L; Lys, J; Lysak, R; Lytken, E; Mack, P; Macqueen, D; Madrak, R; Maeshima, K; Makhoul, K; Maki, T; Maksimovic, P; Malde, S; Manca, G; Margaroli, F; Marginean, R; Marino, C; Marino, C P; Martin, A; Martin, M; Martin, V; Martínez, M; Maruyama, T; Mastrandrea, P; Masubuchi, T; Matsunaga, H; Mattson, M E; Mazini, R; Mazzanti, P; McFarland, K S; McIntyre, P; McNulty, R; Mehta, A; Mehtala, P; Menzemer, S; Menzione, A; Merkel, P; Mesropian, C; Messina, A; Miao, T; Miladinovic, N; Miles, J; Miller, R; Mills, C; Milnik, M; Mitra, A; Mitselmakher, G; Miyamoto, A; Moed, S; Moggi, N; Mohr, B; Moore, R; Morello, M; Fernandez, P Movilla; Mülmenstädt, J; Mukherjee, A; Muller, Th; Mumford, R; Murat, P; Nachtman, J; Nagano, A; Naganoma, J; Nakano, I; Napier, A; Necula, V; Neu, C; Neubauer, M S; Nielsen, J; Nigmanov, T; Nodulman, L; Norniella, O; Nurse, E; Oh, S H; Oh, Y D; Oksuzian, I; Okusawa, T; Oldeman, R; Orava, R; Osterberg, K; Pagliarone, C; Palencia, E; Papadimitriou, V; Paramonov, A A; Parks, B; Pashapour, S; Patrick, J; Pauletta, G; Paulini, M; Paus, C; Pellett, D E; Penzo, A; Phillips, T J; Piacentino, G; Piedra, J; Pinera, L; Pinfold, J; Pitts, K; Plager, C; Pondrom, L; Portell, X; Poukhov, O; Pounder, N; Prakoshyn, F; Pronko, A; Proudfoot, J; Ptohos, F; Punzi, G; Pursley, J; Rademacker, J; Rahaman, A; Ranjan, N; Rappoccio, S; Reisert, B; Rekovic, V; Renton, P; Rescigno, M; Richter, S; Rimondi, F; Ristori, L; Robson, A; Rodrigo, T; Rogers, E; Rolli, S; Roser, R; Rossi, M; Rossin, R; Ruiz, A; Russ, J; Rusu, V; Saarikko, H; Sabik, S; Safonov, A; Sakumoto, W K; Salamanna, G; Saltó, O; Saltzberg, D; Sánchez, C; Santi, L; Sarkar, S; Sartori, L; Sato, K; Savard, P; Savoy-Navarro, A; Scheidle, T; Schlabach, P; Schmidt, E E; Schmidt, M P; Schmitt, M; Schwarz, T; Scodellaro, L; Scott, A L; Scribano, A; Scuri, F; Sedov, A; Seidel, S; Seiya, Y; Semenov, A; Sexton-Kennedy, L; Sfyrla, A; Shapiro, M D; Shears, T; Shepard, P F; Sherman, D; Shimojima, M; Shochet, M; Shon, Y; Shreyber, I; Sidoti, A; Sinervo, P; Sisakyan, A; Sjolin, J; Slaughter, A J; Slaunwhite, J; Sliwa, K; Smith, J R; Snider, F D; Snihur, R; Soderberg, M; Soha, A; Somalwar, S; Sorin, V; Spalding, J; Spinella, F; Spreitzer, T; Squillacioti, P; Stanitzki, M; Staveris-Polykalas, A; Denis, R St; Stelzer, B; Stelzer-Chilton, O; Stentz, D; Strologas, J; Stuart, D; Suh, J S; Sukhanov, A; Sun, H; Suzuki, T; Taffard, A; Takashima, R; Takeuchi, Y; Takikawa, K; Tanaka, M; Tanaka, R; Tecchio, M; Teng, P K; Terashi, K; Thom, J; Thompson, A S; Thomson, E; Tipton, P; Tiwari, V; Tkaczyk, S; Toback, D; Tokar, S; Tollefson, K; Tomura, T; Tonelli, D; Torre, S; Torretta, D; Tourneur, S; Trischuk, W; Tsuchiya, R; Tsuno, S; Turini, N; Ukegawa, F; Unverhau, T; Uozumi, S; Usynin, D; Vallecorsa, S; van Remortel, N; Varganov, A; Vataga, E; Vázquez, F; Velev, G; Veramendi, G; Veszpremi, V; Vidal, R; Vila, I; Vilar, R; Vine, T; Vollrath, I; Volobouev, I; Volpi, G; Würthwein, F; Wagner, P; Wagner, R G; Wagner, R L; Wagner, J; Wagner, W; Wallny, R; Wang, S M; Warburton, A; Waschke, S; Waters, D; Wester, W C; Whitehouse, B; Whiteson, D; Wicklund, A B; Wicklund, E; Williams, G; Williams, H H; Wilson, P; Winer, B L; Wittich, P; Wolbers, S; Wolfe, C; Wright, T; Wu, X; Wynne, S M; Yagil, A; Yamamoto, K; Yamaoka, J; Yamashita, T; Yang, C; Yang, U K; Yang, Y C; Yao, W M; Yeh, G P; Yoh, J; Yorita, K; Yoshida, T; Yu, G B; Yu, I; Yu, S S; Yun, J C; Zanello, L; Zanetti, A; Zaw, I; Zhang, X; Zhou, J; Zucchelli, S

2007-03-16

We present the first observation of exclusive e(+)e(-) production in hadron-hadron collisions, using pp[over] collision data at (square root) s = 1.96 TeV taken by the run II Collider Detector at Fermilab, and corresponding to an integrated luminosity of 532 pb(-1). We require the absence of any particle signatures in the detector except for an electron and a positron candidate, each with transverse energy E(T) > 5 GeV and pseudorapidity |eta| < 2. With these criteria, 16 events are observed compared to a background expectation of 1.9+/-0.3 events. These events are consistent in cross section and properties with the QED process pp[over] --> p + e(+)e(-) + p[over] through two-photon exchange. The measured cross section is 1.6(-0.3)(+0.5)(stat) +/- 0.3(syst) pb. This agrees with the theoretical prediction of 1.71+/-0.01 pb.

Multiplicities of Hadrons Within Jets at STAR

NASA Astrophysics Data System (ADS)

Wheeler, Suzanne; Drachenberg, Jim; STAR Collaboration

2017-09-01

Jet measurements have long been tools used to understand QCD phenomena. There is still much to be learned from the production of hadrons inside of jets. In particular, hadron yields within jets from proton-proton collisions have been proposed as a way to unearth more information on gluon fragmentation functions. In 2011, the STAR experiment at RHIC collected 23 pb-1 of data from proton-proton collisions at √{ s} = 500 GeV. The jets of most interest for gluon fragmentation functions are those with transverse momentum around 6-15 GeV/c. Large acceptance charged particle tracking and electromagnetic calorimetry make STAR an excellent jet detector. Time-of-flight and specific energy loss in the tracking system allow particle identification on the various types of hadrons within the jets, e.g., distinguishing pions from kaons and protons. An integral part of analyzing the data collected is understanding how the finite resolutions of the various detector subsystems influence the measured jet and hadron kinematics. For this reason, Monte Carlo simulations can be used to track the shifting of the hadron and jet kinematics between the generator level and the detector reconstruction level. The status of this analysis will be presented. We would like to acknowledge the Ronald E. McNair program for supporting this research.

Muon–hadron detector of the carpet-2 array

DOE Office of Scientific and Technical Information (OSTI.GOV)

Dzhappuev, D. D.; Kudzhaev, A. U., E-mail: kudjaev@mail.ru; Klimenko, N. F.

The 1-GeV muon–hadron detector of the Carpet-2 multipurpose shower array at the Baksan Neutrino Observatory, Institute for Nuclear Research, Russian Academy of Sciences (INR, Moscow, Russia) is able to record simultaneously muons and hadrons. The procedure developed for this device makes it possible to separate the muon and hadron components to a high degree of precision. The spatial and energy features of the muon and hadron extensive-air-shower components are presented. Experimental data from the Carpet-2 array are contrasted against data from the EAS-TOP and KASCADE arrays and against the results of the calculations based on the CORSIKA (GHEISHA + QGSJET01)more » code package and performed for primary protons and iron nuclei.« less

Development and use of a computer system in a radiotherapy department: SISGRAD.

PubMed

Costa, A; Lalanne, C M; Marcié, S; Leca, M; Rameau, P; Chauvel, P; Héry, M; Lagrange, J L; Verschoore, J

1987-12-01

SISGRAD, the interactive computer system of the Antoine-Lacassagne Cancer Center Radiotherapy Department, has been operational since January 1982. It completes the computerized dosimetry system installed several years earlier and is fully integrated with the institution's central network. SISGRAD is in charge of surveillance of the radiotherapy treatments given by the Center's three radiotherapy units (1400 patients per year); it is also used for administrative purposes in the Department and physically connects all of the Department's operating stations. SISGRAD consists of a series of microcomputers connected to a common mass memory; each microcomputer is used as an intelligent console. SISGRAD was developed to guarantee that the treatments comply with prescriptions, to supply extemporaneous dosimetric data, to improve administrative work, and to supply banks with data for statistical analysis and research. SISGRAD actively intervenes to guarantee treatment quality and helps to improve therapy-related security factors. The present text describes the results of clinical use over a 4-year period. The consequences of integration of the system within the Department are analyzed, with special emphasis being placed on SISGRAD's role in the prevention and detection of errors in treatment prescription and delivery.

The role of radiotherapy in the treatment of carcinoma of the prostate: a survey of clinical practices in Lombardy, Italy, by the AIRO-Lombardia Cooperative Group. Italian Association for Radiation Oncology.

PubMed

Villa, S; Bertoni, F; Bossi, A; Caraffini, B; Corbella, F; Di Lorenzo, I; Italia, C; Leoni, M; Nava, S; Sarti, E; Vavassori, V; Villa, E; Palazzi, M

1998-01-01

We report the results of a survey performed in 1994 by the AIRO-Lombardia Cooperative Group, on the clinical patterns of radiation treatment for prostatic carcinoma in Lombardy, Italy, involving all radiotherapy centers serving an overall local population of about 8,800,000 people. A questionnaire was sent to all 13 radiotherapy centers throughout Lombardy, asking for demographic and treatment details concerning the local population of patients with a localized (T1-4, N0-1, M0) carcinoma of the prostate treated with radiotherapy; 12 centers responded, making the basis for the present report. Analysis of collected data showed that in Lombardy: a) approximately 400 patients per year are irradiated for a localized carcinoma of the prostate, accounting for less than 30% of the total expected number of patients with this disease presentation; b) a complete staging (with PSA, transrectal ultrasonography, abdomino-pelvic CT or MRI scan and total-body bone scan) is performed in over 95% of patients before initiating radiotherapy; c) significant differences exist between radiotherapy centers as regards treatment planning and delivery. An urgent need exists for implementing procedures aimed at standardizing radiotherapy procedures within Lombardy.

Jet-induced medium excitation in γ-hadron correlation at RHIC

DOE PAGES

Chen, Wei; Cao, Shanshan; Luo, Tan; ...

2017-09-25

Both jet transport and jet-induced medium excitation are investigated simultaneously within the coupled Linear Boltzmann Transport and hydro (CoLBT-hydro) model. In this coupled approach, energy-momentum deposition from propagating jet shower partons in the elastic and radiation processes is taken as a source term in hydrodynamics and the hydro background for LBT simulation is updated for next time step. We use CoLBT-hydro model to simulate γ-jet events of Au+Au collisions at RHIC. Hadron spectra from both the hadronization of jet shower partons and jet-induced medium excitation are calculated and compared to experimental data. Parton energy loss of jet shower partons leadsmore » to the suppression of hadron yields at large z T = p h T/p γ T while medium excitations leads to enhancement of hadron yields at small z T. Meanwhile, a significant broadening of low p T hadron yields and the depletion of soft hadrons in the γ direction are observed in the calculation of γ-hadron angular correlation.« less

Jet-induced medium excitation in γ-hadron correlation at RHIC

DOE Office of Scientific and Technical Information (OSTI.GOV)

Chen, Wei; Cao, Shanshan; Luo, Tan

Both jet transport and jet-induced medium excitation are investigated simultaneously within the coupled Linear Boltzmann Transport and hydro (CoLBT-hydro) model. In this coupled approach, energy-momentum deposition from propagating jet shower partons in the elastic and radiation processes is taken as a source term in hydrodynamics and the hydro background for LBT simulation is updated for next time step. We use CoLBT-hydro model to simulate γ-jet events of Au+Au collisions at RHIC. Hadron spectra from both the hadronization of jet shower partons and jet-induced medium excitation are calculated and compared to experimental data. Parton energy loss of jet shower partons leadsmore » to the suppression of hadron yields at large z T = p h T/p γ T while medium excitations leads to enhancement of hadron yields at small z T. Meanwhile, a significant broadening of low p T hadron yields and the depletion of soft hadrons in the γ direction are observed in the calculation of γ-hadron angular correlation.« less

A facility for investigation of multiple hadrons at cosmic-ray energies

NASA Technical Reports Server (NTRS)

Valtonen, E.; Torsti, J. J.; Arvela, H.; Lumme, M.; Nieminen, M.; Peltonen, J.; Vainikka, E.

1985-01-01

An experimental arrangement for studying multiple hadrons produced in high-energy hadron-nucleus interactions is under construction at the university of Turku. The method of investigation is based on the detection of hadrons arriving simultaneously at sea level over an area of a few square meters. The apparatus consists of a hadron spectrometer with position-sensitive detectors in connection with a small air shower array. The position resolution using streamer tube detectors will be about 10 mm. Energy spectra of hadrons or groups of simultaneous hadrons produced at primary energies below 10 to the 16th power eV can be measured in the energy range 1 to 2000 GeV.

Radiotherapy quality assurance report from children's oncology group AHOD0031

PubMed Central

Dharmarajan, Kavita V.; Friedman, Debra L.; FitzGerald, T.J.; McCarten, Kathleen M.; Constine, Louis S.; Chen, Lu; Kessel, Sandy K.; Iandoli, Matt; Laurie, Fran; Schwartz, Cindy L.; Wolden, Suzanne L.

2016-01-01

Purpose A phase III trial assessing response-based therapy in intermediate-risk Hodgkin lymphoma, mandated real-time central review of involved field radiotherapy and imaging records by a centralized review center to maximize protocol compliance. We report the impact of centralized radiotherapy review upon protocol compliance. Methods Review of simulation films, port films, and dosimetry records was required pre-treatment and after treatment completion. Records were reviewed by study-affiliated or review center-affiliated radiation oncologists. A 6–10% deviation from protocol-specified dose was scored as “minor”; >10% was “major”. A volume deviation was scored as “minor” if margins were less than specified, or “major” if fields transected disease-bearing areas. Interventional review and final compliance review scores were assigned to each radiotherapy case and compared. Results Of 1712 patients enrolled, 1173 underwent IFRT at 256 institutions in 7 countries. An interventional review was performed in 88% and a final review in 98%. Overall, minor and major deviations were found in 12% and 6%, respectively. Among the cases for which ≥ 1 pre-IFRT modification was requested by QARC and subsequently made by the treating institution, 100% were made compliant on final review. In contrast, among the cases for which ≥ 1 modification was requested but not made by the treating institution, 10% were deemed compliant on final review. Conclusion In a large trial with complex treatment pathways and heterogeneous radiotherapy fields, central review was performed in a large percentage of cases pre-IFRT and identified frequent potential deviations in a timely manner. When suggested modifications were performed by the institutions, deviations were almost eliminated. PMID:25670539

Status and Prospects for Hadron Production Experiments

DOE Office of Scientific and Technical Information (OSTI.GOV)

Schroeter, Raphaeel

2010-03-30

The latest results from the HARP, MIPP and NA61 Hadron Production Experiments are reviewed and their implications for neutrinos physics experiments are discussed. We emphasize three neutrino sources: accelerator-based neutrino beams, advanced neutrino sources and atmospheric neutrinos. Finally, prospects from additional forthcoming hadron production measurements are presented.

Germany-US Nuclear Theory Exchange Program for QCD Studies of Hadrons & Nuclei 'GAUSTEQ'

DOE Office of Scientific and Technical Information (OSTI.GOV)

Dudek, Jozef; Melnitchouk, Wally

GAUSTEQ was a Germany-U.S. exchange program in nuclear theory whose purpose was to focus research efforts on QCD studies of hadrons and nuclei, centered around the current and future research programs of Jefferson Lab and the Gesellschaft fur Schwerionenforschung (GSI) in Germany. GAUSTEQ provided travel support for theoretical physicists at US institutions conducting collaborative research with physicists in Germany. GSI (with its Darmstadt and Helmholtz Institute Mainz braches) served as the German “hub” for visits of U.S. physicists, while Jefferson Lab served as the corresponding “hub” for visits of German physicists visiting U.S. institutions through the reciprocal GUSTEHP (German-US Theorymore » Exchange in Hadron Physics) program. GAUSTEQ was funded by the Office of Nuclear Physics of the U.S. Department of Energy, under Contract No.DE-SC0006758 and officially managed through Old Dominion University in Norfolk, Virginia. The program ran between 2011 and 2015.« less

Hadron scattering, resonances, and QCD

NASA Astrophysics Data System (ADS)

Briceño, R. A.

2016-11-01

The non-perturbative nature of quantum chromodynamics (QCD) has historically left a gap in our understanding of the connection between the fundamental theory of the strong interactions and the rich structure of experimentally observed phenomena. For the simplest properties of stable hadrons, this is now circumvented with the use of lattice QCD (LQCD). In this talk I discuss a path towards a rigorous determination of few-hadron observables from LQCD. I illustrate the power of the methodology by presenting recently determined scattering amplitudes in the light-meson sector and their resonance content.

New Insights into Color Confinement, Hadron Dynamics, Spectroscopy, and Jet Hadronization from Light-Front Holography and Superconformal Algebra

NASA Astrophysics Data System (ADS)

Brodsky, S. J.

2017-07-01

A fundamental problem in hadron physics is to obtain a relativistic color-confining, first approximation to QCD which can predict both hadron spectroscopy and the frame-independent light-front (LF) wavefunctions underlying hadron dynamics. The QCD Lagrangian with zero quark mass has no explicit mass scale; the classical theory is conformally invariant. Thus, a fundamental problem is to understand how the mass gap and ratios of masses - such as m ρ/ m p - can arise in chiral QCD. De Alfaro, Fubini, and Furlan have made an important observation that a mass scale can appear in the equations of motion without affecting the conformal invariance of the action if one adds a term to the Hamiltonian proportional to the dilatation operator or the special conformal operator and rescales the time variable. If one applies the same procedure to the light-front Hamiltonian, it leads uniquely to a confinement potential κ 4 ζ 2 for mesons, where ζ 2 is the LF radial variable conjugate to the q\\overline{q} invariant mass squared. The same result, including spin terms, is obtained using light-front holography - the duality between light-front dynamics and AdS5, the space of isometries of the conformal group if one modifies the action of AdS5 by the dilaton {e}^{κ^2}{z}^2 in the fifth dimension z . When one generalizes this procedure using superconformal algebra, the resulting light-front eigensolutions predict unified Regge spectroscopy of meson, baryon, and tetraquarks, including remarkable supersymmetric relations between the masses of mesons and baryons of the same parity. One also predicts observables such as hadron structure functions, transverse momentum distributions, and the distribution amplitudes defined from the hadronic light-front wavefunctions. The mass scale κ underlying confinement and hadron masses can be connected to the parameter {Λ}_{\\overline{MS}} in the QCD running coupling by matching the nonperturbative dynamics to the perturbative QCD regime. The

New Insights into Color Confinement, Hadron Dynamics, Spectroscopy, and Jet Hadronization from Light-Front Holography and Superconformal Algebra

DOE Office of Scientific and Technical Information (OSTI.GOV)

Brodsky, S. J.

A fundamental problem in hadron physics is to obtain a relativistic color-confining, first approximation to QCD which can predict both hadron spectroscopy and the frame-independent light-front (LF) wavefunctions underlying hadron dynamics. The QCD Lagrangian with zero quark mass has no explicit mass scale; the classical theory is conformally invariant. Thus, a fundamental problem is to understand how the mass gap and ratios of masses – such as mρ/mp – can arise in chiral QCD. De Alfaro, Fubini, and Furlan have made an important observation that a mass scale can appear in the equations of motion without affecting the conformal invariance of the action if one adds a term to the Hamiltonian proportional to the dilatation operator or the special conformal operator and rescales the time variable. If one applies the same procedure to the light-front Hamiltonian, it leads uniquely to a confinement potential κ 4ζ 2 for mesons, where ζ 2 is the LF radial variable conjugate to themore » $$q\\bar{q}$$ invariant mass squared. The same result, including spin terms, is obtained using light-front holography – the duality between light-front dynamics and AdS 5, the space of isometries of the conformal group if one modifies the action of AdS 5 by the dilaton e $κ^2$ z$^2$ in the fifth dimension z . When one generalizes this procedure using superconformal algebra, the resulting light-front eigensolutions predict unified Regge spectroscopy of meson, baryon, and tetraquarks, including remarkable supersymmetric relations between the masses of mesons and baryons of the same parity. One also predicts observables such as hadron structure functions, transverse momentum distributions, and the distribution amplitudes defined from the hadronic light-front wavefunctions. The mass scale κ underlying confinement and hadron masses can be connected to the parameter Λ $$\\overline{MS}$$ in the QCD running coupling by matching the nonperturbative dynamics to the perturbative QCD

New Insights into Color Confinement, Hadron Dynamics, Spectroscopy, and Jet Hadronization from Light-Front Holography and Superconformal Algebra

DOE PAGES

Brodsky, S. J.

2017-07-11

A fundamental problem in hadron physics is to obtain a relativistic color-confining, first approximation to QCD which can predict both hadron spectroscopy and the frame-independent light-front (LF) wavefunctions underlying hadron dynamics. The QCD Lagrangian with zero quark mass has no explicit mass scale; the classical theory is conformally invariant. Thus, a fundamental problem is to understand how the mass gap and ratios of masses – such as mρ/mp – can arise in chiral QCD. De Alfaro, Fubini, and Furlan have made an important observation that a mass scale can appear in the equations of motion without affecting the conformal invariance of the action if one adds a term to the Hamiltonian proportional to the dilatation operator or the special conformal operator and rescales the time variable. If one applies the same procedure to the light-front Hamiltonian, it leads uniquely to a confinement potential κ 4ζ 2 for mesons, where ζ 2 is the LF radial variable conjugate to themore » $$q\\bar{q}$$ invariant mass squared. The same result, including spin terms, is obtained using light-front holography – the duality between light-front dynamics and AdS 5, the space of isometries of the conformal group if one modifies the action of AdS 5 by the dilaton e $κ^2$ z$^2$ in the fifth dimension z . When one generalizes this procedure using superconformal algebra, the resulting light-front eigensolutions predict unified Regge spectroscopy of meson, baryon, and tetraquarks, including remarkable supersymmetric relations between the masses of mesons and baryons of the same parity. One also predicts observables such as hadron structure functions, transverse momentum distributions, and the distribution amplitudes defined from the hadronic light-front wavefunctions. The mass scale κ underlying confinement and hadron masses can be connected to the parameter Λ $$\\overline{MS}$$ in the QCD running coupling by matching the nonperturbative dynamics to the perturbative QCD

Collins azimuthal asymmetries of hadron production inside jets

DOE PAGES

Kang, Zhong -Bo; Prokudin, Alexei; Ringer, Felix; ...

2017-10-18

Here, we investigate the Collins azimuthal asymmetry of hadrons produced inside jets in transversely polarized proton-proton collisions. Recently, the quark transversity distributions and the Collins fragmentation functions have been extracted within global analyses from data of the processes semi-inclusive deep inelastic scattering and electron-positron annihilation. We calculate the Collins azimuthal asymmetry for charged pions inside jets using these extractions for RHIC kinematics at center-of-mass energies of 200 and 500 GeV. We compare our results with recent data from the STAR Collaboration at RHIC and find good agreement, which confirms the universality of the Collins fragmentation functions. In addition, we furthermore » explore the impact of transverse momentum dependent evolution effects.« less

Collins azimuthal asymmetries of hadron production inside jets

DOE Office of Scientific and Technical Information (OSTI.GOV)

Kang, Zhong -Bo; Prokudin, Alexei; Ringer, Felix

Here, we investigate the Collins azimuthal asymmetry of hadrons produced inside jets in transversely polarized proton-proton collisions. Recently, the quark transversity distributions and the Collins fragmentation functions have been extracted within global analyses from data of the processes semi-inclusive deep inelastic scattering and electron-positron annihilation. We calculate the Collins azimuthal asymmetry for charged pions inside jets using these extractions for RHIC kinematics at center-of-mass energies of 200 and 500 GeV. We compare our results with recent data from the STAR Collaboration at RHIC and find good agreement, which confirms the universality of the Collins fragmentation functions. In addition, we furthermore » explore the impact of transverse momentum dependent evolution effects.« less

[Task sharing with radiotherapy technicians in image-guided radiotherapy].

PubMed

Diaz, O; Lorchel, F; Revault, C; Mornex, F

2013-10-01

The development of accelerators with on-board imaging systems now allows better target volumes reset at the time of irradiation (image-guided radiotherapy [IGRT]). However, these technological advances in the control of repositioning led to a multiplication of tasks for each actor in radiotherapy and increase the time available for the treatment, whether for radiotherapy technicians or radiation oncologists. As there is currently no explicit regulatory framework governing the use of IGRT, some institutional experiments show that a transfer is possible between radiation oncologists and radiotherapy technicians for on-line verification of image positioning. Initial training for every technical and drafting procedures within institutions will improve audit quality by reducing interindividual variability. Copyright © 2013. Published by Elsevier SAS.

Fast Dynamical Evolution of Hadron Resonance Gas via Hagedorn States

NASA Astrophysics Data System (ADS)

Beitel, M.; Gallmeister, K.; Greiner, C.

2017-01-01

Hagedorn states (HS) are a tool to model the hadronization process which occurs in the phase transition region between the quark gluon plasma (QGP) and the hadron resonance gas (HRG). These states are believed to appear near the Hagedorn temperature TH which in our understanding equals the critical temperature Tc . A covariantly formulated bootstrap equation is solved to generate the zoo of these particles characterized baryon number B, strangeness S and electric charge Q. These hadron-like resonances are characterized by being very massive and by not being limited to quantum numbers of known hadrons. All hadronic properties like masses, spectral functions etc. are taken from the hadronic transport model Ultra Relativistic Quantum Molecular Dynamics (UrQMD). Decay chains of single Hagedorn states provide a well description of experimentally observed multiplicity ratios of strange and multi-strange particles as the Ξ0- and the Ω--baryon. In addition, the final energy spectra of resulting hadrons show a thermal-like distribution with the characteristic Hagedorn temperature TH . Box calculations including these Hagedorn states are performed. Indeed, the time scales leading to equilibration of the system are drastically reduced down to 2. . . 5 fm/c.

Enraged about radiotherapy.

PubMed Central

Sikora, K.

1994-01-01

The use of radiotherapy in treating breast cancer has meant that many women are able to avoid mastectomy, which is both physically and psychologically damaging. The side effects of radiotherapy, however, are given little attention. Many women have developed brachial plexus injury after radiotherapy for breast cancer, often resulting in severe pain and loss of use of the arm. There is no effective treatment for this injury and little help can be offered. In addition, many of the women did not require radiotherapy of nodal areas. A pressure group has been formed to support these women, to establish the right to compensation, and to ensure that radiotherapy regimens given to future patients will not damage the brachial plexus. Images p188-a PMID:8312773

Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway.

PubMed

Anshushaug, Malin; Gynnild, Mari Aas; Kaasa, Stein; Kvikstad, Anne; Grønberg, Bjørn H

2015-03-01

Many cancer patients receive chemotherapy and radiotherapy their last 30 days [end of life (EOL)]. The benefit is questionable and side effects are common. The aim of this study was to investigate what characterized the patients who received chemo- and radiotherapy during EOL, knowledge that might be used to improve practice. Patients dead from cancer in 2005 and 2009 were analyzed. Data were collected from hospital medical records. When performance status (PS) was not stated, PS was estimated from other information in the records. A Glasgow Prognostic Score (GPS) of 0, 1 or 2 was assessed from blood values (CRP and albumin). A higher score is associated with a shorter prognosis. In total 616 patients died in 2005; 599 in 2009. Among the 723 analyzed, median age was 71; 42% had metastases at diagnosis (synchronous metastases); 53% had PS 2 and 16% PS 3-4 at the start of last cancer therapy. GPS at the start of last cancer therapy was assessable in 70%; of these, 26% had GPS 1 and 35% GPS 2. Overall, 10% received chemotherapy and 8% radiotherapy during EOL. The proportions varied significantly between the different types of cancer. Multivariate analyses revealed that those at age<70 years, GPS 2, no contact with our Palliative Care Unit and synchronous metastases received most chemotherapy the last 30 days. PS 3-4, GPS 2 and synchronous metastases were strongest associated with radiotherapy the last 30 days. Ten percent received chemotherapy and 8% radiotherapy the last 30 days of life. GPS 2 and synchronous metastases were most significantly associated with cancer therapy the last 30 days of life, indicating that in general, patients with the shortest survival time after diagnosis of cancer received more chemo- and radiotherapy during EOL than other patients.

Perfomance of a compensating lead-scintillator hadronic calorimeter

NASA Astrophysics Data System (ADS)

Bernardi, E.; Drews, G.; Garcia, M. A.; Klanner, R.; Kötz, U.; Levman, G.; Lomperski, M.; Lüke, D.; Ros, E.; Selonke, F.; Tiecke, H.; Tsirou, M.; Vogel, W.

1987-12-01

We have built a sandwich calorimeter consisting of 10 mm thick lead plates and 2.5 mm thick scintillator sheets. The thickness ratio between lead and scintillator was optimized to achieve a good energy resolution for hadrons. We have exposed this calorimeter to electrons, hadrons and muons in the energy range between 3 and 75 GeV, obtaining an average energy resolution of {23%}/{E} for electrons and {44%}/{E} for hadrons. For energies above 10 GeV and after leakage corrections, the ratio of electron response to hardron response is 1.05.

Heavy and light hadron production and D-hadron correlation in relativistic heavy-ion collisions

DOE PAGES

Cao, Shanshan; Luo, Tan; He, Yayun; ...

2017-09-25

We establish a linear Boltzmann transport (LBT) model coupled to hydrodynamical background to study hard parton evolution in heavy-ion collisions. Both elastic and inelastic scatterings are included in our calculations; and heavy and light flavor partons are treated on the same footing. Within this LBT model, we provide good descriptions of heavy and light hadron suppression and anisotropic flow in heavy-ion collisions. Angular correlation functions between heavy and light flavor hadrons are studied for the first time and shown able to quantify not only the amount of heavy quark energy loss, but also how the parton energy is re-distributed inmore » parton showers.« less

Heavy and light hadron production and D-hadron correlation in relativistic heavy-ion collisions

DOE Office of Scientific and Technical Information (OSTI.GOV)

Cao, Shanshan; Luo, Tan; He, Yayun

We establish a linear Boltzmann transport (LBT) model coupled to hydrodynamical background to study hard parton evolution in heavy-ion collisions. Both elastic and inelastic scatterings are included in our calculations; and heavy and light flavor partons are treated on the same footing. Within this LBT model, we provide good descriptions of heavy and light hadron suppression and anisotropic flow in heavy-ion collisions. Angular correlation functions between heavy and light flavor hadrons are studied for the first time and shown able to quantify not only the amount of heavy quark energy loss, but also how the parton energy is re-distributed inmore » parton showers.« less

Hadron multiplicity variation with Q2 and scale breaking of the Hadron distributions in deep inelastic muon-proton scattering

NASA Astrophysics Data System (ADS)

Arneodo, M.; Arvidson, A.; Aubert, J. J.; Badelek, B.; Beaufays, J.; Bee, C. P.; Benchouk, C.; Berghoff, G.; Bird, I.; Blum, D.; Böhm, E.; de Bouard, X.; Brasse, F. W.; Braun, H.; Broll, C.; Brown, S.; Brück, H.; Calen, H.; Chima, J. S.; Ciborowski, J.; Clifft, R.; Coignet, G.; Combley, F.; Coughlan, J.; D'Agostini, G.; Dahlgren, S.; Dengler, F.; Derado, I.; Dreyer, T.; Drees, J.; Düren, M.; Eckardt, V.; Edwards, A.; Edwards, M.; Ernst, T.; Eszes, G.; Favier, J.; Ferrero, M. I.; Figiel, J.; Flauger, W.; Foster, J.; Gabathuler, E.; Gajewski, J.; Gamet, R.; Gayler, J.; Geddes, N.; Giubellino, P.; Grafström, P.; Grard, F.; Haas, J.; Hagberg, E.; Hamacher, K.; Hasert, F. J.; Hayman, P.; Heusse, P.; Jaffré, M.; Jacholkowska, A.; Janata, F.; Jancso, G.; Johnson, A. S.; Kabuss, E. M.; Kellner, G.; Korbel, V.; Korzen, B.; Krüger, J.; Kullander, S.; Landgraf, U.; Lanske, D.; Loken, J.; Long, K.; Malecki, P.; Maire, M.; Manz, A.; Maselli, S.; Mohr, W.; Montanet, F.; Montgomery, H. E.; Nagy, E.; Nassalski, J.; Norton, P. R.; Oakham, F. G.; Osborne, A. M.; Pascaud, C.; Pawlik, B.; Payre, P.; Peroni, C.; Peschel, H.; Pessard, H.; Pettingale, J.; Pietrzyk, B.; Pietrzyk, U.; Pönsgen, B.; Pötsch, M.; Preissner, H.; Renton, P.; Ribarics, P.; Rith, K.; Rondio, E.; Scheer, M.; Schlagböhmer, A.; Schiemann, H.; Schmitz, N.; Schneegans, M.; Schneider, A.; Sholz, M.; Schröder, T.; Schouten, M.; Schultze, K.; Sloan, T.; Stier, H. E.; Stockhausen, W.; Studt, M.; Taylor, G. N.; Thénard, J. M.; Thompson, J. C.; de La Torre, A.; Toth, J.; Urban, L.; Urban, L.; Wallucks, W.; Whalley, M.; Wheeler, S.; Williams, W. S. C.; Wimpenny, S. J.; Windmolders, R.; Wolf, G.

1985-12-01

Measurements are presented of the variation with Q2 (scaling violation) of the hadron multiplicity in deep inelastic muon-proton scattering. An increase in the average multiplicity of both the charged hadrons and K0 mesons is observed with increasing Q2 or xBj for fixed centre-of-mass energy W. The study of the shape of the effective fragmentation function Dh (z, W, Q2) shows that the increase of the particle yield with Q2 takes place for low z particles. The variation of the hadron distributions with Q2 is also studied in the current fragmentation region where a decrease in multiplicity is observed. Such effects are expected from QCD.

Imaging hadron calorimetry for future Lepton Colliders

NASA Astrophysics Data System (ADS)

Repond, José

2013-12-01

To fully exploit the physics potential of a future Lepton Collider requires detectors with unprecedented jet energy and dijet-mass resolution. To meet these challenges, detectors optimized for the application of Particle Flow Algorithms (PFAs) are being designed and developed. The application of PFAs, in turn, requires calorimeters with very fine segmentation of the readout, so-called imaging calorimeters. This talk reviews progress in imaging hadron calorimetry as it is being developed for implementation in a detector at a future Lepton Collider. Recent results from the large prototypes built by the CALICE Collaboration, such as the Scintillator Analog Hadron Calorimeter (AHCAL) and the Digital Hadron Calorimeters (DHCAL and SDHCAL) are being presented. In addition, various R&D efforts beyond the present prototypes are being discussed.

Searching for the rules that govern hadron construction

DOE PAGES

Shepherd, Matthew R.; Dudek, Jozef J.; Mitchell, Ryan E.

2016-06-22

Just as quantum electrodynamics describes how electrons are bound in atoms by the electromagnetic force, mediated by the exchange of photons, quantum chromodynamics (QCD) describes how quarks are bound inside hadrons by the strong force, mediated by the exchange of gluons. QCD seems to allow hadrons constructed from increasingly many quarks to exist, just as atoms with increasing numbers of electrons exist, yet such complex constructions seemed, until recently, not to be present in nature. In this paper, we describe advances in the spectroscopy of mesons that are refining our understanding of the rules for predicting hadron structure from QCD.

XVII International Conference on Hadron Spectroscopy and Structure

NASA Astrophysics Data System (ADS)

2017-09-01

The Hadron 2017 Conference is the seventeenth of a series of biennial conferences started in 1985 at Maryland, USA. Its official name, XVII International Conference on Hadron Spectroscopy and Structure, includes for the first time the term structure to emphasize the importance that this issue has acquired in recent editions of the series. The aim of the conference is to provide an overview of the present status and progress in hadron structure and dynamics, as well as a preview of the forthcoming investigations. It will cover lectures on both experimental and theoretical aspects, including in particular the presentation of new results.

Polyakov loop and the hadron resonance gas model.

PubMed

Megías, E; Arriola, E Ruiz; Salcedo, L L

2012-10-12

The Polyakov loop has been used repeatedly as an order parameter in the deconfinement phase transition in QCD. We argue that, in the confined phase, its expectation value can be represented in terms of hadronic states, similarly to the hadron resonance gas model for the pressure. Specifically, L(T)≈1/2[∑(α)g(α)e(-Δ(α)/T), where g(α) are the degeneracies and Δ(α) are the masses of hadrons with exactly one heavy quark (the mass of the heavy quark itself being subtracted). We show that this approximate sum rule gives a fair description of available lattice data with N(f)=2+1 for temperatures in the range 150 MeVhadrons are present in the QCD spectrum while other sets do not require such states.

Hadron electric polarizability from lattice QCD

NASA Astrophysics Data System (ADS)

Alexandru, Andrei

2017-09-01

Electromagnetic polarizabilities are important parameters for hadron structure, describing the response of the charge and current distributions inside the hadron to an external electromagnetic field. For most hadrons these quantities are poorly constrained experimentally since they can only be measured indirectly. Lattice QCD can be used to compute these quantities directly in terms of quark and gluons degrees of freedom, using the background field method. We present results for the neutron electric polarizability for two different quark masses, light enough to connect to chiral perturbation theory. These are currently the lightest quark masses used in polarizability studies. For each pion mass we compute the polarizability at four different volumes and perform an infinite volume extrapolation. We also discuss the effect of turning on the coupling between the background field and the sea quarks. A.A. is supported in part by the National Science Foundation CAREER Grant PHY-1151648 and by U.S. DOE Grant No. DE-FG02-95ER40907.

Unilateral Radiotherapy for the Treatment of Tonsil Cancer

DOE Office of Scientific and Technical Information (OSTI.GOV)

Chronowski, Gregory M., E-mail: gchronowski@mdanderson.org; Garden, Adam S.; Morrison, William H.

2012-05-01

Purpose: To assess, through a retrospective review, clinical outcomes of patients with squamous cell carcinoma of the tonsil treated at the M. D. Anderson Cancer Center with unilateral radiotherapy techniques that irradiate the involved tonsil region and ipsilateral neck only. Methods and Materials: Of 901 patients with newly diagnosed squamous cell carcinoma of the tonsil treated with radiotherapy at our institution, we identified 102 that were treated using unilateral radiotherapy techniques. All patients had their primary site of disease restricted to the tonsillar fossa or anterior pillar, with <1 cm involvement of the soft palate. Patients had TX (n =more » 17 patients), T1 (n = 52), or T2 (n = 33) disease, with Nx (n = 3), N0 (n = 33), N1 (n = 23), N2a (n = 21), or N2b (n = 22) neck disease. Results: Sixty-one patients (60%) underwent diagnostic tonsillectomy before radiotherapy. Twenty-seven patients (26%) underwent excision of a cervical lymph node or neck dissection before radiotherapy. Median follow-up for surviving patients was 38 months. Locoregional control at the primary site and ipsilateral neck was 100%. Two patients experienced contralateral nodal recurrence (2%). The 5-year overall survival and disease-free survival rates were 95% and 96%, respectively. The 5-year freedom from contralateral nodal recurrence rate was 96%. Nine patients required feeding tubes during therapy. Of the 2 patients with contralateral recurrence, 1 experienced an isolated neck recurrence and was salvaged with contralateral neck dissection only and remains alive and free of disease. The other patient presented with a contralateral base of tongue tumor and involved cervical lymph node, which may have represented a second primary tumor, and died of disease. Conclusions: Unilateral radiotherapy for patients with TX-T2, N0-N2b primary tonsil carcinoma results in high rates of disease control, with low rates of contralateral nodal failure and a low incidence of acute toxicity

Coherent J /ψ photoproduction in hadronic heavy-ion collisions

NASA Astrophysics Data System (ADS)

Zha, W.; Klein, S. R.; Ma, R.; Ruan, L.; Todoroki, T.; Tang, Z.; Xu, Z.; Yang, C.; Yang, Q.; Yang, S.

2018-04-01

Significant excesses of J /ψ yield at very low transverse momentum (pT<0.3 GeV/c ) were observed by the ALICE and STAR collaborations in peripheral hadronic A +A collisions. This is a sign of coherent photoproduction of J /ψ in violent hadronic interactions. Theoretically, the photoproduction of J /ψ in hadronic collisions raises questions about how spectator and nonspectator nucleons participate in the coherent reaction. We argue that the strong interactions in the overlapping region of incoming nuclei may disturb the coherent production, leaving room for different coupling assumptions. The destructive interference between photoproduction on ions moving in opposite directions also needs to be included. This paper presents calculations of J /ψ production from coherent photon-nucleus (γ +A →J /ψ +A ) interactions in hadronic A +A collisions at BNL Relativistic Heavy Ion Collider and CERN Large Hadron Collider energies with both nucleus and spectator coupling hypotheses. The integrated yield of coherent J /ψ as a function of centrality is found to be significantly different, especially towards central collisions, for different coupling scenarios. Differential distributions as a function of transverse momentum, azimuthal angle, and rapidity in different centrality bins are also shown, and found to be more sensitive to the Pomeron coupling than to the photon coupling. These predictions call for future experimental measurements to help better understand the coherent interaction in hadronic heavy-ion collisions.

Characterization of equipment for shaping and imaging hadron minibeams

NASA Astrophysics Data System (ADS)

Pugatch, V.; Brons, S.; Campbell, M.; Kovalchuk, O.; Llopart, X.; Martínez-Rovira, I.; Momot, Ie.; Okhrimenko, O.; Prezado, Y.; Sorokin, Yu.

2017-11-01

For the feasibility studies of spatially fractionated hadron therapy prototypes of the equipment for hadron minibeams shaping and monitoring have been designed, built and tested. The collimators design was based on Monte Carlo simulations (Gate v.6.2). Slit and matrix collimators were used for minibeams shaping. Gafchromic films, micropixel detectors Timepix in a hybrid as well as metal mode were tested for measuring hadrons intensity distribution in minibeams. An overall beam profile was measured by the metal microstrip detector. The performance of a mini-beams shaping and monitoring equipment was characterized exploring low energy protons at the KINR Tandem generator as well as high energy carbon and oxygen ion beams at HIT (Heidelberg). The results demonstrate reliable performance of the tested equipment for shaping and imaging hadron mini-beam structures.

Treatment of salivary gland neoplasms with fast neutron radiotherapy.

PubMed

Douglas, James G; Koh, Wui-jin; Austin-Seymour, Mary; Laramore, George E

2003-09-01

To evaluate the efficacy of fast neutron radiotherapy for the treatment of salivary gland neoplasms. Retrospective analysis. University of Washington Cancer Center, Neutron Facility, Seattle. The medical records of 279 patients treated with curative intent using fast neutron radiotherapy at the University of Washington Cancer Center were reviewed. Of the 279 patients, 263 had evidence of gross residual disease at the time of treatment (16 had no evidence of gross residual disease), 141 had tumors of a major salivary gland, and 138 had tumors of minor salivary glands. The median follow-up period was 36 months (range, 1-142 months). Local-regional control, cause-specific survival, and freedom from metastasis. The 6-year actuarial cause-specific survival rate was 67%. Multivariate analysis revealed that low group stage (I-II) disease, minor salivary sites, lack of skull base invasion, and primary disease were associated with a statistically significant improvement in cause-specific survival. The 6-year actuarial local-regional control rate was 59%. Multivariate analysis revealed size 4 cm or smaller, lack of base of skull invasion, prior surgical resection, and no previous radiotherapy to have a statistically significant improved local-regional control. Sixteen patients without evidence of gross residual disease had a 100% 6-year actuarial local-regional control. The 6-year actuarial freedom from metastasis rate was 64%. Factors associated with decreased development of systemic metastases included negative lymph nodes at the time of treatment and lack of base of skull involvement. The 6-year actuarial rate of development of grade 3 or 4 long-term toxicity (using the Radiation Therapy Oncology Group and European Organization for Research on the Treatment of Cancer criteria) was 10%. No patient experienced grade 5 toxic effects. Neuron radiotherapy is an effective treatment for patients with salivary gland neoplasms who have gross residual disease and achieves excellent

Can automation in radiotherapy reduce costs?

PubMed

Massaccesi, Mariangela; Corti, Michele; Azario, Luigi; Balducci, Mario; Ferro, Milena; Mantini, Giovanna; Mattiucci, Gian Carlo; Valentini, Vincenzo

2015-01-01

Computerized automation is likely to play an increasingly important role in radiotherapy. The objective of this study was to report the results of the first part of a program to implement a model for economical evaluation based on micro-costing method. To test the efficacy of the model, the financial impact of the introduction of an automation tool was estimated. A single- and multi-center validation of the model by a prospective collection of data is planned as the second step of the program. The model was implemented by using an interactive spreadsheet (Microsoft Excel, 2010). The variables to be included were identified across three components: productivity, staff, and equipment. To calculate staff requirements, the workflow of Gemelli ART center was mapped out and relevant workload measures were defined. Profit and loss, productivity and staffing were identified as significant outcomes. Results were presented in terms of earnings before interest and taxes (EBIT). Three different scenarios were hypothesized: baseline situation at Gemelli ART (scenario 1); reduction by 2 minutes of the average duration of treatment fractions (scenario 2); and increased incidence of advanced treatment modalities (scenario 3). By using the model, predicted EBIT values for each scenario were calculated across a period of eight years (from 2015 to 2022). For both scenarios 2 and 3 costs are expected to slightly increase as compared to baseline situation that is particularly due to a little increase in clinical personnel costs. However, in both cases EBIT values are more favorable than baseline situation (EBIT values: scenario 1, 27%, scenario 2, 30%, scenario 3, 28% of revenues). A model based on a micro-costing method was able to estimate the financial consequences of the introduction of an automation tool in our radiotherapy department. A prospective collection of data at Gemelli ART and in a consortium of centers is currently under way to prospectively validate the model.

Radiotherapy and Nuclear Medicine Project for an Integral Oncology Center at the Oaxaca High Specialization Regional Hospital

NASA Astrophysics Data System (ADS)

De Jesús, M.; Trujillo-Zamudio, F. E.

2010-12-01

A building project of Radiotherapy & Nuclear Medicine services (diagnostic and therapy), within an Integral Oncology Center (IOC), requires interdisciplinary participation of architects, biomedical engineers, radiation oncologists and medical physicists. This report focus on the medical physicist role in designing, building and commissioning stages, for the final clinical use of an IOC at the Oaxaca High Specialization Regional Hospital (HRAEO). As a first step, during design stage, the medical physicist participates in discussions about radiation safety and regulatory requirements for the National Regulatory Agency (called CNSNS in Mexico). Medical physicists propose solutions to clinical needs and take decisions about installing medical equipment, in order to fulfill technical and medical requirements. As a second step, during the construction stage, medical physicists keep an eye on building materials and structural specifications. Meanwhile, regulatory documentation must be sent to CNSNS. This documentation compiles information about medical equipment, radioactivity facility, radiation workers and nuclear material data, in order to obtain the license for the linear accelerator, brachytherapy and nuclear medicine facilities. As a final step, after equipment installation, the commissioning stage takes place. As the conclusion, we show that medical physicists are essentials in order to fulfill with Mexican regulatory requirements in medical facilities.

Hadron polarizability data analysis: GoAT

DOE Office of Scientific and Technical Information (OSTI.GOV)

Stegen, H., E-mail: hkstegen@mta.ca; Hornidge, D.; Collicott, C.

The A2 Collaboration at the Institute for Nuclear Physics in Mainz, Germany, is working towards determining the polarizabilities of hadrons from nonperturbative quantum chromodynamics through Compton scattering experiments at low energies. The asymmetry observables are directly related to the scalar and spin polarizabilities of the hadrons. Online analysis software, which will give real-time feedback on asymmetries, efficiencies, energies, and angle distributions, has been developed. The new software is a big improvement over the existing online code and will greatly develop the quality of the acquired data.

Hadron polarizability data analysis: GoAT

NASA Astrophysics Data System (ADS)

Stegen, H.; Collicott, C.; Hornidge, D.; Martel, P.; Ott, P.

2015-12-01

The A2 Collaboration at the Institute for Nuclear Physics in Mainz, Germany, is working towards determining the polarizabilities of hadrons from nonperturbative quantum chromodynamics through Compton scattering experiments at low energies. The asymmetry observables are directly related to the scalar and spin polarizabilities of the hadrons. Online analysis software, which will give real-time feedback on asymmetries, efficiencies, energies, and angle distributions, has been developed. The new software is a big improvement over the existing online code and will greatly develop the quality of the acquired data.

Top quark studies at hadron colliders

DOE Office of Scientific and Technical Information (OSTI.GOV)

Sinervo, P.K.

1997-01-01

The techniques used to study top quarks at hadron colliders are presented. The analyses that discovered the top quark are described, with emphasis on the techniques used to tag b quark jets in candidate events. The most recent measurements of top quark properties by the CDF and DO Collaborations are reviewed, including the top quark cross section, mass, branching fractions, and production properties. Future top quark studies at hadron colliders are discussed, and predictions for event yields and uncertainties in the measurements of top quark properties are presented.

Strange hadron (neutral kaon(short), lambda baryon and Xi baryon) production in deuteron+gold collisions at center of mass energy = 200 GeV at RHIC

NASA Astrophysics Data System (ADS)

Jiang, Hai

The study of identified particles from deuteron(d)+gold(Au) collisions provide a crucial reference to investigate nuclear effects observed in Au+Au collisions where a thermalized partonic state - Quark Gluon Plasma (QGP) - is thought to have been created. The measurements of transverse mass (mT) and momentum (pT) spectra at mid-rapidity (| y| < 1) for the identified strange hadrons: K0S , Λ + Λ and xi- + xi+ from d+Au collisions are presented. The measured pT covers 0.4 < p T < 6.0 GeV/c for K0S and Λ + Λ and 0.6 < pT < 5.0 GeV/c for xi- + xi+. These particles were reconstructed from the topological characteristics of their weak decays in the STAR Time Projection Chamber (TPC). The mT spectra of these particles are well described by a double exponential function which can be understood by two component models: soft (thermal) hadron production at low mT and hard hadron production at high mT. The integrated yields (dN/dy) and mean pT (< pT >) of these particles are calculated from the fit functions for different centralities. The dN/dy normalized to the number of participants (Npart) increase with Npart. The Λ(Λ ) dN/dy values at the mid-rapidity and forward rapidity regions agree with the EPOS model calculations. The measured Λ/ K0S ratios show the greatest baryon enhancement at pT ˜ 2 GeV/c in d+Au collisions. The strangeness enhancement going from d+Au to Au+Au collisions grows with the number of strange quark in a hadron. The magnitude of the enhancement is in the same order as the SPS measurement. The nuclear modification factors RCP normalized to binary collisions indicate that the Cronin effect in d+Au collisions has a distinct particle type dependence. The RCP ratios show a distinct baryon versus meson dependence: the RCP for xi- + xi+ follows that for Λ + Λ while the R CP for the φ is close to that for the K0S . The mechanism based on initial hadron or parton multiple scattering is not sufficient to explain this particle type dependence

A conceptual solution for a beam halo collimation system for the Future Circular hadron-hadron Collider (FCC-hh)

NASA Astrophysics Data System (ADS)

Fiascaris, M.; Bruce, R.; Redaelli, S.

2018-06-01

We present the first conceptual solution for a collimation system for the hadron-hadron option of the Future Circular Collider (FCC-hh). The collimation layout is based on the scaling of the present Large Hadron Collider collimation system to the FCC-hh energy and it includes betatron and momentum cleaning, as well as dump protection collimators and collimators in the experimental insertions for protection of the final focus triplet magnets. An aperture model for the FCC-hh is defined and the geometrical acceptance is calculated at injection and collision energy taking into account mechanical and optics imperfections. The performance of the system is then assessed through the analysis of normalized halo distributions and complete loss maps for an ideal lattice. The performance limitations are discussed and a solution to improve the system performance with the addition of dispersion suppression collimators around the betatron cleaning insertion is presented.

Effects of strong laser fields on hadronic helium atoms

NASA Astrophysics Data System (ADS)

Lee, Han-Chieh; Jiang, Tsin-Fu

2015-12-01

The metastable hadronic helium atoms in microseconds lifetime are available in laboratory, and two-photon spectroscopy was reported recently. This exotic helium atom has an electron in the ground state and a negative hadron rotating around the helium nucleus. We theoretically study the excitation on hadronic helium by femtosecond pulse and elucidate the influence of moleculelike structure and rotation behavior on the photoelectron spectra and high-order harmonic generation. Because of the moleculelike structure, the electronic ground state consists of several angular orbitals. These angular orbitals can enhance photoelectron spectra at high energies, and also influence the harmonic generation spectra considerably. In particular, the harmonic spectra can occur at even harmonic orders because of the transition between these angular orbitals and continuum states. On the other side, the rotation behavior of hadron can induce a frequency shift in the harmonic spectra. The magnitude of the frequency shift depends on the orbiting speed of the hadron, which is considerable because the rotation period is in a few femtoseconds, a time scale that is comparable to that of infrared laser and is feasible in current laser experiments.

Study of baryon production mechanism in e+e- annihilation into hadrons

NASA Astrophysics Data System (ADS)

Topaz Collaboration; Aoki, M.; Itoh, R.; Watanabe, Y.; Kaneyuki, K.; Ohshima, Y.; Ochi, A.; Tanimori, T.; Abe, K.; Abe, T.; Adachi, I.; Adachi, K.; Aoki, M.; Emi, K.; Enomoto, R.; Fujii, H.; Fujii, T.; Fujii, K.; Fujimoto, J.; Fujiwara, N.; Hayashii, H.; Hirano, H.; Howell, B.; Ikeda, H.; Inoue, Y.; Itami, S.; Iwasaki, H.; Iwasaki, M.; Kajikawa, R.; Kato, S.; Kawabata, S.; Kichimi, H.; Kobayashi, M.; Koltick, D.; Levine, I.; Mamada, H.; Miyabayashi, K.; Miyamoto, A.; Nagai, K.; Nakabayashi, K.; Nakamura, M.; Nakano, E.; Nitoh, O.; Noguchi, S.; Ochiai, F.; Ohishi, N.; Ohnishi, Y.; Okuno, H.; Okusawa, T.; Shibata, E.; Sugiyama, A.; Suzuki, S.; Takahashi, K.; Takahashi, T.; Teramoto, Y.; Tauchi, T.; Tomoto, M.; Tsukamoto, T.; Tsumura, T.; Uno, S.; Yamamoto, A.; Yamauchi, M.

1998-11-01

The mechanism of baryon-anti-baryon pair production in e+e- annihilation into hadrons has been studied using the TOPAZ detector at the TRISTAN e+e- collider at an average center-of-mass energy of 58 GeV. The distributions of various p¯p correlations were compared with two prominent models: the cluster-fragmentation model and the string-fragmentation model. We rejected the cluster-fragmentation model at the 90% C.L. Furthermore, in the context of the string-fragmentation model, we favor the ``popcorn'' model, rejecting the ``diquark'' model, where a diquark is considered to be a fundamental entity, at the 95% C.L.

Hadron-rich cosmic-ray families detected by emulsion chamber.

NASA Astrophysics Data System (ADS)

Navia, C. E.; Augusto, C. R. K.; Pinto, F. A.; Shibuya, H.

1995-11-01

Observed hadrons in excess, larger-than-expected charged mesons (pions) in cosmic-ray families detected in emulsion chamber experiment at mountain altitude and produced in a cosmic-ray hadronic interaction not far from the PeV energy region are studied. The hypothesis that these extra hadrons could be a bundle of surviving nuclear fragments (nucleons) is verified through a simulation method using a hybrid code composed of a superposition model to describe the number of interacting nucleon-nucleon pairs in a nucleus-nucleus collision. Together with the UA5 algorithm to describe a nucleon-nucleon collision, atmospheric propagation structure is also considered. A comparison between simulation output with experimental data shows that the surviving-nuclear-fragments hypothesis is not enough to explain the non-pionic hadron excess, even if a heavy dominance composition in the primary flux is considered.

Physics Program at COSY-Juelich with Polarized Hadronic Probes

DOE Office of Scientific and Technical Information (OSTI.GOV)

Kacharava, Andro

2009-08-04

Hadron physics aims at a fundamental understanding of all particles and their interactions that are subject to the strong force. Experiments using hadronic probes could contribute to shed light on open questions on the structure of hadrons and their interaction as well as the symmetries of nature. The COoler SYnchrotron COSY at the Forschungszentrum Juelich accelerates protons and deuterons with momenta up to 3.7 GeV/c. The availability of both an electron cooler as well as a stochastic beam cooling system allows for precision measurements, using polarized proton and deuteron beams in combination with polarized Hydrogen or Deuterium targets.This contribution summarizesmore » the ongoing physics program at the COSY facility using ANKE, WASA and TOF detector systems with polarized hadronic probes, highlighting recent results and outlining the new developments.« less

It Is Tough and Tiring but It Works--Children's Experiences of Undergoing Radiotherapy.

PubMed

Engvall, Gunn; Ångström-Brännström, Charlotte; Mullaney, Tara; Nilsson, Kristina; Wickart-Johansson, Gun; Svärd, Anna-Maja; Nyholm, Tufve; Lindh, Jack; Lindh, Viveca

2016-01-01

Approximately 300 children ages 0 to 18 are diagnosed with cancer in Sweden every year, and 80 to 90 of them undergo radiotherapy treatment. The aim was to describe children's experiences of preparing for and undergoing radiotherapy, and furthermore to describe children's suggestions for improvement. Thirteen children between the ages of 5 and 15 with various cancer diagnoses were interviewed. Data was analyzed using qualitative content analysis. The findings revealed five categories: positive and negative experiences with hospital stays and practical arrangements; age-appropriate information, communication, and guidance to various degrees; struggle with emotions; use of distraction and other suitable coping strategies; and children's suggestions for improvement during radiotherapy. An overarching theme emerged: "It is tough and tiring but it works". Some key areas were: explanatory visits, the need for information and communication, being afraid, discomfort and suffering, the need for media distraction, dealing with emotions, and the need for support. A systematic, family-centered preparation program could possible help families prepare and individualized distraction during radiotherapy could contribute to reducing distress. Further studies with interventions could clarify successful programs.

Current State Of Proton And Carbon-Ion Radiotherapy At The Hyogo Ion Beam Medical Center (HIBMC)

NASA Astrophysics Data System (ADS)

Murakami, Masao; Demizu, Yusuke; Niwa, Yasue; Fujii, Osamu; Terashima, Kazuki; Mima, Masayuki; Miyawaki, Daisuke; Sasaki, Ryohei; Hishikawa, Yoshio; Abe, Mitsuyuki

2011-06-01

HIBMC is the world's first facility to be able to use both proton (PRT) and carbon-ion radiotherapy (CiRT). The medically dedicated synchrotron can accelerate protons up to 230 MeV and carbon ions up to 320 MeV. From April 2001 to March 2010, the facility treated 3275 patients, with 2487 patients treated using PRT and 788 using CiRT. Particle radiotherapy was delivered to patients suffering from malignant tumors originating in the head and neck (502 patients), lungs (330), liver (539), prostate (1283), and the bone & soft tissue (130). The clinical results are as follows: (1) H & N tumors: The 2-year overall survival (OS) rates of patients with olfactory neuroblastoma, mucoepidermoid cancer, adenoid cystic cancer, adenocarcinoma, squamous cell carcinoma, and malignant melanoma was 100%, 86%, 78%, 78%, 66%, and 62%, respectively. (2) Lung cancer: For all 80 patients, the 3-year OS rate was 75% (Stage IA: 74%; Stage IB: 76%) and local control (LC) rate was 82% (IA: 87%; IB: 77%). Grade 3 pulmonary toxicity was observed in only 1 patient. These results are comparable to those obtained by surgery, and indicate proton therapy and carbon-ion therapy are safe and effective for stage I lung cancer. (3) Liver cancer: The 5-year LC rate for 429 tumor patient was 90%, and the 5-year OS rate for 364 patients was 38%. These results seem equivalent to those obtained by surgery or radio-frequency ablation. (4) Prostate cancer: In 290 patients treated by proton radiotherapy, five patients died from other disease in the median follow-up period of 62 months. Biochemical disease-free survival and OS rate at 5 years was 88.2% and 96.5%, respectively. Our proton radiotherapy showed excellent OS and biochemical disease-free survival rates with minimum late morbidities. PRT VS CiRT: From our retrospective analysis, it seems that there is no significant difference in the LC and OS rate in H&N, lung and liver cancer between PRT and CiRT.

Current State Of Proton And Carbon-Ion Radiotherapy At The Hyogo Ion Beam Medical Center (HIBMC)

DOE Office of Scientific and Technical Information (OSTI.GOV)

Murakami, Masao; Hishikawa, Yoshio; Demizu, Yusuke

2011-06-01

HIBMC is the world's first facility to be able to use both proton (PRT) and carbon-ion radiotherapy (CiRT). The medically dedicated synchrotron can accelerate protons up to 230 MeV and carbon ions up to 320 MeV. From April 2001 to March 2010, the facility treated 3275 patients, with 2487 patients treated using PRT and 788 using CiRT. Particle radiotherapy was delivered to patients suffering from malignant tumors originating in the head and neck (502 patients), lungs (330), liver (539), prostate (1283), and the bone and soft tissue (130). The clinical results are as follows: (1) H and N tumors: Themore » 2-year overall survival (OS) rates of patients with olfactory neuroblastoma, mucoepidermoid cancer, adenoid cystic cancer, adenocarcinoma, squamous cell carcinoma, and malignant melanoma was 100%, 86%, 78%, 78%, 66%, and 62%, respectively. (2) Lung cancer: For all 80 patients, the 3-year OS rate was 75%(Stage IA: 74%; Stage IB: 76%) and local control (LC) rate was 82%(IA: 87%; IB: 77%). Grade 3 pulmonary toxicity was observed in only 1 patient. These results are comparable to those obtained by surgery, and indicate proton therapy and carbon-ion therapy are safe and effective for stage I lung cancer. (3) Liver cancer: The 5-year LC rate for 429 tumor patient was 90%, and the 5-year OS rate for 364 patients was 38%. These results seem equivalent to those obtained by surgery or radio-frequency ablation. (4) Prostate cancer: In 290 patients treated by proton radiotherapy, five patients died from other disease in the median follow-up period of 62 months. Biochemical disease-free survival and OS rate at 5 years was 88.2% and 96.5%, respectively. Our proton radiotherapy showed excellent OS and biochemical disease-free survival rates with minimum late morbidities. PRT VS CiRT: From our retrospective analysis, it seems that there is no significant difference in the LC and OS rate in H and N, lung and liver cancer between PRT and CiRT.« less

A Data Analysis Center for Electromagnetic and Hadronic Interaction

DOE Office of Scientific and Technical Information (OSTI.GOV)

Briscoe, William John; Strakovsky, Igor I.; Workman, Ronald L.

2015-05-31

The GW Data Analysis Center (DAC) has made significant progress in its program to enhance and expand the partial-wave and multipole analyses of fundamental reactions, while maintaining and expanding each associated database. These efforts provide guidance to national and international experimental and theoretical efforts, and are an important link between theory and experiment. Our principal goals are focused on baryon and meson physics programs and related topics.

Hyperasymptotics and quark-hadron duality violations in QCD

NASA Astrophysics Data System (ADS)

Boito, Diogo; Caprini, Irinel; Golterman, Maarten; Maltman, Kim; Peris, Santiago

2018-03-01

We investigate the origin of the quark-hadron duality-violating terms in the expansion of the QCD two-point vector correlation function at large energies in the complex q2 plane. Starting from the dispersive representation for the associated polarization, the analytic continuation of the operator product expansion from the Euclidean to the Minkowski region is performed by means of a generalized Borel-Laplace transform, borrowing techniques from hyperasymptotics. We establish a connection between singularities in the Borel plane and quark-hadron duality-violating contributions. Starting with the assumption that for QCD at Nc=∞ the spectrum approaches a Regge trajectory at large energy, we obtain an expression for quark-hadron duality violations at large, but finite Nc.

Venetoclax Synergizes with Radiotherapy for Treatment of B-cell Lymphomas.

PubMed

O'Steen, Shyril; Green, Damian J; Gopal, Ajay K; Orozco, Johnnie J; Kenoyer, Aimee L; Lin, Yukang; Wilbur, D Scott; Hamlin, Donald K; Fisher, Darrell R; Hylarides, Mark D; Gooley, Theodore A; Waltman, Amelia; Till, Brian G; Press, Oliver W

2017-07-15

Constitutive B-cell receptor signaling leads to overexpression of the antiapoptotic BCL-2 protein and is implicated in the pathogenesis of many types of B-cell non-Hodgkin lymphoma (B-NHL). The BCL-2 small-molecule inhibitor venetoclax shows promising clinical response rates in several lymphomas, but is not curative as monotherapy. Radiotherapy is a rational candidate for combining with BCL-2 inhibition, as DNA damage caused by radiotherapy increases the activity of pro-apoptotic BCL-2 pathway proteins, and lymphomas are exquisitely sensitive to radiation. We tested B-NHL responses to venetoclax combined with either external beam radiotherapy or radioimmunotherapy (RIT), which joins the selectivity of antibody targeting with the effectiveness of irradiation. We first tested cytotoxicity of cesium-137 irradiation plus venetoclax in 14 B-NHL cell lines representing five lymphoma subtypes. Combination treatment synergistically increased cell death in 10 of 14 lines. Lack of synergy was predicted by resistance to single-agent venetoclax and high BCL-XL expression. We then assessed the efficacy of external beam radiotherapy plus venetoclax in murine xenograft models of mantle cell (MCL), germinal-center diffuse large B-cell (GCB-DLBCL), and activated B-cell (ABC-DLBCL) lymphomas. In each model, external beam radiotherapy plus venetoclax synergistically increased mouse survival time, curing up to 10%. We finally combined venetoclax treatment of MCL and ABC-DLBCL xenografts with a pretargeted RIT (PRIT) system directed against the CD20 antigen. Optimal dosing of PRIT plus venetoclax cured 100% of mice with no detectable toxicity. Venetoclax combined with radiotherapy may be a promising treatment for a wide range of lymphomas Cancer Res; 77(14); 3885-93. ©2017 AACR . ©2017 American Association for Cancer Research.

Additional strange hadrons from QCD thermodynamics and strangeness freezeout in heavy ion collisions.

PubMed

Bazavov, A; Ding, H-T; Hegde, P; Kaczmarek, O; Karsch, F; Laermann, E; Maezawa, Y; Mukherjee, Swagato; Ohno, H; Petreczky, P; Schmidt, C; Sharma, S; Soeldner, W; Wagner, M

2014-08-15

We compare lattice QCD results for appropriate combinations of net strangeness fluctuations and their correlations with net baryon number fluctuations with predictions from two hadron resonance gas (HRG) models having different strange hadron content. The conventionally used HRG model based on experimentally established strange hadrons fails to describe the lattice QCD results in the hadronic phase close to the QCD crossover. Supplementing the conventional HRG with additional, experimentally uncharted strange hadrons predicted by quark model calculations and observed in lattice QCD spectrum calculations leads to good descriptions of strange hadron thermodynamics below the QCD crossover. We show that the thermodynamic presence of these additional states gets imprinted in the yields of the ground-state strange hadrons leading to a systematic 5-8 MeV decrease of the chemical freeze-out temperatures of ground-state strange baryons.

SU-C-BRD-07: The Radiological Physics Center (RPC): 45 Years of Improving Radiotherapy Dosimetry

DOE Office of Scientific and Technical Information (OSTI.GOV)

Followill, D; Lowenstein, J; Molineu, A

Purpose: The RPC, established in 1968 has contributed to the development, conduct, and QA of NCI funded multi-institutional cooperative group clinical trials and institutions, primarily in the USA/Canada and 242 other countries, participating in trials. Methods: The RPC QA program components were designed to audit the radiation dose calculation chain from the NIST traceable reference beam calibration, to inclusion of dosimetry parameters used to calculate tumor doses, to the delivery of the radiation dose. The QA program included: 1) remote TLD/OSLD audit of machine output, 2) on-site dosimetry review visits, 3) credentialing for advanced technologies, and 4) review of patientmore » treatment records. The RPC presented and published their findings to the radiation oncology community. Results: The number of institutions monitored by the RPC increased from around 1200 in the late 90s, to ∼2000 in 2013. There were over 4000 megavoltage therapy machines and ∼28,000 therapy beams in the 1991 institutions monitored by the RPC by the end of 2013. Within the 14,000 photon, electron and proton beam outputs remotely monitored with TLD/OSLD annually, between 10-20% of the institutions have one or more beams outside the RPC 5% criterion. Dosimetry site visits to photon and proton centers continue to result in 2-4 recommendations affecting key dosimetry parameters that impact patient treatment times. One in four patient treatment records reviewed by the RPC have their dose data corrected by >5% before trial groups use them for outcomes analysis. Twelve of fourteen clinically active proton centers are approved to participate in NCI funded clinical trials. The RPC published 222 peer reviewed articles since 1972. Conclusion: Findings from the RPC suggest that human errors continue to play a role in radiotherapy discrepancies and without the RPC independent QA program, the number of undetected errors and time elapsed before their discovery would have been greater. Work

The Joint Physics Analysis Center: Recent results

NASA Astrophysics Data System (ADS)

Fernández-Ramírez, César

2016-10-01

We review some of the recent achievements of the Joint Physics Analysis Center, a theoretical collaboration with ties to experimental collaborations, that aims to provide amplitudes suitable for the analysis of the current and forthcoming experimental data on hadron physics. Since its foundation in 2013, the group is focused on hadron spectroscopy in preparation for the forthcoming high statistics and high precision experimental data from BELLEII, BESIII, CLAS12, COMPASS, GlueX, LHCb and (hopefully) PANDA collaborations. So far, we have developed amplitudes for πN scattering, KN scattering, pion and J/ψ photoproduction, two kaon photoproduction and three-body decays of light mesons (η, ω, ϕ). The codes for the amplitudes are available to download from the group web page and can be straightforwardly incorporated to the analysis of the experimental data.

Constraints on the I = 1 hadronic τ decay and e+e- →hadrons data sets and implications for (g - 2) μ

NASA Astrophysics Data System (ADS)

Maltman, Kim

2006-02-01

Sum rule tests are performed on the spectral data for (i) flavor ud vector-current-induced hadronic τ decays and (ii) e+e- hadroproduction, in the region below s ∼ 3- 4 GeV2, where discrepancies exist between the isospin-breaking-corrected charged and neutral current I = 1 spectral functions. The τ data is found to be compatible with expectations based on high-scale αs (MZ) determinations, while the electroproduction data displays two problems. The results favor determinations of the leading order hadronic contribution to (g - 2) μ which incorporate hadronic τ decay data over those employing electroproduction data only, and hence a reduced discrepancy between experiment and the Standard Model prediction for (g - 2) μ.

Calibration of the CMS hadron calorimeter in Run 2

NASA Astrophysics Data System (ADS)

Chadeeva, M.; Lychkovskaya, N.

2018-03-01

Various calibration techniques for the CMS Hadron calorimeter in Run 2 and the results of calibration using 2016 collision data are presented. The radiation damage corrections, intercalibration of different channels using the phi-symmetry technique for barrel, endcap and forward calorimeter regions are described, as well as the intercalibration with muons of the outer hadron calorimeter. The achieved intercalibration precision is within 3%. The in situ energy scale calibration is performed in the barrel and endcap regions using isolated charged hadrons and in the forward calorimeter using the Zarrow ee process. The impact of pileup and the developed technique of correction for pileup is also discussed. The achieved uncertainty of the response to hadrons is 3.4% in the barrel and 2.6% in the endcap region (at the pseudorapidity range |η|<2) and is dominated by the systematic uncertainty due to pileup contributions.

Flavor-dependent eigenvolume interactions in a hadron resonance gas

NASA Astrophysics Data System (ADS)

Alba, P.; Vovchenko, V.; Gorenstein, M. I.; Stoecker, H.

2018-06-01

Eigenvolume effects in the hadron resonance gas (HRG) model are studied for experimental hadronic yields in nucleus-nucleus collisions. If particle eigenvolumes are different for different hadron species, the excluded volume HRG (EV-HRG) improves fits to multiplicity data. In particular, using different mass-volume relations for strange and non-strange hadrons we observe a remarkable improvement in the quality of the fits. This effect appears to be rather insensitive to other details in the schemes employed in the EV-HRG. We show that the parameters found from fitting the data of the ALICE Collaboration in central Pb+Pb collisions at the collision energy √{sNN } = 2.76 TeV entail the same improvement for all centralities at the same collision energy, and for the RHIC and SPS data at lower collision energies. Our findings are put in the context of recent fits of lattice QCD results.

PREFACE: 4th International Hadron Physics Conference (TROIA'14)

NASA Astrophysics Data System (ADS)

Dağ, Hüseyin; Erkol, Güray; Küçükarslan, Ayşe; Özpineci, Altuğ

2014-11-01

The 4th International Conference on Hadron Physics, TROIA'14, was held at Canakkale, Turkey on 1-5 July 2014. Ozyegin University, Middle East Technical University, Canakkale Onsekiz Mart University, Turkish Atomic Energy Authority and HadronPhysics2 Consortium sponsored the conference. It aimed at bringing together the experts and the young scientists working on experimental and theoretical hadron physics. About 50 participants from 10 countries attended the conference. The topics covered included: . Chiral Perturbation Theory . QCD Sum Rules . Effective Field Theory . Exotic Hadrons . Hadron Properties from Lattice QCD . Experimental Results and Future Perspectives . Hadronic Distribution Amplitudes The conference presentations were organized such that the morning sessions contained invited talks and afternoon sessions were devoted to contributed talks. The speakers of the invited talks were: C. Alexandrou, A. Gal, L. Tolos, J.R. Pelaez and M. Schindler. We had also guest speakers D. A. Demir and T. Senger. The conference venue was a resort hotel around Canakkale. As a social program, a guided full-day excursion to the excavation site of the ancient Troia town and Assos was organized. We believe that this conference provided a medium for young scientists and experts in the field to effectively communicate and share ideas. We would like to express our sincere thanks to supporting agencies and to all participants for their contributions and stimulating discussions. We are also grateful to the Scientific Secretary, Bora Işıldak, and all other members of the Organizing Committee for their patience and efforts. 30.10.2014 The Editors

Test of a chromomagnetic model for hadron mass differences

NASA Astrophysics Data System (ADS)

Lichtenberg, D. B.; Roncaglia, R.

1993-05-01

An oversimplified model consisting of the QCD color-magnetic interaction has been used previously by Silvestre-Brac and others to compare the masses of exotic and normal hadrons. We show that the model can give qualitatively wrong answers when applied to systems of normal hadrons.

Review of high energy hadron-nucleus data

NASA Astrophysics Data System (ADS)

Lissauer, D.

1987-01-01

In this review we will summarize new data on hardron-nucleus interactions. The possibility that quark-gluon plasma may be created in heavy ion collisions has led to renewed interest in hadron-nucleus collisions. In particular one hopes that understanding the energy loss of hadrons in h-A collissions will allow us to estimate the optimum energy in AA collisions in order to achieve maximum baryon and/or maximum energy density. This will allow us to choose the optimal experimental environment in the search for quark-gluon plasma. This review will thus omit many interesting results from hadron-nucleus collisions, such as the A dependence of lepton pair production, EMC effect and others. We will focus our attention on the following: (i) Estimating the rate of energy loss of the incident hadron as it propagates through the target. (ii) Determining where the enmergy is deposited in central hadron-nucleus collisions. It is clear that there is no direct or unique method of extrapolating our knowledge of h-A collisions to predict what will happen in AA-collisions. The knowledge and understanding of pp and pA collisions is, however, a useful and necessary guide to what one can expect in AA collisions. In this review we will concentrate on three experimental approaches to the study of h-A collisions. In Section 1 we will discuss the present status of pA → p + X inclusive measurements. In Section 2 measurements from visual detectors, in this case results from the 30″ hybrid spectrometer, which allows investigations of global event properties will be presented. In Section 3 data using 2π calorimeters, where one can trigger and measure transverse energy and energy flow over a given rapidity region, will be discussed. The conclusions will be given in Section 4.

Carbon-ion radiotherapy for marginal lymph node recurrences of cervical cancer after definitive radiotherapy: a case report.

PubMed

Tamaki, Tomoaki; Ohno, Tatsuya; Kiyohara, Hiroki; Noda, Shin-ei; Ohkubo, Yu; Ando, Ken; Wakatsuki, Masaru; Kato, Shingo; Kamada, Tadashi; Nakano, Takashi

2013-04-05

Recurrences of cervical cancer after definitive radiotherapy often occur at common iliac or para-aortic lymph nodes as marginal lymph node recurrences. Patients with these recurrences have a chance of long-term survival by optimal re-treatment with radiotherapy. However, the re-irradiation often overlaps the initial and the secondary radiotherapy fields and can result in increased normal tissue toxicities in the bowels or the stomach. Carbon-ion radiotherapy, a form of particle beam radiotherapy using accelerated carbon ions, offers more conformal and sharp dose distribution than X-ray radiotherapy. Therefore, this approach enables the delivery of high radiation doses to the target while sparing its surrounding normal tissues. Marginal lymph node recurrences in common iliac lymph nodes after radiotherapy were treated successfully by carbon-ion radiotherapy in two patients. These two patients were initially treated with a combination of external beam radiotherapy and intracavitary and interstitial brachytherapy. However, the diseases recurred in the lymph nodes near the border of the initial radiotherapy fields after 22 months and 23 months. Because re-irradiation with X-ray radiotherapy may deliver high doses to a section of the bowels, carbon-ion radiotherapy was selected to treat the lymph node recurrences. A total dose of 48 Gy (RBE) in 12 fractions over 3 weeks was given to the lymph node recurrences, and the tumors disappeared completely with no severe acute toxicities. The two patients showed no evidence of disease for 75 months and 63 months after the initial radiotherapy and for 50 months and 37 months after the carbon-ion radiotherapy, respectively. No severe late adverse effects are observed in these patients. The two presented cases suggest that the highly conformal dose distribution of carbon-ion radiotherapy may be beneficial in the treatment of marginal lymph node recurrences after radiotherapy. In addition, the higher biological effect of carbon

The gluon condensation at high energy hadron collisions

NASA Astrophysics Data System (ADS)

Zhu, Wei; Lan, Jiangshan

2017-03-01

We report that the saturation/CGC model of gluon distribution is unstable under action of the chaotic solution in a nonlinear QCD evolution equation, and it evolves to the distribution with a sharp peak at the critical momentum. We find that this gluon condensation is caused by a new kind of shadowing-antishadowing effects, and it leads to a series of unexpected effects in high energy hadron collisions including astrophysical events. For example, the extremely intense fluctuations in the transverse-momentum and rapidity distributions of the gluon jets present the gluon-jet bursts; a sudden increase of the proton-proton cross sections may fill the GZK suppression; the blocking QCD evolution will restrict the maximum available energy of the hadron-hadron colliders.

[Image-guided radiotherapy and partial delegation to radiotherapy technicians: Clermont-Ferrand experience].

PubMed

Loos, G; Moreau, J; Miroir, J; Benhaïm, C; Biau, J; Caillé, C; Bellière, A; Lapeyre, M

2013-10-01

The various image-guided radiotherapy techniques raise the question of how to achieve the control of patient positioning before irradiation session and sharing of tasks between radiation oncologists and radiotherapy technicians. We have put in place procedures and operating methods to make a partial delegation of tasks to radiotherapy technicians and secure the process in three situations: control by orthogonal kV imaging (kV-kV) of bony landmarks, control by kV-kV imaging of intraprostatic fiducial goldmarkers and control by cone beam CT (CBCT) imaging for prostate cancer. Significant medical overtime is required to control these three IGRT techniques. Because of their competence in imaging, these daily controls can be delegated to radiotherapy technicians. However, to secure the process, initial training and regular evaluation are essential. The analysis of the comparison of the use of kV/kV on bone structures allowed us to achieve a partial delegation of control to radiotherapy technicians. Controlling the positioning of the prostate through the use and automatic registration of fiducial goldmarkers allows better tracking of the prostate and can be easily delegated to radiotherapy technicians. The analysis of the use of daily cone beam CT for patients treated with intensity modulated irradiation is underway, and a comparison of practices between radiotherapy technicians and radiation oncologists is ongoing to know if a partial delegation of this control is possible. Copyright © 2013. Published by Elsevier SAS.

Demand for radiotherapy in Spain.

PubMed

Rodríguez, A; Borrás, J M; López-Torrecilla, J; Algara, M; Palacios-Eito, A; Gómez-Caamaño, A; Olay, L; Lara, P C

2017-02-01

Assessing the demand for radiotherapy in Spain based on existing evidence to estimate the human resources and equipment needed so that every person in Spain has access to high-quality radiotherapy when they need it. We used data from the European Cancer Observatory on the estimated incidence of cancer in Spain in 2012, along with the evidence-based indications for radiotherapy developed by the Australian CCORE project, to obtain an optimal radiotherapy utilisation proportion (OUP) for each tumour. About 50.5 % of new cancers in Spain require radiotherapy at least once over the course of the disease. Additional demand for these services comes from reradiation therapy and non-melanoma skin cancer. Approximately, 25-30 % of cancer patients with an indication for radiotherapy do not receive it due to factors that include access, patient preference, familiarity with the treatment among physicians, and especially resource shortages, all of which contribute to its underutilisation. Radiotherapy is underused in Spain. The increasing incidence of cancer expected over the next decade and the greater frequency of reradiations necessitate the incorporation of radiotherapy demand into need-based calculations for cancer services planning.

A New Era of Symmetries in the Hadronic Interaction

NASA Astrophysics Data System (ADS)

Crawford, Christopher

2016-09-01

The search for a weak component of the nuclear force began in 1957, shortly after the proposal of parity violation. While it has been observed in compound nuclei with large nuclear enhancements, a systematic characterization of the hadronic weak interaction is still forthcoming almost sixty years later. New experimental facilities and technology have rejuvenated efforts to map out this ``complexity frontier'' within the Standard Model, and we will soon have precision data from multiple few-body experiments. In parallel, modern effective field theories have provided a systematic model independent description of the hadronic interaction with estimates of higher-order effects. The characterization of discrete symmetries in hadronic systems has recently become important for the design and analysis of other precision symmetries measurements, for example, electron PV scattering and time-reversal violation experiments. These new developments in experiment, theory, and application have ushered in a new era in hadronic parity violation. We acknowledge support from DOE-NP under Contract DE-SC0008107.

Design and performance studies of a hadronic calorimeter for a FCC-hh experiment

NASA Astrophysics Data System (ADS)

Faltova, J.

2018-03-01

The hadron-hadron Future Circular Collider (FCC-hh) project studies the physics reach of a proton-proton machine with a centre-of-mass-energy of 100 TeV and five times greater peak luminosities than at the High-Luminosity LHC (HL-LHC). The high-energy regime of the FCC-hh opens new opportunities for the discovery of physics beyond the standard model. At 100 TeV a large fraction of the W, Z, H bosons and top quarks are produced with a significant boost. It implies an efficient reconstruction of very high energetic objects decaying hadronically. The reconstruction of those boosted objects sets the calorimeter performance requirements in terms of energy resolution, containment of highly energetic hadron showers, and high transverse granularity. We present the current baseline technologies for the calorimeter system in the barrel region of the FCC-hh reference detector: a liquid argon electromagnetic and a scintillator-steel hadronic calorimeters. The focus of this paper is on the hadronic calorimeter and the performance studies for hadrons. The reconstruction of single particles and the achieved energy resolution for the combined system of the electromagnetic and hadronic calorimeters are discussed.

Novel method for detecting the hadronic component of extensive air showers

DOE Office of Scientific and Technical Information (OSTI.GOV)

Gromushkin, D. M., E-mail: DMGromushkin@mephi.ru; Volchenko, V. I.; Petrukhin, A. A.

2015-05-15

A novel method for studying the hadronic component of extensive air showers (EAS) is proposed. The method is based on recording thermal neutrons accompanying EAS with en-detectors that are sensitive to two EAS components: an electromagnetic (e) component and a hadron component in the form of neutrons (n). In contrast to hadron calorimeters used in some arrays, the proposed method makes it possible to record the hadronic component over the whole area of the array. The efficiency of a prototype array that consists of 32 en-detectors was tested for a long time, and some parameters of the neutron EAS componentmore » were determined.« less

Multiplicities of secondary hadrons produced in vp and overlinevp charged current interactions

NASA Astrophysics Data System (ADS)

Grässler, H.; Lanske, D.; Schulte, R.; Jones, G. T.; Middleton, R. P.; O'Neale, S. W.; Böckmann, K.; Gebel, W.; Geich-Gimbel, C.; Nellen, B.; Grant, A.; Klein, H.; Morrison, D. R. O.; Schmid, P.; Wachsmuth, H.; Chima, J. S.; Mobayyen, M. M.; Talebzadeh, M.; Villalobos-Baillie, O.; Aderholz, M.; Deck, L.; Schmitz, N.; Settles, R.; Wernhard, K. L.; Wittek, W.; Corrigan, G.; Myatt, G.; Radojicić, D.; Saitta, B.; Wells, J.; Aachen-Birmingham-Bonn-CERN-Imperial College-München (MPI)-Oxford Collaboration

1983-08-01

In an experiment with the hydrogen bubble chamber BEBC at CERN multiplicities of hadrons produced in νp and overlinevp interactions have been investigated. Results are presented on the multiplicities of charged hadrons and neutral pions, forward and backward multiplicities of charged hadrons and correlations between forward and backward multiplicities. Comparisons are made with hadronic reactions and e +e - annihilation. In the framework of the quark-parton model the data imply similar charged multiplicities for the fragments of a u- and a d-quark, and a larger multiplicities for the fragments of a uu- than for a ud-diquark. The correlation data suggest independent fragmentation of the quark and diquark for hadronic masses above ˜ 7 GeV and local charge compensation within an event.

Constraining Δ G at Low-x with Double Longitudinal Spin Asymmetries for Forward Hadron and Di-Hadron Pairs in PHENIX

NASA Astrophysics Data System (ADS)

Wolin, Scott; Phenix Collaboration

2011-10-01

The gluon polarization, ΔG =∫01 g(x) dx , is constrained in the region 0 . 05 < x < 0 . 2 from measurements of double spin asymmetries, ALL, for inclusive hadron and jet production at mid-rapidity at RHIC. Theoretical analysis of experimental results shows that ∫0. 05 0 . 2 Δg(x) dx = 0 .013-0 . 120 + 0 . 106 . This is not large enough to account for the missing proton spin. However, Δg(x) is unconstrained at low-x, and a measurement sensitive to this region will provide important input for future global analyses. The measurement of ALL for inclusive hadrons and di-hadrons with the Muon Piston Calorimeter (MPC) 3 . 1 < η < 3 . 9 provides this sensitivity down to x 10-3 and will lead to the first constraints of Δg(x) at x < 0 . 05 . The di-hadron measurement is especially interesting as it is sensitive to the sign of ΔG and best constrains the parton kinematics giving the most precise access to xgluon. The inclusive measurement provides a looser constraint on the event kinematics but has a higher yield. We will present the status of these measurements for the 2009 dataset at √{ s} = 500 GeV and √{ s} = 200 GeV.

Single particle momentum and angular distributions in hadron-hadron collisions at ultrahigh energies

NASA Technical Reports Server (NTRS)

Chou, T. T.; Chen, N. Y.

1985-01-01

The forward-backward charged multiplicity distribution (P n sub F, n sub B) of events in the 540 GeV antiproton-proton collider has been extensively studied by the UA5 Collaboration. It was pointed out that the distribution with respect to n = n sub F + n sub B satisfies approximate KNO scaling and that with respect to Z = n sub F - n sub B is binomial. The geometrical model of hadron-hadron collision interprets the large multiplicity fluctuation as due to the widely different nature of collisions at different impact parameters b. For a single impact parameter b, the collision in the geometrical model should exhibit stochastic behavior. This separation of the stochastic and nonstochastic (KNO) aspects of multiparticle production processes gives conceptually a lucid and attractive picture of such collisions, leading to the concept of partition temperature T sub p and the single particle momentum spectrum to be discussed in detail.

Coherent J / ψ photoproduction in hadronic heavy-ion collisions

DOE PAGES

Zha, W.; Klein, S. R.; Ma, R.; ...

2018-04-19

Significant excesses of J/ yield at very low transverse momentum (p T < 0:3 GeV/c) were observed by the ALICE and STAR collaborations in peripheral hadronic A+A collisions. This is a Sign of coherent photoproduction of J/ψ in violent hadronic interactions. Theoretically, the photoproduction of J= in hadronic collisions raises questions about how spectator and non-spectator nucleons participate in the coherent reaction. We argue that the strong interactions in the overlapping region of incoming nuclei may disturb the coherent production, leaving room for different coupling assumptions. The destructive interference between photoproduction on ions moving in opposite directions also needs tomore » be included. This letter presents calculations of J/ψ production from coherent photon-nucleus (γ+A → J/ψ +A) interactions in hadronic A+A collisions at RHIC and LHC energies with both nucleus and spectator coupling hypotheses. The integrated yield of coherent J/ψ as a function of centrality is found to be significantly different, especially towards central collisions, for different coupling scenarios. Differential distributions as a function of transverse momentum, azimuthal angle and rapidity in different centrality bins are also shown, and found to be more sensitive to the Pomeron coupling than to the photon coupling. Lastly, these predictions call for future experimental measurements to help better understand the coherent interaction in hadronic heavy-ion collisions.« less

Coherent J / ψ photoproduction in hadronic heavy-ion collisions

DOE Office of Scientific and Technical Information (OSTI.GOV)

Zha, W.; Klein, S. R.; Ma, R.

Significant excesses of J/ yield at very low transverse momentum (p T < 0:3 GeV/c) were observed by the ALICE and STAR collaborations in peripheral hadronic A+A collisions. This is a Sign of coherent photoproduction of J/ψ in violent hadronic interactions. Theoretically, the photoproduction of J= in hadronic collisions raises questions about how spectator and non-spectator nucleons participate in the coherent reaction. We argue that the strong interactions in the overlapping region of incoming nuclei may disturb the coherent production, leaving room for different coupling assumptions. The destructive interference between photoproduction on ions moving in opposite directions also needs tomore » be included. This letter presents calculations of J/ψ production from coherent photon-nucleus (γ+A → J/ψ +A) interactions in hadronic A+A collisions at RHIC and LHC energies with both nucleus and spectator coupling hypotheses. The integrated yield of coherent J/ψ as a function of centrality is found to be significantly different, especially towards central collisions, for different coupling scenarios. Differential distributions as a function of transverse momentum, azimuthal angle and rapidity in different centrality bins are also shown, and found to be more sensitive to the Pomeron coupling than to the photon coupling. Lastly, these predictions call for future experimental measurements to help better understand the coherent interaction in hadronic heavy-ion collisions.« less

Suppression of high-pT hadrons in Pb+Pb collisions at energies available at the CERN Large Hadron Collider

NASA Astrophysics Data System (ADS)

Chen, Xiao-Fang; Hirano, Tetsufumi; Wang, Enke; Wang, Xin-Nian; Zhang, Hanzhong

2011-09-01

The nuclear modification factor RAA(pT) for large transverse momentum pion spectra in Pb+Pb collisions at s=2.76 TeV is predicted within the next-to-leading order perturbative QCD parton model. The effect of jet quenching is incorporated through medium-modified fragmentation functions within the higher-twist approach. The jet transport parameter that controls medium modification is proportional to the initial parton density, and the coefficient is fixed by data on the suppression of large-pT hadron spectra obtained at the BNL Relativistic Heavy Ion Collider. Data on charged hadron multiplicity dNch/dη=1584±80 in central Pb+Pb collisions from the ALICE experiment at the CERN Large Hadron Collider are used to constrain the initial parton density both for determining the jet transport parameter and the 3 + 1 dimensional (3 + 1D) ideal hydrodynamic evolution of the bulk matter that is employed for the calculation of RPbPb(pT) for neutral pions.

Hadron Cancer Therapy - relative merits of X-ray, proton and carbon beams

NASA Astrophysics Data System (ADS)

Jakel, Oliver

2014-03-01

-Heidelberg University has a long experience in radiotherapy with carbon ions, starting with a pilot project at GSI in 1997. This project was jointly run by the Dep. for Radiation Oncology of Heidelberg University, GSI and the German Cancer Research Center (DKFZ). A hospital based heavy ion center at Heidelberg University, the Heidelberg Ion Beam Therapy Center (HIT) was proposed by the same group in 1998 and started clinical operation in late 2009. Since then nearly 2000 patients were treated with beams of carbon ions and protons. Just recently the operation of the world's first and only gantry for heavy ions also started at HIT. Patient treatments are performed in three rooms. Besides that, a lot of research projects are run in the field of Medical Physics and Radiobiology using a dedicated experimental area and the possibility to use beams of protons, carbon, helium and oxygen ions being delivered with the raster scanning technique.

Hadronic Contribution to Muon g-2 with Systematic Error Correlations

NASA Astrophysics Data System (ADS)

Brown, D. H.; Worstell, W. A.

1996-05-01

We have performed a new evaluation of the hadronic contribution to a_μ=(g-2)/2 of the muon with explicit correlations of systematic errors among the experimental data on σ( e^+e^- → hadrons ). Our result for the lowest order hadronic vacuum polarization contribution is a_μ^hvp = 701.7(7.6)(13.4) × 10-10 where the total systematic error contributions from below and above √s = 1.4 GeV are (12.5) × 10-10 and (4.8) × 10-10 respectively. Therefore new measurements on σ( e^+e^- → hadrons ) below 1.4 GeV in Novosibirsk, Russia can significantly reduce the total error on a_μ^hvp. This contrasts with a previous evaluation which indicated that the dominant error is due to the energy region above 1.4 GeV. The latter analysis correlated systematic errors at each energy point separately but not across energy ranges as we have done. Combination with higher order hadronic contributions is required for a new measurement of a_μ at Brookhaven National Laboratory to be sensitive to electroweak and possibly supergravity and muon substructure effects. Our analysis may also be applied to calculations of hadronic contributions to the running of α(s) at √s= M_Z, the hyperfine structure of muonium, and the running of sin^2 θW in Møller scattering. The analysis of the new Novosibirsk data will also be given.

Lepton jets and low-mass sterile neutrinos at hadron colliders

NASA Astrophysics Data System (ADS)

Dube, Sourabh; Gadkari, Divya; Thalapillil, Arun M.

2017-09-01

Sterile neutrinos, if they exist, are potential harbingers for physics beyond the Standard Model. They have the capacity to shed light on our flavor sector, grand unification frameworks, dark matter sector and origins of baryon antibaryon asymmetry. There have been a few seminal studies that have broached the subject of sterile neutrinos with low, electroweak-scale masses (i.e. ΛQCD≪mNR≪mW± ) and investigated their reach at hadron colliders using lepton jets. These preliminary studies nevertheless assume background-free scenarios after certain selection criteria which are overly optimistic and untenable in realistic situations. These lead to incorrect projections. The unique signal topology and challenging hadronic environment also make this mass-scale regime ripe for a careful investigation. With the above motivations, we attempt to perform the first systematic study of low, electroweak-scale, right-handed neutrinos at hadron colliders, in this unique signal topology. There are currently no active searches at hadron colliders for sterile neutrino states in this mass range, and we frame the study in the context of the 13 TeV high-luminosity Large Hadron Collider and the proposed FCC-hh/SppC 100 TeV p p -collider.

Supersymmetry across the light and heavy-light hadronic spectrum. II.

DOE Office of Scientific and Technical Information (OSTI.GOV)

Dosch, Hans Gunter; de Téramond, Guy F.; Brodsky, Stanley J.

We extend our analysis of the implications of hadronic supersymmetry for heavy-light hadrons in light-front holographic QCD. Although conformal symmetry is strongly broken by the heavy quark mass, supersymmetry and the holographic embedding of semiclassical light-front dynamics derived from five-dimensional anti-de Sitter space nevertheless determine the form of the confining potential in the light-front Hamiltonian to be harmonic. The resulting light-front bound-state equations lead to a heavy-light Regge-like spectrum for both mesons and baryons. The confinement hadron mass scale and their Regge slopes depend, however, on the mass of the heavy quark in the meson or baryon as expected frommore » heavy quark effective theory. Furthermore, this procedure reproduces the observed spectra of heavy-light hadrons with good precision and makes predictions for yet unobserved states.« less

Supersymmetry across the light and heavy-light hadronic spectrum. II.

DOE PAGES

Dosch, Hans Gunter; de Téramond, Guy F.; Brodsky, Stanley J.

2017-02-15

We extend our analysis of the implications of hadronic supersymmetry for heavy-light hadrons in light-front holographic QCD. Although conformal symmetry is strongly broken by the heavy quark mass, supersymmetry and the holographic embedding of semiclassical light-front dynamics derived from five-dimensional anti-de Sitter space nevertheless determine the form of the confining potential in the light-front Hamiltonian to be harmonic. The resulting light-front bound-state equations lead to a heavy-light Regge-like spectrum for both mesons and baryons. The confinement hadron mass scale and their Regge slopes depend, however, on the mass of the heavy quark in the meson or baryon as expected frommore » heavy quark effective theory. Furthermore, this procedure reproduces the observed spectra of heavy-light hadrons with good precision and makes predictions for yet unobserved states.« less

Modern hadron spectroscopy: a bridge between nuclear and particle physics.

NASA Astrophysics Data System (ADS)

Szczepaniak, A. P.

2018-05-01

In this talk I discuss aspects of hadron physics, which soon are expected to shed new light on the fundamental QCD phenomena. In the analysis of hadron reactions and their propertieds I emphasize similarities to the nuclear many body problem.

Modern hadron spectroscopy: a bridge between nuclear and particle physics

DOE Office of Scientific and Technical Information (OSTI.GOV)

Szczepaniak, Adam P.

Here, in this talk I discuss aspects of hadron physics, which soon are expected to shed new light on the fundamental QCD phenomena. In the analysis of hadron reactions and their propertieds I emphasize similarities to the nuclear many body problem.

Modern hadron spectroscopy: a bridge between nuclear and particle physics

DOE PAGES

Szczepaniak, Adam P.

2018-05-01

Here, in this talk I discuss aspects of hadron physics, which soon are expected to shed new light on the fundamental QCD phenomena. In the analysis of hadron reactions and their propertieds I emphasize similarities to the nuclear many body problem.

Improved Head and Neck Free Flap Outcome—Effects of a Treatment Protocol Adjustment from Pre- to Postoperative Radiotherapy

PubMed Central

Eriksson, Bjorn O.; Docherty Skogh, Ann-Charlott; Sommar, Pehr; Hammarstedt, Lalle; Gahm, Caroline

2017-01-01

Background: The impact of preoperative radiotherapy on microvascular reconstructive surgery outcome has been a subject of debate. However, data are conflicting and often dependent on local treatment protocols. We have studied the effects of radiotherapy in a unique, single-center setting where a treatment protocol change was undertaken from pre- to postoperative radiotherapy administration for microsurgical head and neck reconstructions. Methods: A cohort study was conducted for 200 consecutive head and neck free flap cases, where 100 were operated on before and 100 after the treatment protocol adjustment in 2006. Only direct cancer reconstructions were included. Complication rates of anastomosis-related (flap necrosis) and flap bed–related (infection, fistula, and wound dehiscence) complications were compared between irradiated and nonirradiated patients. A multivariate analysis was performed to correct for treatment period. Results: One hundred twenty-six patients had received radiotherapy before reconstruction due to cases of cancer recurrence. There were no significant differences in demographic data or risk factors between irradiated and nonirradiated cases. Irradiated cases had a higher rate of both flap loss (9.5% versus 1.4%; P = 0.034) and flap bed–related complications (29% versus 13%; P = 0.014). However, after multivariate analysis, there was only a significant relationship between preoperative irradiation and infection (odds ratio = 2.51; P = 0.033) and fistula formation (odds ratio = 3.13; P = 0.034). Conclusions: The current single-center study clearly indicates that preoperative radiotherapy is a risk factor for both infection and fistula formation, most likely related to an impaired flap bed. We suggest postoperative radiotherapy administration whenever possible for oncological reasons, otherwise proper antibiotic cover and meticulous flap insetting to prevent radiation-related infection and fistula formation. PMID:28458967

Lattice QCD Calculation of Hadronic Light-by-Light Scattering.

PubMed

Green, Jeremy; Gryniuk, Oleksii; von Hippel, Georg; Meyer, Harvey B; Pascalutsa, Vladimir

2015-11-27

We perform a lattice QCD calculation of the hadronic light-by-light scattering amplitude in a broad kinematical range. At forward kinematics, the results are compared to a phenomenological analysis based on dispersive sum rules for light-by-light scattering. The size of the pion pole contribution is investigated for momenta of typical hadronic size. The presented numerical methods can be used to compute the hadronic light-by-light contribution to the anomalous magnetic moment of the muon. Our calculations are carried out in two-flavor QCD with the pion mass in the range of 270-450 MeV and contain so far only the diagrams with fully connected quark lines.

Intensity-Modulated Radiotherapy in the Treatment of Oropharyngeal Cancer: An Update of the Memorial Sloan-Kettering Cancer Center Experience

DOE Office of Scientific and Technical Information (OSTI.GOV)

Setton, Jeremy; Caria, Nicola; Romanyshyn, Jonathan

2012-01-01

Purpose: To update the Memorial Sloan-Kettering Cancer Center's experience with intensity-modulated radiotherapy (IMRT) in the treatment of oropharyngeal cancer (OPC). Methods and Materials: Between September 1998 and April 2009, 442 patients with histologically confirmed OPC underwent IMRT at our center. There were 379 men and 63 women with a median age of 57 years (range, 27-91). The disease was Stage I in 2%, Stage II in 4%, Stage III in 21%, and Stage IV in 73% of patients. The primary tumor subsite was tonsil in 50%, base of tongue in 46%, pharyngeal wall in 3%, and soft palate in 2%.more » The median prescription dose to the planning target volume of the gross tumor was 70 Gy for definitive (n = 412) cases and 66 Gy for postoperative cases (n = 30). A total 404 patients (91%) received chemotherapy, including 389 (88%) who received concurrent chemotherapy, the majority of which was platinum-based. Results: Median follow-up among surviving patients was 36.8 months (range, 3-135). The 3-year cumulative incidence of local failure, regional failure, and distant metastasis was 5.4%, 5.6%, and 12.5%, respectively. The 3-year OS rate was 84.9%. The incidence of late dysphagia and late xerostomia {>=}Grade 2 was 11% and 29%, respectively. Conclusions: Our results confirm the feasibility of IMRT in achieving excellent locoregional control and low rates of xerostomia. According to our knowledge, this study is the largest report of patients treated with IMRT for OPC.« less

Open issues in hadronic interactions for air showers

NASA Astrophysics Data System (ADS)

Pierog, Tanguy

2017-06-01

In detailed air shower simulations, the uncertainty in the prediction of shower observables for different primary particles and energies is currently dominated by differences between hadronic interaction models. With the results of the first run of the LHC, the difference between post-LHC model predictions has been reduced to the same level as experimental uncertainties of cosmic ray experiments. At the same time new types of air shower observables, like the muon production depth, have been measured, adding new constraints on hadronic models. Currently no model is able to consistently reproduce all mass composition measurements possible within the Pierre Auger Observatory for instance. Comparing the different models, and with LHC and cosmic ray data, we will show that the remaining open issues in hadronic interactions in air shower development are now in the pion-air interactions and in nuclear effects.

Beyond-Standard-Model Tensor Interaction and Hadron Phenomenology.

PubMed

Courtoy, Aurore; Baeßler, Stefan; González-Alonso, Martín; Liuti, Simonetta

2015-10-16

We evaluate the impact of recent developments in hadron phenomenology on extracting possible fundamental tensor interactions beyond the standard model. We show that a novel class of observables, including the chiral-odd generalized parton distributions, and the transversity parton distribution function can contribute to the constraints on this quantity. Experimental extractions of the tensor hadronic matrix elements, if sufficiently precise, will provide a, so far, absent testing ground for lattice QCD calculations.

Issues and opportunities in exotic hadrons

DOE PAGES

Briceno, Raul A.; Cohen, Thomas D.; Coito, S.; ...

2016-04-01

The last few years have been witness to a proliferation of new results concerning heavy exotic hadrons. Experimentally, many new signals have been discovered that could be pointing towards the existence of tetraquarks, pentaquarks, and other exotic configurations of quarks and gluons. Theoretically, advances in lattice field theory techniques place us at the cusp of understanding complex coupled-channel phenomena, modelling grows more sophisticated, and effective field theories are being applied to an ever greater range of situations. Consequently, it is thus an opportune time to evaluate the status of the field. In the following, a series of high priority experimentalmore » and theoretical issues concerning heavy exotic hadrons is presented.« less

PREFACE: 3rd International Conference on Hadron Physics (TROIA'11)

NASA Astrophysics Data System (ADS)

Erkol, Güray; Küçükarslan, Ayşe; Özpineci, Altuğ

2012-03-01

The 3rd International Conference on Hadron Physics, TROIA'11 was held at Canakkale, Turkey on 22-25 August 2011. Ozyegin University, Middle East Technical University, Canakkale Onsekiz Mart University and HadronPhysics2 Consortium sponsored the conference. Its aim was to bring together the experts and young scientists working on experimental and theoretical hadron physics. About 60 participants from 12 countries attended the conference. The topics covered included: Chiral Perturbation Theory QCD Sum Rules Effective Field Theory Exotic Hadrons Hadron Properties from Lattice QCD Experimental Results and Future Perspectives Hadronic Distribution Amplitudes The conference presentations were organized such that the morning sessions contained invited talks and the afternoon sessions were devoted to contributed talks and poster presentations. The speakers of the invited talks were: D Melikhov, M Nielsen, M Oka, E Oset, S Scherer, T T Takahashi and R Wanke. The conference venue was a resort hotel near Canakkale. As a social program, a guided full-day excursion to the excavation site of the ancient town of Troia and Assos was organized. We believe that this conference provided a medium for young scientists and experts in the field to effectively communicate and share ideas. We would like to express our sincere thanks to all participants for their contributions and stimulating discussions. We are also grateful to the Scientific Secretary, Kadir Utku Can, and all other members of the Organizing Committee for their patience and efforts. 13 February 2012 The Editors Güray Erkol Ayşe Küçükarslan Altuğ Özpineci Conference photograph

Overall survival after resection of retroperitoneal sarcoma at academic cancer centers versus community cancer centers: An analysis of the National Cancer Data Base.

PubMed

Berger, Nicholas G; Silva, Jack P; Mogal, Harveshp; Clarke, Callisia N; Bedi, Manpreet; Charlson, John; Christians, Kathleen K; Tsai, Susan; Gamblin, T Clark

2018-02-01

Operative resection remains the definitive curative therapy for retroperitoneal sarcoma. Data published recently show a correlation between improved outcomes for complex oncologic operations and treatment at academic centers. For large retroperitoneal sarcomas, operative resection can be complex and require multidisciplinary care. We hypothesized that survival rates vary between type of treating center for patients undergoing resection for retroperitoneal sarcoma. Patients with stage I to III nonmetastatic retroperitoneal sarcomas who underwent operative resection were identified from the National Cancer Database during the years 2004-2013. Treating centers were categorized as academic cancer centers or community cancer centers. Overall survival was analyzed by log-rank test and graphed using Kaplan-Meier method. A total of 2,762 patients were identified. A majority of patients (59.4%, n = 1,642) underwent resection at an academic cancer centers. Median age at diagnosis was 63 years old. Neoadjuvant radiotherapy was more common at academic cancer centers, while adjuvant radiotherapy was more common at community cancer centers. Improved overall survival was seen at academic cancer centers across all stages compared with community cancer centers (P = .014) but, after multivariable Cox regression analysis, was not a significant independent predictor of survival (hazard ratio = 0.91, 95% confidence interval, 0.79-1.04, P = .171). Academic cancer centers exhibited a greater rate of R0 resection (55.9% vs 47.0%, P < .001) and a lesser odds of positive margins (odds ratio 0.83, 95% confidence interval, 0.69-0.99, P = .044) after multivariable logistic regression. Resection for retroperitoneal sarcoma performed at academic cancer centers was an independent predictor of margin-negative resection but was not a statistically significant factor for survival. This observation suggests that site of care may contribute to some aspect of improved oncologic resection

An overview of the situation in radiotherapy with emphasis on the developing countries.

PubMed

Hanson, G P; Stjernswärd, J; Nofal, M; Durosinmi-Etti, F

1990-11-01

excellent radiotherapy centers throughout the world. The key issues are priority and the commitment of sufficient resources.

It Is Tough and Tiring but It Works—Children’s Experiences of Undergoing Radiotherapy

PubMed Central

Engvall, Gunn; Ångström-Brännström, Charlotte; Mullaney, Tara; Nilsson, Kristina; Wickart-Johansson, Gun; Svärd, Anna-Maja; Nyholm, Tufve; Lindh, Jack; Lindh, Viveca

2016-01-01

Approximately 300 children ages 0 to 18 are diagnosed with cancer in Sweden every year, and 80 to 90 of them undergo radiotherapy treatment. The aim was to describe children’s experiences of preparing for and undergoing radiotherapy, and furthermore to describe children’s suggestions for improvement. Thirteen children between the ages of 5 and 15 with various cancer diagnoses were interviewed. Data was analyzed using qualitative content analysis. The findings revealed five categories: positive and negative experiences with hospital stays and practical arrangements; age-appropriate information, communication, and guidance to various degrees; struggle with emotions; use of distraction and other suitable coping strategies; and children’s suggestions for improvement during radiotherapy. An overarching theme emerged: “It is tough and tiring but it works”. Some key areas were: explanatory visits, the need for information and communication, being afraid, discomfort and suffering, the need for media distraction, dealing with emotions, and the need for support. A systematic, family-centered preparation program could possible help families prepare and individualized distraction during radiotherapy could contribute to reducing distress. Further studies with interventions could clarify successful programs. PMID:27055258

Ultra-peripheral collisions and hadronic structure

NASA Astrophysics Data System (ADS)

Klein, Spencer R.

2017-11-01

Ultra-peripheral collisions are the energy frontier for photon-mediated interactions, reaching, at the Large Hadron Collider (LHC), γ - p center of mass energies five to ten times higher than at HERA and reaching γγ energies higher than at LEP. Photoproduction of heavy quarkonium and dijets in pp and pA collisions probes the gluon distribution in protons at Bjorken-x values down to 3 ×10-6, far smaller than can be otherwise studied. In AA collisions, these reactions probe the gluon distributions in heavy ions, down to x values of a few 10-5. Although more theoretical work is needed to nail down all of the uncertainties, inclusion of these data in current parton distribution function fits would greatly improve the accuracy of the gluon distributions at low Bjorken-x and low/moderate Q2. High-statistics ρ0 data probe the spatial distribution of the interaction sites; the site distribution is given by the Fourier transform of dσ / dt. After introducing UPCs, this review presents recent measurements of dilepton production and light-by-light scattering and recent data on proton and heavy nuclei structure, emphasizing results presented at Quark Matter 2017 (QM2017).

Radiotherapy.

PubMed

Krause, Sonja; Debus, Jürgen; Neuhof, Dirk

2011-01-01

Solitary plasmocytoma occurring in bone (solitary plasmocytoma of the bone, SBP) or in soft tissue (extramedullary plasmocytoma, EP) can be treated effectively and with little toxicity by local radiotherapy. Ten-year local control rates of up to 90% can be achieved. Patients with multiple myeloma often suffer from symptoms such as pain or neurological impairments that are amenable to palliative radiotherapy. In a palliative setting, short treatment schedules and lower radiation doses are used to reduce toxicity and duration of hospitalization. In future, low-dose total body irradiation (TBI) may play a role in a potentially curative regimen with nonmyeloablative conditioning followed by allogenic peripheral blood stem cell transplantation.

Analysis Tools for Next-Generation Hadron Spectroscopy Experiments

NASA Astrophysics Data System (ADS)

Battaglieri, M.; Briscoe, B. J.; Celentano, A.; Chung, S.-U.; D'Angelo, A.; De Vita, R.; Döring, M.; Dudek, J.; Eidelman, S.; Fegan, S.; Ferretti, J.; Filippi, A.; Fox, G.; Galata, G.; García-Tecocoatzi, H.; Glazier, D. I.; Grube, B.; Hanhart, C.; Hoferichter, M.; Hughes, S. M.; Ireland, D. G.; Ketzer, B.; Klein, F. J.; Kubis, B.; Liu, B.; Masjuan, P.; Mathieu, V.; McKinnon, B.; Mitchel, R.; Nerling, F.; Paul, S.; Peláez, J. R.; Rademacker, J.; Rizzo, A.; Salgado, C.; Santopinto, E.; Sarantsev, A. V.; Sato, T.; Schlüter, T.; [Silva]da Silva, M. L. L.; Stankovic, I.; Strakovsky, I.; Szczepaniak, A.; Vassallo, A.; Walford, N. K.; Watts, D. P.; Zana, L.

The series of workshops on New Partial-Wave Analysis Tools for Next-Generation Hadron Spectroscopy Experiments was initiated with the ATHOS 2012 meeting, which took place in Camogli, Italy, June 20-22, 2012. It was followed by ATHOS 2013 in Kloster Seeon near Munich, Germany, May 21-24, 2013. The third, ATHOS3, meeting is planned for April 13-17, 2015 at The George Washington University Virginia Science and Technology Campus, USA. The workshops focus on the development of amplitude analysis tools for meson and baryon spectroscopy, and complement other programs in hadron spectroscopy organized in the recent past including the INT-JLab Workshop on Hadron Spectroscopy in Seattle in 2009, the International Workshop on Amplitude Analysis in Hadron Spectroscopy at the ECT*-Trento in 2011, the School on Amplitude Analysis in Modern Physics in Bad Honnef in 2011, the Jefferson Lab Advanced Study Institute Summer School in 2012, and the School on Concepts of Modern Amplitude Analysis Techniques in Flecken-Zechlin near Berlin in September 2013. The aim of this document is to summarize the discussions that took place at the ATHOS 2012 and ATHOS 2013 meetings. We do not attempt a comprehensive review of the field of amplitude analysis, but offer a collection of thoughts that we hope may lay the ground for such a document.

Analysis Tools for Next-Generation Hadron Spectroscopy Experiments

DOE PAGES

Battaglieri, Marco; Briscoe, William; Celentano, Andrea; ...

2015-01-01

The series of workshops on New Partial-Wave Analysis Tools for Next-Generation Hadron Spectroscopy Experiments was initiated with the ATHOS 2012 meeting, which took place in Camogli, Italy, June 20-22, 2012. It was followed by ATHOS 2013 in Kloster Seeon near Munich, Germany, May 21-24, 2013. The third, ATHOS3, meeting is planned for April 13-17, 2015 at The George Washington University Virginia Science and Technology Campus, USA. The workshops focus on the development of amplitude analysis tools for meson and baryon spectroscopy, and complement other programs in hadron spectroscopy organized in the recent past including the INT-JLab Workshop on Hadron Spectroscopymore » in Seattle in 2009, the International Workshop on Amplitude Analysis in Hadron Spectroscopy at the ECT*-Trento in 2011, the School on Amplitude Analysis in Modern Physics in Bad Honnef in 2011, the Jefferson Lab Advanced Study Institute Summer School in 2012, and the School on Concepts of Modern Amplitude Analysis Techniques in Flecken-Zechlin near Berlin in September 2013. The aim of this document is to summarize the discussions that took place at the ATHOS 2012 and ATHOS 2013 meetings. We do not attempt a comprehensive review of the field of amplitude analysis, but offer a collection of thoughts that we hope may lay the ground for such a document.« less

Hadronic vacuum polarization in true muonium

NASA Astrophysics Data System (ADS)

Lamm, Henry

2017-01-01

In order to reduce the theoretical uncertainty in the prediction, the leading-order hadronic vacuum polarization contribution to the hyperfine splitting of true muonium is reevaluated in two ways. A more complex pionic form factor and better estimates of the perturbative QCD contributions are used to study the model dependence of the previous calculation. The second, more accurate method directly integrates the Drell ratio R (s ) to obtain C1 ,HVP=-0.04874 (9 ) . This corresponds to an energy shift in the hyperfine splitting (HFS) of Δ EHFS,HVP μ=-8202 (16 ) MHz and represents a factor-of-50 reduction in the theoretical uncertainty from hadronic sources. We also compute the contribution in positronium, which is too small at present to detect.

Hadron diffractive production at ultrahigh energies and shadow effects

NASA Astrophysics Data System (ADS)

Anisovich, V. V.; Matveev, M. A.; Nikonov, V. A.

2016-10-01

Shadow effects at collisions of hadrons with light nuclei at high energies were subject of scientific interest of V.N. Gribov, first, we mean his study of the hadron-deuteron scattering, see Sov. Phys. JETP 29, 483 (1969) [Zh. Eksp. Teor. Fiz. 56, 892 (1969)] and discovery of the reinforcement of shadowing due to inelastic diffractive rescatterings. It turns out that the similar effect exists on hadron level though at ultrahigh energies. Diffractive production is considered in the ultrahigh energy region where pomeron exchange amplitudes are transformed into black disk ones due to rescattering corrections. The corresponding corrections in hadron reactions h1 + h3 → h1 + h2 + h3 with small momenta transferred (q1→12 ˜ m2/ln2s, q3→32 ˜ m2/ln2s) are calculated in terms of the K-matrix technique modified for ultrahigh energies. Small values of the momenta transferred are crucial for introducing equations for amplitudes. The three-body equation for hadron diffractive production reaction h1 + h3 → h1 + h2 + h3 is written and solved precisely in the eikonal approach. In the black disk regime final state scattering processes do not change the shapes of amplitudes principally but dump amplitudes by a factor ˜ 1 4; initial state rescatterings result in additional factor ˜ 1 2. In the resonant disk regime initial and final state scatterings damp strongly the production amplitude that corresponds to σinel/σtot → 0 at s →∞ in this mode.

Hadron Diffractive Production at Ultrahigh Energies and Shadow Effects

NASA Astrophysics Data System (ADS)

Anisovich, V. V.; Matveev, M. A.; Nikonov, V. A.

Shadow effects at collisions of hadrons with light nuclei at high energies were subject of scientific interest of V.N. Gribov, first, we mean his study of the hadron-deuteron scattering, see Sov. Phys. JETP 29, 483 (1969) [Zh. Eksp. Teor. Fiz. 56, 892 (1969)] and discovery of the reinforcement of shadowing due to inelastic diffractive rescatterings. It turns out that the similar effect exists on hadron level though at ultrahigh energies... Diffractive production is considered in the ultrahigh energy region where pomeron exchange amplitudes are transformed into black disk ones due to rescattering corrections. The corresponding corrections in hadron reactions h1 + h3 → h1 + h2 + h3 with small momenta transferred (q^2_{1 to 1} m^2/ ln^2 s, q^2_{3 to 3} m^2/ ln^2 s) are calculated in terms of the K-matrix technique modified for ultrahigh energies. Small values of the momenta transferred are crucial for introducing equations for amplitudes. The three-body equation for hadron diffractive production reaction h1 + h3 → h1 + h2 + h3 is written and solved precisely in the eikonal approach. In the black disk regime final state scattering processes do not change the shapes of amplitudes principally but dump amplitudes by a factor 1/4 initial state rescatterings result in additional factor 1/2. In the resonant disk regime initial and final state scatterings damp strongly the production amplitude that corresponds to σ_{inel}/σ_{tot} to 0 at √{s}to ∞ in this mode.

Entropy production during hadronization of a quark-gluon plasma

NASA Astrophysics Data System (ADS)

Biró, Tamás S.; Schram, Zsolt; Jenkovszky, László

2018-02-01

We revisit some physical pictures for the hadronization of quark-gluon plasma, concentrating on the problem of entropy production during processes where the number of degrees of freedom is seemingly reduced due to color confinement. Based on observations on Regge trajectories we propose not having an infinite tower of hadronic resonances. We discuss possible entropy production mechanisms far from equilibrium in terms of stochastic dynamics.

In search of the economic sustainability of Hadron therapy: the real cost of setting up and operating a Hadron facility.

PubMed

Vanderstraeten, Barbara; Verstraete, Jan; De Croock, Roger; De Neve, Wilfried; Lievens, Yolande

2014-05-01

To determine the treatment cost and required reimbursement for a new hadron therapy facility, considering different technical solutions and financing methods. The 3 technical solutions analyzed are a carbon only (COC), proton only (POC), and combined (CC) center, each operating 2 treatment rooms and assumed to function at full capacity. A business model defines the required reimbursement and analyzes the financial implications of setting up a facility over time; activity-based costing (ABC) calculates the treatment costs per type of patient for a center in a steady state of operation. Both models compare a private, full-cost approach with public sponsoring, only taking into account operational costs. Yearly operational costs range between €10.0M (M = million) for a publicly sponsored POC to €24.8M for a CC with private financing. Disregarding inflation, the average treatment cost calculated with ABC (COC: €29,450; POC: €46,342; CC: €46,443 for private financing; respectively €16,059, €28,296, and €23,956 for public sponsoring) is slightly lower than the required reimbursement based on the business model (between €51,200 in a privately funded POC and €18,400 in COC with public sponsoring). Reimbursement for privately financed centers is very sensitive to a delay in commissioning and to the interest rate. Higher throughput and hypofractionation have a positive impact on the treatment costs. Both calculation methods are valid and complementary. The financially most attractive option of a publicly sponsored COC should be balanced to the clinical necessities and the sociopolitical context. Copyright © 2014 Elsevier Inc. All rights reserved.

A conservation law, entropy principle and quantization of fractal dimensions in hadron interactions

NASA Astrophysics Data System (ADS)

Zborovský, I.

2018-04-01

Fractal self-similarity of hadron interactions demonstrated by the z-scaling of inclusive spectra is studied. The scaling regularity reflects fractal structure of the colliding hadrons (or nuclei) and takes into account general features of fragmentation processes expressed by fractal dimensions. The self-similarity variable z is a function of the momentum fractions x1 and x2 of the colliding objects carried by the interacting hadron constituents and depends on the momentum fractions ya and yb of the scattered and recoil constituents carried by the inclusive particle and its recoil counterpart, respectively. Based on entropy principle, new properties of the z-scaling concept are found. They are conservation of fractal cumulativity in hadron interactions and quantization of fractal dimensions characterizing hadron structure and fragmentation processes at a constituent level.

Improving Identification of Dijet Resonances at Hadron Colliders

NASA Astrophysics Data System (ADS)

Izaguirre, Eder; Shuve, Brian; Yavin, Itay

2015-01-01

The experimental detection of resonances has played a vital role in the development of subatomic physics. The overwhelming multijet backgrounds at the Large Hadron Collider (LHC) necessitate the invention of new techniques to identify resonances decaying into a pair of partons. In this Letter we introduce an observable that achieves a significant improvement in several key measurements at the LHC: the Higgs boson decay to a pair of b quarks; W±/Z0 vector-boson hadronic decay; and extensions of the standard model (SM) with a new hadronic resonance. Measuring the Higgs decay to b quarks is a central test of the fermion mass generation mechanism in the SM, whereas the W±/Z0 production rates are important observables of the electroweak sector. Our technique is effective in large parts of phase space where the resonance is mildly boosted and is particularly well suited for experimental searches dominated by systematic uncertainties, which is true of many analyses in the high-luminosity running of the LHC.

Improving identification of dijet resonances at hadron colliders.

PubMed

Izaguirre, Eder; Shuve, Brian; Yavin, Itay

2015-01-30

The experimental detection of resonances has played a vital role in the development of subatomic physics. The overwhelming multijet backgrounds at the Large Hadron Collider (LHC) necessitate the invention of new techniques to identify resonances decaying into a pair of partons. In this Letter we introduce an observable that achieves a significant improvement in several key measurements at the LHC: the Higgs boson decay to a pair of b quarks; W±/Z0 vector-boson hadronic decay; and extensions of the standard model (SM) with a new hadronic resonance. Measuring the Higgs decay to b quarks is a central test of the fermion mass generation mechanism in the SM, whereas the W±/Z0 production rates are important observables of the electroweak sector. Our technique is effective in large parts of phase space where the resonance is mildly boosted and is particularly well suited for experimental searches dominated by systematic uncertainties, which is true of many analyses in the high-luminosity running of the LHC.

Hadron intensity and energy spectrum at 4380 m above level

NASA Technical Reports Server (NTRS)

Cananov, S. D.; Chadranyan, E. K.; Khizanishvili, L. A.; Ladaria, N. K.; Roinishvili, N. N.

1985-01-01

The flux value of hadrons with E (sup gamma) h or = 5 TeV, where E (sup gamma) h or = is the energy transferred into electromagnetic component is presented. It is shown that the energy spectrum slope beta of hadrons with E h or = 20 TeV is equal to 1.9.

Low-Dose Palliative Radiotherapy for Cutaneous B- and T-Cell Lymphomas

DOE Office of Scientific and Technical Information (OSTI.GOV)

Neelis, Karen J.; Schimmel, Erik C.; Vermeer, Maarten H.

Purpose: To determine the efficacy of low-dose palliative radiotherapy for both low-grade malignant cutaneous B-cell lymphomas (CBCLs) and cutaneous T-cell lymphomas (mycosis fungoides). Methods and Materials: A total of 18 patients with low-grade CBCL (10 primary cutaneous marginal zone B-cell and 8 primary cutaneous follicle center lymphomas) with 44 symptomatic plaques and tumors underwent low-dose (4 Gy in two fractions) local radiotherapy. A total of 31 patients with mycosis fungoides were treated at 82 symptomatic sites, initially with 4 Gy and later with 8 Gy in two fractions. Results: The complete response rate for CBCL lesions was 72%. Of themore » 44 B-cell lymphoma lesions, 13 were re-treated to the same site after a median of 6.3 months because of persistent (n = 8) or recurrent (n = 5) symptomatic disease. Of the mycosis fungoides patients treated with 4 Gy in two fractions (17 lesions), 70% failed to respond. Increasing the dose to 8 Gy in two fractions yielded a complete response rate of 92% (60 of 65 lesions). The patients in whom low-dose radiotherapy failed were retreated with 20 Gy in eight fractions. Conclusion: Our results have demonstrated that low-dose involved-field radiotherapy induces a high response rate in both CBCL and cutaneous T-cell lymphoma lesions without any toxicity. Therefore, this treatment is now our standard palliative treatment. At progression, it is safe and feasible to apply greater radiation doses.« less

Rare b-hadron decays as probe of new physics

NASA Astrophysics Data System (ADS)

Lanfranchi, Gaia

2018-05-01

The unexpected absence of unambiguous signals of New Physics (NP) at the TeV scale at the Large Hadron Collider (LHC) puts today flavor physics at the forefront. In particular, rare decays of b-hadrons represent a unique probe to challenge the Standard Model (SM) paradigm and test models of NP at a scale much higher than that accessible by direct searches. This article reviews the status of the field.

Kinetic freeze-out conditions for the production of resonances, hadronic molecules, and light nuclei

NASA Astrophysics Data System (ADS)

Cho, Sungtae; Song, Taesoo; Lee, Su Houng

2018-02-01

We investigate the freeze-out conditions of a particle in an expanding system of interacting particles in order to understand the productions of resonances, hadronic molecules, and light nuclei in heavy-ion collisions. Applying the kinetic freeze-out condition with explicit hydrodynamic calculations for the expanding hadronic phase to the daughter particles of K* mesons, we find that the larger suppression of the yield ratio of K*/K at the Large Hadron Collider (LHC) than at the Relativisitic Heavy Ion Collider (RHIC) compared to the expectations from the statistical hadronization model based on chemical freeze-out parameters reflects the lower kinetic freeze-out temperature at LHC than at RHIC. Furthermore, we point out that for the light nuclei or hadronic molecules that are bound, the freeze-out condition should be applied to the respective particle in the hadronic matter. It is then shown through the rate equation that when the nucleon and pion numbers are kept constant at the chemical freeze-out value during the hadronic phase, the deuteron number quickly approaches an asymptotic value that is close to the statistical model prediction at the chemical freeze-out point. We argue that the reduction seen in K* numbers is a typical result for a particle that has a large natural decay width decaying into daughter particles, while that for deuteron is typical for a stable hadronic bound state.

[Single-dose palliative radiotherapy in inoperable non-small-cell lung carcinoma].

PubMed

Scolaro, T; Bacigalupo, A; Giudici, S; Guenzi, M; Vitale, V

1995-12-01

The treatment of choice for advanced inoperable non-small cell lung cancer (NSCLC) is radiation therapy. Palliative radiotherapy schedules vary considerably in different centers, but a 30-Gy dose given in ten fractions over two weeks is a typical standard schedule. Our study was aimed at investigating whether a shorter course of only one 10-Gy fraction allows good palliation in the treatment of inoperable NSCLC patients whose main symptoms are related to an intrathoracic lesion. Patients of both sexes and any age, untreated with radiotherapy, with inoperable and histologically or cytologically proved NSCLC were examined. Seventeen patients, too advanced for radical "curative" radiotherapy and whose main symptoms were related to primary intrathoracic lesions, entered the study even though they had metastases. On admission, 76% (13/17) of patients had cough 76% (13/17) dyspnea, 70.7% (12/17) chest pain and 23.6% (4/17) hemoptysis. They received a single dose of 10 Gy, delivered with an 18-Mv linear accelerator via anteroposteriorly opposing portals without spinal cord shielding. Treatment volume usually included the macroscopically detected lesion identified with a CT simulator. Palliation of symptoms was achieved in high rates of patients: 46% for cough, 69% for dyspnea, 83% for pain and 75% for hemoptysis. These results were obtained within one month of treatment. Unfortunately, palliation of symptoms did not last long, decreasing to 42% within two months of the end of treatment and to 32% at three months. Four patients were retreated, one patient three months and three patients two months after the end of radiotherapy. Ten Gy to the target volume were administered as retreatment with spinal cord shielding. Side-effects were mild: nausea in 3 patients (17%), vomiting in one patient (5%) and grade-II dysphagia in two patients were observed and classified according to WHO criteria. Pain increased 24 hours after radiotherapy in five patients. We can conclude that

Flavorful leptoquarks at hadron colliders

NASA Astrophysics Data System (ADS)

Hiller, Gudrun; Loose, Dennis; Nišandžić, Ivan

2018-04-01

B -physics data and flavor symmetries suggest that leptoquarks can have masses as low as a few O (TeV ) , predominantly decay to third generation quarks, and highlight p p →b μ μ signatures from single production and p p →b b μ μ from pair production. Abandoning flavor symmetries could allow for inverted quark hierarchies and cause sizable p p →j μ μ and j j μ μ cross sections, induced by second generation couplings. Final states with leptons other than muons including lepton flavor violation (LFV) ones can also arise. The corresponding couplings can also be probed by precision studies of the B →(Xs,K*,ϕ )e e distribution and LFV searches in B -decays. We demonstrate sensitivity in single leptoquark production for the large hadron collider (LHC) and extrapolate to the high luminosity LHC. Exploration of the bulk of the parameter space requires a hadron collider beyond the reach of the LHC, with b -identification capabilities.

Spin degeneracy of Hadronic molecules in the heavy quark region

NASA Astrophysics Data System (ADS)

Yamaguchi, Yasuhiro

2018-03-01

Hadronic molecules have been considered to appear close to the hadron-hadron threshold. For the heavy mesons, \\bar D and B, the one pion exchange potential is enhanced by the mass degeneracy of heavy pseudoscalar and vector mesons, caused by the heavy quark spin symmetry. In this study, we investigate new hadronic molecules formed by the heavy meson {P≤ft( * \\right)} = {\\bar D≤ft( * \\right)},{B≤ft( * \\right)} and a nucleon N, being P (*) N. As the interaction between P (*) and N, the pion and vector meson (ρ and ω) exchanges are considered. By solving the coupled-channel Schrödinger equations for P N and P*N, we obtain the bound and resonant states in the charm and bottom sectors, and in the in nite heavy quark mass limit. In the molecular states, the PN - P*N mixing effect is important, where the tensor force of the one pion exchange potential generates the strong attraction. In the heavy quark limit, we obtain the degeneracy of the states for J P = 1/2- and 3/2-.

Identification and energy calibration of hadronically decaying tau leptons with the ATLAS experiment in pp collisions at [Formula: see text][Formula: see text].

PubMed

Aad, G; Abbott, B; Abdallah, J; Abdel Khalek, S; Abdinov, O; Aben, R; Abi, B; Abolins, M; AbouZeid, O S; Abramowicz, H; Abreu, H; Abreu, R; Abulaiti, Y; Acharya, B S; Adamczyk, L; Adams, D L; Adelman, J; Adomeit, S; Adye, T; Agatonovic-Jovin, T; Aguilar-Saavedra, J A; Agustoni, M; Ahlen, S P; Ahmadov, F; Aielli, G; Akerstedt, H; Åkesson, T P A; Akimoto, G; Akimov, A V; Alberghi, G L; Albert, J; Albrand, S; Alconada Verzini, M J; Aleksa, M; Aleksandrov, I N; Alexa, C; Alexander, G; Alexandre, G; Alexopoulos, T; Alhroob, M; Alimonti, G; Alio, L; Alison, J; Allbrooke, B M M; Allison, L J; Allport, P P; Aloisio, A; Alonso, A; Alonso, F; Alpigiani, C; Altheimer, A; Alvarez Gonzalez, B; Alviggi, M G; Amako, K; Amaral Coutinho, Y; Amelung, C; Amidei, D; Amor Dos Santos, S P; Amorim, A; Amoroso, S; Amram, N; Amundsen, G; Anastopoulos, C; Ancu, L S; Andari, N; Andeen, T; Anders, C F; Anders, G; Anderson, K J; Andreazza, A; Andrei, V; Anduaga, X S; Angelidakis, S; Angelozzi, I; Anger, P; Angerami, A; Anghinolfi, F; Anisenkov, A V; Anjos, N; Annovi, A; Antonaki, A; Antonelli, M; Antonov, A; Antos, J; Anulli, F; Aoki, M; Aperio Bella, L; Apolle, R; Arabidze, G; Aracena, I; Arai, Y; Araque, J P; Arce, A T H; Arduh, F A; Arguin, J-F; Argyropoulos, S; Arik, M; Armbruster, A J; Arnaez, O; Arnal, V; Arnold, H; Arratia, M; Arslan, O; Artamonov, A; Artoni, G; Asai, S; Asbah, N; Ashkenazi, A; Åsman, B; Asquith, L; Assamagan, K; Astalos, R; Atkinson, M; Atlay, N B; Auerbach, B; Augsten, K; Aurousseau, M; Avolio, G; Axen, B; Azuelos, G; Azuma, Y; Baak, M A; Baas, A E; Bacci, C; Bachacou, H; Bachas, K; Backes, M; Backhaus, M; Backus Mayes, J; Badescu, E; Bagiacchi, P; Bagnaia, P; Bai, Y; Bain, T; Baines, J T; Baker, O K; Balek, P; Balli, F; Banas, E; Banerjee, Sw; Bannoura, A A E; Bansil, H S; Barak, L; Baranov, S P; Barberio, E L; Barberis, D; Barbero, M; Barillari, T; Barisonzi, M; Barklow, T; Barlow, N; Barnes, S L; Barnett, B M; Barnett, R M; Barnovska, Z; Baroncelli, A; Barone, G; Barr, A J; Barreiro, F; Barreiro Guimarães da Costa, J; Bartoldus, R; Barton, A E; Bartos, P; Bartsch, V; Bassalat, A; Basye, A; Bates, R L; Batista, S J; Batley, J R; Battaglia, M; Battistin, M; Bauer, F; Bawa, H S; Beattie, M D; Beau, T; Beauchemin, P H; Beccherle, R; Bechtle, P; Beck, H P; Becker, K; Becker, S; Beckingham, M; Becot, C; Beddall, A J; Bedikian, S; Beddall, A; Bednyakov, V A; Bee, C P; Beemster, L J; Beermann, T A; Begel, M; Behr, K; Belanger-Champagne, C; Bell, P J; Bell, W H; Bella, G; Bellagamba, L; Bellerive, A; Bellomo, M; Belotskiy, K; Beltramello, O; Benary, O; Benchekroun, D; Bendtz, K; Benekos, N; Benhammou, Y; Benhar Noccioli, E; Benitez Garcia, J A; Benjamin, D P; Bensinger, J R; Bentvelsen, S; Berge, D; Bergeaas Kuutmann, E; Berger, N; Berghaus, F; Beringer, J; Bernard, C; Bernat, P; Bernius, C; Bernlochner, F U; Berry, T; Berta, P; Bertella, C; Bertoli, G; Bertolucci, F; Bertsche, C; Bertsche, D; Besana, M I; Besjes, G J; Bessidskaia Bylund, O; Bessner, M; Besson, N; Betancourt, C; Bethke, S; Bhimji, W; Bianchi, R M; Bianchini, L; Bianco, M; Biebel, O; Bieniek, S P; Bierwagen, K; Biesiada, J; Biglietti, M; Bilbao De Mendizabal, J; Bilokon, H; Bindi, M; Binet, S; Bingul, A; Bini, C; Black, C W; Black, J E; Black, K M; Blackburn, D; Blair, R E; Blanchard, J-B; Blazek, T; Bloch, I; Blocker, C; Blum, W; Blumenschein, U; Bobbink, G J; Bobrovnikov, V S; Bocchetta, S S; Bocci, A; Bock, C; Boddy, C R; Boehler, M; Boek, T T; Bogaerts, J A; Bogdanchikov, A G; Bogouch, A; Bohm, C; Boisvert, V; Bold, T; Boldea, V; Boldyrev, A S; Bomben, M; Bona, M; Boonekamp, M; Borisov, A; Borissov, G; Borri, M; Borroni, S; Bortfeldt, J; Bortolotto, V; Bos, K; Boscherini, D; Bosman, M; Boterenbrood, H; Boudreau, J; Bouffard, J; Bouhova-Thacker, E V; Boumediene, D; Bourdarios, C; Bousson, N; Boutouil, S; Boveia, A; Boyd, J; Boyko, I R; Bozic, I; Bracinik, J; Brandt, A; Brandt, G; Brandt, O; Bratzler, U; Brau, B; Brau, J E; Braun, H M; Brazzale, S F; Brelier, B; Brendlinger, K; Brennan, A J; Brenner, R; Bressler, S; Bristow, K; Bristow, T M; Britton, D; Brochu, F M; Brock, I; Brock, R; Bronner, J; Brooijmans, G; Brooks, T; Brooks, W K; Brosamer, J; Brost, E; Brown, J; Bruckman de Renstrom, P A; Bruncko, D; Bruneliere, R; Brunet, S; Bruni, A; Bruni, G; Bruschi, M; Bryngemark, L; Buanes, T; Buat, Q; Bucci, F; Buchholz, P; Buckley, A G; Buda, S I; Budagov, I A; Buehrer, F; Bugge, L; Bugge, M K; Bulekov, O; Bundock, A C; Burckhart, H; Burdin, S; Burghgrave, B; Burke, S; Burmeister, I; Busato, E; Büscher, D; Büscher, V; Bussey, P; Buszello, C P; Butler, B; Butler, J M; Butt, A I; Buttar, C M; Butterworth, J M; Butti, P; Buttinger, W; Buzatu, A; Byszewski, M; Cabrera Urbán, S; Caforio, D; Cakir, O; Calafiura, P; Calandri, A; Calderini, G; Calfayan, P; Calkins, R; Caloba, L P; Calvet, D; Calvet, S; Camacho Toro, R; Camarda, S; Cameron, D; Caminada, L M; Caminal Armadans, R; Campana, S; Campanelli, M; Campoverde, A; Canale, V; Canepa, A; Cano Bret, M; Cantero, J; Cantrill, R; Cao, T; Capeans Garrido, M D M; Caprini, I; Caprini, M; Capua, M; Caputo, R; Cardarelli, R; Carli, T; Carlino, G; Carminati, L; Caron, S; Carquin, E; Carrillo-Montoya, G D; Carter, J R; Carvalho, J; Casadei, D; Casado, M P; Casolino, M; Castaneda-Miranda, E; Castelli, A; Castillo Gimenez, V; Castro, N F; Catastini, P; Catinaccio, A; Catmore, J R; Cattai, A; Cattani, G; Caudron, J; Cavaliere, V; Cavalli, D; Cavalli-Sforza, M; Cavasinni, V; Ceradini, F; Cerio, B C; Cerny, K; Cerqueira, A S; Cerri, A; Cerrito, L; Cerutti, F; Cerv, M; Cervelli, A; Cetin, S A; Chafaq, A; Chakraborty, D; Chalupkova, I; Chang, P; Chapleau, B; Chapman, J D; Charfeddine, D; Charlton, D G; Chau, C C; Chavez Barajas, C A; Cheatham, S; Chegwidden, A; Chekanov, S; Chekulaev, S V; Chelkov, G A; Chelstowska, M A; Chen, C; Chen, H; Chen, K; Chen, L; Chen, S; Chen, X; Chen, Y; Cheng, H C; Cheng, Y; Cheplakov, A; Cherkaoui El Moursli, R; Chernyatin, V; Cheu, E; Chevalier, L; Chiarella, V; Chiefari, G; Childers, J T; Chilingarov, A; Chiodini, G; Chisholm, A S; Chislett, R T; Chitan, A; Chizhov, M V; Chouridou, S; Chow, B K B; Chromek-Burckhart, D; Chu, M L; Chudoba, J; Chwastowski, J J; Chytka, L; Ciapetti, G; Ciftci, A K; Ciftci, R; Cinca, D; Cindro, V; Ciocio, A; Citron, Z H; Citterio, M; Ciubancan, M; Clark, A; Clark, P J; Clarke, R N; Cleland, W; Clemens, J C; Clement, C; Coadou, Y; Cobal, M; Coccaro, A; Cochran, J; Coffey, L; Cogan, J G; Cole, B; Cole, S; Colijn, A P; Collot, J; Colombo, T; Compostella, G; Conde Muiño, P; Coniavitis, E; Connell, S H; Connelly, I A; Consonni, S M; Consorti, V; Constantinescu, S; Conta, C; Conti, G; Conventi, F; Cooke, M; Cooper, B D; Cooper-Sarkar, A M; Cooper-Smith, N J; Copic, K; Cornelissen, T; Corradi, M; Corriveau, F; Corso-Radu, A; Cortes-Gonzalez, A; Cortiana, G; Costa, G; Costa, M J; Costanzo, D; Côté, D; Cottin, G; Cowan, G; Cox, B E; Cranmer, K; Cree, G; Crépé-Renaudin, S; Crescioli, F; Cribbs, W A; Crispin Ortuzar, M; Cristinziani, M; Croft, V; Crosetti, G; Cuhadar Donszelmann, T; Cummings, J; Curatolo, M; Cuthbert, C; Czirr, H; Czodrowski, P; D'Auria, S; D'Onofrio, M; Cunha Sargedas De Sousa, M J Da; Via, C Da; Dabrowski, W; Dafinca, A; Dai, T; Dale, O; Dallaire, F; Dallapiccola, C; Dam, M; Daniells, A C; Dano Hoffmann, M; Dao, V; Darbo, G; Darmora, S; Dassoulas, J; Dattagupta, A; Davey, W; David, C; Davidek, T; Davies, E; Davies, M; Davignon, O; Davison, A R; Davison, P; Davygora, Y; Dawe, E; Dawson, I; Daya-Ishmukhametova, R K; De, K; de Asmundis, R; De Castro, S; De Cecco, S; De Groot, N; de Jong, P; De la Torre, H; De Lorenzi, F; De Nooij, L; De Pedis, D; De Salvo, A; De Sanctis, U; De Santo, A; De Vivie De Regie, J B; Dearnaley, W J; Debbe, R; Debenedetti, C; Dechenaux, B; Dedovich, D V; Deigaard, I; Del Peso, J; Del Prete, T; Deliot, F; Delitzsch, C M; Deliyergiyev, M; Dell'Acqua, A; Dell'Asta, L; Dell'Orso, M; Della Pietra, M; Della Volpe, D; Delmastro, M; Delsart, P A; Deluca, C; DeMarco, D A; Demers, S; Demichev, M; Demilly, A; Denisov, S P; Derendarz, D; Derkaoui, J E; Derue, F; Dervan, P; Desch, K; Deterre, C; Deviveiros, P O; Dewhurst, A; Dhaliwal, S; Di Ciaccio, A; Di Ciaccio, L; Di Domenico, A; Di Donato, C; Di Girolamo, A; Di Girolamo, B; Di Mattia, A; Di Micco, B; Di Nardo, R; Di Simone, A; Di Sipio, R; Di Valentino, D; Dias, F A; Diaz, M A; Diehl, E B; Dietrich, J; Dietzsch, T A; Diglio, S; Dimitrievska, A; Dingfelder, J; Dita, P; Dita, S; Dittus, F; Djama, F; Djobava, T; Djuvsland, J I; do Vale, M A B; Dobos, D; Doglioni, C; Doherty, T; Dohmae, T; Dolejsi, J; Dolezal, Z; Dolgoshein, B A; Donadelli, M; Donati, S; Dondero, P; Donini, J; Dopke, J; Doria, A; Dova, M T; Doyle, A T; Dris, M; Dubbert, J; Dube, S; Dubreuil, E; Duchovni, E; Duckeck, G; Ducu, O A; Duda, D; Dudarev, A; Dudziak, F; Duflot, L; Duguid, L; Dührssen, M; Dunford, M; Duran Yildiz, H; Düren, M; Durglishvili, A; Duschinger, D; Dwuznik, M; Dyndal, M; Ebke, J; Edson, W; Edwards, N C; Ehrenfeld, W; Eifert, T; Eigen, G; Einsweiler, K; Ekelof, T; El Kacimi, M; Ellert, M; Elles, S; Ellinghaus, F; Ellis, N; Elmsheuser, J; Elsing, M; Emeliyanov, D; Enari, Y; Endner, O C; Endo, M; Engelmann, R; Erdmann, J; Ereditato, A; Eriksson, D; Ernis, G; Ernst, J; Ernst, M; Ernwein, J; Errede, D; Errede, S; Ertel, E; Escalier, M; Esch, H; Escobar, C; Esposito, B; Etienvre, A I; Etzion, E; Evans, H; Ezhilov, A; Fabbri, L; Facini, G; Fakhrutdinov, R M; Falciano, S; Falla, R J; Faltova, J; Fang, Y; Fanti, M; Farbin, A; Farilla, A; Farooque, T; Farrell, S; Farrington, S M; Farthouat, P; Fassi, F; Fassnacht, P; Fassouliotis, D; Favareto, A; Fayard, L; Federic, P; Fedin, O L; Fedorko, W; Feigl, S; Feligioni, L; Feng, C; Feng, E J; Feng, H; Fenyuk, A B; Fernandez Perez, S; Ferrag, S; Ferrando, J; Ferrari, A; Ferrari, P; Ferrari, R; Ferreira de Lima, D E; Ferrer, A; Ferrere, D; Ferretti, C; Ferretto Parodi, A; Fiascaris, M; Fiedler, F; Filipčič, A; Filipuzzi, M; Filthaut, F; Fincke-Keeler, M; Finelli, K D; Fiolhais, M C N; Fiorini, L; Firan, A; Fischer, A; Fischer, J; Fisher, W C; Fitzgerald, E A; Flechl, M; Fleck, I; Fleischmann, P; Fleischmann, S; Fletcher, G T; Fletcher, G; Flick, T; Floderus, A; Flores Castillo, L R; Flowerdew, M J; Formica, A; Forti, A; Fortin, D; Fournier, D; Fox, H; Fracchia, S; Francavilla, P; Franchini, M; Franchino, S; Francis, D; Franconi, L; Franklin, M; Fraternali, M; French, S T; Friedrich, C; Friedrich, F; Froidevaux, D; Frost, J A; Fukunaga, C; Fullana Torregrosa, E; Fulsom, B G; Fuster, J; Gabaldon, C; Gabizon, O; Gabrielli, A; Gabrielli, A; Gadatsch, S; Gadomski, S; Gagliardi, G; Gagnon, P; Galea, C; Galhardo, B; Gallas, E J; Gallop, B J; Gallus, P; Galster, G; Gan, K K; Gao, J; Gao, Y S; Garay Walls, F M; Garberson, F; García, C; García Navarro, J E; Garcia-Sciveres, M; Gardner, R W; Garelli, N; Garonne, V; Gatti, C; Gaudio, G; Gaur, B; Gauthier, L; Gauzzi, P; Gavrilenko, I L; Gay, C; Gaycken, G; Gazis, E N; Ge, P; Gecse, Z; Gee, C N P; Geerts, D A A; Geich-Gimbel, Ch; Gellerstedt, K; Gemme, C; Gemmell, A; Genest, M H; Gentile, S; George, M; George, S; Gerbaudo, D; Gershon, A; Ghazlane, H; Ghodbane, N; Giacobbe, B; Giagu, S; Giangiobbe, V; Giannetti, P; Gianotti, F; Gibbard, B; Gibson, S M; Gilchriese, M; Gillam, T P S; Gillberg, D; Gilles, G; Gingrich, D M; Giokaris, N; Giordani, M P; Giordano, R; Giorgi, F M; Giorgi, F M; Giraud, P F; Giugni, D; Giuliani, C; Giulini, M; Gjelsten, B K; Gkaitatzis, S; Gkialas, I; Gkougkousis, E L; Gladilin, L K; Glasman, C; Glatzer, J; Glaysher, P C F; Glazov, A; Glonti, G L; Glonti, G L; Goblirsch-Kolb, M; Goddard, J R; Godlewski, J; Goeringer, C; Goldfarb, S; Golling, T; Golubkov, D; Gomes, A; Gomez Fajardo, L S; Gonçalo, R; Goncalves Pinto Firmino Da Costa, J; Gonella, L; González de la Hoz, S; Gonzalez Parra, G; Gonzalez-Sevilla, S; Goossens, L; Gorbounov, P A; Gordon, H A; Gorelov, I; Gorini, B; Gorini, E; Gorišek, A; Gornicki, E; Goshaw, A T; Gössling, C; Gostkin, M I; Gouighri, M; Goujdami, D; Goulette, M P; Goussiou, A G; Goy, C; Grabas, H M X; Graber, L; Grabowska-Bold, I; Grafström, P; Grahn, K-J; Gramling, J; Gramstad, E; Grancagnolo, S; Grassi, V; Gratchev, V; Gray, H M; Graziani, E; Grebenyuk, O G; Greenwood, Z D; Gregersen, K; Gregor, I M; Grenier, P; Griffiths, J; Grillo, A A; Grimm, K; Grinstein, S; Gris, Ph; Grishkevich, Y V; Grivaz, J-F; Grohs, J P; Grohsjean, A; Gross, E; Grosse-Knetter, J; Grossi, G C; Grout, Z J; Guan, L; Guenther, J; Guescini, F; Guest, D; Gueta, O; Guicheney, C; Guido, E; Guillemin, T; Guindon, S; Gul, U; Gumpert, C; Guo, J; Gupta, S; Gutierrez, P; Gutierrez Ortiz, N G; Gutschow, C; Guttman, N; Guyot, C; Gwenlan, C; Gwilliam, C B; Haas, A; Haber, C; Hadavand, H K; Haddad, N; Haefner, P; Hageböck, S; Hajduk, Z; Hakobyan, H; Haleem, M; Hall, D; Halladjian, G; Hallewell, G D; Hamacher, K; Hamal, P; Hamano, K; Hamer, M; Hamilton, A; Hamilton, S; Hamity, G N; Hamnett, P G; Han, L; Hanagaki, K; Hanawa, K; Hance, M; Hanke, P; Hanna, R; Hansen, J B; Hansen, J D; Hansen, P H; Hara, K; Hard, A S; Harenberg, T; Hariri, F; Harkusha, S; Harper, D; Harrington, R D; Harris, O M; Harrison, P F; Hartjes, F; Hasegawa, M; Hasegawa, S; Hasegawa, Y; Hasib, A; Hassani, S; Haug, S; Hauschild, M; Hauser, R; Havranek, M; Hawkes, C M; Hawkings, R J; Hawkins, A D; Hayashi, T; Hayden, D; Hays, C P; Hays, J M; Hayward, H S; Haywood, S J; Head, S J; Heck, T; Hedberg, V; Heelan, L; Heim, S; Heim, T; Heinemann, B; Heinrich, L; Hejbal, J; Helary, L; Heller, C; Heller, M; Hellman, S; Hellmich, D; Helsens, C; Henderson, J; Henderson, R C W; Heng, Y; Hengler, C; Henrichs, A; Henriques Correia, A M; Henrot-Versille, S; Herbert, G H; Hernández Jiménez, Y; Herrberg-Schubert, R; Herten, G; Hertenberger, R; Hervas, L; Hesketh, G G; Hessey, N P; Hickling, R; Higón-Rodriguez, E; Hill, E; Hill, J C; Hiller, K H; Hillier, S J; Hinchliffe, I; Hines, E; Hirose, M; Hirschbuehl, D; Hobbs, J; Hod, N; Hodgkinson, M C; Hodgson, P; Hoecker, A; Hoeferkamp, M R; Hoenig, F; Hoffmann, D; Hohlfeld, M; Holmes, T R; Hong, T M; Hooft van Huysduynen, L; Hopkins, W H; Horii, Y; Horton, A J; Hostachy, J-Y; Hou, S; Hoummada, A; Howard, J; Howarth, J; Hrabovsky, M; Hristova, I; Hrivnac, J; Hryn'ova, T; Hrynevich, A; Hsu, C; Hsu, P J; Hsu, S-C; Hu, D; Hu, X; Huang, Y; Hubacek, Z; Hubaut, F; Huegging, F; Huffman, T B; Hughes, E W; Hughes, G; Huhtinen, M; Hülsing, T A; Hurwitz, M; Huseynov, N; Huston, J; Huth, J; Iacobucci, G; Iakovidis, G; Ibragimov, I; Iconomidou-Fayard, L; Ideal, E; Idrissi, Z; Iengo, P; Igonkina, O; Iizawa, T; Ikegami, Y; Ikematsu, K; Ikeno, M; Ilchenko, Y; Iliadis, D; Ilic, N; Inamaru, Y; Ince, T; Ioannou, P; Iodice, M; Iordanidou, K; Ippolito, V; Irles Quiles, A; Isaksson, C; Ishino, M; Ishitsuka, M; Ishmukhametov, R; Issever, C; Istin, S; Iturbe Ponce, J M; Iuppa, R; Ivarsson, J; Iwanski, W; Iwasaki, H; Izen, J M; Izzo, V; Jackson, B; Jackson, M; Jackson, P; Jaekel, M R; Jain, V; Jakobs, K; Jakobsen, S; Jakoubek, T; Jakubek, J; Jamin, D O; Jana, D K; Jansen, E; Jansen, H; Janssen, J; Janus, M; Jarlskog, G; Javadov, N; Javůrek, T; Jeanty, L; Jejelava, J; Jeng, G-Y; Jennens, D; Jenni, P; Jentzsch, J; Jeske, C; Jézéquel, S; Ji, H; Jia, J; Jiang, Y; Jimenez Belenguer, M; Jin, S; Jinaru, A; Jinnouchi, O; Joergensen, M D; Johansson, K E; Johansson, P; Johns, K A; Jon-And, K; Jones, G; Jones, R W L; Jones, T J; Jongmanns, J; Jorge, P M; Joshi, K D; Jovicevic, J; Ju, X; Jung, C A; Jungst, R M; Jussel, P; Juste Rozas, A; Kaci, M; Kaczmarska, A; Kado, M; Kagan, H; Kagan, M; Kajomovitz, E; Kalderon, C W; Kama, S; Kamenshchikov, A; Kanaya, N; Kaneda, M; Kaneti, S; Kantserov, V A; Kanzaki, J; Kaplan, B; Kapliy, A; Kar, D; Karakostas, K; Karastathis, N; Kareem, M J; Karnevskiy, M; Karpov, S N; Karpova, Z M; Karthik, K; Kartvelishvili, V; Karyukhin, A N; Kashif, L; Kasieczka, G; Kass, R D; Kastanas, A; Kataoka, Y; Katre, A; Katzy, J; Kaushik, V; Kawagoe, K; Kawamoto, T; Kawamura, G; Kazama, S; Kazanin, V F; Kazarinov, M Y; Keeler, R; Kehoe, R; Keil, M; Keller, J S; Kempster, J J; Keoshkerian, H; Kepka, O; Kerševan, B P; Kersten, S; Kessoku, K; Keung, J; Keyes, R A; Khalil-Zada, F; Khandanyan, H; Khanov, A; Kharlamov, A; Khodinov, A; Khomich, A; Khoo, T J; Khoriauli, G; Khovanskiy, V; Khramov, E; Khubua, J; Kim, H Y; Kim, H; Kim, S H; Kimura, N; Kind, O; King, B T; King, M; King, R S B; King, S B; Kirk, J; Kiryunin, A E; Kishimoto, T; Kisielewska, D; Kiss, F; Kiuchi, K; Kladiva, E; Klein, M; Klein, U; Kleinknecht, K; Klimek, P; Klimentov, A; Klingenberg, R; Klinger, J A; Klioutchnikova, T; Klok, P F; Kluge, E-E; Kluit, P; Kluth, S; Kneringer, E; Knoops, E B F G; Knue, A; Kobayashi, D; Kobayashi, T; Kobel, M; Kocian, M; Kodys, P; Koffas, T; Koffeman, E; Kogan, L A; Kohlmann, S; Kohout, Z; Kohriki, T; Koi, T; Kolanoski, H; Koletsou, I; Koll, J; Komar, A A; Komori, Y; Kondo, T; Kondrashova, N; Köneke, K; König, A C; König, S; Kono, T; Konoplich, R; Konstantinidis, N; Kopeliansky, R; Koperny, S; Köpke, L; Kopp, A K; Korcyl, K; Kordas, K; Korn, A; Korol, A A; Korolkov, I; Korolkova, E V; Korotkov, V A; Kortner, O; Kortner, S; Kostyukhin, V V; Kotov, V M; Kotwal, A; Kourkoumeli-Charalampidi, A; Kourkoumelis, C; Kouskoura, V; Koutsman, A; Kowalewski, R; Kowalski, T Z; Kozanecki, W; Kozhin, A S; Kramarenko, V A; Kramberger, G; Krasnopevtsev, D; Krasny, M W; Krasznahorkay, A; Kraus, J K; Kravchenko, A; Kreiss, S; Kretz, M; Kretzschmar, J; Kreutzfeldt, K; Krieger, P; Kroeninger, K; Kroha, H; Kroll, J; Kroseberg, J; Krstic, J; Kruchonak, U; Krüger, H; Kruker, T; Krumnack, N; Krumshteyn, Z V; Kruse, A; Kruse, M C; Kruskal, M; Kubota, T; Kucuk, H; Kuday, S; Kuehn, S; Kugel, A; Kuhl, A; Kuhl, T; Kukhtin, V; Kulchitsky, Y; Kuleshov, S; Kuna, M; Kunigo, T; Kupco, A; Kurashige, H; Kurochkin, Y A; Kurumida, R; Kus, V; Kuwertz, E S; Kuze, M; Kvita, J; Kyriazopoulos, D; La Rosa, A; La Rotonda, L; Lacasta, C; Lacava, F; Lacey, J; Lacker, H; Lacour, D; Lacuesta, V R; Ladygin, E; Lafaye, R; Laforge, B; Lagouri, T; Lai, S; Laier, H; Lambourne, L; Lammers, S; Lampen, C L; Lampl, W; Lançon, E; Landgraf, U; Landon, M P J; Lang, V S; Lankford, A J; Lanni, F; Lantzsch, K; Laplace, S; Lapoire, C; Laporte, J F; Lari, T; Manghi, F Lasagni; Lassnig, M; Laurelli, P; Lavrijsen, W; Law, A T; Laycock, P; Le Dortz, O; Le Guirriec, E; Le Menedeu, E; LeCompte, T; Ledroit-Guillon, F; Lee, C A; Lee, H; Lee, S C; Lee, L; Lefebvre, G; Lefebvre, M; Legger, F; Leggett, C; Lehan, A; Lehmann Miotto, G; Lei, X; Leight, W A; Leisos, A; Leister, A G; Leite, M A L; Leitner, R; Lellouch, D; Lemmer, B; Leney, K J C; Lenz, T; Lenzen, G; Lenzi, B; Leone, R; Leone, S; Leonidopoulos, C; Leontsinis, S; Leroy, C; Lester, C G; Lester, C M; Levchenko, M; Levêque, J; Levin, D; Levinson, L J; Levy, M; Lewis, A; Lewis, G H; Leyko, A M; Leyton, M; Li, B; Li, B; Li, H; Li, H L; Li, L; Li, L; Li, S; Li, Y; Liang, Z; Liao, H; Liberti, B; Lichard, P; Lie, K; Liebal, J; Liebig, W; Limbach, C; Limosani, A; Lin, S C; Lin, T H; Linde, F; Lindquist, B E; Linnemann, J T; Lipeles, E; Lipniacka, A; Lisovyi, M; Liss, T M; Lissauer, D; Lister, A; Litke, A M; Liu, B; Liu, D; Liu, J B; Liu, K; Liu, L; Liu, M; Liu, M; Liu, Y; Livan, M; Lleres, A; Llorente Merino, J; Lloyd, S L; Lo Sterzo, F; Lobodzinska, E; Loch, P; Lockman, W S; Loebinger, F K; Loevschall-Jensen, A E; Loginov, A; Lohse, T; Lohwasser, K; Lokajicek, M; Lombardo, V P; Long, B A; Long, J D; Long, R E; Lopes, L; Lopez Mateos, D; Lopez Paredes, B; Lopez Paz, I; Lorenz, J; Lorenzo Martinez, N; Losada, M; Loscutoff, P; Lou, X; Lounis, A; Love, J; Love, P A; Lowe, A J; Lu, F; Lu, N; Lubatti, H J; Luci, C; Lucotte, A; Luehring, F; Lukas, W; Luminari, L; Lundberg, O; Lund-Jensen, B; Lungwitz, M; Lynn, D; Lysak, R; Lytken, E; Ma, H; Ma, L L; Maccarrone, G; Macchiolo, A; Machado Miguens, J; Macina, D; Madaffari, D; Madar, R; Maddocks, H J; Mader, W F; Madsen, A; Maeno, M; Maeno, T; Maevskiy, A; Magradze, E; Mahboubi, K; Mahlstedt, J; Mahmoud, S; Maiani, C; Maidantchik, C; Maier, A A; Maio, A; Majewski, S; Makida, Y; Makovec, N; Mal, P; Malaescu, B; Malecki, Pa; Maleev, V P; Malek, F; Mallik, U; Malon, D; Malone, C; Maltezos, S; Malyshev, V M; Malyukov, S; Mamuzic, J; Mandelli, B; Mandelli, L; Mandić, I; Mandrysch, R; Maneira, J; Manfredini, A; Manhaes de Andrade Filho, L; Manjarres Ramos, J A; Mann, A; Manning, P M; Manousakis-Katsikakis, A; Mansoulie, B; Mantifel, R; Mapelli, L; March, L; Marchand, J F; Marchiori, G; Marcisovsky, M; Marino, C P; Marjanovic, M; Marroquim, F; Marsden, S P; Marshall, Z; Marti, L F; Marti-Garcia, S; Martin, B; Martin, B; Martin, T A; Martin, V J; Martin Dit Latour, B; Martinez, H; Martinez, M; Martin-Haugh, S; Martyniuk, A C; Marx, M; Marzano, F; Marzin, A; Masetti, L; Mashimo, T; Mashinistov, R; Masik, J; Maslennikov, A L; Massa, I; Massa, L; Massol, N; Mastrandrea, P; Mastroberardino, A; Masubuchi, T; Mättig, P; Mattmann, J; Maurer, J; Maxfield, S J; Maximov, D A; Mazini, R; Mazzaferro, L; Mc Goldrick, G; Mc Kee, S P; McCarn, A; McCarthy, R L; McCarthy, T G; McCubbin, N A; McFarlane, K W; Mcfayden, J A; Mchedlidze, G; McMahon, S J; McPherson, R A; Mechnich, J; Medinnis, M; Meehan, S; Mehlhase, S; Mehta, A; Meier, K; Meineck, C; Meirose, B; Melachrinos, C; Mellado Garcia, B R; Meloni, F; Mengarelli, A; Menke, S; Meoni, E; Mercurio, K M; Mergelmeyer, S; Meric, N; Mermod, P; Merola, L; Meroni, C; Merritt, F S; Merritt, H; Messina, A; Metcalfe, J; Mete, A S; Meyer, C; Meyer, C; Meyer, J-P; Meyer, J; Middleton, R P; Migas, S; Miglioranzi, S; Mijović, L; Mikenberg, G; Mikestikova, M; Mikuž, M; Milic, A; Miller, D W; Mills, C; Milov, A; Milstead, D A; Minaenko, A A; Minami, Y; Minashvili, I A; Mincer, A I; Mindur, B; Mineev, M; Ming, Y; Mir, L M; Mirabelli, G; Mitani, T; Mitrevski, J; Mitsou, V A; Miucci, A; Miyagawa, P S; Mjörnmark, J U; Moa, T; Mochizuki, K; Mohapatra, S; Mohr, W; Molander, S; Moles-Valls, R; Mönig, K; Monini, C; Monk, J; Monnier, E; Montejo Berlingen, J; Monticelli, F; Monzani, S; Moore, R W; Morange, N; Moreno, D; Moreno Llácer, M; Morettini, P; Morgenstern, M; Morii, M; Morisbak, V; Moritz, S; Morley, A K; Mornacchi, G; Morris, J D; Morton, A; Morvaj, L; Moser, H G; Mosidze, M; Moss, J; Motohashi, K; Mount, R; Mountricha, E; Mouraviev, S V; Moyse, E J W; Muanza, S; Mudd, R D; Mueller, F; Mueller, J; Mueller, K; Mueller, T; Mueller, T; Muenstermann, D; Munwes, Y; Murillo Quijada, J A; Murray, W J; Musheghyan, H; Musto, E; Myagkov, A G; Myska, M; Nackenhorst, O; Nadal, J; Nagai, K; Nagai, R; Nagai, Y; Nagano, K; Nagarkar, A; Nagasaka, Y; Nagata, K; Nagel, M; Nairz, A M; Nakahama, Y; Nakamura, K; Nakamura, T; Nakano, I; Namasivayam, H; Nanava, G; Naranjo Garcia, R F; Narayan, R; Nattermann, T; Naumann, T; Navarro, G; Nayyar, R; Neal, H A; Nechaeva, P Yu; Neep, T J; Nef, P D; Negri, A; Negri, G; Negrini, M; Nektarijevic, S; Nellist, C; Nelson, A; Nelson, T K; Nemecek, S; Nemethy, P; Nepomuceno, A A; Nessi, M; Neubauer, M S; Neumann, M; Neves, R M; Nevski, P; Newman, P R; Nguyen, D H; Nickerson, R B; Nicolaidou, R; Nicquevert, B; Nielsen, J; Nikiforou, N; Nikiforov, A; Nikolaenko, V; Nikolic-Audit, I; Nikolics, K; Nikolopoulos, K; Nilsson, P; Ninomiya, Y; Nisati, A; Nisius, R; Nobe, T; Nodulman, L; Nomachi, M; Nomidis, I; Norberg, S; Nordberg, M; Novgorodova, O; Nowak, S; Nozaki, M; Nozka, L; Ntekas, K; Nunes Hanninger, G; Nunnemann, T; Nurse, E; Nuti, F; O'Brien, B J; O'grady, F; O'Neil, D C; O'Shea, V; Oakham, F G; Oberlack, H; Obermann, T; Ocariz, J; Ochi, A; Ochoa, M I; Oda, S; Odaka, S; Ogren, H; Oh, A; Oh, S H; Ohm, C C; Ohman, H; Oide, H; Okamura, W; Okawa, H; Okumura, Y; Okuyama, T; Olariu, A; Olchevski, A G; Olivares Pino, S A; Oliveira Damazio, D; Oliver Garcia, E; Olszewski, A; Olszowska, J; Onofre, A; Onyisi, P U E; Oram, C J; Oreglia, M J; Oren, Y; Orestano, D; Orlando, N; Oropeza Barrera, C; Orr, R S; Osculati, B; Ospanov, R; Otero Y Garzon, G; Otono, H; Ouchrif, M; Ouellette, E A; Ould-Saada, F; Ouraou, A; Oussoren, K P; Ouyang, Q; Ovcharova, A; Owen, M; Ozcan, V E; Ozturk, N; Pachal, K; Pacheco Pages, A; Padilla Aranda, C; Pagáčová, M; Pagan Griso, S; Paganis, E; Pahl, C; Paige, F; Pais, P; Pajchel, K; Palacino, G; Palestini, S; Palka, M; Pallin, D; Palma, A; Palmer, J D; Pan, Y B; Panagiotopoulou, E; Panduro Vazquez, J G; Pani, P; Panikashvili, N; Panitkin, S; Pantea, D; Paolozzi, L; Papadopoulou, Th D; Papageorgiou, K; Paramonov, A; Paredes Hernandez, D; Parker, M A; Parodi, F; Parsons, J A; Parzefall, U; Pasqualucci, E; Passaggio, S; Passeri, A; Pastore, F; Pastore, Fr; Pásztor, G; Pataraia, S; Patel, N D; Pater, J R; Patricelli, S; Pauly, T; Pearce, J; Pedersen, L E; Pedersen, M; Pedraza Lopez, S; Pedro, R; Peleganchuk, S V; Pelikan, D; Peng, H; Penning, B; Penwell, J; Perepelitsa, D V; Perez Codina, E; Pérez García-Estañ, M T; Perini, L; Pernegger, H; Perrella, S; Perrino, R; Peschke, R; Peshekhonov, V D; Peters, K; Peters, R F Y; Petersen, B A; Petersen, T C; Petit, E; Petridis, A; Petridou, C; Petrolo, E; Petrucci, F; Pettersson, N E; Pezoa, R; Phillips, P W; Piacquadio, G; Pianori, E; Picazio, A; Piccaro, E; Piccinini, M; Piegaia, R; Pignotti, D T; Pilcher, J E; Pilkington, A D; Pina, J; Pinamonti, M; Pinder, A; Pinfold, J L; Pingel, A; Pinto, B; Pires, S; Pitt, M; Pizio, C; Plazak, L; Pleier, M-A; Pleskot, V; Plotnikova, E; Plucinski, P; Pluth, D; Poddar, S; Podlyski, F; Poettgen, R; Poggioli, L; Pohl, D; Pohl, M; Polesello, G; Policicchio, A; Polifka, R; Polini, A; Pollard, C S; Polychronakos, V; Pommès, K; Pontecorvo, L; Pope, B G; Popeneciu, G A; Popovic, D S; Poppleton, A; Portell Bueso, X; Pospisil, S; Potamianos, K; Potrap, I N; Potter, C J; Potter, C T; Poulard, G; Poveda, J; Pozdnyakov, V; Pralavorio, P; Pranko, A; Prasad, S; Pravahan, R; Prell, S; Price, D; Price, J; Price, L E; Prieur, D; Primavera, M; Proissl, M; Prokofiev, K; Prokoshin, F; Protopapadaki, E; Protopopescu, S; Proudfoot, J; Przybycien, M; Przysiezniak, H; Ptacek, E; Puddu, D; Pueschel, E; Puldon, D; Purohit, M; Puzo, P; Qian, J; Qin, G; Qin, Y; Quadt, A; Quarrie, D R; Quayle, W B; Queitsch-Maitland, M; Quilty, D; Qureshi, A; Radeka, V; Radescu, V; Radhakrishnan, S K; Radloff, P; Rados, P; Ragusa, F; Rahal, G; Rajagopalan, S; Rammensee, M; Rangel-Smith, C; Rao, K; Rauscher, F; Rave, T C; Ravenscroft, T; Raymond, M; Read, A L; Readioff, N P; Rebuzzi, D M; Redelbach, A; Redlinger, G; Reece, R; Reeves, K; Rehnisch, L; Reisin, H; Relich, M; Rembser, C; Ren, H; Ren, Z L; Renaud, A; Rescigno, M; Resconi, S; Rezanova, O L; Reznicek, P; Rezvani, R; Richter, R; Ridel, M; Rieck, P; Rieger, J; Rijssenbeek, M; Rimoldi, A; Rinaldi, L; Ritsch, E; Riu, I; Rizatdinova, F; Rizvi, E; Robertson, S H; Robichaud-Veronneau, A; Robinson, D; Robinson, J E M; Robson, A; Roda, C; Rodrigues, L; Roe, S; Røhne, O; Rolli, S; Romaniouk, A; Romano, M; Romero Adam, E; Rompotis, N; Ronzani, M; Roos, L; Ros, E; Rosati, S; Rosbach, K; Rose, M; Rose, P; Rosendahl, P L; Rosenthal, O; Rossetti, V; Rossi, E; Rossi, L P; Rosten, R; Rotaru, M; Roth, I; Rothberg, J; Rousseau, D; Royon, C R; Rozanov, A; Rozen, Y; Ruan, X; Rubbo, F; Rubinskiy, I; Rud, V I; Rudolph, C; Rudolph, M S; Rühr, F; Ruiz-Martinez, A; Rurikova, Z; Rusakovich, N A; Ruschke, A; Russell, H L; Rutherfoord, J P; Ruthmann, N; Ryabov, Y F; Rybar, M; Rybkin, G; Ryder, N C; Saavedra, A F; Sabato, G; Sacerdoti, S; Saddique, A; Sadeh, I; Sadrozinski, H F-W; Sadykov, R; Safai Tehrani, F; Sakamoto, H; Sakurai, Y; Salamanna, G; Salamon, A; Saleem, M; Salek, D; Sales De Bruin, P H; Salihagic, D; Salnikov, A; Salt, J; Salvatore, D; Salvatore, F; Salvucci, A; Salzburger, A; Sampsonidis, D; Sanchez, A; Sánchez, J; Sanchez Martinez, V; Sandaker, H; Sandbach, R L; Sander, H G; Sanders, M P; Sandhoff, M; Sandoval, T; Sandoval, C; Sandstroem, R; Sankey, D P C; Sansoni, A; Santoni, C; Santonico, R; Santos, H; Santoyo Castillo, I; Sapp, K; Sapronov, A; Saraiva, J G; Sarrazin, B; Sartisohn, G; Sasaki, O; Sasaki, Y; Sauvage, G; Sauvan, E; Savard, P; Savu, D O; Sawyer, C; Sawyer, L; Saxon, D H; Saxon, J; Sbarra, C; Sbrizzi, A; Scanlon, T; Scannicchio, D A; Scarcella, M; Scarfone, V; Schaarschmidt, J; Schacht, P; Schaefer, D; Schaefer, R; Schaepe, S; Schaetzel, S; Schäfer, U; Schaffer, A C; Schaile, D; Schamberger, R D; Scharf, V; Schegelsky, V A; Scheirich, D; Schernau, M; Scherzer, M I; Schiavi, C; Schieck, J; Schillo, C; Schioppa, M; Schlenker, S; Schmidt, E; Schmieden, K; Schmitt, C; Schmitt, S; Schneider, B; Schnellbach, Y J; Schnoor, U; Schoeffel, L; Schoening, A; Schoenrock, B D; Schorlemmer, A L S; Schott, M; Schouten, D; Schovancova, J; Schramm, S; Schreyer, M; Schroeder, C; Schuh, N; Schultens, M J; Schultz-Coulon, H-C; Schulz, H; Schumacher, M; Schumm, B A; Schune, Ph; Schwanenberger, C; Schwartzman, A; Schwarz, T A; Schwegler, Ph; Schwemling, Ph; Schwienhorst, R; Schwindling, J; Schwindt, T; Schwoerer, M; Sciacca, F G; Scifo, E; Sciolla, G; Scuri, F; Scutti, F; Searcy, J; Sedov, G; Sedykh, E; Seema, P; Seidel, S C; Seiden, A; Seifert, F; Seixas, J M; Sekhniaidze, G; Sekula, S J; Selbach, K E; Seliverstov, D M; Sellers, G; Semprini-Cesari, N; Serfon, C; Serin, L; Serkin, L; Serre, T; Seuster, R; Severini, H; Sfiligoj, T; Sforza, F; Sfyrla, A; Shabalina, E; Shamim, M; Shan, L Y; Shang, R; Shank, J T; Shapiro, M; Shatalov, P B; Shaw, K; Shehu, C Y; Sherwood, P; Shi, L; Shimizu, S; Shimmin, C O; Shimojima, M; Shiyakova, M; Shmeleva, A; Saadi, D Shoaleh; Shochet, M J; Short, D; Shrestha, S; Shulga, E; Shupe, M A; Shushkevich, S; Sicho, P; Sidiropoulou, O; Sidorov, D; Sidoti, A; Siegert, F; Sijacki, Dj; Silva, J; Silver, Y; Silverstein, D; Silverstein, S B; Simak, V; Simard, O; Simic, Lj; Simion, S; Simioni, E; Simmons, B; Simon, D; Simoniello, R; Sinervo, P; Sinev, N B; Siragusa, G; Sircar, A; Sisakyan, A N; Sivoklokov, S Yu; Sjölin, J; Sjursen, T B; Skottowe, H P; Skovpen, K Yu; Skubic, P; Slater, M; Slavicek, T; Slawinska, M; Sliwa, K; Smakhtin, V; Smart, B H; Smestad, L; Smirnov, S Yu; Smirnov, Y; Smirnova, L N; Smirnova, O; Smith, K M; Smizanska, M; Smolek, K; Snesarev, A A; Snidero, G; Snyder, S; Sobie, R; Socher, F; Soffer, A; Soh, D A; Solans, C A; Solar, M; Solc, J; Soldatov, E Yu; Soldevila, U; Solodkov, A A; Soloshenko, A; Solovyanov, O V; Solovyev, V; Sommer, P; Song, H Y; Soni, N; Sood, A; Sopczak, A; Sopko, B; Sopko, V; Sorin, V; Sosebee, M; Soualah, R; Soueid, P; Soukharev, A M; South, D; Spagnolo, S; Spanò, F; Spearman, W R; Spettel, F; Spighi, R; Spigo, G; Spiller, L A; Spousta, M; Spreitzer, T; Denis, R D St; Staerz, S; Stahlman, J; Stamen, R; Stamm, S; Stanecka, E; Stanek, R W; Stanescu, C; Stanescu-Bellu, M; Stanitzki, M M; Stapnes, S; Starchenko, E A; Stark, J; Staroba, P; Starovoitov, P; Staszewski, R; Stavina, P; Steinberg, P; Stelzer, B; Stelzer, H J; Stelzer-Chilton, O; Stenzel, H; Stern, S; Stewart, G A; Stillings, J A; Stockton, M C; Stoebe, M; Stoicea, G; Stolte, P; Stonjek, S; Stradling, A R; Straessner, A; Stramaglia, M E; Strandberg, J; Strandberg, S; Strandlie, A; Strauss, E; Strauss, M; Strizenec, P; Ströhmer, R; Strom, D M; Stroynowski, R; Strubig, A; Stucci, S A; Stugu, B; Styles, N A; Su, D; Su, J; Subramaniam, R; Succurro, A; Sugaya, Y; Suhr, C; Suk, M; Sulin, V V; Sultansoy, S; Sumida, T; Sun, S; Sun, X; Sundermann, J E; Suruliz, K; Susinno, G; Sutton, M R; Suzuki, Y; Svatos, M; Swedish, S; Swiatlowski, M; Sykora, I; Sykora, T; Ta, D; Taccini, C; Tackmann, K; Taenzer, J; Taffard, A; Tafirout, R; Taiblum, N; Takai, H; Takashima, R; Takeda, H; Takeshita, T; Takubo, Y; Talby, M; Talyshev, A A; Tam, J Y C; Tan, K G; Tanaka, J; Tanaka, R; Tanaka, S; Tanaka, S; Tanasijczuk, A J; Tannenwald, B B; Tannoury, N; Tapprogge, S; Tarem, S; Tarrade, F; Tartarelli, G F; Tas, P; Tasevsky, M; Tashiro, T; Tassi, E; Tavares Delgado, A; Tayalati, Y; Taylor, F E; Taylor, G N; Taylor, W; Teischinger, F A; Teixeira Dias Castanheira, M; Teixeira-Dias, P; Temming, K K; Ten Kate, H; Teng, P K; Teoh, J J; Terada, S; Terashi, K; Terron, J; Terzo, S; Testa, M; Teuscher, R J; Therhaag, J; Theveneaux-Pelzer, T; Thomas, J P; Thomas-Wilsker, J; Thompson, E N; Thompson, P D; Thompson, P D; Thompson, R J; Thompson, A S; Thomsen, L A; Thomson, E; Thomson, M; Thong, W M; Thun, R P; Tian, F; Tibbetts, M J; Tikhomirov, V O; Tikhonov, Yu A; Timoshenko, S; Tiouchichine, E; Tipton, P; Tisserant, S; Todorov, T; Todorova-Nova, S; Tojo, J; Tokár, S; Tokushuku, K; Tollefson, K; Tolley, E; Tomlinson, L; Tomoto, M; Tompkins, L; Toms, K; Topilin, N D; Torrence, E; Torres, H; Torró Pastor, E; Toth, J; Touchard, F; Tovey, D R; Tran, H L; Trefzger, T; Tremblet, L; Tricoli, A; Trigger, I M; Trincaz-Duvoid, S; Tripiana, M F; Trischuk, W; Trocmé, B; Troncon, C; Trottier-McDonald, M; Trovatelli, M; True, P; Trzebinski, M; Trzupek, A; Tsarouchas, C; Tseng, J C-L; Tsiareshka, P V; Tsionou, D; Tsipolitis, G; Tsirintanis, N; Tsiskaridze, S; Tsiskaridze, V; Tskhadadze, E G; Tsukerman, I I; Tsulaia, V; Tsuno, S; Tsybychev, D; Tudorache, A; Tudorache, V; Tuna, A N; Tupputi, S A; Turchikhin, S; Turecek, D; Turk Cakir, I; Turra, R; Turvey, A J; Tuts, P M; Tykhonov, A; Tylmad, M; Tyndel, M; Uchida, K; Ueda, I; Ueno, R; Ughetto, M; Ugland, M; Uhlenbrock, M; Ukegawa, F; Unal, G; Undrus, A; Unel, G; Ungaro, F C; Unno, Y; Unverdorben, C; Urban, J; Urbaniec, D; Urquijo, P; Usai, G; Usanova, A; Vacavant, L; Vacek, V; Vachon, B; Valencic, N; Valentinetti, S; Valero, A; Valery, L; Valkar, S; Valladolid Gallego, E; Vallecorsa, S; Valls Ferrer, J A; Van Den Wollenberg, W; Van Der Deijl, P C; van der Geer, R; van der Graaf, H; Van Der Leeuw, R; van der Ster, D; van Eldik, N; van Gemmeren, P; Van Nieuwkoop, J; van Vulpen, I; van Woerden, M C; Vanadia, M; Vandelli, W; Vanguri, R; Vaniachine, A; Vankov, P; Vannucci, F; Vardanyan, G; Vari, R; Varnes, E W; Varol, T; Varouchas, D; Vartapetian, A; Varvell, K E; Vazeille, F; Vazquez Schroeder, T; Veatch, J; Veloso, F; Velz, T; Veneziano, S; Ventura, A; Ventura, D; Venturi, M; Venturi, N; Venturini, A; Vercesi, V; Verducci, M; Verkerke, W; Vermeulen, J C; Vest, A; Vetterli, M C; Viazlo, O; Vichou, I; Vickey, T; Vickey Boeriu, O E; Viehhauser, G H A; Viel, S; Vigne, R; Villa, M; Villaplana Perez, M; Vilucchi, E; Vincter, M G; Vinogradov, V B; Virzi, J; Vivarelli, I; Vives Vaque, F; Vlachos, S; Vladoiu, D; Vlasak, M; Vogel, A; Vogel, M; Vokac, P; Volpi, G; Volpi, M; von der Schmitt, H; von Radziewski, H; von Toerne, E; Vorobel, V; Vorobev, K; Vos, M; Voss, R; Vossebeld, J H; Vranjes, N; Vranjes Milosavljevic, M; Vrba, V; Vreeswijk, M; Vu Anh, T; Vuillermet, R; Vukotic, I; Vykydal, Z; Wagner, P; Wagner, W; Wahlberg, H; Wahrmund, S; Wakabayashi, J; Walder, J; Walker, R; Walkowiak, W; Wall, R; Waller, P; Walsh, B; Wang, C; Wang, C; Wang, F; Wang, H; Wang, H; Wang, J; Wang, J; Wang, K; Wang, R; Wang, S M; Wang, T; Wang, X; Wanotayaroj, C; Warburton, A; Ward, C P; Wardrope, D R; Warsinsky, M; Washbrook, A; Wasicki, C; Watkins, P M; Watson, A T; Watson, I J; Watson, M F; Watts, G; Watts, S; Waugh, B M; Webb, S; Weber, M S; Weber, S W; Webster, J S; Weidberg, A R; Weinert, B; Weingarten, J; Weiser, C; Weits, H; Wells, P S; Wenaus, T; Wendland, D; Weng, Z; Wengler, T; Wenig, S; Wermes, N; Werner, M; Werner, P; Wessels, M; Wetter, J; Whalen, K; White, A; White, M J; White, R; White, S; Whiteson, D; Wicke, D; Wickens, F J; Wiedenmann, W; Wielers, M; Wienemann, P; Wiglesworth, C; Wiik-Fuchs, L A M; Wijeratne, P A; Wildauer, A; Wildt, M A; Wilkens, H G; Williams, H H; Williams, S; Willis, C; Willocq, S; Wilson, A; Wilson, J A; Wingerter-Seez, I; Winklmeier, F; Winter, B T; Wittgen, M; Wittig, T; Wittkowski, J; Wollstadt, S J; Wolter, M W; Wolters, H; Wosiek, B K; Wotschack, J; Woudstra, M J; Wozniak, K W; Wright, M; Wu, M; Wu, S L; Wu, X; Wu, Y; Wulf, E; Wyatt, T R; Wynne, B M; Xella, S; Xiao, M; Xu, D; Xu, L; Yabsley, B; Yacoob, S; Yakabe, R; Yamada, M; Yamaguchi, H; Yamaguchi, Y; Yamamoto, A; Yamamoto, S; Yamamura, T; Yamanaka, T; Yamauchi, K; Yamazaki, Y; Yan, Z; Yang, H; Yang, H; Yang, U K; Yang, Y; Yanush, S; Yao, L; Yao, W-M; Yasu, Y; Yatsenko, E; Yau Wong, K H; Ye, J; Ye, S; Yeletskikh, I; Yen, A L; Yildirim, E; Yilmaz, M; Yoosoofmiya, R; Yorita, K; Yoshida, R; Yoshihara, K; Young, C; Young, C J S; Youssef, S; Yu, D R; Yu, J; Yu, J M; Yu, J; Yuan, L; Yurkewicz, A; Yusuff, I; Zabinski, B; Zaidan, R; Zaitsev, A M; Zaman, A; Zambito, S; Zanello, L; Zanzi, D; Zeitnitz, C; Zeman, M; Zemla, A; Zengel, K; Zenin, O; Ženiš, T; Zerwas, D; Zevi Della Porta, G; Zhang, D; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, R; Zhang, X; Zhang, Z; Zhao, Y; Zhao, Z; Zhemchugov, A; Zhong, J; Zhou, B; Zhou, L; Zhou, N; Zhu, C G; Zhu, H; Zhu, J; Zhu, Y; Zhuang, X; Zhukov, K; Zibell, A; Zieminska, D; Zimine, N I; Zimmermann, C; Zimmermann, R; Zimmermann, S; Zimmermann, S; Zinonos, Z; Ziolkowski, M; Zobernig, G; Zoccoli, A; Zur Nedden, M; Zurzolo, G; Zutshi, V; Zwalinski, L

This paper describes the trigger and offline reconstruction, identification and energy calibration algorithms for hadronic decays of tau leptons employed for the data collected from pp collisions in 2012 with the ATLAS detector at the LHC center-of-mass energy [Formula: see text] [Formula: see text]. The performance of these algorithms is measured in most cases with [Formula: see text] decays to tau leptons using the full 2012 dataset, corresponding to an integrated luminosity of 20.3 fb[Formula: see text]. An uncertainty on the offline reconstructed tau energy scale of 2-4 %, depending on transverse energy and pseudorapidity, is achieved using two independent methods. The offline tau identification efficiency is measured with a precision of 2.5 % for hadronically decaying tau leptons with one associated track, and of 4 % for the case of three associated tracks, inclusive in pseudorapidity and for a visible transverse energy greater than 20 [Formula: see text]. For hadronic tau lepton decays selected by offline algorithms, the tau trigger identification efficiency is measured with a precision of 2-8 %, depending on the transverse energy. The performance of the tau algorithms, both offline and at the trigger level, is found to be stable with respect to the number of concurrent proton-proton interactions and has supported a variety of physics results using hadronically decaying tau leptons at ATLAS.

Neutrino Emissivity in the Quark-Hadron Mixed Phase

NASA Astrophysics Data System (ADS)

Spinella, William; Weber, Fridolin; Orsaria, Milva; Contrera, Gustavo

2018-05-01

In this work we investigate the effect a crystalline quark-hadron mixed phase can have on the neutrino emissivity from the cores of neutron stars. To this end we use relativistic mean-field equations of state to model hadronic matter and a nonlocal extension of the three-flavor Nambu-Jona-Lasinio model for quark matter. Next we determine the extent of the quark-hadron mixed phase and its crystalline structure using the Glendenning construction, allowing for the formation of spherical blob, rod, and slab rare phase geometries. Finally we calculate the neutrino emissivity due to electron-lattice interactions utilizing the formalism developed for the analogous process in neutron star crusts. We find that the contribution to the neutrino emissivity due to the presence of a crystalline quark-hadron mixed phase is substantial compared to other mechanisms at fairly low temperatures ($\\lesssim 10^9$ K) and quark fractions ($\\lesssim 30\\%$), and that contributions due to lattice vibrations are insignificant compared to static-lattice contributions. There are a number of open issues that need to be addressed in a future study on the neutrino emission rates caused by electron-quark blob bremsstrahlung. Chiefly among them are the role of collective oscillations of matter, electron band structures, and of gaps at the boundaries of the Brillouin zones on bremsstrahlung, as discussed in the summary section of this paper. We hope this paper will stimulate studies addressing these issues.

A new possible picture of the hadron structure

DOE Office of Scientific and Technical Information (OSTI.GOV)

Pokrovsky, Yury E.

A new chiral-scale invariant version of the bag model (CSB) is developed and applied to calculations of masses and radii for single bag states. The mass formula of the CSB model contains no free parameters and connects masses and radii of the bags with fundamental QCD scales, namely with {lambda}{sub QCD}, , , and quark masses. For high angular momentum states the CSB model well describes hadron Regge trajectories and predicts thin flux tubes with R{sub tube}{approx_equal}0.25 fm close to the small tube radii introduced a posteriori in modern models. For low angular momentum states this model predicts smallmore » radii of the bags R{sub bag}{approx_equal}0.25 fm close to the radii associated with constituent quarks. Masses of the lowest angular momentum bags are obtained close to the data for well known hadron resonances ({pi}(1300), {omega}(1420), N(1440),{delta}(1600), etc.). These resonances are predicted to be almost single bag states. But ground states of SU(3) hadrons (N(940), {pi}(140), etc.) are treated as strongly bounded multi bag states--BagBag-mesons, and BagBagBag-baryons like in the old Fermi, Yang, and Sakata models. As well, this model predicts the low mass excitations of SU(3) hadrons newly observed for nucleons at the following masses 1004, 1044, and 1094 MeV.« less

QCD as a Theory of Hadrons

NASA Astrophysics Data System (ADS)

Narison, Stephan

2004-05-01

About Stephan Narison; Outline of the book; Preface; Acknowledgements; Part I. General Introduction: 1. A short flash on particle physics; 2. The pre-QCD era; 3. The QCD story; 4. Field theory ingredients; Part II. QCD Gauge Theory: 5. Lagrangian and gauge invariance; 6. Quantization using path integral; 7. QCD and its global invariance; Part III. MS scheme for QCD and QED: Introduction; 8. Dimensional regularization; 9. The MS renormalization scheme; 10. Renormalization of operators using the background field method; 11. The renormalization group; 12. Other renormalization schemes; 13. MS scheme for QED; 14. High-precision low-energy QED tests; Part IV. Deep Inelastic Scattering at Hadron Colliders: 15. OPE for deep inelastic scattering; 16. Unpolarized lepton-hadron scattering; 17. The Altarelli-Parisi equation; 18. More on unpolarized deep inelastic scatterings; 19. Polarized deep-inelastic processes; 20. Drell-Yan process; 21. One 'prompt photon' inclusive production; Part V. Hard Processes in e+e- Collisions: Introduction; 22. One hadron inclusive production; 23. gg scatterings and the 'spin' of the photon; 24. QCD jets; 25. Total inclusive hadron productions; Part VI. Summary of QCD Tests and as Measurements; Part VII. Power Corrections in QCD: 26. Introduction; 27. The SVZ expansion; 28. Technologies for evaluating Wilson coefficients; 29. Renormalons; 30. Beyond the SVZ expansion; Part VIII. QCD Two-Point Functions: 31. References guide to original works; 32. (Pseudo)scalar correlators; 33. (Axial-)vector two-point functions; 34. Tensor-quark correlator; 35. Baryonic correlators; 36. Four-quark correlators; 37. Gluonia correlators; 38. Hybrid correlators; 39. Correlators in x-space; Part IX. QCD Non-Perturbative Methods: 40. Introduction; 41. Lattice gauge theory; 42. Chiral perturbation theory; 43. Models of the QCD effective action; 44. Heavy quark effective theory; 45. Potential approaches to quarkonia; 46. On monopole and confinement; Part X. QCD

QCD as a Theory of Hadrons

NASA Astrophysics Data System (ADS)

Narison, Stephan

2007-07-01

About Stephan Narison; Outline of the book; Preface; Acknowledgements; Part I. General Introduction: 1. A short flash on particle physics; 2. The pre-QCD era; 3. The QCD story; 4. Field theory ingredients; Part II. QCD Gauge Theory: 5. Lagrangian and gauge invariance; 6. Quantization using path integral; 7. QCD and its global invariance; Part III. MS scheme for QCD and QED: Introduction; 8. Dimensional regularization; 9. The MS renormalization scheme; 10. Renormalization of operators using the background field method; 11. The renormalization group; 12. Other renormalization schemes; 13. MS scheme for QED; 14. High-precision low-energy QED tests; Part IV. Deep Inelastic Scattering at Hadron Colliders: 15. OPE for deep inelastic scattering; 16. Unpolarized lepton-hadron scattering; 17. The Altarelli-Parisi equation; 18. More on unpolarized deep inelastic scatterings; 19. Polarized deep-inelastic processes; 20. Drell-Yan process; 21. One 'prompt photon' inclusive production; Part V. Hard Processes in e+e- Collisions: Introduction; 22. One hadron inclusive production; 23. gg scatterings and the 'spin' of the photon; 24. QCD jets; 25. Total inclusive hadron productions; Part VI. Summary of QCD Tests and as Measurements; Part VII. Power Corrections in QCD: 26. Introduction; 27. The SVZ expansion; 28. Technologies for evaluating Wilson coefficients; 29. Renormalons; 30. Beyond the SVZ expansion; Part VIII. QCD Two-Point Functions: 31. References guide to original works; 32. (Pseudo)scalar correlators; 33. (Axial-)vector two-point functions; 34. Tensor-quark correlator; 35. Baryonic correlators; 36. Four-quark correlators; 37. Gluonia correlators; 38. Hybrid correlators; 39. Correlators in x-space; Part IX. QCD Non-Perturbative Methods: 40. Introduction; 41. Lattice gauge theory; 42. Chiral perturbation theory; 43. Models of the QCD effective action; 44. Heavy quark effective theory; 45. Potential approaches to quarkonia; 46. On monopole and confinement; Part X. QCD

High energy hadrons in air shower cores at mountain altitude

DOE Office of Scientific and Technical Information (OSTI.GOV)

van Staa, R.; Aschenbach, B.; Boehm, E.

1974-01-01

At the Pic du Midi (730 g cm/sup -2/) in France an air shower array has been operated to study high-energy hadrons in air shower cores. The array consists of 13 scintillation counters of 0.25 mi each and a 14 mi high energy hadron detector. 2050 showers please delete the above abstract no 21733====

Energy reconstruction of hadrons in highly granular combined ECAL and HCAL systems

NASA Astrophysics Data System (ADS)

Israeli, Y.

2018-05-01

This paper discusses the hadronic energy reconstruction of two combined electromagnetic and hadronic calorimeter systems using physics prototypes of the CALICE collaboration: the silicon-tungsten electromagnetic calorimeter (Si-W ECAL) and the scintillator-SiPM based analog hadron calorimeter (AHCAL); and the scintillator-tungsten electromagnetic calorimeter (ScECAL) and the AHCAL. These systems were operated in hadron beams at CERN and FNAL, permitting the study of the performance in combined ECAL and HCAL systems. Two techniques for the energy reconstruction are used, a standard reconstruction based on calibrated sub-detector energy sums, and one based on a software compensation algorithm making use of the local energy density information provided by the high granularity of the detectors. The software compensation-based algorithm improves the hadronic energy resolution by up to 30% compared to the standard reconstruction. The combined system data show comparable energy resolutions to the one achieved for data with showers starting only in the AHCAL and therefore demonstrate the success of the inter-calibration of the different sub-systems, despite of their different geometries and different readout technologies.

Hadron Mass Effects: Kaons at HERMES vs. COMPASS

DOE Office of Scientific and Technical Information (OSTI.GOV)

Guerrero Teran, Juan V.; Accardi, Alberto

Experimental data for integrated kaon multiplicities taken at HERMES and COMPASS measurements look incompatible with each other. In this talk, we investigate the effects of hadron masses calculated at leading-order and leading twist at the kinematics of these two experiments. We present evidence that Hadron Mass Corrections can fully reconcile the data for the K+/K- multiplicity ratio, and can also sizeably reduce the apparent large discrepancy in the case of K++K- data. Residual differences in the shape of the latter one remains to be understood.

Spin, twist and hadron structure in deep inelastic processes

NASA Astrophysics Data System (ADS)

Jaffe, R. L.; Meyer, H.; Piller, G.

These notes provide an introduction to polarization effects in deep inelastic processes in QCD. We emphasize recent work on transverse asymmetries, subdominant effects, and the role of polarization in fragmentation and in purely hadronic processes. After a review of kinematics and some basic tools of short distance analysis, we study the twist, helicity, chirality and transversity dependence of a variety of high energy processes sensitive to the quark and gluon substructure of hadrons.

Cause-specific colostomy rates after radiotherapy for anal cancer: a Danish multicentre cohort study.

PubMed

Sunesen, Kåre G; Nørgaard, Mette; Lundby, Lilli; Havsteen, Hanne; Buntzen, Steen; Thorlacius-Ussing, Ole; Laurberg, Søren

2011-09-10

In anal cancer, colostomy-free survival is a measure of anal sphincter preservation after treatment with radiotherapy or chemoradiotherapy. Failure to control anal cancer and complications of treatment are alternative indications for colostomy. However, no data exist on cause-specific colostomy rates. We examined this in a cohort study. Through national registries and review of medical records, we identified patients with anal cancer diagnosed from 1995 to 2003 who had curative-intent radiotherapy or chemoradiotherapy in four Danish centers. We computed cumulative incidence of tumor-related colostomy and therapy-related colostomy, treating colostomy and death as competing events. Follow-up started at completion of radiotherapy and continued throughout 2008. We used competing risk regression to compute hazard ratios (HRs) to compare the cumulative incidence of cause-specific colostomies between age, sex, tumor size, chemotherapy, and local excision before radiotherapy. We included 235 patients with anal cancer. The 5-year cumulative incidences of tumor-related and therapy-related colostomy were 26% (95% CI, 21% to 32%) and 8% (95% CI, 5% to 12%), respectively. Tumor size greater than 6 cm versus less than 4 cm was a risk factor for tumor-related colostomy (adjusted HR, 3.8; 95% CI, 1.7 to 8.1), and local excision before radiotherapy was a risk factor for therapy-related colostomy (adjusted HR, 4.5; 95% CI, 1.5 to 13.5). After curative-intent radiotherapy or chemoradiotherapy, one third of patients had a colostomy, of which one third were related to therapy. Large tumor size was associated with a higher risk of tumor-related colostomy, whereas history of prior excision was associated with an increased incidence of therapy-related colostomy.

Long-term Outcomes and Quality of Life of 186 Patients With Primary Parotid Carcinoma Treated With Surgery and Radiotherapy at the Daniel den Hoed Cancer Center

DOE Office of Scientific and Technical Information (OSTI.GOV)

Al-Mamgani, Abrahim, E-mail: a.al-mamgani@erasmusmc.nl; Rooij, Peter van; Verduijn, Gerda M.

2012-09-01

Purpose: To assess the outcomes, toxicity, and quality of life (QOL) of patients with primary parotid carcinoma treated with surgery and postoperative radiotherapy at the Daniel den Hoed Cancer Center. Methods and Materials: Between 1995 and 2010, 186 patients with parotid carcinoma were treated with parotidectomy with or without neck dissection, followed by radiotherapy. Elective nodal irradiation (ENI) was applied to high-risk, node-negative disease. End points were locoregional control (LRC), disease-free survival (DFS), cause-specific survival (CSS), and overall survival (OS), late toxicity, and QOL. Results: After a median follow-up of 58 months (range, 4-172 months), the 5-year Kaplan-Meier estimates formore » LRC, DFS, CSS, and OS were 89%, 83%, 80%, and 68%, respectively. Forty-five events were reported: 24 distant metastases (DM) and 21 locoregional failures (LRF). Event-free survival rates by histological types were 89%, 78%, 76%, 74%, and 70% for acinic cell, mucoepidermoid, adenoid cystic, adenocarcinoma, and squamous cell carcinoma, respectively. More LRF were reported in patients with squamous cell and high-grade mucoepidermoid carcinoma (21% and 19%, respectively) than in patients with other histological types (p = 0.04) and more DM in patients with adenoid cystic and adenocarcinoma (20% and 19%, respectively) than in patients with other types (p = 0.03). None of the high-risk node-negative patients who received ENI developed regional failure. On multivariate analysis, T stage, N stage, grade, and presence of perineural invasion and facial paralysis correlated significantly with DFS. The 5-year cumulative incidence of grade {>=}2 late toxicity was 8%. QOL scores deteriorate during and shortly after treatment but returned in almost all scales to baseline scores within 6 months. Conclusions: Of the entire group, surgery and postoperative radiotherapy resulted in excellent outcomes with minimal side effects and preservation of good QOL scores. However

Melatonin prevents possible radiotherapy-induced thyroid injury.

PubMed

Arıcıgil, Mitat; Dündar, Mehmet Akif; Yücel, Abitter; Eryılmaz, Mehmet Akif; Aktan, Meryem; Alan, Mehmet Akif; Fındık, Sıdıka; Kılınç, İbrahim

2017-12-01

We aimed to investigate the protective effect of melatonin in radiotherapy-induced thyroid gland injury in an experimental rat model. Thirty-two rats were divided into four groups: the control group, melatonin treatment group, radiotherapy group and melatonin plus radiotherapy group. The neck region of each rat was defined by simulation and radiated with 2 Gray (Gy) per min with 6-MV photon beams, for a total dose of 18 Gy. Melatonin was administered at a dose of 50 mg/kg through intraperitoneal injection, 15 min prior to radiation exposure. Thirty days after the beginning of the study, rats were decapitated and analyses of blood and thyroid tissue were performed. Tumor necrosis factor-α (TNF-α), interleukin-1 beta (IL-1β), thiobarbituric acid reactive substances (TBARS) and nitric oxide (NO) levels in the radiotherapy group were significantly higher than those in the melatonin plus radiotherapy group (p < .05), whereas interleukin-10 (IL-10) and glutathione (GSH) values were higher in the melatonin plus radiotherapy group (p < .05). The infiltration of inflammatory cells and percentage of apoptosis in the radiotherapy group were significantly higher than those in the melatonin plus radiotherapy group (p < .05). Melatonin helped protect thyroid gland structure against the undesired cytotoxic effects of radiotherapy in rats.

Multibeam inverse intensity-modulated radiotherapy (IMRT) for whole breast irradiation: a single center experience in China.

PubMed

Yang, Zhaozhi; Zhang, Li; Chen, Xingxing; Ma, Jinli; Mei, Xin; Chen, Jiayi; Yu, Xiaoli; Guo, Xiaomao

2015-10-27

To present the clinical experience in our cancer center with multibeam inverse intensity-modulated radiotherapy (IMRT) for early stage breast cancer (BC) patients with whole breast irradiation (WBI). We retrospectively analyzed 622 patients with Stage 0 to III BC treated from 2008 to 2011 with wide local excision and WBI, using an inverse IMRT technique. All of the patients were prescribed a total dose of 50 Gy to the whole breast in 2-Gy fractions, followed by a tumor bed boost of 10 Gy in 5 fractions using an electron beam. Of all of the patients, 132 (21.2%) received whole breast plus regional lymph node (RLN) irradiation. 438 of 622 patients had records of acute skin toxicity based on common terminology criteria (CTC) for adverse events. Two hundred eighty (64%) patients had Grade 0/1 toxicity, 153 (35%) had Grade 2 and only 4 patients experienced grade 3 toxicity. Seventy patients (16%) had moist desquamation. Univariate analysis revealed that breast planning target volume was the only predictive factor for Grade ≥2 acute dermatitis (P = 0.002). After 4 years, 170 patients reported cosmetic results by self-assessment, of whom 151 (89%) patients reported good/excellent cosmetic results, and 17 (11%) patients reported fair assessments. For invasive cancer, the four-year rate of freedom from locoregional recurrence survival was 98.3%. Regarding carcinoma in situ, no patients experienced recurrence. BC patients who underwent conservative surgery followed by inverse IMRT plan exhibited acceptable acute toxicities and clinical outcomes. Longer follow-up is needed.

Examining Determinants of Radiotherapy Access: Do Cost and Radiotherapy Inconvenience Affect Uptake of Breast-conserving Treatment for Early Breast Cancer?

PubMed

Lam, J; Cook, T; Foster, S; Poon, R; Milross, C; Sundaresan, P

2015-08-01

Radiotherapy utilisation is likely affected by multiple factors pertaining to radiotherapy access. Radiotherapy is an integral component of breast-conserving treatment (BCT) for early breast cancer. We aimed to determine if stepwise improvements in radiotherapy access in regional Australia affected the uptake of BCT and thus radiotherapy. Breast cancer operations in the Central Coast of New South Wales between January 2010 and March 2014 for T1-2N0-1M0 invasive or in situ (≤5 cm) disease in female patients eligible for BCT were examined. BCT uptake was calculated for three 1 year periods: period 1 (local radiotherapy available at cost to user or out of area radiotherapy with travel cost and inconvenience); period 2 (as per period 1 + publicly funded transport and radiotherapy at out of area facilities at no cost to user); period 3 (as per period 1 + publicly funded local radiotherapy at no cost to user). In total, 574 cases met eligibility criteria. BCT declined with increasing distance to publicly funded radiotherapy (P = 0.035). BCT rates for periods 1, 2 and 3 were 63% (113/180), 61% (105/173) and 71% (156/221). There were no statistically significant differences in BCT between periods 1 and 2 in the whole cohort or within age, histology or tumour size subgroups. Overall, there was a 9% increase in BCT in the whole cohort in period 3 compared with periods 1 and 2 (P = 0.031). This increase was statistically significant for women over 70 years (19% increase, P = 0.034), for women with ductal carcinoma in situ (25% increase, P = 0.013) and for women with primary tumours that were ≤10 mm (21% increase, P = 0.016). Improving the affordability of radiotherapy through publicly funded transport and radiotherapy at out of area facilities did not improve BCT uptake in a region where radiotherapy was locally available, albeit at cost to the user. Improving both affordability and convenience through the provision of local publicly funded radiotherapy increased BCT

Effects of jet-induced medium excitation in γ-hadron correlation in A+A collisions

NASA Astrophysics Data System (ADS)

Chen, Wei; Cao, Shanshan; Luo, Tan; Pang, Long-Gang; Wang, Xin-Nian

2018-02-01

Coupled Linear Boltzmann Transport and hydrodynamics (CoLBT-hydro) is developed for co-current and event-by-event simulations of jet transport and jet-induced medium excitation (j.i.m.e.) in high-energy heavy-ion collisions. This is made possible by a GPU parallelized (3 + 1)D hydrodynamics that has a source term from the energy-momentum deposition by propagating jet shower partons and provides real time update of the bulk medium evolution for subsequent jet transport. Hadron spectra in γ-jet events of A+A collisions at RHIC and LHC are calculated for the first time that include hadrons from both the modified jet and j.i.m.e. CoLBT-hydro describes well experimental data at RHIC on the suppression of leading hadrons due to parton energy loss. It also predicts the enhancement of soft hadrons from j.i.m.e. The onset of soft hadron enhancement occurs at a constant transverse momentum due to the thermal nature of soft hadrons from j.i.m.e. which also have a significantly broadened azimuthal distribution relative to the jet direction. Soft hadrons in the γ direction are, on the other hand, depleted due to a diffusion wake behind the jet.

Effects of jet-induced medium excitation in γ-hadron correlation in A+A collisions

DOE PAGES

Chen, Wei; Cao, Shanshan; Luo, Tan; ...

2017-12-07

Coupled Linear Boltzmann Transport and hydrodynamics (CoLBT-hydro) is developed for co-current and event-by-event simulations of jet transport and jet-induced medium excitation (j.i.m.e.) in high-energy heavy-ion collisions. This is made possible by a GPU parallelized (3+1)D hydrodynamics that has a source term from the energy-momentum deposition by propagating jet shower partons and provides real time update of the bulk medium evolution for subsequent jet transport. Hadron spectra in γ-jet events of A+A collisions at RHIC and LHC are calculated for the first time that include hadrons from both the modified jet and j.i.m.e. CoLBT-hydro describes well experimental data at RHIC onmore » the suppression of leading hadrons due to parton energy loss. It also predicts the enhancement of soft hadrons from j.i.m.e. The onset of soft hadron enhancement occurs at a constant transverse momentum due to the thermal nature of soft hadrons from j.i.m.e. which also have a significantly broadened azimuthal distribution relative to the jet direction. Soft hadrons in the γ direction are, on the other hand, depleted due to a diffusion wake behind the jet.« less

Effects of jet-induced medium excitation in γ-hadron correlation in A+A collisions

DOE Office of Scientific and Technical Information (OSTI.GOV)

Chen, Wei; Cao, Shanshan; Luo, Tan

Coupled Linear Boltzmann Transport and hydrodynamics (CoLBT-hydro) is developed for co-current and event-by-event simulations of jet transport and jet-induced medium excitation (j.i.m.e.) in high-energy heavy-ion collisions. This is made possible by a GPU parallelized (3+1)D hydrodynamics that has a source term from the energy-momentum deposition by propagating jet shower partons and provides real time update of the bulk medium evolution for subsequent jet transport. Hadron spectra in γ-jet events of A+A collisions at RHIC and LHC are calculated for the first time that include hadrons from both the modified jet and j.i.m.e. CoLBT-hydro describes well experimental data at RHIC onmore » the suppression of leading hadrons due to parton energy loss. It also predicts the enhancement of soft hadrons from j.i.m.e. The onset of soft hadron enhancement occurs at a constant transverse momentum due to the thermal nature of soft hadrons from j.i.m.e. which also have a significantly broadened azimuthal distribution relative to the jet direction. Soft hadrons in the γ direction are, on the other hand, depleted due to a diffusion wake behind the jet.« less

Geant4 hadronic physics for space radiation environment.

PubMed

Ivantchenko, Anton V; Ivanchenko, Vladimir N; Molina, Jose-Manuel Quesada; Incerti, Sebastien L

2012-01-01

To test and to develop Geant4 (Geometry And Tracking version 4) Monte Carlo hadronic models with focus on applications in a space radiation environment. The Monte Carlo simulations have been performed using the Geant4 toolkit. Binary (BIC), its extension for incident light ions (BIC-ion) and Bertini (BERT) cascades were used as main Monte Carlo generators. For comparisons purposes, some other models were tested too. The hadronic testing suite has been used as a primary tool for model development and validation against experimental data. The Geant4 pre-compound (PRECO) and de-excitation (DEE) models were revised and improved. Proton, neutron, pion, and ion nuclear interactions were simulated with the recent version of Geant4 9.4 and were compared with experimental data from thin and thick target experiments. The Geant4 toolkit offers a large set of models allowing effective simulation of interactions of particles with matter. We have tested different Monte Carlo generators with our hadronic testing suite and accordingly we can propose an optimal configuration of Geant4 models for the simulation of the space radiation environment.

Three dimensional conformal radiotherapy for synchronous bilateral breast irradiation using a mono iso-center technique

NASA Astrophysics Data System (ADS)

Mani, Karthick Raj; Basu, Saumen; Bhuiyan, Md Anisuzzaman; Ahmed, Sharif; Sumon, Mostafa Aziz; Haque, Kh Anamul; Sengupta, Ashim Kumar; Un Nabi, Md Rashid; Das, K. J. Maria

2017-06-01

Objective: The purpose of this study is to demonstrate the synchronous bilateral breast irradiation radiotherapy technique using a single isocenter. Materials and Methods: Six patients of synchronous bilateral breast were treated with single isocenter technique from February 2011 to June 2016. All the patients underwent a CT-simulation using appropriate positioning device. Target volumes and critical structures like heart, lung, esophagus, thyroid, etc., were delineated slice by slice in the CT data. An isocenter was placed above the sternum on the skin and both medial tangential and lateral tangential of the breast / chest wall were created using asymmetrical jaws to avoid the beam divergence through the lung and heart. The field weighting were adjusted manually to obtain a homogenous dose distribution. The planning objectives were to deliver uniform doses around the target and keep the doses to the organ at risk within the permissible limit. The beam energy of 6 MV or combination of 6 MV and 15 MV photons were used in the tangential fields according to the tangential separation. Boluses were used for all the mastectomy patients to increase the doses on the chest wall. In addition to that enhanced dynamic wedge and field in field technique were also used to obtain a homogenous distribution around the target volume and reduce the hot spots. The isocenter was just kept on the skin, such that the beam junctions will be overlapped only on the air just above the sternum. Acute toxicity during the treatment and late toxicity were recorded during the patient's follow-up. Results: During the radiotherapy treatment follow-up there were no acute skin reactions in the field junctions, but one patient had grade 1 esophagitis and two patients had grade 2 skin reactions in the chest wall. With a median follow-up of 38.5 months (range: 8 - 49 months), no patients had a local recurrence, but one patients with triple negative disease had a distant metastases in brain and died

Masses of constituent quarks confined in open bottom hadrons

NASA Astrophysics Data System (ADS)

Borka Jovanović, V.; Borka, D.; Jovanović, P.; Milošević, J.; Ignjatović, S. R.

2014-12-01

We apply color-spin and flavor-spin quark-quark interactions to the meson and baryon constituent quarks, and calculate constituent quark masses, as well as the coupling constants of these interactions. The main goal of this paper was to determine constituent quark masses from light and open bottom hadron masses, using the fitting method we have developed and clustering of hadron groups. We use color-spin Fermi-Breit (FB) and flavor-spin Glozman-Riska (GR) hyperfine interaction (HFI) to determine constituent quark masses (especially b quark mass). Another aim was to discern between the FB and GR HFI because our previous findings had indicated that both interactions were satisfactory. Our improved fitting procedure of constituent quark masses showed that on average color-spin (FB) HFI yields better fits. The method also shows the way how the constituent quark masses and the strength of the interaction constants appear in different hadron environments.

Geant4 hadronic physics validation with ATLAS Tile Calorimeter test-beam data

DOE Office of Scientific and Technical Information (OSTI.GOV)

Alexa, C.; Constantinescu, S.; Dita, S.

We present comparison studies between Geant4 shower packages and ATLAS Tile Calorimeter test-beam data collected at CERN in H8 beam line at the SPS. Emphasis is put on hadronic physics lists and data concerning differences between Tilecal response to pions and protons of same energy. The ratio between the pure hadronic fraction of pion and the pure hadronic fraction of proton F{sub h}{sup {pi}}/F{sub h}{sup p} was estimated with Tilecal test-beam data and compared with Geant4 simulations.

Optimizing integrated luminosity of future hadron colliders

NASA Astrophysics Data System (ADS)

Benedikt, Michael; Schulte, Daniel; Zimmermann, Frank

2015-10-01

The integrated luminosity, a key figure of merit for any particle-physics collider, is closely linked to the peak luminosity and to the beam lifetime. The instantaneous peak luminosity of a collider is constrained by a number of boundary conditions, such as the available beam current, the maximum beam-beam tune shift with acceptable beam stability and reasonable luminosity lifetime (i.e., the empirical "beam-beam limit"), or the event pileup in the physics detectors. The beam lifetime at high-luminosity hadron colliders is largely determined by particle burn off in the collisions. In future highest-energy circular colliders synchrotron radiation provides a natural damping mechanism, which can be exploited for maximizing the integrated luminosity. In this article, we derive analytical expressions describing the optimized integrated luminosity, the corresponding optimum store length, and the time evolution of relevant beam parameters, without or with radiation damping, while respecting a fixed maximum value for the total beam-beam tune shift or for the event pileup in the detector. Our results are illustrated by examples for the proton-proton luminosity of the existing Large Hadron Collider (LHC) at its design parameters, of the High-Luminosity Large Hadron Collider (HL-LHC), and of the Future Circular Collider (FCC-hh).

Measurement of the bottom hadron lifetime at the Z 0 resonancce

DOE Office of Scientific and Technical Information (OSTI.GOV)

Fujino, Donald Hideo

1992-06-01

We have measured the bottom hadron lifetime from bmore » $$\\bar{b}$$ events produced at the Z 0 resonance. Using the precision vertex detectors of the Mark II detector at the Stanford Linear Collider, we developed an impact parameter tag to identify bottom hadrons. The vertex tracking system resolved impact parameters to 30 μm for high momentum tracks, and 70 μm for tracks with a momentum of 1 GeV. We selected B hadrons with an efficiency of 40% and a sample purity of 80%, by requiring there be at least two tracks in a single jet that significantly miss the Z 0 decay vertex. From a total of 208 hadronic Z 0 events collected by the Mark II detector in 1990, we tagged 53 jets, of which 22 came from 11 double-tagged events. The jets opposite the tagged ones, referred as the ``untagged`` sample, are rich in B hadrons and unbiased in B decay times. The variable Σδ is the sum of impact parameters from tracks in the jet, and contains vital information on the B decay time. We measured the B lifetime from a one-parameter likelihood fit to the untagged Σδ distribution, obtaining τ b = 1.53 $$+0.55\\atop{-0.45}$$ ± 0.16 ps which agrees with the current world average. The first error is statistical and the second is systematic. The systematic error was dominated by uncertainties in the track resolution function. As a check, we also obtained consistent results using the Σδ distribution from the tagged jets and from the entire hadronic sample without any bottom enrichment.« less

Color Confinement, Hadron Dynamics, and Hadron Spectroscopy from Light-Front Holography and Superconformal Algebra

DOE PAGES

Brodsky, Stanley J.

2018-01-01

Tmore » he QCD light-front Hamiltonian equation H L F Ψ = M 2 Ψ derived from quantization at fixed LF time τ = t     +     z / c provides a causal, frame-independent method for computing hadron spectroscopy as well as dynamical observables such as structure functions, transverse momentum distributions, and distribution amplitudes. he QCD Lagrangian with zero quark mass has no explicit mass scale. de Alfaro, Fubini, and Furlan (dAFF) have made an important observation that a mass scale can appear in the equations of motion without affecting the conformal invariance of the action if one adds a term to the Hamiltonian proportional to the dilatation operator or the special conformal operator. If one applies the dAFF procedure to the QCD light-front Hamiltonian, it leads to a color-confining potential κ 4 ζ 2 for mesons, where ζ 2 is the LF radial variable conjugate to the q q ¯ invariant mass squared. he same result, including spin terms, is obtained using light-front holography, the duality between light-front dynamics and A d S 5 , if one modifies the A d S 5 action by the dilaton e κ 2 z 2 in the fifth dimension z . When one generalizes this procedure using superconformal algebra, the resulting light-front eigensolutions provide a unified Regge spectroscopy of meson, baryon, and tetraquarks, including remarkable supersymmetric relations between the masses of mesons and baryons and a universal Regge slope. he pion q q ¯ eigenstate has zero mass at m q = 0 . he superconformal relations also can be extended to heavy-light quark mesons and baryons. his approach also leads to insights into the physics underlying hadronization at the amplitude level. I will also discuss the remarkable features of the Poincaré invariant, causal vacuum defined by light-front quantization and its impact on the interpretation of the cosmological constant. AdS/QCD also predicts the analytic form of the nonperturbative running coupling α s ( Q 2 ) ∝ e - Q 2 / 4 κ 2 . he

Color Confinement, Hadron Dynamics, and Hadron Spectroscopy from Light-Front Holography and Superconformal Algebra

DOE Office of Scientific and Technical Information (OSTI.GOV)

Brodsky, Stanley J.

Tmore » he QCD light-front Hamiltonian equation H L F Ψ = M 2 Ψ derived from quantization at fixed LF time τ = t     +     z / c provides a causal, frame-independent method for computing hadron spectroscopy as well as dynamical observables such as structure functions, transverse momentum distributions, and distribution amplitudes. he QCD Lagrangian with zero quark mass has no explicit mass scale. de Alfaro, Fubini, and Furlan (dAFF) have made an important observation that a mass scale can appear in the equations of motion without affecting the conformal invariance of the action if one adds a term to the Hamiltonian proportional to the dilatation operator or the special conformal operator. If one applies the dAFF procedure to the QCD light-front Hamiltonian, it leads to a color-confining potential κ 4 ζ 2 for mesons, where ζ 2 is the LF radial variable conjugate to the q q ¯ invariant mass squared. he same result, including spin terms, is obtained using light-front holography, the duality between light-front dynamics and A d S 5 , if one modifies the A d S 5 action by the dilaton e κ 2 z 2 in the fifth dimension z . When one generalizes this procedure using superconformal algebra, the resulting light-front eigensolutions provide a unified Regge spectroscopy of meson, baryon, and tetraquarks, including remarkable supersymmetric relations between the masses of mesons and baryons and a universal Regge slope. he pion q q ¯ eigenstate has zero mass at m q = 0 . he superconformal relations also can be extended to heavy-light quark mesons and baryons. his approach also leads to insights into the physics underlying hadronization at the amplitude level. I will also discuss the remarkable features of the Poincaré invariant, causal vacuum defined by light-front quantization and its impact on the interpretation of the cosmological constant. AdS/QCD also predicts the analytic form of the nonperturbative running coupling α s ( Q 2 ) ∝ e - Q 2 / 4 κ 2 . he

Constraining the hadronic spectrum through QCD thermodynamics on the lattice

NASA Astrophysics Data System (ADS)

Alba, Paolo; Bellwied, Rene; Borsányi, Szabolcs; Fodor, Zoltan; Günther, Jana; Katz, Sandor D.; Mantovani Sarti, Valentina; Noronha-Hostler, Jacquelyn; Parotto, Paolo; Pasztor, Attila; Vazquez, Israel Portillo; Ratti, Claudia

2017-08-01

Fluctuations of conserved charges allow us to study the chemical composition of hadronic matter. A comparison between lattice simulations and the hadron resonance gas (HRG) model suggested the existence of missing strange resonances. To clarify this issue we calculate the partial pressures of mesons and baryons with different strangeness quantum numbers using lattice simulations in the confined phase of QCD. In order to make this calculation feasible, we perform simulations at imaginary strangeness chemical potentials. We systematically study the effect of different hadronic spectra on thermodynamic observables in the HRG model and compare to lattice QCD results. We show that, for each hadronic sector, the well-established states are not enough in order to have agreement with the lattice results. Additional states, either listed in the Particle Data Group booklet (PDG) but not well established, or predicted by the quark model (QM), are necessary in order to reproduce the lattice data. For mesons, it appears that the PDG and the quark model do not list enough strange mesons, or that, in this sector, interactions beyond those included in the HRG model are needed to reproduce the lattice QCD results.

Study of hadron bundles observed in Chacaltaya two-story emulsion chamber

NASA Technical Reports Server (NTRS)

Aoki, H.

1985-01-01

The existence of hadron-rich families associated with few gamma-ray emission named Centauro and Mini-Centauro phemonena was reported. It was investigated whether these are produced by the special type of interaction different from the ordinary pion multiple production or not. The experimental results are compared with simulation calculation based on ordinary multiple pion production model. Both hadron multiplicity distribution, obtained from the present observation and the simulation calculation, show almost the same distribution which means that hadron bundles of such smaller multiplicities are considered to originate from successive interactions of surviving nucleon with the nature of multiple production during passage through the atmosphere.

Elliptic flow due to charged hadrons for Au+Au collisions at RHIC energy 62.4 GeV

DOE Office of Scientific and Technical Information (OSTI.GOV)

Kumar, Somani Ajit, E-mail: ajit.somani@gmail.com; Sudhir, Bhardwaj; Ashish, Agnihotri

Elliptic flow is an important observable in search of Quark Gluon Plasma. The elliptic flow parameter dependence on centrality due to charged hadrons were studied using events generated by event generator AMPT at center of mass energy of 62.4 GeV per nucleon pair for Au+Au collisions. This study performed for pseudorapidity range from −0.35 to 0.35 and transverse momentum bins p{sub t} = 0.2 to 1 GeV/c and 1 to 2 GeV/c. We compared the results obtained from simulated data and RHIC-PHENIX data.

The launch of the first UK charity devoted to radiotherapy: ACORRN -- Action Radiotherapy.

PubMed

Price, P

2011-01-01

The Academic Clinical Oncology and Radiobiology Research Network (ACORRN) was set up to support research and development in radiotherapy in the UK. This innovative networking initiative was launched initially by the National Cancer Research Institute in 2005 to harness the power of the radiation research base in the UK. Through an interactive website a co-ordinated network of multidisciplinary radiation researchers has been established. The network has developed to a stage where it can be self-funding and dedicated to improving radiotherapy for cancer. A patient interactive section and extended support for service development will ensure that anyone treated in the UK will have immediate access to the best knowledge in the country. This provides a solution for cost-effectiveness and future improvement of cancer care and is seen as a new model to support healthcare development and delivery. The charity ACORRN - Action Radiotherapy aims to support radiotherapy research and development and was launched in the House of Lords in July 2010.

Stereotactic radiosurgery versus stereotactic radiotherapy for patients with vestibular schwannoma: a Leksell Gamma Knife Society 2000 debate.

PubMed

Linskey, M E

2000-12-01

By definition, the term "radiosurgery" refers to the delivery of a therapeutic radiation dose in a single fraction, not simply the use of stereotaxy. Multiple-fraction delivery is better termed "stereotactic radiotherapy." There are compelling radiobiological principles supporting the biological superiority of single-fraction radiation for achieving an optimal therapeutic response for the slowly proliferating, late-responding, tissue of a schwannoma. It is axiomatic that complication avoidance requires precise three-dimensional conformality between treatment and tumor volumes. This degree of conformality can only be achieved through complex multiisocenter planning. Alternative radiosurgery devices are generally limited to delivering one to four isocenters in a single treatment session. Although they can reproduce dose plans similar in conformality to early gamma knife dose plans by using a similar number of isocenters, they cannot reproduce the conformality of modern gamma knife plans based on magnetic resonance image-targeted localization and five to 30 isocenters. A disturbing trend is developing in which institutions without nongamma knife radiosurgery (GKS) centers are championing and/or shifting to hypofractionated stereotactic radiotherapy for vestibular schwannomas. This trend appears to be driven by a desire to reduce complication rates to compete with modern GKS results by using complex multiisocenter planning. Aggressive advertising and marketing from some of these centers even paradoxically suggests biological superiority of hypofractionation approaches over single-dose radiosurgery for vestibular schwannomas. At the same time these centers continue to use the term radiosurgery to describe their hypofractionated radiotherapy approach in an apparent effort to benefit from a GKS "halo effect." It must be reemphasized that as neurosurgeons our primary duty is to achieve permanent tumor control for our patients and not to eliminate complications at the

Stereotactic radiosurgery versus stereotactic radiotherapy for patients with vestibular schwannoma: a Leksell Gamma Knife Society 2000 debate.

PubMed

Linskey, Mark E

2013-12-01

By definition, the term "radiosurgery" refers to the delivery of a therapeutic radiation dose in a single fraction, not simply the use of stereotaxy. Multiple-fraction delivery is better termed "stereotactic radiotherapy." There are compelling radiobiological principles supporting the biological superiority of single-fraction radiation for achieving an optimal therapeutic response for the slowly proliferating, late-responding, tissue of a schwannoma. It is axiomatic that complication avoidance requires precise three-dimensional conformality between treatment and tumor volumes. This degree of conformality can only be achieved through complex multiisocenter planning. Alternative radiosurgery devices are generally limited to delivering one to four isocenters in a single treatment session. Although they can reproduce dose plans similar in conformality to early gamma knife dose plans by using a similar number of isocenters, they cannot reproduce the conformality of modern gamma knife plans based on magnetic resonance image--targeted localization and five to 30 isocenters. A disturbing trend is developing in which institutions without nongamma knife radiosurgery (GKS) centers are championing and/or shifting to hypofractionated stereotactic radiotherapy for vestibular schwannomas. This trend appears to be driven by a desire to reduce complication rates to compete with modern GKS results by using complex multiisocenter planning. Aggressive advertising and marketing from some of these centers even paradoxically suggests biological superiority of hypofractionation approaches over single-dose radiosurgery for vestibular schwannomas. At the same time these centers continue to use the term radiosurgery to describe their hypofractionated radiotherapy approach in an apparent effort to benefit from a GKS "halo effect." It must be reemphasized that as neurosurgeons our primary duty is to achieve permanent tumor control for our patients and not to eliminate complications at the

New method to measure the attenuation of hadrons in extensive air showers

NASA Astrophysics Data System (ADS)

Apel, W. D.; Arteaga, J. C.; Badea, F.; Bekk, K.; Bertaina, M.; Blümer, J.; Bozdog, H.; Brancus, I. M.; Brüggemann, M.; Buchholz, P.; Cantoni, E.; Chiavassa, A.; Cossavella, F.; Daumiller, K.; de Souza, V.; di Pierro, F.; Doll, P.; Engel, R.; Engler, J.; Finger, M.; Fuhrmann, D.; Ghia, P. L.; Gils, H. J.; Glasstetter, R.; Grupen, C.; Haungs, A.; Heck, D.; Hildebrand, D.; Hörandel, J. R.; Huege, T.; Isar, P. G.; Kampert, K.-H.; Kang, D.; Kickelbick, D.; Klages, H. O.; Kolotaev, Y.; Łuczak, P.; Mathes, H. J.; Mayer, H. J.; Milke, J.; Mitrica, B.; Morello, C.; Navarra, G.; Nehls, S.; Oehlschläger, J.; Ostapchenko, S.; Over, S.; Petcu, M.; Pierog, T.; Rebel, H.; Roth, M.; Schieler, H.; Schröder, F.; Sima, O.; Stümpert, M.; Toma, G.; Trinchero, G. C.; Ulrich, H.; van Buren, J.; Walkowiak, W.; Weindl, A.; Wochele, J.; Wommer, M.; Zabierowski, J.

2009-07-01

Extensive air showers are generated through interactions of high-energy cosmic rays impinging the Earth’s atmosphere. A new method is described to infer the attenuation of hadrons in air showers. The numbers of electrons and muons, registered with the scintillator array of the KASCADE experiment, are used to estimate the energy of the shower inducing primary particle. A large hadron calorimeter is used to measure the hadronic energy reaching observation level. The ratio of energy reaching ground level to the energy of the primary particle is used to derive an attenuation length of hadrons in air showers. In the energy range from 106 to 3×107GeV the attenuation length obtained increases from 170 to 210g/cm2. The experimental results are compared to predictions of simulations based on contemporary high-energy interaction models.

DRoplet and hAdron generator for nuclear collisions: An update

NASA Astrophysics Data System (ADS)

Tomášik, Boris

2016-10-01

The Monte Carlo generator DRAGON simulates hadron production in ultrarelativistic nuclear collisions. The underlying theoretical description is provided by the blast-wave model. DRAGON includes second-order angular anisotropy in transverse shape and the amplitude of the transverse expansion velocity. It also allows to simulate hadron production from a fragmented fireball, e.g. as resulting from spinodal decomposition happening at the first-order phase transition.

Measurement of q ˆ in Relativistic Heavy Ion Collisions using di-hadron correlations

DOE PAGES

Tannenbaum, M. J.

2017-06-06

The propagation of partons from hard scattering through the Quark Gluon Plasma produced in A+A collisions at RHIC and the LHC is represented in theoretical analyses by the transport coefficientmore » $$\\hat{q}$$ and predicted to cause both energy loss of the outgoing partons, observed as suppression of particles or jets with large transverse momentum p T, and broadening of the azimuthal correlations of the outgoing di-jets or di-hadrons from the outgoing parton-pair, which has not been observed. The widths of azimuthal correlations of di-hadrons with the same trigger particle p Tt and associated p Ta transverse momenta in p+p and Au+Au are so-far statistically indistinguishable as shown in recent as well as older di-hadron measurements and also with jet-hadron and hadron-jet measurements. The azimuthal width of the di-hadron correlations in p+p collisions, beyond the fragmentation transverse momentum, j T, is dominated by k T, the so-called intrinsic transverse momentum of a parton in a nucleon, which can be measured. The broadening should produce a larger k T in A+A than in p+p collisions. The present work introduces the observation that the k T measured in p+p collisions for di-hadrons with p Tt and p Ta must be reduced to compensate for the energy loss of both the trigger and away parent partons when comparing to the k T measured with the same di-hadron p Tt and p Ta in Au+Au collisions. This idea is applied to a recent STAR di-hadron measurement, with result <$$\\hat{q}$$L>=2.1±0.6 GeV 2. This is more precise but in agreement with a theoretical calculation of <$$\\hat{q}$$L>=14$$+42\\atop{-14}$$ GeV 2 using the same data. Assuming a length ≈7 fm for central Au+Au collisions the present result gives $$\\hat{q}$$≈0.30±0.09 GeV 2/fm, in fair agreement with the JET collaboration result from single hadron suppression of $$\\hat{q}$$≈1.2±0.3 GeV 2/fm at an initial time τ 0=0.6 fm/c in Au+Au collisions at √sNN=200 GeV.« less

Measurement of q ˆ in Relativistic Heavy Ion Collisions using di-hadron correlations

DOE Office of Scientific and Technical Information (OSTI.GOV)

Tannenbaum, M. J.

The propagation of partons from hard scattering through the Quark Gluon Plasma produced in A+A collisions at RHIC and the LHC is represented in theoretical analyses by the transport coefficientmore » $$\\hat{q}$$ and predicted to cause both energy loss of the outgoing partons, observed as suppression of particles or jets with large transverse momentum p T, and broadening of the azimuthal correlations of the outgoing di-jets or di-hadrons from the outgoing parton-pair, which has not been observed. The widths of azimuthal correlations of di-hadrons with the same trigger particle p Tt and associated p Ta transverse momenta in p+p and Au+Au are so-far statistically indistinguishable as shown in recent as well as older di-hadron measurements and also with jet-hadron and hadron-jet measurements. The azimuthal width of the di-hadron correlations in p+p collisions, beyond the fragmentation transverse momentum, j T, is dominated by k T, the so-called intrinsic transverse momentum of a parton in a nucleon, which can be measured. The broadening should produce a larger k T in A+A than in p+p collisions. The present work introduces the observation that the k T measured in p+p collisions for di-hadrons with p Tt and p Ta must be reduced to compensate for the energy loss of both the trigger and away parent partons when comparing to the k T measured with the same di-hadron p Tt and p Ta in Au+Au collisions. This idea is applied to a recent STAR di-hadron measurement, with result <$$\\hat{q}$$L>=2.1±0.6 GeV 2. This is more precise but in agreement with a theoretical calculation of <$$\\hat{q}$$L>=14$$+42\\atop{-14}$$ GeV 2 using the same data. Assuming a length ≈7 fm for central Au+Au collisions the present result gives $$\\hat{q}$$≈0.30±0.09 GeV 2/fm, in fair agreement with the JET collaboration result from single hadron suppression of $$\\hat{q}$$≈1.2±0.3 GeV 2/fm at an initial time τ 0=0.6 fm/c in Au+Au collisions at √sNN=200 GeV.« less

Material Activation Benchmark Experiments at the NuMI Hadron Absorber Hall in Fermilab

NASA Astrophysics Data System (ADS)

Matsumura, H.; Matsuda, N.; Kasugai, Y.; Toyoda, A.; Yashima, H.; Sekimoto, S.; Iwase, H.; Oishi, K.; Sakamoto, Y.; Nakashima, H.; Leveling, A.; Boehnlein, D.; Lauten, G.; Mokhov, N.; Vaziri, K.

2014-06-01

In our previous study, double and mirror symmetric activation peaks found for Al and Au arranged spatially on the back of the Hadron absorber of the NuMI beamline in Fermilab were considerably higher than those expected purely from muon-induced reactions. From material activation bench-mark experiments, we conclude that this activation is due to hadrons with energy greater than 3 GeV that had passed downstream through small gaps in the hadron absorber.

Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy.

PubMed

Chronowski, G M; Ha, C S; Wilder, R B; Cabanillas, F; Manning, J; Cox, J D

2001-08-01

Although surgery is considered standard therapy for unicentric Castleman disease, favorable responses to radiotherapy also have been documented. The authors undertook this study to analyze the clinical factors, treatment approaches, and outcomes of patients with unicentric or multicentric Castleman disease, and to report the outcomes of patients with unicentric Castleman disease treated with radiotherapy. The authors reviewed the medical records of 22 patients who had received a histologic diagnosis of Castleman disease at the University of Texas M. D. Anderson Cancer Center between 1988 and 1999. One patient with a concurrent histopathologic diagnosis of nonsecretory multiple myeloma was excluded from the study. In all patients, the diagnosis of Castleman disease was based on the results of lymph node biopsies. Disease was categorized as being either unicentric or multicentric and further subdivided into hyaline vascular, plasma cell, or mixed variant histologic types. Clinical variables and outcomes were analyzed according to treatment, which consisted of surgery, chemotherapy, or radiotherapy. Records from 21 patients were analyzed: 12 had unicentric disease, and 9 had multicentric disease. The mean follow-up time for the entire series was 51 months (median, 40 months). Four patients with unicentric disease were treated with radiotherapy alone: 2 remain alive and symptom free, 2 died of causes unrelated to Castleman disease and had no evidence of disease at last follow-up. Eight patients with unicentric disease were treated with complete or partial surgical resection, and all are alive and asymptomatic. All nine patients with multicentric disease were treated with combination chemotherapy: five are alive with no evidence of disease, and four are alive with progressive disease. Surgery results in excellent rates of cure in patients with unicentric Castleman disease; radiotherapy can also achieve clinical response and cure in selected patients. Multicentric

Status of hadron therapy in Europe and the role of ENLIGHT

NASA Astrophysics Data System (ADS)

Dosanjh, Manjit; Hoffmann, Hans Falk; Magrin, Giulio

2007-02-01

Cancer is a major social problem, and it is the main cause of death between the ages 45-65 years. In the treatment of cancer, radio therapy (RT) plays an essential role. RT with hadrons (protons and light ions), due to their unique physical and radiobiological properties, offers several advantages over photons. In particular, they penetrate the patient with minimal diffusion, they deposit maximum energy at the end of their range, and they can be shaped as narrow focused and scanned pencil beams of variable penetration depth. Hadron beams allow highly conformal treatment (where the beam conforms to the shape of the tumour) of deep-seated tumours with great accuracy, while delivering minimal doses to surrounding tissues. Hadron therapy, thus, has great prospects for being used in early stages of tumour disease not amenable to surgery. It is likely that, besides its more impressive effect on radio-resistant tumours, post-treatment morbidity will be lower in patients treated with hadrons due to the lower dose and toxicity to normal tissues. Visionary physicist and founder of Fermilab, Robert Wilson first proposed the use of hadrons for cancer treatment in 1946. This idea was first put into practise at the Lawrence Berkeley Laboratory (LBL) where 30 patients were treated with protons between 1954 and 1957. Since then the total number of patients treated with hadrons in the world now exceeds 50,000, of which 5000 new patients were treated last year. Several dedicated hospital-based centres with significant capacity for treating patients are now taking the place of the first R&D facilities hosted by the Physics Research Laboratories (e.g. LBL, GSI). Europe is playing a key role in the advancement of light ion therapy facilities with five financed centres using actively scanned carbon ions (of which two are already under construction in Heidelberg and Pavia) and several proton therapy centres which will become operational soon. In the US, three proton therapy centres are

Expanding global access to radiotherapy.

PubMed

Atun, Rifat; Jaffray, David A; Barton, Michael B; Bray, Freddie; Baumann, Michael; Vikram, Bhadrasain; Hanna, Timothy P; Knaul, Felicia M; Lievens, Yolande; Lui, Tracey Y M; Milosevic, Michael; O'Sullivan, Brian; Rodin, Danielle L; Rosenblatt, Eduardo; Van Dyk, Jacob; Yap, Mei Ling; Zubizarreta, Eduardo; Gospodarowicz, Mary

2015-09-01

Radiotherapy is a critical and inseparable component of comprehensive cancer treatment and care. For many of the most common cancers in low-income and middle-income countries, radiotherapy is essential for effective treatment. In high-income countries, radiotherapy is used in more than half of all cases of cancer to cure localised disease, palliate symptoms, and control disease in incurable cancers. Yet, in planning and building treatment capacity for cancer, radiotherapy is frequently the last resource to be considered. Consequently, worldwide access to radiotherapy is unacceptably low. We present a new body of evidence that quantifies the worldwide coverage of radiotherapy services by country. We show the shortfall in access to radiotherapy by country and globally for 2015-35 based on current and projected need, and show substantial health and economic benefits to investing in radiotherapy. The cost of scaling up radiotherapy in the nominal model in 2015-35 is US$26·6 billion in low-income countries, $62·6 billion in lower-middle-income countries, and $94·8 billion in upper-middle-income countries, which amounts to $184·0 billion across all low-income and middle-income countries. In the efficiency model the costs were lower: $14·1 billion in low-income, $33·3 billion in lower-middle-income, and $49·4 billion in upper-middle-income countries-a total of $96·8 billion. Scale-up of radiotherapy capacity in 2015-35 from current levels could lead to saving of 26·9 million life-years in low-income and middle-income countries over the lifetime of the patients who received treatment. The economic benefits of investment in radiotherapy are very substantial. Using the nominal cost model could produce a net benefit of $278·1 billion in 2015-35 ($265·2 million in low-income countries, $38·5 billion in lower-middle-income countries, and $239·3 billion in upper-middle-income countries). Investment in the efficiency model would produce in the same period an even

Physics and Analysis at a Hadron Collider - An Introduction (1/3)

ScienceCinema

None

2018-05-11

This is the first lecture of three which together discuss the physics of hadron colliders with an emphasis on experimental techniques used for data analysis. This first lecture provides a brief introduction to hadron collider physics and collider detector experiments as well as offers some analysis guidelines. The lectures are aimed at graduate students.

Identification and energy calibration of hadronically decaying tau leptons with the ATLAS experiment in pp collisions at $$\\sqrt{s}=8$$ $$\\,\\hbox {TeV}$$ TeV

DOE PAGES

Aad, G.; Abbott, B.; Abdallah, J.; ...

2015-07-02

This study describes the trigger and offline reconstruction, identification and energy calibration algorithms for hadronic decays of tau leptons employed for the data collected from pp collisions in 2012 with the ATLAS detector at the LHC center-of-mass energy √s=8 TeV. The performance of these algorithms is measured in most cases with Z decays to tau leptons using the full 2012 dataset, corresponding to an integrated luminosity of 20.3 fb –1. An uncertainty on the offline reconstructed tau energy scale of 2–4%, depending on transverse energy and pseudorapidity, is achieved using two independent methods. The offline tau identification efficiency is measuredmore » with a precision of 2.5% for hadronically decaying tau leptons with one associated track, and of 4% for the case of three associated tracks, inclusive in pseudorapidity and for a visible transverse energy greater than 20 GeV. For hadronic tau lepton decays selected by offline algorithms, the tau trigger identification efficiency is measured with a precision of 2–8%, depending on the transverse energy. The performance of the tau algorithms, both offline and at the trigger level, is found to be stable with respect to the number of concurrent proton–proton interactions and has supported a variety of physics results using hadronically decaying tau leptons at ATLAS.« less

Gluon and Wilson loop TMDs for hadrons of spin ≤ 1

NASA Astrophysics Data System (ADS)

Boer, Daniël; Cotogno, Sabrina; van Daal, Tom; Mulders, Piet J.; Signori, Andrea; Zhou, Ya-Jin

2016-10-01

In this paper we consider the parametrizations of gluon transverse momentum dependent (TMD) correlators in terms of TMD parton distribution functions (PDFs). These functions, referred to as TMDs, are defined as the Fourier transforms of hadronic matrix elements of nonlocal combinations of gluon fields. The nonlocality is bridged by gauge links, which have characteristic paths (future or past pointing), giving rise to a process dependence that breaks universality. For gluons, the specific correlator with one future and one past pointing gauge link is, in the limit of small x, related to a correlator of a single Wilson loop. We present the parametrization of Wilson loop correlators in terms of Wilson loop TMDs and discuss the relation between these functions and the small- x `dipole' gluon TMDs. This analysis shows which gluon TMDs are leading or suppressed in the small- x limit. We discuss hadronic targets that are unpolarized, vector polarized (relevant for spin-1 /2 and spin-1 hadrons), and tensor polarized (relevant for spin-1 hadrons). The latter are of interest for studies with a future Electron-Ion Collider with polarized deuterons.

Comparison of Clinical Outcomes of Surgery Followed by Local Brain Radiotherapy and Surgery Followed by Whole Brain Radiotherapy in Patients With Single Brain Metastasis: Single-Center Retrospective Analysis

DOE Office of Scientific and Technical Information (OSTI.GOV)

Hashimoto, Kenji; Narita, Yoshitaka, E-mail: yonarita@ncc.go.jp; Miyakita, Yasuji

2011-11-15

Purpose: Data comparing the clinical outcomes of local brain radiotherapy (LBRT) and whole brain RT (WBRT) in patients with a single brain metastasis after tumor removal are limited. Patients and Methods: A retrospective analysis was performed to compare the patterns of treatment failure, cause of death, progression-free survival, median survival time, and Karnofsky performance status for long-term survivors among patients who underwent surgery followed by either LBRT or WBRT between 1990 and 2008 at the National Cancer Center Hospital. Results: A total of 130 consecutive patients were identified. The median progression-free survival period among the patients who received postoperative LBRTmore » (n = 64) and WBRT (n = 66) was 9.7 and 11.5 months, respectively (p = .75). The local recurrence rates (LBRT, 9.4% vs. WBRT, 12.1%) and intracranial new metastasis rate (LBRT, 42.2% vs. WBRT, 33.3%) were similar in each arm. The incidence of leptomeningeal metastasis was also equivalent (LBRT, 9.4% vs. WBRT, 10.6%). The median survival time for the LBRT and WBRT patients was 13.9 and 16.7 months, respectively (p = .88). A neurologic cause of death was noted in 35.6% of the patients in the LBRT group and 36.7% of the WBRT group (p = .99). The Karnofsky performance status at 2 years was comparable between the two groups. Conclusions: The clinical outcomes of LBRT and WBRT were similar. A prospective evaluation is warranted.« less

Hadron interactions and exotic hadrons from lattice QCD

NASA Astrophysics Data System (ADS)

Ikeda, Yoichi

2014-09-01

One of the interesting subjects in hadron physics is to look for the multiquark configurations. One of candidates is the H-dibaryon (udsuds), and the possibility of the bound H-dibaryon has been recently studied from lattice QCD. We also extend the HAL QCD method to define potentials on the lattice between baryons to meson-meson systems including charm quarks to search for the bound tetraquark Tcc (ud c c) and Tcs (ud c s). In the presentation, after reviewing the HAL QCD method, we report the results on the H-dibaryon, the tetraquark Tcc (ud c c) and Tcs (ud c s), where we have employed the relativistic heavy quark action to treat the charm quark dynamics with pion masses, mπ = 410, 570, 700 MeV.

Hadronic and nuclear interactions in QCD

DOE Office of Scientific and Technical Information (OSTI.GOV)

Not Available

Despite the evidence that QCD - or something close to it - gives a correct description of the structure of hadrons and their interactions, it seems paradoxical that the theory has thus far had very little impact in nuclear physics. One reason for this is that the application of QCD to distances larger than 1 fm involves coherent, non-perturbative dynamics which is beyond present calculational techniques. For example, in QCD the nuclear force can evidently be ascribed to quark interchange and gluon exchange processes. These, however, are as complicated to analyze from a fundamental point of view as is themore » analogous covalent bond in molecular physics. Since a detailed description of quark-quark interactions and the structure of hadronic wavefunctions is not yet well-understood in QCD, it is evident that a quantitative first-principle description of the nuclear force will require a great deal of theoretical effort. Another reason for the limited impact of QCD in nuclear physics has been the conventional assumption that nuclear interactions can for the most part be analyzed in terms of an effective meson-nucleon field theory or potential model in isolation from the details of short distance quark and gluon structure of hadrons. These lectures, argue that this view is untenable: in fact, there is no correspondence principle which yields traditional nuclear physics as a rigorous large-distance or non-relativistic limit of QCD dynamics. On the other hand, the distinctions between standard nuclear physics dynamics and QCD at nuclear dimensions are extremely interesting and illuminating for both particle and nuclear physics.« less

Radiotherapy for gastric lymphoma: a planning study of 3D conformal radiotherapy, the half-beam method, and intensity-modulated radiotherapy.

PubMed

Inaba, Koji; Okamoto, Hiroyuki; Wakita, Akihisa; Nakamura, Satoshi; Kobayashi, Kazuma; Harada, Ken; Kitaguchi, Mayuka; Sekii, Shuhei; Takahashi, Kana; Yoshio, Kotaro; Murakami, Naoya; Morota, Madoka; Ito, Yoshinori; Sumi, Minako; Uno, Takashi; Itami, Jun

2014-11-01

During radiotherapy for gastric lymphoma, it is difficult to protect the liver and kidneys in cases where there is considerable overlap between these organs and the target volume. This study was conducted to compare the three radiotherapy planning techniques of four-fields 3D conformal radiotherapy (3DCRT), half-field radiotherapy (the half-beam method) and intensity-modulated radiotherapy (IMRT) used to treat primary gastric lymphoma in which the planning target volume (PTV) had a large overlap with the left kidney. A total of 17 patients with gastric diffuse large B-cell lymphoma (DLBCL) were included. In DLBCL, immunochemotherapy (Rituximab + CHOP) was followed by radiotherapy of 40 Gy to the whole stomach and peri-gastric lymph nodes. 3DCRT, the half-field method, and IMRT were compared with respect to the dose-volume histogram (DVH) parameters and generalized equivalent uniform dose (gEUD) to the kidneys, liver and PTV. The mean dose and gEUD for 3DCRT was higher than for IMRT and the half-beam method in the left kidney and both kidneys. The mean dose and gEUD of the left kidney was 2117 cGy and 2224 cGy for 3DCRT, 1520 cGy and 1637 cGy for IMRT, and 1100 cGy and 1357 cGy for the half-beam method, respectively. The mean dose and gEUD of both kidneys was 1335 cGy and 1559 cGy for 3DCRT, 1184 cGy and 1311 cGy for IMRT, and 700 cGy and 937 cGy for the half-beam method, respectively. Dose-volume histograms (DVHs) of the liver revealed a larger volume was irradiated in the dose range <25 Gy with 3DCRT, while the half-beam method irradiated a larger volume of liver with the higher dose range (>25 Gy). IMRT and the half-beam method had the advantages of dose reduction for the kidneys and liver. © The Author 2014. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Radiation Oncology.

Finite size of hadrons and Bose-Einstein correlations

NASA Astrophysics Data System (ADS)

Bialas, A.; Zalewski, K.

2013-11-01

It is observed that the finite size of hadrons produced in high energy collisions implies that their positions are correlated, since the probability to find two hadrons on top of each other is highly reduced. It is then shown that this effect can naturally explain the values of the correlation function below one, observed at LEP and LHC for pairs of identical pions. to emphasize the role of inter-hadron correlations in the explanation of the observed negative values of C(p1,p2)-1 and to point out that a natural source of such inter-hadron correlations can be provided by the finite sizes of the produced hadrons. Several comments are in order.(i) Our use of the Θ-function to parametrize the excluded volume correlations is clearly only a crude approximation. For a precise description of data almost certainly a more sophisticated parametrization of the effect will be needed. In particular, note that with our parametrization the correlation in space-time does not affect the single-particle and two-particle non-symmetrized momentum distributions. The same comment applies to our use of Gaussians.(ii) It has been recently found [6,7] that in pp collisions at LHC, the volume of the system (as determined from the fitted HBT parameters) depends weakly on the multiplicity of the particles produced in the collision. This suggests that large multiplicity in an event is due to a longer emission time. If true, this should be also reflected in the HBT measurements and it may be interesting to investigate this aspect of the problem in more detail.(iii) To investigate further the space and/or time correlations between the emitted particles more information is needed. It would be interesting to study the minima in the correlation functions separately for the “side”, “out” and “long” directions. Such studies may allow to determine the size of the “excluded volume” and compare it with other estimates [14,15]. We also feel that with the present accuracy and statistics of

Identification techniques for highly boosted W bosons that decay into hadrons

DOE PAGES

Khachatryan, Vardan

2014-12-02

In searches for new physics in the energy regime of the LHC, it is becoming increasingly important to distinguish single-jet objects that originate from the merging of the decay products of W bosons produced with high transverse momenta from jets initiated by single partons. Algorithms are defined to identify such W jets for different signals of interest, using techniques that are also applicable to other decays of bosons to hadrons that result in a single jet, such as those from highly boosted Z and Higgs bosons. The efficiency for tagging W jets is measured in data collected with the CMSmore » detector at a center-of-mass energy of 8 TeV, corresponding to an integrated luminosity of 19.7 fb -1. The performance of W tagging in data is compared with predictions from several Monte Carlo simulators.« less

Hadronic vs. electromagnetic pulse shape discrimination in CsI(Tl) for high energy physics experiments

NASA Astrophysics Data System (ADS)

Longo, S.; Roney, J. M.

2018-03-01

Pulse shape discrimination using CsI(Tl) scintillators to perform neutral hadron particle identification is explored with emphasis towards application at high energy electron-positron collider experiments. Through the analysis of the pulse shape differences between scintillation pulses from photon and hadronic energy deposits using neutron and proton data collected at TRIUMF, it is shown that the pulse shape variations observed for hadrons can be modelled using a third scintillation component for CsI(Tl), in addition to the standard fast and slow components. Techniques for computing the hadronic pulse amplitudes and shape variations are developed and it is shown that the intensity of the additional scintillation component can be computed from the ionization energy loss of the interacting particles. These pulse modelling and simulation methods are integrated with GEANT4 simulation libraries and the predicted pulse shape for CsI(Tl) crystals in a 5 × 5 array of 5 × 5 × 30 cm3 crystals is studied for hadronic showers from 0.5 and 1 GeV/c KL0 and neutron particles. Using a crystal level and cluster level approach for photon vs. hadron cluster separation we demonstrate proof-of-concept for neutral hadron detection using CsI(Tl) pulse shape discrimination in high energy electron-positron collider experiments.

Retrospective evaluation of the effectiveness of radiotherapy in patients with plantar fascitis (heel spurs).

PubMed

Kędzierawski, Piotr; Stando, Rafał; Macek, Paweł

2017-01-01

The aim of the study was the evaluation of the effectiveness of radiotherapy in patients with the feet pain caused by heel spurs. Treatment options for patients reporting these symptoms include use of suitable orthopedic footwear, the use of general or topical non-steroidal anti-inflammatory drugs or steroids, physiotherapy, manual therapy, shock wave or appropriate surgical procedures. Radiotherapy is one of the method used in patients with chronic pain syndrome. The material consisted of 47 patients treated in Radiotherapy Department at the Holycross Cancer Center. The time of follow-up ranged from 1 to 129 months. After treatment patients were observed. During the first follow-up visit a complete relief of symptoms was observed in 37 patients, and the pain was felt by 10 patients for 4 months after the treatment. One patient was re-irradiated 6 months after treatment because of persistent pain. At 16 and 17 months after the onset of treatment, pain was reported by two patients. These patients were re-irradiated. One patient had recurrence of pain 48 months after completion of radiation. After the second irradiation the pain was relieved. The remaining patients, with the exception of two, experienced remission of pain, which has been documented. Tolerance of the treatment was very good. No complications of radiation were observed. Radiotherapy remains an attractive treatment for patients with inflammation of the heel fascia.

Cardiac Side-effects From Breast Cancer Radiotherapy.

PubMed

Taylor, C W; Kirby, A M

2015-11-01

Breast cancer radiotherapy reduces the risk of cancer recurrence and death. However, it usually involves some radiation exposure of the heart and analyses of randomised trials have shown that it can increase the risk of heart disease. Estimates of the absolute risks of radiation-related heart disease are needed to help oncologists plan each individual woman's treatment. The risk for an individual woman varies according to her estimated cardiac radiation dose and her background risk of ischaemic heart disease in the absence of radiotherapy. When it is known, this risk can then be compared with the absolute benefit of the radiotherapy. At present, many UK cancer centres are already giving radiotherapy with mean heart doses of less than 3 Gy and for most women the benefits of the radiotherapy will probably far outweigh the risks. Technical approaches to minimising heart dose in breast cancer radiotherapy include optimisation of beam angles, use of multileaf collimator shielding, intensity-modulated radiotherapy, treatment in a prone position, treatment in deep inspiration (including the use of breath-hold and gating techniques), proton therapy and partial breast irradiation. The multileaf collimator is suitable for many women with upper pole left breast cancers, but for women with central or lower pole cancers, breath-holding techniques are now recommended in national UK guidelines. Ongoing work aims to identify ways of irradiating pan-regional lymph nodes that are effective, involve minimal exposure of organs at risk and are feasible to plan, deliver and verify. These will probably include wide tangent-based field-in-field intensity-modulated radiotherapy or arc radiotherapy techniques in combination with deep inspiratory breath-hold, and proton beam irradiation for women who have a high predicted heart dose from intensity-modulated radiotherapy. Copyright © 2015 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

New techniques for assessing response after hypofractionated radiotherapy for lung cancer

PubMed Central

Mattonen, Sarah A.; Huang, Kitty; Ward, Aaron D.; Senan, Suresh

2014-01-01

Hypofractionated radiotherapy (HFRT) is an effective and increasingly-used treatment for early stage non-small cell lung cancer (NSCLC). Stereotactic ablative radiotherapy (SABR) is a form of HFRT and delivers biologically effective doses (BEDs) in excess of 100 Gy10 in 3-8 fractions. Excellent long-term outcomes have been reported; however, response assessment following SABR is complicated as radiation induced lung injury can appear similar to a recurring tumor on CT. Current approaches to scoring treatment responses include Response Evaluation Criteria in Solid Tumors (RECIST) and positron emission tomography (PET), both of which appear to have a limited role in detecting recurrences following SABR. Novel approaches to assess response are required, but new techniques should be easily standardized across centers, cost effective, with sensitivity and specificity that improves on current CT and PET approaches. This review examines potential novel approaches, focusing on the emerging field of quantitative image feature analysis, to distinguish recurrence from fibrosis after SABR. PMID:24688782

Hadron mass corrections in semi-inclusive deep-inelastic scattering

DOE PAGES

Guerrero Teran, Juan Vicente; Ethier, James J.; Accardi, Alberto; ...

2015-09-24

We found that the spin-dependent cross sections for semi-inclusive lepton-nucleon scattering are derived in the framework of collinear factorization, including the effects of masses of the target and produced hadron at finite Q 2. At leading order the cross sections factorize into products of parton distribution and fragmentation functions evaluated in terms of new, mass-dependent scaling variables. Furthermore, the size of the hadron mass corrections is estimated at kinematics relevant for current and future experiments, and the implications for the extraction of parton distributions from semi-inclusive measurements are discussed.

A measurement of the hadronic branching ratio of the W boson to charm and strange quarks using strange hadrons in the final stage

NASA Astrophysics Data System (ADS)

Dallison, Stephen

A measurement has been made of the partial branching ratio, Rcs, of the W boson into a pair of jets originating from charmed (c) and strange (s) quarks. This was achieved by identifying final state hadrons among the decay products. Events generated using Monte Carlo simulations were used to construct multiplicity distributions for events where the W decays to cs quarks and events where the W decays to non-cs quarks. This was done by counting individually the numbers of K+/-, Ks0 and A candidates in each type of decay. These distributions were used as reference histograms and compared to multiplicity distributions for all hadronic events obtained using OPAL data taken from 1998 to 2000. The information derived from these distributions was used to extract a value of Values of Rcs were measured separately for charged kaons (K+/-), and neutral hadrons (Ks0 + Lambda). The charged kaon analysis was performed twice, once using an artificial neural network and again using a standard cut-based method. The values for the charged kaon and neutral hadron analyses were combined and weighted according to their overall errors. The final value for Rcs was found to be 0.499 +/- 0.060, Where the error represents a combination of the statistical and systematic uncertainties. The measured value of Rcs was used to determine a value for the CKM matrix element |Vcs|. This value was found to be |Vcs| = 0.999 +/- 0.060.

Probing leptophilic dark sectors with hadronic processes

NASA Astrophysics Data System (ADS)

D'Eramo, Francesco; Kavanagh, Bradley J.; Panci, Paolo

2017-08-01

We study vector portal dark matter models where the mediator couples only to leptons. In spite of the lack of tree-level couplings to colored states, radiative effects generate interactions with quark fields that could give rise to a signal in current and future experiments. We identify such experimental signatures: scattering of nuclei in dark matter direct detection; resonant production of lepton-antilepton pairs at the Large Hadron Collider; and hadronic final states in dark matter indirect searches. Furthermore, radiative effects also generate an irreducible mass mixing between the vector mediator and the Z boson, severely bounded by ElectroWeak Precision Tests. We use current experimental results to put bounds on this class of models, accounting for both radiatively induced and tree-level processes. Remarkably, the former often overwhelm the latter.

Superconformal Algebraic Approach to Hadron Structure

DOE Office of Scientific and Technical Information (OSTI.GOV)

de Teramond, Guy F.; Brodsky, Stanley J.; Deur, Alexandre

2017-03-01

Fundamental aspects of nonperturbative QCD dynamics which are not obvious from its classical Lagrangian, such as the emergence of a mass scale and confinement, the existence of a zero mass bound state, the appearance of universal Regge trajectories and the breaking of chiral symmetry are incorporated from the onset in an effective theory based on superconformal quantum mechanics and its embedding in a higher dimensional gravitational theory. In addition, superconformal quantum mechanics gives remarkable connections between the light meson and nucleon spectra. This new approach to hadron physics is also suitable to describe nonperturbative QCD observables based on structure functions,more » such as GPDs, which are not amenable to a first-principle computation. The formalism is also successful in the description of form factors, the nonperturbative behavior of the strong coupling and diffractive processes. We also discuss in this article how the framework can be extended rather successfully to the heavy-light hadron sector.« less

Molecular PET imaging for biology-guided adaptive radiotherapy of head and neck cancer.

PubMed

Hoeben, Bianca A W; Bussink, Johan; Troost, Esther G C; Oyen, Wim J G; Kaanders, Johannes H A M

2013-10-01

Integration of molecular imaging PET techniques into therapy selection strategies and radiation treatment planning for head and neck squamous cell carcinoma (HNSCC) can serve several purposes. First, pre-treatment assessments can steer decisions about radiotherapy modifications or combinations with other modalities. Second, biology-based objective functions can be introduced to the radiation treatment planning process by co-registration of molecular imaging with planning computed tomography (CT) scans. Thus, customized heterogeneous dose distributions can be generated with escalated doses to tumor areas where radiotherapy resistance mechanisms are most prevalent. Third, monitoring of temporal and spatial variations in these radiotherapy resistance mechanisms early during the course of treatment can discriminate responders from non-responders. With such information available shortly after the start of treatment, modifications can be implemented or the radiation treatment plan can be adapted tailing the biological response pattern. Currently, these strategies are in various phases of clinical testing, mostly in single-center studies. Further validation in multicenter set-up is needed. Ultimately, this should result in availability for routine clinical practice requiring stable production and accessibility of tracers, reproducibility and standardization of imaging and analysis methods, as well as general availability of knowledge and expertise. Small studies employing adaptive radiotherapy based on functional dynamics and early response mechanisms demonstrate promising results. In this context, we focus this review on the widely used PET tracer (18)F-FDG and PET tracers depicting hypoxia and proliferation; two well-known radiation resistance mechanisms.

The role of intraoperative radiotherapy in solid tumors.

PubMed

Skandarajah, A R; Lynch, A C; Mackay, J R; Ngan, S; Heriot, A G

2009-03-01

Combined multimodality therapy is becoming standard treatment for many solid tumors, but the role of intraoperative radiotherapy in the management of solid tumors remains uncertain. The aim is to review the indication, application, and outcomes of intraoperative radiotherapy in the management of nongynecological solid tumors. A literature search was performed using Medline, Embase, Ovid, and Cochrane database for studies between 1965 and 2008 assessing intraoperative radiotherapy, using the keywords "intraoperative radiotherapy," "colorectal cancer," "breast cancer," "gastric cancer," "pancreatic cancer," "soft tissue tumor," and "surgery." Only publications in English with available abstracts and regarding adult humans were included, and the evidence was critically evaluated. Our search retrieved 864 publications. After exclusion of nonclinical papers, duplicated papers and exclusion of brachytherapy papers, 77 papers were suitable to assess the current role of intraoperative radiotherapy. The clinical application and evidence base of intraoperative radiotherapy for each cancer is presented. Current studies in all common cancers show an additional benefit in local recurrence rates when intraoperative radiotherapy is included in the multimodal treatment. However, intraoperative radiotherapy may not improve overall survival and has significant morbidity depending on the site of the tumor. Intraoperative radiotherapy does have a role in the multidisciplinary management of solid tumors, but further studies are required to more precisely determine the extent of benefit.

Genome-wide transcription responses to synchrotron microbeam radiotherapy.

PubMed

Sprung, Carl N; Yang, Yuqing; Forrester, Helen B; Li, Jason; Zaitseva, Marina; Cann, Leonie; Restall, Tina; Anderson, Robin L; Crosbie, Jeffrey C; Rogers, Peter A W

2012-10-01

The majority of cancer patients achieve benefit from radiotherapy. A significant limitation of radiotherapy is its relatively low therapeutic index, defined as the maximum radiation dose that causes acceptable normal tissue damage to the minimum dose required to achieve tumor control. Recently, a new radiotherapy modality using synchrotron-generated X-ray microbeam radiotherapy has been demonstrated in animal models to ablate tumors with concurrent sparing of normal tissue. Very little work has been undertaken into the cellular and molecular mechanisms that differentiate microbeam radiotherapy from broad beam. The purpose of this study was to investigate and compare the whole genome transcriptional response of in vivo microbeam radiotherapy versus broad beam irradiated tumors. We hypothesized that gene expression changes after microbeam radiotherapy are different from those seen after broad beam. We found that in EMT6.5 tumors at 4-48 h postirradiation, microbeam radiotherapy differentially regulates a number of genes, including major histocompatibility complex (MHC) class II antigen gene family members, and other immunity-related genes including Ciita, Ifng, Cxcl1, Cxcl9, Indo and Ubd when compared to broad beam. Our findings demonstrate molecular differences in the tumor response to microbeam versus broad beam irradiation and these differences provide insight into the underlying mechanisms of microbeam radiotherapy and broad beam.

Palliative radiotherapy practice within Western European countries: impact of the radiotherapy financing system?

PubMed

Lievens, Y; Van den Bogaert, W; Rijnders, A; Kutcher, G; Kesteloot, K

2000-09-01

To analyze the reimbursement modalities for radiotherapy in the different Western European countries, as well as to investigate if these differences have an impact on the palliative radiotherapy practice for bone metastases. A questionnaire was sent to 565 radiotherapy centres included in the 1997 ESTRO directory. In this questionnaire the reimbursement strategy applied in the different centres was assessed, with respect to the use of a budget (departmental or hospital budget), case payment and/or fee-for-service reimbursement. The differences were analyzed according to country and to type and size of the radiotherapy centre. A total of 170 centres (86% of the responders) returned the questionnaire. Most frequent is budget reimbursement: some form of budget reimbursement is found in 69% of the centres, whereas 46% of the centres are partly reimbursed through fee-for-service and 35% through case payment. The larger the department, the more frequent the reimbursement through a budget or a case payment system and the less the importance of fee-for-service reimbursement (chi(2): P=0.0012; logit: P=0.0055). Whereas private centres are almost equally reimbursed by fee-for-service financing as by budget or case payment, radiotherapy departments in university hospitals receive the largest part of their financial resources through a budget or by case payment (83%) (chi(2): P=0.002; logit: P=0.0073). A correlation between the country and the radiotherapy reimbursement system was also demonstrated (P=0.002), radiotherapy centres in Spain, the Netherlands and the United Kingdom being almost entirely reimbursed through a budget and/or case payment and centres in Germany and Switzerland mostly through a fee-for-service system. In budget and case payment financing lower total number of fractions and lower total dose (chi(2): P=0.003; logit: P=0.0120) as well as less shielding blocks (chi(2): P=0.003; logit: P=0.0066) are used. A same tendency is found for the use of isodose

Estimating radiotherapy demands in South East Asia countries in 2025 and 2035 using evidence-based optimal radiotherapy fractions.

PubMed

Yahya, Noorazrul; Roslan, Nurhaziqah

2018-01-08

As about 50% of cancer patients may require radiotherapy, the demand of radiotherapy as the main treatment to treat cancer is likely to rise due to rising cancer incidence. This study aims to quantify the radiotherapy demand in countries in Southeast Asia (SEA) in 2025 and 2035 using evidence-based optimal radiotherapy fractions. SEA country-specific cancer incidence by tumor site for 2015, 2025 and 2035 was extracted from the GLOBOCAN database. We utilized the optimal radiotherapy utilization rate model by Wong et al. (2016) to calculate the optimal number of fractions for all tumor sites in each SEA country. The available machines (LINAC & Co-60) were extracted from the IAEA's Directory of Radiotherapy Centres (DIRAC) from which the number of available fractions was calculated. The incidence of cancers in SEA countries are expected to be 1.1 mil cases (2025) and 1.4 mil (2035) compared to 0.9 mil (2015). The number of radiotherapy fractions needed in 2025 and 2035 are 11.1 and 14.1 mil, respectively, compared to 7.6 mil in 2015. In 2015, the radiotherapy fulfillment rate (RFR; required fractions/available fractions) varied between countries with Brunei, Singapore and Malaysia are highest (RFR > 1.0 - available fractions > required fractions), whereas Cambodia, Indonesia, Laos, Myanmar, Philippines, Timor-Leste and Vietnam have RFR < 0.5. RFR is correlated to GDP per capita (ρ = 0.73, P = 0.01). To allow RFR ≥1 in 2025 and 2035, another 866 and 1177 machines are required, respectively. The number are lower if longer running hours are implemented. With the optimal number of radiotherapy fractions, estimation for number of machines required can be obtained which will guide acquisition of machines in SEA countries. RFR is low with access varied based on the economic status. © 2018 John Wiley & Sons Australia, Ltd.

Elliptic flow of charm and strange hadrons in high-multiplicity pPb collisions at $$\\sqrt{s_{_\\mathrm{NN}}} =$$ 8.16 TeV

DOE Office of Scientific and Technical Information (OSTI.GOV)

Sirunyan, Albert M; et al.

The elliptic azimuthal anisotropy coefficient (more » $$v_2$$) is measured for charm (D$^0$) and strange (K$$_\\mathrm{S}^0$$, $$\\Lambda$$, $$\\Xi^-$$, and $$\\Omega^-$$) hadrons, using a data sample of pPb collisions collected by the CMS experiment, at a nucleon-nucleon center-of-mass energy $$\\sqrt{s_{_\\mathrm{NN}}} =$$ 8.16 TeV. A significant positive $$v_2$$ signal from long-range azimuthal correlations is observed for all particle species in high-multiplicity pPb collisions. The measurement represents the first observation of possible long-range collectivity for open heavy flavor hadrons in small systems. The results suggest that charm quarks have a smaller $$v_2$$ than the lighter quarks, probably reflecting a weaker collective behavior. This effect is not seen in the larger PbPb collision system at $$\\sqrt{s_{_\\mathrm{NN}}} =$$ 5.02 TeV, also presented.« less

Cetuximab and Radiotherapy in Laryngeal Preservation for Cancers of the Larynx and Hypopharynx

PubMed Central

Bonner, James; Giralt, Jordi; Harari, Paul; Spencer, Sharon; Schulten, Jeltje; Hossain, Anwar; Chang, Shao-Chun; Chin, Steve; Baselga, José

2016-01-01

IMPORTANCE The appropriate use of surgery or radiotherapy-based approaches for organ preservation has been the subject of much debate. Unfortunately, there has been a lack of improvement in overall survival for patients with laryngeal carcinoma in the last 30 years. OBJECTIVE To assess the rates of laryngeal preservation and laryngectomy-free survival in patients receiving cetuximab and radiotherapy (CRT) and patients receiving radiotherapy alone. DESIGN, SETTING, AND PARTICIPANTS Patients were enrolled in a multicenter, open-label, stratified, randomized, phase 3 study from April 1, 1999, through March 31, 2002, from 73 centers in the United States and 14 other countries. A secondary subgroup analysis of patients with hypopharyngeal and laryngeal carcinoma was undertaken. Rates of laryngeal preservation and laryngectomy-free survival were estimated by the Kaplan-Meier method. The hazard ratios (HRs) were calculated using a Cox proportional hazards regression model. Quality of life was evaluated using the European Organization for Research and Treatment of Cancer core questionnaire and head and neck module. MAIN OUTCOMES AND MEASURES Laryngeal preservation and laryngectomy-free survival. RESULTS Of the 424 patients included in the trial, 168 treated patients with cancer of the larynx or hypopharynx were included in this analysis (90 in the CRT group and 78 in the radiotherapy alone group). The median (range) age of the patients was 59 (40-80) years in the CRT group and 61 (35-81) years in the radiotherapy alone group. In the CRT group, 72 patients (80.0%) were male and 18 (20.0%) were female. In the radiotherapy alone group, 62 (79.5%) were male and 16 (20.5%) were female. The rates of laryngeal preservation at 2 years were 87.9% for CRT vs 85.7% for radiotherapy alone, with an HR of 0.57 (95% CI, 0.23-1.42; P = .22). Similarly, the HR for laryngectomy-free survival comparing CRT vs radiotherapy alone was 0.78 (95% CI, 0.54-1.11; P = .17). This study was not

A case study of the neuropsychological outcomes following microsurgery, conventional radiotherapy and stereotactic radiotherapy for an adult's recurrent craniopharyngioma.

PubMed

Preece, David; Allan, Alfred; Becerra, Rodrigo

2016-01-01

To examine the neuropsychological outcomes for an adult patient, 2 years after receiving microsurgery and conventional radiotherapy for a recurrent craniopharyngioma; and the impact of a further intervention, stereotactic radiotherapy, on this level of neuropsychological functioning. JD, a 30 year old male whose recurrent craniopharyngioma had 2 years earlier been treated with two operations and conventional radiotherapy. JD was assessed (using standardized clinical tests) before and after a course of stereotactic radiotherapy. Prior to stereotactic radiotherapy (and 2 years after microsurgery and conventional radiotherapy) JD's IQ was intact, but considerable impairments were present in executive functioning, memory, theory of mind and processing speed. Fifteen months after stereotactic radiotherapy, all neuropsychological domains remained largely static or improved, supporting the utility of this treatment option in the neuropsychological domain. However, deficits in executive functioning, memory and processing speed remained. These findings suggest that, even after multiple treatments, substantial cognitive impairments can be present in an adult patient with a recurrent craniopharyngioma. This profile of deficits underlines the inadequacy of relying purely on IQ as a marker for cognitive health in this population and emphasizes the need to include neuropsychological impairments as a focus of rehabilitation with these patients.

Hadronic model for the non-thermal radiation from the binary system AR Scorpii

NASA Astrophysics Data System (ADS)

Bednarek, W.

2018-05-01

AR Scorpii is a close binary system containing a rotation powered white dwarf and a low-mass M type companion star. This system shows non-thermal emission extending up to the X-ray energy range. We consider hybrid (lepto-hadronic) and pure hadronic models for the high energy non-thermal processes in this binary system. Relativistic electrons and hadrons are assumed to be accelerated in a strongly magnetised, turbulent region formed in collision of a rotating white dwarf magnetosphere and a magnetosphere/dense atmosphere of the M-dwarf star. We propose that the non-thermal X-ray emission is produced either by the primary electrons or the secondary e± pairs from decay of charged pions created in collisions of hadrons with the companion star atmosphere. We show that the accompanying γ-ray emission from decay of neutral pions, which are produced by these same protons, is expected to be on the detectability level of the present and/or the future satellite and Cherenkov telescopes. The γ-ray observations of the binary system AR Sco should allow us to constrain the efficiency of hadron and electron acceleration and also the details of the radiation processes.

Investigation of charged-hadron production in proton–nucleus interactions at the energy of 50 GeV

DOE Office of Scientific and Technical Information (OSTI.GOV)

Bordanovskii, A. Yu.; Volkov, A. A.; Elumahov, D. K.

2016-07-15

Cross sections for the production of high-transverse-momentum charged hadrons in proton–nucleus interactions at the incident-proton energy of 50 GeV were measured with the aid of the FODS double-arm spectrometer. Single hadrons (charged pions and protons) emitted at a c.m. angle of about 90° and high-effective-mass pairs of hadrons flying apart at a c.m. angle of 180° were detected simultaneously. Results on the production of single hadrons are presented.

High-energy photon-hadron scattering in holographic QCD

DOE Office of Scientific and Technical Information (OSTI.GOV)

Nishio, Ryoichi; Institute for the Physics and Mathematics of the Universe, University of Tokyo, Kashiwano-ha 5-1-5, 277-8583; Watari, Taizan

2011-10-01

This article provides an in-depth look at hadron high-energy scattering by using gravity dual descriptions of strongly coupled gauge theories. Just like deeply inelastic scattering (DIS) and deeply virtual Compton scattering (DVCS) serve as clean experimental probes into nonperturbative internal structure of hadrons, elastic scattering amplitude of a hadron and a (virtual) photon in gravity dual can be exploited as a theoretical probe. Since the scattering amplitude at sufficiently high energy (small Bjorken x) is dominated by parton contributions (=Pomeron contributions) even in strong coupling regime, there is a chance to learn a lesson for generalized parton distribution (GPD) bymore » using gravity dual models. We begin with refining derivation of the Brower-Polchinski-Strassler-Tan (BPST) Pomeron kernel in gravity dual, paying particular attention to the role played by the complex spin variable j. The BPST Pomeron on warped spacetime consists of a Kaluza-Klein tower of 4D Pomerons with nonlinear trajectories, and we clarify the relation between Pomeron couplings and the Pomeron form factor. We emphasize that the saddle-point value j* of the scattering amplitude in the complex j-plane representation is a very important concept in understanding qualitative behavior of the scattering amplitude. The total Pomeron contribution to the scattering is decomposed into the saddle-point contribution and at most a finite number of pole contributions, and when the pole contributions are absent (which we call saddle-point phase), kinematical variable (q,x,t)-dependence of ln(1/q) evolution and ln(1/x) evolution parameters {gamma}{sub eff} and {lambda}{sub eff} in DIS and t-slope parameter B of DVCS in HERA experiment are all reproduced qualitatively in gravity dual. All of these observations shed a new light on modeling of GPD. Straightforward application of those results to other hadron high-energy scattering is also discussed.« less

Update on J /ψ regeneration in a hadron gas

NASA Astrophysics Data System (ADS)

Abreu, L. M.; Khemchandani, K. P.; Torres, A. Martínez; Navarra, F. S.; Nielsen, M.

2018-04-01

In heavy-ion collisions, after the quark-gluon plasma there is a hadronic gas phase. Using effective Lagrangians, we study the interactions of charmed mesons which lead to J /ψ production and absorption in this gas. We update and extend previous calculations introducing strange meson interactions and also including the interactions mediated by the recently measured exotic charmonium resonances Z (3900 ) and Z (4025 ) . These resonances open new reaction channels for the J /ψ , which could potentially lead to changes in its multiplicity. We compute the J /ψ production cross section in processes such as D(s) (*)+D¯(*)→J /ψ +(π ,ρ ,K ,K*) and also the J /ψ absorption cross section in the corresponding inverse processes. Using the obtained cross sections as input to solve the appropriate rate equation, we conclude that the interactions in the hadron gas phase lead to a 20-24% reduction of the J /ψ abundance. Within the uncertainties of the calculation, this reduction is the same at the Relativistic Heavy Ion Collider and the large Hadron Collider.

Deciphering the MSSM Higgs mass at future hadron colliders

DOE PAGES

Agrawal, Prateek; Fan, JiJi; Reece, Matthew; ...

2017-06-06

Here, future hadron colliders will have a remarkable capacity to discover massive new particles, but their capabilities for precision measurements of couplings that can reveal underlying mechanisms have received less study. In this work we study the capability of future hadron colliders to shed light on a precise, focused question: is the higgs mass of 125 GeV explained by the MSSM? If supersymmetry is realized near the TeV scale, a future hadron collider could produce huge numbers of gluinos and electroweakinos. We explore whether precision measurements of their properties could allow inference of the scalar masses and tan β withmore » sufficient accuracy to test whether physics beyond the MSSM is needed to explain the higgs mass. We also discuss dark matter direct detection and precision higgs physics as complementary probes of tan β. For concreteness, we focus on the mini-split regime of MSSM parameter space at a 100 TeV pp collider, with scalar masses ranging from 10s to about 1000 TeV.« less

Innovations in Radiotherapy Technology.

PubMed

Feain, I J; Court, L; Palta, J R; Beddar, S; Keall, P

2017-02-01

Many low- and middle-income countries, together with remote and low socioeconomic populations within high-income countries, lack the resources and services to deal with cancer. The challenges in upgrading or introducing the necessary services are enormous, from screening and diagnosis to radiotherapy planning/treatment and quality assurance. There are severe shortages not only in equipment, but also in the capacity to train, recruit and retain staff as well as in their ongoing professional development via effective international peer-review and collaboration. Here we describe some examples of emerging technology innovations based on real-time software and cloud-based capabilities that have the potential to redress some of these areas. These include: (i) automatic treatment planning to reduce physics staffing shortages, (ii) real-time image-guided adaptive radiotherapy technologies, (iii) fixed-beam radiotherapy treatment units that use patient (rather than gantry) rotation to reduce infrastructure costs and staff-to-patient ratios, (iv) cloud-based infrastructure programmes to facilitate international collaboration and quality assurance and (v) high dose rate mobile cobalt brachytherapy techniques for intraoperative radiotherapy. Copyright © 2016 The Royal College of Radiologists. All rights reserved.

Comparison of Local Recurrence Among Early Breast Cancer Patients Treated With Electron Intraoperative Radiotherapy vs Hypofractionated Photon Radiotherapy an Observational Study.

PubMed

Guenzi, Marina; Bonzano, Elisabetta; Corvò, Renzo; Merolla, Francesca; Pastorino, Alice; Cavagnetto, Francesca; Garelli, Stefania; Cutolo, Carlo Alberto; Friedman, Daniele; Belgioia, Liliana

2018-01-01

To evaluate local recurrence (LR) in women with early breast cancer (BC) who underwent intraoperative radiation therapy with electrons particles (IORT-E) or adjuvant hypofractionated external radiotherapy (HYPOFX). We retrospectively analyzed 470 patients with early BC treated at our center from September 2009 to December 2012. 235 women were treated with breast-conserving surgery and immediate IORT-E (21 Gy/1 fraction) while 235 patients underwent wide excision followed by hypofractionated whole-breast irradiation. Radiotherapy modality was chosen according to an individualized decision based on tumor features, stage, technical feasibility, age, and acceptance to be enrolled in the IORT-E group. After a median follow-up of 6 years, we observed 8 (3.4%) and 1 (0.42%) LR in the IORT-E and in the HYPOFX group ( p  = 0.02), respectively. The two groups differed in the prevalence of clinical characteristics ( p  < 0.05): age, tumor size, surgical margins, receptors, ki67, and histology. 4 and 1 woman in the IORT-E and HYPOFX group died of BC, respectively ( p  = 0.167). OS and DFS hazard ratio [HR] were 2.14 (95% IC, 1.10-4.15) and 2.09 (95% IC, 1.17-3.73), respectively. Our comparison showed that IORT-E and HYPOFX are two effective radiotherapy modalities after conservative surgery in early BC. However, at 6 years a significant higher rate of LR occurred in patients submitted to IORT-E with respect to HYPOFX. This finding may be correlated to some subsets of patients who, depending on the biological characteristics of the BC, may be less suitable to IORT-E.

Breast Cancer Patients’ Experience of External-Beam Radiotherapy

PubMed Central

Schnur, Julie B.; Ouellette, Suzanne C.; Bovbjerg, Dana H.; Montgomery, Guy H.

2013-01-01

Radiotherapy is a critical component of treatment for the majority of women with breast cancer, particularly those who receive breast conserving surgery. Although medically beneficial, radiotherapy can take a physical and psychological toll on patients. However, little is known about the specific thoughts and feelings experienced by women undergoing breast cancer radiotherapy. Therefore, the study aim was to use qualitative research methods to develop an understanding of these thoughts and feelings based on 180 diary entries, completed during radiotherapy by 15 women with Stage 0-III breast cancer. Thematic analysis identified four primary participant concerns: (a) a preoccupation with time; (b) fantasies (both optimistic and pessimistic) about life following radiotherapy; (c) the toll their side-effect experience takes on their self-esteem; and (d) feeling mystified by radiotherapy. These themes are consistent with previous literature on illness and identity. These findings have implications for the treatment and care of women undergoing breast cancer radiotherapy. PMID:19380502

Prognosis was not deteriorated by multiple primary cancers in esophageal cancer patients treated by radiotherapy

PubMed Central

Shirai, Katsuyuki; Tamaki, Yoshio; Kitamoto, Yoshizumi; Murata, Kazutoshi; Satoh, Yumi; Higuchi, Keiko; Ishikawa, Hitoshi; Nonaka, Tetsuo; Takahashi, Takeo; Nakano, Takashi

2013-01-01

Esophageal cancer patients are often associated with multiple primary cancers (MPC). The aim of this study is to evaluate the effect of MPC on prognosis in esophageal cancer patients treated by radiotherapy. Between 2001 and 2008, esophageal cancer patients treated by definitive radiotherapy at Gunma Cancer Center were retrospectively reviewed. Exclusion criteria were preoperative or postoperative radiotherapy, palliative radiotherapy, follow-up of <6 months, radiation dose of <50 Gy and no information on MPC. We analyzed 167 esophageal cancer patients and 56 (33.5%) were associated with MPC. Gastric cancer was the most frequent tumor (38.2%), followed by head and neck cancer (26.5%). Median follow-up time was 31.5 months (range 6.1–87.3 months). Patients with MPC included more stage I/II esophageal cancer than those without MPC (66.1% vs. 36.9%, P < 0.01). The 5-year overall survival rate for esophageal cancer with MPC was relatively better than those without MPC (46.1% vs. 26.7%), although the difference did not reach statistical significance in univariate analysis (P = 0.09). Stage I/II esophageal cancer patients had a significantly better overall survival than stage III/IV patients (P < 0.01). Among esophageal cancer patients with MPC, there was no difference in overall survival between antecedent and synchronous cancer (P = 0.59). Our study indicated that the prognosis of esophageal cancer patients treated by radiotherapy was primarily determined by the clinical stage itself, but not the presence of MPC. PMID:23381956

Bremsstrahlung from colour charges as a source of soft particle production in hadronic collisions

NASA Astrophysics Data System (ADS)

Bialas, A.; Jezabek, M.

2004-06-01

It is proposed that soft particle production in hadronic collisions is dominated by multiple gluon exchanges between partons from the colliding hadrons, followed by radiation of hadronic clusters from the coloured partons distributed uniformly in rapidity. This explains naturally two dominant features of the data: (a) the linear increase of rapidity spectra in the regions of limiting fragmentation and, (b) the proportionality between the increasing width of the limiting fragmentation region and the height of the central plateau.

Selected Topics on Hadronic B Decays From BaBar

DOE Office of Scientific and Technical Information (OSTI.GOV)

Suzuki, K.; /SLAC

Recent measurements of branching fractions and decay-rate asymmetries in charmless hadronic B decays at the BaBar experiment are presented. The selected topics include Dalitz plot analyses of B {yields} K{sup +} {pi}{sup -}{pi} and signal searches in B {yields} PP and PV, where isoscalar mesons are involved, and in B {yields} b{sub 1}P, P and V denote a pseudoscalar and vector meson, respectively. Several measurements in charmless hadronic B decays have indicated possible deviations from the theoretical predictions within the Standard Model. The measurements presented would contribute to searching for and resolving such puzzles.

Coherent lepton pair production in hadronic heavy ion collisions

NASA Astrophysics Data System (ADS)

Zha, W.; Ruan, L.; Tang, Z.; Xu, Z.; Yang, S.

2018-06-01

Recently, significant enhancements of e+e- pair production at very low transverse momentum (pT < 0.15 GeV/c) were observed by the STAR collaboration in peripheral hadronic A+A collisions. This excesses can not be described by the QGP thermal radiation and ρ in-medium broadening calculations. This is a sign of coherent photon-photon interactions, which were conventionally studied only in ultra-peripheral collisions. In this article, we present calculations of lepton pair (e+e- and μ+μ-) production from coherent photon-photon interactions in hadronic A+A collisions at RHIC and LHC energies within the STAR and ALICE acceptance.

Hadron production in diffractive deep-inelastic scattering

NASA Astrophysics Data System (ADS)

H1 Collaboration; Adloff, C.; Aid, S.; Anderson, M.; Andreev, V.; Andrieu, B.; Arkadov, V.; Arndt, C.; Ayyaz, I.; Babaev, A.; Bähr, J.; Bán, J.; Baranov, P.; Barrelet, E.; Barschke, R.; Bartel, W.; Bassler, U.; Bate, P.; Beck, M.; Beglarian, A.; Behrend, H.-J.; Beier, C.; Belousov, A.; Berger, Ch.; Bernardi, G.; Bertrand-Coremans, G.; Beyer, R.; Biddulph, P.; Bizot, J. C.; Borras, K.; Boudry, V.; Braemer, A.; Braunschweig, W.; Brisson, V.; Brown, D. P.; Brückner, W.; Bruel, P.; Bruncko, D.; Brune, C.; Bürger, J.; Büsser, F. W.; Buniatian, A.; Burke, S.; Buschhorn, G.; Calvet, D.; Campbell, A. J.; Carli, T.; Chabert, E.; Charlet, M.; Clarke, D.; Clerbaux, B.; Cocks, S.; Contreras, J. G.; Cormack, C.; Coughlan, J. A.; Cousinou, M.-C.; Cox, B. E.; Cozzika, G.; Cvach, J.; Dainton, J. B.; Dau, W. D.; Daum, K.; David, M.; de Roeck, A.; de Wolf, E. A.; Delcourt, B.; Diaconu, C.; Dirkmann, M.; Dixon, P.; Dlugosz, W.; Donovan, K. T.; Dowell, J. D.; Droutskoi, A.; Ebert, J.; Eckerlin, G.; Eckstein, D.; Efremenko, V.; Egli, S.; Eichler, R.; Eisele, F.; Eisenhandler, E.; Elsen, E.; Enzenberger, M.; Erdmann, M.; Fahr, A. B.; Favart, L.; Fedotov, A.; Felst, R.; Feltesse, J.; Ferencei, J.; Ferrarotto, F.; Flamm, K.; Fleischer, M.; Flügge, G.; Fomenko, A.; Formánek, J.; Foster, J. M.; Franke, G.; Gabathuler, E.; Gabathuler, K.; Gaede, F.; Garvey, J.; Gayler, J.; Gebauer, M.; Gerhards, R.; Glazov, A.; Goerlich, L.; Gogitidze, N.; Goldberg, M.; Gorelov, I.; Grab, C.; Grässler, H.; Greenshaw, T.; Griffiths, R. K.; Grindhammer, G.; Gruber, C.; Hadig, T.; Haidt, D.; Hajduk, L.; Haller, T.; Hampel, M.; Haustein, V.; Haynes, W. J.; Heinemann, B.; Heinzelmann, G.; Henderson, R. C. W.; Hengstmann, S.; Henschel, H.; Heremans, R.; Herynek, I.; Hewitt, K.; Hiller, K. H.; Hilton, C. D.; Hladký, J.; Höppner, M.; Hoffmann, D.; Holtom, T.; Horisberger, R.; Hudgson, V. L.; Hütte, M.; Ibbotson, M.; Isolarş Sever, Ç.; Itterbeck, H.; Jacquet, M.; Jaffre, M.; Janoth, J.; Jansen, D. M.; Jönsson, L.; Johnson, D. P.; Jung, H.; Kander, M.; Kant, D.; Kathage, U.; Katzy, J.; Kaufmann, H. H.; Kaufmann, O.; Kausch, M.; Kazarian, S.; Kenyon, I. R.; Kermiche, S.; Keuker, C.; Kiesling, C.; Klein, M.; Kleinwort, C.; Knies, G.; Köhne, J. H.; Kolanoski, H.; Kolya, S. D.; Korbel, V.; Kostka, P.; Kotelnikov, S. K.; Krämerkämper, T.; Krasny, M. W.; Krehbiel, H.; Krücker, D.; Küpper, A.; Küster, H.; Kuhlen, M.; Kurča, T.; Laforge, B.; Lahmann, R.; Landon, M. P. J.; Lange, W.; Langenegger, U.; Lebedev, A.; Lehmann, M.; Lehner, F.; Lemaitre, V.; Levonian, S.; Lindstroem, M.; Lipinski, J.; List, B.; Lobo, G.; Lubimov, V.; Lüke, D.; Lytkin, L.; Magnussen, N.; Mahlke-Krüger, H.; Malinovski, E.; Maraček, R.; Marage, P.; Marks, J.; Marshall, R.; Martin, G.; Martin, R.; Martyn, H.-U.; Martyniak, J.; Maxfield, S. J.; McMahon, S. J.; McMahon, T. R.; Mehta, A.; Meier, K.; Merkel, P.; Metlica, F.; Meyer, A.; Meyer, A.; Meyer, H.; Meyer, J.; Meyer, P.-O.; Migliori, A.; Mikocki, S.; Milstead, D.; Moeck, J.; Mohr, R.; Mohrdieck, S.; Moreau, F.; Morris, J. V.; Mroczko, E.; Müller, D.; Müller, K.; Murín, P.; Nagovizin, V.; Nahnhauer, R.; Naroska, B.; Naumann, Th.; Négri, I.; Newman, P. R.; Newton, D.; Nguyen, H. K.; Nicholls, T. C.; Niebergall, F.; Niebuhr, C.; Niedzballa, Ch.; Niggli, H.; Nix, O.; Nowak, G.; Nunnemann, T.; Oberlack, H.; Olsson, J. E.; Ozerov, D.; Palmen, P.; Panaro, E.; Panitch, A.; Pascaud, C.; Passaggio, S.; Patel, G. D.; Pawletta, H.; Peppel, E.; Perez, E.; Phillips, J. P.; Pieuchot, A.; Pitzl, D.; Pöschl, R.; Pope, G.; Povh, B.; Rabbertz, K.; Reimer, P.; Reisert, B.; Rick, H.; Riess, S.; Rizvi, E.; Robmann, P.; Roosen, R.; Rosenbauer, K.; Rostovtsev, A.; Rouse, F.; Royon, C.; Rusakov, S.; Rybicki, K.; Sankey, D. P. C.; Schacht, P.; Scheins, J.; Schiek, S.; Schleif, S.; Schleper, P.; von Schlippe, W.; Schmidt, D.; Schmidt, G.; Schoeffel, L.; Schöning, A.; Schröder, V.; Schultz-Coulon, H.-C.; Schwab, B.; Sefkow, F.; Semenov, A.; Shekelyan, V.; Sheviakov, I.; Shtarkov, L. N.; Siegmon, G.; Siewert, U.; Sirois, Y.; Skillicorn, I. O.; Sloan, T.; Smirnov, P.; Smith, M.; Solochenko, V.; Soloviev, Y.; Specka, A.; Spiekermann, J.; Spitzer, H.; Squinabol, F.; Steffen, P.; Steinberg, R.; Steinhart, J.; Stella, B.; Stellberger, A.; Stiewe, J.; Stolze, K.; Straumann, U.; Struczinski, W.; Sutton, J. P.; Swart, M.; Tapprogge, S.; Taševský, M.; Tchernyshov, V.; Tchetchelnitski, S.; Theissen, J.; Thompson, G.; Thompson, P. D.; Tobien, N.; Todenhagen, R.; Truöl, P.; Tsipolitis, G.; Turnau, J.; Tzamariudaki, E.; Udluft, S.; Usik, A.; Valkár, S.; Valkárová, A.; Vallée, C.; van Esch, P.; van Mechelen, P.; Vazdik, Y.; Villet, G.; Wacker, K.; Wallny, R.; Walter, T.; Waugh, B.; Weber, G.; Weber, M.; Wegener, D.; Wegner, A.; Wengler, T.; Werner, M.; West, L. R.; Wiesand, S.; Wilksen, T.; Willard, S.; Winde, M.; Winter, G.-G.; Wittek, C.; Wittmann, E.; Wobisch, M.; Wollatz, H.; Wünsch, E.; Žáček, J.; Zálešák, J.; Zhang, Z.; Zhokin, A.; Zini, P.; Zomer, F.; Zsembery, J.; Zurnedden, M.

1998-05-01

Characteristics of hadron production in diffractive deep-inelastic positron-proton scattering are studied using data collected in 1994 by the H1 experiment at HERA. The following distributions are measured in the centre-of-mass frame of the photon dissociation system: the hadronic energy flow, the Feynman-x (xF) variable for charged particles, the squared transverse momentum of charged particles (pT*2), and the mean pT*2 as a function of xF. These distributions are compared with results in the γ*p centre-of-mass frame from inclusive deep-inelastic scattering in the fixed-target experiment EMC, and also with the predictions of several Monte Carlo calculations. The data are consistent with a picture in which the partonic structure of the diffractive exchange is dominated at low Q2 by hard gluons.

Unraveling hadron structure with generalized parton distributions

DOE Office of Scientific and Technical Information (OSTI.GOV)

Andrei Belitsky; Anatoly Radyushkin

2004-10-01

The recently introduced generalized parton distributions have emerged as a universal tool to describe hadrons in terms of quark and gluonic degrees of freedom. They combine the features of form factors, parton densities and distribution amplitudes - the functions used for a long time in studies of hadronic structure. Generalized parton distributions are analogous to the phase-space Wigner quasi-probability function of non-relativistic quantum mechanics which encodes full information on a quantum-mechanical system. We give an extensive review of main achievements in the development of this formalism. We discuss physical interpretation and basic properties of generalized parton distributions, their modeling andmore » QCD evolution in the leading and next-to-leading orders. We describe how these functions enter a wide class of exclusive reactions, such as electro- and photo-production of photons, lepton pairs, or mesons.« less

Probing leptophilic dark sectors with hadronic processes

DOE PAGES

D'Eramo, Francesco; Kavanagh, Bradley J.; Panci, Paolo

2017-05-29

We study vector portal dark matter models where the mediator couples only to leptons. In spite of the lack of tree-level couplings to colored states, radiative effects generate interactions with quark fields that could give rise to a signal in current and future experiments. We identify such experimental signatures: scattering of nuclei in dark matter direct detection; resonant production of lepton–antilepton pairs at the Large Hadron Collider; and hadronic final states in dark matter indirect searches. Furthermore, radiative effects also generate an irreducible mass mixing between the vector mediator and the Z boson, severely bounded by ElectroWeak Precision Tests. Wemore » use current experimental results to put bounds on this class of models, accounting for both radiatively induced and tree-level processes. Remarkably, the former often overwhelm the latter.« less

Very Early Salvage Radiotherapy Improves Distant Metastasis-Free Survival.

PubMed

Abugharib, Ahmed; Jackson, William C; Tumati, Vasu; Dess, Robert T; Lee, Jae Y; Zhao, Shuang G; Soliman, Moaaz; Zumsteg, Zachary S; Mehra, Rohit; Feng, Felix Y; Morgan, Todd M; Desai, Neil; Spratt, Daniel E

2017-03-01

Early salvage radiotherapy following radical prostatectomy for prostate cancer is commonly advocated in place of adjuvant radiotherapy. We aimed to determine the optimal definition of early salvage radiotherapy. We performed a multi-institutional retrospective study of 657 men who underwent salvage radiotherapy between 1986 and 2013. Two comparisons were made to determine the optimal definition of early salvage radiotherapy, including 1) the time from radical prostatectomy to salvage radiotherapy (less than 9, 9 to 21, 22 to 47 or greater than 48 months) and 2) the level of detectable pre-salvage radiotherapy prostate specific antigen (0.01 to 0.2, greater than 0.2 to 0.5 or greater than 0.5 ng/ml). Outcomes included freedom from salvage androgen deprivation therapy, and biochemical relapse-free, distant metastases-free and prostate cancer specific survival. Median followup was 9.8 years. Time from radical prostatectomy to salvage radiotherapy did not correlate with 10-year biochemical relapse-free survival rates (R 2 = 0.18). Increasing pre-salvage radiotherapy prostate specific antigen strongly correlated with biochemical relapse-free survival (R 2 = 0.91). Increasing detectable pre-salvage radiotherapy prostate specific antigen (0.01 to 0.2, greater than 0.2 to 0.5 and greater than 0.5 ng/ml) predicted worse 10-year biochemical relapse-free survival (62%, 44% and 27%), freedom from salvage androgen deprivation therapy (77%, 66% and 49%), distant metastases-free survival (86%, 79% and 66%, each p <0.001) and prostate cancer specific survival (93%, 89% and 80%, respectively, p = 0.001). On multivariable analysis early salvage radiotherapy (prostate specific antigen greater than 0.2 to 0.5 ng/ml) was associated with a twofold increase in biochemical failure, use of salvage androgen deprivation therapy and distant metastases compared to very early salvage radiotherapy (prostate specific antigen 0.01 to 0.2 ng/ml). The duration from radical prostatectomy to salvage

Risk-adaptive radiotherapy

NASA Astrophysics Data System (ADS)

Kim, Yusung

Currently, there is great interest in integrating biological information into intensity-modulated radiotherapy (IMRT) treatment planning with the aim of boosting high-risk tumor subvolumes. Selective boosting of tumor subvolumes can be accomplished without violating normal tissue complication constraints using information from functional imaging. In this work we have developed a risk-adaptive optimization-framework that utilizes a nonlinear biological objective function. Employing risk-adaptive radiotherapy for prostate cancer, it is possible to increase the equivalent uniform dose (EUD) by up to 35.4 Gy in tumor subvolumes having the highest risk classification without increasing normal tissue complications. Subsequently, we have studied the impact of functional imaging accuracy, and found on the one hand that loss in sensitivity had a large impact on expected local tumor control, which was maximal when a low-risk classification for the remaining low risk PTV was chosen. While on the other hand loss in specificity appeared to have a minimal impact on normal tissue sparing. Therefore, it appears that in order to improve the therapeutic ratio a functional imaging technique with a high sensitivity, rather than specificity, is needed. Last but not least a comparison study between selective boosting IMRT strategies and uniform-boosting IMRT strategies yielding the same EUD to the overall PTV was carried out, and found that selective boosting IMRT considerably improves expected TCP compared to uniform-boosting IMRT, especially when lack of control of the high-risk tumor subvolumes is the cause of expected therapy failure. Furthermore, while selective boosting IMRT, using physical dose-volume objectives, did yield similar rectal and bladder sparing when compared its equivalent uniform-boosting IMRT plan, risk-adaptive radiotherapy, utilizing biological objective functions, did yield a 5.3% reduction in NTCP for the rectum. Hence, in risk-adaptive radiotherapy the

Measurement of the bottom hadron lifetime at the Z sup 0 resonancce

DOE Office of Scientific and Technical Information (OSTI.GOV)

Fujino, D.H.

1992-06-01

We have measured the bottom hadron lifetime from b{bar b} events produced at the Z{sup 0} resonance. Using the precision vertex detectors of the Mark II detector at the Stanford Linear Collider, we developed an impact parameter tag to identify bottom hadrons. The vertex tracking system resolved impact parameters to 30 {mu}m for high momentum tracks, and 70 {mu}m for tracks with a momentum of 1 GeV. We selected B hadrons with an efficiency of 40% and a sample purity of 80%, by requiring there be at least two tracks in a single jet that significantly miss the Z{sup 0}more » decay vertex. From a total of 208 hadronic Z{sup 0} events collected by the Mark II detector in 1990, we tagged 53 jets, of which 22 came from 11 double-tagged events. The jets opposite the tagged ones, referred as the untagged'' sample, are rich in B hadrons and unbiased in B decay times. The variable {Sigma}{delta} is the sum of impact parameters from tracks in the jet, and contains vital information on the B decay time. We measured the B lifetime from a one-parameter likelihood fit to the untagged {Sigma}{delta} distribution, obtaining {tau}{sub b} = 1.53{sub {minus}0.45}{sup +0.55}{plus minus}0.16 ps which agrees with the current world average. The first error is statistical and the second is systematic. The systematic error was dominated by uncertainties in the track resolution function. As a check, we also obtained consistent results using the {Sigma}{delta} distribution from the tagged jets and from the entire hadronic sample without any bottom enrichment.« less

Simulation studies of reconstruction of hadron shower direction in INO ICAL detector

NASA Astrophysics Data System (ADS)

Devi, M. M.; Dighe, A.; Indumathi, D.; Lakshmi, S. M.

2018-03-01

The proposed Iron Calorimeter (ICAL) at India-based Neutrino Observatory (INO) will be a 50 kt magnetised iron detector for the detection of atmospheric neutrinos. The atmospheric neutrinos interact via both charged current (CC) and neutral current (NC) interactions with the target iron to produce the detectable final state particles. While CC νμ (bar nuμ) leave a muon track and a hadron shower in the detector, the NC will leave only a hadron shower apart from the secondary invisible neutrino. A GEANT4 based simulation studies to reconstruct hadron showers in CC and NC, using two techniques namely the Orientation Matrix Method (OMM) and the Raw Hit Method (RHM) are presented here. While OMM requires information about the interaction vertex obtained from muon track reconstruction, RHM requires only the shower hit positions and timings and no vertex information and hence can be used for NC events as well. Hadrons from neutrino events generated with NUANCE neutrino generator are analysed. For hadrons in the energy range 0.5-15 GeV produced in CC νμ and bar nuμ interactions, a Δθ'h resolution of around 19o-9o (around 20.5o-12o) is obtained in the |cosθ'h|=[0.8, 1] bin with OMM (RHM). For NC events in the same true energy and direction bins, Δθ'h resolution varies from around 20.5o-13o, from RHM only. OMM (RHM) gives a resolution of about 55o-20o (38o-14o) for the angle between the muon and the hadron shower, βμ h', in the [E'had;cos θ'h] range [0.5-15 GeV; [0.8,1.0

Measurement of the hadronic background in the identification of muons

DOE Office of Scientific and Technical Information (OSTI.GOV)

Leuchs, Reinhard

1982-10-01

A 2 /times/ 2 m/sup 2/-sized prototype of the muon detector for the UA1 experiment at the pp storage ring of the European Nuclear Research Center CERN was tested in a negative pion beam with 10 GeV/c momentum. The muon detector consists of drift tubes with an optimized, simple electric field configuration. The spatial resolution of the drift tubes lies between 0.2 and 0.3 mm for perpendicular particle incidence, and decreases up to 1 mm for an incidence angle of 60/degree/. Non-linearities in the location-time relation are explainable from the shape of the electric field. The hadronic punch-through was studiedmore » in connection with the calorimeters of the UA1 experiment. This punch-through forms a strong source of background in muon identification. In the momentum range from 2 GeV/c to 10 GeV/c and an equivalent calorimeter thickness of 102 cm of iron the probability for hadronic punch-through W/sub h/ is described. W/sub h/ is taken with respect to an incident pion. By inserting additional calorimeters, each equivalent to 24.3 cm of iron, the punch-through is reduced by a factor of 1/3. Only at high particle momenta above 5 GeV/c does the information from the calorimeters make punch-through suppression possible. At lower momenta in the range of 2 to 3 GeV/c an angle cut for the tracks in the muon detector as reconstructed in two projections is very effective. This suppresses the punch-through by a factor of 20 to 50, without losing more than 5% of the muons with a momentum greater than 10 GeV/c. 36 refs., 46 figs., 5 tabs.« less

Analog VS Digital Hadron Calorimetry at a Future Electron-Positron Linear Collider

NASA Astrophysics Data System (ADS)

Magill, Stephen R.

2005-02-01

Precision jet measurements at a future e+e- linear collider may only be possible using so-called Particle Flow Algorithms (PFAs). While there are many possible implementations of P-flow techniques, they all have in common separation of induced calorimeter showers from charged and neutral hadrons (as well as photons) within a jet. Shower reconstruction in the calorimeter becomes more important than energy measurement of hadrons. The calorimeter cells must be highly granular both transverse to the particle trajectory and in longitudinal segmentation. It is probable that as the cell size decreases, it will be harder to get an energy measure from each cell (analog calorimetry). Using only the hit information (digital calorimetry) may be the best way to measure the neutral hadron energy contribution to jets. In this paper, comparisons of analog and digital methods of measuring the contributions of neutral hadrons to jets are made in simulation and in the context of a particular PFA, indicating that the digital method is at least equal to the analog case in jet energy resolution.

Hadronization Studies via π 0 Electroproduction off D, C, Fe, and Pb

DOE Office of Scientific and Technical Information (OSTI.GOV)

Mineeva, Taisiya

2013-12-01

Propagation of partons and formation of hadrons is a topic of interest to multiple communities. New data available from Drell-Yan measurements at FermiLab, heavy ion collisions in RHIC and LHC, SIDIS measurements from HERMES at DESY and Jefferson Lab, all bring different types of information on short distance processes. DIS data obtained in the well understood nuclear medium provide direct information on hadron formation, essential to lay the groundwork for testing theoretical tools. A series of semi-inclusive DIS measurements were performed on D, C, Fe, Pb nuclei. The data were collected during the EG2 run period using the CLAS at Jefferson Lab. A double-target system consisting of liquid deuterium and one of the solid targets was exposed to a 5.014 GeV electron beam. The goal of the experiment is to extract hadronic multiplicity ratios (Rmore » $$h\\atop{A}$$) off nuclei of varying size. These are believed to have sensitivity to the parton fragmentation as well as in-medium hadronization.« less

Survey on deep learning for radiotherapy.

PubMed

Meyer, Philippe; Noblet, Vincent; Mazzara, Christophe; Lallement, Alex

2018-07-01

More than 50% of cancer patients are treated with radiotherapy, either exclusively or in combination with other methods. The planning and delivery of radiotherapy treatment is a complex process, but can now be greatly facilitated by artificial intelligence technology. Deep learning is the fastest-growing field in artificial intelligence and has been successfully used in recent years in many domains, including medicine. In this article, we first explain the concept of deep learning, addressing it in the broader context of machine learning. The most common network architectures are presented, with a more specific focus on convolutional neural networks. We then present a review of the published works on deep learning methods that can be applied to radiotherapy, which are classified into seven categories related to the patient workflow, and can provide some insights of potential future applications. We have attempted to make this paper accessible to both radiotherapy and deep learning communities, and hope that it will inspire new collaborations between these two communities to develop dedicated radiotherapy applications. Copyright © 2018 Elsevier Ltd. All rights reserved.

Specific recommendations for accurate and direct use of PET-CT in PET guided radiotherapy for head and neck sites

DOE Office of Scientific and Technical Information (OSTI.GOV)

Thomas, C. M., E-mail: christopher.thomas@gstt.nhs.uk; Convery, D. J.; Greener, A. G.

2014-04-15

Purpose: To provide specific experience-based guidance and recommendations for centers wishing to develop, validate, and implement an accurate and efficient process for directly using positron emission tomography-computed tomography (PET-CT) for the radiotherapy planning of head and neck cancer patients. Methods: A PET-CT system was modified with hard-top couch, external lasers and radiotherapy immobilization and indexing devices and was subject to a commissioning and quality assurance program. PET-CT imaging protocols were developed specifically for radiotherapy planning and the image quality and pathway tested using phantoms and five patients recruited into an in-house study. Security and accuracy of data transfer was testedmore » throughout the whole data pathway. The patient pathway was fully established and tested ready for implementation in a PET-guided dose-escalation trial for head and neck cancer patients. Results: Couch deflection was greater than for departmental CT simulator machines. An area of high attenuation in the couch generated image artifacts and adjustments were made accordingly. Using newly developed protocols CT image quality was suitable to maintain delineation and treatment accuracy. Upon transfer of data to the treatment planning system a half pixel offset between PET and CT was observed and corrected. By taking this into account, PET to CT alignment accuracy was maintained below 1 mm in all systems in the data pathway. Transfer of structures delineated in the PET fusion software to the radiotherapy treatment planning system was validated. Conclusions: A method to perform direct PET-guided radiotherapy planning was successfully validated and specific recommendations were developed to assist other centers. Of major concern is ensuring that the quality of PET and CT data is appropriate for radiotherapy treatment planning and on-treatment verification. Couch movements can be compromised, bore-size can be a limitation for certain

Post-radiotherapy hypothyroidism in dogs treated for thyroid carcinomas.

PubMed

Amores-Fuster, I; Cripps, P; Blackwood, L

2017-03-01

Hypothyroidism is a common adverse event after head and neck radiotherapy in human medicine, but uncommonly reported in canine patients. Records of 21 dogs with histologically or cytologically confirmed thyroid carcinoma receiving definitive or hypofractionated radiotherapy were reviewed. Nine cases received 48 Gy in 12 fractions, 10 received 36 Gy in 4 fractions and 2 received 32 Gy in 4 fractions. Seventeen cases had radiotherapy in a post-operative setting. Ten cases developed hypothyroidism (47.6%) after radiotherapy. The development of hypothyroidism was not associated with the radiotherapy protocol used. Median time to diagnosis of hypothyroidism was 6 months (range, 1-13 months). Hypothyroidism is a common side effect following radiotherapy for thyroid carcinomas. Monitoring of thyroid function following radiotherapy is recommended. No specific risk factors have been identified. © 2015 John Wiley & Sons Ltd.

Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.

PubMed

Kerns, Sarah L; Dorling, Leila; Fachal, Laura; Bentzen, Søren; Pharoah, Paul D P; Barnes, Daniel R; Gómez-Caamaño, Antonio; Carballo, Ana M; Dearnaley, David P; Peleteiro, Paula; Gulliford, Sarah L; Hall, Emma; Michailidou, Kyriaki; Carracedo, Ángel; Sia, Michael; Stock, Richard; Stone, Nelson N; Sydes, Matthew R; Tyrer, Jonathan P; Ahmed, Shahana; Parliament, Matthew; Ostrer, Harry; Rosenstein, Barry S; Vega, Ana; Burnet, Neil G; Dunning, Alison M; Barnett, Gillian C; West, Catharine M L

2016-08-01

Nearly 50% of cancer patients undergo radiotherapy. Late radiotherapy toxicity affects quality-of-life in long-term cancer survivors and risk of side-effects in a minority limits doses prescribed to the majority of patients. Development of a test predicting risk of toxicity could benefit many cancer patients. We aimed to meta-analyze individual level data from four genome-wide association studies from prostate cancer radiotherapy cohorts including 1564 men to identify genetic markers of toxicity. Prospectively assessed two-year toxicity endpoints (urinary frequency, decreased urine stream, rectal bleeding, overall toxicity) and single nucleotide polymorphism (SNP) associations were tested using multivariable regression, adjusting for clinical and patient-related risk factors. A fixed-effects meta-analysis identified two SNPs: rs17599026 on 5q31.2 with urinary frequency (odds ratio [OR] 3.12, 95% confidence interval [CI] 2.08-4.69, p-value 4.16×10(-8)) and rs7720298 on 5p15.2 with decreased urine stream (OR 2.71, 95% CI 1.90-3.86, p-value=3.21×10(-8)). These SNPs lie within genes that are expressed in tissues adversely affected by pelvic radiotherapy including bladder, kidney, rectum and small intestine. The results show that heterogeneous radiotherapy cohorts can be combined to identify new moderate-penetrance genetic variants associated with radiotherapy toxicity. The work provides a basis for larger collaborative efforts to identify enough variants for a future test involving polygenic risk profiling. Copyright © 2016 The Ohio State University Wexner Medical Center. Published by Elsevier B.V. All rights reserved.

Contribution of a kaon component in the viscosity and conductivity of a hadronic medium

NASA Astrophysics Data System (ADS)

Rahaman, Mahfuzur; Ghosh, Snigdha; Ghosh, Sabyasachi; Sarkar, Sourav; Alam, Jan-e.

2018-03-01

With the help of effective Lagrangian densities of strange hadrons, we calculated the kaon relaxation time from several loop and scattering diagrams at tree level, which basically represent contributions from 1 ↔2 and 2 ↔2 types of collisions. Using the total relaxation time of a kaon, the shear viscosity and electrical conductivity of this kaon component have been estimated. The high temperature, close to transition temperature, where the kaon relaxation time is lower than the lifetime of Relativistic Heavy Ion Collider or Large Hadron Collider matter may be the only relevant domain for this component to contribute in hadronic dissipation. Our results suggest that the kaon can play an important role in the enhancement of shear viscosity and electrical conductivity of hadronic matter near the transition temperature.

Promising diphoton signals of the little radion at hadron colliders

DOE Office of Scientific and Technical Information (OSTI.GOV)

Davoudiasl, H.; McElmurry, T; Soni, A.

2010-12-28

In little Randall-Sundrum models, the bulk couplings of the radion to massless gauge fields can yield a greatly enhanced diphoton signal at hadron colliders. We examine the implications of the Tevatron data for the little radion and also show that the 7 TeV run at the Large Hadron Collider will have an impressive reach in this channel. The diphoton signal is crucial in the search for a light radion, or the dual dilaton, and can potentially probe the ultraviolet scale of the theory.

SU(3) group structure of strange flavor hadrons

NASA Astrophysics Data System (ADS)

Hong, Soon-Tae

2015-01-01

We provide the isoscalar factors of the SU(3) Clebsch-Gordan series 8⊗ 35 which are extensions of the previous works of de Swart, McNamee and Chilton and play practical roles in current ongoing strange flavor hadron physics research. To this end, we pedagogically study the SU(3) Lie algebra, its spin symmetries, and its eigenvalues for irreducible representations. We also evaluate the values of the Wigner D functions related to the isoscalar factors; these functions are immediately applicable to strange flavor hadron phenomenology. Exploiting these SU(3) group properties associated with the spin symmetries, we investigate the decuplet-to-octet transition magnetic moments and the baryon octet and decuplet magnetic moments in the flavor symmetric limit to construct the Coleman-Glashow-type sum rules.

A search for jet handedness in hadronic Z{sup 0} decays

DOE Office of Scientific and Technical Information (OSTI.GOV)

Hasegawa, Yoji

1995-03-01

Transport of polarization through hadronization process is one of the fundamental interest in Quantum Chromodynamics which is a theory of strong interactions. In the low energy region where the hadronization occurs, QCD calculations are difficult, therefore at present the transport can be investigated experimentally. In this study the authors have searched for signatures of polarization of quarks and antiquarks in hadronic jets from Z{sup 0} {yields} q{bar q} decays. The polarization of quarks and antiquark produced by Z{sup 0} decays are predicted by the Standard Model of elementary particle physics. The authors defined several quantities depending on {open_quotes}jet handedness{close_quotes} methodsmore » and studied the correlation between the predicted polarization and the quantities. The signal was estimated by analyzing power which represents degree of the polarization transport through the hadronization process. The Z{sup 0} decays were measured by SLC Large Detector and the polarized electron beam provided by SLAC Linear Collider was useful for this study. The data from the 1993 run showed no signature of the transport of quark and antiquark polarization. Upper limits on magnitude of the analyzing power were set in the range 0.05-0.15 depending on the methods.« less

Mellin-Barnes approach to hadronic vacuum polarization and gμ-2

NASA Astrophysics Data System (ADS)

Charles, Jérôme; de Rafael, Eduardo; Greynat, David

2018-04-01

It is shown that with a precise determination of a few derivatives of the hadronic vacuum polarization (HVP) self-energy function Π (Q2) at Q2=0 , from lattice QCD (LQCD) or from a dedicated low-energy experiment, one can obtain an evaluation of the lowest order HVP contribution to the anomalous magnetic moment of the muon aμHVP with an accuracy comparable to the one reached using the e+e- annihilation cross section into hadrons. The technique of Mellin-Barnes approximants (MBa) that we propose is illustrated in detail with the example of the two loop vacuum polarization function in QED. We then apply it to the first few moments of the hadronic spectral function obtained from experiment and show that the resulting MBa evaluations of aμHVP converge very quickly to the full experimental determination.

Using hadron-in-jet data in a global analysis of D* fragmentation functions

NASA Astrophysics Data System (ADS)

Anderle, Daniele P.; Kaufmann, Tom; Stratmann, Marco; Ringer, Felix; Vitev, Ivan

2017-08-01

We present a novel global QCD analysis of charged D*-meson fragmentation functions at next-to-leading order accuracy. This is achieved by making use of the available data for single-inclusive D*-meson production in electron-positron annihilation, hadron-hadron collisions, and, for the first time, in-jet fragmentation in proton-proton scattering. It is shown how to include all relevant processes efficiently and without approximations within the Mellin moment technique, specifically for the in-jet fragmentation cross section. The presented technical framework is generic and can be straightforwardly applied to future analyses of fragmentation functions for other hadron species, as soon as more in-jet fragmentation data become available. We choose to work within the zero mass variable flavor number scheme which is applicable for sufficiently high energies and transverse momenta. The obtained optimum set of parton-to-D* fragmentation functions is accompanied by Hessian uncertainty sets which allow one to propagate hadronization uncertainties to other processes of interest.

Identified hadron production in pp collisions measured with ALICE.

NASA Astrophysics Data System (ADS)

Corrales Morales, Yasser; ALICE Collaboration

2017-07-01

The production of identified hadrons in proton-proton collisions is frequently studied as a reference for the investigation of the strongly-interacting medium created in heavy-ion collisions. In addition, at LHC energies measurements in pp and p-Pb collisions as a function of the event multiplicity have shown some features reminiscent of those related to collective effects in Pb-Pb collisions. Thanks to its excellent PID capabilities and p Τ coverage, the ALICE detector offers a unique opportunity for the measurement of p Τ spectra, integrated yields (dN/dy) and mean transverse momenta (

) of identified light-flavour hadrons at midrapidity over a wide p Τ range. In this contribution, results on π, K, p, {{{K}}}{{S}}0, Λ, Ξ, Ω and K*0 as a function of multiplicity in pp collisions at \\sqrt{s}=7 {TeV} are presented. The results are compared with those measured in p-Pb and Pb-Pb collisions. A similar evolution of the spectral shape, the p Τ-differential particle ratios and the integrated yield ratios with the charged particle multiplicity in both small and large systems is observed. The production rates of strange hadrons in pp collisions increase more than those of non-strange particles, showing an enhancement pattern with multiplicity which is remarkably similar to the one measured in p-Pb collisions. In addition, results on the production of light flavour hadrons in pp collisions at \\sqrt{s}=13 {TeV}, the highest centre-of-mass energy reached so far in the laboratory, are also presented and the behaviour observed as a function of \\sqrt{s} are discussed.

Effectiveness of Radiotherapy for Elderly Patients With Glioblastoma

DOE Office of Scientific and Technical Information (OSTI.GOV)

Scott, Jacob; Tsai, Ya-Yu; Chinnaiyan, Prakash

Purpose: Radiotherapy plays a central role in the definitive treatment of glioblastoma. However, the optimal management of elderly patients with glioblastoma remains controversial, as the relative benefit in this patient population is unclear. To better understand the role that radiation plays in the treatment of glioblastoma in the elderly, we analyzed factors influencing patient survival using a large population-based registry. Methods and Materials: A total of 2,836 patients more than 70 years of age diagnosed with glioblastoma between 1993 and 2005 were identified from the Surveillance, Epidemiology, and End Results (SEER) registry. Demographic and clinical variables used in the analysismore » included gender, ethnicity, tumor size, age at diagnosis, surgery, and radiotherapy. Cancer-specific survival and overall survival were evaluated using the Kaplan-Meier method. Univariate and multivariate analysis were performed using Cox regression. Results: Radiotherapy was administered in 64% of these patients, and surgery was performed in 68%. Among 2,836 patients, 46% received surgery and radiotherapy, 22% underwent surgery only, 18% underwent radiotherapy only, and 14% did not undergo either treatment. The median survival for patients who underwent surgery and radiotherapy was 8 months. The median survival for patients who underwent radiotherapy only was 4 months, and for patients who underwent surgery only was 3 months. Those who received neither surgery nor radiotherapy had a median survival of 2 months (p < 0.001). Multivariate analysis showed that radiotherapy significantly improved cancer-specific survival (hazard ratio [HR], 0.43, 95% confidence interval [CI] 0.38-0.49) after adjusting for surgery, tumor size, gender, ethnicity, and age at diagnosis. Other factors associated with Cancer-specific survival included surgery, tumor size, age at diagnosis, and ethnicity. Analysis using overall survival as the endpoint yielded very similar results. Conclusions

Hadronic density of states from string theory.

PubMed

Pando Zayas, Leopoldo A; Vaman, Diana

2003-09-12

We present an exact calculation of the finite temperature partition function for the hadronic states corresponding to a Penrose-Güven limit of the Maldacena-Nùñez embedding of the N=1 super Yang-Mills (SYM) into string theory. It is established that the theory exhibits a Hagedorn density of states. We propose a semiclassical string approximation to the finite temperature partition function for confining gauge theories admitting a supergravity dual, by performing an expansion around classical solutions characterized by temporal windings. This semiclassical approximation reveals a hadronic energy density of states of a Hagedorn type, with the coefficient determined by the gauge theory string tension as expected for confining theories. We argue that our proposal captures primarily information about states of pure N=1 SYM theory, given that this semiclassical approximation does not entail a projection onto states of large U(1) charge.

Renal function and urological complications after radical hysterectomy with postoperative radiotherapy and platinum-based chemotherapy for cervical cancer.

PubMed

Okadome, Masao; Saito, Toshiaki; Kitade, Shoko; Ariyoshi, Kazuya; Shimamoto, Kumi; Kawano, Hiroyuki; Minami, Kazuhito; Nakamura, Motonobu; Shimokawa, Mototsugu; Okushima, Kazuhiro; Kubo, Yuichiro; Kunitake, Naonobu

2018-02-01

We aimed to clarify renal functional changes long term and serious urological complications in women with cervical cancer who undergo radical hysterectomy followed by pelvic radiotherapy and/or platinum-based chemotherapy to treat the initial disease. Data on 380 women who underwent radical hysterectomy at the National Kyushu Cancer Center from January 1997 to December 2013 were reviewed. Main outcome measures were the estimated glomerular filtration rate (eGFR) and monitored abnormal urological findings. Postoperative eGFR was significantly lower than preoperative eGFR in 179 women with surgery alone and in 201 women with additional pelvic radiotherapy and/or chemotherapy (both P < 0.01). Two types of univariate analyses for eGFR reduction in women after treatment showed that older age, advanced stage, pelvic radiotherapy, and platinum-based chemotherapy were significant variables on both analyses. Two types of multivariate analyses showed that platinum-based chemotherapy or pelvic radiotherapy were associated with impaired renal function (odds ratio 1.96, 95% confidence interval 1.08-3.54 and odds ratio 2.85, 95% confidence interval 1.12-7.24, for the respective analyses). There was a higher rate of bladder wall thickening in women with pelvic radiotherapy had than those without it (17.4% vs. 2.7%, P < 0.01). One serious urological complication (intraperitoneal rupture of the bladder) occurred among women who underwent pelvic radiotherapy (0.6% vs. 0%). Surgeons should be aware that eGFR is reduced after platinum-based chemotherapy and/or postoperative pelvic radiotherapy. Serious and life-threatening urological complications are rare, but surgeons should be aware of the possibility during the long follow-up. © The Author 2017. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Coherent lepton pair production in hadronic heavy ion collisions

DOE Office of Scientific and Technical Information (OSTI.GOV)

Zha, W.; Ruan, L.; Tang, Z.

Recently, significant enhancements of e +e - pair production at very low transverse momentum (p T < 0.15 GeV/c) were observed by the STAR collaboration in peripheral hadronic A+A collisions. This excesses can not be described by the QGP thermal radiation and Rho in-medium broadening calculations. This is a sign of coherent photon-photon interactions, which were conventionally studied only in ultra-peripheral collisions. Here in this article, we present calculations of lepton pair (e +e - and μ +μ -) production from coherent photon-photon interactions in hadronic A+A collisions at RHIC and LHC energies within the STAR and ALICE acceptance.

Coherent lepton pair production in hadronic heavy ion collisions

DOE PAGES

Zha, W.; Ruan, L.; Tang, Z.; ...

2018-04-06

Recently, significant enhancements of e +e - pair production at very low transverse momentum (p T < 0.15 GeV/c) were observed by the STAR collaboration in peripheral hadronic A+A collisions. This excesses can not be described by the QGP thermal radiation and Rho in-medium broadening calculations. This is a sign of coherent photon-photon interactions, which were conventionally studied only in ultra-peripheral collisions. Here in this article, we present calculations of lepton pair (e +e - and μ +μ -) production from coherent photon-photon interactions in hadronic A+A collisions at RHIC and LHC energies within the STAR and ALICE acceptance.

Light-front field theory in the description of hadrons

NASA Astrophysics Data System (ADS)

Ji, Chueng-Ryong

2017-03-01

We discuss the use of light-front field theory in the descriptions of hadrons. In particular, we clarify the confusion in the prevailing notion of the equivalence between the infinite momentum frame and the light-front dynamics and the advantage of the light-front dynamics in hadron physics. As an application, we present our recent work on the flavor asymmetry in the proton sea and identify the presence of the delta-function contributions associated with end-point singularities arising from the chiral effective theory calculation. The results pave the way for phenomenological applications of pion cloud models that are manifestly consistent with the chiral symmetry properties of QCD.

Statistical hadronization with exclusive channels in e +e - annihilation

DOE PAGES

Ferroni, L.; Becattini, F.

2012-01-01

We present a systematic analysis of exclusive hadronic channels in e +e - collisions at centre-of-mass energies between 2.1 and 2.6 GeV within the statistical hadronization model. Because of the low multiplicities involved, calculations have been carried out in the full microcanonical ensemble, including conservation of energy-momentum, angular momentum, parity, isospin, and all relevant charges. We show that the data is in an overall good agreement with the model for an energy density of about 0.5 GeV/fm 3 and an extra strangeness suppression parameter γ S 0:7, essentially the same values found with fits to inclusive multiplicities at higher energy.

Reduced risk of compressive optic neuropathy using orbital radiotherapy in patients with active thyroid eye disease.

PubMed

Shams, Pari N; Ma, Roy; Pickles, Tom; Rootman, Jack; Dolman, Peter J

2014-06-01

To compare the risk of developing compressive optic neuropathy in patients with active thyroid eye disease (TED) treated with corticosteroids with or without orbital radiotherapy. Retrospective single-center case-control study. The clinical charts of 351 patients with active TED who received corticosteroids with or without orbital radiotherapy between 1999 and 2010 were reviewed. Patients with compressive optic neuropathy at the time of presentation were excluded. Group 1 received corticosteroids only and Group 2 received corticosteroids as well as orbital radiotherapy. The primary outcome measure was the development of compressive optic neuropathy. Secondary outcome measures were changes in other parameters indicating the activity of TED, including soft tissue inflammation, diplopia, ocular motility restriction, and appearance. There were 144 cases in Group 1 and 105 in Group 2. Both groups were matched for age, sex, and stability of thyroid function. The 2 groups differed only in the modality of treatment for active TED. The main indication for treatment in both groups was soft tissue inflammation. Corticosteroids were initiated an average of 2.6 months following symptom onset in Group 1 and 2.5 months in Group 2. Group 2 received orbital radiotherapy on average 4.2 months following the initiation of corticosteroid therapy and 8% (9/105) were intolerant to corticosteroids. At an average of 3.2 years follow-up, compressive optic neuropathy had developed in 17% (25/144) of Group 1 and 0% of Group 2 (P < .0001), on average 5.5 months following the initiation of corticosteroid therapy. Although both groups experienced a significant reduction in periocular inflammation, the radiotherapy-treated group demonstrated a significantly greater improvement in ocular motility. The rate of compressive optic neuropathy was significantly lower and improvement in ocular motility greater in patients receiving orbital radiotherapy in addition to corticosteroids. Patients with active

A test of the hadronic interaction model EPOS with air shower data

NASA Astrophysics Data System (ADS)

Apel, W. D.; Arteaga, J. C.; Badea, F.; Bekk, K.; Bertaina, M.; Blümer, J.; Bozdog, H.; Brancus, I. M.; Brüggemann, M.; Buchholz, P.; Cantoni, E.; Chiavassa, A.; Cossavella, F.; Daumiller, K.; de Souza, V.; Di Pierro, F.; Doll, P.; Engel, R.; Engler, J.; Finger, M.; Fuhrmann, D.; Ghia, P. L.; Gils, H. J.; Glasstetter, R.; Grupen, C.; Haungs, A.; Heck, D.; Hörandel, J. R.; Huege, T.; Isar, P. G.; Kampert, K.-H.; Kang, D.; Kickelbick, D.; Klages, H. O.; Kolotaev, Y.; Luczak, P.; Mathes, H. J.; Mayer, H. J.; Milke, J.; Mitrica, B.; Morello, C.; Navarra, G.; Nehls, S.; Oehlschläger, J.; Ostapchenko, S.; Over, S.; Petcu, M.; Pierog, T.; Rebel, H.; Roth, M.; Schieler, H.; Schröder, F.; Sima, O.; Stümpert, M.; Toma, G.; Trinchero, G. C.; Ulrich, H.; van Buren, J.; Walkowiak, W.; Weindl, A.; Wochele, J.; Wommer, M.; Zabierowski, J.

2009-03-01

Predictions of the hadronic interaction model EPOS 1.61 as implemented in the air shower simulation program CORSIKA are compared to observations with the KASCADE experiment. The investigations reveal that the predictions of EPOS are not compatible with KASCADE measurements. The discrepancies seen are most likely due to use of a set of inelastic hadronic cross sections that are too high.

Test of the hadronic interaction model EPOS with KASCADE air shower data

NASA Astrophysics Data System (ADS)

Hörandel, J. R.; Apel, W. D.; Arteaga, J. C.; Badea, F.; Bekk, K.; Bertaina, M.; Blümer, J.; Bozdog, H.; Brancus, I. M.; Brüggemann, M.; Buchholz, P.; Cantoni, E.; Chiavassa, A.; Cossavella, F.; Daumiller, K.; de Souza, V.; di Pierro, F.; Doll, P.; Engel, R.; Engler, J.; Finger, M.; Fuhrmann, D.; Ghia, P. L.; Gils, H. J.; Glasstetter, R.; Grupen, C.; Haungs, A.; Heck, D.; Huege, T.; Isar, P. G.; Kampert, K.-H.; Kang, D.; Kickelbick, D.; Klages, H. O.; Kolotaev, Y.; Łuczak, P.; Mathes, H. J.; Mayer, H. J.; Milke, J.; Mitrica, B.; Morello, C.; Navarra, G.; Nehls, S.; Oehlschläger, J.; Ostapchenko, S.; Over, S.; Petcu, M.; Pierog, T.; Rebel, H.; Roth, M.; Schieler, H.; Schröder, F.; Sima, O.; Stümpert, M.; Toma, G.; Trinchero, G.; Ulrich, H.; Walkowiak, W.; Weindl, A.; Wochele, J.; Wommer, M.; Zabierowski, J.; KASCADE-Grande Collaboration

2009-12-01

Predictions of the hadronic interaction model EPOS 1.61 as implemented in the air shower simulation program CORSIKA are compared to observations with the KASCADE experiment. The investigations reveal that the predictions of EPOS are not compatible with KASCADE measurements. The discrepancies seen are most likely due to use of a set of inelastic hadronic cross sections that are too high.

Consistent simulation of direct-photon production in hadron collisions including associated two-jet production

NASA Astrophysics Data System (ADS)

Odaka, Shigeru; Kurihara, Yoshimasa

2016-05-01

We have developed an event generator for direct-photon production in hadron collisions, including associated 2-jet production in the framework of the GR@PPA event generator. The event generator consistently combines γ + 2-jet production processes with the lowest-order γ + jet and photon-radiation (fragmentation) processes from quantum chromodynamics (QCD) 2-jet production using a subtraction method. The generated events can be fed to general-purpose event generators to facilitate the addition of hadronization and decay simulations. Using the obtained event information, we can simulate photon isolation and hadron-jet reconstruction at the particle (hadron) level. The simulation reasonably reproduces measurement data obtained at the large hadron collider (LHC) concerning not only the inclusive photon spectrum, but also the correlation between the photon and jet. The simulation implies that the contribution of the γ + 2-jet is very large, especially in low photon-pT ( ≲ 50 GeV) regions. Discrepancies observed at low pT, although marginal, may indicate the necessity for the consideration of further higher-order processes. Unambiguous particle-level definition of the photon-isolation condition for the signal events is desired to be given explicitly in future measurements.

Heavy Hadron Spectroscopy at CDF

NASA Astrophysics Data System (ADS)

Fernández Ramos, Juan Pablo

2010-12-01

We present recent CDF results on the properties of hadrons containing heavy quarks. These include measurements of charm and Σb-Σb∗- baryon's masses, lifetimes and masses of Ωb-, Ξb- and Bc- and a measurement of exclusive B+, B0 and Λb lifetimes as well as lifetime ratios (charge conjugate modes are implied throughout the text). We also summarize new measurements of exotic particles X(3872) and Y(4140).

Outcome of accelerated radiotherapy alone or accelerated radiotherapy followed by exenteration of the nasal cavity in dogs with intranasal neoplasia: 53 cases (1990-2002).

PubMed

Adams, William M; Bjorling, Dale E; McAnulty, Jonathan E; Green, Eric M; Forrest, Lisa J; Vail, David M

2005-09-15

To compare long-term results of radiotherapy alone versus radiotherapy followed by exenteration of the nasal cavity in dogs with malignant intranasal neoplasia. Retrospective study. 53 dogs with malignant intranasal neoplasia. All dogs underwent radiotherapy consisting of administration of 10 fractions of 4.2 Gy each on consecutive weekdays. For dogs in the surgery group (n=13), follow-up computed tomography was performed, and dogs were scheduled for surgery if persistent or recurrent tumor was seen. Perioperative complications for dogs that underwent surgery included hemorrhage requiring transfusion (2 dogs) and subcutaneous emphysema (8). Rhinitis and osteomyelitis-osteonecrosis occurred significantly more frequently in dogs in the radiotherapy and surgery group (9 and 4 dogs, respectively) than in dogs in the radiotherapy-only group (4 and 3 dogs, respectively). Two- and 3-year survival rates were 44% and 24%, respectively, for dogs in the radiotherapy group and 69% and 58%, respectively, for dogs in the surgery group. Overall median survival time for dogs in the radiotherapy and surgery group (477 months) was significantly longer than time for dogs in the radiotherapy-only group (19.7 months). Results suggest that exenteration of the nasal cavity significantly prolongs survival time in dogs with intranasal neoplasia that have undergone radiotherapy. Exenteration after radiotherapy may increase the risk of chronic complications.

Small animal radiotherapy research platforms

NASA Astrophysics Data System (ADS)

Verhaegen, Frank; Granton, Patrick; Tryggestad, Erik

2011-06-01

Advances in conformal radiation therapy and advancements in pre-clinical radiotherapy research have recently stimulated the development of precise micro-irradiators for small animals such as mice and rats. These devices are often kilovolt x-ray radiation sources combined with high-resolution CT imaging equipment for image guidance, as the latter allows precise and accurate beam positioning. This is similar to modern human radiotherapy practice. These devices are considered a major step forward compared to the current standard of animal experimentation in cancer radiobiology research. The availability of this novel equipment enables a wide variety of pre-clinical experiments on the synergy of radiation with other therapies, complex radiation schemes, sub-target boost studies, hypofractionated radiotherapy, contrast-enhanced radiotherapy and studies of relative biological effectiveness, to name just a few examples. In this review we discuss the required irradiation and imaging capabilities of small animal radiation research platforms. We describe the need for improved small animal radiotherapy research and highlight pioneering efforts, some of which led recently to commercially available prototypes. From this, it will be clear that much further development is still needed, on both the irradiation side and imaging side. We discuss at length the need for improved treatment planning tools for small animal platforms, and the current lack of a standard therein. Finally, we mention some recent experimental work using the early animal radiation research platforms, and the potential they offer for advancing radiobiology research.

Role of intraoperative radiotherapy in the treatment of sacral chordoma.

PubMed

Jullien-Petrelli, Ariel Christian; García-Sabrido, J L; Orue-Echebarria, M I; Lozano, P; Álvarez, A; Serrano, J; Calvo, F M; Calvo-Haro, J A; Lasso, J M; Asencio, J M

2018-04-01

Sacral chordoma is a rare entity with high local recurrence rates when complete resection is not achieved. To date, there are no series available in literature combining surgery and intraoperative radiotherapy (IORT). The objective of this study was to report the experience of our center in the management of sacral chordoma combining radical resection with both external radiotherapy and IORT. This is a retrospective case series. The patient sample included 15 patients with sacral chordoma resected in our center from 1998 to 2015. The outcome measures were overall survival (OS), disease-free survival (DFS), and rates of local and distant recurrences. We retrospectively reviewed the records of all the patients with sacral chordoma resected in our center from 1998 to December 2015. Overall survival, DFS, and rates of local and distant recurrences were calculated. Results between patients treated with or without IORT were compared. A total of 15 patients were identified: 8 men and 7 women. The median age was 59 years (range 28-77). Intraoperative radiotherapy was applied in nine patients and six were treated with surgical resection without IORT. In 13 patients, we performed the treatment of the primary tumor, and in two patients, we performed the treatment of recurrence disease. A posterior approach was used in four patients. Wide surgical margins (zero residue) were achieved in six patients, marginal margins (microscopic residue) were achieved in seven patients, and there were no patients with intralesional (R2) margins. At a median follow-up of 38 months (range 11-209 months), the 5-year OS in the IORT group was 100% versus 53% in the group of non-IORT (p=.05). The median DFS in the IORT group was 85 months, and that in the non-IORT group was 41 months. In the group without IORT, two patients died and nobody died during the follow-up in the group treated with IORT. High-sacrectomy treated patients had a median survival of 41 months, and low-sacrectomy treated

Radiotherapy in patients with connective tissue diseases.

PubMed

Giaj-Levra, Niccolò; Sciascia, Savino; Fiorentino, Alba; Fersino, Sergio; Mazzola, Rosario; Ricchetti, Francesco; Roccatello, Dario; Alongi, Filippo

2016-03-01

The decision to offer radiotherapy in patients with connective tissue diseases continues to be challenging. Radiotherapy might trigger the onset of connective tissue diseases by increasing the expression of self-antigens, diminishing regulatory T-cell activity, and activating effectors of innate immunity (dendritic cells) through Toll-like receptor-dependent mechanisms, all of which could potentially lead to breaks of immune tolerance. This potential risk has raised some debate among radiation oncologists about whether patients with connective tissue diseases can tolerate radiation as well as people without connective tissue diseases. Because the number of patients with cancer and connective tissue diseases needing radiotherapy will probably increase due to improvements in medical treatment and longer life expectancy, the issue of interactions between radiotherapy and connective tissue diseases needs to be clearer. In this Review, we discuss available data and evidence for patients with connective tissue diseases treated with radiotherapy. Copyright © 2016 Elsevier Ltd. All rights reserved.

Time, space and technology in radiotherapy departments: how do these factors impact on patients' experiences of radiotherapy?

PubMed

Merchant, S; O'Connor, M; Halkett, G

2017-03-01

Radiation therapists (RTs) plan and deliver radiotherapy treatment for patients diagnosed with cancer. They need to communicate regularly with their patients and may have a role to play in reducing patient anxiety and distress. The objectives were to explore how the environment of radiotherapy departments supports or inhibits communication generally and information giving and supportive care provision in particular. An ethnographic approach was used to gather rich descriptive data through observations and interviews conducted in two Australian radiotherapy centres. Time, space and a technology driven culture was found to negatively affect the quality of interaction that occurred between RTs and their patients. This research has shown design/modification of spaces is needed in the radiotherapy environment to reflect a patient care centred culture and to enhance opportunities for RTs to provide supportive care for their patients. © 2015 John Wiley & Sons Ltd.

Systematic Uncertainties in High-Energy Hadronic Interaction Models

NASA Astrophysics Data System (ADS)

Zha, M.; Knapp, J.; Ostapchenko, S.

2003-07-01

Hadronic interaction models for cosmic ray energies are uncertain since our knowledge of hadronic interactions is extrap olated from accelerator experiments at much lower energies. At present most high-energy models are based on Grib ov-Regge theory of multi-Pomeron exchange, which provides a theoretical framework to evaluate cross-sections and particle production. While experimental data constrain some of the model parameters, others are not well determined and are therefore a source of systematic uncertainties. In this paper we evaluate the variation of results obtained with the QGSJET model, when modifying parameters relating to three ma jor sources of uncertainty: the form of the parton structure function, the role of diffractive interactions, and the string hadronisation. Results on inelastic cross sections, on secondary particle production and on the air shower development are discussed.

Observation of new charmless decays of bottom hadrons.

PubMed

Aaltonen, T; Adelman, J; Akimoto, T; Alvarez González, B; Amerio, S; Amidei, D; Anastassov, A; Annovi, A; Antos, J; Apollinari, G; Apresyan, A; Arisawa, T; Artikov, A; Ashmanskas, W; Attal, A; Aurisano, A; Azfar, F; Azzurri, P; Badgett, W; Barbaro-Galtieri, A; Barnes, V E; Barnett, B A; Bartsch, V; Bauer, G; Beauchemin, P-H; Bedeschi, F; Beecher, D; Behari, S; Bellettini, G; Bellinger, J; Benjamin, D; Beretvas, A; Beringer, J; Bhatti, A; Binkley, M; Bisello, D; Bizjak, I; Blair, R E; Blocker, C; Blumenfeld, B; Bocci, A; Bodek, A; Boisvert, V; Bolla, G; Bortoletto, D; Boudreau, J; Boveia, A; Brau, B; Bridgeman, A; Brigliadori, L; Bromberg, C; Brubaker, E; Budagov, J; Budd, H S; Budd, S; Burke, S; Burkett, K; Busetto, G; Bussey, P; Buzatu, A; Byrum, K L; Cabrera, S; Calancha, C; Campanelli, M; Campbell, M; Canelli, F; Canepa, A; Carls, B; Carlsmith, D; Carosi, R; Carrillo, S; Carron, S; Casal, B; Casarsa, M; Castro, A; Catastini, P; Cauz, D; Cavaliere, V; Cavalli-Sforza, M; Cerri, A; Cerrito, L; Chang, S H; Chen, Y C; Chertok, M; Chiarelli, G; Chlachidze, G; Chlebana, F; Cho, K; Chokheli, D; Chou, J P; Choudalakis, G; Chuang, S H; Chung, K; Chung, W H; Chung, Y S; Chwalek, T; Ciobanu, C I; Ciocci, M A; Clark, A; Clark, D; Compostella, G; Convery, M E; Conway, J; Cordelli, M; Cortiana, G; Cox, C A; Cox, D J; Crescioli, F; Cuenca Almenar, C; Cuevas, J; Culbertson, R; Cully, J C; Dagenhart, D; Datta, M; Davies, T; de Barbaro, P; De Cecco, S; Deisher, A; De Lorenzo, G; Dell'Orso, M; Deluca, C; Demortier, L; Deng, J; Deninno, M; Derwent, P F; di Giovanni, G P; Dionisi, C; Di Ruzza, B; Dittmann, J R; D'Onofrio, M; Donati, S; Dong, P; Donini, J; Dorigo, T; Dube, S; Efron, J; Elagin, A; Erbacher, R; Errede, D; Errede, S; Eusebi, R; Fang, H C; Farrington, S; Fedorko, W T; Feild, R G; Feindt, M; Fernandez, J P; Ferrazza, C; Field, R; Flanagan, G; Forrest, R; Frank, M J; Franklin, M; Freeman, J C; Furic, I; Gallinaro, M; Galyardt, J; Garberson, F; Garcia, J E; Garfinkel, A F; Genser, K; Gerberich, H; Gerdes, D; Gessler, A; Giagu, S; Giakoumopoulou, V; Giannetti, P; Gibson, K; Gimmell, J L; Ginsburg, C M; Giokaris, N; Giordani, M; Giromini, P; Giunta, M; Giurgiu, G; Glagolev, V; Glenzinski, D; Gold, M; Goldschmidt, N; Golossanov, A; Gomez, G; Gomez-Ceballos, G; Goncharov, M; González, O; Gorelov, I; Goshaw, A T; Goulianos, K; Gresele, A; Grinstein, S; Grosso-Pilcher, C; Grundler, U; Guimaraes da Costa, J; Gunay-Unalan, Z; Haber, C; Hahn, K; Hahn, S R; Halkiadakis, E; Han, B-Y; Han, J Y; Happacher, F; Hara, K; Hare, D; Hare, M; Harper, S; Harr, R F; Harris, R M; Hartz, M; Hatakeyama, K; Hays, C; Heck, M; Heijboer, A; Heinrich, J; Henderson, C; Herndon, M; Heuser, J; Hewamanage, S; Hidas, D; Hill, C S; Hirschbuehl, D; Hocker, A; Hou, S; Houlden, M; Hsu, S-C; Huffman, B T; Hughes, R E; Husemann, U; Hussein, M; Huston, J; Incandela, J; Introzzi, G; Iori, M; Ivanov, A; James, E; Jang, D; Jayatilaka, B; Jeon, E J; Jha, M K; Jindariani, S; Johnson, W; Jones, M; Joo, K K; Jun, S Y; Jung, J E; Junk, T R; Kamon, T; Kar, D; Karchin, P E; Kato, Y; Kephart, R; Keung, J; Khotilovich, V; Kilminster, B; Kim, D H; Kim, H S; Kim, H W; Kim, J E; Kim, M J; Kim, S B; Kim, S H; Kim, Y K; Kimura, N; Kirsch, L; Klimenko, S; Knuteson, B; Ko, B R; Kondo, K; Kong, D J; Konigsberg, J; Korytov, A; Kotwal, A V; Kreps, M; Kroll, J; Krop, D; Krumnack, N; Kruse, M; Krutelyov, V; Kubo, T; Kuhr, T; Kulkarni, N P; Kurata, M; Kwang, S; Laasanen, A T; Lami, S; Lammel, S; Lancaster, M; Lander, R L; Lannon, K; Lath, A; Latino, G; Lazzizzera, I; LeCompte, T; Lee, E; Lee, H S; Lee, S W; Leone, S; Lewis, J D; Lin, C-S; Linacre, J; Lindgren, M; Lipeles, E; Lister, A; Litvintsev, D O; Liu, C; Liu, T; Lockyer, N S; Loginov, A; Loreti, M; Lovas, L; Lucchesi, D; Luci, C; Lueck, J; Lujan, P; Lukens, P; Lungu, G; Lyons, L; Lys, J; Lysak, R; Macqueen, D; Madrak, R; Maeshima, K; Makhoul, K; Maki, T; Maksimovic, P; Malde, S; Malik, S; Manca, G; Manousakis-Katsikakis, A; Margaroli, F; Marino, C; Marino, C P; Martin, A; Martin, V; Martínez, M; Martínez-Ballarín, R; Maruyama, T; Mastrandrea, P; Masubuchi, T; Mathis, M; Mattson, M E; Mazzanti, P; McFarland, K S; McIntyre, P; McNulty, R; Mehta, A; Mehtala, P; Menzione, A; Merkel, P; Mesropian, C; Miao, T; Miladinovic, N; Miller, R; Mills, C; Milnik, M; Mitra, A; Mitselmakher, G; Miyake, H; Moggi, N; Moon, C S; Moore, R; Morello, M J; Morlock, J; Movilla Fernandez, P; Mülmenstädt, J; Mukherjee, A; Muller, Th; Mumford, R; Murat, P; Mussini, M; Nachtman, J; Nagai, Y; Nagano, A; Naganoma, J; Nakamura, K; Nakano, I; Napier, A; Necula, V; Nett, J; Neu, C; Neubauer, M S; Neubauer, S; Nielsen, J; Nodulman, L; Norman, M; Norniella, O; Nurse, E; Oakes, L; Oh, S H; Oh, Y D; Oksuzian, I; Okusawa, T; Orava, R; Osterberg, K; Griso, S Pagan; Palencia, E; Papadimitriou, V; Papaikonomou, A; Paramonov, A A; Parks, B; Pashapour, S; Patrick, J; Pauletta, G; Paulini, M; Paus, C; Peiffer, T; Pellett, D E; Penzo, A; Phillips, T J; Piacentino, G; Pianori, E; Pinera, L; Pitts, K; Plager, C; Pondrom, L; Poukhov, O; Pounder, N; Prakoshyn, F; Pronko, A; Proudfoot, J; Ptohos, F; Pueschel, E; Punzi, G; Pursley, J; Rademacker, J; Rahaman, A; Ramakrishnan, V; Ranjan, N; Redondo, I; Renton, P; Renz, M; Rescigno, M; Richter, S; Rimondi, F; Ristori, L; Robson, A; Rodrigo, T; Rodriguez, T; Rogers, E; Rolli, S; Roser, R; Rossi, M; Rossin, R; Roy, P; Ruiz, A; Russ, J; Rusu, V; Saarikko, H; Safonov, A; Sakumoto, W K; Saltó, O; Santi, L; Sarkar, S; Sartori, L; Sato, K; Savoy-Navarro, A; Schlabach, P; Schmidt, A; Schmidt, E E; Schmidt, M A; Schmidt, M P; Schmitt, M; Schwarz, T; Scodellaro, L; Scribano, A; Scuri, F; Sedov, A; Seidel, S; Seiya, Y; Semenov, A; Sexton-Kennedy, L; Sforza, F; Sfyrla, A; Shalhout, S Z; Shears, T; Shepard, P F; Shimojima, M; Shiraishi, S; Shochet, M; Shon, Y; Shreyber, I; Sidoti, A; Sinervo, P; Sisakyan, A; Slaughter, A J; Slaunwhite, J; Sliwa, K; Smith, J R; Snider, F D; Snihur, R; Soha, A; Somalwar, S; Sorin, V; Spalding, J; Spreitzer, T; Squillacioti, P; Stanitzki, M; St Denis, R; Stelzer, B; Stelzer-Chilton, O; Stentz, D; Strologas, J; Strycker, G L; Stuart, D; Suh, J S; Sukhanov, A; Suslov, I; Suzuki, T; Taffard, A; Takashima, R; Takeuchi, Y; Tanaka, R; Tecchio, M; Teng, P K; Terashi, K; Tesarek, R; Thom, J; Thompson, A S; Thompson, G A; Thomson, E; Tipton, P; Ttito-Guzmán, P; Tkaczyk, S; Toback, D; Tokar, S; Tollefson, K; Tomura, T; Tonelli, D; Torre, S; Torretta, D; Totaro, P; Tourneur, S; Trovato, M; Tsai, S-Y; Tu, Y; Turini, N; Ukegawa, F; Vallecorsa, S; van Remortel, N; Varganov, A; Vataga, E; Vázquez, F; Velev, G; Vellidis, C; Vidal, M; Vidal, R; Vila, I; Vilar, R; Vine, T; Vogel, M; Volobouev, I; Volpi, G; Wagner, P; Wagner, R G; Wagner, R L; Wagner, W; Wagner-Kuhr, J; Wakisaka, T; Wallny, R; Wang, S M; Warburton, A; Waters, D; Weinberger, M; Weinelt, J; Wester, W C; Whitehouse, B; Whiteson, D; Wicklund, A B; Wicklund, E; Wilbur, S; Williams, G; Williams, H H; Wilson, P; Winer, B L; Wittich, P; Wolbers, S; Wolfe, C; Wright, T; Wu, X; Würthwein, F; Xie, S; Yagil, A; Yamamoto, K; Yamaoka, J; Yang, U K; Yang, Y C; Yao, W M; Yeh, G P; Yoh, J; Yorita, K; Yoshida, T; Yu, G B; Yu, I; Yu, S S; Yun, J C; Zanello, L; Zanetti, A; Zhang, X; Zheng, Y; Zucchelli, S

2009-07-17

We search for new charmless decays of neutral b hadrons to pairs of charged hadrons, using 1 fb(-1) of data collected by the CDF II detector at the Fermilab Tevatron. We report the first observation of the Bs0-->K-pi+ decay and measure B(Bs0-->K-pi+)=(5.0+/-0.7(stat)+/-0.8(syst))x10(-6). We also report the first observation of charmless b-baryon decays, and measure B(Lambdab0-->ppi-)=(3.5+/-0.6(stat)+/-0.9(syst))x10(-6) and B(Lambdab0-->pK-)=(5.6+/-0.8(stat)+/-1.5(syst))x10(-6). No evidence is found for other modes, and we set the limit B(Bs0-->pi+pi;-)<1.2x10(-6) at 90% C.L.

Extra dimension searches at hadron colliders to next-to-leading order-QCD

NASA Astrophysics Data System (ADS)

Kumar, M. C.; Mathews, Prakash; Ravindran, V.

2007-11-01

The quantitative impact of NLO-QCD corrections for searches of large and warped extra dimensions at hadron colliders are investigated for the Drell-Yan process. The K-factor for various observables at hadron colliders are presented. Factorisation, renormalisation scale dependence and uncertainties due to various parton distribution functions are studied. Uncertainties arising from the error on experimental data are estimated using the MRST parton distribution functions.

Interacting hadron resonance gas model in the K -matrix formalism

NASA Astrophysics Data System (ADS)

Dash, Ashutosh; Samanta, Subhasis; Mohanty, Bedangadas

2018-05-01

An extension of hadron resonance gas (HRG) model is constructed to include interactions using relativistic virial expansion of partition function. The noninteracting part of the expansion contains all the stable baryons and mesons and the interacting part contains all the higher mass resonances which decay into two stable hadrons. The virial coefficients are related to the phase shifts which are calculated using K -matrix formalism in the present work. We have calculated various thermodynamics quantities like pressure, energy density, and entropy density of the system. A comparison of thermodynamic quantities with noninteracting HRG model, calculated using the same number of hadrons, shows that the results of the above formalism are larger. A good agreement between equation of state calculated in K -matrix formalism and lattice QCD simulations is observed. Specifically, the lattice QCD calculated interaction measure is well described in our formalism. We have also calculated second-order fluctuations and correlations of conserved charges in K -matrix formalism. We observe a good agreement of second-order fluctuations and baryon-strangeness correlation with lattice data below the crossover temperature.

Measurements of hadron mean free path for the particle-producing collisions in nuclear matter

NASA Technical Reports Server (NTRS)

Strugalski, Z.

1985-01-01

It is not obvious a priority that the cross-section for a process in hadron collisions with free nucleons is the same as that for the process in hadron collisions with nucleons inside a target nucleus. The question arises: what is the cross-section for a process in a hadron collision with nucleon on inside the atomic nucleus. The answer to it must be found in experiments. The mean free path for particle-producing collisions of pions in nuclear matter is determined experimentally using pion-xenon nucleus collisions at 3.5 GeV/c momentum. Relation between the mean free path in question lambda sub in nucleons fm squared and the cross-section in units of fm squared/nucleon for collisions of the hadron with free nucleon is: lambda sub i = k/cross section sub i, where k = 3.00 plus or minus 0.26.

Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus.

PubMed

Wong, R; Malthaner, R

2001-01-01

Esophageal carcinoma can be managed primarily with either a surgical or radiotherapeutic (non surgical) approach. Strategies to improve the outcome of either modality alone include the use of combined modalities. Combination chemotherapy radiotherapy is one approach that has been explored over the years with increasing application in clinical practice especially in North America. To evaluate the effectiveness of combined chemotherapy and radiotherapy versus radiotherapy alone in the outcome of patients with localized esophageal carcinoma. Outcomes of interest include overall survival, cause specific survival, local recurrence, dysphagia relief, quality of life, acute and chronic toxicities. The Cochrane strategy for identifying randomized trials was combined with MeSH headings including esophageal neoplasms, radiotherapy, chemotherapy combined modality, drug therapy combination. Medline, Cancerlit and Embase were searched using this strategy. In addition, the Cochrane library was also searched. References from relevant articles and personal files were included. Randomized controlled trials in patients with localized esophageal cancer, with one arm employing radiotherapy alone, and one arm employing combination radiotherapy chemotherapy were included. Studies comparing non chemotherapy agents such as pure radiotherapy sensitisers, immunostimulants, planned esophagectomy, were excluded. Data were extracted by two independent reviewers, and the trial quality was assessed using both the Jadad scoring and Detsky checklist. Sensitivity analysis was planned to explore sources of heterogeneity where heterogeneity existed. The factors hypothesized a priori included combination versus sequential treatment, quality of study, biological effective radiotherapy dose (i.e. Radiotherapy dose) cisplatin versus non cisplatin containing trials, and 5FU versus non 5FU containing trials. Odds Ratio (OR) and 95% confidence limits were used to assess the significance of the difference

Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus.

PubMed

Rebecca, W O; Richard, M A

2003-01-01

Esophageal carcinoma can be managed primarily with either a surgical or radiotherapeutic (non surgical) approach. Strategies to improve the outcome of either modality alone include the use of combined modalities. Combination chemotherapy radiotherapy is one approach that has been explored over the years with increasing application in clinical practice especially in North America. To evaluate the effectiveness of combined chemotherapy and radiotherapy versus radiotherapy alone in the outcome of patients with localized esophageal carcinoma. Outcomes of interest include overall survival, cause specific survival, local recurrence, dysphagia relief, quality of life, acute and chronic toxicities. The Cochrane strategy for identifying randomized trials was combined with MeSH headings including esophageal neoplasms, radiotherapy, chemotherapy combined modality, drug therapy combination. MEDLINE, CancerLIT and EMBASE were searched using this strategy. In addition, the Cochrane library was also searched. References from relevant articles and personal files were included. Randomized controlled trials in patients with localized esophageal cancer, with one arm employing radiotherapy alone, and one arm employing combination radiotherapy chemotherapy were included. Studies comparing non chemotherapy agents such as pure radiotherapy sensitisers, immunostimulants, planned esophagectomy, were excluded. Data were extracted by two independent reviewers, and the trial quality was assessed using both the Jadad scoring and Detsky checklist. Sensitivity analysis was planned to explore sources of heterogeneity where heterogeneity existed. The factors hypothesized a priori included combination versus sequential treatment, quality of study, biological effective radiotherapy dose (i.e. Radiotherapy dose) cisplatin versus non cisplatin containing trials, and 5FU versus non 5FU containing trials. Odds Ratio (OR) and 95% confidence limits were used to assess the significance of the difference

Test of high-energy hadronic interaction models with high-altitude cosmic-ray data

NASA Astrophysics Data System (ADS)

Haungs, A.; Kempa, J.

2003-09-01

Emulsion experiments placed at high mountain altitudes register hadrons and high-energy γ-rays with an energy threshold in the TeV region. These secondary shower particles are produced in the forward direction of interactions of mainly primary protons and alpha-particles in the Earth's atmosphere. Single γ's and hadrons are mainly produced by the interactions of the primary cosmic-ray nuclei of primary energy below 1015eV. Therefore the measurements are sensitive to the physics of high-energy hadronic interaction models, e.g., as implemented in the Monte Carlo air shower simulation program CORSIKA. By use of detailed simulations invoking various different models for the hadronic interactions we compare the predictions for the single-particle spectra with data of the Pamir experiment. For higher primary energies characteristics of so-called gamma-ray families are used for the comparisons. Including detailed simulations for the Pamir detector we found that the data are incompatible with the HDPM and SIBYLL 1.6 models, but are in agreement with QGSJET, NEXUS, and VENUS.

Identified hadron spectra from PHOBOS

NASA Astrophysics Data System (ADS)

Veres, Gábor I.; the PHOBOS Collaboration; Back, B. B.; Baker, M. D.; Ballintijn, M.; Barton, D. S.; Becker, B.; Betts, R. R.; Bickley, A. A.; Bindel, R.; Busza, W.; Carroll, A.; Decowski, M. P.; García, E.; Gburek, T.; George, N.; Gulbrandsen, K.; Gushue, S.; Halliwell, C.; Hamblen, J.; Harrington, A. S.; Henderson, C.; Hofman, D. J.; Hollis, R. S.; Hołyński, R.; Holzman, B.; Iordanova, A.; Johnson, E.; Kane, J. L.; Khan, N.; Kulinich, P.; Kuo, C. M.; Lee, J. W.; Lin, W. T.; Manly, S.; Mignerey, A. C.; Nouicer, R.; Olszewski, A.; Pak, R.; Park, I. C.; Pernegger, H.; Reed, C.; Roland, C.; Roland, G.; Sagerer, J.; Sarin, P.; Sedykh, I.; Skulski, W.; Smith, C. E.; Steinberg, P.; Stephans, G. S. F.; Sukhanov, A.; Tonjes, M. B.; Trzupek, A.; Vale, C.; van Nieuwenhuizen, G. J.; Verdier, R.; Wolfs, F. L. H.; Wosiek, B.; Wozniak, K.; Wysłouch, B.; Zhang, J.

2004-08-01

Transverse momentum spectra of pions, kaons and protons, as well as antiparticle to particle ratios near mid-rapidity from d+Au collisions at \\sqrt{sNN} = 200 GeV have been measured by the PHOBOS experiment at RHIC. The transverse momentum range of particle identification was extended to beyond 3 GeV/c using the TOF detector and a new trigger system. The pseudorapidity dependence of the nuclear modification factor for charged hadrons in d+Au collisions is presented.

Charmonium dissociation in collisions with ϕ mesons in hadronic matter

NASA Astrophysics Data System (ADS)

Ji, Shi-Tao; Xu, Xiao-Ming

2017-02-01

The ϕ-charmonium dissociation reactions in hadronic matter are studied. Unpolarised cross sections for , or , , , or , , or and are calculated in the Born approximation, in the quark-interchange mechanism and with a temperature-dependent quark potential. The potential leads to remarkable temperature dependence of the cross sections. With the cross sections and the ϕ distribution function we calculate the dissociation rates of the charmonia in interactions with the ϕ meson in hadronic matter. The dependence of the rates on temperature and charmonium momentum is relevant to the influence of ϕ mesons on charmonium suppression. Supported by National Natural Science Foundation of China (11175111)

Evidence-based optimal number of radiotherapy fractions for cancer: A useful tool to estimate radiotherapy demand.

PubMed

Wong, Karen; Delaney, Geoff P; Barton, Michael B

2016-04-01

The recently updated optimal radiotherapy utilisation model estimated that 48.3% of all cancer patients should receive external beam radiotherapy at least once during their disease course. Adapting this model, we constructed an evidence-based model to estimate the optimal number of fractions for notifiable cancers in Australia to determine equipment and workload implications. The optimal number of fractions was calculated based on the frequency of specific clinical conditions where radiotherapy is indicated and the evidence-based recommended number of fractions for each condition. Sensitivity analysis was performed to assess the impact of variables on the model. Of the 27 cancer sites, the optimal number of fractions for the first course of radiotherapy ranged from 0 to 23.3 per cancer patient, and 1.5 to 29.1 per treatment course. Brain, prostate and head and neck cancers had the highest average number of fractions per course. Overall, the optimal number of fractions was 9.4 per cancer patient (range 8.7-10.0) and 19.4 per course (range 18.0-20.7). These results provide valuable data for radiotherapy services planning and comparison with actual practice. The model can be easily adapted by inserting population-specific epidemiological data thus making it applicable to other jurisdictions. Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Hadronic Leading Order Contribution to the Muon g-2

NASA Astrophysics Data System (ADS)

Nomura, Daisuke

2018-05-01

We calculate the Standard Model (SM) prediction for the muon anomalous magnetic moment. By using the latest experimental data for e+e- → hadrons as input to dispersive integrals, we obtain the values of the leading order (LO) and the next-to-leading-order (NLO) hadronic vacuum polarisation contributions as ahad, LO VPμ = (693:27 ± 2:46) × 10-10 and ahad, NLO VP μ = (_9.82 ± 0:04) × 1010-10, respectively. When combined with other contributions to the SM prediction, we obtain aμ(SM) = (11659182:05 ± 3.56) × 10-10; which is deviated from the experimental value by Δaμ(exp) _ aμ(SM) = (27.05 ± 7.26) × 10-10. This means that there is a 3.7 σ discrepancy between the experimental value and the SM prediction. We also discuss another closely related quantity, the running QED coupling at the Z-pole, α(M2 Z). By using the same e+e- → hadrons data as input, our result for the 5-flavour quark contribution to the running QED coupling at the Z pole is Δ(5)had(M2 Z) = (276.11 ± 1.11) × 10-4, from which we obtain Δ(M2 Z) = 128.946 ± 0.015.

Pion and proton showers in the CALICE scintillator-steel analogue hadron calorimeter

NASA Astrophysics Data System (ADS)

Bilki, B.; Repond, J.; Xia, L.; Eigen, G.; Thomson, M. A.; Ward, D. R.; Benchekroun, D.; Hoummada, A.; Khoulaki, Y.; Chang, S.; Khan, A.; Kim, D. H.; Kong, D. J.; Oh, Y. D.; Blazey, G. C.; Dyshkant, A.; Francis, K.; Lima, J. G. R.; Salcido, R.; Zutshi, V.; Salvatore, F.; Kawagoe, K.; Miyazaki, Y.; Sudo, Y.; Suehara, T.; Tomita, T.; Ueno, H.; Yoshioka, T.; Apostolakis, J.; Dannheim, D.; Folger, G.; Ivantchenko, V.; Klempt, W.; Lucaci-Timoce, A.-I.; Ribon, A.; Schlatter, D.; Sicking, E.; Uzhinskiy, V.; Giraud, J.; Grondin, D.; Hostachy, J.-Y.; Morin, L.; Brianne, E.; Cornett, U.; David, D.; Ebrahimi, A.; Falley, G.; Gadow, K.; Göttlicher, P.; Günter, C.; Hartbrich, O.; Hermberg, B.; Karstensen, S.; Krivan, F.; Krüger, K.; Lu, S.; Lutz, B.; Morozov, S.; Morgunov, V.; Neubüser, C.; Reinecke, M.; Sefkow, F.; Smirnov, P.; Tran, H. L.; Buhmann, P.; Garutti, E.; Laurien, S.; Matysek, M.; Ramilli, M.; Briggl, K.; Eckert, P.; Harion, T.; Munwes, Y.; Schultz-Coulon, H.-Ch.; Shen, W.; Stamen, R.; Norbeck, E.; Northacker, D.; Onel, Y.; van Doren, B.; Wilson, G. W.; Wing, M.; Combaret, C.; Caponetto, L.; Eté, R.; Grenier, G.; Han, R.; Ianigro, J. C.; Kieffer, R.; Laktineh, I.; Lumb, N.; Mathez, H.; Mirabito, L.; Petrukhin, A.; Steen, A.; Berenguer Antequera, J.; Calvo Alamillo, E.; Fouz, M.-C.; Marin, J.; Puerta-Pelayo, J.; Verdugo, A.; Corriveau, F.; Bobchenko, B.; Chistov, R.; Chadeeva, M.; Danilov, M.; Drutskoy, A.; Epifantsev, A.; Markin, O.; Mironov, D.; Mizuk, R.; Novikov, E.; Rusinov, V.; Tarkovsky, E.; Besson, D.; Buzhan, P.; Ilyin, A.; Popova, E.; Gabriel, M.; Kiesling, C.; van der Kolk, N.; Simon, F.; Soldner, C.; Szalay, M.; Tesar, M.; Weuste, L.; Amjad, M. S.; Bonis, J.; Callier, S.; Conforti di Lorenzo, S.; Cornebise, P.; Dulucq, F.; Fleury, J.; Frisson, T.; Martin-Chassard, G.; Pöschl, R.; Raux, L.; Richard, F.; Rouëné, J.; Seguin-Moreau, N.; de la Taille, Ch.; Anduze, M.; Boudry, V.; Brient, J.-C.; Clerc, C.; Cornat, R.; Frotin, M.; Gastaldi, F.; Matthieu, A.; Mora de Freitas, P.; Musat, G.; Ruan, M.; Videau, H.; Zacek, J.; Cvach, J.; Gallus, P.; Havranek, M.; Janata, M.; Kvasnicka, J.; Lednicky, D.; Marcisovsky, M.; Polak, I.; Popule, J.; Tomasek, L.; Tomasek, M.; Sicho, P.; Smolik, J.; Vrba, V.; Zalesak, J.; Jeans, D.; Weber, S.

2015-04-01

Showers produced by positive hadrons in the highly granular CALICE scintillator-steel analogue hadron calorimeter were studied. The experimental data were collected at CERN and FNAL for single particles with initial momenta from 10 to 80 GeV/c. The calorimeter response and resolution and spatial characteristics of shower development for proton- and pion-induced showers for test beam data and simulations using GEANT4 version 9.6 are compared.

Measurements of Absolute Hadronic Branching Fractions of the Λ_{c}^{+} Baryon.

PubMed

Ablikim, M; Achasov, M N; Ai, X C; Albayrak, O; Albrecht, M; Ambrose, D J; Amoroso, A; An, F F; An, Q; Bai, J Z; Baldini Ferroli, R; Ban, Y; Bennett, D W; Bennett, J V; Bertani, M; Bettoni, D; Bian, J M; Bianchi, F; Boger, E; Boyko, I; Briere, R A; Cai, H; Cai, X; Cakir, O; Calcaterra, A; Cao, G F; Cetin, S A; Chang, J F; Chelkov, G; Chen, G; Chen, H S; Chen, H Y; Chen, J C; Chen, M L; Chen, S J; Chen, X; Chen, X R; Chen, Y B; Cheng, H P; Chu, X K; Cibinetto, G; Dai, H L; Dai, J P; Dbeyssi, A; Dedovich, D; Deng, Z Y; Denig, A; Denysenko, I; Destefanis, M; De Mori, F; Ding, Y; Dong, C; Dong, J; Dong, L Y; Dong, M Y; Dou, Z L; Du, S X; Duan, P F; Eren, E E; Fan, J Z; Fang, J; Fang, S S; Fang, X; Fang, Y; Farinelli, R; Fava, L; Fedorov, O; Feldbauer, F; Felici, G; Feng, C Q; Fioravanti, E; Fritsch, M; Fu, C D; Gao, Q; Gao, X L; Gao, X Y; Gao, Y; Gao, Z; Garzia, I; Goetzen, K; Gong, L; Gong, W X; Gradl, W; Greco, M; Gu, M H; Gu, Y T; Guan, Y H; Guo, A Q; Guo, L B; Guo, Y; Guo, Y P; Haddadi, Z; Hafner, A; Han, S; Hao, X Q; Harris, F A; He, K L; Held, T; Heng, Y K; Hou, Z L; Hu, C; Hu, H M; Hu, J F; Hu, T; Hu, Y; Huang, G S; Huang, J S; Huang, X T; Huang, Y; Hussain, T; Ji, Q; Ji, Q P; Ji, X B; Ji, X L; Jiang, L W; Jiang, X S; Jiang, X Y; Jiao, J B; Jiao, Z; Jin, D P; Jin, S; Johansson, T; Julin, A; Kalantar-Nayestanaki, N; Kang, X L; Kang, X S; Kavatsyuk, M; Ke, B C; Kiese, P; Kliemt, R; Kloss, B; Kolcu, O B; Kopf, B; Kornicer, M; Kuehn, W; Kupsc, A; Lange, J S; Lara, M; Larin, P; Leng, C; Li, C; Li, Cheng; Li, D M; Li, F; Li, F Y; Li, G; Li, H B; Li, J C; Li, Jin; Li, K; Li, K; Li, Lei; Li, P R; Li, Q Y; Li, T; Li, W D; Li, W G; Li, X L; Li, X M; Li, X N; Li, X Q; Li, Z B; Liang, H; Liang, Y F; Liang, Y T; Liao, G R; Lin, D X; Liu, B J; Liu, C X; Liu, D; Liu, F H; Liu, Fang; Liu, Feng; Liu, H B; Liu, H H; Liu, H H; Liu, H M; Liu, J; Liu, J B; Liu, J P; Liu, J Y; Liu, K; Liu, K Y; Liu, L D; Liu, P L; Liu, Q; Liu, S B; Liu, X; Liu, Y B; Liu, Z A; Liu, Zhiqing; Loehner, H; Lou, X C; Lu, H J; Lu, J G; Lu, Y; Lu, Y P; Luo, C L; Luo, M X; Luo, T; Luo, X L; Lyu, X R; Ma, F C; Ma, H L; Ma, L L; Ma, Q M; Ma, T; Ma, X N; Ma, X Y; Ma, Y M; Maas, F E; Maggiora, M; Mao, Y J; Mao, Z P; Marcello, S; Messchendorp, J G; Min, J; Mitchell, R E; Mo, X H; Mo, Y J; Morales Morales, C; Muchnoi, N Yu; Muramatsu, H; Nefedov, Y; Nerling, F; Nikolaev, I B; Ning, Z; Nisar, S; Niu, S L; Niu, X Y; Olsen, S L; Ouyang, Q; Pacetti, S; Pan, Y; Patteri, P; Pelizaeus, M; Peng, H P; Peters, K; Pettersson, J; Ping, J L; Ping, R G; Poling, R; Prasad, V; Qi, H R; Qi, M; Qian, S; Qiao, C F; Qin, L Q; Qin, N; Qin, X S; Qin, Z H; Qiu, J F; Rashid, K H; Redmer, C F; Ripka, M; Rong, G; Rosner, Ch; Ruan, X D; Santoro, V; Sarantsev, A; Savrié, M; Schoenning, K; Schumann, S; Shan, W; Shao, M; Shen, C P; Shen, P X; Shen, X Y; Sheng, H Y; Song, W M; Song, X Y; Sosio, S; Spataro, S; Sun, G X; Sun, J F; Sun, S S; Sun, Y J; Sun, Y Z; Sun, Z J; Sun, Z T; Tang, C J; Tang, X; Tapan, I; Thorndike, E H; Tiemens, M; Ullrich, M; Uman, I; Varner, G S; Wang, B; Wang, B L; Wang, D; Wang, D Y; Wang, K; Wang, L L; Wang, L S; Wang, M; Wang, P; Wang, P L; Wang, S G; Wang, W; Wang, W P; Wang, X F; Wang, Y D; Wang, Y F; Wang, Y Q; Wang, Z; Wang, Z G; Wang, Z H; Wang, Z Y; Weber, T; Wei, D H; Wei, J B; Weidenkaff, P; Wen, S P; Wiedner, U; Wolke, M; Wu, L H; Wu, Z; Xia, L; Xia, L G; Xia, Y; Xiao, D; Xiao, H; Xiao, Z J; Xie, Y G; Xiu, Q L; Xu, G F; Xu, L; Xu, Q J; Xu, Q N; Xu, X P; Yan, L; Yan, W B; Yan, W C; Yan, Y H; Yang, H J; Yang, H X; Yang, L; Yang, Y X; Ye, M; Ye, M H; Yin, J H; Yu, B X; Yu, C X; Yu, J S; Yuan, C Z; Yuan, W L; Yuan, Y; Yuncu, A; Zafar, A A; Zallo, A; Zeng, Y; Zeng, Z; Zhang, B X; Zhang, B Y; Zhang, C; Zhang, C C; Zhang, D H; Zhang, H H; Zhang, H Y; Zhang, J J; Zhang, J L; Zhang, J Q; Zhang, J W; Zhang, J Y; Zhang, J Z; Zhang, K; Zhang, L; Zhang, X Y; Zhang, Y; Zhang, Y H; Zhang, Y N; Zhang, Y T; Zhang, Yu; Zhang, Z H; Zhang, Z P; Zhang, Z Y; Zhao, G; Zhao, J W; Zhao, J Y; Zhao, J Z; Zhao, Lei; Zhao, Ling; Zhao, M G; Zhao, Q; Zhao, Q W; Zhao, S J; Zhao, T C; Zhao, Y B; Zhao, Z G; Zhemchugov, A; Zheng, B; Zheng, J P; Zheng, W J; Zheng, Y H; Zhong, B; Zhou, L; Zhou, X; Zhou, X K; Zhou, X R; Zhou, X Y; Zhu, K; Zhu, K J; Zhu, S; Zhu, S H; Zhu, X L; Zhu, Y C; Zhu, Y S; Zhu, Z A; Zhuang, J; Zotti, L; Zou, B S; Zou, J H

2016-02-05

We report the first measurement of absolute hadronic branching fractions of Λ_{c}^{+} baryon at the Λ_{c}^{+}Λ[over ¯]_{c}^{-} production threshold, in the 30 years since the Λ_{c}^{+} discovery. In total, 12 Cabibbo-favored Λ_{c}^{+} hadronic decay modes are analyzed with a double-tag technique, based on a sample of 567  pb^{-1} of e^{+}e^{-} collisions at sqrt[s]=4.599  GeV recorded with the BESIII detector. A global least-squares fitter is utilized to improve the measured precision. Among the measurements for twelve Λ_{c}^{+} decay modes, the branching fraction for Λ_{c}^{+}→pK^{-}π^{+} is determined to be (5.84±0.27±0.23)%, where the first uncertainty is statistical and the second is systematic. In addition, the measurements of the branching fractions of the other 11 Cabibbo-favored hadronic decay modes are significantly improved.

Hadron production experiments

NASA Astrophysics Data System (ADS)

Popov, Boris A.

2013-02-01

The HARP and NA61/SHINE hadroproduction experiments as well as their implications for neutrino physics are discussed. HARP measurements have already been used for predictions of neutrino beams in K2K and MiniBooNE/SciBooNE experiments and are also being used to improve the atmospheric neutrino flux predictions and to help in the optimization of neutrino factory and super-beam designs. First measurements released recently by the NA61/SHINE experiment are of significant importance for a precise prediction of the J-PARC neutrino beam used for the T2K experiment. Both HARP and NA61/SHINE experiments provide also a large amount of input for validation and tuning of hadron production models in Monte-Carlo generators.

Introduction to the EC's Marie Curie Initial Training Network (MC-ITN) project: Particle Training Network for European Radiotherapy (PARTNER).

PubMed

Dosanjh, Manjit; Magrin, Giulio

2013-07-01

PARTNER (Particle Training Network for European Radiotherapy) is a project funded by the European Commission's Marie Curie-ITN funding scheme through the ENLIGHT Platform for 5.6 million Euro. PARTNER has brought together academic institutes, research centres and leading European companies, focusing in particular on a specialized radiotherapy (RT) called hadron therapy (HT), interchangeably referred to as particle therapy (PT). The ultimate goal of HT is to deliver more effective treatment to cancer patients leading to major improvement in the health of citizens. In Europe, several hundred million Euro have been invested, since the beginning of this century, in PT. In this decade, the use of HT is rapidly growing across Europe, and there is an urgent need for qualified researchers from a range of disciplines to work on its translational research. In response to this need, the European community of HT, and in particular 10 leading academic institutes, research centres, companies and small and medium-sized enterprises, joined together to form the PARTNER consortium. All partners have international reputations in the diverse but complementary fields associated with PT: clinical, radiobiological and technological. Thus the network incorporates a unique set of competencies, expertise, infrastructures and training possibilities. This paper describes the status and needs of PT research in Europe, the importance of and challenges associated with the creation of a training network, the objectives, the initial results, and the expected long-term benefits of the PARTNER initiative.

Gold Nanoparticle Hyperthermia Reduces Radiotherapy Dose

PubMed Central

Lin, Lynn; Slatkin, Daniel N.; Dilmanian, F. Avraham; Vadas, Timothy M.; Smilowitz, Henry M.

2014-01-01

Gold nanoparticles can absorb near infrared light, resulting in heating and ablation of tumors. Gold nanoparticles have also been used for enhancing the dose of X-rays in tumors during radiotherapy. The combination of hyperthermia and radiotherapy is synergistic, importantly allowing a reduction in X-ray dose with improved therapeutic results. Here we intratumorally infused small 15 nm gold nanoparticles engineered to be transformed from infrared-transparent to infrared-absorptive by the tumor, which were then heated by infrared followed by X-ray treatment. Synergy was studied using a very radioresistant subcutaneous squamous cell carcinoma (SCCVII) in mice. It was found that the dose required to control 50% of the tumors, normally 55 Gy, could be reduced to <15 Gy (a factor of >3.7). Gold nanoparticles therefore provide a method to combine hyperthermia and radiotherapy to drastically reduce the X-ray radiation needed, thus sparing normal tissue, reducing the side effects, and making radiotherapy more effective. PMID:24990355

Higgs Boson Searches at Hadron Colliders (1/4)

ScienceCinema

Jakobs, Karl

2018-05-21

In these Academic Training lectures, the phenomenology of Higgs bosons and search strategies at hadron colliders are discussed. After a brief introduction on Higgs bosons in the Standard Model and a discussion of present direct and indirect constraints on its mass the status of the theoretical cross section calculations for Higgs boson production at hadron colliders is reviewed. In the following lectures important experimental issues relevant for Higgs boson searches (trigger, measurements of leptons, jets and missing transverse energy) are presented. This is followed by a detailed discussion of the discovery potential for the Standard Model Higgs boson for both the Tevatron and the LHC experiments. In addition, various scenarios beyond the Standard Model, primarily the MSSM, are considered. Finally, the potential and strategies to measured Higgs boson parameters and the investigation of alternative symmetry breaking scenarios are addressed.

Local Quark-Hadron Duality in Electron Scattering

DOE Office of Scientific and Technical Information (OSTI.GOV)

Wally Melnitchouk

2007-09-10

We present some recent developments in the study of quark-hadron duality in structure functions in the resonance region. To understand the workings of local duality we introduce the concept of truncated moments, which are used to describe the Q^2 dependence of specific resonance regions within a QCD framework.

Hypothyroidism After Head-and-Neck Radiotherapy in Children and Adolescents: Preliminary Results of the 'Registry for the Evaluation of Side Effects After Radiotherapy in Childhood and Adolescence' (RiSK)

DOE Office of Scientific and Technical Information (OSTI.GOV)

Boelling, Tobias, E-mail: Tobias.Boelling@uni-muenster.de; Department of Radiotherapy, Paracelsus Clinic Osnabrueck, Osnabrueck; Geisenheiser, Alina

Purpose: The 'Registry for the Evaluation of Side Effects After Radiotherapy in Childhood and Adolescence' (RiSK) has been established to prospectively characterize dose-volume effects of radiation in terms of side effects. The aim of this analysis was to characterize the function of the thyroid gland after radiotherapy to the head-and-neck region in children and adolescents. Methods and Materials: Detailed information regarding radiation doses to at-risk organs has been collected across Germany since 2001. Thyroid function was evaluated by blood value examinations of thyroid-stimulating hormone, triiodothyronine, and thyroxine. Information regarding thyroid hormone substitution was requested from the treating physicians. Results: Untilmore » May 2009, 1,086 patients from 62 centers were recruited, including 404 patients (median age, 10.9 years) who had received radiotherapy to the thyroid gland and/or hypophysis. Follow-up information was available for 264 patients (60.9%; median follow-up, 40 months), with 60 patients (22.7%) showing pathologic values. In comparison to patients treated with prophylactic cranial irradiation (median dose, 12 Gy), patients with radiation doses of 15 to 25 Gy to the thyroid gland had a hazard ratio of 3.072 (p = 0.002) for the development of pathologic thyroid blood values. Patients with greater than 25 Gy to the thyroid gland and patients who underwent craniospinal irradiation had hazard ratios of 3.768 (p = 0.009) and 5.674 (p < 0.001), respectively. The cumulative incidence of thyroid hormone substitution therapy did not differ between defined subgroups. Conclusions: Radiation-induced thyroid function impairment, including damage to the thyroid gland and/or hypophysis, can frequently be observed after radiotherapy in children. A structured follow-up examination is advised.« less

Identified hadron spectra from PHOBOS

NASA Astrophysics Data System (ADS)

Veres, Gábor I.; PHOBOS Collaboration; Back, B. B.; Baker, M. D.; Ballintijn, M.; Barton, D. S.; Becker, B.; Betts, R. R.; Bickley, A. A.; Bindel, R.; Busza, W.; Carroll, A.; Decowski, M. P.; García, E.; Gburek, T.; George, N.; Gulbrandsen, K.; Gushue, S.; Halliwell, C.; Hamblen, J.; Harrington, A. S.; Henderson, C.; Hofman, D. J.; Hollis, R. S.; Holynski, R.; Holzman, B.; Iordanova, A.; Johnson, E.; Kane, J. L.; Khan, N.; Kulinich, P.; Kuo, C. M.; Lee, J. W.; Lin, W. T.; Manly, S.; Mignerey, A. C.; Nouicer, R.; Olszewski, A.; Pak, R.; Park, I. C.; Pernegger, H.; Reed, C.; Roland, C.; Roland, G.; Sagerer, J.; Sarin, P.; Sedykh, I.; Skulski, W.; Smith, C. E.; Steinberg, P.; Stephans, G. S. F.; Sukhanov, A.; Tonjes, M. B.; Trzupek, A.; Vale, C.; van Nieuwenhuizen, G. J.; Verdier, R.; Wolfs, F. L. H.; Wosiek, B.; Wozniak, K.; Wyslouch, B.; Zhang, J.

2004-08-01

Transverse momentum spectra of pions, kaons and protons, as well as antiparticle to particle ratios near mid-rapidity from d+Au collisions at \\sqrt{s_{{\\rm NN}}} = 200\\,{\\rm GeV} have been measured by the PHOBOS experiment at RHIC. The transverse momentum range of particle identification was extended to beyond 3 GeV/c using the TOF detector and a new trigger system. The pseudorapidity dependence of the nuclear modification factor for charged hadrons in d+Au collisions is presented.

The decay width of stringy hadrons

NASA Astrophysics Data System (ADS)

Sonnenschein, Jacob; Weissman, Dorin

2018-02-01

In this paper we further develop a string model of hadrons by computing their strong decay widths and comparing them to experiment. The main decay mechanism is that of a string splitting into two strings. The corresponding total decay width behaves as Γ = π/2 ATL where T and L are the tension and length of the string and A is a dimensionless universal constant. We show that this result holds for a bosonic string not only in the critical dimension. The partial width of a given decay mode is given by Γi / Γ =Φi exp ⁡ (- 2 πCmsep2 / T) where Φi is a phase space factor, msep is the mass of the "quark" and "antiquark" created at the splitting point, and C is a dimensionless coefficient close to unity. Based on the spectra of hadrons we observe that their (modified) Regge trajectories are characterized by a negative intercept. This implies a repulsive Casimir force that gives the string a "zero point length". We fit the theoretical decay width to experimental data for mesons on the trajectories of ρ, ω, π, η, K*, ϕ, D, and Ds*, and of the baryons N, Δ, Λ, and Σ. We examine both the linearity in L and the exponential suppression factor. The linearity was found to agree with the data well for mesons but less for baryons. The extracted coefficient for mesons A = 0.095 ± 0.015 is indeed quite universal. The exponential suppression was applied to both strong and radiative decays. We discuss the relation with string fragmentation and jet formation. We extract the quark-diquark structure of baryons from their decays. A stringy mechanism for Zweig suppressed decays of quarkonia is proposed and is shown to reproduce the decay width of ϒ states. The dependence of the width on spin and flavor symmetry is discussed. We further apply this model to the decays of glueballs and exotic hadrons.

Charge structure of the hadronic final state in deep-inelastic muon-nucleon scattering

NASA Astrophysics Data System (ADS)

Arneodo, M.; Arvidson, A.; Aubert, J. J.; Bedełek, J.; Beaufays, J.; Bee, C. P.; Benchouk, C.; Berghoff, G.; Bird, I.; Blum, D.; Böhm, E.; de Bouard, X.; Brasse, F. W.; Braun, H.; Broll, C.; Brown, S.; Brück, H.; Calen, H.; Chima, J. S.; Ciborowski, J.; Clifft, R.; Coignet, G.; Combley, F.; Coughlan, J.; D'Agostini, G.; Dahlgren, S.; Dengler, F.; Derado, I.; Dreyer, T.; Drees, J.; Düren, M.; Eckardt, V.; Edwards, A.; Edwards, M.; Ernst, T.; Eszes, G.; Favier, J.; Ferrero, M. I.; Figiel, J.; Flauger, W.; Foster, J.; Ftáčnik, J.; Gabathuler, E.; Gajewski, J.; Gamet, R.; Gayler, J.; Geddes, N.; Grafström, P.; Grard, F.; Haas, J.; Hagberg, E.; Hasert, F. J.; Hayman, P.; Heusse, P.; Jaffré, M.; Jachołkowska, A.; Janata, F.; Jancsó, G.; Johnson, A. S.; Kabuss, E. M.; Kellner, G.; Korbel, V.; Krüger, J.; Kullander, S.; Landgraf, U.; Lanske, D.; Loken, J.; Long, K.; Maire, M.; Malecki, P.; Manz, A.; Maselli, S.; Mohr, W.; Montanet, F.; Montgomery, H. E.; Nagy, E.; Nassalski, J.; Norton, P. R.; Oakham, F. G.; Osborne, A. M.; Pascaud, C.; Pawlik, B.; Payre, P.; Peroni, C.; Peschel, H.; Pessard, H.; Pettinghale, J.; Pietrzyk, B.; Pietrzyk, U.; Pönsgen, B.; Pötsch, M.; Renton, P.; Ribarics, P.; Rith, K.; Rondio, E.; Sandacz, A.; Scheer, M.; Schlagböhmer, A.; Schiemann, H.; Schmitz, N.; Schneegans, M.; Schneider, A.; Scholz, M.; Schröder, T.; Schultze, K.; Sloan, T.; Stier, H. E.; Studt, M.; Taylor, G. N.; Thénard, J. M.; Thompson, J. C.; de La Torre, A.; Toth, J.; Urban, L.; Wallucks, W.; Whalley, M.; Wheeler, S.; Williams, W. S. C.; Wimpenny, S. J.; Windmolders, R.; Wolf, G.

1988-09-01

The general charge properties of the hadronic final state produced in μ + p and μ + d interactions at 280 GeV are investigated. Quark charge retention and local charge compensation is observed. The ratio F {2/ n }/ F {2/ p } of the neutron to proton structure function is derived from the measurement of the average hadronic charge in μ d interactions.

Fragmentation uncertainties in hadronic observables for top-quark mass measurements

NASA Astrophysics Data System (ADS)

Corcella, Gennaro; Franceschini, Roberto; Kim, Doojin

2018-04-01

We study the Monte Carlo uncertainties due to modeling of hadronization and showering in the extraction of the top-quark mass from observables that use exclusive hadronic final states in top decays, such as t →anything + J / ψ or t →anything + (B →charged tracks), where B is a B-hadron. To this end, we investigate the sensitivity of the top-quark mass, determined by means of a few observables already proposed in the literature as well as some new proposals, to the relevant parameters of event generators, such as HERWIG 6 and PYTHIA 8. We find that constraining those parameters at O (1%- 10%) is required to avoid a Monte Carlo uncertainty on mt greater than 500 MeV. For the sake of achieving the needed accuracy on such parameters, we examine the sensitivity of the top-quark mass measured from spectral features, such as peaks, endpoints and distributions of EB, mBℓ, and some mT2-like variables. We find that restricting oneself to regions sufficiently close to the endpoints enables one to substantially decrease the dependence on the Monte Carlo parameters, but at the price of inflating significantly the statistical uncertainties. To ameliorate this situation we study how well the data on top-quark production and decay at the LHC can be utilized to constrain the showering and hadronization variables. We find that a global exploration of several calibration observables, sensitive to the Monte Carlo parameters but very mildly to mt, can offer useful constraints on the parameters, as long as such quantities are measured with a 1% precision.

Polarization and Resummation in Slepton Production at Hadron Colliders

NASA Astrophysics Data System (ADS)

Klasen, M.

2006-10-01

In R-parity conserving supersymmetric (SUSY) models, sleptons are produced in pairs at hadron colliders through neutral and charged electroweak currents. We demonstrate that the polarization of the initial hadron beams allows for a direct extraction of the slepton mixing angle and thus for a determination of the underlying SUSY-breaking mechanism. We also perform a first precision calculation of the transverse-momentum ( q T) spectrum of the slepton pairs by resumming soft multiple-gluon emission at next-to-leading logarithmic order. The results show a relevant contribution of resummation both in the small and intermediate q T-regions, which strongly influences the extraction of the missing transverse-momentum signal and the subsequent slepton mass-determination, and little dependence on unphysical scales and non-perturbative contributions.

Transverse momentum of hadrons produced in ν and overlineν interactions on an isoscalar target in BEBC

NASA Astrophysics Data System (ADS)

Deden, H.; Fritze, P.; Grässler, H.; Hasert, F. J.; Morfin, J.; Schulte, R.; Böckmann, K.; Geich-Gimbel, C.; Kokott, T. P.; Nellen, B.; Pech, R.; Saarikko, H.; Bosetti, P. C.; Cundy, D. C.; Grant, A. L.; Hulth, P. O.; Pape, L.; Scott, W. G.; Skjeggestad, O.; Mermikides, M.; Simopoulou, E.; Vayaki, A.; Barnham, K. W. J.; Butterworth, I.; Chima, J. S.; Clayton, E. F.; Miller, D. B.; Mobayyen, M.; Penfold, C.; Powell, K. J.; Batley, J. R.; Giles, R.; Grossmann, P.; Lloyd, J. L.; Myatt, G.; Perkins, D. H.; Radojicic, D.; Renton, P.; Saitta, B.; Bloch, M.; Bolognese, T.; Tallini, B.; Velasco, J.; Vignaud, D.; Aachen-Bonn-CERN-Demokritos Athens-I. C. London-Oxford-Saclay Collaboration

1981-04-01

The average transverse momentum squared, < p⊥2>, of hadrons is studied as a function of W2 and of Q2 for ν and overlineν interactions on an isoscalar target. An increase of < p⊥2> with W2 is observed for the hadrons emitted forward in the hadronic c.m.s. The p⊥ dependence of the fragmentation function is found to factorise from the structure function at fixed W, but does not factorise at fixed Q2. Unlike the case of forward-going particles, the < p⊥2> of hadrons going backward in the c.m.s. shows no strong dependence on W2.

Updates on clinical studies of selenium supplementation in radiotherapy

PubMed Central

2014-01-01

To establish guidelines for the selenium supplementation in radiotherapy we assessed the benefits and risks of selenium supplementation in radiotherapy. Clinical studies on the use of selenium in radiotherapy were searched in the PubMed electronic database in January 2013. Sixteen clinical studies were identified among the 167 articles selected in the initial search. Ten articles were observational studies, and the other 6 articles reported studies on the effects of selenium supplementation in patients with cancer who underwent radiotherapy. The studies were conducted worldwide including European, American and Asian countries between 1987 and 2012. Plasma, serum or whole blood selenium levels were common parameters used to assess the effects of radiotherapy and the selenium supplementation status. Selenium supplementation improved the general conditions of the patients, improved their quality of life and reduced the side effects of radiotherapy. At the dose of selenium used in these studies (200–500 μg/day), selenium supplementation did not reduce the effectiveness of radiotherapy, and no toxicities were reported. Selenium supplementation may offer specific benefits for several types of cancer patients who undergo radiotherapy. Because high-dose selenium and long-term supplementation may be unsafe due to selenium toxicity, more evidence-based information and additional research are needed to ensure the therapeutic benefits of selenium supplementation. PMID:24885670

PREFACE: The first meeting of the APS Topical Group on Hadronic Physics

NASA Astrophysics Data System (ADS)

Barnes, Ted; Godfrey, Steve; Petrov, Alexey A.; Swanson, Eric

2005-01-01

The first meeting of the APS Topical Group on Hadronic Physics (`GHP') took place on 24-26 October 2004, at Fermilab. Two factors contributed to the decision to hold this meeting. First, the Topical Group on Hadronic Physics had recently been established, and there was general agreement that a conference devoted to the physics of hadrons was an important group activity. Second, many exciting new experimental results on hadron spectroscopy had been announced recently, and there was intense interest in these new developments. The meeting was very well attended, with over 120 scientists participating; this was triple our original estimate of the likely audience for this meeting. The plenary sessions covered a broad range of topics, as we considered it important to promote communication between the communities pursuing research in different areas of hadron physics. The topics discussed included new results from RHIC on the QGP, the status of experiments on the flavour-exotic pentaquark and other new baryons, the new open-charm Ds and hidden-charm X states, conventional light quark resonances, glueballs and hybrids, and new facilities. Finally, a `town meeting' was held to discuss funding prospects for hadronic physics and related issues, which included a panel discussion with representatives from DOE, NSF and JLab. These plenary sessions were supplemented by 14 parallel sessions, giving a total of approximately 80 presentations. To make the conference more accessible to younger researchers, as well as to simiplify administration, there was no conference fee for this meeting. This was possible as a result of the generous financial support of our hosts at Fermilab, for which we are very appreciative. We are also grateful to Larry Cardman for arranging Jlab assistance in producing and distributing the conference poster, to Gerald Ragghianti for designing the poster and proceedings cover, and to Lali Chatterjee and the Institute of Physics for arranging publication of the

ATM Mutations and the Development of Severe Radiation-Induced Morbidity Following Radiotherapy for Breast Cancer

DTIC Science & Technology

2006-07-01

patients who are carriers of an alteration in this gene . This project is innovative as it represents the first study to use the powerful DHPLC mutation ...development of adverse responses to radiotherapy (5-6). The first gene to have received significant attention was the mutated in ataxia telangiectasia (AT...Group and Concannon PJ. 2003. Designing and implementing quality control for multi-center screening of mutations in the ATM gene among women with

Enhancing radiotherapy for lung cancer using immunoadjuvants delivered in situ from new design radiotherapy biomaterials: a preclinical study

NASA Astrophysics Data System (ADS)

Hao, Yao; Yasmin-Karim, Sayeda; Moreau, Michele; Sinha, Neeharika; Sajo, Erno; Ngwa, Wilfred

2016-12-01

Studies show that radiotherapy of a primary tumor in combination with immunoadjuvants (IA) can result in increased survival or immune-mediated regression of metastasis outside the radiation field, a phenomenon known as abscopal effect. However, toxicities due to repeated systematic administration of IA have been shown to be a major obstacle in clinical trials. To minimize the toxicities and prime a more potent immune response, Ngwa et al have proposed that inert radiotherapy biomaterials such as fiducials could be upgraded to multifunctional ones loaded with IA for in situ delivery directly into the tumor sub-volume at no additional inconvenience to patients. In this preliminary study, the potential of such an approach is investigated for lung cancer using anti-CD40 antibody. First the benefit of using the anti-CD40 delivered in situ to enhance radiotherapy was tested in mice with subcutaneous tumors generated with the Lewis Lung cancer cell line LL/2 (LLC-1). The tumors were implanted on both flanks of the mice to simulate metastasis. Tumors on one flank were treated with and without anti-CD40 and the survival benefits compared. An experimentally determined in vivo diffusion coefficient for nanoparticles was then employed to estimate the time for achieving intratumoral distribution of the needed minimal concentrations of anti-CD40 nanoparticles if released from a multifuntional radiotherapy biomaterials. The studies show that the use of anti-CD40 significantly enhanced radiotherapy effect, slowing the growth of the treated and untreated tumors, and increasing survival. Meanwhile our calculations indicate that for a 2-4 cm tumor and 7 mg g-1 IA concentrations, it would take 4.4-17.4 d, respectively, following burst release, for the required concentration of IA nanoparticles to accumulate throughout the tumor during image-guided radiotherapy. The distribution of IA could be customized as a function of loading concentrations or nanoparticle size to fit current

Enhancing radiotherapy for lung cancer using immunoadjuvants delivered in situ from new design radiotherapy biomaterials: a preclinical study.

PubMed

Hao, Yao; Yasmin-Karim, Sayeda; Moreau, Michele; Sinha, Neeharika; Sajo, Erno; Ngwa, Wilfred

2016-12-21

Studies show that radiotherapy of a primary tumor in combination with immunoadjuvants (IA) can result in increased survival or immune-mediated regression of metastasis outside the radiation field, a phenomenon known as abscopal effect. However, toxicities due to repeated systematic administration of IA have been shown to be a major obstacle in clinical trials. To minimize the toxicities and prime a more potent immune response, Ngwa et al have proposed that inert radiotherapy biomaterials such as fiducials could be upgraded to multifunctional ones loaded with IA for in situ delivery directly into the tumor sub-volume at no additional inconvenience to patients. In this preliminary study, the potential of such an approach is investigated for lung cancer using anti-CD40 antibody. First the benefit of using the anti-CD40 delivered in situ to enhance radiotherapy was tested in mice with subcutaneous tumors generated with the Lewis Lung cancer cell line LL/2 (LLC-1). The tumors were implanted on both flanks of the mice to simulate metastasis. Tumors on one flank were treated with and without anti-CD40 and the survival benefits compared. An experimentally determined in vivo diffusion coefficient for nanoparticles was then employed to estimate the time for achieving intratumoral distribution of the needed minimal concentrations of anti-CD40 nanoparticles if released from a multifuntional radiotherapy biomaterials. The studies show that the use of anti-CD40 significantly enhanced radiotherapy effect, slowing the growth of the treated and untreated tumors, and increasing survival. Meanwhile our calculations indicate that for a 2-4 cm tumor and 7 mg g -1 IA concentrations, it would take 4.4-17.4 d, respectively, following burst release, for the required concentration of IA nanoparticles to accumulate throughout the tumor during image-guided radiotherapy. The distribution of IA could be customized as a function of loading concentrations or nanoparticle size to fit current

Radiotherapy demand and activity in England 2006-2020.

PubMed

Round, C E; Williams, M V; Mee, T; Kirkby, N F; Cooper, T; Hoskin, P; Jena, R

2013-09-01

This paper compares the predictions of radiotherapy demand for England from the Malthus model with those from the earlier National Radiotherapy Advisory Group (NRAG) model, from the international literature and also with observed radiotherapy usage in England as a whole as recorded in the English radiotherapy dataset (RTDS). We reviewed the evidence base for radiotherapy for each type and stage of cancer using national and international guidelines, meta-analyses, systematic reviews and key clinical trials. Twenty-two decision trees were constructed and radiotherapy demand was calculated using English cancer incidence data for 2007, 2008 and 2009, accurate to the Primary Care Trust (PCT) level (population 91,500-1,282,384). The stage at presentation was obtained from English cancer registry data. In predictive mode, the model can take account of changes in cancer incidence as the population grows and ages. The Malthus model indicates reduced indications for radiotherapy, principally for lung cancer and rarer tumours. Our estimate of the proportion of patients who should receive radiotherapy at some stage of their illness is 40.6%. This is lower than previous estimates of about 50%. Nevertheless, the overall estimate of demand in terms of attendances is similar for the NRAG and Malthus models. The latter models that 48,827 attendances should have been delivered per million population in 2011. National data from RTDS show 32,071 attendances per million in 2011. A 50% increase in activity would be required to match estimated demand. This underprovision extends across all cancers and represents reduced access and the use of dose fractionation at odds with international norms of evidence-based practice. By 2016, demand is predicted to grow to about 55,206 attendances per million and by 2020 to 60,057. Services have increased their activity by 14% between 2006 and 2011, but estimated demand has increased by 11%. Access remains low and English radiotherapy dose

Signatures of chiral symmetry restoration and its survival throughout the hadronic phase interactions

NASA Astrophysics Data System (ADS)

Bratkovskaya, E. L.; Moreau, P.; Palmese, A.; Cassing, W.; Seifert, E.; Steinert, T.

2018-02-01

The effect of the chiral symmetry restoration (CSR) on observables from heavy-ion collisions is studied in the energy range =3-20 GeV within the Parton-Hadron-String Dynamics (PHSD) transport approach. The PHSD includes the deconfinement phase transition as well as essential aspects of CSR in the dense and hot hadronic medium, which are incorporated in the Schwinger mechanism for the hadronic particle production. We adopt different parametrizations of the nuclear equation of state from the non-linear σ - ω model, which enter in the computation of the quark scalar density for the CSR mechanism, in order to estimate the uncertainty in our calculations. For the pion-nucleon ∑-term we adopt ∑π ≈ 45 MeV which corresponds to a 'world average'. Our systematic studies show that chiral symmetry restoration plays a crucial role in the description of heavy-ion collisions at =3-20 GeV, realizing an increase of the hadronic particle production in the strangeness sector with respect to the non-strange one. We identify particle abundances and rapidity spectra to be suitable probes in order to extract information about CSR, while transverse mass spectra are less sensitive ones. Our results provide a microscopic explanation for the "horn" structure in the excitation function of the K+/π+ ratio: the CSR in the hadronic phase produces the steep increase of this particle ratio up to ≈ 7 GeV, while the drop at higher energies is associated to the appearance of a deconfined partonic medium.

Higgs boson production at hadron colliders at N3LO in QCD

NASA Astrophysics Data System (ADS)

Mistlberger, Bernhard

2018-05-01

We present the Higgs boson production cross section at Hadron colliders in the gluon fusion production mode through N3LO in perturbative QCD. Specifically, we work in an effective theory where the top quark is assumed to be infinitely heavy and all other quarks are considered to be massless. Our result is the first exact formula for a partonic hadron collider cross section at N3LO in perturbative QCD. Furthermore, our result is an analytic computation of a hadron collider cross section involving elliptic integrals. We derive numerical predictions for the Higgs boson cross section at the LHC. Previously this result was approximated by an expansion of the cross section around the production threshold of the Higgs boson and we compare our findings. Finally, we study the impact of our new result on the state of the art prediction for the Higgs boson cross section at the LHC.

Forward hadron calorimeter at MPD/NICA

NASA Astrophysics Data System (ADS)

Golubeva, M.; Guber, F.; Ivashkin, A.; Izvestnyy, A.; Kurepin, A.; Morozov, S.; Parfenov, P.; Petukhov, O.; Taranenko, A.; Selyuzhenkov, I.; Svintsov, I.

2017-01-01

Forward hadron calorimeter (FHCAL) at MPD/NICA experimental setup is described. The main purpose of the FHCAL is to provide an experimental measurement of a heavy-ion collision centrality (impact parameter) and orientation of its reaction plane. Precise event-by-event estimate of these basic observables is crucial for many physics phenomena studies to be performed by the MPD experiment. The simulation results of FHCAL performance are presented.

Mutations of Electrons as Constituents of Hadrons

NASA Astrophysics Data System (ADS)

Driscoll, R. B.

1997-04-01

Conjecture (C) 1: Coulomb-charged constituents of electron (e) are attracted to its barycentre by lepto-strong force F=K/r^2+f; f is stably perturbative for r < the "radius" of e. An exterior magnetic field (MF) with gradient (G) secularly perturbs the eccentricities but not the energies of the constituents' orbits, changing the spin (s) and magnetic moment (μ) of e. (C) 2: F coheres two or more e's dynamically with r approximately equal to the "radius" of e. The resulting MF and G at each e oscillate. Stable values of s and μ result for each e which differs from the atomic values. Binding energies change the masses of the e's. A hadron results. (C) 3: An e similarly may bind to a proton to form a Rutherford- Santilli neutron. The proton is negligibly mutated.(References: H. Dehmelt, Science 247, 539 (1990); T.E. Phipps, Jr., Heretical Verities (Classic Non-fiction Library, Urbana, 1986); R.M. Santilli, Hadronic Mechanics (Ukrainian Academy of Sciences, Kiev, 1995 and 1996), 3 volumes.)

Strange hadron production at low transverse momenta

NASA Astrophysics Data System (ADS)

Veres, Gábor I.; PHOBOS Collaboration; Back, B. B.; Baker, M. D.; Ballintijn, M.; Barton, D. S.; Becker, B.; Betts, R. R.; Bickley, A. A.; Bindel, R.; Budzanowski, A.; Busza, W.; Carroll, A.; Decowski, M. P.; García, E.; Gburek, T.; George, N.; Gulbrandsen, K.; Gushue, S.; Halliwell, C.; Hamblen, J.; Harrington, A. S.; Henderson, C.; Hofman, D. J.; Hollis, R. S.; Holynski, R.; Holzman, B.; Iordanova, A.; Johnson, E.; Kane, J. L.; Khan, N.; Kulinich, P.; Kuo, C. M.; Lee, J. W.; Lin, W. T.; Manly, S.; Mignerey, A. C.; Noell, A.; Nouicer, R.; Olszewski, A.; Pak, R.; Park, I. C.; Pernegger, H.; Reed, C.; Remsberg, L. P.; Roland, C.; Roland, G.; Sagerer, J.; Sarin, P.; Sawicki, P.; Sedykh, I.; Skulski, W.; Smith, C. E.; Steinberg, P.; Stephans, G. S. F.; Sukhanov, A.; Teng, R.; Tonjes, M. B.; Trzupek, A.; Vale, C.; van Nieuwenhuizen, G. J.; Verdier, R.; Wadsworth, B.; Wolfs, F. L. H.; Wosiek, B.; Woźniak, K.; Wuosmaa, A. H.; Wyslouch, B.; Zhang, J.

2004-01-01

Some of the latest results of the PHOBOS experiment from the \\sqrt{s_{NN}}= 200\\ GeV Au+Au data are discussed. Those relevant to strangeness production are emphasized. These observations relate to the nature of the matter created when heavy ions collide at the highest achieved energy. The invariant yields of strange and non-strange charged hadrons at very low transverse momentum have been measured, and used to differentiate between different dynamical scenarios. In the intermediate transverse momentum range, the measured ratios of strange and anti-strange kaons approach one, while the antibaryon to baryon ratio is still significantly less, independent of collision centrality and transverse momentum. At high transverse momenta, we find that central and peripheral Au+Au collisions produce similar numbers of charged hadrons per participant nucleon pair, rather than per binary nucleon-nucleon collision. Finally, we describe the upgrades of PHOBOS completed for the 2003 d+Au and p+p run, which extend the transverse momentum range over which particle identification is possible and, at the same time, implement a trigger system selective for high-pT particles.

Radiotherapy for Vestibular Schwannomas: A Critical Review

DOE Office of Scientific and Technical Information (OSTI.GOV)

Murphy, Erin S., E-mail: murphye3@ccf.or; Suh, John H.

2011-03-15

Vestibular schwannomas are slow-growing tumors of the myelin-forming cells that cover cranial nerve VIII. The treatment options for patients with vestibular schwannoma include active observation, surgical management, and radiotherapy. However, the optimal treatment choice remains controversial. We have reviewed the available data and summarized the radiotherapeutic options, including single-session stereotactic radiosurgery, fractionated conventional radiotherapy, fractionated stereotactic radiotherapy, and proton beam therapy. The comparisons of the various radiotherapy modalities have been based on single-institution experiences, which have shown excellent tumor control rates of 91-100%. Both stereotactic radiosurgery and fractionated stereotactic radiotherapy have successfully improved cranial nerve V and VII preservation tomore » >95%. The mixed data regarding the ideal hearing preservation therapy, inherent biases in patient selection, and differences in outcome analysis have made the comparison across radiotherapeutic modalities difficult. Early experience using proton therapy for vestibular schwannoma treatment demonstrated local control rates of 84-100% but disappointing hearing preservation rates of 33-42%. Efforts to improve radiotherapy delivery will focus on refined dosimetry with the goal of reducing the dose to the critical structures. As future randomized trials are unlikely, we suggest regimented pre- and post-treatment assessments, including validated evaluations of cranial nerves V, VII, and VIII, and quality of life assessments with long-term prospective follow-up. The results from such trials will enhance the understanding of therapy outcomes and improve our ability to inform patients.« less

Locally Advanced Stage IV Squamous Cell Carcinoma of the Head and Neck: Impact of Pre-Radiotherapy Hemoglobin Level and Interruptions During Radiotherapy

DOE Office of Scientific and Technical Information (OSTI.GOV)

Rades, Dirk; Department of Radiation Oncology, University Medical Center Hamburg-Eppendorf, Hamburg; Stoehr, Monika

2008-03-15

Purpose: Stage IV head and neck cancer patients carry a poor prognosis. Clear understanding of prognostic factors can help to optimize care for the individual patient. This study investigated 11 potential prognostic factors including pre-radiotherapy hemoglobin level and interruptions during radiotherapy for overall survival (OS), metastases-free survival (MFS), and locoregional control (LC) after radiochemotherapy. Methods and Materials: Eleven factors were investigated in 153 patients receiving radiochemotherapy for Stage IV squamous cell head and neck cancer: age, gender, Karnofsky performance score (KPS), tumor site, grading, T stage, N stage, pre-radiotherapy hemoglobin level, surgery, chemotherapy type, and interruptions during radiotherapy >1 week.more » Results: On multivariate analysis, improved OS was associated with KPS 90-100 (relative risk [RR], 2.36; 95% confidence interval [CI], 1.20-4.93; p = .012), hemoglobin {>=}12 g/dL (RR, 1.88; 95% CI, 1.01-3.53; p = .048), and no radiotherapy interruptions (RR, 2.59; 95% CI, 1.15-5.78; p = .021). Improved LC was significantly associated with lower T stage (RR, 2.17; 95% CI, 1.16-4.63; p = .013), hemoglobin {>=}12 g/dL (RR, 4.12; 95% CI, 1.92-9.09; p < .001), surgery (RR, 2.67; 95% CI, 1.28-5.88; p = .008), and no radiotherapy interruptions (RR, 3.32; 95% CI, 1.26-8.79; p = .015). Improved MFS was associated with KPS 90-100 (RR, 3.41; 95% CI, 1.46-8.85; p = .012). Conclusions: Significant predictors for outcome in Stage IV head and neck cancer were performance status, stage, surgery, pre-radiotherapy hemoglobin level, and interruptions during radiotherapy >1 week. It appears important to avoid anemia and radiotherapy interruptions to achieve the best treatment results.« less

Stereotactic Body Radiotherapy for Medically Inoperable Lung Cancer: Prospective, Single-Center Study of 108 Consecutive Patients

DOE Office of Scientific and Technical Information (OSTI.GOV)

Taremi, Mojgan, E-mail: mojgan.taremi@rmp.uhn.on.ca; Department of Radiation Oncology, University Health Network, Toronto, ON; Department of Radiation Oncology, VU University Medical Center, Amsterdam

2012-02-01

Purpose: To present the results of stereotactic body radiotherapy (SBRT) for medically inoperable patients with Stage I non-small-cell lung cancer (NSCLC) and contrast outcomes in patients with and without a pathologic diagnosis. Methods and Materials: Between December 2004 and October 2008, 108 patients (114 tumors) underwent treatment according to the prospective research ethics board-approved SBRT protocols at our cancer center. Of the 108 patients, 88 (81.5%) had undergone pretreatment whole-body [18F]-fluorodeoxyglucose positron emission tomography/computed tomography. A pathologic diagnosis was unavailable for 33 (28.9%) of the 114 lesions. The SBRT schedules included 48 Gy in 4 fractions or 54-60 Gy inmore » 3 fractions for peripheral lesions and 50-60 Gy in 8-10 fractions for central lesions. Toxicity and radiologic response were assessed at the 3-6-month follow-up visits using conventional criteria. Results: The mean tumor diameter was 2.4-cm (range, 0.9-5.7). The median follow-up was 19.1 months (range, 1-55.7). The estimated local control rate at 1 and 4 years was 92% (95% confidence interval [CI], 86-97%) and 89% (95% CI, 81-96%). The cause-specific survival rate at 1 and 4 years was 92% (95% CI, 87-98%) and 77% (95% CI, 64-89%), respectively. No statistically significant difference was found in the local, regional, and distant control between patients with and without pathologically confirmed NSCLC. The most common acute toxicity was Grade 1 or 2 fatigue (53 of 108 patients). No toxicities of Grade 4 or greater were identified. Conclusions: Lung SBRT for early-stage NSCLC resulted in excellent local control and cause-specific survival with minimal toxicity. The disease-specific outcomes were comparable for patients with and without a pathologic diagnosis. SBRT can be considered an option for selected patients with proven or presumed early-stage NSCLC.« less

Electron Generation of Leptons and Hadrons with Conjugate α-QUANTIZED Lifetimes and Masses

NASA Astrophysics Data System (ADS)

Mac Gregor, Malcolm H.

In elementary particle theories the fine structure constant α = e2/ℏc serves as the coupling constant for lepton interactions (QED), but is assumed to play no role in hadron interactions (QCD). However, experiments have long indicated an α spacing in the lifetimes of the long-lived threshold-state hadrons, and they also suggest an α-related mass structure. Lifetimes and masses are conjugate quantum mechanical variables, so the α-dependence of these two variables is a mutual property. The relevance of α to hadron interactions is an experimental question, independent of theory. In the present paper we first make a detailed analysis of the experimental lifetime data. This analysis demonstrates that out of 156 particles with well-determined lifetimes τ, the 120 short excited-state lifetimes τ<10-21 sec have a continuum of values, but the 36 long threshold-state lifetimes τ>10-21 sec occur in α-spaced groups that cleanly sort out the s, c, b quark flavors. These 36 metastable lifetimes also exhibit a factor-of-3 c-to-b "flavor structure" and a pervasive factor-of-2 "hyperfine structure." We then invoke the conjugate relationship between lifetimes and masses to trace out an α-defined set of mass quanta that tie together leptons and hadrons. Mass generation occurs via an initial "α-leap" from an electron pair to a "platform state" M, and then subsequent excitations by a dominant quantum X. The low-mass "MX octet" of particles — μ, p, τ, π, η, η‧, K, ϕ — is reproduced to an average accuracy of 0.4%, with no adjustable parameters except a small binding energy for hadronic pairs. Without the inclusion of lepton masses, the spectrum of hadron masses is difficult to understand. These conjugate α-quantized results reinforce the reality of the spin 1/2 u, d, s, c, b quarks, and they also lead to the identification of a closely-related set of spinless mass quanta for the pseudoscalar mesons.

Internet-based computer technology on radiotherapy.

PubMed

Chow, James C L

2017-01-01

Recent rapid development of Internet-based computer technologies has made possible many novel applications in radiation dose delivery. However, translational speed of applying these new technologies in radiotherapy could hardly catch up due to the complex commissioning process and quality assurance protocol. Implementing novel Internet-based technology in radiotherapy requires corresponding design of algorithm and infrastructure of the application, set up of related clinical policies, purchase and development of software and hardware, computer programming and debugging, and national to international collaboration. Although such implementation processes are time consuming, some recent computer advancements in the radiation dose delivery are still noticeable. In this review, we will present the background and concept of some recent Internet-based computer technologies such as cloud computing, big data processing and machine learning, followed by their potential applications in radiotherapy, such as treatment planning and dose delivery. We will also discuss the current progress of these applications and their impacts on radiotherapy. We will explore and evaluate the expected benefits and challenges in implementation as well.

ÖGRO survey on radiotherapy capacity in Austria : Status quo and estimation of future demands.

PubMed

Zurl, Brigitte; Bayerl, Anja; De Vries, Alexander; Geinitz, Hans; Hawliczek, Robert; Knocke-Abulesz, Tomas-Henrik; Lukas, Peter; Pötter, Richard; Raunik, Wolfgang; Scholz, Brigitte; Schratter-Sehn, Annemarie; Sedlmayer, Felix; Seewald, Dietmar; Selzer, Edgar; Kapp, Karin S

2018-04-01

A comprehensive evaluation of the current national and regional radiotherapy capacity in Austria with an estimation of demands for 2020 and 2030 was performed by the Austrian Society for Radiation Oncology, Radiobiology and Medical Radiophysics (ÖGRO). All Austrian centers provided data on the number of megavoltage (MV) units, treatment series, fractions, percentage of retreatments and complex treatment techniques as well as the daily operating hours for the year 2014. In addition, waiting times until the beginning of radiotherapy were prospectively recorded over the first quarter of 2015. National and international epidemiological prediction data were used to estimate future demands. For a population of 8.51 million, 43 MV units were at disposal. In 14 radiooncological centers, a total of 19,940 series with a mean number of 464 patients per MV unit/year and a mean fraction number of 20 (range 16-24) per case were recorded. The average re-irradiation ratio was 14%. The survey on waiting times until start of treatment showed provision shortages in 40% of centers with a mean waiting time of 13.6 days (range 0.5-29.3 days) and a mean maximum waiting time of 98.2 days. Of all centers, 21% had no or only a limited ability to deliver complex treatment techniques. Predictions for 2020 and 2030 indicate an increased need in the overall number of MV units to a total of 63 and 71, respectively. This ÖGRO survey revealed major regional differences in radiooncological capacity. Considering epidemiological developments, an aggravation of the situation can be expected shortly. This analysis serves as a basis for improved public regional health care planning.

Performance of the Prototype Readout System for the CMS Endcap Hadron Calorimeter Upgrade

NASA Astrophysics Data System (ADS)

Chaverin, Nate; Dittmann, Jay; Hatakeyama, Kenichi; Pastika, Nathaniel; CMS Collaboration

2016-03-01

The Compact Muon Solenoid (CMS) experiment at the CERN Large Hadron Collider (LHC) will upgrade the photodetectors and readout systems of the endcap hadron calorimeter during the technical stop scheduled for late 2016 and early 2017. A major milestone for this project was a highly successful testbeam run at CERN in August 2015. The testbeam run served as a full integration test of the electronics, allowing a study of the response of the preproduction electronics to the true detector light profile, as well as a test of the light yield of various new plastic scintillator materials. We present implications for the performance of the hadron calorimeter front-end electronics based on testbeam data, and we report on the production status of various components of the system in preparation for the upgrade.

Radiation and polarization signatures of the 3D multizone time-dependent hadronic blazar model

DOE PAGES

Zhang, Haocheng; Diltz, Chris; Bottcher, Markus

2016-09-23

We present a newly developed time-dependent three-dimensional multizone hadronic blazar emission model. By coupling a Fokker–Planck-based lepto-hadronic particle evolution code, 3DHad, with a polarization-dependent radiation transfer code, 3DPol, we are able to study the time-dependent radiation and polarization signatures of a hadronic blazar model for the first time. Our current code is limited to parameter regimes in which the hadronic γ-ray output is dominated by proton synchrotron emission, neglecting pion production. Our results demonstrate that the time-dependent flux and polarization signatures are generally dominated by the relation between the synchrotron cooling and the light-crossing timescale, which is largely independent ofmore » the exact model parameters. We find that unlike the low-energy polarization signatures, which can vary rapidly in time, the high-energy polarization signatures appear stable. Lastly, future high-energy polarimeters may be able to distinguish such signatures from the lower and more rapidly variable polarization signatures expected in leptonic models.« less

Engaging undergraduate students in hadron physics research and instrumentation

NASA Astrophysics Data System (ADS)

Horn, Tanja

2017-09-01

Nuclear physics research is fundamental to our understanding of the visible universe and at the same time intertwined with our daily life. Nuclear physics studies the origin and structure of the atomic nuclei in terms of their basic constituents, the quarks and gluons. Atoms and molecules would not exist without underlying quark-gluon interactions, which build nearly all the mass of the visible universe from an assembly of massless gluons and nearly-massless quarks. The study of hadron structure with electromagnetic probes through exclusive and semi-inclusive scattering experiments carried out at the 12 GeV Jefferson Laboratory plays an important role in this effort. In particular, planned precision measurements of pion and kaon form factors and longitudinal-transverse separated deep exclusive pion and kaon electroproduction cross sections to the highest momentum transfers achievable play an important role in understanding hadron structure and masses and provide essential constraints for 3D hadron imaging. While a growing fraction of nuclear physics research is carried out at large international laboratories, individual university research groups play critical roles in the success of that research. These include data analysis projects and the development of state-of-the-art instrumentation demanded by increasingly sophisticated experiments. These efforts are empowered by the creativity of university faculty, staff, postdocs, and provide students with unique hands-on experience. As an example, an aerogel Cherenkov detector enabling strangeness physics research in Hall C at Jefferson Lab was constructed at the Catholic University of America with the help of 16 undergraduate and high school students. The ''Conference Experience for Undergraduates'' (CEU) provides a venue for these students who have conducted research in nuclear physics. This presentation will present the experiences of one of the participants in the first years of the CEU, her current research program

MC generator HARDPING: Nuclear effects in hard interactions of leptons and hadrons with nuclei

DOE Office of Scientific and Technical Information (OSTI.GOV)

Berdnikov, Ya. A.; Ivanov, A. E.; Kim, V. T.

2016-01-22

Hadron and lepton production in hard interaction of high-energy particles with nuclei are considered in context of developing of Monte Carlo generator HARDPING (Hard Probe Interaction Generator). Such effects as energy losses and multiple re-scattering initial and produced hadrons and their constituents are taken into account. These effects are implemented in current version of generator HARDPING. Data of experiments HERMES on hadron production in lepton-nuclei collisions and E866 on muon pair production in proton-nuclei collisions were described with current version of generator HARDPING. Predictions from recent version HARPING 3.0 for lepton pairs production at proton beam energy I20 GeV aremore » presented.« less

Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer.

PubMed

James, Nicholas D; Hussain, Syed A; Hall, Emma; Jenkins, Peter; Tremlett, Jean; Rawlings, Christine; Crundwell, Malcolm; Sizer, Bruce; Sreenivasan, Thiagarajan; Hendron, Carey; Lewis, Rebecca; Waters, Rachel; Huddart, Robert A

2012-04-19

Radiotherapy is an alternative to cystectomy in patients with muscle-invasive bladder cancer. In other disease sites, synchronous chemoradiotherapy has been associated with increased local control and improved survival, as compared with radiotherapy alone. In this multicenter, phase 3 trial, we randomly assigned 360 patients with muscle-invasive bladder cancer to undergo radiotherapy with or without synchronous chemotherapy. The regimen consisted of fluorouracil (500 mg per square meter of body-surface area per day) during fractions 1 to 5 and 16 to 20 of radiotherapy and mitomycin C (12 mg per square meter) on day 1. Patients were also randomly assigned to undergo either whole-bladder radiotherapy or modified-volume radiotherapy (in which the volume of bladder receiving full-dose radiotherapy was reduced) in a partial 2-by-2 factorial design (results not reported here). The primary end point was survival free of locoregional disease. Secondary end points included overall survival and toxic effects. At 2 years, rates of locoregional disease-free survival were 67% (95% confidence interval [CI], 59 to 74) in the chemoradiotherapy group and 54% (95% CI, 46 to 62) in the radiotherapy group. With a median follow-up of 69.9 months, the hazard ratio in the chemoradiotherapy group was 0.68 (95% CI, 0.48 to 0.96; P=0.03). Five-year rates of overall survival were 48% (95% CI, 40 to 55) in the chemoradiotherapy group and 35% (95% CI, 28 to 43) in the radiotherapy group (hazard ratio, 0.82; 95% CI, 0.63 to 1.09; P=0.16). Grade 3 or 4 adverse events were slightly more common in the chemoradiotherapy group than in the radiotherapy group during treatment (36.0% vs. 27.5%, P=0.07) but not during follow-up (8.3% vs. 15.7%, P=0.07). Synchronous chemotherapy with fluorouracil and mitomycin C combined with radiotherapy significantly improved locoregional control of bladder cancer, as compared with radiotherapy alone, with no significant increase in adverse events. (Funded by Cancer

Quality assurance in radiotherapy.

PubMed

Kouloulias, V E

2003-03-01

In 1999, the European Organisation for Research and Treatment of Cancer (EORTC), being a European pioneer in the field of cancer research as well as in quality assurance (QA), launched an Emmanuel van der Schueren fellowship for QA in radiotherapy. In this paper, the work that has been done during the first E. van der Schueren fellowship is reported, focusing on four phase III EORTC clinical trials: 22921 for rectal cancer, 22961 and 22991 for prostate cancer and 22922 for breast cancer. A historical review of the QA programme of the EORTC Radiotherapy group during the past 20 years is included.

Concurrent radiotherapy: fotemustine combination for newly diagnosed malignant glioma patients, a phase II study.

PubMed

Beauchesne, Patrick D; Taillandier, L; Bernier, V; Carnin, C

2009-06-01

Fotemustine is a nitrosourea compound used for the treatment of malignant gliomas, especially in France. Recently, an EORTC-NCIC study has shown that a concomitant combination of radiotherapy plus temozolomide (an oral cytotoxic drug) improved survival in glioblastoma patients. We set out to test a concurrent combination of radiotherapy and fotemustine for newly malignant gliomas. A prospective single-center phase II study opened for accrual in September 2004. Patients over 18 years of age able to give informed consent and with histologically proven, newly diagnosed supratentorial malignant gliomas were eligible. All patients were treated by a standard cranial irradiation (conformal irradiation, tumor bulk plus a margin of 2.5 cm) and concomitant daily administration of 10 mg/m(2) of fotemustine (5 days per week, 6 weeks, 1 h 30 min before radiation therapy). Adjuvant chemotherapy, fotemustine, was administered at tumor progression as standard and classic regimen. Twenty-two patients were enrolled, 16 men and 6 women, median age 56 years (range 32-74), median Karnofsky performance status 70 (range 60-90). Histology included 16 glioblastomas, 3 anaplastic astrocytomas, 2 anaplastic oligodendrogliomas and 1 mixed glioma. Eight patients underwent surgery (three total resections). Fourteen patients had a stereotactic biopsy. The concurrent radiotherapy-fotemustine combination was well tolerated: toxicity was mild and three hematologic toxicities grade 3-4 were observed. Median survival from the initial diagnosis was 9.9 months, two patients are currently alive. Median survival was 11 months for surgery and 9 months for stereotactic biopsy. Concomitant radiotherapy-fotemustine combination is safe and well tolerated. Overall survival of over 10 months for the whole population compares favorably with other reports.

Adjuvant radiotherapy for stage I endometrial cancer.

PubMed

Kong, A; Johnson, N; Cornes, P; Simera, I; Collingwood, M; Williams, C; Kitchener, H

2007-04-18

The role of adjuvant radiotherapy (both pelvic external beam radiotherapy and vaginal intracavity brachytherapy) in stage I endometrial cancer following total abdominal hysterectomy and bilateral salpingo-oophorectomy (TAH and BSO) remains unclear. To assess the efficacy of adjuvant radiotherapy following surgery for stage I endometrial cancer. The Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, CancerLit, Physician Data Query (PDQ) of National Cancer Institute. Handsearching was also carried out where appropriate. Randomised controlled trials (RCTs) which compared adjuvant radiotherapy versus no radiotherapy following surgery for patients with stage I endometrial cancer were included. Quality of the studies was assessed and data collected using a predefined data collection form. The primary endpoint was overall survival. Secondary endpoints were locoregional recurrence, distant recurrence and endometrial cancer death. Data on quality of life (QOL) and morbidity were also collected. A meta-analysis on included trials was performed using the Cochrane Collaboration Review Manager Software 4.2. The meta-analysis was performed on four trials (1770 patients). The addition of pelvic external beam radiotherapy to surgery reduced locoregional recurrence, a relative risk (RR) of 0.28 (95% confidence interval (CI) 0.17 to 0.44, p < 0.00001), which is a 72% reduction in the risk of pelvic relapse (95% CI 56% to 83%) and an absolute risk reduction of 6% (95% CI of 4 to 8%). The number needed to treat (NNT) to prevent one locoregional recurrence is 16.7 patients (95% CI 12.5 to 25). The reduction in the risk of locoregional recurrence did not translate into either a reduction in the risk of distant recurrence or death from all causes or endometrial cancer death. A subgroup analysis of women with multiple high risk factors (including stage 1c and grade 3) showed a trend toward the reduction in the risk of death from all causes and endometrial cancer

Weak decays of heavy hadrons into dynamically generated resonances

DOE PAGES

Oset, Eulogio; Liang, Wei -Hong; Bayar, Melahat; ...

2016-01-28

In this study, we present a review of recent works on weak decay of heavy mesons and baryons with two mesons, or a meson and a baryon, interacting strongly in the final state. The aim is to learn about the interaction of hadrons and how some particular resonances are produced in the reactions. It is shown that these reactions have peculiar features and act as filters for some quantum numbers which allow to identify easily some resonances and learn about their nature. The combination of basic elements of the weak interaction with the framework of the chiral unitary approach allowmore » for an interpretation of results of many reactions and add a novel information to different aspects of the hadron interaction and the properties of dynamically generated resonances.« less

A retrospective study of 606 cases of nasopharyngeal carcinoma with or without oropharyngeal candidiasis during radiotherapy

PubMed Central

Xia, Wei-Xiong; Yang, Jing; Yu, Ya-Hui; Liang, Hu; Huang, Xin-Jun; Liu, Guo-Ying; Li, Wang-Zhong; Xiang, Yan-Qun; Guo, Xiang; Lv, Xing

2017-01-01

Background To evaluate the clinical characteristics, treatment-related toxicities and survival in patients with nasopharyngeal carcinoma (NPC) with or without oropharyngealcandidiasis (OPC) during radiotherapy. Methods The current study was conducted with NPC patients undergoing radiotherapy at Sun Yat-Sen University Cancer Center between June 2011 and May 2012. A clinical diagnosis of candidiasis was determined on the basis of a positive potassium hydroxide (KOH) test and the presence of pseudomembranous (white) form of candidal overgrowth. The Cox proportional hazard regression model was used to test the association of OPC and related survival rates. Results Compared with the non-OPC group, the OPC group had significantly increased occurrence rates of grade 3–4 mucositis (14.5% vs. 7.4%, P = 0.049), anaemia (11.3% vs. 4.4%, P = 0.020), hepatotoxicity (4.8% vs. 1.1%, P = 0.021) and critical weight loss (85.5% vs. 56.6%, P<0.001) during radiotherapy. The OPC group had a significantly lower disease-free survival (DFS) (70.9% vs. 82.6%, P = 0.012), mainly as a result of a reduction in locoregional relapse-free survival (LRFS) (87.0%vs. 94.9%, P = 0.025). After stratification by T stage, the 5-year DFS in T3-4 patients were 82.0% and 68.8% in non-OPC and OPC groups, respectively (P = 0.022). Multivariate analyses indicated that OPC was a prognostic factor for LRFS and DFS. Conclusions OPC during radiotherapy may worsen the nutritional status of NPC patients according to weight loss and anaemia, leading to a negative impact on 5-year locoregional relapse-free survival and disease-specific survival. Further investigations are needed to explore whether prevention and treatment of OPC during radiotherapy will be useful. PMID:28797119

A retrospective study of 606 cases of nasopharyngeal carcinoma with or without oropharyngeal candidiasis during radiotherapy.

PubMed

Qiu, Wen-Ze; Ke, Liang-Ru; Xia, Wei-Xiong; Yang, Jing; Yu, Ya-Hui; Liang, Hu; Huang, Xin-Jun; Liu, Guo-Ying; Li, Wang-Zhong; Xiang, Yan-Qun; Guo, Xiang; Lv, Xing

2017-01-01

To evaluate the clinical characteristics, treatment-related toxicities and survival in patients with nasopharyngeal carcinoma (NPC) with or without oropharyngealcandidiasis (OPC) during radiotherapy. The current study was conducted with NPC patients undergoing radiotherapy at Sun Yat-Sen University Cancer Center between June 2011 and May 2012. A clinical diagnosis of candidiasis was determined on the basis of a positive potassium hydroxide (KOH) test and the presence of pseudomembranous (white) form of candidal overgrowth. The Cox proportional hazard regression model was used to test the association of OPC and related survival rates. Compared with the non-OPC group, the OPC group had significantly increased occurrence rates of grade 3-4 mucositis (14.5% vs. 7.4%, P = 0.049), anaemia (11.3% vs. 4.4%, P = 0.020), hepatotoxicity (4.8% vs. 1.1%, P = 0.021) and critical weight loss (85.5% vs. 56.6%, P<0.001) during radiotherapy. The OPC group had a significantly lower disease-free survival (DFS) (70.9% vs. 82.6%, P = 0.012), mainly as a result of a reduction in locoregional relapse-free survival (LRFS) (87.0%vs. 94.9%, P = 0.025). After stratification by T stage, the 5-year DFS in T3-4 patients were 82.0% and 68.8% in non-OPC and OPC groups, respectively (P = 0.022). Multivariate analyses indicated that OPC was a prognostic factor for LRFS and DFS. OPC during radiotherapy may worsen the nutritional status of NPC patients according to weight loss and anaemia, leading to a negative impact on 5-year locoregional relapse-free survival and disease-specific survival. Further investigations are needed to explore whether prevention and treatment of OPC during radiotherapy will be useful.

The response of a bonner sphere spectrometer to charged hadrons.

PubMed

Agosteo, S; Dimovasili, E; Fassò, A; Silari, M

2004-01-01

Bonner sphere spectrometers (BSSs) are employed in neutron spectrometry and dosimetry since many years. Recent developments have seen the addition to a conventional BSS of one or more detectors (moderator plus thermal neutron counter) specifically designed to improve the overall response of the spectrometer to neutrons above 10 MeV. These additional detectors employ a shell of material with a high mass number (such as lead) within the polyethylene moderator, in order to slow down high-energy neutrons via (n,xn) reactions. A BSS can be used to measure neutron spectra both outside accelerator shielding and from an unshielded target. Measurements were recently performed at CERN of the neutron yield and spectral fluence at various angles from unshielded, semi-thick copper, silver and lead targets, bombarded by a mixed proton/pion beam with 40 GeV per c momentum. These experiments have provided evidence that under certain circumstances, the use of lead-enriched moderators may present a problem: these detectors were found to have a significant response to the charged hadron component accompanying the neutrons emitted from the target. Conventional polyethylene moderators show a similar behaviour but less pronounced. These secondary hadrons interact with the moderator and generate neutrons, which are in turn detected by the counter. To investigate this effect and determine a correction factor to be applied to the unfolding procedure, a series of Monte Carlo simulations were performed with the FLUKA code. These simulations aimed at determining the response of the BSS to charged hadrons under the specific experimental situation. Following these results, a complete response matrix of the extended BSS to charged pions and protons was calculated with FLUKA. An experimental verification was carried out with a 120 GeV per c hadron beam at the CERF facility at CERN.

Radiation-induced heart disease in lung cancer radiotherapy

PubMed Central

Ming, Xin; Feng, Yuanming; Yang, Chengwen; Wang, Wei; Wang, Ping; Deng, Jun

2016-01-01

Abstract Background: Radiation-induced heart disease (RIHD), which affects the patients’ prognosis with both acute and late side effects, has been published extensively in the radiotherapy of breast cancer, lymphoma and other benign diseases. Studies on RIHD in lung cancer radiotherapy, however, are less extensive and clear even though the patients with lung cancer are delivered with higher doses to the heart during radiation treatment. Methods: In this article, after extensive literature search and analysis, we reviewed the current evidence on RIHD in lung cancer patients after their radiation treatments and investigated the potential risk factors for RIHD as compared to other types of cancers. Result: Cardiac toxicity has been found highly relevant in lung cancer radiotherapy. So far, the crude incidence of cardiac complications in the lung cancer patients after radiotherapy has been up to 33%. Conclusion: The dose to the heart, the lobar location of tumor, the treatment modality, the history of heart and pulmonary disease and smoking were considered as potential risk factors for RIHD in lung cancer radiotherapy. As treatment techniques improve over the time with better prognosis for lung cancer survivors, an improved prediction model can be established to further reduce the cardiac toxicity in lung cancer radiotherapy. PMID:27741117

Radiotherapy-induced hypopituitarism: a review.

PubMed

Sathyapalan, Thozhukat; Dixit, Sanjay

2012-05-01

Hypopituitarism is a disorder caused by impaired hormonal secretions from the hypothalamic-pituitary axis. Radiotherapy is the most common cause of iatrogenic hypopituitarism. The hypothalamic-pituitary axis inadvertently gets irradiated in patients receiving prophylactic cranial radiotherapy for leukemia, total body irradiation and radiotherapy for intracranial, base skull, sinonasal and nasopharyngeal tumors. Radiation-induced hypopituitarism (RIH) is insidious, progressive and largely nonreversible. Mostly, RIH involves one hypothalamic-pituitary axis; however, multiple hormonal axes deficiency starts developing at higher doses. Although the clinical effects of the hypopituitarism are more profound in children and young adults, its implications in older adults are being increasingly recognized. The risk continues to persist or increase up to 10 years following radiation exposure. The clinical management of hypopituitarism is challenging both for the patients and healthcare providers. Here we have reviewed the scale of the problem, the risk factors and the management of RIH.

Probing the hadronic phase with resonances of different lifetimes in Pb-Pb collisions with ALICE

NASA Astrophysics Data System (ADS)

Agrawal, Neelima

2018-02-01

The ALICE experiment has measured the production of a rich set of hadronic resonances, such as ρ(770)0, K*(892)0, ϕ(1020), ∑±(1385), Λ(1520) and Ξ*0 in pp, p-Pb and Pb-Pb collisions at various energies at the LHC. A comprehensive overview and the latest results are presented in this paper. Special focus is given to the role of hadronic resonances for the study of final-state effects in high-energy collisions. In particular, the measurement of resonance production in heavy-ion collisions has the capability to provide insight into the existence of a prolonged hadronic phase after hadronisation. The observation of the suppression of the production of Λ(1520) resonance in central Pb-Pb collisions at =2.76 TeV adds further support to the existence of such a dense hadronic phase, as already evidenced by the ratios K*(892)0/K and ρ(770)0/π.

Protection of quality and innovation in radiation oncology: the prospective multicenter trial the German Society of Radiation Oncology (DEGRO-QUIRO study). Evaluation of time, attendance of medical staff, and resources during radiotherapy with IMRT.

PubMed

Vorwerk, H; Zink, K; Schiller, R; Budach, V; Böhmer, D; Kampfer, S; Popp, W; Sack, H; Engenhart-Cabillic, R

2014-05-01

A number of national and international societies published recommendations regarding the required equipment and manpower assumed to be necessary to treat a number of patients with radiotherapy. None of these recommendations were based on actual time measurements needed for specific radiotherapy procedures. The German Society of Radiation Oncology (DEGRO) was interested in substantiating these recommendations by prospective evaluations of all important core procedures of radiotherapy in the most frequent cancers treated by radiotherapy. The results of the examinations of radiotherapy with intensity-modulated radiation therapy (IMRT) in patients with different tumor entities are presented in this manuscript. Four radiation therapy centers [University Hospital of Marburg, University Hospital of Giessen, University Hospital of Berlin (Charité), Klinikum rechts der Isar der Technischen Universität München] participated in this prospective study. The workload of the different occupational groups and room occupancies for the core procedures of radiotherapy were prospectively documented during a 2-month period per center and subsequently statistically analyzed. The time needed per patient varied considerably between individual patients and between centers for all the evaluated procedures. The technical preparation (contouring of target volume and organs at risk, treatment planning, and approval of treatment plan) was the most time-consuming process taking 3 h 54 min on average. The time taken by the medical physicists for this procedure amounted to about 57%. The training part of the preparation time was 87% of the measured time for the senior physician and resident. The total workload for all involved personnel comprised 74.9 min of manpower for the first treatment, 39.7 min for a routine treatment with image guidance, and 22.8 min without image guidance. The mean room occupancy varied between 10.6 min (routine treatment without image guidance) and 23.7 min (first

Branon search in hadronic colliders

DOE Office of Scientific and Technical Information (OSTI.GOV)

Cembranos, J.A.R.; Departamento de Fisica Teorica, Universidad Complutense de Madrid, 28040 Madrid; Dobado, A.

2004-11-01

In the context of the brane-world scenarios with compactified extra dimensions, we study the production of brane fluctuations (branons) in hadron colliders (pp, pp, and e{sup {+-}}p) in terms of the brane tension parameter f, the branon mass M, and the number of branons N. From the absence of monojet events at HERA and Tevatron (run I), we set bounds on these parameters and we also study how such bounds could be improved at Tevatron (run II) and the future LHC. The single-photon channel is also analyzed for the two last colliders.

Hadron Physics at the Charm and Bottom Thresholds and Other Novel QCD Physics Topics at the NICA Accelerator Facility

DOE Office of Scientific and Technical Information (OSTI.GOV)

Brodsky, Stanley J.; /SLAC

The NICA collider project at the Joint Institute for Nuclear Research in Dubna will have the capability of colliding protons, polarized deuterons, and nuclei at an effective nucleon-nucleon center-of mass energy in the range {radical}s{sub NN} = 4 to 11 GeV. I briefly survey a number of novel hadron physics processes which can be investigated at the NICA collider. The topics include the formation of exotic heavy quark resonances near the charm and bottom thresholds, intrinsic strangeness, charm, and bottom phenomena, hidden-color degrees of freedom in nuclei, color transparency, single-spin asymmetries, the RHIC baryon anomaly, and non-universal antishadowing.

Confinement and diffusion time-scales of CR hadrons in AGN-inflated bubbles

NASA Astrophysics Data System (ADS)

Prokhorov, D. A.; Churazov, E. M.

2017-09-01

While rich clusters are powerful sources of X-rays, γ-ray emission from these large cosmic structures has not been detected yet. X-ray radiative energy losses in the central regions of relaxed galaxy clusters are so strong that one needs to consider special sources of energy, likely active galactic nucleus (AGN) feedback, to suppress catastrophic cooling of the gas. We consider a model of AGN feedback that postulates that the AGN supplies the energy to the gas by inflating bubbles of relativistic plasma, whose energy content is dominated by cosmic-ray (CR) hadrons. If most of these hadrons can quickly escape the bubbles, then collisions of CRs with thermal protons in the intracluster medium (ICM) should lead to strong γ-ray emission, unless fast diffusion of CRs removes them from the cluster. Therefore, the lack of detections with modern γ-ray telescopes sets limits on the confinement time of CR hadrons in bubbles and CR diffusive propagation in the ICM.

Multiplicities of charged hadrons in 280 GeV/c muon-proton scattering

NASA Astrophysics Data System (ADS)

Arneodo, M.; Arvidson, A.; Aubert, J. J.; Badelek, B.; Beaufays, J.; Becks, K. H.; Bee, C. P.; Benchouk, C.; Berghoff, G.; Bird, I.; Blum, D.; Böhm, E.; De Bouard, X.; Brasse, F. W.; Braun, H.; Broll, C.; Brown, S.; Brück, H.; Calen, H.; Callebaut, D.; Chima, J. S.; Ciborowski, J.; Clifft, R.; Coignet, G.; Combley, F.; Coughlan, J.; D'Agostini, G.; Dahlgren, S.; Dengler, F.; Derado, I.; Dreyer, T.; Drees, J.; Düren, M.; Eckardt, V.; Edwards, A.; Edwards, M.; Ernst, T.; Eszes, G.; Favier, J.; Ferrero, M. I.; Figiel, J.; Flauger, W.; Foster, J.; Gabathuler, E.; Gajewski, J.; Gamet, R.; Gayler, J.; Geddes, N.; Giubellino, P.; Grafström, P.; Grard, F.; Hass, J.; Hagberg, E.; Hasert, F. J.; Hayman, P.; Heusse, P.; Hoppe, C.; Jaffré, M.; Jacholkowska, A.; Janata, F.; Jancso, G.; Johnson, A. S.; Kabuss, E. M.; Kellner, G.; Kesteman, J.; Korbel, V.; Krüger, J.; Kullander, S.; Landgraf, U.; Lanske, D.; Loken, J.; Long, K.; Maire, M.; Manz, A.; Mohr, W.; Montanet, F.; Montgomery, H. E.; Nagy, E.; Nassalski, J.; Norton, P. R.; Oakham, F. G.; Osborne, A. M.; Pascaud, C.; Pawlik, B.; Payre, P.; Peroni, C.; Pessard, H.; Pettingale, J.; Pietrzyk, B.; Pönsgen, B.; Pötsch, M.; Renton, P.; Ribarics, P.; Rith, K.; Rondio, E.; Scheer, M.; Schlagböhmer, A.; Schiemann, H.; Schmitz, N.; Schneegans, M.; Schröder, T.; Schouten, M.; Schultze, K.; Sholz, M.; Sloan, T.; Stier, H. E.; Stockhausen, W.; Studt, M.; Taylor, G. N.; Thénard, J. M.; Thompson, J. C.; De La Torre, A.; Toth, J.; Urban, L.; Urban, L.; Wahlen, H.; Wallucks, W.; Whalley, M.; Wheeler, S.; Williams, W. S. C.; Wimpenny, S. J.; Windmolders, R.; Wolf, G.; European Muon Collaboration

Properties of the hadron multiplicity distributions in 280 GeV/ c μ +p interactions have been investigated. The c.m. energy dependence in the range from 4 to 20 GeV of the total charged multiplicities are presented. No variation faster than logarithmic is seen in the energy range of this experiment. Comparison with νp and overlineνp data at lower energy has been made and shows good agreement between μ +p and overlineνp total charged multiplicities. It has been found that the average forward multiplicity (charged hadrons with xF > 0) exceeds the average backward multiplicity (charged hadrons with xF < 0) in the whole energy range and presents a different energy variation. The average forward multiplicity has been compared to e +e - data and shows a similar dependence on energy. Little correlation was observed between the forward and backward multiplicities indicating that the current and target regions fragment almost independently.

Commissioning of the CMS Hadron Forward Calorimeters Phase I Upgrade

NASA Astrophysics Data System (ADS)

Bilki, B.; Onel, Y.

2018-03-01

The final phase of the CMS Hadron Forward Calorimeters Phase I Upgrade was performed during the Extended Year End Technical Stop of 2016-2017. In the framework of the upgrade, the PMT boxes were reworked to implement two channel readout in order to exploit the benefits of the multi-anode PMTs in background tagging and signal recovery. The front-end electronics were also upgraded to QIE10-based electronics which implement larger dynamic range and a 6-bit TDC. Following this major upgrade, the Hadron Forward Calorimeters were commissioned for operation readiness in 2017. Here we describe the details and the components of the upgrade, and discuss the operational experience and results obtained during the upgrade and commissioning.

The upgrade of the CMS hadron calorimeter with silicon photomultipliers

DOE PAGES

Strobbe, N.

2017-01-26

The upgrade of the hadron calorimeter of the CMS experiment at the CERN Large Hadron Collider is currently underway. The endcap sections will be upgraded in the winter of 2016–2017 and the barrel sections during the second LHC long shutdown in 2019. The existing photosensors will be replaced with about 16 000 new silicon photomultipliers (SiPMs), resulting in the first large installation of SiPMs in a radiation environment. All associated front-end electronics will also be upgraded. Here, this paper discusses the motivation for the upgrade and provides a description 17 of the new system, including the SiPMs with associated controlmore » electronics and the front-end readout cards.« less

Examining the Crossover from the Hadronic to Partonic Phase in QCD

DOE Office of Scientific and Technical Information (OSTI.GOV)

Xu Mingmei; Yu Meiling; Liu Lianshou

2008-03-07

A mechanism, consistent with color confinement, for the transition between perturbative and physical vacua during the gradual crossover from the hadronic to partonic phase is proposed. The essence of this mechanism is the appearance and growing up of a kind of grape-shape perturbative vacuum inside the physical one. A percolation model based on simple dynamics for parton delocalization is constructed to exhibit this mechanism. The crossover from hadronic matter to sQGP (strongly coupled quark-gluon plasma) as well as the transition from sQGP to weakly coupled quark-gluon plasma with increasing temperature is successfully described by using this model.

Hadron resonance gas with repulsive interactions and fluctuations of conserved charges

DOE PAGES

Huovinen, Pasi; Petreczky, Peter

2017-12-11

We discuss the role of repulsive baryon-baryon interactions in a hadron gas using relativistic virial expansion and repulsive mean field approaches. The fluctuations of the baryon number as well as strangeness-baryon correlations are calculated in the hadron resonance gas with repulsive interactions and compared with the recent lattice QCD results. In particular, we calculate the difference between the second and fourth order fluctuations and correlations of baryon number and strangeness, that have been proposed as probes of deconfinement. We show that for not too high temperatures these differences could be understood in terms of repulsive interactions.

A search for higher twist effects in the hadronic distributions in deep inelastic muon proton scattering

NASA Astrophysics Data System (ADS)

Aubert, J. J.; Bassompierre, G.; Becks, K. H.; Benchouk, C.; Best, C.; Böhm, E.; de Bouard, X.; Brasse, F. W.; Broll, C.; Brown, S.; Carr, J.; Clifft, R.; Cobb, J. H.; Coignet, G.; Combley, F.; Court, G. R.; D'Agostini, G.; Dau, W. D.; Davies, J. K.; Déclais, Y.; Dosselli, U.; Drees, J.; Edwards, A.; Edwards, M.; Favier, J.; Ferrero, M. I.; Flauger, W.; Forsbach, H.; Gabathuler, E.; Gamet, R.; Gayler, J.; Gerhardt, V.; Gössling, C.; Haas, J.; Hamacher, K.; Hayman, P.; Henckes, M.; Korbel, V.; Korzen, B.; Landgraf, U.; Leenen, M.; Maire, M.; Mohr, W.; Montgomery, H. E.; Moser, K.; Mount, R. P.; Nagy, E.; Nassalski, J.; Norton, P. R.; McNicholas, J.; Osborne, A. M.; Payre, P.; Peroni, C.; Peschel, H.; Pessard, H.; Pietrzyk, U.; Rith, K.; Schneegans, M.; Schneider, A.; Sloan, T.; Stier, H. E.; Stockhausen, W.; Thénard, J. M.; Thompson, J. C.; Urban, L.; Villers, M.; Wahlen, H.; Whalley, M.; Williams, D.; Williams, W. S. C.; Williamson, J.; Wimpenny, S. J.

1986-03-01

The hadronic distributions in Q 2, y, z, p T and ϕ in deep inelastic muon proton scattering have been studied to search for higher twist effects in the hadronic final state. The expected effects are not observed.

Study of the dependence of direct soft photon production on the jet characteristics in hadronic Z 0 decays

NASA Astrophysics Data System (ADS)

Abdallah, J.; Abreu, P.; Adam, W.; Adzic, P.; Albrecht, T.; Alemany-Fernandez, R.; Allmendinger, T.; Allport, P. P.; Amaldi, U.; Amapane, N.; Amato, S.; Anashkin, E.; Andreazza, A.; Andringa, S.; Anjos, N.; Antilogus, P.; Apel, W.-D.; Arnoud, Y.; Ask, S.; Asman, B.; Augustin, J. E.; Augustinus, A.; Baillon, P.; Ballestrero, A.; Bambade, P.; Barbier, R.; Bardin, D.; Barker, G. J.; Baroncelli, A.; Battaglia, M.; Baubillier, M.; Becks, K.-H.; Begalli, M.; Behrmann, A.; Ben-Haim, E.; Benekos, N.; Benvenuti, A.; Berat, C.; Berggren, M.; Bertrand, D.; Besancon, M.; Besson, N.; Bloch, D.; Blom, M.; Bluj, M.; Bonesini, M.; Boonekamp, M.; Booth, P. S. L.; Borisov, G.; Botner, O.; Bouquet, B.; Bowcock, T. J. V.; Boyko, I.; Bracko, M.; Brenner, R.; Brodet, E.; Bruckman, P.; Brunet, J. M.; Buschbeck, B.; Buschmann, P.; Calvi, M.; Camporesi, T.; Canale, V.; Carena, F.; Castro, N.; Cavallo, F.; Chapkin, M.; Charpentier, Ph.; Checchia, P.; Chierici, R.; Chliapnikov, P.; Chudoba, J.; Chung, S. U.; Cieslik, K.; Collins, P.; Contri, R.; Cosme, G.; Cossutti, F.; Costa, M. J.; Crennell, D.; Cuevas, J.; D'Hondt, J.; da Silva, T.; da Silva, W.; Della Ricca, G.; de Angelis, A.; de Boer, W.; de Clercq, C.; de Lotto, B.; de Maria, N.; de Min, A.; de Paula, L.; di Ciaccio, L.; di Simone, A.; Doroba, K.; Drees, J.; Eigen, G.; Ekelof, T.; Ellert, M.; Elsing, M.; Espirito Santo, M. C.; Fanourakis, G.; Fassouliotis, D.; Feindt, M.; Fernandez, J.; Ferrer, A.; Ferro, F.; Flagmeyer, U.; Foeth, H.; Fokitis, E.; Fulda-Quenzer, F.; Fuster, J.; Gandelman, M.; Garcia, C.; Gavillet, Ph.; Gazis, E.; Gokieli, R.; Golob, B.; Gomez-Ceballos, G.; Goncalves, P.; Graziani, E.; Grosdidier, G.; Grzelak, K.; Guy, J.; Haag, C.; Hallgren, A.; Hamacher, K.; Hamilton, K.; Haug, S.; Hauler, F.; Hedberg, V.; Hennecke, M.; Hoffman, J.; Holmgren, S.-O.; Holt, P. J.; Houlden, M. A.; Jackson, J. N.; Jarlskog, G.; Jarry, P.; Jeans, D.; Johansson, E. K.; Jonsson, P.; Joram, C.; Jungermann, L.; Kapusta, F.; Katsanevas, S.; Katsoufis, E.; Kernel, G.; Kersevan, B. P.; Kerzel, U.; King, B. T.; Kjaer, N. J.; Kluit, P.; Kokkinias, P.; Kourkoumelis, C.; Kouznetsov, O.; Krumstein, Z.; Kucharczyk, M.; Lamsa, J.; Leder, G.; Ledroit, F.; Leinonen, L.; Leitner, R.; Lemonne, J.; Lepeltier, V.; Lesiak, T.; Liebig, W.; Liko, D.; Lipniacka, A.; Lopes, J. H.; Lopez, J. M.; Loukas, D.; Lutz, P.; Lyons, L.; MacNaughton, J.; Malek, A.; Maltezos, S.; Mandl, F.; Marco, J.; Marco, R.; Marechal, B.; Margoni, M.; Marin, J.-C.; Mariotti, C.; Markou, A.; Martinez-Rivero, C.; Masik, J.; Mastroyiannopoulos, N.; Matorras, F.; Matteuzzi, C.; Mazzucato, F.; Mazzucato, M.; Mc Nulty, R.; Meroni, C.; Migliore, E.; Mitaroff, W.; Mjoernmark, U.; Moa, T.; Moch, M.; Moenig, K.; Monge, R.; Montenegro, J.; Moraes, D.; Moreno, S.; Morettini, P.; Mueller, U.; Muenich, K.; Mulders, M.; Mundim, L.; Murray, W.; Muryn, B.; Myatt, G.; Myklebust, T.; Nassiakou, M.; Navarria, F.; Nawrocki, K.; Nemecek, S.; Nicolaidou, R.; Nikolenko, M.; Oblakowska-Mucha, A.; Obraztsov, V.; Olshevski, A.; Onofre, A.; Orava, R.; Osterberg, K.; Ouraou, A.; Oyanguren, A.; Paganoni, M.; Paiano, S.; Palacios, J. P.; Palka, H.; Papadopoulou, Th. D.; Pape, L.; Parkes, C.; Parodi, F.; Parzefall, U.; Passeri, A.; Passon, O.; Peralta, L.; Perepelitsa, V.; Perrotta, A.; Petrolini, A.; Piedra, J.; Pieri, L.; Pierre, F.; Pimenta, M.; Piotto, E.; Podobnik, T.; Poireau, V.; Pol, M. E.; Polok, G.; Pozdniakov, V.; Pukhaeva, N.; Pullia, A.; Radojicic, D.; Rebecchi, P.; Rehn, J.; Reid, D.; Reinhardt, R.; Renton, P.; Richard, F.; Ridky, J.; Rivero, M.; Rodriguez, D.; Romero, A.; Ronchese, P.; Roudeau, P.; Rovelli, T.; Ruhlmann-Kleider, V.; Ryabtchikov, D.; Sadovsky, A.; Salmi, L.; Salt, J.; Sander, C.; Savoy-Navarro, A.; Schwickerath, U.; Sekulin, R.; Siebel, M.; Sisakian, A.; Smadja, G.; Smirnova, O.; Sokolov, A.; Sopczak, A.; Sosnowski, R.; Spassov, T.; Stanitzki, M.; Stocchi, A.; Strauss, J.; Stugu, B.; Szczekowski, M.; Szeptycka, M.; Szumlak, T.; Tabarelli, T.; Tegenfeldt, F.; Timmermans, J.; Tkatchev, L.; Tobin, M.; Todorovova, S.; Tome, B.; Tonazzo, A.; Tortosa, P.; Travnicek, P.; Treille, D.; Tristram, G.; Trochimczuk, M.; Troncon, C.; Turluer, M.-L.; Tyapkin, I. A.; Tyapkin, P.; Tzamarias, S.; Uvarov, V.; Valenti, G.; van Dam, P.; van Eldik, J.; van Remortel, N.; van Vulpen, I.; Vegni, G.; Veloso, F.; Venus, W.; Verdier, P.; Verzi, V.; Vilanova, D.; Vitale, L.; Vrba, V.; Wahlen, H.; Washbrook, A. J.; Weiser, C.; Wicke, D.; Wickens, J.; Wilkinson, G.; Winter, M.; Witek, M.; Yushchenko, O.; Zalewska, A.; Zalewski, P.; Zavrtanik, D.; Zhuravlov, V.; Zimin, N. I.; Zintchenko, A.; Zupan, M.; DELPHI Collaboration

2010-06-01

An analysis of the direct soft photon production rate as a function of the parent jet characteristics is presented, based on hadronic events collected by the DELPHI experiment at LEP1. The dependences of the photon rates on the jet kinematic characteristics (momentum, mass, etc.) and on the jet charged, neutral and total hadron multiplicities are reported. Up to a scale factor of about four, which characterizes the overall value of the soft photon excess, a similarity of the observed soft photon behavior to that of the inner hadronic bremsstrahlung predictions is found for the momentum, mass, and jet charged multiplicity dependences. However for the dependence of the soft photon rate on the jet neutral and total hadron multiplicities a prominent difference is found for the observed soft photon signal as compared to the expected bremsstrahlung from final state hadrons. The observed linear increase of the soft photon production rate with the jet total hadron multiplicity and its strong dependence on the jet neutral multiplicity suggest that the rate is proportional to the number of quark pairs produced in the fragmentation process, with the neutral pairs being more effectively radiating than the charged ones.

Definitive radiotherapy for cervical esophageal cancer.

PubMed

Cao, Caineng; Luo, Jingwei; Gao, Li; Xu, Guozhen; Yi, Junlin; Huang, Xiaodong; Wang, Kai; Zhang, Shiping; Qu, Yuan; Li, Suyan; Xiao, Jianping; Zhang, Zhong

2015-02-01

The role of contemporary radiotherapy (RT) has not yet been elucidated, mainly because of the low incidence of cervical esophageal cancer. The purpose of this study was to analyze the outcome in patients with cervical esophageal cancer treated with definitive RT. A total of 115 patients with cervical esophageal cancer treated with definitive RT during January 2001 through April 2012 in our center were analyzed. Eighty patients received RT alone and 35 patients received concurrent chemoradiotherapy with cisplatin administered either weekly (30 mg/m2) or every 3 weeks (80 mg/m2). The median follow-up time was 17.1 months. For all patients, the overall 2-year local failure-free survival (LFFS), regional failure-free survival (RFFS), distant failure-free survival (DFFS), and overall survival (OS) rate was 68.3%, 83.3%, 75.7%, and 47.6%, respectively. Definitive RT accomplished a satisfactory local control rate and contributed to organ preservation for patients with cervical esophageal cancer. 2015. © 2014 Wiley Periodicals, Inc.

Hadronic Interaction Models and the Air Shower Simulation Program CORSIKA

NASA Astrophysics Data System (ADS)

Heck, D.; KASCADE Collaboration

The Monte Carlo program CORSIKA simulates the 4-dimensional evolution of extensive air showers in the atmosphere initiated by photons, hadrons or nuclei. It contains links to the hadronic interaction models DPMJET, HDPM, NEXUS, QGSJET, SIBYLL, and VENUS. These codes are employed to treat the hadronic interactions at energies above 80 GeV. Since their first implementation in 1996 the models DPMJET and SIBYLL have been revised to versions II.5 and 2.1, respectively. Also the treatment of diffractive interactions by QGSJET has been slightly modified. The models DPMJET, QGSJET and SIBYLL are able to simulate collisions even at the highest energies reaching up to 1020 eV, which are at the focus of present research. The recently added NEXUS 2 program uses a unified approach combining Gribov-Regge theory and perturbative QCD. This model is based on the universality hypothesis of the behavior of highenergy interactions and presently works up to 1017 eV. A comparison of simulations performed with different models gives an indication on the systematic uncertainties of simulated air shower properties, which arise from the extrapolations to energies, kinematic ranges, or projectile-target combinations not covered by man-made colliders. Results obtained with the most actual programs are presented.

Quark–hadron phase structure, thermodynamics, and magnetization of QCD matter

NASA Astrophysics Data System (ADS)

Nasser Tawfik, Abdel; Magied Diab, Abdel; Hussein, M. T.

2018-05-01

The SU(3) Polyakov linear-sigma model (PLSM) is systematically implemented to characterize the quark-hadron phase structure and to determine various thermodynamic quantities and the magnetization of quantum chromodynamic (QCD) matter. Using mean-field approximation, the dependence of the chiral order parameter on a finite magnetic field is also calculated. Under a wide range of temperatures and magnetic field strengths, various thermodynamic quantities including trace anomaly, speed of sound squared, entropy density, and specific heat are presented, and some magnetic properties are described as well. Where available these results are compared to recent lattice QCD calculations. The temperature dependence of these quantities confirms our previous finding that the transition temperature is reduced with the increase in the magnetic field strength, i.e. QCD matter is characterized by an inverse magnetic catalysis. Furthermore, the temperature dependence of the magnetization showing that QCD matter has paramagnetic properties slightly below and far above the pseudo-critical temperature is confirmed as well. The excellent agreement with recent lattice calculations proves that our QCD-like approach (PLSM) seems to possess the correct degrees of freedom in both the hadronic and partonic phases and describes well the dynamics deriving confined hadrons to deconfined quark-gluon plasma.

Surgery Followed by Radiotherapy Versus Radiotherapy Alone for Metastatic Spinal Cord Compression From Unfavorable Tumors

DOE Office of Scientific and Technical Information (OSTI.GOV)

Rades, Dirk, E-mail: Rades.Dirk@gmx.net; Huttenlocher, Stefan; Bajrovic, Amira

Purpose: Despite a previously published randomized trial, controversy exists regarding the benefit of adding surgery to radiotherapy for metastatic spinal cord compression (MSCC). It is thought that patients with MSCC from relatively radioresistant tumors or tumors associated with poor functional outcome after radiotherapy alone may benefit from surgery. This study focuses on these tumors. Methods and Materials: Data from 67 patients receiving surgery plus radiotherapy (S+RT) were matched to 134 patients (1:2) receiving radiotherapy alone (RT). Groups were matched for 10 factors and compared for motor function, ambulatory status, local control, and survival. Additional separate matched-pair analyses were performed formore » patients receiving direct decompressive surgery plus stabilization of involved vertebrae (DDSS) and patients receiving laminectomy (LE). Results: Improvement of motor function occurred in 22% of patients after S+RT and 16% after RT (p = 0.25). Posttreatment ambulatory rates were 67% and 61%, respectively (p = 0.68). Of nonambulatory patients, 29% and 19% (p = 0.53) regained ambulatory status. One-year local control rates were 85% and 89% (p = 0.87). One-year survival rates were 38% and 24% (p = 0.20). The matched-pair analysis of patients receiving LE showed no significant differences between both therapies. In the matched-pair analysis of patients receiving DDSS, improvement of motor function occurred more often after DDSS+RT than RT (28% vs. 19%, p = 0.024). Posttreatment ambulatory rates were 86% and 67% (p = 0.30); 45% and 18% of patients regained ambulatory status (p = 0.29). Conclusions: Patients with MSCC from an unfavorable primary tumor appeared to benefit from DDSS but not LE when added to radiotherapy in terms of improved functional outcome.« less

Recruitment in Radiotherapy

ERIC Educational Resources Information Center

Deeley, T. J.; And Others

1976-01-01

The Faculty Board of Radiotherapy and Oncology of the Royal College of Radiobiologists surveyed the factors thought to influence recruitment into the specialty. Possible factors listed in replies of 36 questionnaires are offered. (LBH)

Chiral effective theory methods and their application to the structure of hadrons from lattice QCD

NASA Astrophysics Data System (ADS)

Shanahan, P. E.

2016-12-01

For many years chiral effective theory (ChEFT) has enabled and supported lattice QCD calculations of hadron observables by allowing systematic effects from unphysical lattice parameters to be controlled. In the modern era of precision lattice simulations approaching the physical point, ChEFT techniques remain valuable tools. In this review we discuss the modern uses of ChEFT applied to lattice studies of hadron structure in the context of recent determinations of important and topical quantities. We consider muon g-2, strangeness in the nucleon, the proton radius, nucleon polarizabilities, and sigma terms relevant to the prediction of dark-matter-hadron interaction cross-sections, among others.

Design and Construction of a Vertex Chamber and Measurement of the Average Beta-Hadron Lifetime

NASA Astrophysics Data System (ADS)

Nelson, Harry Norman

Four parameters describe the mixing of the three quark generations in the Standard Model of the weak charged current interaction. These four parameters are experimental inputs to the model. A measurement of the mean lifetime of hadrons containing b-quarks, or B-Hadrons, constrains the magnitudes of two of these parameters. Measurement of the B-Hadron lifetime requires a device that can measure the locations of the stable particles that result from B-Hadron decay. This device must function reliably in an inaccessible location, and survive high radiation levels. We describe the design and construction of such a device, a gaseous drift chamber. Tubes of 6.9 mm diameter, having aluminized mylar walls of 100 μm thickness are utilized in this Vertex Chamber. It achieves a spatial resolution of 45 mum, and a resolution in extrapolation to the B-Hadron decay location of 87 mum. Its inner layer is 4.6 cm from e^+e ^- colliding beams. The Vertex Chamber is situated within the MAC detector at PEP. We have analyzed both the 94 pb ^{-1} of integrated luminosity accumulated at sqrt{s} = 29 GeV with the Vertex Chamber in place as well as the 210 pb^{-1} accumulated previously. We require a lepton with large momentum transverse to the event thrust axis to obtain a sample of events enriched in B-Hadron decays. The distribution of signed impact parameters of all tracks in these events is used to measure the B-Hadron flight distance, and hence lifetime. The trimmed mean signed impact parameters are 130 +/- 19 μm for data accumulated with the Vertex Chamber, and 162 +/- 25 μm for previous data. Together these indicate an average B-Hadron lifetime of tau_{b} = (1.37_sp{-0.19}{+0.22} stat. +/- 0.11 sys.) times (1 +/- 0.15 sys.) psec. We separate additive and multiplicative systematic errors because the second does not degrade the statistical significance of the difference of the result from 0. If b-c dominates b-quark decay the corresponding weak mixing matrix element mid V_ {cb

Search for charmless hadronic decays of B mesons with the SLAC SLD detector

NASA Astrophysics Data System (ADS)

Abe, Kenji; Abe, Koya; Abe, T.; Adam, I.; Akagi, T.; Akimoto, H.; Allen, N. J.; Ash, W. W.; Aston, D.; Baird, K. G.; Baltay, C.; Band, H. R.; Barakat, M. B.; Bardon, O.; Barklow, T. L.; Bashindzhagyan, G. L.; Bauer, J. M.; Bellodi, G.; Benvenuti, A. C.; Bilei, G. M.; Bisello, D.; Blaylock, G.; Bogart, J. R.; Bower, G. R.; Brau, J. E.; Breidenbach, M.; Bugg, W. M.; Burke, D.; Burnett, T. H.; Burrows, P. N.; Byrne, R. M.; Calcaterra, A.; Calloway, D.; Camanzi, B.; Carpinelli, M.; Cassell, R.; Castaldi, R.; Castro, A.; Cavalli-Sforza, M.; Chou, A.; Church, E.; Cohn, H. O.; Coller, J. A.; Convery, M. R.; Cook, V.; Cowan, R. F.; Coyne, D. G.; Crawford, G.; Damerell, C. J.; Danielson, M. N.; Daoudi, M.; de Groot, N.; dell'orso, R.; Dervan, P. J.; de Sangro, R.; Dima, M.; Dong, D. N.; Doser, M.; Dubois, R.; Eisenstein, B. I.; Erofeeva, I.; Eschenburg, V.; Etzion, E.; Fahey, S.; Falciai, D.; Fan, C.; Fernandez, J. P.; Fero, M. J.; Flood, K.; Frey, R.; Gifford, J.; Gillman, T.; Gladding, G.; Gonzalez, S.; Goodman, E. R.; Hart, E. L.; Harton, J. L.; Hasuko, K.; Hedges, S. J.; Hertzbach, S. S.; Hildreth, M. D.; Huber, J.; Huffer, M. E.; Hughes, E. W.; Huynh, X.; Hwang, H.; Iwasaki, M.; Jackson, D. J.; Jacques, P.; Jaros, J. A.; Jiang, Z. Y.; Johnson, A. S.; Johnson, J. R.; Johnson, R. A.; Junk, T.; Kajikawa, R.; Kalelkar, M.; Kamyshkov, Y.; Kang, H. J.; Karliner, I.; Kawahara, H.; Kim, Y. D.; King, M. E.; King, R.; Kofler, R. R.; Krishna, N. M.; Kroeger, R. S.; Langston, M.; Lath, A.; Leith, D. W.; Lia, V.; Lin, C.; Liu, M. X.; Liu, X.; Loreti, M.; Lu, A.; Lynch, H. L.; Ma, J.; Mahjouri, M.; Mancinelli, G.; Manly, S.; Mantovani, G.; Markiewicz, T. W.; Maruyama, T.; Masuda, H.; Mazzucato, E.; McKemey, A. K.; Meadows, B. T.; Menegatti, G.; Messner, R.; Mockett, P. M.; Moffeit, K. C.; Moore, T. B.; Morii, M.; Muller, D.; Murzin, V.; Nagamine, T.; Narita, S.; Nauenberg, U.; Neal, H.; Nussbaum, M.; Oishi, N.; Onoprienko, D.; Osborne, L. S.; Panvini, R. S.; Park, C. H.; Pavel, T. J.; Peruzzi, I.; Piccolo, M.; Piemontese, L.; Pitts, K. T.; Plano, R. J.; Prepost, R.; Prescott, C. Y.; Punkar, G. D.; Quigley, J.; Ratcliff, B. N.; Reeves, T. W.; Reidy, J.; Reinertsen, P. L.; Rensing, P. E.; Rochester, L. S.; Rowson, P. C.; Russell, J. J.; Saxton, O. H.; Schalk, T.; Schindler, R. H.; Schumm, B. A.; Schwiening, J.; Sen, S.; Serbo, V. V.; Shaevitz, M. H.; Shank, J. T.; Shapiro, G.; Sherden, D. J.; Shmakov, K. D.; Simopoulos, C.; Sinev, N. B.; Smith, S. R.; Smy, M. B.; Snyder, J. A.; Staengle, H.; Stahl, A.; Stamer, P.; Steiner, H.; Steiner, R.; Strauss, M. G.; Su, D.; Suekane, F.; Sugiyama, A.; Suzuki, S.; Swartz, M.; Szumilo, A.; Takahashi, T.; Taylor, F. E.; Thom, J.; Torrence, E.; Toumbas, N. K.; Usher, T.; Vannini, C.; Va'vra, J.; Vella, E.; Venuti, J. P.; Verdier, R.; Verdini, P. G.; Wagner, D. L.; Wagner, S. R.; Waite, A. P.; Walston, S.; Watts, S. J.; Weidemann, A. W.; Weiss, E. R.; Whitaker, J. S.; White, S. L.; Wickens, F. J.; Williams, B.; Williams, D. C.; Williams, S. H.; Willocq, S.; Wilson, R. J.; Wisniewski, W. J.; Wittlin, J. L.; Woods, M.; Word, G. B.; Wright, T. R.; Wyss, J.; Yamamoto, R. K.; Yamartino, J. M.; Yang, X.; Yashima, J.; Yellin, S. J.; Young, C. C.; Yuta, H.; Zapalac, G.; Zdarko, R. W.; Zhou, J.

2000-10-01

Based on a sample of approximately 500 000 hadronic Z0 decays accumulated between 1993 and 1998, the SLD experiment has set limits on 24 fully charged two-body and quasi-two-body exclusive charmless hadronic decays of B+, B0, and B0s mesons. The precise tracking capabilities of the SLD detector provided for the efficient reduction of combinatoric backgrounds, yielding the most precise available limits for ten of these modes.

Search for Supersymmetry in Hadronic Final States

NASA Astrophysics Data System (ADS)

Mulholland, Troy

We present a search for supersymmetry in purely hadronic final states with large missing transverse momentum using data collected by the CMS detector at the CERN LHC. The data were produced in proton-proton collisions with center-of-mass energy of 13 TeV and correspond to an integrated luminosity of 35.9 fb -1. Data are analyzed with variables defined in terms of jet multiplicity, bottom quark tagged jet multiplicity, the scalar sum of jet transverse momentum, the magnitude of the vector sum of jet transverse momentum, and angular separation between jets and the vector sum of transverse momentum. We perform the search on the data using two analysis techniques: a boosted decision tree trained on simulated data using the above variables as features and a four-dimensional fit with rectangular search regions. In both analyses, standard model background estimations are derived from data-driven techniques and the signal data are separated into exclusive search regions. The observed yields in the search regions agree with background expectations. We derive upper limits on the production cross sections of pairs of gluinos and pairs of top squarks at 95% confidence using simplified models with the lightest supersymmetric particle assumed to be a weakly interacting neutralino. Gluinos as heavy as 1960 GeV and top squarks as heavy as 980 GeV are excluded. The limits significantly extend the exclusions obtained from previous results.

Centrality and Transverse Momentum Dependence of Elliptic Flow of Multistrange Hadrons and ϕ Meson in Au +Au Collisions at √{sN N}=200 GeV

NASA Astrophysics Data System (ADS)

Adamczyk, L.; Adkins, J. K.; Agakishiev, G.; Aggarwal, M. M.; Ahammed, Z.; Alekseev, I.; Aparin, A.; Arkhipkin, D.; Aschenauer, E. C.; Averichev, G. S.; Bairathi, V.; Banerjee, A.; Bellwied, R.; Bhasin, A.; Bhati, A. K.; Bhattarai, P.; Bielcik, J.; Bielcikova, J.; Bland, L. C.; Bordyuzhin, I. G.; Bouchet, J.; Brandin, A. V.; Bunzarov, I.; Butterworth, J.; Caines, H.; Calderón de la Barca Sánchez, M.; Campbell, J. M.; Cebra, D.; Cervantes, M. C.; Chakaberia, I.; Chaloupka, P.; Chang, Z.; Chattopadhyay, S.; Chen, J. H.; Chen, X.; Cheng, J.; Cherney, M.; Christie, W.; Contin, G.; Crawford, H. J.; Das, S.; De Silva, L. C.; Debbe, R. R.; Dedovich, T. G.; Deng, J.; Derevschikov, A. A.; di Ruzza, B.; Didenko, L.; Dilks, C.; Dong, X.; Drachenberg, J. L.; Draper, J. E.; Du, C. M.; Dunkelberger, L. E.; Dunlop, J. C.; Efimov, L. G.; Engelage, J.; Eppley, G.; Esha, R.; Evdokimov, O.; Eyser, O.; Fatemi, R.; Fazio, S.; Federic, P.; Fedorisin, J.; Feng, Z.; Filip, P.; Fisyak, Y.; Flores, C. E.; Fulek, L.; Gagliardi, C. A.; Garand, D.; Geurts, F.; Gibson, A.; Girard, M.; Greiner, L.; Grosnick, D.; Gunarathne, D. S.; Guo, Y.; Gupta, S.; Gupta, A.; Guryn, W.; Hamad, A.; Hamed, A.; Haque, R.; Harris, J. W.; He, L.; Heppelmann, S.; Heppelmann, S.; Hirsch, A.; Hoffmann, G. W.; Hofman, D. J.; Horvat, S.; Huang, X.; Huang, B.; Huang, H. Z.; Huck, P.; Humanic, T. J.; Igo, G.; Jacobs, W. W.; Jang, H.; Jiang, K.; Judd, E. G.; Kabana, S.; Kalinkin, D.; Kang, K.; Kauder, K.; Ke, H. W.; Keane, D.; Kechechyan, A.; Khan, Z. H.; Kikoła, D. P.; Kisel, I.; Kisiel, A.; Kochenda, L.; Koetke, D. D.; Kollegger, T.; Kosarzewski, L. K.; Kraishan, A. F.; Kravtsov, P.; Krueger, K.; Kulakov, I.; Kumar, L.; Kycia, R. A.; Lamont, M. A. C.; Landgraf, J. M.; Landry, K. D.; Lauret, J.; Lebedev, A.; Lednicky, R.; Lee, J. H.; Li, Z. M.; Li, W.; Li, X.; Li, X.; Li, C.; Li, Y.; Lisa, M. A.; Liu, F.; Ljubicic, T.; Llope, W. J.; Lomnitz, M.; Longacre, R. S.; Luo, X.; Ma, Y. G.; Ma, G. L.; Ma, L.; Ma, R.; Magdy, N.; Majka, R.; Manion, A.; Margetis, S.; Markert, C.; Masui, H.; Matis, H. S.; McDonald, D.; Meehan, K.; Minaev, N. G.; Mioduszewski, S.; Mishra, D.; Mohanty, B.; Mondal, M. M.; Morozov, D. A.; Mustafa, M. K.; Nandi, B. K.; Nasim, Md.; Nayak, T. K.; Nigmatkulov, G.; Nogach, L. V.; Noh, S. Y.; Novak, J.; Nurushev, S. B.; Odyniec, G.; Ogawa, A.; Oh, K.; Okorokov, V.; Olvitt, D.; Page, B. S.; Pak, R.; Pan, Y. X.; Pandit, Y.; Panebratsev, Y.; Pawlik, B.; Pei, H.; Perkins, C.; Peterson, A.; Pile, P.; Planinic, M.; Pluta, J.; Poljak, N.; Poniatowska, K.; Porter, J.; Posik, M.; Poskanzer, A. M.; Putschke, J.; Qiu, H.; Quintero, A.; Ramachandran, S.; Raniwala, R.; Raniwala, S.; Ray, R. L.; Ritter, H. G.; Roberts, J. B.; Rogachevskiy, O. V.; Romero, J. L.; Roy, A.; Ruan, L.; Rusnak, J.; Rusnakova, O.; Sahoo, N. R.; Sahu, P. K.; Sakrejda, I.; Salur, S.; Sandweiss, J.; Sarkar, A.; Schambach, J.; Scharenberg, R. P.; Schmah, A. M.; Schmidke, W. B.; Schmitz, N.; Seger, J.; Seyboth, P.; Shah, N.; Shahaliev, E.; Shanmuganathan, P. V.; Shao, M.; Sharma, B.; Sharma, M. K.; Shen, W. Q.; Shi, S. S.; Shou, Q. Y.; Sichtermann, E. P.; Sikora, R.; Simko, M.; Singha, S.; Skoby, M. J.; Smirnov, D.; Smirnov, N.; Song, L.; Sorensen, P.; Spinka, H. M.; Srivastava, B.; Stanislaus, T. D. S.; Stepanov, M.; Stock, R.; Strikhanov, M.; Stringfellow, B.; Sumbera, M.; Summa, B.; Sun, X.; Sun, X. M.; Sun, Y.; Sun, Z.; Surrow, B.; Svirida, N.; Szelezniak, M. A.; Tang, A. H.; Tang, Z.; Tarnowsky, T.; Tawfik, A.; Thomas, J. H.; Timmins, A. R.; Tlusty, D.; Tokarev, M.; Trentalange, S.; Tribble, R. E.; Tribedy, P.; Tripathy, S. K.; Trzeciak, B. A.; Tsai, O. D.; Ullrich, T.; Underwood, D. G.; Upsal, I.; Van Buren, G.; van Nieuwenhuizen, G.; Vandenbroucke, M.; Varma, R.; Vasiliev, A. N.; Vertesi, R.; Videbæk, F.; Viyogi, Y. P.; Vokal, S.; Voloshin, S. A.; Vossen, A.; Wang, Y.; Wang, G.; Wang, J. S.; Wang, H.; Wang, Y.; Wang, F.; Webb, J. C.; Webb, G.; Wen, L.; Westfall, G. D.; Wieman, H.; Wissink, S. W.; Witt, R.; Wu, Y. F.; Wu, Y.; Xiao, Z. G.; Xie, W.; Xin, K.; Xu, N.; Xu, Z.; Xu, Q. H.; Xu, Y. F.; Xu, H.; Yang, Q.; Yang, Y.; Yang, Y.; Yang, S.; Yang, C.; Ye, Z.; Yepes, P.; Yi, L.; Yip, K.; Yoo, I.-K.; Yu, N.; Zbroszczyk, H.; Zha, W.; Zhang, Z.; Zhang, Y.; Zhang, J. B.; Zhang, J.; Zhang, S.; Zhang, J.; Zhang, X. P.; Zhao, J.; Zhong, C.; Zhou, L.; Zhu, X.; Zoulkarneeva, Y.; Zyzak, M.; STAR Collaboration

2016-02-01

We present high precision measurements of elliptic flow near midrapidity (|y |<1.0 ) for multistrange hadrons and ϕ meson as a function of centrality and transverse momentum in Au +Au collisions at center of mass energy √{sN N}=200 GeV . We observe that the transverse momentum dependence of ϕ and Ω v2 is similar to that of π and p , respectively, which may indicate that the heavier strange quark flows as strongly as the lighter up and down quarks. This observation constitutes a clear piece of evidence for the development of partonic collectivity in heavy-ion collisions at the top RHIC energy. Number of constituent quark scaling is found to hold within statistical uncertainty for both 0%-30% and 30%-80% collision centrality. There is an indication of the breakdown of previously observed mass ordering between ϕ and proton v2 at low transverse momentum in the 0%-30% centrality range, possibly indicating late hadronic interactions affecting the proton v2.

Radiation-related quality of life parameters after targeted intraoperative radiotherapy versus whole breast radiotherapy in patients with breast cancer: results from the randomized phase III trial TARGIT-A.

PubMed

Welzel, Grit; Boch, Angela; Sperk, Elena; Hofmann, Frank; Kraus-Tiefenbacher, Uta; Gerhardt, Axel; Suetterlin, Marc; Wenz, Frederik

2013-01-07

Intraoperative radiotherapy (IORT) is a new treatment approach for early stage breast cancer. This study reports on the effects of IORT on radiation-related quality of life (QoL) parameters. Two hundred and thirty women with stage I-III breast cancer (age, 31 to 84 years) were entered into the study. A single-center subgroup of 87 women from the two arms of the randomized phase III trial TARGIT-A (TARGeted Intra-operative radioTherapy versus whole breast radiotherapy for breast cancer) was analyzed. Furthermore, results were compared to non-randomized control groups: n = 90 receiving IORT as a tumor bed boost followed by external beam whole breast radiotherapy (EBRT) outside of TARGIT-A (IORT-boost), and n = 53 treated with EBRT followed by an external-beam boost (EBRT-boost). QoL was collected using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaires C30 (QLQ-C30) and BR23 (QLQ-BR23). The mean follow-up period in the TARGIT-A groups was 32 versus 39 months in the non-randomized control groups. Patients receiving IORT alone reported less general pain (21.3 points), breast (7.0 points) and arm (15.1 points) symptoms, and better role functioning (78.7 points) as patients receiving EBRT (40.9; 19.0; 32.8; and 60.5 points, respectively, P < 0.01). Patients receiving IORT alone also had fewer breast symptoms than TARGIT-A patients receiving IORT followed by EBRT for high risk features on final pathology (IORT-EBRT; 7.0 versus 29.7 points, P < 0.01). There were no significant differences between TARGIT-A patients receiving IORT-EBRT compared to non-randomized IORT-boost or EBRT-boost patients and patients receiving EBRT without a boost. In the randomized setting, important radiation-related QoL parameters after IORT were superior to EBRT. Non-randomized comparisons showed equivalent parameters in the IORT-EBRT group and the control groups.

[Description of latest generation equipment in external radiotherapy].

PubMed

Pellejero, S; Lozares, S; Mañeru, F

2009-01-01

Both the planning systems and the form of administering radiotherapy have changed radically since the introduction of 3D planning. At present treatment planning based on computerised axial tomography (CAT) images is standard practice in radiotherapy services. In recent years lineal accelerators for medical use have incorporated technology capable of administering intensity modulated radiation beams (IMRT). With this mode distributions of conformed doses are generated that adjust to the three dimensional form of the white volume, providing appropriate coverage and a lower dose to nearby risk organs. The use of IMRT is rapidly spreading amongst radiotherapy centres throughout the world. This growing use of IMRT has focused attention on the need for greater control of the geometric uncertainties in positioning the patient and control of internal movements. To this end, both flat and volumetric image systems have been incorporated into the treatment equipment, making image-guided radiotherapy (IGRT) possible. This article offers a brief description of the latest advances included in the planning and administration of radiotherapy treatment.

PET imaging in adaptive radiotherapy of gastrointestinal tumours.

PubMed

Bulens, Philippe; Thomas, Melissa; Deroose, Christophe M; Haustermans, Karin

2018-06-04

Radiotherapy is the standard of care in the multimodality treatment of a variety of gastrointestinal (GI) tumours, such as oesophageal cancer, gastric cancer, rectal cancer and anal cancer. Additionally, radiotherapy has served as an alternative for surgery in patients with liver cancer, cancer of the biliary tract and pancreatic cancer. Positron-emission tomography (PET), generally in combination with computed tomography (CT), has an established role in the diagnosis, response assessment and (re-)staging of several GI tumours. However, the additional value of PET in adaptive radiotherapy, i.e. during the radiation treatment course and in the delineation process, is still unclear. When performed during radiotherapy, PET aims at assessing treatment-induced variations in functional tumour volumes to reduce the radiation target volume. Moreover, in the radiation treatment planning, tumour delineation could be more accurate by incorporating PET to identify the metabolic tumour volume. This review focuses on the additional value of PET for adaptive radiotherapy protocols as well as for the target volume adaptation for individualised treatment strategies in oesophageal, gastric, pancreatic, liver, biliary tract, rectal and anal neoplasms.

The Future of Hadrons: The Nexus of Subatomic Physics

DOE Office of Scientific and Technical Information (OSTI.GOV)

Quigg, Chris

2011-09-01

The author offers brief observations on matters discussed at the XIV International Conference on Hadron Spectroscopy and explore prospects for hadron physics. Quantum chromodynamics (QCD) has been validated as a new law of nature. It is internally consistent up to very high energies, and so could be a complete theory of the strong interactions. Whether QCD is the final answer for the strong interactions is a subject for continuing experimental tests, which are being extended in experimentation at the Large Hadron Collider. Beyond the comparison of perturbative calculations with experiment, it remains critically important to test the confinement hypothesis bymore » searching for free quarks, or for signatures of unconfined color. Sensitive negative searches for quarks continue to be interesting, and the definitive observation of free quarks would be revolutionary. Breakdowns of factorization would compromise the utility of perturbative QCD. Other discoveries that would require small or large revisions to QCD include the observation of new kinds of colored matter beyond quarks and gluons, the discovery that quarks are composite, or evidence that SU(3){sub c} gauge symmetry is the vestige of a larger, spontaneously broken, color symmetry. While probing our underlying theory for weakness or new openings, we have plenty to do to apply QCD to myriad experimental settings, to learn its implications for matter under unusual conditions, and to become more adept at calculating its consequences. New experimental tools provide the means for progress on a very broad front.« less

Issues and Opportunities in Exotic Hadrons

NASA Astrophysics Data System (ADS)

Briceño, R. A.; Cohen, T. D.; Coito, S.; Dudek, J. J.; Eichten, E.; Fischer, C. S.; Fritsch, M.; Gradl, W.; Jackura, A.; Kornicer, M.; Krein, G.; Lebed, R. F.; Machado, F. A.; Mitchell, R. E.; Morningstar, C. J.; Peardon, M.; Pennington, M. R.; Peters, K.; Richard, J. M.; Shen, C. P.; Shepherd, M. R.; Skwarnicki, T.; Swanson, E. S.; Szczepaniak, A. P.; Yuan, C. Z.

2016-04-01

The last few years have been witness to a proliferation of new results concerning heavy exotic hadrons. Experimentally, many new signals have been discovered that could be pointing towards the existence of tetraquarks, pentaquarks, and other exotic configurations of quarks and gluons. Theoretically, advances in lattice field theory techniques place us at the cusp of understanding complex coupled-channel phenomena, modelling grows more sophisticated, and effective field theories are being applied to an ever greater range of situations. It is thus an opportune time to evaluate the status of the field. In the following, a series of high priority experimental and theoretical issues concerning heavy exotic hadrons is presented. Supported by U.S. Department of Energy (Cohen); the Institute of Modern Physics and Chinese Academy of Sciences under contract Y104160YQ0 and agreement No. 2015-BH-02 (Coito); the U.S. Department of Energy, for grant DE-AC05-06OR23177, under which Jefferson Science Associates, LLC, manages and operates Jefferson Laboratory and DE-SC0006765, Early Career award (Dudek); Fermilab, operated by the Fermi Research Alliance under contract number DEAC02-07CH11359 with the U.S. Department of Energy (Eichten); BMBF, under contract No. 06GI7121, and the DAAD under contract No. 56889822 and by the Helmholtz International Center for FAIR within the LOEWE program of the State of Hesse (Fischer); the German Research Foundation DFG under contract number Collaborative Research Centre CRC-1044 (Gradl); the Conselho Nacional de Desenvolvimento Científico e Tecnológico - CNPq, Grant No. 305894/2009-9 and Fundação de Amparo à Pesquisa do Estado de São Paulo - FAPESP, Grant No. 2013/01907-0 (Krein); U.S. National Science Foundation, under grants PHY-1068286 and PHY-1403891 (Lebed); the Brazilian National Council for Scientific and Technological Development under grant CNPq/CAPES-208188/2014-2 (Machado); U.S. Department of Energy under grant DE-FG02-05ER41374

Contribution of FDOPA PET to radiotherapy planning for advanced glioma

NASA Astrophysics Data System (ADS)

Dowson, Nicholas; Fay, Michael; Thomas, Paul; Jeffree, Rosalind; McDowall, Robert; Winter, Craig; Coulthard, Alan; Smith, Jye; Gal, Yaniv; Bourgeat, Pierrick; Salvado, Olivier; Crozier, Stuart; Rose, Stephen

2014-03-01

Despite radical treatment with surgery, radiotherapy and chemotherapy, advanced gliomas recur within months. Geographic misses in radiotherapy planning may play a role in this seemingly ineluctable recurrence. Planning is typically performed on post-contrast MRIs, which are known to underreport tumour volume relative to FDOPA PET scans. FDOPA PET fused with contrast enhanced MRI has demonstrated greater sensitivity and specificity than MRI alone. One sign of potential misses would be differences between gross target volumes (GTVs) defined using MRI alone and when fused with PET. This work examined whether such a discrepancy may occur. Materials and Methods: For six patients, a 75 minute PET scan using 3,4-dihydroxy-6-18F-fluoro-L-phynel-alanine (18F-FDOPA) was taken within 2 days of gadolinium enhanced MRI scans. In addition to standard radiotherapy planning by an experienced radiotherapy oncologist, a second gross target volume (GTV) was defined by an experienced nuclear medicine specialist for fused PET and MRI, while blinded to the radiotherapy plans. The volumes from standard radiotherapy planning were compared to the PET defined GTV. Results: The comparison indicated radiotherapy planning would change in several cases if FDOPA PET data was available. PET-defined contours were external to 95% prescribed dose for several patients. However, due to the radiotherapy margins, the discrepancies were relatively small in size and all received a dose of 50 Gray or more. Conclusions: Given the limited size of the discrepancies it is uncertain that geographic misses played a major role in patient outcome. Even so, the existence of discrepancies indicates that FDOPA PET could assist in better defining margins when planning radiotherapy for advanced glioma, which could be important for highly conformal radiotherapy plans.

Slepton Pair Production at Hadron Colliders

NASA Astrophysics Data System (ADS)

Fuks, B.

2007-04-01

In R-parity conserving supersymmetric models, sleptons are produced in pairs at hadron colliders. We show that measurements of the longitudinal single-spin asymmetry at possible polarization upgrades of existing colliders allow for a direct extraction of the slepton mixing angle. A calculation of the transverse-momentum spectrum shows the importance of resummed contributions at next-to-leading logarithmic accuracy in the small and intermediate transverse-momentum regions and little dependence on unphysical scales and non-perturbative contributions.

Adjuvant radiotherapy after breast conserving surgery - a comparative effectiveness research study.

PubMed

Corradini, Stefanie; Niyazi, Maximilian; Niemoeller, Olivier M; Li, Minglun; Roeder, Falk; Eckel, Renate; Schubert-Fritschle, Gabriele; Scheithauer, Heike R; Harbeck, Nadia; Engel, Jutta; Belka, Claus

2015-01-01

The purpose of this retrospective outcome study was to validate the effectiveness of postoperative radiotherapy in breast conserving therapy (BCT) and to evaluate possible causes for omission of radiotherapy after breast conserving surgery (BCS) in a non-trial population. Data were provided by the population-based Munich Cancer Registry. The study included epidemiological data of 30.811 patients diagnosed with breast cancer from 1998 to 2012. The effect of omitting radiotherapy was analysed using Kaplan-Meier-estimates and Cox proportional hazard regression. Variables predicting omission of radiotherapy were analysed using multivariate logistic regression. Use of postoperative radiotherapy after BCS was associated with significant improvements in local control and survival. 10-year loco-regional recurrence-free-survival was 90.8% with postoperative radiotherapy vs. 77.6% with surgery alone (p<0.001). 10-year overall survival rates were 55.2% with surgery alone vs. 82.2% following postoperative radiotherapy (p<0.001). Variables predicting omission of postoperative radiotherapy included advanced age (women ⩾80 years; OR: 0.082; 95% CI: 0.071-0.094, p<0.001). This study shows a decrease in local control and a survival disadvantage if postoperative radiotherapy after breast conserving surgery is omitted in an unselected cohort of primary breast cancer patients. Due to its epidemiological nature, it cannot answer the question in whom postoperative radiotherapy can be safely omitted. Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

The ATLAS Experiment at the CERN Large Hadron Collider

NASA Astrophysics Data System (ADS)

ATLAS Collaboration; Aad, G.; Abat, E.; Abdallah, J.; Abdelalim, A. A.; Abdesselam, A.; Abdinov, O.; Abi, B. A.; Abolins, M.; Abramowicz, H.; Acerbi, E.; Acharya, B. S.; Achenbach, R.; Ackers, M.; Adams, D. L.; Adamyan, F.; Addy, T. N.; Aderholz, M.; Adorisio, C.; Adragna, P.; Aharrouche, M.; Ahlen, S. P.; Ahles, F.; Ahmad, A.; Ahmed, H.; Aielli, G.; Åkesson, P. F.; Åkesson, T. P. A.; Akimov, A. V.; Alam, S. M.; Albert, J.; Albrand, S.; Aleksa, M.; Aleksandrov, I. N.; Aleppo, M.; Alessandria, F.; Alexa, C.; Alexander, G.; Alexopoulos, T.; Alimonti, G.; Aliyev, M.; Allport, P. P.; Allwood-Spiers, S. E.; Aloisio, A.; Alonso, J.; Alves, R.; Alviggi, M. G.; Amako, K.; Amaral, P.; Amaral, S. P.; Ambrosini, G.; Ambrosio, G.; Amelung, C.; Ammosov, V. V.; Amorim, A.; Amram, N.; Anastopoulos, C.; Anderson, B.; Anderson, K. J.; Anderssen, E. C.; Andreazza, A.; Andrei, V.; Andricek, L.; Andrieux, M.-L.; Anduaga, X. S.; Anghinolfi, F.; Antonaki, A.; Antonelli, M.; Antonelli, S.; Apsimon, R.; Arabidze, G.; Aracena, I.; Arai, Y.; Arce, A. T. H.; Archambault, J. P.; Arguin, J.-F.; Arik, E.; Arik, M.; Arms, K. E.; Armstrong, S. R.; Arnaud, M.; Arnault, C.; Artamonov, A.; Asai, S.; Ask, S.; Åsman, B.; Asner, D.; Asquith, L.; Assamagan, K.; Astbury, A.; Athar, B.; Atkinson, T.; Aubert, B.; Auerbach, B.; Auge, E.; Augsten, K.; Aulchenko, V. M.; Austin, N.; Avolio, G.; Avramidou, R.; Axen, A.; Ay, C.; Azuelos, G.; Baccaglioni, G.; Bacci, C.; Bachacou, H.; Bachas, K.; Bachy, G.; Badescu, E.; Bagnaia, P.; Bailey, D. C.; Baines, J. T.; Baker, O. K.; Ballester, F.; Baltasar Dos Santos Pedrosa, F.; Banas, E.; Banfi, D.; Bangert, A.; Bansal, V.; Baranov, S. P.; Baranov, S.; Barashkou, A.; Barberio, E. L.; Barberis, D.; Barbier, G.; Barclay, P.; Bardin, D. Y.; Bargassa, P.; Barillari, T.; Barisonzi, M.; Barnett, B. M.; Barnett, R. M.; Baron, S.; Baroncelli, A.; Barone, M.; Barr, A. J.; Barreiro, F.; Barreiro Guimarães da Costa, J.; Barrillon, P.; Barriuso Poy, A.; Barros, N.; Bartheld, V.; Bartko, H.; Bartoldus, R.; Basiladze, S.; Bastos, J.; Batchelor, L. E.; Bates, R. L.; Batley, J. R.; Batraneanu, S.; Battistin, M.; Battistoni, G.; Batusov, V.; Bauer, F.; Bauss, B.; Baynham, D. E.; Bazalova, M.; Bazan, A.; Beauchemin, P. H.; Beaugiraud, B.; Beccherle, R. B.; Beck, G. A.; Beck, H. P.; Becks, K. H.; Bedajanek, I.; Beddall, A. J.; Beddall, A.; Bednár, P.; Bednyakov, V. A.; Bee, C.; Behar Harpaz, S.; Belanger, G. A. N.; Belanger-Champagne, C.; Belhorma, B.; Bell, P. J.; Bell, W. H.; Bella, G.; Bellachia, F.; Bellagamba, L.; Bellina, F.; Bellomo, G.; Bellomo, M.; Beltramello, O.; Belymam, A.; Ben Ami, S.; Ben Moshe, M.; Benary, O.; Benchekroun, D.; Benchouk, C.; Bendel, M.; Benedict, B. H.; Benekos, N.; Benes, J.; Benhammou, Y.; Benincasa, G. P.; Benjamin, D. P.; Bensinger, J. R.; Benslama, K.; Bentvelsen, S.; Beretta, M.; Berge, D.; Bergeaas, E.; Berger, N.; Berghaus, F.; Berglund, S.; Bergsma, F.; Beringer, J.; Bernabéu, J.; Bernardet, K.; Berriaud, C.; Berry, T.; Bertelsen, H.; Bertin, A.; Bertinelli, F.; Bertolucci, S.; Besson, N.; Beteille, A.; Bethke, S.; Bialas, W.; Bianchi, R. M.; Bianco, M.; Biebel, O.; Bieri, M.; Biglietti, M.; Bilokon, H.; Binder, M.; Binet, S.; Bingefors, N.; Bingul, A.; Bini, C.; Biscarat, C.; Bischof, R.; Bischofberger, M.; Bitadze, A.; Bizzell, J. P.; Black, K. M.; Blair, R. E.; Blaising, J. J.; Blanch, O.; Blanchot, G.; Blocker, C.; Blocki, J.; Blondel, A.; Blum, W.; Blumenschein, U.; Boaretto, C.; Bobbink, G. J.; Bocci, A.; Bocian, D.; Bock, R.; Boehm, M.; Boek, J.; Bogaerts, J. A.; Bogouch, A.; Bohm, C.; Bohm, J.; Boisvert, V.; Bold, T.; Boldea, V.; Bondarenko, V. G.; Bonino, R.; Bonis, J.; Bonivento, W.; Bonneau, P.; Boonekamp, M.; Boorman, G.; Boosten, M.; Booth, C. N.; Booth, P. S. L.; Booth, P.; Booth, J. R. A.; Borer, K.; Borisov, A.; Borjanovic, I.; Bos, K.; Boscherini, D.; Bosi, F.; Bosman, M.; Bosteels, M.; Botchev, B.; Boterenbrood, H.; Botterill, D.; Boudreau, J.; Bouhova-Thacker, E. V.; Boulahouache, C.; Bourdarios, C.; Boutemeur, M.; Bouzakis, K.; Boyd, G. R.; Boyd, J.; Boyer, B. H.; Boyko, I. R.; Bozhko, N. I.; Braccini, S.; Braem, A.; Branchini, P.; Brandenburg, G. W.; Brandt, A.; Brandt, O.; Bratzler, U.; Braun, H. M.; Bravo, S.; Brawn, I. P.; Brelier, B.; Bremer, J.; Brenner, R.; Bressler, S.; Breton, D.; Brett, N. D.; Breugnon, P.; Bright-Thomas, P. G.; Brochu, F. M.; Brock, I.; Brock, R.; Brodbeck, T. J.; Brodet, E.; Broggi, F.; Broklova, Z.; Bromberg, C.; Brooijmans, G.; Brouwer, G.; Broz, J.; Brubaker, E.; Bruckman de Renstrom, P. A.; Bruncko, D.; Bruni, A.; Bruni, G.; Bruschi, M.; Buanes, T.; Buchanan, N. J.; Buchholz, P.; Budagov, I. A.; Büscher, V.; Bugge, L.; Buira-Clark, D.; Buis, E. J.; Bujor, F.; Buran, T.; Burckhart, H.; Burckhart-Chromek, D.; Burdin, S.; Burns, R.; Busato, E.; Buskop, J. J. F.; Buszello, K. P.; Butin, F.; Butler, J. M.; Buttar, C. M.; Butterworth, J.; Butterworth, J. M.; Byatt, T.; Cabrera Urbán, S.; Cabruja Casas, E.; Caccia, M.; Caforio, D.; Cakir, O.; Calafiura, P.; Calderini, G.; Calderón Terol, D.; Callahan, J.; Caloba, L. P.; Caloi, R.; Calvet, D.; Camard, A.; Camarena, F.; Camarri, P.; Cambiaghi, M.; Cameron, D.; Cammin, J.; Campabadal Segura, F.; Campana, S.; Canale, V.; Cantero, J.; Capeans Garrido, M. D. M.; Caprini, I.; Caprini, M.; Caprio, M.; Caracinha, D.; Caramarcu, C.; Carcagno, Y.; Cardarelli, R.; Cardeira, C.; Cardiel Sas, L.; Cardini, A.; Carli, T.; Carlino, G.; Carminati, L.; Caron, B.; Caron, S.; Carpentieri, C.; Carr, F. S.; Carter, A. A.; Carter, J. R.; Carvalho, J.; Casadei, D.; Casado, M. P.; Cascella, M.; Caso, C.; Castelo, J.; Castillo Gimenez, V.; Castro, N.; Castrovillari, F.; Cataldi, G.; Cataneo, F.; Catinaccio, A.; Catmore, J. R.; Cattai, A.; Caughron, S.; Cauz, D.; Cavallari, A.; Cavalleri, P.; Cavalli, D.; Cavalli-Sforza, M.; Cavasinni, V.; Ceradini, F.; Cerna, C.; Cernoch, C.; Cerqueira, A. S.; Cerri, A.; Cerutti, F.; Cervetto, M.; Cetin, S. A.; Cevenini, F.; Chalifour, M.; Chamizo llatas, M.; Chan, A.; Chapman, J. W.; Charlton, D. G.; Charron, S.; Chekulaev, S. V.; Chelkov, G. A.; Chen, H.; Chen, L.; Chen, T.; Chen, X.; Cheng, S.; Cheng, T. L.; Cheplakov, A.; Chepurnov, V. F.; Cherkaoui El Moursli, R.; Chesneanu, D.; Cheu, E.; Chevalier, L.; Chevalley, J. L.; Chevallier, F.; Chiarella, V.; Chiefari, G.; Chikovani, L.; Chilingarov, A.; Chiodini, G.; Chouridou, S.; Chren, D.; Christiansen, T.; Christidi, I. A.; Christov, A.; Chu, M. L.; Chudoba, J.; Chuguev, A. G.; Ciapetti, G.; Cicalini, E.; Ciftci, A. K.; Cindro, V.; Ciobotaru, M. D.; Ciocio, A.; Cirilli, M.; Citterio, M.; Ciubancan, M.; Civera, J. V.; Clark, A.; Cleland, W.; Clemens, J. C.; Clement, B. C.; Clément, C.; Clements, D.; Clifft, R. W.; Cobal, M.; Coccaro, A.; Cochran, J.; Coco, R.; Coe, P.; Coelli, S.; Cogneras, E.; Cojocaru, C. D.; Colas, J.; Colijn, A. P.; Collard, C.; Collins-Tooth, C.; Collot, J.; Coluccia, R.; Comune, G.; Conde Muiño, P.; Coniavitis, E.; Consonni, M.; Constantinescu, S.; Conta, C.; Conventi, F. A.; Cook, J.; Cooke, M.; Cooper-Smith, N. J.; Cornelissen, T.; Corradi, M.; Correard, S.; Corso-Radu, A.; Coss, J.; Costa, G.; Costa, M. J.; Costanzo, D.; Costin, T.; Coura Torres, R.; Courneyea, L.; Couyoumtzelis, C.; Cowan, G.; Cox, B. E.; Cox, J.; Cragg, D. A.; Cranmer, K.; Cranshaw, J.; Cristinziani, M.; Crosetti, G.; Cuenca Almenar, C.; Cuneo, S.; Cunha, A.; Curatolo, M.; Curtis, C. J.; Cwetanski, P.; Czyczula, Z.; D'Auria, S.; D'Onofrio, M.; Da Rocha Gesualdi Mello, A.; Da Silva, P. V. M.; Da Silva, R.; Dabrowski, W.; Dael, A.; Dahlhoff, A.; Dai, T.; Dallapiccola, C.; Dallison, S. J.; Dalmau, J.; Daly, C. H.; Dam, M.; Damazio, D.; Dameri, M.; Danielsen, K. M.; Danielsson, H. O.; Dankers, R.; Dannheim, D.; Darbo, G.; Dargent, P.; Daum, C.; Dauvergne, J. P.; David, M.; Davidek, T.; Davidson, N.; Davidson, R.; Dawson, I.; Dawson, J. W.; Daya, R. K.; De, K.; de Asmundis, R.; de Boer, R.; DeCastro, S.; DeGroot, N.; de Jong, P.; de La Broise, X.; DeLa Cruz-Burelo, E.; DeLa Taille, C.; DeLotto, B.; DeOliveira Branco, M.; DePedis, D.; de Saintignon, P.; DeSalvo, A.; DeSanctis, U.; DeSanto, A.; DeVivie DeRegie, J. B.; DeZorzi, G.; Dean, S.; Dedes, G.; Dedovich, D. V.; Defay, P. O.; Degele, R.; Dehchar, M.; Deile, M.; DelPapa, C.; DelPeso, J.; DelPrete, T.; Delagnes, E.; Delebecque, P.; Dell'Acqua, A.; Della Pietra, M.; della Volpe, D.; Delmastro, M.; Delpierre, P.; Delruelle, N.; Delsart, P. A.; Deluca Silberberg, C.; Demers, S.; Demichev, M.; Demierre, P.; Demirköz, B.; Deng, W.; Denisov, S. P.; Dennis, C.; Densham, C. J.; Dentan, M.; Derkaoui, J. E.; Derue, F.; Dervan, P.; Desch, K. K.; Dewhurst, A.; Di Ciaccio, A.; Di Ciaccio, L.; Di Domenico, A.; Di Girolamo, A.; Di Girolamo, B.; Di Luise, S.; Di Mattia, A.; Di Simone, A.; Diaz Gomez, M. M.; Diehl, E. B.; Dietl, H.; Dietrich, J.; Dietsche, W.; Diglio, S.; Dima, M.; Dindar, K.; Dinkespiler, B.; Dionisi, C.; Dipanjan, R.; Dita, P.; Dita, S.; Dittus, F.; Dixon, S. D.; Djama, F.; Djilkibaev, R.; Djobava, T.; do Vale, M. A. B.; Dobbs, M.; Dobinson, R.; Dobos, D.; Dobson, E.; Dobson, M.; Dodd, J.; Dogan, O. B.; Doherty, T.; Doi, Y.; Dolejsi, J.; Dolenc, I.; Dolezal, Z.; Dolgoshein, B. A.; Domingo, E.; Donega, M.; Dopke, J.; Dorfan, D. E.; Dorholt, O.; Doria, A.; Dos Anjos, A.; Dosil, M.; Dotti, A.; Dova, M. T.; Dowell, J. D.; Doyle, A. T.; Drake, G.; Drakoulakos, D.; Drasal, Z.; Drees, J.; Dressnandt, N.; Drevermann, H.; Driouichi, C.; Dris, M.; Drohan, J. G.; Dubbert, J.; Dubbs, T.; Duchovni, E.; Duckeck, G.; Dudarev, A.; Dührssen, M.; Dür, H.; Duerdoth, I. P.; Duffin, S.; Duflot, L.; Dufour, M.-A.; Dumont Dayot, N.; Duran Yildiz, H.; Durand, D.; Dushkin, A.; Duxfield, R.; Dwuznik, M.; Dydak, F.; Dzahini, D.; Díez Cornell, S.; Düren, M.; Ebenstein, W. L.; Eckert, S.; Eckweiler, S.; Eerola, P.; Efthymiopoulos, I.; Egede, U.; Egorov, K.; Ehrenfeld, W.; Eifert, T.; Eigen, G.; Einsweiler, K.; Eisenhandler, E.; Ekelof, T.; Eklund, L. M.; El Kacimi, M.; Ellert, M.; Elles, S.; Ellis, N.; Elmsheuser, J.; Elsing, M.; Ely, R.; Emeliyanov, D.; Engelmann, R.; Engström, M.; Ennes, P.; Epp, B.; Eppig, A.; Epshteyn, V. S.; Ereditato, A.; Eremin, V.; Eriksson, D.; Ermoline, I.; Ernwein, J.; Errede, D.; Errede, S.; Escalier, M.; Escobar, C.; Espinal Curull, X.; Esposito, B.; Esteves, F.; Etienne, F.; Etienvre, A. I.; Etzion, E.; Evans, H.; Evdokimov, V. N.; Evtoukhovitch, P.; Eyring, A.; Fabbri, L.; Fabjan, C. W.; Fabre, C.; Faccioli, P.; Facius, K.; Fadeyev, V.; Fakhrutdinov, R. M.; Falciano, S.; Falleau, I.; Falou, A. C.; Fang, Y.; Fanti, M.; Farbin, A.; Farilla, A.; Farrell, J.; Farthouat, P.; Fasching, D.; Fassi, F.; Fassnacht, P.; Fassouliotis, D.; Fawzi, F.; Fayard, L.; Fayette, F.; Febbraro, R.; Fedin, O. L.; Fedorko, I.; Feld, L.; Feldman, G.; Feligioni, L.; Feng, C.; Feng, E. J.; Fent, J.; Fenyuk, A. B.; Ferencei, J.; Ferguson, D.; Ferland, J.; Fernando, W.; Ferrag, S.; Ferrari, A.; Ferrari, P.; Ferrari, R.; Ferrer, A.; Ferrer, M. L.; Ferrere, D.; Ferretti, C.; Ferro, F.; Fiascaris, M.; Fichet, S.; Fiedler, F.; Filimonov, V.; Filipčič, A.; Filippas, A.; Filthaut, F.; Fincke-Keeler, M.; Finocchiaro, G.; Fiorini, L.; Firan, A.; Fischer, P.; Fisher, M. J.; Fisher, S. M.; Flaminio, V.; Flammer, J.; Flechl, M.; Fleck, I.; Flegel, W.; Fleischmann, P.; Fleischmann, S.; Fleta Corral, C. M.; Fleuret, F.; Flick, T.; Flix, J.; Flores Castillo, L. R.; Flowerdew, M. J.; Föhlisch, F.; Fokitis, M.; Fonseca Martin, T. M.; Fopma, J.; Forbush, D. A.; Formica, A.; Foster, J. M.; Fournier, D.; Foussat, A.; Fowler, A. J.; Fox, H.; Francavilla, P.; Francis, D.; Franz, S.; Fraser, J. T.; Fraternali, M.; Fratianni, S.; Freestone, J.; French, R. S.; Fritsch, K.; Froidevaux, D.; Frost, J. A.; Fukunaga, C.; Fulachier, J.; Fullana Torregrosa, E.; Fuster, J.; Gabaldon, C.; Gadomski, S.; Gagliardi, G.; Gagnon, P.; Gallas, E. J.; Gallas, M. V.; Gallop, B. J.; Gan, K. K.; Gannaway, F. C.; Gao, Y. S.; Gapienko, V. A.; Gaponenko, A.; Garciá, C.; Garcia-Sciveres, M.; Garcìa Navarro, J. E.; Garde, V.; Gardner, R. W.; Garelli, N.; Garitaonandia, H.; Garonne, V. G.; Garvey, J.; Gatti, C.; Gaudio, G.; Gaumer, O.; Gautard, V.; Gauzzi, P.; Gavrilenko, I. L.; Gay, C.; Gayde, J.-C.; Gazis, E. N.; Gazo, E.; Gee, C. N. P.; Geich-Gimbel, C.; Gellerstedt, K.; Gemme, C.; Genest, M. H.; Gentile, S.; George, M. A.; George, S.; Gerlach, P.; Gernizky, Y.; Geweniger, C.; Ghazlane, H.; Ghete, V. M.; Ghez, P.; Ghodbane, N.; Giacobbe, B.; Giagu, S.; Giakoumopoulou, V.; Giangiobbe, V.; Gianotti, F.; Gibbard, B.; Gibson, A.; Gibson, M. D.; Gibson, S. M.; Gieraltowski, G. F.; Gil Botella, I.; Gilbert, L. M.; Gilchriese, M.; Gildemeister, O.; Gilewsky, V.; Gillman, A. R.; Gingrich, D. M.; Ginzburg, J.; Giokaris, N.; Giordani, M. P.; Girard, C. G.; Giraud, P. F.; Girtler, P.; Giugni, D.; Giusti, P.; Gjelsten, B. K.; Glasman, C.; Glazov, A.; Glitza, K. W.; Glonti, G. L.; Gnanvo, K. G.; Godlewski, J.; Göpfert, T.; Gössling, C.; Göttfert, T.; Goldfarb, S.; Goldin, D.; Goldschmidt, N.; Golling, T.; Gollub, N. P.; Golonka, P. J.; Golovnia, S. N.; Gomes, A.; Gomes, J.; Gonçalo, R.; Gongadze, A.; Gonidec, A.; Gonzalez, S.; González de la Hoz, S.; González Millán, V.; Gonzalez Silva, M. L.; Gonzalez-Pineiro, B.; González-Sevilla, S.; Goodrick, M. J.; Goodson, J. J.; Goossens, L.; Gorbounov, P. A.; Gordeev, A.; Gordon, H.; Gorelov, I.; Gorfine, G.; Gorini, B.; Gorini, E.; Gorišek, A.; Gornicki, E.; Gorokhov, S. A.; Gorski, B. T.; Goryachev, S. V.; Goryachev, V. N.; Gosselink, M.; Gostkin, M. I.; Gouanère, M.; Gough Eschrich, I.; Goujdami, D.; Goulette, M.; Gousakov, I.; Gouveia, J.; Gowdy, S.; Goy, C.; Grabowska-Bold, I.; Grabski, V.; Grafström, P.; Grah, C.; Grahn, K.-J.; Grancagnolo, F.; Grancagnolo, S.; Grassmann, H.; Gratchev, V.; Gray, H. M.; Graziani, E.; Green, B.; Greenall, A.; Greenfield, D.; Greenwood, D.; Gregor, I. M.; Grewal, A.; Griesmayer, E.; Grigalashvili, N.; Grigson, C.; Grillo, A. A.; Grimaldi, F.; Grimm, K.; Gris, P. L. Y.; Grishkevich, Y.; Groenstege, H.; Groer, L. S.; Grognuz, J.; Groh, M.; Gross, E.; Grosse-Knetter, J.; Grothe, M. E. M.; Grudzinski, J.; Gruse, C.; Gruwe, M.; Grybel, K.; Grybos, P.; Gschwendtner, E. M.; Guarino, V. J.; Guicheney, C. J.; Guilhem, G.; Guillemin, T.; Gunther, J.; Guo, B.; Gupta, A.; Gurriana, L.; Gushchin, V. N.; Gutierrez, P.; Guy, L.; Guyot, C.; Gwenlan, C.; Gwilliam, C. B.; Haas, A.; Haas, S.; Haber, C.; Haboubi, G.; Hackenburg, R.; Hadash, E.; Hadavand, H. K.; Haeberli, C.; Härtel, R.; Haggerty, R.; Hahn, F.; Haider, S.; Hajduk, Z.; Hakimi, M.; Hakobyan, H.; Hakobyan, H.; Haller, J.; Hallewell, G. D.; Hallgren, B.; Hamacher, K.; Hamilton, A.; Han, H.; Han, L.; Hanagaki, K.; Hance, M.; Hanke, P.; Hansen, C. J.; Hansen, F. H.; Hansen, J. R.; Hansen, J. B.; Hansen, J. D.; Hansen, P. H.; Hansl-Kozanecka, T.; Hanson, G.; Hansson, P.; Hara, K.; Harder, S.; Harel, A.; Harenberg, T.; Harper, R.; Hart, J. C.; Hart, R. G. G.; Hartjes, F.; Hartman, N.; Haruyama, T.; Harvey, A.; Hasegawa, Y.; Hashemi, K.; Hassani, S.; Hatch, M.; Hatley, R. W.; Haubold, T. G.; Hauff, D.; Haug, F.; Haug, S.; Hauschild, M.; Hauser, R.; Hauviller, C.; Havranek, M.; Hawes, B. M.; Hawkings, R. J.; Hawkins, D.; Hayler, T.; Hayward, H. S.; Haywood, S. J.; Hazen, E.; He, M.; He, Y. P.; Head, S. J.; Hedberg, V.; Heelan, L.; Heinemann, F. E. W.; Heldmann, M.; Hellman, S.; Helsens, C.; Henderson, R. C. W.; Hendriks, P. J.; Henriques Correia, A. M.; Henrot-Versille, S.; Henry-Couannier, F.; Henß, T.; Herten, G.; Hertenberger, R.; Hervas, L.; Hess, M.; Hessey, N. P.; Hicheur, A.; Hidvegi, A.; Higón-Rodriguez, E.; Hill, D.; Hill, J.; Hill, J. C.; Hill, N.; Hillier, S. J.; Hinchliffe, I.; Hindson, D.; Hinkelbein, C.; Hodges, T. A.; Hodgkinson, M. C.; Hodgson, P.; Hoecker, A.; Hoeferkamp, M. R.; Hoffman, J.; Hoffmann, A. E.; Hoffmann, D.; Hoffmann, H. F.; Holder, M.; Hollins, T. I.; Hollyman, G.; Holmes, A.; Holmgren, S. O.; Holt, R.; Holtom, E.; Holy, T.; Homer, R. J.; Homma, Y.; Homola, P.; Honerbach, W.; Honma, A.; Hooton, I.; Horazdovsky, T.; Horn, C.; Horvat, S.; Hostachy, J.-Y.; Hott, T.; Hou, S.; Houlden, M. A.; Hoummada, A.; Hover, J.; Howell, D. F.; Hrivnac, J.; Hruska, I.; Hryn'ova, T.; Huang, G. S.; Hubacek, Z.; Hubaut, F.; Huegging, F.; Huffman, B. T.; Hughes, E.; Hughes, G.; Hughes-Jones, R. E.; Hulsbergen, W.; Hurst, P.; Hurwitz, M.; Huse, T.; Huseynov, N.; Huston, J.; Huth, J.; Iacobucci, G.; Ibbotson, M.; Ibragimov, I.; Ichimiya, R.; Iconomidou-Fayard, L.; Idarraga, J.; Idzik, M.; Iengo, P.; Iglesias Escudero, M. C.; Igonkina, O.; Ikegami, Y.; Ikeno, M.; Ilchenko, Y.; Ilyushenka, Y.; Imbault, D.; Imbert, P.; Imhaeuser, M.; Imori, M.; Ince, T.; Inigo-Golfin, J.; Inoue, K.; Ioannou, P.; Iodice, M.; Ionescu, G.; Ishii, K.; Ishino, M.; Ishizawa, Y.; Ishmukhametov, R.; Issever, C.; Ito, H.; Ivashin, A. V.; Iwanski, W.; Iwasaki, H.; Izen, J. M.; Izzo, V.; Jackson, J.; Jackson, J. N.; Jaekel, M.; Jagielski, S.; Jahoda, M.; Jain, V.; Jakobs, K.; Jakubek, J.; Jansen, E.; Jansweijer, P. P. M.; Jared, R. C.; Jarlskog, G.; Jarp, S.; Jarron, P.; Jelen, K.; Jen-La Plante, I.; Jenni, P.; Jeremie, A.; Jez, P.; Jézéquel, S.; Jiang, Y.; Jin, G.; Jin, S.; Jinnouchi, O.; Joffe, D.; Johansen, L. G.; Johansen, M.; Johansson, K. E.; Johansson, P.; Johns, K. A.; Jon-And, K.; Jones, M.; Jones, R.; Jones, R. W. L.; Jones, T. W.; Jones, T. J.; Jones, A.; Jonsson, O.; Joo, K. K.; Joos, D.; Joos, M.; Joram, C.; Jorgensen, S.; Joseph, J.; Jovanovic, P.; Junnarkar, S. S.; Juranek, V.; Jussel, P.; Kabachenko, V. V.; Kabana, S.; Kaci, M.; Kaczmarska, A.; Kado, M.; Kagan, H.; Kagawa, S.; Kaiser, S.; Kajomovitz, E.; Kakurin, S.; Kalinovskaya, L. V.; Kama, S.; Kambara, H.; Kanaya, N.; Kandasamy, A.; Kandasamy, S.; Kaneda, M.; Kantserov, V. A.; Kanzaki, J.; Kaplan, B.; Kapliy, A.; Kaplon, J.; Karagounis, M.; Karagoz Unel, M.; Karr, K.; Karst, P.; Kartvelishvili, V.; Karyukhin, A. N.; Kashif, L.; Kasmi, A.; Kass, R. D.; Kastanas, A.; Kataoka, M.; Kataoka, Y.; Katsoufis, E.; Katunin, S.; Kawagoe, K.; Kawai, M.; Kawamoto, T.; Kayumov, F.; Kazanin, V. A.; Kazarinov, M. Y.; Kazarov, A.; Kazi, S. I.; Keates, J. R.; Keeler, R.; Keener, P. T.; Kehoe, R.; Keil, M.; Kekelidze, G. D.; Kelly, M.; Kennedy, J.; Kenyon, M.; Kepka, O.; Kerschen, N.; Kerševan, B. P.; Kersten, S.; Ketterer, C.; Khakzad, M.; Khalilzade, F.; Khandanyan, H.; Khanov, A.; Kharchenko, D.; Khodinov, A.; Kholodenko, A. G.; Khomich, A.; Khomutnikov, V. P.; Khoriauli, G.; Khovanskiy, N.; Khovanskiy, V.; Khramov, E.; Khubua, J.; Kieft, G.; Kierstead, J. A.; Kilvington, G.; Kim, H.; Kim, H.; Kim, S. H.; Kind, P.; King, B. T.; Kirk, J.; Kirsch, G. P.; Kirsch, L. E.; Kiryunin, A. E.; Kisielewska, D.; Kisielewski, B.; Kittelmann, T.; Kiver, A. M.; Kiyamura, H.; Kladiva, E.; Klaiber-Lodewigs, J.; Kleinknecht, K.; Klier, A.; Klimentov, A.; Kline, C. R.; Klingenberg, R.; Klinkby, E. B.; Klioutchnikova, T.; Klok, P. F.; Klous, S.; Kluge, E.-E.; Kluit, P.; Klute, M.; Kluth, S.; Knecht, N. K.; Kneringer, E.; Knezo, E.; Knobloch, J.; Ko, B. R.; Kobayashi, T.; Kobel, M.; Kodys, P.; König, A. C.; König, S.; Köpke, L.; Koetsveld, F.; Koffas, T.; Koffeman, E.; Kohout, Z.; Kohriki, T.; Kokott, T.; Kolachev, G. M.; Kolanoski, H.; Kolesnikov, V.; Koletsou, I.; Kollefrath, M.; Kolos, S.; Kolya, S. D.; Komar, A. A.; Komaragiri, J. R.; Kondo, T.; Kondo, Y.; Kondratyeva, N. V.; Kono, T.; Kononov, A. I.; Konoplich, R.; Konovalov, S. P.; Konstantinidis, N.; Kootz, A.; Koperny, S.; Kopikov, S. V.; Korcyl, K.; Kordas, K.; Koreshev, V.; Korn, A.; Korolkov, I.; Korotkov, V. A.; Korsmo, H.; Kortner, O.; Kostrikov, M. E.; Kostyukhin, V. V.; Kotamäki, M. J.; Kotchetkov, D.; Kotov, S.; Kotov, V. M.; Kotov, K. Y.; Kourkoumelis, C.; Koutsman, A.; Kovalenko, S.; Kowalewski, R.; Kowalski, H.; Kowalski, T. Z.; Kozanecki, W.; Kozhin, A. S.; Kral, V.; Kramarenko, V.; Kramberger, G.; Kramer, A.; Krasel, O.; Krasny, M. W.; Krasznahorkay, A.; Krepouri, A.; Krieger, P.; Krivkova, P.; Krobath, G.; Kroha, H.; Krstic, J.; Kruchonak, U.; Krüger, H.; Kruger, K.; Krumshteyn, Z. V.; Kubik, P.; Kubischta, W.; Kubota, T.; Kudin, L. G.; Kudlaty, J.; Kugel, A.; Kuhl, T.; Kuhn, D.; Kukhtin, V.; Kulchitsky, Y.; Kundu, N.; Kupco, A.; Kupper, M.; Kurashige, H.; Kurchaninov, L. L.; Kurochkin, Y. A.; Kus, V.; Kuykendall, W.; Kuzhir, P.; Kuznetsova, E. K.; Kvasnicka, O.; Kwee, R.; La Marra, D.; La Rosa, M.; La Rotonda, L.; Labarga, L.; Labbe, J. A.; Lacasta, C.; Lacava, F.; Lacker, H.; Lacour, D.; Lacuesta, V. R.; Ladygin, E.; Lafaye, R.; Laforge, B.; Lagouri, T.; Lai, S.; Lamanna, E.; Lambacher, M.; Lambert, F.; Lampl, W.; Lancon, E.; Landgraf, U.; Landon, M. P. J.; Landsman, H.; Langstaff, R. R.; Lankford, A. J.; Lanni, F.; Lantzsch, K.; Lanza, A.; Lapin, V. V.; Laplace, S.; Laporte, J. F.; Lara, V.; Lari, T.; Larionov, A. V.; Lasseur, C.; Lau, W.; Laurelli, P.; Lavorato, A.; Lavrijsen, W.; Lazarev, A. B.; LeBihan, A.-C.; LeDortz, O.; LeManer, C.; LeVine, M.; Leahu, L.; Leahu, M.; Lebel, C.; Lechowski, M.; LeCompte, T.; Ledroit-Guillon, F.; Lee, H.; Lee, J. S. H.; Lee, S. C.; Lefebvre, M.; Lefevre, R. P.; Legendre, M.; Leger, A.; LeGeyt, B. C.; Leggett, C.; Lehmacher, M.; Lehmann Miotto, G.; Lehto, M.; Leitner, R.; Lelas, D.; Lellouch, D.; Leltchouk, M.; Lendermann, V.; Leney, K. J. C.; Lenz, T.; Lenzen, G.; Lepidis, J.; Leroy, C.; Lessard, J.-R.; Lesser, J.; Lester, C. G.; Letheren, M.; Fook Cheong, A. Leung; Levêque, J.; Levin, D.; Levinson, L. J.; Levitski, M. S.; Lewandowska, M.; Leyton, M.; Li, J.; Li, W.; Liabline, M.; Liang, Z.; Liang, Z.; Liberti, B.; Lichard, P.; Liebig, W.; Lifshitz, R.; Liko, D.; Lim, H.; Limper, M.; Lin, S. C.; Lindahl, A.; Linde, F.; Lindquist, L.; Lindsay, S. W.; Linhart, V.; Lintern, A. J.; Liolios, A.; Lipniacka, A.; Liss, T. M.; Lissauer, A.; List, J.; Litke, A. M.; Liu, S.; Liu, T.; Liu, Y.; Livan, M.; Lleres, A.; Llosá Llácer, G.; Lloyd, S. L.; Lobkowicz, F.; Loch, P.; Lockman, W. S.; Loddenkoetter, T.; Loebinger, F. K.; Loginov, A.; Loh, C. W.; Lohse, T.; Lohwasser, K.; Lokajicek, M.; Loken, J.; Lokwitz, S.; Long, M. C.; Lopes, L.; Lopez Mateos, D.; Losty, M. J.; Lou, X.; Loureiro, K. F.; Lovas, L.; Love, J.; Lowe, A.; Lozano Fantoba, M.; Lu, F.; Lu, J.; Lu, L.; Lubatti, H. J.; Lucas, S.; Luci, C.; Lucotte, A.; Ludwig, A.; Ludwig, I.; Ludwig, J.; Luehring, F.; Lüke, D.; Luijckx, G.; Luisa, L.; Lumb, D.; Luminari, L.; Lund, E.; Lund-Jensen, B.; Lundberg, B.; Lundquist, J.; Lupi, A.; Lupu, N.; Lutz, G.; Lynn, D.; Lynn, J.; Lys, J.; Lysan, V.; Lytken, E.; López-Amengual, J. M.; Ma, H.; Ma, L. L.; Maaß en, M.; Maccarrone, G.; Mace, G. G. R.; Macina, D.; Mackeprang, R.; Macpherson, A.; MacQueen, D.; Macwaters, C.; Madaras, R. J.; Mader, W. F.; Maenner, R.; Maeno, T.; Mättig, P.; Mättig, S.; Magrath, C. A.; Mahalalel, Y.; Mahboubi, K.; Mahout, G.; Maidantchik, C.; Maio, A.; Mair, G. M.; Mair, K.; Makida, Y.; Makowiecki, D.; Malecki, P.; Maleev, V. P.; Malek, F.; Malon, D.; Maltezos, S.; Malychev, V.; Malyukov, S.; Mambelli, M.; Mameghani, R.; Mamuzic, J.; Manabe, A.; Manara, A.; Manca, G.; Mandelli, L.; Mandić, I.; Mandl, M.; Maneira, J.; Maneira, M.; Mangeard, P. S.; Mangin-Brinet, M.; Manjavidze, I. D.; Mann, W. A.; Manolopoulos, S.; Manousakis-Katsikakis, A.; Mansoulie, B.; Manz, A.; Mapelli, A.; Mapelli, L.; March, L.; Marchand, J. F.; Marchesotti, M.; Marcisovsky, M.; Marin, A.; Marques, C. N.; Marroquim, F.; Marshall, R.; Marshall, Z.; Martens, F. K.; Garcia, S. Marti i.; Martin, A. J.; Martin, B.; Martin, B.; Martin, F. F.; Martin, J. P.; Martin, Ph; Martinez, G.; Martínez Lacambra, C.; Martinez Outschoorn, V.; Martini, A.; Martins, J.; Maruyama, T.; Marzano, F.; Mashimo, T.; Mashinistov, R.; Masik, J.; Maslennikov, A. L.; Maß, M.; Massa, I.; Massaro, G.; Massol, N.; Mathes, M.; Matheson, J.; Matricon, P.; Matsumoto, H.; Matsunaga, H.; Maugain, J. M.; Maxfield, S. J.; May, E. N.; Mayer, J. K.; Mayri, C.; Mazini, R.; Mazzanti, M.; Mazzanti, P.; Mazzoni, E.; Mazzucato, F.; McKee, S. P.; McCarthy, R. L.; McCormick, C.; McCubbin, N. A.; McDonald, J.; McFarlane, K. W.; McGarvie, S.; McGlone, H.; McLaren, R. A.; McMahon, S. J.; McMahon, T. R.; McMahon, T. J.; McPherson, R. A.; Mechtel, M.; Meder-Marouelli, D.; Medinnis, M.; Meera-Lebbai, R.; Meessen, C.; Mehdiyev, R.; Mehta, A.; Meier, K.; Meinhard, H.; Meinhardt, J.; Meirosu, C.; Meisel, F.; Melamed-Katz, A.; Mellado Garcia, B. R.; Mendes Jorge, P.; Mendez, P.; Menke, S.; Menot, C.; Meoni, E.; Merkl, D.; Merola, L.; Meroni, C.; Merritt, F. S.; Messmer, I.; Metcalfe, J.; Meuser, S.; Meyer, J.-P.; Meyer, T. C.; Meyer, W. T.; Mialkovski, V.; Michelotto, M.; Micu, L.; Middleton, R.; Miele, P.; Migliaccio, A.; Mijović, L.; Mikenberg, G.; Mikestikova, M.; Mikestikova, M.; Mikulec, B.; Mikuž, M.; Miller, D. W.; Miller, R. J.; Miller, W.; Milosavljevic, M.; Milstead, D. A.; Mima, S.; Minaenko, A. A.; Minano, M.; Minashvili, I. A.; Mincer, A. I.; Mindur, B.; Mineev, M.; Mir, L. M.; Mirabelli, G.; Miralles Verge, L.; Misawa, S.; Miscetti, S.; Misiejuk, A.; Mitra, A.; Mitrofanov, G. Y.; Mitsou, V. A.; Miyagawa, P. S.; Miyazaki, Y.; Mjörnmark, J. U.; Mkrtchyan, S.; Mladenov, D.; Moa, T.; Moch, M.; Mochizuki, A.; Mockett, P.; Modesto, P.; Moed, S.; Mönig, K.; Möser, N.; Mohn, B.; Mohr, W.; Mohrdieck-Möck, S.; Moisseev, A. M.; Moles Valls, R. M.; Molina-Perez, J.; Moll, A.; Moloney, G.; Mommsen, R.; Moneta, L.; Monnier, E.; Montarou, G.; Montesano, S.; Monticelli, F.; Moore, R. W.; Moore, T. B.; Moorhead, G. F.; Moraes, A.; Morel, J.; Moreno, A.; Moreno, D.; Morettini, P.; Morgan, D.; Morii, M.; Morin, J.; Morley, A. K.; Mornacchi, G.; Morone, M.-C.; Morozov, S. V.; Morris, E. J.; Morris, J.; Morrissey, M. C.; Moser, H. G.; Mosidze, M.; Moszczynski, A.; Mouraviev, S. V.; Mouthuy, T.; Moye, T. H.; Moyse, E. J. W.; Mueller, J.; Müller, M.; Muijs, A.; Muller, T. R.; Munar, A.; Munday, D. J.; Murakami, K.; Murillo Garcia, R.; Murray, W. J.; Myagkov, A. G.; Myska, M.; Nagai, K.; Nagai, Y.; Nagano, K.; Nagasaka, Y.; Nairz, A. M.; Naito, D.; Nakamura, K.; Nakamura, Y.; Nakano, I.; Nanava, G.; Napier, A.; Nassiakou, M.; Nasteva, I.; Nation, N. R.; Naumann, T.; Nauyock, F.; Nderitu, S. K.; Neal, H. A.; Nebot, E.; Nechaeva, P.; Neganov, A.; Negri, A.; Negroni, S.; Nelson, C.; Nemecek, S.; Nemethy, P.; Nepomuceno, A. A.; Nessi, M.; Nesterov, S. Y.; Neukermans, L.; Nevski, P.; Newcomer, F. M.; Nichols, A.; Nicholson, C.; Nicholson, R.; Nickerson, R. B.; Nicolaidou, R.; Nicoletti, G.; Nicquevert, B.; Niculescu, M.; Nielsen, J.; Niinikoski, T.; Niinimaki, M. J.; Nikitin, N.; Nikolaev, K.; Nikolic-Audit, I.; Nikolopoulos, K.; Nilsen, H.; Nilsson, B. S.; Nilsson, P.; Nisati, A.; Nisius, R.; Nodulman, L. J.; Nomachi, M.; Nomoto, H.; Noppe, J.-M.; Nordberg, M.; Norniella Francisco, O.; Norton, P. R.; Novakova, J.; Nowak, M.; Nozaki, M.; Nunes, R.; Nunes Hanninger, G.; Nunnemann, T.; Nyman, T.; O'Connor, P.; O'Neale, S. W.; O'Neil, D. C.; O'Neill, M.; O'Shea, V.; Oakham, F. G.; Oberlack, H.; Obermaier, M.; Oberson, P.; Ochi, A.; Ockenfels, W.; Odaka, S.; Odenthal, I.; Odino, G. A.; Ogren, H.; Oh, S. H.; Ohshima, T.; Ohshita, H.; Okawa, H.; Olcese, M.; Olchevski, A. G.; Oliver, C.; Oliver, J.; Olivo Gomez, M.; Olszewski, A.; Olszowska, J.; Omachi, C.; Onea, A.; Onofre, A.; Oram, C. J.; Ordonez, G.; Oreglia, M. J.; Orellana, F.; Oren, Y.; Orestano, D.; Orlov, I. O.; Orr, R. S.; Orsini, F.; Osborne, L. S.; Osculati, B.; Osuna, C.; Otec, R.; Othegraven, R.; Ottewell, B.; Ould-Saada, F.; Ouraou, A.; Ouyang, Q.; Øye, O. K.; Ozcan, V. E.; Ozone, K.; Ozturk, N.; Pacheco Pages, A.; Padhi, S.; Padilla Aranda, C.; Paganis, E.; Paige, F.; Pailler, P. M.; Pajchel, K.; Palestini, S.; Palla, J.; Pallin, D.; Palmer, M. J.; Pan, Y. B.; Panikashvili, N.; Panin, V. N.; Panitkin, S.; Pantea, D.; Panuskova, M.; Paolone, V.; Paoloni, A.; Papadopoulos, I.; Papadopoulou, T.; Park, I.; Park, W.; Parker, M. A.; Parker, S.; Parkman, C.; Parodi, F.; Parsons, J. A.; Parzefall, U.; Pasqualucci, E.; Passardi, G.; Passeri, A.; Passmore, M. S.; Pastore, F.; Pastore, Fr; Pataraia, S.; Pate, D.; Pater, J. R.; Patricelli, S.; Pauly, T.; Pauna, E.; Peak, L. S.; Peeters, S. J. M.; Peez, M.; Pei, E.; Peleganchuk, S. V.; Pellegrini, G.; Pengo, R.; Pequenao, J.; Perantoni, M.; Perazzo, A.; Pereira, A.; Perepelkin, E.; Perera, V. J. O.; Perez Codina, E.; Perez Reale, V.; Peric, I.; Perini, L.; Pernegger, H.; Perrin, E.; Perrino, R.; Perrodo, P.; Perrot, G.; Perus, P.; Peshekhonov, V. D.; Petereit, E.; Petersen, J.; Petersen, T. C.; Petit, P. J. F.; Petridou, C.; Petrolo, E.; Petrucci, F.; Petti, R.; Pezzetti, M.; Pfeifer, B.; Phan, A.; Phillips, A. W.; Phillips, P. W.; Piacquadio, G.; Piccinini, M.; Pickford, A.; Piegaia, R.; Pier, S.; Pilcher, J. E.; Pilkington, A. D.; Pimenta Dos Santos, M. A.; Pina, J.; Pinfold, J. L.; Ping, J.; Pinhão, J.; Pinto, B.; Pirotte, O.; Placakyte, R.; Placci, A.; Plamondon, M.; Plano, W. G.; Pleier, M.-A.; Pleskach, A. V.; Podkladkin, S.; Podlyski, F.; Poffenberger, P.; Poggioli, L.; Pohl, M.; Polak, I.; Polesello, G.; Policicchio, A.; Polini, A.; Polychronakos, V.; Pomarede, D. M.; Pommès, K.; Ponsot, P.; Pontecorvo, L.; Pope, B. G.; Popescu, R.; Popovic, D. S.; Poppleton, A.; Popule, J.; Portell Bueso, X.; Posch, C.; Pospelov, G. E.; Pospichal, P.; Pospisil, S.; Postranecky, M.; Potrap, I. N.; Potter, C. J.; Poulard, G.; Pousada, A.; Poveda, J.; Prabhu, R.; Pralavorio, P.; Prasad, S.; Prast, J.; Prat, S.; Prata, M.; Pravahan, R.; Preda, T.; Pretzl, K.; Pribyl, L.; Price, D.; Price, L. E.; Price, M. J.; Prichard, P. M.; Prieur, D.; Primavera, M.; Primor, D.; Prokofiev, K.; Prosso, E.; Proudfoot, J.; Przysiezniak, H.; Puigdengoles, C.; Purdham, J.; Purohit, M.; Puzo, P.; Pylaev, A. N.; Pylypchenko, Y.; Qi, M.; Qian, J.; Qian, W.; Qian, Z.; Qing, D.; Quadt, A.; Quarrie, D. R.; Quayle, W. B.; Rabbers, J. J.; Radeka, V.; Rafi, J. M.; Ragusa, F.; Rahimi, A. M.; Rahm, D.; Raine, C.; Raith, B.; Rajagopalan, S.; Rajek, S.; Rammer, H.; Ramstedt, M.; Rangod, S.; Ratoff, P. N.; Raufer, T.; Rauscher, F.; Rauter, E.; Raymond, M.; Reads, A. L.; Rebuzzi, D.; Redlinger, G. R.; Reeves, K.; Rehak, M.; Reichold, A.; Reinherz-Aronis, E.; Reisinger, I.; Reljic, D.; Rembser, C.; Ren, Z.; Renaudin-Crepe, S. R. C.; Renkel, P.; Rensch, B.; Rescia, S.; Rescigno, M.; Resconi, S.; Resende, B.; Rewiersma, P.; Rey, J.; Rey-Campagnolle, M.; Rezaie, E.; Reznicek, P.; Richards, R. A.; Richer, J.-P.; Richter, R. H.; Richter, R.; Richter-Was, E.; Ridel, M.; Riegler, W.; Rieke, S.; Rijpstra, M.; Rijssenbeek, M.; Rimoldi, A.; Rios, R. R.; Riu Dachs, I.; Rivline, M.; Rivoltella, G.; Rizatdinova, F.; Robertson, S. H.; Robichaud-Veronneau, A.; Robins, S.; Robinson, D.; Robson, A.; Rochford, J. H.; Roda, C.; Rodier, S.; Roe, S.; Røhne, O.; Rohrbach, F.; Roldán, J.; Rolli, S.; Romance, J. B.; Romaniouk, A.; Romanov, V. M.; Romeo, G.; Roos, L.; Ros, E.; Rosati, S.; Rosenbaum, F.; Rosenbaum, G. A.; Rosenberg, E. I.; Rosselet, L.; Rossi, L. P.; Rossi, L.; Rotaru, M.; Rothberg, J.; Rottländer, I.; Rousseau, D.; Rozanov, A.; Rozen, Y.; Ruber, R.; Ruckert, B.; Rudolph, G.; Rühr, F.; Ruggieri, F.; Ruggiero, G.; Ruiz, H.; Ruiz-Martinez, A.; Rulikowska-Zarebska, E.; Rumiantsev, V.; Rumyantsev, L.; Runge, K.; Runolfsson, O.; Rusakovich, N. A.; Rust, D. R.; Rutherfoord, J. P.; Ruwiedel, C.; Ryabov, Y. F.; Ryadovikov, V.; Ryan, P.; Rybkine, G.; da Costa, J. Sá; Saavedra, A. F.; Saboumazrag, S.; F-W Sadrozinski, H.; Sadykov, R.; Sakamoto, H.; Sala, P.; Salamon, A.; Saleem, M.; Salihagic, D.; Salt, J.; Saltó Bauza, O.; Salvachúa Ferrando, B. M.; Salvatore, D.; Salzburger, A.; Sampsonidis, D.; Samset, B. H.; Sánchez Sánchez, C. A.; Sanchis Lozano, M. A.; Sanchis Peris, E.; Sandaker, H.; Sander, H. G.; Sandhoff, M.; Sandvoss, S.; Sankey, D. P. C.; Sanny, B.; Sansone, S.; Sansoni, A.; Santamarina Rios, C.; Santander, J.; Santi, L.; Santoni, C.; Santonico, R.; Santos, J.; Sapinski, M.; Saraiva, J. G.; Sarri, F.; Sasaki, O.; Sasaki, T.; Sasao, N.; Satsounkevitch, I.; Sauvage, D.; Sauvage, G.; Savard, P.; Savine, A. Y.; Savinov, V.; Savoy-Navarro, A.; Savva, P.; Saxon, D. H.; Says, L. P.; Sbarra, C.; Sbrissa, E.; Sbrizzi, A.; Scannicchio, D. A.; Schaarschmidt, J.; Schacht, P.; Schäfer, U.; Schaffer, A. C.; Schaile, D.; Schaller, M.; Schamov, A. G.; Schegelsky, V. A.; Scheirich, D.; Schernau, M.; Scherzer, M. I.; Schiavi, C.; Schick, H.; Schieck, J.; Schieferdecker, P.; Schioppa, M.; Schlager, G.; Schlenker, S.; Schlereth, J. L.; Schmid, P.; Schmidt, M. P.; Schmitt, C.; Schmitt, K.; Schmitz, M.; Schmücker, H.; Schoerner, T.; Scholte, R. C.; Schott, M.; Schouten, D.; Schram, M.; Schricker, A.; Schroff, D.; Schuh, S.; Schuijlenburg, H. W.; Schuler, G.; Schultes, J.; Schultz-Coulon, H.-C.; Schumacher, J.; Schumacher, M.; Schune, Ph; Schwartzman, A.; Schweiger, D.; Schwemling, Ph; Schwick, C.; Schwienhorst, R.; Schwierz, R.; Schwindling, J.; Scott, W. G.; Secker, H.; Sedykh, E.; Seguin-Moreau, N.; Segura, E.; Seidel, S. C.; Seiden, A.; Seixas, J. M.; Sekhniaidze, G.; Seliverstov, D. M.; Selldén, B.; Seman, M.; Semprini-Cesari, N.; Serfon, C.; Serin, L.; Seuster, R.; Severini, H.; Sevior, M. E.; Sexton, K. A.; Sfyrla, A.; Shah, T. P.; Shan, L.; Shank, J. T.; Shapiro, M.; Shatalov, P. B.; Shaver, L.; Shaw, C.; Shears, T. G.; Sherwood, P.; Shibata, A.; Shield, P.; Shilov, S.; Shimojima, M.; Shin, T.; Shiyakova, M.; Shmeleva, A.; Shoa, M.; Shochet, M. J.; Shupe, M. A.; Sicho, P.; Sidoti, A.; Siebel, A.; Siebel, M.; Siegrist, J.; Sijacki, D.; Silva, J.; Silverstein, S. B.; Simak, V.; Simic, Lj; Simion, S.; Simmons, B.; Simonyan, M.; Sinervo, P.; Sipica, V.; Siragusa, G.; Sisakyan, A. N.; Sivoklokov, S.; Sjölin, J.; Skubic, P.; Skvorodnev, N.; Slattery, P.; Slavicek, T.; Sliwa, K.; Sloan, T. J.; Sloper, J.; Smakhtin, V.; Small, A.; Smirnov, S. Yu; Smirnov, Y.; Smirnova, L.; Smirnova, O.; Smith, N. A.; Smith, B. C.; Smith, D. S.; Smith, J.; Smith, K. M.; Smith, B.; Smizanska, M.; Smolek, K.; Snesarev, A. A.; Snow, S. W.; Snow, J.; Snuverink, J.; Snyder, S.; Soares, M.; Soares, S.; Sobie, R.; Sodomka, J.; Söderberg, M.; Soffer, A.; Solans, C. A.; Solar, M.; Sole, D.; Solfaroli Camillocci, E.; Solodkov, A. A.; Solov'yanov, O. V.; Soloviev, I.; Soluk, R.; Sondericker, J.; Sopko, V.; Sopko, B.; Sorbi, M.; Soret Medel, J.; Sosebee, M.; Sosnovtsev, V. V.; Sospedra Suay, L.; Soukharev, A.; Soukup, J.; Spagnolo, S.; Spano, F.; Speckmayer, P.; Spegel, M.; Spencer, E.; Spighi, R.; Spigo, G.; Spila, F.; Spiriti, E.; Spiwoks, R.; Spogli, L.; Spousta, M.; Sprachmann, G.; Spurlock, B.; St. Denis, R. D.; Stahl, T.; Staley, R. J.; Stamen, R.; Stancu, S. N.; Stanecka, E.; Stanek, R. W.; Stanescu, C.; Stapnes, S.; Starchenko, E. A.; Staroba, P.; Stastny, J.; Staude, A.; Stavina, P.; Stavrianakou, M.; Stavropoulos, G.; Stefanidis, E.; Steffens, J. L.; Stekl, I.; Stelzer, H. J.; Stenzel, H.; Stewart, G.; Stewart, T. D.; Stiller, W.; Stockmanns, T.; Stodulski, M.; Stonjek, S.; Stradling, A.; Straessner, A.; Strandberg, J.; Strandlie, A.; Strauss, M.; Strickland, V.; Striegel, D.; Strizenec, P.; Ströhmer, R.; Strom, D. M.; Strong, J. A.; Stroynowski, R.; Stugu, B.; Stumer, I.; Su, D.; Subramania, S.; Suchkov, S. I.; Sugaya, Y.; Sugimoto, T.; Suk, M.; Sulin, V. V.; Sultanov, S.; Sun, Z.; Sundal, B.; Sushkov, S.; Susinno, G.; Sutcliffe, P.; Sutton, M. R.; Sviridov, Yu M.; Sykora, I.; Szczygiel, R. R.; Szeless, B.; Szymocha, T.; Sánchez, J.; Ta, D.; Taboada Gameiro, S.; Tadel, M.; Tafirout, R.; Taga, A.; Takai, H.; Takashima, R.; Takeda, H.; Takeshita, T.; Talby, M.; Talyshev, A.; Tamsett, M. C.; Tanaka, J.; Tanaka, K.; Tanaka, R.; Tanaka, S.; Tanaka, S.; Tanaka, Y.; Tappern, G. P.; Tapprogge, S.; Tarem, S.; Tarrade, F.; Tarrant, J.; Tartarelli, G.; Tas, P.; Tasevsky, M.; Tayalati, Y.; Taylor, F. E.; Taylor, G.; Taylor, G. N.; Taylor, R. P.; Tcherniatine, V.; Tegenfeldt, F.; Teixeira-Dias, P.; Ten Kate, H.; Teng, P. K.; Ter-Antonyan, R.; Terada, S.; Terron, J.; Terwort, M.; Teuscher, R. J.; Tevlin, C. M.; Thadome, J.; Thion, J.; Thioye, M.; Thomas, A.; Thomas, J. P.; Thomas, T. L.; Thomas, E.; Thompson, R. J.; Thompson, A. S.; Thun, R. P.; Tic, T.; Tikhomirov, V. O.; Tikhonov, Y. A.; Timm, S.; Timmermans, C. J. W. P.; Tipton, P.; Tique Aires Viegas, F. J.; Tisserant, S.; Titov, M.; Tobias, J.; Tocut, V. M.; Toczek, B.; Todorova-Nova, S.; Tojo, J.; Tokár, S.; Tokushuku, K.; Tomasek, L.; Tomasek, M.; Tomasz, F.; Tomoto, M.; Tompkins, D.; Tompkins, L.; Toms, K.; Tonazzo, A.; Tong, G.; Tonoyan, A.; Topfel, C.; Topilin, N. D.; Torrence, E.; Torres Pais, J. G.; Toth, J.; Touchard, F.; Tovey, D. R.; Tovey, S. N.; Towndrow, E. F.; Trefzger, T.; Treichel, M.; Treis, J.; Tremblet, L.; Tribanek, W.; Tricoli, A.; Trigger, I. M.; Trilling, G.; Trincaz-Duvoid, S.; Tripiana, M. F.; Trischuk, W.; Trka, Z.; Trocmé, B.; Troncon, C.; C-L Tseng, J.; Tsiafis, I.; Tsiareshka, P. V.; Tsipolitis, G.; Tskhadadze, E. G.; Tsukerman, I. I.; Tsulaia, V.; Tsuno, S.; Turala, M.; Turk Cakir, I.; Turlay, E.; Tuts, P. M.; Twomey, M. S.; Tyndel, M.; Typaldos, D.; Tyrvainen, H.; Tzamarioudaki, E.; Tzanakos, G.; Ueda, I.; Uhrmacher, M.; Ukegawa, F.; Ullán Comes, M.; Unal, G.; Underwood, D. G.; Undrus, A.; Unel, G.; Unno, Y.; Urkovsky, E.; Usai, G.; Usov, Y.; Vacavant, L.; Vacek, V.; Vachon, B.; Vahsen, S.; Valderanis, C.; Valenta, J.; Valente, P.; Valero, A.; Valkar, S.; Valls Ferrer, J. A.; Van der Bij, H.; van der Graaf, H.; van der Kraaij, E.; Van Eijk, B.; van Eldik, N.; van Gemmeren, P.; van Kesteren, Z.; van Vulpen, I.; Van Berg, R.; Vandelli, W.; Vandoni, G.; Vaniachine, A.; Vannucci, F.; Varanda, M.; Varela Rodriguez, F.; Vari, R.; Varnes, E. W.; Varouchas, D.; Vartapetian, A.; Varvell, K. E.; Vassilakopoulos, V. I.; Vassilieva, L.; Vataga, E.; Vaz, L.; Vazeille, F.; Vedrine, P.; Vegni, G.; Veillet, J. J.; Vellidis, C.; Veloso, F.; Veness, R.; Veneziano, S.; Ventura, A.; Ventura, S.; Vercesi, V.; Verducci, M.; Verkerke, W.; Vermeulen, J. C.; Vertogardov, L.; Vetterli, M. C.; Vichou, I.; Vickey, T.; Viehhauser, G. H. A.; Vigeolas, E.; Villa, M.; Villani, E. G.; Villate, J.; Villella, I.; Vilucchi, E.; Vincent, P.; Vincke, H.; Vincter, M. G.; Vinogradov, V. B.; Virchaux, M.; Viret, S.; Virzi, J.; Vitale, A.; Vivarelli, I.; Vives, R.; Vives Vaques, F.; Vlachos, S.; Vogt, H.; Vokac, P.; Vollmer, C. F.; Volpi, M.; Volpini, G.; von Boehn-Buchholz, R.; von der Schmitt, H.; von Toerne, E.; Vorobel, V.; Vorobiev, A. P.; Vorozhtsov, A. S.; Vorozhtsov, S. B.; Vos, M.; Voss, K. C.; Voss, R.; Vossebeld, J. H.; Vovenko, A. S.; Vranjes, N.; Vrba, V.; Vreeswijk, M.; Anh, T. Vu; Vuaridel, B.; Vudragovic, M.; Vuillemin, V.; Vuillermet, R.; Wänanen, A.; Wahlen, H.; Walbersloh, J.; Walker, R.; Walkowiak, W.; Wall, R.; Wallny, R. S.; Walsh, S.; Wang, C.; Wang, J. C.; Wappler, F.; Warburton, A.; Ward, C. P.; Warner, G. P.; Warren, M.; Warsinsky, M.; Wastie, R.; Watkins, P. M.; Watson, A. T.; Watts, G.; Waugh, A. T.; Waugh, B. M.; Weaverdyck, C.; Webel, M.; Weber, G.; Weber, J.; Weber, M.; Weber, P.; Weidberg, A. R.; Weilhammer, P. M.; Weingarten, J.; Weiser, C.; Wellenstein, H.; Wellisch, H. P.; Wells, P. S.; Wemans, A.; Wen, M.; Wenaus, T.; Wendler, S.; Wengler, T.; Wenig, S.; Wermes, N.; Werneke, P.; Werner, P.; Werthenbach, U.; Wheeler-Ellis, S. J.; Whitaker, S. P.; White, A.; White, M. J.; White, S.; Whittington, D.; Wicek, F.; Wicke, D.; Wickens, F. J.; Wiedenmann, W.; Wielers, M.; Wienemann, P.; Wiesmann, M.; Wiesmann, M.; Wijnen, T.; Wildauer, A.; Wilhelm, I.; Wilkens, H. G.; Williams, H. H.; Willis, W.; Willocq, S.; Wilmut, I.; Wilson, J. A.; Wilson, A.; Wingerter-Seez, I.; Winton, L.; Witzeling, W.; Wlodek, T.; Woehrling, E.; Wolter, M. W.; Wolters, H.; Wosiek, B.; Wotschack, J.; Woudstra, M. J.; Wright, C.; Wu, S. L.; Wu, X.; Wuestenfeld, J.; Wunstorf, R.; Xella-Hansen, S.; Xiang, A.; Xie, S.; Xie, Y.; Xu, G.; Xu, N.; Yamamoto, A.; Yamamoto, S.; Yamaoka, H.; Yamazaki, Y.; Yan, Z.; Yang, H.; Yang, J. C.; Yang, S.; Yang, U. K.; Yang, Y.; Yang, Z.; Yao, W.-M.; Yao, Y.; Yarradoddi, K.; Yasu, Y.; Ye, J.; Yilmaz, M.; Yoosoofmiya, R.; Yorita, K.; Yoshida, H.; Yoshida, R.; Young, C.; Youssef, S. P.; Yu, D.; Yu, J.; Yu, M.; Yu, X.; Yuan, J.; Yurkewicz, A.; Zaets, V. G.; Zaidan, R.; Zaitsev, A. M.; Zajac, J.; Zajacova, Z.; Zalite, A. Yu; Zalite, Yo K.; Zanello, L.; Zarzhitsky, P.; Zaytsev, A.; Zdrazil, M.; Zeitnitz, C.; Zeller, M.; Zema, P. F.; Zendler, C.; Zenin, A. V.; Zenis, T.; Zenonos, Z.; Zenz, S.; Zerwas, D.; Zhang, H.; Zhang, J.; Zheng, W.; Zhang, X.; Zhao, L.; Zhao, T.; Zhao, X.; Zhao, Z.; Zhelezko, A.; Zhemchugov, A.; Zheng, S.; Zhichao, L.; Zhou, B.; Zhou, N.; Zhou, S.; Zhou, Y.; Zhu, C. G.; Zhu, H. Z.; Zhuang, X. A.; Zhuravlov, V.; Zilka, B.; Zimin, N. I.; Zimmermann, S.; Ziolkowski, M.; Zitoun, R.; Zivkovic, L.; Zmouchko, V. V.; Zobernig, G.; Zoccoli, A.; Zoeller, M. M.; Zolnierowski, Y.; Zsenei, A.; zur Nedden, M.; Zychacek, V.

2008-08-01

The ATLAS detector as installed in its experimental cavern at point 1 at CERN is described in this paper. A brief overview of the expected performance of the detector when the Large Hadron Collider begins operation is also presented.

Radiotherapy in poor risk patients with stage I cancer of the endometrium: results of not giving external beam radiotherapy.

PubMed

DeCruze, B; Guthrie, D

1999-01-01

Poor prognosis (poorly differentiated and/or deep myometrial invasion) Stage I endometrial cancer can have a relapse rate as high as 50%. Traditionally, most clinical oncologists treat these patients with external beam radiotherapy after surgery but there is no evidence to show that this improves survival. The retrospective study looks at the results of not giving external beam radiotherapy in 25 consecutive patients and compares the results with a group of 13 consecutive patients who did have such treatment. The two groups were comparable with regard to age, degree of differentiation and degree of invasion. Survival was comparable in the two groups. There is no evidence of any obvious decrease in survival from withholding external beam radiotherapy, but this was not a prospective randomized controlled trial. This study illustrates that it is essential that the Medical Research Council ASTEC trial should be supported because this will determine the true place of external beam radiotherapy in such patients.

Hadron-collider limits on new electroweak interactions from the heterotic string

DOE Office of Scientific and Technical Information (OSTI.GOV)

del Aguila, F.; Moreno, J.M.; Quiros, M.

1990-01-01

We evaluate the {ital Z}{prime}{r arrow}{ital l}{sup +}l{sup {minus}} cross section at present and future hadron colliders, for the minimal (E{sub 6}) extended electroweak models inspired by superstrings (including renormalization effects on new gauge couplings and new mixing angles). Popular models are discussed for comparison. Analytical expressions for the bounds on the mass of a new gauge boson, {ital M}{sub {ital Z}{prime}}, as a function of the bound on the ratio {ital R}{equivalent to}{sigma}({ital Z}{prime}){ital B}(Z{prime}{r arrow}l{sup +}{ital l}{sup {minus}})/{sigma}({ital Z}){ital B} ({ital Z}{r arrow}{ital l}{sup +}{ital l}{sup {minus}}), are given for the CERN S{ital p {bar p}}S, Fermilab Teva-more » tron, Serpukhov UNK, CERN Large Hadron Collider, and Superconducting Super Collider for the different models. In particular, the {ital M}{sub {ital Z}{prime}} bounds from the present {ital R} limit at CERN, as well as from the eventually available {ital R} limits at Fermilab and at the future hadron colliders (after three months of running at the expected luminosity), are given explicitly.« less

Vaginal dilator therapy for women receiving pelvic radiotherapy.

PubMed

Miles, Tracie; Johnson, Nick

2014-09-08

Vaginal dilation therapy is advocated after pelvic radiotherapy to prevent stenosis (abnormal narrowing of the vagina), but can be uncomfortable and psychologically distressing. To assess the benefits and harms of different types of vaginal dilation methods offered to women treated by pelvic radiotherapy for cancer. Searches included the Cochrane Central Register of Controlled Trials (CENTRAL 2013, Issue 5), MEDLINE (1950 to June week 2, 2013), EMBASE (1980 to 2013 week 24) and CINAHL (1982 to 2013). Comparative data of any type, which evaluated dilation or penetration of the vagina after pelvic radiotherapy treatment for cancer. Two review authors independently assessed whether potentially relevant studies met the inclusion criteria. We found no trials and therefore analysed no data. We identified no studies for inclusion in the original review or for this update. However, we felt that some studies that were excluded warranted discussion. These included one randomised trial (RCT), which showed no improvement in sexual scores associated with encouraging women to practise dilation therapy; a recent small RCT that did not show any advantage to dilation over vibration therapy during radiotherapy; two non-randomised comparative studies; and five correlation studies. One of these showed that objective measurements of vaginal elasticity and length were not linked to dilation during radiotherapy, but the study lacked power. One study showed that women who dilated tolerated a larger dilator, but the risk of objectivity and bias with historical controls was high. Another study showed that the vaginal measurements increased in length by a mean of 3 cm after dilation was introduced 6 to 10 weeks after radiotherapy, but there was no control group; another case series showed the opposite. Three recent studies showed less stenosis associated with prophylactic dilation after radiotherapy. One small case series suggested that dilation years after radiotherapy might restore the

Testing the QCD string at large Nc from the thermodynamics of the hadronic phase

NASA Astrophysics Data System (ADS)

Cohen, Thomas D.

2007-02-01

It is generally believed that in the limit of a large number of colors (Nc) the description of confinement via flux tubes becomes valid and QCD can be modeled accurately via a hadronic string theory—at least for highly excited states. QCD at large Nc also has a well-defined deconfinement transition at a temperature Tc. In this talk it is shown how the thermodyanmics of the metastable hadronic phase of QCD (above Tc) at large NC can be related directly to properties of the effective QCD string. The key points in the derivation is the weakly interacting nature of hadrons at large Nc and the existence of a Hagedorn temperature TH for the effective string theory. From this it can be seen at large Nc and near TH, the energy density and pressure of the hadronic phase scale as E ˜ (TH - T)-(D⊥-6)/2 (for D⊥ < 6) and P ˜ (TH - T)-(D⊥-4)/2 (for D⊥ < 4) where D⊥ is the effective number of transverse dimensions of the string theory. This behavior for D⊥ < 6 is qualitatively different from typical models in statistical mechanics and if observed on the lattice would provide a direct test of the stringy nature of large Nc QCD. However since it can be seen that TH > Tc this behavior is of relevance only to the metastable phase. The prospect of using this result to extract D⊥ via lattice simulations of the metastable hadronic phase at moderately large Nc is discussed.

PET/CT image registration: preliminary tests for its application to clinical dosimetry in radiotherapy.

PubMed

Baños-Capilla, M C; García, M A; Bea, J; Pla, C; Larrea, L; López, E

2007-06-01

The quality of dosimetry in radiotherapy treatment requires the accurate delimitation of the gross tumor volume. This can be achieved by complementing the anatomical detail provided by CT images through fusion with other imaging modalities that provide additional metabolic and physiological information. Therefore, use of multiple imaging modalities for radiotherapy treatment planning requires an accurate image registration method. This work describes tests carried out on a Discovery LS positron emission/computed tomography (PET/CT) system by General Electric Medical Systems (GEMS), for its later use to obtain images to delimit the target in radiotherapy treatment. Several phantoms have been used to verify image correlation, in combination with fiducial markers, which were used as a system of external landmarks. We analyzed the geometrical accuracy of two different fusion methods with the images obtained with these phantoms. We first studied the fusion method used by the PET/CT system by GEMS (hardware fusion) on the basis that there is satisfactory coincidence between the reconstruction centers in CT and PET systems; and secondly the fiducial fusion, a registration method, by means of least-squares fitting algorithm of a landmark points system. The study concluded with the verification of the centroid position of some phantom components in both imaging modalities. Centroids were estimated through a calculation similar to center-of-mass, weighted by the value of the CT number and the uptake intensity in PET. The mean deviations found for the hardware fusion method were: deltax/ +/-sigma = 3.3 mm +/- 1.0 mm and /deltax/ +/-sigma = 3.6 mm +/- 1.0 mm. These values were substantially improved upon applying fiducial fusion based on external landmark points: /deltax/ +/-sigma = 0.7 mm +/- 0.8 mm and /deltax/ +/-sigma = 0.3 mm 1.7 mm. We also noted that differences found for each of the fusion methods were similar for both the axial and helical CT image acquisition

On the production of hidden-flavored hadronic states at high energy

NASA Astrophysics Data System (ADS)

Wang, Wei

2018-04-01

I discuss the production mechanism of hidden-flavored hadrons at high energy. Using e+e‑ collisions and light-meson pair production in high energy exclusive processes, I demonstrate that hidden quark pairs do not necessarily participate in short-distance hard scattering. Implications are then explored in a few examples. Finally, I discuss the production mechanism of X(3872) in hadron collisions, where some misunderstandings have arisen in the literature. Supported by the Thousand Talents Plan for Young Professionals, National Natural Science Foundation of China (11575110, 11655002, 11735010, 11747611), Natural Science Foundation of Shanghai (15DZ2272100) and Scientific Research Foundation for Re- turned Overseas Chinese Scholars, Ministry of Education

Hadronic vacuum polarization in QCD and its evaluation in Euclidean spacetime

NASA Astrophysics Data System (ADS)

de Rafael, Eduardo

2017-07-01

We discuss a new technique to evaluate integrals of QCD Green's functions in the Euclidean based on their Mellin-Barnes representation. We present as a first application the evaluation of the lowest order hadronic vacuum polarization (HVP) contribution to the anomalous magnetic moment of the muon 1/2 (gμ-2 )HVP≡aμHVP . It is shown that with a precise determination of the slope and curvature of the HVP function at the origin from lattice QCD (LQCD), one can already obtain a result for aμHVP which may serve as a test of the determinations based on experimental measurements of the e+e- annihilation cross section into hadrons.

Hadron spectrum of quenched QCD on a 32{sup 3} {times} 64 lattice

DOE Office of Scientific and Technical Information (OSTI.GOV)

Kim, Seyong; Sinclair, D.K.

1992-10-01

Preliminary results from a hadron spectrum calculation of quenched Quantumchromodynamics on a 32{sup 3} {times} 64 lattice at {beta} = 6.5 are reported. The hadron spectrum calculation is done with staggered quarks of masses, m{sub q}a = 0.001, 0.005 and 0.0025. We use two different sources in order to be able to extract the {Delta} mass in addition to the usual local light hadron masses. The numerical simulation is executed on the Intel Touchstone Delta computer. The peak speed of the Delta for a 16 {times} 32 mesh configuration is 41 Gflops for 32 bit precision. The sustained speed formore » our updating code is 9.5 Gflops. A multihit metropolis algorithm combined with an over-relaxation method is used in the updating and the conjugate gradient method is employed for Dirac matrix inversion. Configurations are stored every 1000 sweeps.« less

Hadron spectrum of quenched QCD on a 32[sup 3] [times] 64 lattice

DOE Office of Scientific and Technical Information (OSTI.GOV)

Kim, Seyong; Sinclair, D.K.

1992-10-01

Preliminary results from a hadron spectrum calculation of quenched Quantumchromodynamics on a 32[sup 3] [times] 64 lattice at [beta] = 6.5 are reported. The hadron spectrum calculation is done with staggered quarks of masses, m[sub q]a = 0.001, 0.005 and 0.0025. We use two different sources in order to be able to extract the [Delta] mass in addition to the usual local light hadron masses. The numerical simulation is executed on the Intel Touchstone Delta computer. The peak speed of the Delta for a 16 [times] 32 mesh configuration is 41 Gflops for 32 bit precision. The sustained speed formore » our updating code is 9.5 Gflops. A multihit metropolis algorithm combined with an over-relaxation method is used in the updating and the conjugate gradient method is employed for Dirac matrix inversion. Configurations are stored every 1000 sweeps.« less

Jet-hadron correlations relative to the event plane at the LHC with ALICE

NASA Astrophysics Data System (ADS)

Mazer, Joel; Alice Collaboration

2017-11-01

In ultra relativistic heavy-ion collisions at the Large Hadron Collider (LHC), conditions are met to produce a hot, dense and strongly interacting medium known as the Quark Gluon Plasma (QGP). Quarks and gluons from incoming nuclei collide to produce partons at high momenta early in the collisions. By fragmenting into collimated sprays of hadrons, these partons form 'jets'. The outgoing partons scatter and interact with the medium, leading to a manifestation of medium modifications of jets in the final state, known as jet quenching. Within the framework of perturbative QCD, jet production is well understood in pp collisions. We use jets measured in pp interactions as a baseline reference for comparing to heavy-ion collision systems to detect and study jet quenching. The jet quenching mechanism can be studied through the angular correlations of jets with charged hadrons and is examined in transverse momentum (pT) bins of the jets, pT bins of the associated hadrons, and as a function of collision centrality. A robust and precise background subtraction method is used in this analysis to remove the complex, flow dominated, heavy-ion background. The analysis of angular correlations for different orientations of the jet relative to the event plane allows for the study of the path-length dependence of medium modifications to jets. The event plane dependence of azimuthal angular correlations of charged hadrons with respect to the axis of an R = 0.2 reconstructed full (charged + neutral) jet in Pb-Pb collisions at √{sNN} = 2.76 TeV in ALICE is presented. Results are compared for three angular bins of the jet relative to the event plane in mid-peripheral events. The yields relative to the event plane are presented and then quantified through yield ratio calculations. The results show no significant path-length dependence on the medium modifications.

Oral mucosal melanoma treated with carbon ion radiotherapy: a case report.

PubMed

Musha, Atsushi; Saitoh, Jun-Ichi; Shirai, Katsuyuki; Yokoo, Satoshi; Ohno, Tatsuya; Nakano, Takashi

2016-10-18

Oral mucosal melanoma is a rare disease with a relatively poor prognosis. Carbon ion radiotherapy has been shown to be effective against radiotherapy-resistant tumors owing to its excellent dose concentration and high biological effect. Our patient was a 66-year-old Japanese man with oral mucosal melanoma of his right maxillary gingiva (T4aN0M0). He received carbon ion radiotherapy at 57.6 Gy (relative biological effectiveness) in 16 fractions for 4 weeks. Concomitant chemotherapy (dacarbazine + nimustine + vincristine) was administered at the same time as carbon ion radiotherapy initiation. Two courses of adjuvant chemotherapy were given after carbon ion radiotherapy. Although he experienced grade 2 acute oral mucositis, his symptoms improved within a few weeks of undergoing carbon ion radiotherapy. He was alive at the time of reporting, 35 months after treatment, without any recurrence. Late toxicity has not been observed. Carbon ion radiotherapy for oral mucosal melanoma resulted in a good local effect.

Beyond the Large Hadron Collider: A First Look at Cryogenics for CERN Future Circular Colliders

NASA Astrophysics Data System (ADS)

Lebrun, Philippe; Tavian, Laurent

Following the first experimental discoveries at the Large Hadron Collider (LHC) and the recent update of the European strategy in particle physics, CERN has undertaken an international study of possible future circular colliders beyond the LHC. The study, conducted with the collaborative participation of interested institutes world-wide, considers several options for very high energy hadron-hadron, electron-positron and hadron-electron colliders to be installed in a quasi-circular underground tunnel in the Geneva basin, with a circumference of 80 km to 100 km. All these machines would make intensive use of advanced superconducting devices, i.e. high-field bending and focusing magnets and/or accelerating RF cavities, thus requiring large helium cryogenic systems operating at 4.5 K or below. Based on preliminary sets of parameters and layouts for the particle colliders under study, we discuss the main challenges of their cryogenic systems and present first estimates of the cryogenic refrigeration capacities required, with emphasis on the qualitative and quantitative steps to be accomplished with respect to the present state-of-the-art.

Test of interaction models up to 40 PeV by studying hadronic cores of EAS

NASA Astrophysics Data System (ADS)

KASCADE Collaboration; Apel, W. D.; Badea, A. F.; Bekk, K.; Blümer, J.; Bozdog, H.; Brancus, I. M.; Daumiller, K.; Doll, P.; Engel, R.; Engler, J.; Gils, H. J.; Glasstetter, R.; Haungs, A.; Heck, D.; Hörandel, J. R.; Kampert, K.-H.; Klages, H. O.; Mathes, H. J.; Mayer, H. J.; Milke, J.; Oehlschläger, J.; Ostapchenko, S.; Petcu, M.; Pierog, T.; Rebel, H.; Risse, A.; Risse, M.; Roth, M.; Schatz, G.; Schieler, H.; Ulrich, H.; van Buren, J.; Weindl, A.; Wochele, J.; Zabierowski, J.

2007-12-01

The interpretation of extensive air shower measurements often requires a comparison with shower simulations in the atmosphere. These calculations rely on hadronic interaction models which have to extrapolate into kinematical and energy regions not explored by present-day collider experiments. The KASCADE experiment with its large hadron calorimeter and the detector array for the electromagnetic and muonic components provides experimental data to check such interaction models. For the simulations the program CORSIKA is used, which has several hadronic event generators embedded. For high-energy interactions (E_{\\rm{lab}}\\gtrsim100 \\ {\\rm{GeV}}) the models DPMJET, \\{\\sc NEX{\\sc US}} , QGSJET and SIBYLL have been used. Low-energy interactions have been treated by GHEISHA and FLUKA. Different hadronic observables are investigated as well as their correlations with the electromagnetic and muonic shower components up to primary energies of about 40 PeV. Although the predictions of the more recent models are to a large extent compatible with the measured data within the range given by proton and iron primary particles, there are still significant differences between the individual models.

Atomic Number Dependence of Hadron Production at Large Transverse Momentum in 300 GeV Proton--Nucleus Collisions

DOE R&D Accomplishments Database

Cronin, J. W.; Frisch, H. J.; Shochet, M. J.; Boymond, J. P.; Mermod, R.; Piroue, P. A.; Sumner, R. L.

1974-07-15

In an experiment at the Fermi National Accelerator Laboratory we have compared the production of large transverse momentum hadrons from targets of W, Ti, and Be bombarded by 300 GeV protons. The hadron yields were measured at 90 degrees in the proton-nucleon c.m. system with a magnetic spectrometer equipped with 2 Cerenkov counters and a hadron calorimeter. The production cross-sections have a dependence on the atomic number A that grows with P{sub 1}, eventually leveling off proportional to A{sup 1.1}.

Higher moments of multiplicity fluctuations in a hadron-resonance gas with exact conservation laws

NASA Astrophysics Data System (ADS)

Fu, Jing-Hua

2017-09-01

Higher moments of multiplicity fluctuations of hadrons produced in central nucleus-nucleus collisions are studied within the hadron-resonance gas model in the canonical ensemble. Exact conservation of three charges, baryon number, electric charge, and strangeness is enforced in the large volume limit. Moments up to the fourth order of various particles are calculated at CERN Super Proton Synchrotron, BNL Relativistic Heavy Ion Collider (RHIC), and CERN Large Hadron Collider energies. The asymptotic fluctuations within a simplified model with only one conserved charge in the canonical ensemble are discussed where simple analytical expressions for moments of multiplicity distributions can be obtained. Moments products of net-proton, net-kaon, and net-charge distributions in Au + Au collisions at RHIC energies are calculated. The pseudorapidity coverage dependence of net-charge fluctuation is discussed.

Re-irradiation for oligo-recurrence from esophageal cancer with radiotherapy history: a multi-institutional study.

PubMed

Jingu, Keiichi; Niibe, Yuzuru; Yamashita, Hideomi; Katsui, Kuniaki; Matsumoto, Toshihiko; Nishina, Tomohiro; Terahara, Atsuro

2017-09-05

Neoadjuvant chemoradiotherapy following surgery has recently become a standard therapy. The purpose of the present study was to determine the effectiveness and toxicity of re-irradiation for oligo-recurrence in lymph nodes from esophageal cancer treated by definitive radiotherapy or by surgery with additional radiotherapy. We reviewed retrospectively 248 patients treated with (chemo)radiotherapy for oligo-recurrence in lymph nodes from esophageal cancer in five Japanese high-volume centers between 2000 and 2015. Thirty-three patients in whom re-irradiation was performed were enrolled in this study, and the results for patients in whom re-irradiation was performed were compared with the results for other patients. Median maximum lymph node diameter was 22 mm. Median total radiation dose was 60 Gy. The median calculated biological effective dose using the LQ model with α/β = 10 Gy (BED10) in patients in whom re-irradiation was performed was significantly lower than the median BED10 in others. There was no different factor except for BED10, histology and irradiation field between patients with a past irradiation history and patients without a past irradiation history. The median observation period in surviving patients in whom re-irradiation was performed was 21.7 months. The 3-year overall survival rate in the 33 patients with a past irradiation history was 17.9%, with a median survival period of 16.0 months. Overall survival rate and local control rate in patients with a past irradiation history were significantly worse than those in patients without a past irradiation history (log-rank test, p = 0.016 and p = 0.0007, respectively). One patient in whom re-irradiation was performed died from treatment-related gastric hemorrhage. Results in the present study suggested that re-irradiation for oligo-recurrence in lymph nodes from esophageal cancer treated by definitive radiotherapy or by surgery with additional radiotherapy might be acceptable but

Bladder filling variation during conformal radiotherapy for rectal cancer

NASA Astrophysics Data System (ADS)

Sithamparam, S.; Ahmad, R.; Sabarudin, A.; Othman, Z.; Ismail, M.

2017-05-01

Conformal radiotherapy for rectal cancer is associated with small bowel toxicity mainly diarrhea. Treating patients with a full bladder is one of the practical solutions to reduce small bowel toxicity. Previous studies on prostate and cervix cancer patients revealed that maintaining consistent bladder volume throughout radiotherapy treatment is challenging. The aim of this study was to measure bladder volume variation throughout radiotherapy treatment. This study also measured the association between bladder volume changes and diarrhea. Twenty two rectal cancer patients were recruited prospectively. Patients were planned for treatment with full bladder following departmental bladder filling protocol and the planning bladder volume was measured during CT-simulation. During radiotherapy, the bladder volume was measured weekly using cone-beam computed tomography (CBCT) and compared to planning bladder volume. Incidence and severity of diarrhea were recorded during the weekly patient review. There was a negative time trend for bladder volume throughout five weeks treatment. The mean bladder volume decreased 18 % from 123 mL (SD 54 mL) during CT-simulation to 101 mL (SD 71 mL) on the 5th week of radiotherapy, but the decrease is not statistically significant. However, there was a large variation of bladder volume within each patient during treatment. This study showed an association between changes of bladder volume and diarrhea (P = 0.045). In conclusion bladder volume reduced throughout radiotherapy treatment for conformal radiotherapy for rectal cancer and there was a large variation of bladder volume within patients.

A combined analysis of the hadronic and leptonic decays of the Z 0

NASA Astrophysics Data System (ADS)

Akrawy, M. Z.; Alexander, G.; Allison, J.; Allport, P. P.; Anderson, K. J.; Armitage, J. C.; Arnison, G. T. J.; Ashton, P.; Azuelos, G.; Baines, J. T. M.; Ball, A. H.; Banks, J.; Barker, G. J.; Barlow, R. J.; Batley, J. R.; Becker, J.; Behnke, T.; Bell, K. W.; Bella, G.; Bethke, S.; Biebel, O.; Binder, U.; Bloodworth, I. J.; Bock, P.; Breuker, H.; Brown, R. M.; Brun, R.; Buijs, A.; Burckhart, H. J.; Capiluppi, P.; Carnegie, R. K.; Carter, A. A.; Carter, J. R.; Chang, C. Y.; Charlton, D. G.; Chrin, J. T. M.; Cohen, I.; Collins, W. J.; Conboy, J. E.; Couch, M.; Coupland, M.; Cuffiani, M.; Dado, S.; Dallavalle, G. M.; Deninno, M. M.; Dieckmann, A.; Dittmar, M.; Dixit, M. S.; Duchovni, E.; Duerdoth, I. P.; Dumas, D.; El Mamouni, H.; Elcombe, P. A.; Estabrooks, P. G.; Etzion, E.; Fabbri, F.; Farthouat, P.; Fischer, H. M.; Fong, D. G.; French, M. T.; Fukunaga, C.; Gandois, B.; Ganel, O.; Gary, J. W.; Gascon, J.; Geddes, N. I.; Gee, C. N. P.; Geich-Gimbel, C.; Gensler, S. W.; Gentit, F. X.; Giacomelli, G.; Gibson, V.; Gibson, W. R.; Gillies, J. D.; Goldberg, J.; Goodrick, M. J.; Gorn, W.; Granite, D.; Gross, E.; Grosse-Wiesmann, P.; Grunhaus, J.; Hagedorn, H.; Hagemann, J.; Hansroul, M.; Hargrove, C. K.; Hart, J.; Hattersley, P. M.; Hauschild, M.; Hawkes, C. M.; Heflin, E.; Hemingway, R. J.; Heuer, R. D.; Hill, J. C.; Hillier, S. J.; Ho, C.; Hobbs, J. D.; Hobson, P. R.; Hochman, D.; Holl, B.; Homer, R. J.; Hou, S. R.; Howarth, C. P.; Hughes-Jones, R. E.; Igo-Kemenes, P.; Ihssen, H.; Imrie, D. C.; Jawahery, A.; Jeffreys, P. W.; Jeremie, H.; Jimack, M.; Jobes, M.; Jones, R. W. L.; Jovanovic, P.; Karlen, D.; Kawagoe, K.; Kawamoto, T.; Kellogg, R. G.; Kennedy, B. W.; Kleinwort, C.; Klem, D. E.; Knop, G.; Kobayashi, T.; Kokott, T. P.; Köpke, L.; Kowalewski, R.; Kreutzmann, H.; Von Krogh, J.; Kroll, J.; Kuwano, M.; Kyberd, P.; Lafferty, G. D.; Lamarche, F.; Larson, W. J.; Lasota, M. M. B.; Layter, J. G.; Le Du, P.; Leblanc, P.; Lee, A. M.; Lellouch, D.; Lennert, P.; Lessard, L.; Levinson, L.; Lloyd, S. L.; Loebinger, F. K.; Lorah, J. M.; Lorazo, B.; Losty, M. J.; Ludwig, J.; Lupu, N.; Ma, J.; Macbeth, A. A.; Mannelli, M.; Marcellini, S.; Maringer, G.; Martin, A. J.; Martin, J. P.; Mashimo, T.; Mättig, P.; Maur, U.; McMahon, T. J.; McPherson, A. C.; Meijers, F.; Menszner, D.; Merritt, F. S.; Mes, H.; Michelini, A.; Middleton, R. P.; Mikenberg, G.; Miller, D. J.; Milstene, C.; Minowa, M.; Mohr, W.; Montanari, A.; Mori, T.; Moss, M. W.; Muller, A.; Murphy, P. G.; Murray, W. J.; Nellen, B.; Nguyen, H. H.; Nozaki, M.; O'Dowd, A. J. P.; O'Neale, S. W.; O'Neill, B. P.; Oakham, F. G.; Odorici, F.; Ogg, M.; Oh, H.; Oreglia, M. J.; Orito, S.; Patrick, G. N.; Pawley, S. J.; Pfister, P.; Pilcher, J. E.; Pinfold, J. L.; Plane, D. E.; Poli, B.; Pouladdej, A.; Pritchard, T. W.; Quast, G.; Raab, J.; Redmond, M. W.; Rees, D. L.; Regimbald, M.; Riles, K.; Roach, C. M.; Robins, S. A.; Rollnik, A.; Roney, J. M.; Rossberg, S.; Rossi, A. M.; Routenburg, P.; Runge, K.; Runolfsson, O.; Sanghera, S.; Sansum, R. A.; Sasaki, M.; Saunders, B. J.; Schaile, A. D.; Schaile, O.; Schappert, W.; Scharff-Hansen, P.; Von der Schmitt, H.; Schreiber, S.; Schwarz, J.; Shapira, A.; Shen, B. C.; Sherwood, P.; Simon, A.; Siroli, G. P.; Skuja, A.; Smith, A. M.; Smith, T. J.; Snow, G. A.; Spreadbury, E. J.; Springer, R. W.; Sproston, M.; Stephens, K.; Stier, H. E.; Ströhmer, R.; Strom, D.; Takeda, H.; Takeshita, T.; Tsukamoto, T.; Turner, M. F.; Tysarczyk-Niemeyer, G.; Van den Plas, D.; Vandalen, G. J.; Virtue, C. J.; Wagner, A.; Wahl, C.; Ward, C. P.; Ward, D. R.; Waterhouse, J.; Watkins, P. M.; Watson, A. T.; Watson, N. K.; Weber, M.; Weisz, S.; Wermes, N.; Weymann, M.; Wilson, G. W.; Wilson, J. A.; Wingerter, I.; Winterer, V.-H.; Wood, N. C.; Wotton, S.; Wuensch, B.; Wyatt, T. R.; Yaari, R.; Yang, Y.; Yekutieli, G.; Yoshida, T.; Zeuner, W.; Zorn, G. T.; Zylberajch, S.; OPAL Collaboration

1990-04-01

We report on a measurement of the mass of the Z 0 boson, its total width, and its partial decay widths into hadrons and leptons. On the basis of 25 801 hadronic decays and 1999 decays into electrons, muons or taus, selected over eleven energy points between 88.28 GeV and 95.04 GeV, we obtain from a combined fit to hadrons and leptons a mass of Mz=91.154±0.021 (exp)±0.030 (LEP) GeV, and a total width of Γz=2.536±0.045 GeV. The errors on Mz have been separated into the experimental error and the uncertainty due to the LEP beam energy. The measured leptonic partial widths are Γee=81.2±2.6 MeV, Γμμ=82.6± 5.8 MeV, and Γττ=85.7±7.1 MeV, consistent with lepton universality. From a fit assuming lepton universality we obtain Γℓ + ℓ - = 81.9±2.0 MeV. The hadronic partial width is Γhad=1838±46 MeV. From the measured total and partial widths a model independent value for the invisible width is calculated to be Γinv=453±44 MeV. The errors quoted include both the statistical and the systematic uncertainties.

Cost-effectiveness of modern radiotherapy techniques in locally advanced pancreatic cancer.

PubMed

Murphy, James D; Chang, Daniel T; Abelson, Jon; Daly, Megan E; Yeung, Heidi N; Nelson, Lorene M; Koong, Albert C

2012-02-15

Radiotherapy may improve the outcome of patients with pancreatic cancer but at an increased cost. In this study, the authors evaluated the cost-effectiveness of modern radiotherapy techniques in the treatment of locally advanced pancreatic cancer. A Markov decision-analytic model was constructed to compare the cost-effectiveness of 4 treatment regimens: gemcitabine alone, gemcitabine plus conventional radiotherapy, gemcitabine plus intensity-modulated radiotherapy (IMRT); and gemcitabine with stereotactic body radiotherapy (SBRT). Patients transitioned between the following 5 health states: stable disease, local progression, distant failure, local and distant failure, and death. Health utility tolls were assessed for radiotherapy and chemotherapy treatments and for radiation toxicity. SBRT increased life expectancy by 0.20 quality-adjusted life years (QALY) at an increased cost of $13,700 compared with gemcitabine alone (incremental cost-effectiveness ratio [ICER] = $69,500 per QALY). SBRT was more effective and less costly than conventional radiotherapy and IMRT. An analysis that excluded SBRT demonstrated that conventional radiotherapy had an ICER of $126,800 per QALY compared with gemcitabine alone, and IMRT had an ICER of $1,584,100 per QALY compared with conventional radiotherapy. A probabilistic sensitivity analysis demonstrated that the probability of cost-effectiveness at a willingness to pay of $50,000 per QALY was 78% for gemcitabine alone, 21% for SBRT, 1.4% for conventional radiotherapy, and 0.01% for IMRT. At a willingness to pay of $200,000 per QALY, the probability of cost-effectiveness was 73% for SBRT, 20% for conventional radiotherapy, 7% for gemcitabine alone, and 0.7% for IMRT. The current results indicated that IMRT in locally advanced pancreatic cancer exceeds what society considers cost-effective. In contrast, combining gemcitabine with SBRT increased clinical effectiveness beyond that of gemcitabine alone at a cost potentially acceptable by

Towards a Unified Quark-Hadron-Matter Equation of State for Applications in Astrophysics and Heavy-Ion Collisions

NASA Astrophysics Data System (ADS)

Bastian, Niels-Uwe; Blaschke, David; Fischer, Tobias; Röpke, Gerd

2018-05-01

We outline an approach to a unified equation of state for quark-hadron matter on the basis of a $\\Phi-$derivable approach to the generalized Beth-Uhlenbeck equation of state for a cluster decomposition of thermodynamic quantities like the density. To this end we summarize the cluster virial expansion for nuclear matter and demonstrate the equivalence of the Green's function approach and the $\\Phi-$derivable formulation. For an example, the formation and dissociation of deuterons in nuclear matter is discussed. We formulate the cluster $\\Phi-$derivable approach to quark-hadron matter which allows to take into account the specifics of chiral symmetry restoration and deconfinement in triggering the Mott-dissociation of hadrons. This approach unifies the description of a strongly coupled quark-gluon plasma with that of a medium-modified hadron resonance gas description which are contained as limiting cases. The developed formalism shall replace the common two-phase approach to the description of the deconfinement and chiral phase transition that requires a phase transition construction between separately developed equations of state for hadronic and quark matter phases. Applications to the phenomenology of heavy-ion collisions and astrophysics are outlined.

Clinical experience with image-guided radiotherapy in an accelerated partial breast intensity-modulated radiotherapy protocol.

PubMed

Leonard, Charles E; Tallhamer, Michael; Johnson, Tim; Hunter, Kari; Howell, Kathryn; Kercher, Jane; Widener, Jodi; Kaske, Terese; Paul, Devchand; Sedlacek, Scot; Carter, Dennis L

2010-02-01

To explore the feasibility of fiducial markers for the use of image-guided radiotherapy (IGRT) in an accelerated partial breast intensity modulated radiotherapy protocol. Nineteen patients consented to an institutional review board approved protocol of accelerated partial breast intensity-modulated radiotherapy with fiducial marker placement and treatment with IGRT. Patients (1 patient with bilateral breast cancer; 20 total breasts) underwent ultrasound guided implantation of three 1.2- x 3-mm gold markers placed around the surgical cavity. For each patient, table shifts (inferior/superior, right/left lateral, and anterior/posterior) and minimum, maximum, mean error with standard deviation were recorded for each of the 10 BID treatments. The dose contribution of daily orthogonal films was also examined. All IGRT patients underwent successful marker placement. In all, 200 IGRT treatment sessions were performed. The average vector displacement was 4 mm (range, 2-7 mm). The average superior/inferior shift was 2 mm (range, 0-5 mm), the average lateral shift was 2 mm (range, 1-4 mm), and the average anterior/posterior shift was 3 mm (range, 1 5 mm). This study shows that the use of IGRT can be successfully used in an accelerated partial breast intensity-modulated radiotherapy protocol. The authors believe that this technique has increased daily treatment accuracy and permitted reduction in the margin added to the clinical target volume to form the planning target volume. Copyright 2010 Elsevier Inc. All rights reserved.

Children Undergoing Radiotherapy: Swedish Parents’ Experiences and Suggestions for Improvement

PubMed Central

Mullaney, Tara; Nilsson, Kristina; Wickart-Johansson, Gun; Svärd, Anna-Maja; Nyholm, Tufve; Lindh, Jack; Lindh, Viveca

2015-01-01

Approximately 300 children, from 0 to 18 years old, are diagnosed with cancer in Sweden every year. Of these children, 80–90 of them undergo radiotherapy treatment for their cancer. Although radiotherapy is an encounter with advanced technology, few studies have investigated the child’s and the parent’s view of the procedure. As part of an ongoing multicenter study aimed to improve patient preparation and the care environment in pediatric radiotherapy, this article reports the findings from interviews with parents at baseline. The aim of the present study was twofold: to describe parents’ experience when their child undergoes radiotherapy treatment, and to report parents’ suggestions for improvements during radiotherapy for their children. Sixteen mothers and sixteen fathers of children between 2–16 years old with various cancer diagnoses were interviewed. Data were analyzed using content analysis. The findings showed that cancer and treatment turns people’s lives upside down, affecting the entire family. Further, the parents experience the child’s suffering and must cope with intense feelings. Radiotherapy treatment includes preparation by skilled and empathetic staff. The parents gradually find that they can deal with the process; and lastly, parents have suggestions for improvements during the radiotherapy treatment. An overarching theme emerged: that despair gradually turns to a sense of security, with a sustained focus on and close interaction with the child. In conclusion, an extreme burden was experienced around the start of radiotherapy, though parents gradually coped with the process. PMID:26509449

Diffractive Higgs boson production at the Fermilab Tevatron and the CERN Large Hadron Collider.

PubMed

Enberg, R; Ingelman, G; Kissavos, A; Tîmneanu, N

2002-08-19

Improved possibilities to find the Higgs boson in diffractive events, having less hadronic activity, depend on whether the cross section is large enough. Based on the soft color interaction models that successfully describe diffractive hard scattering at DESY HERA and the Fermilab Tevatron, we find that only a few diffractive Higgs events may be produced at the Tevatron, but we predict a substantial rate at the CERN Large Hadron Collider.

Radiotherapy access in Belgium: How far are we from evidence-based utilisation?

PubMed

Lievens, Y; De Schutter, H; Stellamans, K; Rosskamp, M; Van Eycken, L

2017-10-01

Underutilisation of radiotherapy has been observed worldwide. To evaluate the current situation in Belgium, optimal utilisation proportions (OUPs) adopted from the European SocieTy for Radiotherapy and Oncology - Health Economics in Radiation Oncology (ESTRO-HERO) project were compared to actual utilisation proportions (AUPs) and with radiotherapy advised during the multidisciplinary cancer team (MDT) meetings. In addition, the impact of independent variables was analysed. AUPs and advised radiotherapy were calculated overall and by cancer type for 110,810 unique cancer diagnoses in 2009-2010. Radiotherapy utilisation was derived from reimbursement data and distinguished between palliative and curative intent external beam radiotherapy (EBRT) and/or brachytherapy (BT). Sensitivity analyses regarding the influence of the follow-up period, the survival length and patient's age were performed. Advised radiotherapy was calculated based on broad treatment categories as reported at MDT meetings. The overall AUP of 37% (39% including BT) was lower than the OUP of 53%, but in line with advised radiotherapy (35%). Large variations by tumour type were observed: in some tumours (e.g. lung and prostate cancer) AUP was considerably lower than OUP, whereas in others there was reasonable concordance (e.g. breast and rectal cancer). Overall, 84% of treatments started within 9 months following diagnosis. Survival time influenced AUP in a cancer type-dependent way. Elderly patients received less radiotherapy. Although the actually delivered radiotherapy in Belgium aligns well to MDT advices, it is lower than the evidence-based optimum. Further analysis of potential barriers is needed for radiotherapy forecasting and planning, and in order to promote adequate access to radiotherapy. Copyright © 2017 Elsevier Ltd. All rights reserved.

Radiotherapy in the treatment of solitary plasmacytoma.

PubMed

Jyothirmayi, R; Gangadharan, V P; Nair, M K; Rajan, B

1997-05-01

Solitary plasmacytoma of bone (SPB) and extramedullary plasmacytoma (EMP) are rare. High local control rates are reported with radiotherapy, although the optimal dose and extent of radiotherapy portals remains controversial. Between 1983 and 1993, 30 patients with solitary plasmacytoma were seen at the Regional Cancer Centre, Trivandrum, India. 23 patients had SPB and seven EMP. The mean age was 52 years and the male to female ratio 3.2:1. Diagnosis of SPB was confirmed by biopsy in 16 patients and tumour excision in seven. 20 patients received megavoltage radiotherapy to the bone lesion with limited margins, and one received chemotherapy. Two patients who underwent complete tumour excision received no further treatment. All seven patients with EMP received megavoltage radiotherapy, four following biopsy and three after tumour excision. Local control was achieved in all patients with SPB. Nine progressed to multiple myeloma and one developed a solitary plasmacytoma in another bone. Six patients with EMP achieved local control. Three later progressed to multiple myeloma and one had local relapse. Median time to relapse was 28 months in SPB and 30 months in EMP. 5-year overall survival rates were 82% and 57% for patients with SPB and EMP, respectively. The corresponding progression free survival rates were 55% and 50%, respectively. Age, sex, site of tumour, serum M protein and haemoglobin levels did not significantly influence progression free survival. The extent of surgery, radiotherapy dose or time to relapse were not significant prognostic factors. Radiotherapy appears to be an effective modality of treatment of solitary plasmacytoma. No dose-response relationship is observed, and high local control rates are achieved with limited portals. Progression to multiple myeloma is the commonest pattern of failure, although no prognostic factors for progression are identified. The role of chemotherapy in preventing disease progression needs further evaluation.

ENLIGHT: European network for Light ion hadron therapy.

PubMed

Dosanjh, Manjit; Amaldi, Ugo; Mayer, Ramona; Poetter, Richard

2018-04-03

The European Network for Light Ion Hadron Therapy (ENLIGHT) was established in 2002 following various European particle therapy network initiatives during the 1980s and 1990s (e.g. EORTC task group, EULIMA/PIMMS accelerator design). ENLIGHT started its work on major topics related to hadron therapy (HT), such as patient selection, clinical trials, technology, radiobiology, imaging and health economics. It was initiated through CERN and ESTRO and dealt with various disciplines such as (medical) physics and engineering, radiation biology and radiation oncology. ENLIGHT was funded until 2005 through the EC FP5 programme. A regular annual meeting structure was started in 2002 and continues until today bringing together the various disciplines and projects and institutions in the field of HT at different European places for regular exchange of information on best practices and research and development. Starting in 2006 ENLIGHT coordination was continued through CERN in collaboration with ESTRO and other partners involved in HT. Major projects within the EC FP7 programme (2008-2014) were launched for R&D and transnational access (ULICE, ENVISION) and education and training networks (Marie Curie ITNs: PARTNER, ENTERVISION). These projects were instrumental for the strengthening of the field of hadron therapy. With the start of 4 European carbon ion and proton centres and the upcoming numerous European proton therapy centres, the future scope of ENLIGHT will focus on strengthening current and developing European particle therapy research, multidisciplinary education and training and general R&D in technology and biology with annual meetings and a continuously strong CERN support. Collaboration with the European Particle Therapy Network (EPTN) and other similar networks will be pursued. Copyright © 2018 CERN. Published by Elsevier B.V. All rights reserved.

Role of MR-DWI and MR-PWI in the radiotherapy of implanted pulmonary VX-2 carcinoma in rabbits.

PubMed

Zhang, Qiang; Zhang, Mingmin; Liu, Zhaoxin; Shi, Baoqi; Qi, Fuliang; Wang, Haijiang; Lv, Yuan; Jin, Haijiao; Zhang, Weijing

2014-10-01

To detect the activity of tumor cells and tumor blood flow before and after the radiotherapy of implanted pulmonary VX-2 carcinoma in rabbit models by using magnetic resonance diffusion-weighted imaging (MR-DWI) and magnetic resonance perfusion weighted imaging (MR-PWI), and to evaluate the effectiveness and safety of the radiotherapy based on the changes in the MR-DWI and MR-PWI parameters at different treatment stages. A total of 56 rabbit models with implanted pulmonary VX-2 carcinoma were established, and then equally divided into treatment group and control group. MR-DWI and MR-PWI were separately performed using a Philips Acheiva 1.5T MRI machine (Philips, Netherland). MRI image processing was performed using special perfusion software and the WORKSPACE advanced workstation for MRI. MR-DWI was applied for the observation of tumor signals and the measurement of apparent diffusion coefficient (ADC) values; whereas MR-PWI was used for the measurement of wash in rate (WIR), wash out rate (WOR), and maximum enhancement rate (MER). The radiation treatment was performed using Siemens PRIMUS linear accelerator. In the treatment group, the radiotherapy was performed 21 days later on a once weekly dosage of 1,000 cGy to yield a total dosage of 5,000 cGy. THE ADC PARAMETERS IN THE REGION OF INTEREST ON DWI WERE AS FOLLOWS: on the treatment day for the implanted pulmonary VX-2 carcinoma, the t values at the center and the edge of the lesions were 1.352 and 1.461 in the treatment group and control group (P>0.05). During weeks 0-1 after treatment, the t values at the center and the edge of the lesions were 1.336 and 1.137 (P>0.05). During weeks 1-2, the t values were 1.731 and 1.736 (P<0.05). During weeks 2-3, the t values were 1.742 and 1.749 (P<0.05). During weeks 3-4, the t values were 2.050 and 2.127 (P<0.05). During weeks 4-5, the t values were 2.764 and 2.985 (P<0.05). The ADC values in the treatment group were significantly higher than in the control group. After

[Head and neck adaptive radiotherapy].

PubMed

Graff, P; Huger, S; Kirby, N; Pouliot, J

2013-10-01

Onboard volumetric imaging systems can provide accurate data of the patient's anatomy during a course of head and neck radiotherapy making it possible to assess the actual delivered dose and to evaluate the dosimetric impact of complex daily positioning variations and gradual anatomic changes such as geometric variations of tumors and normal tissues or shrinkage of external contours. Adaptive radiotherapy is defined as the correction of a patient's treatment planning to adapt for individual variations observed during treatment. Strategies are developed to selectively identify patients that require replanning because of an intolerable dosimetric drift. Automated tools are designed to limit time consumption. Deformable image registration algorithms are the cornerstones of these strategies, but a better understanding of their limits of validity is required before adaptive radiotherapy can be safely introduced to daily practice. Moreover, strict evaluation of the clinical benefits is yet to be proven. Copyright © 2013 Société française de radiothérapie oncologique (SFRO). Published by Elsevier SAS. All rights reserved.

Suppression of back-to-back hadron pairs at forward rapidity in d+Au collisions at √s(NN)=200 GeV.

PubMed

Adare, A; Afanasiev, S; Aidala, C; Ajitanand, N N; Akiba, Y; Al-Bataineh, H; Alexander, J; Angerami, A; Aoki, K; Apadula, N; Aramaki, Y; Atomssa, E T; Averbeck, R; Awes, T C; Azmoun, B; Babintsev, V; Bai, M; Baksay, G; Baksay, L; Barish, K N; Bassalleck, B; Basye, A T; Bathe, S; Baublis, V; Baumann, C; Bazilevsky, A; Belikov, S; Belmont, R; Bennett, R; Berdnikov, A; Berdnikov, Y; Bhom, J H; Blau, D S; Bok, J S; Boyle, K; Brooks, M L; Buesching, H; Bumazhnov, V; Bunce, G; Butsyk, S; Campbell, S; Caringi, A; Chen, C-H; Chi, C Y; Chiu, M; Choi, I J; Choi, J B; Choudhury, R K; Christiansen, P; Chujo, T; Chung, P; Chvala, O; Cianciolo, V; Citron, Z; Cole, B A; Conesa del Valle, Z; Connors, M; Csanád, M; Csörgo, T; Dahms, T; Dairaku, S; Danchev, I; Das, K; Datta, A; David, G; Dayananda, M K; Denisov, A; Deshpande, A; Desmond, E J; Dharmawardane, K V; Dietzsch, O; Dion, A; Donadelli, M; Drapier, O; Drees, A; Drees, K A; Durham, J M; Durum, A; Dutta, D; D'Orazio, L; Edwards, S; Efremenko, Y V; Ellinghaus, F; Engelmore, T; Enokizono, A; En'yo, H; Esumi, S; Fadem, B; Fields, D E; Finger, M; Finger, M; Fleuret, F; Fokin, S L; Fraenkel, Z; Frantz, J E; Franz, A; Frawley, A D; Fujiwara, K; Fukao, Y; Fusayasu, T; Garishvili, I; Glenn, A; Gong, H; Gonin, M; Goto, Y; Granier de Cassagnac, R; Grau, N; Greene, S V; Grim, G; Grosse Perdekamp, M; Gunji, T; Gustafsson, H-Å; Haggerty, J S; Hahn, K I; Hamagaki, H; Hamblen, J; Han, R; Hanks, J; Haslum, E; Hayano, R; He, X; Heffner, M; Hemmick, T K; Hester, T; Hill, J C; Hohlmann, M; Holzmann, W; Homma, K; Hong, B; Horaguchi, T; Hornback, D; Huang, S; Ichihara, T; Ichimiya, R; Ikeda, Y; Imai, K; Inaba, M; Isenhower, D; Ishihara, M; Issah, M; Isupov, A; Ivanischev, D; Iwanaga, Y; Jacak, B V; Jia, J; Jiang, X; Jin, J; Johnson, B M; Jones, T; Joo, K S; Jouan, D; Jumper, D S; Kajihara, F; Kamin, J; Kang, J H; Kapustinsky, J; Karatsu, K; Kasai, M; Kawall, D; Kawashima, M; Kazantsev, A V; Kempel, T; Khanzadeev, A; Kijima, K M; Kikuchi, J; Kim, A; Kim, B I; Kim, D J; Kim, E J; Kim, Y-J; Kinney, E; Kiss, Á; Kistenev, E; Kochenda, L; Komkov, B; Konno, M; Koster, J; Král, A; Kravitz, A; Kunde, G J; Kurita, K; Kurosawa, M; Kwon, Y; Kyle, G S; Lacey, R; Lai, Y S; Lajoie, J G; Lebedev, A; Lee, D M; Lee, J; Lee, K B; Lee, K S; Leitch, M J; Leite, M A L; Li, X; Lichtenwalner, P; Liebing, P; Linden Levy, L A; Liška, T; Litvinenko, A; Liu, H; Liu, M X; Love, B; Lynch, D; Maguire, C F; Makdisi, Y I; Malakhov, A; Malik, M D; Manko, V I; Mannel, E; Mao, Y; Masui, H; Matathias, F; McCumber, M; McGaughey, P L; Means, N; Meredith, B; Miake, Y; Mibe, T; Mignerey, A C; Miki, K; Milov, A; Mitchell, J T; Mohanty, A K; Moon, H J; Morino, Y; Morreale, A; Morrison, D P; Moukhanova, T V; Murakami, T; Murata, J; Nagamiya, S; Nagle, J L; Naglis, M; Nagy, M I; Nakagawa, I; Nakamiya, Y; Nakamura, K R; Nakamura, T; Nakano, K; Nam, S; Newby, J; Nguyen, M; Nihashi, M; Nouicer, R; Nyanin, A S; Oakley, C; O'Brien, E; Oda, S X; Ogilvie, C A; Oka, M; Okada, K; Onuki, Y; Oskarsson, A; Ouchida, M; Ozawa, K; Pak, R; Pantuev, V; Papavassiliou, V; Park, I H; Park, S K; Park, W J; Pate, S F; Pei, H; Peng, J-C; Pereira, H; Peresedov, V; Peressounko, D Yu; Petti, R; Pinkenburg, C; Pisani, R P; Proissl, M; Purschke, M L; Qu, H; Rak, J; Ravinovich, I; Read, K F; Reygers, K; Riabov, V; Riabov, Y; Richardson, E; Roach, D; Roche, G; Rolnick, S D; Rosati, M; Rosen, C A; Rosendahl, S S E; Rukoyatkin, P; Ružička, P; Sahlmueller, B; Saito, N; Sakaguchi, T; Sakashita, K; Samsonov, V; Sano, S; Sato, T; Sawada, S; Sedgwick, K; Seele, J; Seidl, R; Seto, R; Sharma, D; Shein, I; Shibata, T-A; Shigaki, K; Shimomura, M; Shoji, K; Shukla, P; Sickles, A; Silva, C L; Silvermyr, D; Silvestre, C; Sim, K S; Singh, B K; Singh, C P; Singh, V; Slunečka, M; Soltz, R A; Sondheim, W E; Sorensen, S P; Sourikova, I V; Stankus, P W; Stenlund, E; Stoll, S P; Sugitate, T; Sukhanov, A; Sziklai, J; Takagui, E M; Taketani, A; Tanabe, R; Tanaka, Y; Taneja, S; Tanida, K; Tannenbaum, M J; Tarafdar, S; Taranenko, A; Themann, H; Thomas, D; Thomas, T L; Togawa, M; Toia, A; Tomášek, L; Torii, H; Towell, R S; Tserruya, I; Tsuchimoto, Y; Vale, C; Valle, H; van Hecke, H W; Vazquez-Zambrano, E; Veicht, A; Velkovska, J; Vértesi, R; Virius, M; Vrba, V; Vznuzdaev, E; Wang, X R; Watanabe, D; Watanabe, K; Watanabe, Y; Wei, F; Wei, R; Wessels, J; White, S N; Winter, D; Woody, C L; Wright, R M; Wysocki, M; Yamaguchi, Y L; Yamaura, K; Yang, R; Yanovich, A; Ying, J; Yokkaichi, S; You, Z; Young, G R; Younus, I; Yushmanov, I E; Zajc, W A; Zhou, S; Zolin, L

2011-10-21

Back-to-back hadron pair yields in d+Au and p+p collisions at √s(NN)=200 GeV were measured with the PHENIX detector at the Relativistic Heavy Ion Collider. Rapidity separated hadron pairs were detected with the trigger hadron at pseudorapidity |η|<0.35 and the associated hadron at forward rapidity (deuteron direction, 3.0<η<3.8). Pairs were also detected with both hadrons measured at forward rapidity; in this case, the yield of back-to-back hadron pairs in d+Au collisions with small impact parameters is observed to be suppressed by a factor of 10 relative to p+p collisions. The kinematics of these pairs is expected to probe partons in the Au nucleus with a low fraction x of the nucleon momenta, where the gluon densities rise sharply. The observed suppression as a function of nuclear thickness, p(T), and η points to cold nuclear matter effects arising at high parton densities. © 2011 American Physical Society

Adler function and hadronic contribution to the muon g-2 in a nonlocal chiral quark model

NASA Astrophysics Data System (ADS)

Dorokhov, Alexander E.

2004-11-01

The behavior of the vector Adler function at spacelike momenta is studied in the framework of a covariant chiral quark model with instantonlike quark-quark interaction. This function describes the transition between the high-energy asymptotically free region of almost massless current quarks to the low-energy hadronized regime with massive constituent quarks. The model reproduces the Adler function and V-A correlator extracted from the ALEPH and OPAL data on hadronic τ lepton decays, transformed into the Euclidean domain via dispersion relations. The leading order contribution from the hadronic part of the photon vacuum polarization to the anomalous magnetic moment of the muon, ahvp(1)μ, is estimated.

Design, construction and commissioning of the Digital Hadron Calorimeter—DHCAL

NASA Astrophysics Data System (ADS)

Adams, C.; Bambaugh, A.; Bilki, B.; Butler, J.; Corriveau, F.; Cundiff, T.; Drake, G.; Francis, K.; Furst, B.; Guarino, V.; Haberichter, B.; Hazen, E.; Hoff, J.; Holm, S.; Kreps, A.; DeLurgio, P.; Matijas, Z.; Dal Monte, L.; Mucia, N.; Norbeck, E.; Northacker, D.; Onel, Y.; Pollack, B.; Repond, J.; Schlereth, J.; Skrzecz, F.; Smith, J. R.; Trojand, D.; Underwood, D.; Velasco, M.; Walendziak, J.; Wood, K.; Wu, S.; Xia, L.; Zhang, Q.; Zhao, A.

2016-07-01

A novel hadron calorimeter is being developed for future lepton colliding beam detectors. The calorimeter is optimized for the application of Particle Flow Algorithms (PFAs) to the measurement of hadronic jets and features a very finely segmented readout with 1 × 1 cm2 cells. The active media of the calorimeter are Resistive Plate Chambers (RPCs) with a digital, i.e. one-bit, readout. To first order the energy of incident particles in this calorimeter is reconstructed as being proportional to the number of pads with a signal over a given threshold. A large-scale prototype calorimeter with approximately 500,000 readout channels has been built and underwent extensive testing in the Fermilab and CERN test beams. This paper reports on the design, construction, and commissioning of this prototype calorimeter.

Recent Advances in Image-Guided Radiotherapy for Head and Neck Carcinoma

PubMed Central

Nath, Sameer K.; Simpson, Daniel R.; Rose, Brent S.; Sandhu, Ajay P.

2009-01-01

Radiotherapy has a well-established role in the management of head and neck cancers. Over the past decade, a variety of new imaging modalities have been incorporated into the radiotherapy planning and delivery process. These technologies are collectively referred to as image-guided radiotherapy and may lead to significant gains in tumor control and radiation side effect profiles. In the following review, these techniques as they are applied to head and neck cancer patients are described, and clinical studies analyzing their use in target delineation, patient positioning, and adaptive radiotherapy are highlighted. Finally, we conclude with a brief discussion of potential areas of further radiotherapy advancement. PMID:19644564

A Kindler syndrome-associated squamous cell carcinoma treated with radiotherapy.

PubMed

Caldeira, Ademar; Trinca, William Correia; Flores, Thais Pires; Costa, Andrea Barleze; Brito, Claudio de Sá; Weigert, Karen Loureiro; Matos, Maryana Schwartzhaupt; Nicolini, Carmela; Obst, Fernando Mariano

2016-01-01

Kindler syndrome1, 2 is a genetic disorder mainly characterized by increased skin fragility and photosensitivity,3, 4 making the use of treatments based on radiation difficult or even prohibited. Thus, cases reporting Kindler syndrome patients treated with radiotherapy are rare. In this study, we report clinical outcomes and care provided for a rare case of a Kindler syndrome patient submitted to radiotherapy. Diagnosed with squamous cell carcinoma involving the buccal mucosa, the patient was exclusively treated with radiotherapy, with 70 Gy delivered on the PTV with the Volumetric Modulated Arc technique. The patient's reaction regarding control of the lesion is relevant compared to patients not affected by the syndrome. We noticed acute reactions of the skin and buccal mucosa after few radiotherapy sessions, followed by a fast reduction in the tumor volume. The efficacy of radiotherapy along with multidisciplinary actions allowed treatment continuity, leading to a complete control of the lesion and life quality improvement and showed that the use of radiotherapy on Kindler syndrome patients is possible.

Pencilbeam irradiation technique for whole brain radiotherapy: technical and biological challenges in a small animal model.

PubMed

Schültke, Elisabeth; Trippel, Michael; Bräuer-Krisch, Elke; Renier, Michel; Bartzsch, Stefan; Requardt, Herwig; Döbrössy, Máté D; Nikkhah, Guido

2013-01-01

We have conducted the first in-vivo experiments in pencilbeam irradiation, a new synchrotron radiation technique based on the principle of microbeam irradiation, a concept of spatially fractionated high-dose irradiation. In an animal model of adult C57 BL/6J mice we have determined technical and physiological limitations with the present technical setup of the technique. Fifty-eight animals were distributed in eleven experimental groups, ten groups receiving whole brain radiotherapy with arrays of 50 µm wide beams. We have tested peak doses ranging between 172 Gy and 2,298 Gy at 3 mm depth. Animals in five groups received whole brain radiotherapy with a center-to-center (ctc) distance of 200 µm and a peak-to-valley ratio (PVDR) of ∼ 100, in the other five groups the ctc was 400 µm (PVDR ∼ 400). Motor and memory abilities were assessed during a six months observation period following irradiation. The lower dose limit, determined by the technical equipment, was at 172 Gy. The LD50 was about 1,164 Gy for a ctc of 200 µm and higher than 2,298 Gy for a ctc of 400 µm. Age-dependent loss in motor and memory performance was seen in all groups. Better overall performance (close to that of healthy controls) was seen in the groups irradiated with a ctc of 400 µm.

Signals of doubly-charged Higgsinos at the CERN Large Hadron Collider

DOE Office of Scientific and Technical Information (OSTI.GOV)

Demir, Durmus A.; Deutsches Elektronen--Synchrotron, DESY, D-22603 Hamburg; Frank, Mariana

2008-08-01

Several supersymmetric models with extended gauge structures, motivated by either grand unification or by neutrino mass generation, predict light doubly-charged Higgsinos. In this work we study productions and decays of doubly-charged Higgsinos present in left-right supersymmetric models, and show that they invariably lead to novel collider signals not found in the minimal supersymmetric model or in any of its extensions motivated by the {mu} problem or even in extra dimensional theories. We investigate their distinctive signatures at the Large Hadron Collider in both pair- and single-production modes, and show that they are powerful tools in determining the underlying model viamore » the measurements at the Large Hadron Collider experiments.« less

New results on low energy exclusive hadronic final states from BABAR

NASA Astrophysics Data System (ADS)

Gary, J. William

2018-01-01

The 3.6 standard deviation discrepancy between the standard model (SM) prediction for the muon anomalous magnetic moment gμ - 2 and the corresponding experimental measurement is one of the most persistent and intriguing potential signals in particle physics for physics beyond the SM. The largest uncertainty in the SM prediction for gμ - 2 arises from the uncertainty in the measured low energy inclusive e+e- → hadrons cross section. New results from the BABAR experiment at SLAC for the e+e- → π+ π- π0 π0 and e+e- → KK ππ cross sections are presented that significantly reduce this uncertainty. New BABAR results for other low energy exclusive hadronic processes are also discussed.

Determining transport coefficients for a microscopic simulation of a hadron gas

NASA Astrophysics Data System (ADS)

Pratt, Scott; Baez, Alexander; Kim, Jane

2017-02-01

Quark-gluon plasmas produced in relativistic heavy-ion collisions quickly expand and cool, entering a phase consisting of multiple interacting hadronic resonances just below the QCD deconfinement temperature, T ˜155 MeV. Numerical microscopic simulations have emerged as the principal method for modeling the behavior of the hadronic stage of heavy-ion collisions, but the transport properties that characterize these simulations are not well understood. Methods are presented here for extracting the shear viscosity and two transport parameters that emerge in Israel-Stewart hydrodynamics. The analysis is based on studying how the stress-energy tensor responds to velocity gradients. Results are consistent with Kubo relations if viscous relaxation times are twice the collision time.

Combinations of Radiotherapy and Immunotherapy for Melanoma: A Review of Clinical Outcomes

PubMed Central

Barker, Christopher A.; Postow, Michael A.

2015-01-01

Radiotherapy has long played a role in the management of melanoma. Recent advances have also demonstrated the efficacy of immunotherapy in the treatment of melanoma. Preclinical data suggest a biologic interaction between radiotherapy and immunotherapy. Several clinical studies corroborate these findings. This review will summarize the outcomes of studies reporting on patients with melanoma treated with a combination of radiotherapy and immunotherapy. Vaccine therapies often use irradiated melanoma cells, and may be enhanced by radiotherapy. The cytokines interferon-alpha and interleukin-2 have been combined with radiotherapy in several small studies, with some evidence suggesting increased toxicity and/or efficacy. Ipilimumab, a monoclonal antibody which blocks cytotoxic T-lymphocyte antigen-4, has been combined with radiotherapy in several notable case studies and series. Finally, pilot studies of adoptive cell transfer have suggested radiotherapy may improve the efficacy of treatment. The review will demonstrate that the combination of radiotherapy and immunotherapy has been reported in several notable case studies, series and clinical trials. These clinical results suggest interaction and the need for further study. PMID:24661650

Postoperative Radiotherapy Patterns of Care and Survival Implications for Medulloblastoma in Young Children.

PubMed

Kann, Benjamin H; Park, Henry S; Lester-Coll, Nataniel H; Yeboa, Debra N; Benitez, Viviana; Khan, Atif J; Bindra, Ranjit S; Marks, Asher M; Roberts, Kenneth B

2016-12-01

Postoperative radiotherapy to the craniospinal axis is standard-of-care for pediatric medulloblastoma but is associated with long-term morbidity, particularly in young children. With the advent of modern adjuvant chemotherapy strategies, postoperative radiotherapy deferral has gained acceptance in children younger than 3 years, although it remains controversial in older children. To analyze recent postoperative radiotherapy national treatment patterns and implications for overall survival in patients with medulloblastoma ages 3 to 8 years. Using the National Cancer Data Base, patients ages 3 to 8 years diagnosed as having histologically confirmed medulloblastoma in 2004 to 2012, without distant metastases, who underwent surgery and adjuvant chemotherapy with or without postoperative radiotherapy at facilities nationwide accredited by the Commission on Cancer were identified. Patients were designated as having "postoperative radiotherapy upfront" if they received radiotherapy within 90 days of surgery or "postoperative radiotherapy deferred" otherwise. Factors associated with postoperative radiotherapy deferral were identified using multivariable logistic regression. Overall survival (OS) was compared using Kaplan-Meier analysis with log-rank tests and multivariable Cox regression. Statistical tests were 2-sided. Postoperative radiotherapy utilization and overall survival. Among 816 patients, 123 (15.1%) had postoperative radiotherapy deferred, and 693 (84.9%) had postoperative radiotherapy upfront; 36.8% of 3-year-olds and 4.1% of 8-year-olds had postoperative radiotherapy deferred (P < .001). On multivariable logistic regression, variables associated with postoperative radiotherapy deferral were age (odds ratio [OR], 0.57 per year; 95% CI, 0.49-0.67 per year) and year of diagnosis (OR, 1.18 per year; 95% CI, 1.08-1.29 per year). On survival analysis, with median follow-up of 4.8 years, OS was improved for those receiving postoperative radiotherapy upfront vs

A DICOM based radiotherapy plan database for research collaboration and reporting

NASA Astrophysics Data System (ADS)

Westberg, J.; Krogh, S.; Brink, C.; Vogelius, I. R.

2014-03-01

Purpose: To create a central radiotherapy (RT) plan database for dose analysis and reporting, capable of calculating and presenting statistics on user defined patient groups. The goal is to facilitate multi-center research studies with easy and secure access to RT plans and statistics on protocol compliance. Methods: RT institutions are able to send data to the central database using DICOM communications on a secure computer network. The central system is composed of a number of DICOM servers, an SQL database and in-house developed software services to process the incoming data. A web site within the secure network allows the user to manage their submitted data. Results: The RT plan database has been developed in Microsoft .NET and users are able to send DICOM data between RT centers in Denmark. Dose-volume histogram (DVH) calculations performed by the system are comparable to those of conventional RT software. A permission system was implemented to ensure access control and easy, yet secure, data sharing across centers. The reports contain DVH statistics for structures in user defined patient groups. The system currently contains over 2200 patients in 14 collaborations. Conclusions: A central RT plan repository for use in multi-center trials and quality assurance was created. The system provides an attractive alternative to dummy runs by enabling continuous monitoring of protocol conformity and plan metrics in a trial.

Secondary malignancy following radiotherapy for thyroid eye disease.

PubMed

Gillis, Christopher C; Chang, Eun Hae; Al-Kharazi, Khalid; Pickles, Tom

2016-01-01

To describe the first case of a secondary meningioma in a patient after radiation treatment for thyroid eye disease (TED). Secondarily to identify any additional cases of secondary malignancy resulting from radiotherapy for thyroid eye disease from our institutional experience. Thyroid eye disease (TED) is a self-limiting auto-immune disorder causing expansion of orbital soft tissue from deposition of glycosaminoglycans and collagen, leading to significant cosmetic and functional morbidity. Established management options for TED include: glucocorticosteroids, orbital radiotherapy, and surgical orbital decompression. Two large series on radiotherapy for TED have been reported without any cases of secondary malignancy. The case of a patient with visual failure, found to have a sphenoid wing meningioma after previous TED radiotherapy is described. We then reviewed 575 patients with at least 3-year follow-up receiving radiotherapy for TED at British Columbia Cancer Agency to identify other possible secondary malignancies. The patient had postoperative improvement in her vision without any identified complications. Three additional cases of hematologic malignancy were identified. The calculated risk in our population of developing a radiation-induced meningioma after TED with at least 3 years of follow-up of is 0.17% (1/575); with hematopoetic malignancies the risk for secondary malignancy is 0.7% (4/575). Our calculated risk for secondary malignancy (0.17%, 0.7%) is similar to the reported theoretical risk published in the literature (0.3-1.2%). There is real risk for the development of a secondary malignancy after radiotherapy treatment of TED and treatment options should include consideration for this potential.

Fractionated Proton Radiotherapy for Benign Cavernous Sinus Meningiomas

DOE Office of Scientific and Technical Information (OSTI.GOV)

Slater, Jerry D., E-mail: jdslater@dominion.llumc.edu; Loredo, Lilia N.; Chung, Arthur

2012-08-01

Purpose: To evaluate the efficacy of fractionated proton radiotherapy for a population of patients with benign cavernous sinus meningiomas. Methods and Materials: Between 1991 and 2002, 72 patients were treated at Loma Linda University Medical Center with proton therapy for cavernous sinus meningiomas. Fifty-one patients had biopsy or subtotal resection; 47 had World Health Organization grade 1 pathology. Twenty-one patients had no histologic verification. Twenty-two patients received primary proton therapy; 30 had 1 previous surgery; 20 had more than 1 surgery. The mean gross tumor volume was 27.6 cm{sup 3}; mean clinical target volume was 52.9 cm{sup 3}. Median totalmore » doses for patients with and without histologic verification were 59 and 57 Gy, respectively. Mean and median follow-up periods were 74 months. Results: The overall 5-year actuarial control rate was 96%; the control rate was 99% in patients with grade 1 or absent histologic findings and 50% for those with atypical histology. All 21 patients who did not have histologic verification and 46 of 47 patients with histologic confirmation of grade 1 tumor demonstrated disease control at 5 years. Control rates for patients without previous surgery, 1 surgery, and 2 or more surgeries were 95%, 96%, and 95%, respectively. Conclusions: Fractionated proton radiotherapy for grade 1 cavernous sinus meningiomas achieves excellent control rates with minimal toxicities, regardless of surgical intervention or use of histologic diagnosis. Disease control for large lesions can be achieved by primary fractionated proton therapy.« less

History of the development of radiotherapy in Latin America.

PubMed

Pinillos, Luis; Pinto, Joseph A; Sarria, Gustavo

2017-01-01

Radiotherapy was the first nonsurgical treatment for malignant tumours and represents one of the oldest disciplines of oncology. In Latin America, as in many parts of the world, the history of modern oncology begins with the implementation of radiation therapy facilities. The development of radiotherapy in Latin America was possible thanks to the seminal work of radiation oncologists in different countries. As a large territory, there is a need to implement modern facilities and equipment, but unfortunately there are disparities in the access and quality of radiotherapy services across Latin America and even within individual countries. In this review, we describe the history, challenges and success in the implementation of radiotherapy and the frustration caused by the lack of facilities in several Latin American countries.

Is Adaptive Treatment Planning Required for Stereotactic Radiotherapy of Stage I Non-Small-Cell Lung Cancer?

DOE Office of Scientific and Technical Information (OSTI.GOV)

Haasbeek, Cornelis J.A.; Lagerwaard, Frank J.; Cuijpers, Johan P.

2007-04-01

Purpose: Changes in position or size of target volumes have been observed during radiotherapy for lung cancer. The need for adaptive treatment planning during stereotactic radiotherapy of Stage I tumors was retrospectively analyzed using repeat four-dimensional computed tomography (4DCT) scans. Methods and Materials: A planning study was performed for 60 tumors in 59 patients using 4DCT scans repeated after two or more treatment fractions. Planning target volumes (PTV) encompassed all tumor mobility, and dose distributions from the initial plan were projected onto PTVs derived from the repeat 4DCT. A dosimetric and volumetric analysis was performed. Results: The repeat 4DCT scansmore » were performed at a mean of 6.6 days (range, 2-12 days) after the first fraction of stereotactic radiotherapy. In 25% of cases the repeat PTV was larger, but the difference exceeded 1 mL in 5 patients only. The mean 3D displacement between the center of mass of both PTVs was 2.0 mm. The initial 80% prescription isodose ensured a mean coverage of 98% of repeat PTVs, and this isodose fully encompassed the repeat internal target volumes in all but 1 tumor. 'Inadequate' coverage in the latter was caused by a new area of atelectasis adjacent to the tumor on the repeat 4DCT. Conclusions: Limited 'time trends' were observed in PTVs generated by repeated uncoached 4DCT scans, and the dosimetric consequences proved to be minimal. Treatment based only on the initial PTV would not have resulted in major tumor underdosage, indicating that adaptive treatment planning is of limited value for fractionated stereotactic radiotherapy.« less

LHC: The Large Hadron Collider

ScienceCinema

Lincoln, Don

2018-01-16

The Large Hadron Collider (or LHC) is the world’s most powerful particle accelerator. In 2012, scientists used data taken by it to discover the Higgs boson, before pausing operations for upgrades and improvements. In the spring of 2015, the LHC will return to operations with 163% the energy it had before and with three times as many collisions per second. It’s essentially a new and improved version of itself. In this video, Fermilab’s Dr. Don Lincoln explains both some of the absolutely amazing scientific and engineering properties of this modern scientific wonder.

Microcystic adnexal carcinoma following radiotherapy in childhood

DOE Office of Scientific and Technical Information (OSTI.GOV)

Borenstein, A.; Seidman, D.S.; Trau, H.

1991-04-01

A 36-year-old man was treated by radiotherapy for tinea capitis many years before discovery of microcystic adnexal carcinoma (MAC). Because of patient's refusal of any surgical intervention, we were able to follow the natural course of this tumor for 13 years. This case emphasizes the typical slow development of (MAC). The implication of the association of MAC and radiotherapy are discussed.

Hadron production measurements for neutrino physics

DOE Office of Scientific and Technical Information (OSTI.GOV)

Panman, Jaap

2008-02-21

One of the limiting factors for the precision of neutrino oscillation experiments is the uncertainty in the composition and spectrum of the neutrino flux. Recently, dedicated hadron production experiments have been taking data and are being planned to supply measurements which can significantly reduce these uncertainties. The HARP experiment has presented results on the measurements of the double-differential production cross-section of charged pions in proton interactions with beryllium, carbon, aluminium, copper, tin, tantalum and lead targets. These results are relevant for a detailed understanding of neutrino flux in accelerator neutrino experiments K2K (p-Al data) and MiniBooNE/SciBooNE (p-Be data), for amore » better prediction of atmospheric neutrino fluxes (p-C, {pi}{sup +}-C and {pi}{sup -}-C data) as well as for a systematic improvement of hadron production models. The E910 experiment at BNL has recently published their p-Be data. NA49 has measured pion production spectra in p-C interactions and a new experiment, NA61, is starting to take data using essentially the same detector. NA61 plans to measure production spectra for the T2K experiment and for the calculation of extended air showers. MIPP has taken data with a copy of the NuMI target and is progressing in the analysis of these data. An upgrade of the readout of this experiment can greatly increase its potential.« less

Large Hadron Collider commissioning and first operation.

PubMed

Myers, S

2012-02-28

A history of the commissioning and the very successful early operation of the Large Hadron Collider (LHC) is described. The accident that interrupted the first commissioning, its repair and the enhanced protection system put in place are fully described. The LHC beam commissioning and operational performance are reviewed for the period from 2010 to mid-2011. Preliminary plans for operation and future upgrades for the LHC are given for the short and medium term.

Hadronic expansion dynamics in central Pb+Pb collisions at 158 GeV per nucleon

DOE PAGES

Appelshäuser, H.

1998-03-24

Two-particle correlation functions of negative hadrons over wide phase space, and transverse mass spectra of negative hadrons and deuterons near mid-rapidity have been measured in central Pb+Pb collisions at 158 GeV per nucleon by the NA49 experiment at the CERN SPS. A novel Coulomb correction procedure for the negative two-particle correlations is employed making use of the measured oppositely charged particle correlation. Within an expanding source scenario these results are used to extract the dynamic characteristics of the hadronic source, resolving the ambiguities between the temperature and transverse expansion velocity of the source, that are unavoidable when single and twomore » particle spectra are analysed separately. Lastly, the source shape, the total duration of the source expansion, the duration of particle emission, the freeze-out temperature and the longitudinal and transverse expansion velocities are deduced.« less

Light flavour hadron production in pp collisions at \\sqrt{s} = 13 TeV with ALICE

NASA Astrophysics Data System (ADS)

Tonatiuh Jiménez Bustamante, Raúl; ALICE Collaboration

2017-04-01

The ALICE detector has excellent Particle IDentification (PID) capabilities in the central barrel (|η| < 0.9). This allows identified hadron production to be measured over a wide transverse momentum (pT) range, using different sub-detectors and techniques: their specific energy loss (dE/dx), the velocity determination via time-of-flight measurement, the Cherenkov angle or their characteristic weak decay topology. Results on identified light flavour hadron production at mid-rapidity measured by ALICE in proton-proton collisions at \\sqrt{s} = 13 TeV are presented and compared with previous measurements performed at lower energies. The results cover a wide range of particle species including long-lived hadrons, resonances and multi-strange baryons over the pT range from 150 MeV/c up to 20 GeV/c, depending on the particle species.

Integer programming for improving radiotherapy treatment efficiency.

PubMed

Lv, Ming; Li, Yi; Kou, Bo; Zhou, Zhili

2017-01-01

Patients received by radiotherapy departments are diverse and may be diagnosed with different cancers. Therefore, they need different radiotherapy treatment plans and thus have different needs for medical resources. This research aims to explore the best method of scheduling the admission of patients receiving radiotherapy so as to reduce patient loss and maximize the usage efficiency of service resources. A mix integer programming (MIP) model integrated with special features of radiotherapy is constructed. The data used here is based on the historical data collected and we propose an exact method to solve the MIP model. Compared with the traditional First Come First Served (FCFS) method, the new method has boosted patient admission as well as the usage of linear accelerators (LINAC) and beds. The integer programming model can be used to describe the complex problem of scheduling radio-receiving patients, to identify the bottleneck resources that hinder patient admission, and to obtain the optimal LINAC-bed radio under the current data conditions. Different management strategies can be implemented by adjusting the settings of the MIP model. The computational results can serve as a reference for the policy-makers in decision making.

Radiotherapy for breast cancer: The predictable consequences of an unmet need.

PubMed

Rodin, Danielle; Knaul, Felicia M; Lui, Tracey Y; Gospodarowicz, Mary

2016-10-01

Radiotherapy has had a transformative impact on the treatment of breast cancer, but is unavailable to the majority of breast cancer patients in low- and middle-income countries. In these settings, where many women present with advanced disease at an age when they are often the primary caregiver for their families, the lack of access to radiotherapy is particularly devastating. Until recently, this disparity has been largely neglected in the medical literature and it had been difficult to convince governments, industry, and policymakers of the importance of investing in radiotherapy, as well as broader cancer control strategies, in low-resource settings. The Lancet Radiotherapy Commission report published in 2015 challenged many assumptions about the affordability of radiotherapy treatment. Data from the Commission is presented here to support radiotherapy investment for breast cancer and discuss how the morbidity and premature mortality among adult women caused by breast cancer has a huge detrimental effect on both the health sector and the economy. Copyright © 2016. Published by Elsevier Ltd.

Spectra of hadrons and muons in the atmosphere: primary spectra, characteristics of hadron-air interactions

NASA Astrophysics Data System (ADS)

Yushkov, A. V.; Lagutin, A. A.

2008-01-01

Self-consistency of interaction models QGSJET 01, SIBYLL 2.1, NEXUS 3.97 and QGSJET II is checked in terms of their ability to reproduce simultaneously experimental data on fluxes of muons and hadrons. From this point of view SIBYLL 2.1 gives the most acceptable, though not quite satisfactory, results. Analysis of the situation for muons supports our previous conclusions, that the high-energy muon deficit is due both to underestimation of primary light nuclei fluxes in direct emulsion chamber experiments and to softness of p+A→π, K+X inclusive spectra in fragmentation region, especially prominent in case of QGSJET 01 model.